<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40746702</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2836-9386</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>NEJM AI</Title><ISOAbbreviation>NEJM AI</ISOAbbreviation></Journal><ArticleTitle>AI Opportunistic Coronary Calcium Screening at Veterans Affairs Hospitals.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1056/aioa2400937</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronary artery calcium (CAC) is highly predictive of cardiovascular events. Although millions of chest computed tomography (CT) scans are performed annually in the United States, CAC is not routinely quantified from scans done for noncardiac purposes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a deep learning algorithm, AI-CAC, using 446 expert segmentations to automatically quantify CAC on noncontrast, nongated CT scans. Our study differs from prior works by utilizing imaging data from 98 medical centers across the Veterans Affairs national health care system, capturing extensive heterogeneity in imaging protocols, scanners, and patients. AI-CAC performance on nongated scans was compared against clinical standard electrocardiogram (ECG)-gated CAC scoring in 795 patients with paired gated scans within 1 year of their nongated scan. In addition, the model was tested on 8052 low-dose CTs (LDCTs) to simulate opportunistic CAC screening.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nongated AI-CAC differentiated zero versus nonzero and less than 100 versus 100 or greater Agatston scores with accuracies of 89.4% (F1 0.93) and 87.3% (F1 0.89), respectively. Nongated AI-CAC was predictive of 10-year all-cause mortality (CAC 0 vs. &gt;400 group: 25.4% vs. 60.2%, Cox hazard ratio 3.49; P&lt;0.005), and composite first-time stroke, myocardial infarction, or death (CAC 0 vs. &gt;400 group: 33.5% vs. 63.8%, Cox hazard ratio 3.00; P&lt;0.005). In the LDCT dataset, 3091 out of 8052 (38.4%) individuals had AI-CAC scores &gt;400. Four cardiologists qualitatively reviewed a random sample of the &gt;400 AI-CAC LDCT patients and verified that 527 of the 531 (99.2%) would benefit from lipid-lowering therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This nongated CT CAC algorithm was developed across a national health care system and shows strong performance in evaluation against paired gated CT scans. The model code and weights are available at https://github.com/Raffi-Hagopian/AI-CAC/. (Funded by the Veterans Affairs health care system.).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagopian</LastName><ForeName>Raffi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0004-6118-4832</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strebel</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0003-3962-5366</Identifier><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernatz</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7758-8100</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0009-0008-8904-3467</Identifier><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Offerman</LastName><ForeName>Erik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8196-8675</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuniga</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0004-5482-343X</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cy Y</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-5514-1244</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Angie T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0009-0002-0573-3644</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwaz</LastName><ForeName>James A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0009-0008-1073-8777</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfc;rnberg</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6544-4268</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sunny P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0009-0006-7853-8443</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>Evan P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0001-7963-6818</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, University of Colorado School of Public Health, Denver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0009-0001-9266-7229</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>R Spencer</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0009-0006-6824-1056</Identifier><AffiliationInfo><Affiliation>Medical Informatics Data Science and Emerging Technology (MinDSET), Veterans Affairs Kansas City Healthcare System, Kansas City, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jeannie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9043-8791</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentili</LastName><ForeName>Amilcare</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5623-7512</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Veterans Affairs San Diego Healthcare System, San Diego, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of California, San Diego, San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aerts</LastName><ForeName>Hugo J W L</ForeName><Initials>HJWL</Initials><Identifier Source="ORCID">0000-0002-2122-2003</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VA999999</GrantID><Acronym>ImVA</Acronym><Agency>Intramural VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>NEJM AI</MedlineTA><NlmUniqueID>9918752186406676</NlmUniqueID><ISSNLinking>2836-9386</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40746702</ArticleId><ArticleId IdType="mid">NIHMS2096765</ArticleId><ArticleId IdType="pmc">PMC12311810</ArticleId><ArticleId IdType="doi">10.1056/aioa2400937</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McEvoy JW, Blaha MJ, DeFilippis AP, et al. Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 2010;56:1613&#x2013;1622. DOI: 10.1016/j.jacc.2010.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.06.038</ArticleId><ArticleId IdType="pubmed">21050970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen MB, Nordestgaard BG. Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat. JAMA Cardiol 2019;4:1131&#x2013;1138. DOI: 10.1001/jamacardio.2019.3665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.3665</ArticleId><ArticleId IdType="pmc">PMC6777225</ArticleId><ArticleId IdType="pubmed">31577339</ArticleId></ArticleIdList></Reference><Reference><Citation>Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827&#x2013;832. DOI: 10.1016/0735-1097(90)90282-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(90)90282-T</ArticleId><ArticleId IdType="pubmed">2407762</ArticleId></ArticleIdList></Reference><Reference><Citation>Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336&#x2013;1345. DOI: 10.1056/NEJMoa072100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa072100</ArticleId><ArticleId IdType="pubmed">18367736</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596&#x2013;e646. DOI: 10.1161/CIR.0000000000000678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000678</ArticleId><ArticleId IdType="pmc">PMC7734661</ArticleId><ArticleId IdType="pubmed">30879355</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Zhao Y, de Bock GH, et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging 2013;6:514&#x2013;521. DOI: 10.1161/CIRCIMAGING.113.000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.000092</ArticleId><ArticleId IdType="pubmed">23756678</ArticleId></ArticleIdList></Reference><Reference><Citation>Takx RAP, de Jong PA, Leiner T, et al. Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability. PLoS One 2014;9:e91239. DOI: 10.1371/journal.pone.0091239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091239</ArticleId><ArticleId IdType="pmc">PMC3953377</ArticleId><ArticleId IdType="pubmed">24625525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Espinosa C, Gonz&#xe1;lez G, Washko GR, Cazorla M, Est&#xe9;par RS. Automated Agatston score computation in non-ECG gated CT scans using deep learning. Proc SPIE Int Soc Opt Eng 2018;10574:105742K. DOI: 10.1117/12.2293681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.2293681</ArticleId><ArticleId IdType="pmc">PMC6095680</ArticleId><ArticleId IdType="pubmed">30122801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeleznik R, Foldyna B, Eslami P, et al. Deep convolutional neural networks to predict cardiovascular risk from computed tomography. Nat Commun 2021;12:715. DOI: 10.1038/s41467-021-20966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-20966-2</ArticleId><ArticleId IdType="pmc">PMC7846726</ArticleId><ArticleId IdType="pubmed">33514711</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng D, Chute C, Khandwala N, et al. Automated coronary calcium scoring using deep learning with multicenter external validation. NPJ Digit Medi 2021;4:88. DOI: 10.1038/s41746-021-00460-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00460-1</ArticleId><ArticleId IdType="pmc">PMC8169744</ArticleId><ArticleId IdType="pubmed">34075194</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieszko K, Shanbhag A, Killekar A, et al. Deep learning of coronary calcium scores from PET/CT attenuation maps accurately predicts adverse cardiovascular events. Cardiovasc Imaging 2023;16:675&#x2013;687. DOI: 10.1016/j.jcmg.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.06.006</ArticleId><ArticleId IdType="pubmed">36284402</ArticleId></ArticleIdList></Reference><Reference><Citation>van Velzen SGM, Lessmann N, Velthuis BK, et al. Deep learning for automatic calcium scoring in CT: validation using multiple cardiac CT and chest CT protocols. Radiology 2020;295:66&#x2013;79. DOI: 10.1148/radiol.2020191621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020191621</ArticleId><ArticleId IdType="pmc">PMC7106943</ArticleId><ArticleId IdType="pubmed">32043947</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman K, Shiyovich A, Huck DM, et al. Artificial intelligence in coronary artery calcium scoring detection and quantification. Diagnostics 2024;14:125. DOI: 10.3390/diagnostics14020125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14020125</ArticleId><ArticleId IdType="pmc">PMC10814920</ArticleId><ArticleId IdType="pubmed">38248002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu AT, Rodriguez F, Ngo S, et al. Incidental coronary artery calcium: opportunistic screening of previous nongated chest computed tomography scans to improve statin rates (NOTIFY-1 project). Circulation 2023;147:703&#x2013;714. DOI: 10.1161/CIRCULATIONAHA.122.062746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062746</ArticleId><ArticleId IdType="pmc">PMC10108579</ArticleId><ArticleId IdType="pubmed">36342823</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Veterans Affairs. Veterans Health Administration. About VHA. January
20, 2025.  (https://www.va.gov/health/aboutvha.asp).</Citation></Reference><Reference><Citation>Gassett AJ, Sheppard L, McClelland RL, et al. Risk factors for long-term coronary artery calcium progression in the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2015;4:e001726. DOI: 10.1161/JAHA.114.001726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.001726</ArticleId><ArticleId IdType="pmc">PMC4599452</ArticleId><ArticleId IdType="pubmed">26251281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 2012;30:1323&#x2013;1341. DOI: 10.1016/j.mri.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2012.05.001</ArticleId><ArticleId IdType="pmc">PMC3466397</ArticleId><ArticleId IdType="pubmed">22770690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatamizadeh A, Nath V, Tang Y, Yang D, Roth HR, Xu D. Swin UNETR: swin transformers for semantic segmentation of brain tumors in MRI images. In: International MICCAI Brainlesion Workshop, September 22&#x2013;27, 2021. Cham: Springer International Publishing, 2021:272&#x2013;284.</Citation></Reference><Reference><Citation>Ronneberger O, Fischer P, Brox T. U-net: convolutional networks for biomedical image segmentation. In Medical Image Computing and Computer-Assisted Intervention &#x2014; MICCAI 2015: 18th International Conference, Munich, Germany, October 5&#x2013;9, 2015, Proceedings, Part III. Cham: Springer International Publishing, 2015:234&#x2013;241.</Citation></Reference><Reference><Citation>Paszke A, Gross S, Massa F, et al. PyTorch: an imperative style, high-performance deep learning library. December 3, 2019. ( 10.48550/arXiv.1912.01703). Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1912.01703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso MJ, Li W, Brown R, et al. Monai: an open-source framework for deep learning in healthcare. November 4, 2022 ( 10.48550/arXiv.2211.02701). Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2211.02701</ArticleId></ArticleIdList></Reference><Reference><Citation>van Assen M, Martin SS, Varga-Szemes A, et al. Automatic coronary calcium scoring in chest CT using a deep neural network in direct comparison with non-contrast cardiac CT: a validation study. Eur J Radiol 2021;134:109428. DOI: 10.1016/j.ejrad.2020.109428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109428</ArticleId><ArticleId IdType="pubmed">33285350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Liu J, Guo N, et al. Performance of artificial intelligence-based coronary artery calcium scoring in non-gated chest CT. Eur J Radiol 2021;145:110034. DOI: 10.1016/j.ejrad.2021.110034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2021.110034</ArticleId><ArticleId IdType="pubmed">34837795</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Guo H, Xu M, et al. Automatic coronary artery calcium scoring on routine chest computed tomography (CT): comparison of a deep learning algorithm and a dedicated calcium scoring CT. Quant Imaging Med Surg 2022;12:2684&#x2013;2695. DOI: 10.21037/qims-21-1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-21-1017</ArticleId><ArticleId IdType="pmc">PMC9014138</ArticleId><ArticleId IdType="pubmed">35502379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol 2018;72:1141&#x2013;1156. DOI: 10.1016/j.jacc.2018.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.06.046</ArticleId><ArticleId IdType="pubmed">30165986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40603582</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-0590</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Nature cardiovascular research</Title><ISOAbbreviation>Nat Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Multimodal AI to forecast arrhythmic death in hypertrophic cardiomyopathy.</ArticleTitle><Pagination><StartPage>891</StartPage><EndPage>903</EndPage><MedlinePgn>891-903</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s44161-025-00679-1</ELocationID><Abstract><AbstractText>Sudden cardiac death from ventricular arrhythmias is a leading cause of mortality worldwide. Arrhythmic death prognostication is challenging in patients with hypertrophic cardiomyopathy (HCM), a setting where current clinical guidelines show low performance and inconsistent accuracy. Here, we present a deep learning approach, MAARS (Multimodal Artificial intelligence for ventricular Arrhythmia Risk Stratification), to forecast lethal arrhythmia events in patients with HCM by analyzing multimodal medical data. MAARS' transformer-based neural networks learn from electronic health records, echocardiogram and radiology reports, and contrast-enhanced cardiac magnetic resonance images, the latter being a unique feature of this model. MAARS achieves an area under the curve of 0.89 (95% confidence interval (CI) 0.79-0.94) and 0.81 (95% CI 0.69-0.93) in internal and external cohorts and outperforms current clinical guidelines by 0.27-0.35 (internal) and 0.22-0.30 (external). In contrast to clinical guidelines, it demonstrates fairness across demographic subgroups. We interpret MAARS' predictions on multiple levels to promote artificial intelligence transparency and derive risk factors warranting further investigation.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Changxin</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3585-5979</Identifier><AffiliationInfo><Affiliation>Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Minglang</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-7861-350X</Identifier><AffiliationInfo><Affiliation>Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kholmovski</LastName><ForeName>Eugene G</ForeName><Initials>EG</Initials><Identifier Source="ORCID">0000-0002-3271-7247</Identifier><AffiliationInfo><Affiliation>Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Popescu</LastName><ForeName>Dan M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Dai-Yin</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherer</LastName><ForeName>Erica</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0003-7458-4328</Identifier><AffiliationInfo><Affiliation>Sanger Heart &amp; Vascular Institute, Atrium Health, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binka</LastName><ForeName>Edem</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Pediatric Cardiology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmerman</LastName><ForeName>Stefan L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0002-9422-6742</Identifier><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chrispin</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hays</LastName><ForeName>Allison G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0003-2138-1589</Identifier><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phelan</LastName><ForeName>Dermot M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Sanger Heart &amp; Vascular Institute, Atrium Health, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>M Roselle</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Hypertrophic Cardiomyopathy Center of Excellence, Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trayanova</LastName><ForeName>Natalia A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-8661-063X</Identifier><AffiliationInfo><Affiliation>Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA. ntrayanova@jhu.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. ntrayanova@jhu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL166759</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL174440</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>R01HL166759</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>R01 HL174440</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35HL1431598</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Cardiovasc Res</MedlineTA><NlmUniqueID>9918284280206676</NlmUniqueID><ISSNLinking>2731-0590</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="Y">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="Y">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003661" MajorTopicYN="Y">Decision Support Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="N">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064847" MajorTopicYN="Y">Multimodal Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>3</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>23</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40603582</ArticleId><ArticleId IdType="pmc">PMC12259465</ArticleId><ArticleId IdType="doi">10.1038/s44161-025-00679-1</ArticleId><ArticleId IdType="pii">10.1038/s44161-025-00679-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fishman, G. I. et al. Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. <i>Circulation</i><b>122</b>, 2335&#x2013;2348 (2010).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3016224</ArticleId><ArticleId IdType="pubmed">21147730</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag, A. S., Luepker, R. V., Roger, V. L. &amp; Gersh, B. J. Sudden cardiac death: epidemiology and risk factors. <i>Nat. Rev. Cardiol.</i><b>7</b>, 216&#x2013;225 (2010).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5014372</ArticleId><ArticleId IdType="pubmed">20142817</ArticleId></ArticleIdList></Reference><Reference><Citation>John, R. M. et al. Ventricular arrhythmias and sudden cardiac death. <i>Lancet</i><b>380</b>, 1520&#x2013;1529 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23101719</ArticleId></ArticleIdList></Reference><Reference><Citation>Rea, T. D. &amp; Page, R. L. Community approaches to improve resuscitation after out-of-hospital sudden cardiac arrest. <i>Circulation</i><b>121</b>, 1134&#x2013;1140 (2010).
</Citation><ArticleIdList><ArticleId IdType="pubmed">20212292</ArticleId></ArticleIdList></Reference><Reference><Citation>Estes, N. A. M. 3rd Predicting and preventing sudden cardiac death. <i>Circulation</i><b>124</b>, 651&#x2013;656 (2011).
</Citation><ArticleIdList><ArticleId IdType="pubmed">21810674</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant, F. M., Levy, W. C. &amp; Kramer, D. B. Time to shock the system: moving beyond the current paradigm for primary prevention implantable cardioverter-defibrillator use. <i>J. Am. Heart Assoc.</i><b>9</b>, e015139 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335546</ArticleId><ArticleId IdType="pubmed">32089058</ArticleId></ArticleIdList></Reference><Reference><Citation>Merchant, F. M., Jones, P., Wehrenberg, S., Lloyd, M. S. &amp; Saxon, L. A. Incidence of defibrillator shocks after elective generator exchange following uneventful first battery life. <i>J. Am. Heart Assoc.</i><b>3</b>, e001289 (2014).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338723</ArticleId><ArticleId IdType="pubmed">25385346</ArticleId></ArticleIdList></Reference><Reference><Citation>Semsarian, C., Ingles, J., Maron, M. S. &amp; Maron, B. J. New perspectives on the prevalence of hypertrophic cardiomyopathy. <i>J. Am. Coll. Cardiol.</i><b>65</b>, 1249&#x2013;1254 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron, B. J. et al. Management of hypertrophic cardiomyopathy: <i>JACC</i> state-of-the-art review. <i>J. Am. Coll. Cardiol.</i><b>79</b>, 390&#x2013;414 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">35086661</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron, B. J. et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults. <i>Circulation</i><b>92</b>, 785&#x2013;789 (1995).
</Citation><ArticleIdList><ArticleId IdType="pubmed">7641357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahluwalia, M., Kpodonu, J. &amp; Agu, E. Risk stratification in hypertrophic cardiomyopathy: leveraging artificial intelligence to provide guidance in the future. <i>JACC Adv.</i><b>2</b>, 100562 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11198167</ArticleId><ArticleId IdType="pubmed">38939491</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;rjesson, E., Svennblad, B., Wisten, A., B&#xf6;rjesson, M. &amp; Stattin, E.-L. Symptoms and ECG changes precede sudden cardiac death in hypertrophic cardiomyopathy&#x2014;a nationwide study among the young in Sweden. <i>PLoS ONE</i><b>17</b>, e0273567 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9473420</ArticleId><ArticleId IdType="pubmed">36103477</ArticleId></ArticleIdList></Reference><Reference><Citation>Cal&#xf2;, L. et al. The value of the 12-lead electrocardiogram in the prediction of sudden cardiac death. <i>Eur. Heart J. Suppl.</i><b>25</b>, C218&#x2013;C226 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10132628</ArticleId><ArticleId IdType="pubmed">37125292</ArticleId></ArticleIdList></Reference><Reference><Citation>van Velzen, H. G. et al. Value of genetic testing for the prediction of long-term outcome in patients with hypertrophic cardiomyopathy. <i>Am. J. Cardiol.</i><b>118</b>, 881&#x2013;887 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27476098</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernesniemi, J. A. et al. Predicting sudden cardiac death using common genetic risk variants for coronary artery disease. <i>Eur. Heart J.</i><b>36</b>, 1669&#x2013;1675 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25908775</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, L. et al. Genetic variants associated with unexplained sudden cardiac death in adult white and African American individuals. <i>JAMA Cardiol.</i><b>6</b>, 1013&#x2013;1022 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8173469</ArticleId><ArticleId IdType="pubmed">34076677</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto, J. B. et al. Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test&#x2013;retest performance. <i>Lancet Digit. Health</i><b>3</b>, e20&#x2013;e28 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33735065</ArticleId></ArticleIdList></Reference><Reference><Citation>Navidi, Z. et al. Interpretable machine learning for automated left ventricular scar quantification in hypertrophic cardiomyopathy patients. <i>PLOS Digit. Health</i><b>2</b>, e0000159 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931226</ArticleId><ArticleId IdType="pubmed">36812626</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubenbacher, R., Mehrad, B., Shmulevich, I. &amp; Trayanova, N. Digital twins in medicine. <i>Nat. Comput. Sci.</i><b>4</b>, 184&#x2013;191 (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11102043</ArticleId><ArticleId IdType="pubmed">38532133</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Hara, R. P. et al. Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy. <i>eLife</i><b>11</b>, e73325 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789259</ArticleId><ArticleId IdType="pubmed">35076018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochav, S. M. et al. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. <i>Int. J. Cardiol.</i><b>327</b>, 117&#x2013;124 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33181159</ArticleId></ArticleIdList></Reference><Reference><Citation>Smole, T. et al. A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy. <i>Comput. Biol. Med.</i><b>135</b>, 104648 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34280775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya, M. et al. Identifying ventricular arrhythmias and their predictors by applying machine learning methods to electronic health records in patients with hypertrophic cardiomyopathy (HCM-VAr-Risk Model). <i>Am. J. Cardiol.</i><b>123</b>, 1681&#x2013;1689 (2019).
</Citation><ArticleIdList><ArticleId IdType="pubmed">30952382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, K. et al. Machine learning in hypertrophic cardiomyopathy: nonlinear model from clinical and CMR features predicting cardiovascular events. <i>JACC Cardiovasc. Imaging</i><b>17</b>, 880&#x2013;893 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">39001729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolk, M. Z. H. et al. Multimodal explainable artificial intelligence identifies patients with non-ischaemic cardiomyopathy at risk of lethal ventricular arrhythmias. <i>Sci. Rep.</i><b>14</b>, 14889 (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11211323</ArticleId><ArticleId IdType="pubmed">38937555</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen, S. R. et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. <i>Circulation</i><b>142</b>, e558&#x2013;e631 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33215931</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo, E. et al. 2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC). <i>Eur. Heart J.</i><b>44</b>, 3503&#x2013;3626 (2023).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony, C. et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). <i>Eur. Heart J.</i><b>35</b>, 2010&#x2013;2020 (2014).
</Citation><ArticleIdList><ArticleId IdType="pubmed">24126876</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosovitskiy, A. et al. An image is worth 16&#xd7;16 words: transformers for image recognition at scale. In <i>International Conference on Learning Representations 2021</i>https://openreview.net/pdf?id=YicbFdNTTy (2021).</Citation></Reference><Reference><Citation>Nagrani, A. et al. Attention bottlenecks for multimodal fusion. In <i>35th Conference on Neural Information Processing Systems (NeurIPS 2021)</i>https://proceedings.neurips.cc/paper_files/paper/2021/file/76ba9f564ebbc35b1014ac498fafadd0-Paper.pdf (NeurIPS, 2021).</Citation></Reference><Reference><Citation>Corian&#xf2;, M. et al. Deep learning-based prediction of major arrhythmic events in dilated cardiomyopathy: a proof of concept study. <i>PLoS ONE</i><b>19</b>, e0297793 (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10903812</ArticleId><ArticleId IdType="pubmed">38421987</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapley, L. A value for <i>n</i>-person games. <i>Contributions to the Theory of Games II</i> (1953) 307&#x2013;317. In <i>Classics in Game Theory</i> (ed. Kuhn, H. W.) 69&#x2013;79 (Princeton Univ. Press, 1997); 10.1515/9781400829156-012</Citation></Reference><Reference><Citation>O&#x2019;Mahony, C. et al. Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis. <i>Heart</i>10.1136/heartjnl-2018-313700 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">30366935</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, Y. et al. Validation of the 2020 AHA/ACC risk stratification for sudden cardiac death in Chinese patients with hypertrophic cardiomyopathy. <i>Front. Cardiovasc. Med.</i><b>8</b>, 691653 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8415905</ArticleId><ArticleId IdType="pubmed">34485400</ArticleId></ArticleIdList></Reference><Reference><Citation>Zegkos, T. et al. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with hypertrophic cardiomyopathy. <i>Hellenic J. Cardiol.</i><b>63</b>, 15&#x2013;21 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34147674</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahony, C. et al. International external validation study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM). <i>Circulation</i><b>137</b>, 1015&#x2013;1023 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">29191938</ArticleId></ArticleIdList></Reference><Reference><Citation>Vriesendorp, P. A. et al. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy. <i>Circ. Arrhythm. Electrophysiol.</i><b>8</b>, 829&#x2013;835 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25922410</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J. et al. Radiomics analysis derived from LGE-MRI predict sudden cardiac death in participants with hypertrophic cardiomyopathy. <i>Front. Cardiovasc. Med.</i><b>8</b>, 766287 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702805</ArticleId><ArticleId IdType="pubmed">34957254</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu, D. M. et al. Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart. <i>Nat. Cardiovasc. Res.</i><b>1</b>, 334&#x2013;343 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9022904</ArticleId><ArticleId IdType="pubmed">35464150</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta, J. N., Falcone, G. J., Rajpurkar, P. &amp; Topol, E. J. Multimodal biomedical AI. <i>Nat. Med.</i><b>28</b>, 1773&#x2013;1784 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">36109635</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, P. P., Zadeh, A. &amp; Morency, L.-P. Foundations and trends in multimodal machine learning: principles, challenges, and open questions. <i>ACM Comput. Surv.</i>10.1145/3656580 (2024).</Citation></Reference><Reference><Citation>Maron, M. S. et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. <i>N. Engl. J. Med.</i><b>348</b>, 295&#x2013;303 (2003).
</Citation><ArticleIdList><ArticleId IdType="pubmed">12540642</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, D. et al. Clinical outcomes in patients with nonobstructive, labile, and obstructive hypertrophic cardiomyopathy. <i>J. Am. Heart Assoc.</i><b>7</b>, e006657 (2018).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866314</ArticleId><ArticleId IdType="pubmed">29478967</ArticleId></ArticleIdList></Reference><Reference><Citation>Parcharidou, D. et al. The natural history of hypertrophic cardiomyopathy in a large Mediterranean cohort. <i>J. Cardiovasc. Med. (Hagerstown)</i><b>21</b>, 428&#x2013;434 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">32355065</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozios, I. et al. Rest and stress longitudinal systolic left ventricular mechanics in hypertrophic cardiomyopathy: implications for prognostication. <i>J. Am. Soc. Echocardiogr.</i><b>31</b>, 578&#x2013;586 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">29426649</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron, M. S. et al. Contemporary natural history and management of nonobstructive hypertrophic cardiomyopathy. <i>J. Am. Coll. Cardiol.</i><b>67</b>, 1399&#x2013;1409 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27012399</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozios, I. et al. Comparison of outcomes in patients with nonobstructive, labile-obstructive, and chronically obstructive hypertrophic cardiomyopathy. <i>Am. J. Cardiol.</i><b>116</b>, 938&#x2013;944 (2015).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554842</ArticleId><ArticleId IdType="pubmed">26239580</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley, R. D. et al. Evaluation of clinical prediction models (part 3): calculating the sample size required for an external validation study. <i>BMJ</i><b>384</b>, e074821 (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11778934</ArticleId><ArticleId IdType="pubmed">38253388</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinkel, A. F. L. et al. Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis. <i>Circ. Heart Fail.</i><b>5</b>, 552&#x2013;559 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22821634</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahmy, A. S. et al. Radiomics of late gadolinium enhancement reveals prognostic value of myocardial scar heterogeneity in hypertrophic cardiomyopathy. <i>JACC Cardiovasc. Imaging</i><b>17</b>, 16&#x2013;27 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37354155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya, M. et al. Machine learning methods for identifying atrial fibrillation cases and their predictors in patients with hypertrophic cardiomyopathy: the HCM-AF-Risk Model. <i>CJC Open</i><b>3</b>, 801&#x2013;813 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209373</ArticleId><ArticleId IdType="pubmed">34169259</ArticleId></ArticleIdList></Reference><Reference><Citation>Popescu, D. M. et al. Anatomically informed deep learning on contrast-enhanced cardiac magnetic resonance imaging for scar segmentation and clinical feature extraction. <i>Cardiovasc. Digit. Health J.</i>10.1016/j.cvdhj.2021.11.007 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8890075</ArticleId><ArticleId IdType="pubmed">35265930</ArticleId></ArticleIdList></Reference><Reference><Citation>van Buuren, S. &amp; Groothuis-Oudshoorn, K. MICE: multivariate imputation by chained equations in R. <i>J. Stat. Softw.</i><b>45</b>, 1&#x2013;67 (2011).</Citation></Reference><Reference><Citation>Lin, T.-Y., Goyal, P., Girshick, R., He, K. &amp; Doll&#xe1;r, P. Focal loss for dense object detection. <i>IEEE Trans. Pattern Anal. Mach. Intell</i>. 10.1109/TPAMI.2018.2858826 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">30040631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg, S. M. &amp; Lee, S.-I. A unified approach to interpreting model predictions. In <i>31st Conference on Neural Information Processing Systems (NIPS 2017)</i>https://proceedings.neurips.cc/paper_files/paper/2017/file/8a20a8621978632d76c43dfd28b67767-Paper.pdf (2017).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40240132</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-201X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Apr</Month><Day>16</Day></PubDate></JournalIssue><Title>Heart (British Cardiac Society)</Title><ISOAbbreviation>Heart</ISOAbbreviation></Journal><ArticleTitle>Clinical implementation of an AI-enabled ECG for hypertrophic cardiomyopathy detection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">heartjnl-2024-325608</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/heartjnl-2024-325608</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypertrophic cardiomyopathy (HCM) is often underdiagnosed. Artificial intelligence (AI)-based notification of HCM suspicion on a 12-lead ECG has been proposed to assist patient identification and evaluation. However, there has been no study to date to assess clinical implementation of this approach.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In an open-label, multicentre prospective cohort study, Viz HCM (Viz.ai)-an AI-ECG software alerting of suspected HCM-was implemented at five healthcare systems between January and December 2023 to identify patients &gt;18 years of age without prior HCM diagnosis. The coprimary endpoints were the percentage of HCM-suspected cases viewed by users and the types of follow-up actions. Additional outcome measures included the time to follow-up, demographic characteristics of enrolled patients and follow-up outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 145&#x2009;848 patients screened with algorithm-compliant ECGs, 4348 (3%) were alerted for suspected HCM. Users viewed 69% (3017/4348) of AI-suspected HCM cases. 217 patients met the study criteria and were enrolled with broad representation across racial and ethnic groups-including 23% Black, 9% Asian and 12% Hispanic or Latino. Of the enrolled patients, 182 (84%) had an indication for a total of 243 follow-up actions. The median (interquartile) time from ECG to diagnostic imaging indicating HCM was 7.5 (1.0-37.2)&#x2009;days. From the 217 enrolled patients, 17 (7.8%) were newly diagnosed with HCM-8 inpatient and 9 outpatient. During the study, deployment of an optimised algorithm operating point helped reduce the alert percentage of algorithm-screened patients from 4.4% (2097/47868) to 2.3% (2251/97980), p&lt;0.0001, with no difference in the enrolment rate by alerts reviewed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An AI-based ECG device for HCM can be implemented successfully in a variety of clinical workflows to help identify new patients with HCM. Future study is warranted to assess scalability and comparisons to standard of care.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Love</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-7989-2376</Identifier><AffiliationInfo><Affiliation>Viz Ai Inc, San Francisco, California, USA cjlove.mit@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampert</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Mount Sinai Fuster Heart Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huneycutt</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>TriStar Centennial Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musat</LastName><ForeName>Dan L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Valley Hospital, Ridgewood, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Mahek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Methodist Healthcare System of San Antonio Ltd, San Antonio, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enciso</LastName><ForeName>Jorge E Silva</ForeName><Initials>JES</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doherty</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>TriStar Centennial Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentry</LastName><ForeName>James L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>TriStar Centennial Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Methodist Healthcare System of San Antonio Ltd, San Antonio, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Ethan C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Viz Ai Inc, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>Vivek Y</ForeName><Initials>VY</Initials><AffiliationInfo><Affiliation>Mount Sinai Fuster Heart Hospital, New York, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heart</MedlineTA><NlmUniqueID>9602087</NlmUniqueID><ISSNLinking>1355-6037</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiomyopathy, Hypertrophic</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword></KeywordList><CoiStatement>Competing interests: CJL and EC disclose employment with Viz.ai. JL and BD disclose a consulting relationship with Viz.ai.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>21</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40240132</ArticleId><ArticleId IdType="doi">10.1136/heartjnl-2024-325608</ArticleId><ArticleId IdType="pii">heartjnl-2024-325608</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40739597</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-4683</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>Cardiology in review</Title><ISOAbbreviation>Cardiol Rev</ISOAbbreviation></Journal><ArticleTitle>AI-Guided Decision Support in Acute Cardiac Care: From Chest Pain to STEMI.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/CRD.0000000000001016</ELocationID><Abstract><AbstractText>Artificial intelligence (AI) is rapidly transforming the landscape of acute cardiac care, offering novel opportunities to enhance diagnostic accuracy, risk stratification, and clinical decision-making. This literature review explores the current and emerging applications of AI in managing acute cardiovascular conditions, including myocardial infarction, arrhythmias, and heart failure. Methods such as machine learning, deep learning, and natural language processing have demonstrated potential in analyzing electrocardiograms, imaging, electronic health records, and wearable data to support timely and individualized care. Despite encouraging results from retrospective studies and pilot implementations, several barriers hinder broader clinical integration. Key limitations include data quality issues, lack of model transparency, clinician skepticism, regulatory uncertainties, and concerns about equity and bias. The review emphasizes the need for prospective validation, interpretability, workflow integration, and interdisciplinary collaboration to ensure safe and effective deployment. Future directions include the development of multimodal and foundation models, AI-enabled point-of-care tools, and frameworks for bias mitigation and regulatory oversight. As AI technologies evolve, their sustainable and ethical implementation will be essential to achieving meaningful improvements in patient outcomes and health system efficiency.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Hadrian Hoang-Vu</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thu</LastName><ForeName>Audrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Touro College of Osteopathic Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twayana</LastName><ForeName>Anu Radha</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Texas Tech University Health Sciences Center at Permian Basin, Odessa, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuertes</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basta</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Krutagni Adwait</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Maggie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Internal Medicine, Hackensack University Medical Center-Palisades Medical Center, North Bergen, NJ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frishman</LastName><ForeName>Wiliam H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Medicine, New York Medical College, Valhalla, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aronow</LastName><ForeName>Wilbert S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Departments of Cardiology and Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cardiol Rev</MedlineTA><NlmUniqueID>9304686</NlmUniqueID><ISSNLinking>1061-5377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute cardiac care</Keyword><Keyword MajorTopicYN="N">algorithmic bias</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiovascular diagnostics</Keyword><Keyword MajorTopicYN="N">clinical decision support</Keyword><Keyword MajorTopicYN="N">health equity</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">real-time monitoring</Keyword></KeywordList><CoiStatement>Disclosures: The authors have no conflicts of interest to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40739597</ArticleId><ArticleId IdType="doi">10.1097/CRD.0000000000001016</ArticleId><ArticleId IdType="pii">00045415-990000000-00562</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kuhlman J, Moorhead D, Kerpchar J, et al. Clinical transformation through change management case study: chest pain in the emergency department. EClinicalMedicine. 2019;10:78&#x2013;83.</Citation></Reference><Reference><Citation>Sweeney M, Bleeze G, Storey S, et al. The impact of an acute chest pain pathway on the investigation and management of cardiac chest pain. Future Healthc J. 2020;7:53&#x2013;59.</Citation></Reference><Reference><Citation>Shamaki GR, Safiriyu I, Antia A, et al. Prevalence, predictors, and in-hospital outcomes of ST-elevation myocardial infarction among young adults without traditional cardiovascular risk factors in the United States. Am Heart J Plus. 2024;43:100408.</Citation></Reference><Reference><Citation>Akbar H, Mountfort S. Acute ST-Segment Elevation Myocardial Infarction (STEMI); 2025.</Citation></Reference><Reference><Citation>Latifi AN, Akram A, Dengle S, et al. Use of guideline-directed medical therapy in patients with ST-elevation myocardial infarction. Cureus. 2020;12:e9398.</Citation></Reference><Reference><Citation>Yukselen Z, Majmundar V, Dasari M, et al. Chest pain risk stratification in the emergency department: current perspectives. Open Access Emerg Med. 202443;Volume 16:29&#x2013;43.</Citation></Reference><Reference><Citation>Tzimas G, Antiochos P, Monney P, et al. Atypical electrocardiographic presentations in need of primary percutaneous coronary intervention. Am J Cardiol. 2019;124:1305&#x2013;1314.</Citation></Reference><Reference><Citation>Schmitz T, Wein B, Raake P, et al. Do patients with diabetes with new onset acute myocardial infarction present with different symptoms than non-diabetic patients? Front Cardiovasc Med. 2024;11:1324451.</Citation></Reference><Reference><Citation>Patibandla S, Gupta K, Alsayouri K. Cardiac biomarkers. In: StatPearls [Internet]. StatPearls Publishing; 2025.</Citation></Reference><Reference><Citation>Wang J, Gao W, Chen G, et al.; BIPass Investigators. Biomarker-based risk model to predict cardiovascular events in patients with acute coronary syndromes&#x2014;results from BIPass registry. Lancet Reg Health West Pac. 2022;25:100479.</Citation></Reference><Reference><Citation>Miranda DF, Lobo AS, Walsh B, et al. New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardial infarction in the emergency department. Can J Cardiol. 2018;34:132&#x2013;145.</Citation></Reference><Reference><Citation>Alrawashdeh A, Ihtoub S, Alkhatib ZI, et al. Prehospital ECG interpretation methods for ST-Elevation MI detection and catheterization laboratory activation: a systematic review and meta-analysis. Arch Acad Emerg Med. 2025;13:e47.</Citation></Reference><Reference><Citation>Sadr H, Nazari M, Khodaverdian Z, et al. Unveiling the potential of artificial intelligence in revolutionizing disease diagnosis and prediction: a comprehensive review of machine learning and deep learning approaches. Eur J Med Res. 2025;30:418.</Citation></Reference><Reference><Citation>Herman R, Meyers HP, Smith SW, et al. International evaluation of an artificial intelligence&#x2013;powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health. 2024;5:123&#x2013;133.</Citation></Reference><Reference><Citation>Lee MS, Shin TG, Lee Y, et al.; ROMIAE Study Group. Artificial intelligence applied to electrocardiogram to rule out acute myocardial infarction: the ROMIAE multicentre study. Eur Heart J. 2025;46:1917&#x2013;1929.</Citation></Reference><Reference><Citation>Baker PO, Karim SR, Smith SW, et al. Artificial intelligence driven prehospital ECG interpretation for the reduction of false positive emergent cardiac catheterization lab activations: a retrospective cohort study. Prehosp Emerg Care. 2025;29:218&#x2013;226.</Citation></Reference><Reference><Citation>Singh A, Museedi AS, Grossman SA. Acute coronary syndrome. In: StatPearls [Internet]. StatPearls Publishing; 2025.</Citation></Reference><Reference><Citation>Siregar F, Sari D. Comparison of immature platelet fraction (IPF) values for ACS patients with unstable angina pectoris (UAP), non-ST elevation myocardial infarct (NSTEMI), and ST elevation myocardial infarct (STEMI). Biosci Med. 2024;8:5015&#x2013;5024.</Citation></Reference><Reference><Citation>Chernikov AO, Chernyshova VA, Konstantinova EV, et al. Differential diagnosis of acute coronary syndrome without ST-segment elevation in a middle-aged patient. Med Sovet. 2024;100:92&#x2013;100.</Citation></Reference><Reference><Citation>Acar D. A condition that poses diagnostic challenges in the emergency department is the presentation of chest pain among healthcare professionals. Ege Tip Bilim Derg. 2025;7:97&#x2013;100.</Citation></Reference><Reference><Citation>Romero ASC, Holguin SAT. Diagnostic challengein late onset CADASIL with atypical presentation-case report. Alzheimer&#x2019;s Dementia. 2024;20.</Citation></Reference><Reference><Citation>Theofilis P, Antonopoulos A, Sagris M, et al. Silent myocardial ischemia: from pathophysiology to diagnosis and treatment. Biomedicines. 2024;12:259.</Citation></Reference><Reference><Citation>Khan R, Akhter J, Munir U, et al. Frequency of non-ST segment elevation myocardial infarction (NSTEMI) in acute coronary syndrome with normal electrocardiogram (ECG): insights from a cardiology hospital in Pakistan. Cureus. 2020;12:e8758.</Citation></Reference><Reference><Citation>Jorge E, Sol&#xe9;-Gonz&#xe1;lez E, Amor&#xf3;s-Figueras G, et al. Influence of left bundle branch block on the electrocardiographic changes induced by acute coronary artery occlusion of distinct location and duration. Front Physiol. 2019;10:82.</Citation></Reference><Reference><Citation>Westwood M, Ramaekers B, Grimm S, et al. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation. Health Technol Assess. 2021;25:1&#x2013;276.</Citation></Reference><Reference><Citation>De Gennaro L, Brunetti ND, Cuculo A, et al. Increased troponin levels in nonischemic cardiac conditions and noncardiac diseases. J Interv Cardiol. 2008;21:129&#x2013;139.</Citation></Reference><Reference><Citation>Sarker IH. AI-based modeling: techniques, applications and research issues towards automation, intelligent and smart systems. SN Comput Sci. 2022;3:158.</Citation></Reference><Reference><Citation>Lari MQ, Kumar D, Kumar A, et al. Artificial intelligence for cardiovascular diseases. Recent Adv Comput Sci Commun. 2024;18.</Citation></Reference><Reference><Citation>Maleki Varnosfaderani S, Forouzanfar M. The role of AI in hospitals and clinics: transforming healthcare in the 21st century. Bioengineering (Basel). 2024;11:337.</Citation></Reference><Reference><Citation>Singh A, Soni N. Detection of cardiovascular disease using AI. Int J Sci Res Eng Manag. 2024;08:1&#x2013;5.</Citation></Reference><Reference><Citation>Taylor RA, Chmura C, Hinson J, et al. Impact of artificial intelligence-based triage decision support on emergency department care. NEJM AI. 2025;2.</Citation></Reference><Reference><Citation>Mariani A, Spaccarotella CAM, Rea FS, et al. Artificial intelligence and its role in the diagnosis and prediction of adverse events in acute coronary syndrome: a narrative review of the literature. Life (Basel, Switzerland). 2025;15:515.</Citation></Reference><Reference><Citation>Lin C-S, Liu W-T, Tsai D-J, et al. AI-enabled electrocardiography alert intervention and all-cause mortality: a pragmatic randomized clinical trial. Nat Med. 2024;30:1461&#x2013;1470.</Citation></Reference><Reference><Citation>Singh M, Kumar A, Khanna NN, et al. Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review. EClinicalMedicine. 2024;73:102660.</Citation></Reference><Reference><Citation>Dixon D, Sattar H, Moros N, et al. Unveiling the influence of AI predictive analytics on patient outcomes: a comprehensive narrative review. Cureus. 2024;16:e59954.</Citation></Reference><Reference><Citation>Muzammil MA, Javid S, Afridi AK, et al. Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases. J Electrocardiol. 2024;83:30&#x2013;40.</Citation></Reference><Reference><Citation>Chen K-W, Wang Y-C, Liu M-H, et al. Artificial intelligence-assisted remote detection of ST-elevation myocardial infarction using a mini-12-lead electrocardiogram device in prehospital ambulance care. Front Cardiovasc Med. 2022;9:1078223.</Citation></Reference><Reference><Citation>Sadeghi Z, Alizadehsani R, CIFCI MA, et al. A review of explainable artificial intelligence in healthcare. Comput Electr Eng. 2024;118:109370.</Citation></Reference><Reference><Citation>Al-Zaiti S, Besomi L, Bouzid Z, et al. Machine learning-based prediction of acute coronary syndrome using only the pre-hospital 12-lead electrocardiogram. Nat Commun. 2020;11:3966.</Citation></Reference><Reference><Citation>Moon J, Kim J-H, Hong SJ, et al. Deep learning model for identifying acute heart failure patients using electrocardiography in the emergency room. Eur Heart J Acute Cardiovasc Care. 2025;14:74&#x2013;82.</Citation></Reference><Reference><Citation>Doudesis D, Lee KK, Boeddinghaus J, et al.; CoDE-ACS Investigators. Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations. Nat Med. 2023;29:1201&#x2013;1210.</Citation></Reference><Reference><Citation>Khan E, Lambrakis K, Liao Z, et al. Machine-learning for phenotyping and prognostication of myocardial infarction and injury in suspected acute coronary syndrome. JACC: Advances. 2024;3:101011.</Citation></Reference><Reference><Citation>de Koning E, van der Haas Y, Saguna S, et al. AI algorithm to predict acute coronary syndrome in prehospital cardiac care: retrospective cohort study. JMIR Cardio. 2023;7:e51375.</Citation></Reference><Reference><Citation>Khan E, Lambrakis K, Briffa T, et al. Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting research evidence to practice using artificial intelligence. (RAPIDx AI)&#x2014;a cluster randomized study design. Am Heart J. 2025;285:106&#x2013;118.</Citation></Reference><Reference><Citation>Al-Zaiti SS, Martin-Gill C, Z&#xe8;gre-Hemsey JK, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023;29:1804&#x2013;1813.</Citation></Reference><Reference><Citation>Toprak B, Solleder H, Di Carluccio E, et al.; Artificial Intelligence in Suspected Myocardial Infarction Study (ARTEMIS) Group. Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospective study. Lancet Digit Health. 2024;6:e729&#x2013;e738.</Citation></Reference><Reference><Citation>Chen S-H, Wu C-C, Chen K-F. Navigating AI in cardiology: a scoping review of integration through clinical decision support systems for acute coronary syndrome. Biomed J. 2025:100853. doi:10.1016/j.bj.2025.100853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2025.100853</ArticleId></ArticleIdList></Reference><Reference><Citation>Moazemi S, Vahdati S, Li J, et al. Artificial intelligence for clinical decision support for monitoring patients in cardiovascular ICUs: a systematic review. Front Med (Lausanne). 2023;10:1109411.</Citation></Reference><Reference><Citation>Kalmady SV, Salimi A, Sun W, et al. Development and validation of machine learning algorithms based on electrocardiograms for cardiovascular diagnoses at the population level. NPJ Digit Med. 2024;7:133.</Citation></Reference><Reference><Citation>Hassannataj Joloudari J, Mojrian S, Nodehi I, et al. Application of artificial intelligence techniques for automated detection of myocardial infarction: a review. Physiol Meas. 2022;43:08TR01.</Citation></Reference><Reference><Citation>Liu W-C, Lin C-S, Tsai C-S, et al. A deep learning algorithm for detecting acute myocardial infarction. EuroIntervention. 2021;17:765&#x2013;773.</Citation></Reference><Reference><Citation>B&#xfc;scher A, Plagwitz L, Yildirim K, et al. Deep learning electrocardiogram model for risk stratification of coronary revascularization need in the emergency department. Eur Heart J. 2025. doi:10.1093/eurheartj/ehaf254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaf254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson S, Gedon D, Lampa E, et al. Development and validation of deep learning ECG-based prediction of myocardial infarction in emergency department patients. Sci Rep. 2022;12:19615.</Citation></Reference><Reference><Citation>Xiao R, Ding C, Hu X, et al. Integrating multimodal information in machine learning for classifying acute myocardial infarction. Physiol Meas. 2023;44:044002.</Citation></Reference><Reference><Citation>Lee S-H, Jeon KL, Lee Y-J, et al. Development of clinically validated artificial intelligence model for detecting ST-segment elevation myocardial infarction. Ann Emerg Med. 2024;84:540&#x2013;548.</Citation></Reference><Reference><Citation>Sbrollini A, ter Haar CC, Leoni C, et al. Advanced repeated structuring and learning procedure to detect acute myocardial ischemia in serial 12-lead ECGs. Physiol Meas. 2023;44:084003.</Citation></Reference><Reference><Citation>Bishop AJ, Nehme Z, Nanayakkara S, et al. Artificial neural networks for ECG interpretation in acute coronary syndrome: a scoping review. Am J Emerg Med. 2024;83:1&#x2013;8.</Citation></Reference><Reference><Citation>Zhao Y, Xiong J, Hou Y, et al. Early detection of ST-segment elevated myocardial infarction by artificial intelligence with 12-lead electrocardiogram. Int J Cardiol. 2020;317:223&#x2013;230.</Citation></Reference><Reference><Citation>Hinson JS, Levin SR, Steinhart BD, et al. Enhancing emergency department triage equity with artificial intelligence: outcomes from a multisite implementation. Ann Emerg Med. 2025;85:288&#x2013;290.</Citation></Reference><Reference><Citation>Tsai CH, Eghdam A, Davoody N, et al. Effects of electronic health record implementation and barriers to adoption and use: a scoping review and qualitative analysis of the content. Life (Basel, Switzerland). 2020;10:327.</Citation></Reference><Reference><Citation>Ginestra JC, Giannini HM, Schweickert WD, et al. Clinician perception of a machine learning&#x2013;based early warning system designed to predict severe sepsis and septic shock*. Crit Care Med. 2019;47:1477&#x2013;1484.</Citation></Reference><Reference><Citation>Wang Y-C, Chen K-W, Tsai B-Y, et al. Implementation of an all-day artificial intelligence&#x2013;based triage system to accelerate door-to-balloon times. Mayo Clin Proc. 2022;97:2291&#x2013;2303.</Citation></Reference><Reference><Citation>Hinson JS, Taylor RA, Venkatesh A, et al. Accelerated chest pain treatment with artificial intelligence&#x2013;informed, risk-driven triage. JAMA Intern Med. 2024;184:1125&#x2013;1127.</Citation></Reference><Reference><Citation>Porto BM. Improving triage performance in emergency departments using machine learning and natural language processing: a systematic review. BMC Emerg Med. 2024;24:219.</Citation></Reference><Reference><Citation>Da&#x2019;Costa A, Teke J, Origbo JE, et al. AI-driven triage in emergency departments: a review of benefits, challenges, and future directions. Int J Med Inform. 2025;197:105838.</Citation></Reference><Reference><Citation>Lee AT, Ramasamy RK, Subbarao A. Barriers to and facilitators of technology adoption in emergency departments: a comprehensive review. Int J Environ Res Public Health. 2025;22:479.</Citation></Reference><Reference><Citation>Chenais G, Lagarde E, Gil-Jardin&#xe9; C. Artificial intelligence in emergency medicine: viewpoint of current applications and foreseeable opportunities and challenges. J Med Internet Res. 2023;25:e40031.</Citation></Reference><Reference><Citation>Tyler S, Olis M, Aust N, et al. Use of artificial intelligence in triage in hospital emergency departments: a scoping review. Cureus. 2024;16:e59906.</Citation></Reference><Reference><Citation>Lopez-Ayala P, Boeddinghaus J, Nestelberger T, et al.; APACE investigators. External validation of the myocardial-ischaemic-injury-index machine learning algorithm for the early diagnosis of myocardial infarction: a multicentre cohort study. Lancet Digit Health. 2024;6:e480&#x2013;e488.</Citation></Reference><Reference><Citation>Shafiq M, Mazzotti DR, Gibson C. Risk stratification of patients who present with chest pain and have normal troponins using a machine learning model. World J Cardiol. 2022;14:565&#x2013;575.</Citation></Reference><Reference><Citation>Mohammad MA, Olesen KKW, Koul S, et al. Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study. Lancet Digit Health. 2022;4:e37&#x2013;e45.</Citation></Reference><Reference><Citation>Lee W, Lee J, Woo S-I, et al. Machine learning enhances the performance of short and long-term mortality prediction model in non-ST-segment elevation myocardial infarction. Sci Rep. 2021;11:12886.</Citation></Reference><Reference><Citation>Bj&#xf6;rkelund A, Ohlsson M, Lundager Forberg J, et al. Machine learning compared with rule-in/rule-out algorithms and logistic regression to predict acute myocardial infarction based on troponin T concentrations. J Am Coll Emerg Physicians Open. 2021;2:e12363.</Citation></Reference><Reference><Citation>Zhang P-I, Hsu C-C, Kao Y, et al. Real-time AI prediction for major adverse cardiac events in emergency department patients with chest pain. Scand J Trauma Resusc Emerg Med. 2020;28:93.</Citation></Reference><Reference><Citation>Lee SH, Hong WP, Kim J, et al. Smartphone AI vs. medical experts: a comparative study in prehospital STEMI diagnosis. Yonsei Med J. 2024;65:174&#x2013;180.</Citation></Reference><Reference><Citation>Lin C, Liu W-T, Chang C-H, et al. Artificial intelligence&#x2013;powered rapid identification of ST-elevation myocardial infarction via electrocardiogram (ARISE) &#x2014; a pragmatic randomized controlled trial. NEJM AI. 2024;1.</Citation></Reference><Reference><Citation>Herman R, Lauwers R, Pletnickx D, et al. Abstract 4139994: deep-learning assisted ECG-based emergent cathlab activation: first prospective implementation of a smartphone-based system. Circulation. 2024;150:A4139994&#x2013;A4139994.</Citation></Reference><Reference><Citation>Silva Marques J, Oliveira C, Pinto FJ. Fusion mixed reality: a novel approach to merge the physical and virtual cath lab. Eur Heart J. 2024;45:5101&#x2013;5101.</Citation></Reference><Reference><Citation>Dash D, Dash U, Abu-Dakka B. Artificial intelligence-driven techniques for interventional cardiology: a current appraisal. Cardiovasc Revasc Med. 2025. doi: 10.1016/j.carrev.2025.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carrev.2025.06.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez K, Wisniewski D, Ari A, et al. Investigation into application of AI and telemedicine in rural communities: a systematic literature review. Healthcare (Basel). 2025;13:324.</Citation></Reference><Reference><Citation>Maita KC, Maniaci MJ, Haider CR, et al. The impact of digital health solutions on bridging the health care gap in rural areas: a scoping review. Perm J. 2024;28:130&#x2013;143.</Citation></Reference><Reference><Citation>Takahashi EA, Schwamm LH, Adeoye OM, et al.; American Heart Association Council on Cardiovascular Radiology and Intervention, Council on Hypertension, Council on the Kidney in Cardiovascular Disease, and Stroke Council. An overview of telehealth in the management of cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2022;146:e558&#x2013;e568.</Citation></Reference><Reference><Citation>Zhu Y, Zhao Y, Wu Y. Effectiveness of mobile health applications on clinical outcomes and health behaviors in patients with coronary heart disease: a systematic review and meta-analysis. Int J Nurs Sci. 2024;11:258&#x2013;275.</Citation></Reference><Reference><Citation>Yadav S, Sethi R, Pradhan A, et al. &#x201c;Routine&#x201d; versus &#x201c;Smart Phone Application Based &#x2013; Intense&#x201d; follow up of patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact on clinical outcomes and patient satisfaction. IJC Heart Vasc. 2021;35:100832.</Citation></Reference><Reference><Citation>Hughes A, Shandhi MMH, Master H, et al. Wearable devices in cardiovascular medicine. Circ Res. 2023;132:652&#x2013;670.</Citation></Reference><Reference><Citation>Doolub G, Khurshid S, Theriault-Lauzier P, et al. Revolutionising acute cardiac care with artificial intelligence: opportunities and challenges. Can J Cardiol. 2024;40:1813&#x2013;1827.</Citation></Reference><Reference><Citation>Khera R, Oikonomou EK, Nadkarni GN, et al. Transforming cardiovascular care with artificial intelligence: from discovery to practice. J Am Coll Cardiol. 2024;84:97&#x2013;114.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40821349</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Evaluating the Quality of Cardiovascular Disease Information From AI Chatbots: A Comparative Study.</ArticleTitle><Pagination><StartPage>e88085</StartPage><MedlinePgn>e88085</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e88085</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.88085</ELocationID><Abstract><AbstractText>Artificial intelligence (AI) is increasingly being utilized as an informational resource, with chatbots attracting users for their ability to generate instantaneous responses. This study evaluates the understandability, actionability, readability, quality, and misinformation in medical information provided by four prominent chatbots - Bard, ChatGPT 3.5, Claude 2.0, and Perplexity - on three prevalent cardiovascular diseases (CVDs): myocardial infarctions, heart failure, and arrhythmias. These chatbots were used because of their popularity and high usage rates among chatbots. Using Google Trends, the top five U.S. search queries related to heart attack, arrhythmia, and heart failure from September 29, 2018, to September 29, 2023, were identified. The top five queries were chosen in relation to these topics because they accounted for over 80% of the public's searches related to these topics. The chatbot responses were blinded and analyzed by two evaluators using DISCERN for quality, Patient Education Materials Assessment Tool (PEMAT) for understandability and actionability, and Flesch-Kincaid scores for readability. Statistical tests included the Kruskal-Wallis test for DISCERN, the chi-square test for PEMAT, and one-way ANOVA for Flesch-Kincaid scores. Bard generated responses with a statistically lower Flesch-Kincaid reading score than the other chatbots. Bard and ChatGPT 3.5 provided more actionable responses. Among the CVD topics, "heart attack" yielded lower-grade-level responses and more actionable information compared to "arrhythmia" and "heart failure." This study is among the first to assess AI credibility in disseminating cardiovascular information. It highlights how acute pathologic events may prompt more actionable and accessible chatbot responses. As AI continues to evolve, collaboration among healthcare professionals, researchers, and developers is crucial to ensuring the safe and effective use of AI in patient education and public health.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Singavarapu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singavarapu</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khemlani</LastName><ForeName>Amber</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Menachem</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berglas</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazar</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabarriti</LastName><ForeName>Abdo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Urology, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmia</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiology</Keyword><Keyword MajorTopicYN="N">chatbot</Keyword><Keyword MajorTopicYN="N">chatgpt</Keyword><Keyword MajorTopicYN="N">claude</Keyword><Keyword MajorTopicYN="N">gemini</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">perplexity</Keyword></KeywordList><CoiStatement>Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40821349</ArticleId><ArticleId IdType="pmc">PMC12356239</ArticleId><ArticleId IdType="doi">10.7759/cureus.88085</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The breakthrough of large language models release for medical applications: 1-year timeline and perspectives. Cascella M, Semeraro F, Montomoli J, Bellini V, Piazza O, Bignami E. J Med Syst. 2024;48:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10873461</ArticleId><ArticleId IdType="pubmed">38366043</ArticleId></ArticleIdList></Reference><Reference><Citation>Assessing the accuracy and reliability of AI-generated medical responses: an evaluation of the Chat-GPT model. Johnson D, Goodman R, Patrinely J, et al. Res Sq. 2023</Citation></Reference><Reference><Citation>Patients' use of the Internet for medical information. Diaz JA, Griffith RA, Ng JJ, Reinert SE, Friedmann PD, Moulton AW. J Gen Intern Med. 2002;17:180&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1495021</ArticleId><ArticleId IdType="pubmed">11929503</ArticleId></ArticleIdList></Reference><Reference><Citation>Presiado M, Montero A, Lopes L, Hamel L. KFF health misinformation tracking poll: artificial intelligence and health information.  [
May;
2025 
]. 2024. https://www.kff.org/health-information-trust/poll-finding/kff-health-misinformation-tracking-poll-artificial-intelligence-and-health-information/ https://www.kff.org/health-information-trust/poll-finding/kff-health-misinformation-tracking-poll-artificial-intelligence-and-health-information/</Citation></Reference><Reference><Citation>A comparative analysis of generative artificial intelligence tools for natural language processing. Iorliam A, Ingio JA. https://publikasi.dinus.ac.id/index.php/jcta/article/view/9447 J Comput Theor Appl. 2024;1:311&#x2013;325.</Citation></Reference><Reference><Citation>Transforming chronic disease management with chatbots: key use cases for personalized and cost-effective care. Haque A, Chowdhury M. TechRxiv. 2023</Citation></Reference><Reference><Citation>Artificial intelligence-based conversational agents for chronic conditions: systematic literature review. Schachner T, Keller R, V Wangenheim F. J Med Internet Res. 2020;22:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7522733</ArticleId><ArticleId IdType="pubmed">32924957</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiology of geographic disparities of myocardial infarction among older adults in the United States: analysis of 2000-2017 Medicare data. Yu B, Akushevich I, Yashkin AP, Kravchenko J. Front Cardiovasc Med. 2021;8:707102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458897</ArticleId><ArticleId IdType="pubmed">34568451</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Lakshminarayan K, Anderson DC, Herzog CA, Qureshi AI. https://doi.org/10.1097/NRL.0b013e31815cffae. Neurologist. 2008;14:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619693</ArticleId><ArticleId IdType="pubmed">18469671</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart failure epidemiology and outcomes statistics: a report of the Heart Failure Society of America. Bozkurt B, Ahmad T, Alexander KM, et al. J Card Fail. 2023;29:1412&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10864030</ArticleId><ArticleId IdType="pubmed">37797885</ArticleId></ArticleIdList></Reference><Reference><Citation>DISCERN: an instrument for judging the quality of written consumer health information on treatment choices. Charnock D, Shepperd S, Needham G, Gann R. J Epidemiol Community Health. 1999;53:105&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1756830</ArticleId><ArticleId IdType="pubmed">10396471</ArticleId></ArticleIdList></Reference><Reference><Citation>Development of the Patient Education Materials Assessment Tool (PEMAT): a new measure of understandability and actionability for print and audiovisual patient information. Shoemaker SJ, Wolf MS, Brach C. https://doi.org/10.1016/j.pec.2014.05.027. Patient Educ Couns. 2014;96:395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5085258</ArticleId><ArticleId IdType="pubmed">24973195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincaid J, Fishburne R Jr., Rogers R, Chissom B. Naval Technical Training Command Millington TN Research Branch; 1975. Derivation of new readability formulas (automated readability index, fog count, and flesch reading ease formula) for Navy enlisted personnel.</Citation></Reference><Reference><Citation>Assessment of artificial intelligence chatbot responses to top searched queries about cancer. Pan A, Musheyev D, Bockelman D, Loeb S, Kabarriti AE. JAMA Oncol. 2023;9:1437&#x2013;1440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10450581</ArticleId><ArticleId IdType="pubmed">37615960</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of prompts to simplify cardiovascular disease information generated using a large language model: cross-sectional study. Mishra V, Sarraju A, Kalwani NM, Dexter JP. J Med Internet Res. 2024;26:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11074888</ArticleId><ArticleId IdType="pubmed">38648104</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence-powered patient education for comprehensive and individualized understanding for patients. Tariq R, Khanna S. Clin Gastroenterol Hepatol. 2024;22:1550&#x2013;1551.</Citation><ArticleIdList><ArticleId IdType="pubmed">37944575</ArticleId></ArticleIdList></Reference><Reference><Citation>Assessing the response quality and readability of chatbots in cardiovascular health, oncology, and psoriasis: a comparative study. Olszewski R, Watros K, Ma&#x144;czak M, Owoc J, Jeziorski K, Brzezi&#x144;ski J. Int J Med Inform. 2024;190:105562.</Citation><ArticleIdList><ArticleId IdType="pubmed">39059084</ArticleId></ArticleIdList></Reference><Reference><Citation>Reliability of Google Trends: analysis of the limits and potential of web infoveillance during COVID-19 pandemic and for future research. Rovetta A. Front Res Metr Anal. 2021;6:670226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186442</ArticleId><ArticleId IdType="pubmed">34113751</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40705383</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-5830</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Coronary artery disease</Title><ISOAbbreviation>Coron Artery Dis</ISOAbbreviation></Journal><ArticleTitle>AI-enhanced recognition of occlusions in acute coronary syndrome (AERO-ACS): a retrospective study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/MCA.0000000000001555</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Artificial intelligence (AI) augmentation of ECG assessment has significant potential to improve patient outcomes in acute coronary syndrome.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to evaluate the performance of a novel AI device (PMCardio) in assessing angiographic occlusion myocardial infarction (OMI) and predicting clinical outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used a 1-year retrospective cohort of angiographic data from patients presenting with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). The device analyzed precatheterization ECGs to identify OMI, defined as a culprit vessel with thrombolysis In myocardial infarction (TIMI) 0-2 flow or TIMI 3 flow and peak cardiac troponin I&#x2005;&gt;&#x2005;10.0 ng/ml.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 217 patients were included: 72 STEMI (32%) and 145 NSTEMI (65%). Angiographic OMI was confirmed in 60 (83%) STEMI and 51 (35%) NSTEMI cases. The AI model achieved a sensitivity of 86.5%, specificity of 82.2%, and an area under the curve of 0.84. Traditional STEMI criteria had a sensitivity of 54.1% and a specificity of 88.7%. The AI model was 100% sensitive in detecting STEMI-OMI. The odds ratio for mortality in AI-detected OMI patients was 12.44 (1.56-98.98), unplanned readmissions 1.15 (0.53-2.51), and reduced ejection fraction at 1 year 0.24 (0.26-2.16).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The AI model demonstrated higher sensitivity and similar specificity compared with traditional STEMI criteria, improving OMI detection while reducing false positives. These findings suggest potential benefits in triage accuracy and resource utilization, but further prospective validation is needed to determine its clinical impact.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>James W H</ForeName><Initials>JWH</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torelli</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverman</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Sara Saravia</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaish</LastName><ForeName>Esha</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katic</LastName><ForeName>Luka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagourney</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robbins</LastName><ForeName>Lexi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinney</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barman</LastName><ForeName>Nitin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhan</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Northwell, Cardiovascular Institute, Lenox Hill Hospital, New Hyde Park, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Coron Artery Dis</MedlineTA><NlmUniqueID>9011445</NlmUniqueID><ISSNLinking>0954-6928</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary angiography</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40705383</ArticleId><ArticleId IdType="doi">10.1097/MCA.0000000000001555</ArticleId><ArticleId IdType="pii">00019501-990000000-00394</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foo CY, Bonsu KO, Nallamothu BK, Reid CM, Dhippayom T, Reidpath DD, Chaiyakunapruk N. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart 2018; 104:1362&#x2013;1369.</Citation></Reference><Reference><Citation>de Alencar Neto JN, Scheffer MK, Correia BP, Franchini KG, Felicioni SP, De Marchi MFN. Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion. Int J Cardiol 2024; 402:131889.</Citation></Reference><Reference><Citation>Menown IB, Mackenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J 2000; 21:275&#x2013;283.</Citation></Reference><Reference><Citation>Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343:311&#x2013;322.</Citation></Reference><Reference><Citation>Macfarlane PW, Browne D, Devine B, Clark E, Miller E, Seyal J, Hampton D. Modification of ACC/ESC criteria for acute myocardial infarction. J Electrocardiol 2004; 37:98&#x2013;103.</Citation></Reference><Reference><Citation>Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, et al. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. Am Heart J 2009; 157:716&#x2013;723.</Citation></Reference><Reference><Citation>Schmitt C, Lehmann G, Schmieder S, Karch M, Neumann FJ, Sch&#xf6;mig A. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest 2001; 120:1540&#x2013;1546.</Citation></Reference><Reference><Citation>Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, et al.; TIMI Study Group. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv 2010; 3:806&#x2013;811.</Citation></Reference><Reference><Citation>Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2017; 38:3082&#x2013;3089.</Citation></Reference><Reference><Citation>Abusharekh M, Kampf J, Dykun I, Souri K, Backmann V, Al-Rashid F, et al. Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality. Eur Heart J Qual Care Clin Outcomes 2024; 10:402&#x2013;410.</Citation></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44:3720&#x2013;3826.</Citation></Reference><Reference><Citation>Herman R, Meyers HP, Smith SW, Bertolone DT, Leone A, Bermpeis K, et al. International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health 2023; 5:123&#x2013;133.</Citation></Reference><Reference><Citation>Pendell Meyers H, Bracey A, Lee D, Lichtenheld A, Li WJ, Singer DD, et al. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction. Int J Cardiol Heart Vasc 2021; 33:100767.</Citation></Reference><Reference><Citation>Meyers HP, Bracey A, Lee D, Lichtenheld A, Li WJ, Singer DD, et al. Comparison of the ST-elevation myocardial infarction (STEMI) vs. NSTEMI and occlusion MI (OMI) vs. NOMI paradigms of acute MI. J Emerg Med 2021; 60:273&#x2013;284.</Citation></Reference><Reference><Citation>Aslanger EK, Yildirimt&#xfc;rk O, &#x15e;im&#x15f;ek B, Bozbeyo&#x11f;lu E, &#x15e;im&#x15f;ek MA, Y&#xfc;cel Karabay C, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study). Int J Cardiol Heart Vasc 2020; 30:100603.</Citation></Reference><Reference><Citation>Herman R, Smith SW, Meyers HP, Bertolone DT, Leone A, Bermpeis K, et al. Poor prognosis of total culprit artery occlusion in patients presenting with NSTEMI. Eur Heart J 2023; 44:ehad655.1536. doi: 10.1093/eurheartj/ehad655.1536.</Citation></Reference><Reference><Citation>Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol 2021; 18:465&#x2013;478.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40478367</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1572-8595</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</Title><ISOAbbreviation>J Interv Card Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>AI-guided spatiotemporal dispersion mapping for individualized ablation in an all-comer cohort with atrial fibrillation.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10840-025-02083-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Artificial intelligence (AI)-guided spatiotemporal dispersion (stD) mapping has been shown to improve outcomes in patients with persistent atrial fibrillation (AF). However, the relationship between stD mapping and markers of atrial cardiomyopathy, dispersion patterns in paroxysmal versus persistent AF, stability of dispersion regions, and stD-guided ablation-related outcomes in all-comer cohorts remain elusive.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective single-center analysis, AF patients underwent high-density electroanatomical mapping alongside multiple instances of stD mapping using VOLTA AF Explorer software. Pulmonary vein isolation (PVI) and targeted ablation of left atrial dispersion regions were performed. Clinical, echocardiographic, biomarker, and low-voltage area (LVA) data were collected as markers of left atrial remodeling.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">stD mapping identified dispersion in 92% of patients. Mean time since AF diagnosis was 7&#x2009;&#xb1;&#x2009;1&#xa0;years. Overall, 58% of patients showed dispersion exclusively co-localizing with low-voltage areas, while 42% had dispersion extending into intermediate or normal voltage regions. Dispersion burden correlated strongly with LVA extent and other remodeling markers such as NT-proBNP and LAVI. Persistent AF patients exhibited a significantly higher number of dispersion sites compared to paroxysmal AF. Dispersion patterns remained largely consistent before and after cardioversion in persistent AF, with the posterior left atrial wall emerging as a common hotspot. At follow-up, AF recurred in 33% of paroxysmal and 60% of persistent AF patients who had dispersion ablation limited to the left atrium. Despite these recurrences, most patients reported an improvement in symptomatic burden.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AI-guided stD mapping effectively identifies atrial remodeling beyond classical voltage-derived substrate, supporting its potential as a useful adjunctive tool in AF characterization.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heil</LastName><ForeName>Emanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagres</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boldt</LastName><ForeName>Leif-Hendrick</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parwani</LastName><ForeName>Abdul</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaschke</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoeppenthau</LastName><ForeName>Doreen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attanasio</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe4;ttasch</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tscholl</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hindricks</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerds-Li</LastName><ForeName>Jin-Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hohendanner</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0194-4615</Identifier><AffiliationInfo><Affiliation>Deutsches Herzzentrum Der Charit&#xe9; (DHZC), Charit&#xe9;platz 1, 10117, Berlin, Germany. felix.hohendanner@dhzc-charite.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany. felix.hohendanner@dhzc-charite.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Interv Card Electrophysiol</MedlineTA><NlmUniqueID>9708966</NlmUniqueID><ISSNLinking>1383-875X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Spatiotemporal dispersion</Keyword><Keyword MajorTopicYN="N">Substrate mapping</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The&#xa0;authors declare that they have no competing interests relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40478367</ArticleId><ArticleId IdType="doi">10.1007/s10840-025-02083-y</ArticleId><ArticleId IdType="pii">10.1007/s10840-025-02083-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Haissaguerre M, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199809033391003</ArticleId><ArticleId IdType="pubmed">9725923</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gelder, I.C., et al., 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). European Heart Journal, 2024. 45(36): p. 3314&#x2013;3414.</Citation></Reference><Reference><Citation>Wong KCK, et al. No benefit of complex fractionated atrial electrogram ablation in addition to circumferential pulmonary vein ablation and linear ablation. Circ Arrhythm Electrophysiol. 2015;8(6):1316&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.114.002504</ArticleId><ArticleId IdType="pubmed">26283145</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y, et al. Mapping-guided ablation for persistent atrial fibrillation (MAP-AF): a multicenter, single-blind, randomized controlled trial. Circ Arrhythm Electrophysiol. 2024;17(8):e012829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.124.012829</ArticleId><ArticleId IdType="pubmed">39051110</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrouche NF, et al. Effect of MRI-guided fibrosis ablation vs conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the DECAAF II randomized clinical trial. JAMA. 2022;327(23):2296&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.8831</ArticleId><ArticleId IdType="pubmed">35727277</ArticleId><ArticleId IdType="pmc">9214588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistler PM, et al. Effect of catheter ablation using pulmonary vein isolation with vs without posterior left atrial wall isolation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation: the CAPLA randomized clinical trial. JAMA. 2023;329(2):127&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.23722</ArticleId><ArticleId IdType="pubmed">36625809</ArticleId><ArticleId IdType="pmc">9856612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, B., et al., STABLE-SR (electrophysiological substrate ablation in the left atrium during sinus rhythm) for the treatment of nonparoxysmal atrial fibrillation: a prospective, multicenter randomized clinical trial. Circ Arrhythm Electrophysiol, 2017. 10(11).</Citation></Reference><Reference><Citation>Huo Y, et al. Low-voltage myocardium-guided ablation trial of persistent atrial fibrillation. NEJM Evidence. 2022;1(11):EVIDoa2200141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/EVIDoa2200141</ArticleId><ArticleId IdType="pubmed">38319851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chieng D, et al. Impact of posterior left atrial voltage on ablation outcomes in persistent atrial fibrillation. JACC Clin Electrophysiol. 2023;9(11):2291&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2023.08.002</ArticleId><ArticleId IdType="pubmed">37715741</ArticleId></ArticleIdList></Reference><Reference><Citation>Schade A, et al. Voltage-guided ablation in persistent atrial fibrillation-favorable 1-year outcome and predictors. J Interv Card Electrophysiol. 2021;62(2):249&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-020-00882-z</ArticleId><ArticleId IdType="pubmed">33030630</ArticleId></ArticleIdList></Reference><Reference><Citation>Deisenhofer, I., et al., Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial. Nat Med, 2025.</Citation></Reference><Reference><Citation>Seitz J, et al. Artificial intelligence-adjudicated spatiotemporal dispersion: a patient-unique fingerprint of persistent atrial fibrillation. Heart Rhythm. 2024;21(5):540&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2024.01.007</ArticleId><ArticleId IdType="pubmed">38215808</ArticleId></ArticleIdList></Reference><Reference><Citation>Seitz J, et al. AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation: a wholly patient-tailored approach. J Am Coll Cardiol. 2017;69(3):303&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.10.065</ArticleId><ArticleId IdType="pubmed">28104073</ArticleId><ArticleId IdType="pmc">5568427</ArticleId></ArticleIdList></Reference><Reference><Citation>Heil E, et al. Simultaneous atrial fibrillation and sinus rhythm in a heart transplant recipient: ablation guided by novel dispersion analysis: a case report. Eur Heart J Case Rep. 2025;9(4):152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjcr/ytaf152</ArticleId></ArticleIdList></Reference><Reference><Citation>Parmar BR, et al. Poor scar formation after ablation is associated with atrial fibrillation recurrence. J Interv Card Electrophysiol. 2015;44(3):247&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-015-0060-y</ArticleId><ArticleId IdType="pubmed">26455362</ArticleId><ArticleId IdType="pmc">4728137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesan AN, et al. Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis. J Am Heart Assoc. 2013;2(2):e004549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.112.004549</ArticleId><ArticleId IdType="pubmed">23537812</ArticleId><ArticleId IdType="pmc">3647286</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarnette JA, et al. Outcomes of persistent and long-standing persistent atrial fibrillation ablation: a systematic review and meta-analysis. Europace. 2018;20:f366&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eux297</ArticleId><ArticleId IdType="pubmed">29267853</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultan A, et al. Predictors of atrial fibrillation recurrence after catheter ablation: data from the German Ablation Registry. Sci Rep. 2017;7(1):16678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16938-6</ArticleId><ArticleId IdType="pubmed">29192223</ArticleId><ArticleId IdType="pmc">5709464</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40649092</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Advanced Diagnosis of Hypertrophic Cardiomyopathy with AI-ECG and Differences Based on Ethnicity and HCM Subtype.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14134718</ELocationID><Abstract><AbstractText><b>Background/Objective:</b> Hypertrophic cardiomyopathy (HCM) often presents later in the disease course, with frequent misdiagnoses and population-level underdiagnoses. Underserved patients may have even greater diagnostic delays. We aimed to test the hypothesis in a retrospective cohort that artificial intelligence analysis of ECGs (AI-ECG) could have afforded the opportunity for earlier diagnosis of HCM in one health system. <b>Methods:</b> We collected all available ECGs from patients referred to an HCM Center of Excellence over 15 years, both before and after HCM diagnosis. We applied AI-ECG to each ECG in a blinded fashion to predict the probability of HCM. We calculated the time between each patient's AI-ECG diagnosis and clinical diagnosis. We examined the sensitivity and specificity of AI-ECG for all patients, and by septal subtype and genetic test result. <b>Results:</b> 3499 ECGs were analyzed in 404 patients (age 56 &#xb1; 18 years, 52% female). AI-ECG correctly identified HCM in 155 patients with a sensitivity of 67%, specificity of 95%, positive predictive value of 94%, and a negative predictive value of 69%. The AUC was similar using mean probability from all ECGs for each patient (AUC 0.91 [0.88, 0.94]) or using probability from the first ECG (AUC 0.91 [0.87,0.93]). AI-ECG diagnosed 27 patients over 1 year before clinical diagnosis, and up to 16.3 years early. Black patients were more likely than White patients to have an AI-ECG diagnosis before a clinical diagnosis (<i>p</i> = 0.005). <b>Conclusions:</b> AI-ECG offers the potential for advanced HCM diagnosis. Differences in identification timing between subgroups highlight inequities in current care and show the potential of AI-ECG for the greatest benefit in underserved ethnic groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewontin</LastName><ForeName>Myra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilchick</LastName><ForeName>Kenneth C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bivona</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-2057-7731</Identifier><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrish</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClean</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7819-7988</Identifier><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amos</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GR104884-CC1083-BU01-FD084-FN009</GrantID><Agency>Viz.ai</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40649092</ArticleId><ArticleId IdType="pmc">PMC12250434</ArticleId><ArticleId IdType="doi">10.3390/jcm14134718</ArticleId><ArticleId IdType="pii">jcm14134718</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785&#x2013;789. doi: 10.1161/01.CIR.92.4.785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.4.785</ArticleId><ArticleId IdType="pubmed">7641357</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron M.S., Hellawell J.L., Lucove J.C., Farzaneh-Far R., Olivotto I. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States. Am. J. Cardiol. 2016;117:1651&#x2013;1654. doi: 10.1016/j.amjcard.2016.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.02.044</ArticleId><ArticleId IdType="pubmed">27006153</ArticleId></ArticleIdList></Reference><Reference><Citation>Semsarian C., Ingles J., Maron M.S., Maron B.J. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. 2015;65:1249&#x2013;1254. doi: 10.1016/j.jacc.2015.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.01.019</ArticleId><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Butzner M., Leslie D.L., Cuffee Y., Hollenbeak C.S., Sciamanna C., Abraham T. Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era. Front. Cardiovasc. Med. 2022;8:765876. doi: 10.3389/fcvm.2021.765876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.765876</ArticleId><ArticleId IdType="pmc">PMC8770922</ArticleId><ArticleId IdType="pubmed">35071348</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.S., Sutton M.B., Gao W., Fine J.T., Xie J., Desai N.R., Owens A.T. Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States. J. Med. Econ. 2023;26:682&#x2013;690. doi: 10.1080/13696998.2023.2208966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2023.2208966</ArticleId><ArticleId IdType="pubmed">37170479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zytnick D., Heard D., Ahmad F., Cresci S., Owens A.T., Shay C.M. Exploring experiences of hypertrophic cardiomyopathy diagnosis, treatment, and impacts on quality of life among middle-aged and older adults: An interview study. Heart Lung. 2021;50:788&#x2013;793. doi: 10.1016/j.hrtlng.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2021.06.004</ArticleId><ArticleId IdType="pubmed">34225089</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag A.S., Kuskowski M.A., Maron B.J. Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2006;98:1507&#x2013;1511. doi: 10.1016/j.amjcard.2006.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.07.029</ArticleId><ArticleId IdType="pubmed">17126660</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 2000;342:365&#x2013;373. doi: 10.1056/NEJM200002103420601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200002103420601</ArticleId><ArticleId IdType="pubmed">10666426</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissler-Snir A., Saberi S., Wong T.C., Pantazis A., Owens A., Leunig A., Alvarez C., Rader F. Atrial Fibrillation in Hypertrophic Cardiomyopathy. JACC Adv. 2024;3:101210. doi: 10.1016/j.jacadv.2024.101210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101210</ArticleId><ArticleId IdType="pmc">PMC11379995</ArticleId><ArticleId IdType="pubmed">39247675</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson P., M&#xf6;rner S. EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias. J. Cardiovasc. Electrophysiol. 2021;32:129&#x2013;135. doi: 10.1111/jce.14792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14792</ArticleId><ArticleId IdType="pmc">PMC7821320</ArticleId><ArticleId IdType="pubmed">33108031</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissler-Snir A., Chan R.H., Adler A., Care M., Chauhan V., Gollob M.H., Ziv-Baran T., Fourey D., Hindieh W., Rakowski H., et al. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2016;118:1258&#x2013;1263. doi: 10.1016/j.amjcard.2016.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.07.043</ArticleId><ArticleId IdType="pubmed">27567133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen S.R., Ho C.Y., Asif I.M., Balaji S., Burke M.A., Day S.M., Dearani J.A., Epps K.C., Evanovich L., Ferrari V.A., et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1239&#x2013;e1311. doi: 10.1161/CIR.0000000000001250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001250</ArticleId><ArticleId IdType="pubmed">38718139</ArticleId></ArticleIdList></Reference><Reference><Citation>Finocchiaro G., Sheikh N., Biagini E., Papadakis M., Maurizi N., Sinagra G., Pelliccia A., Rapezzi C., Sharma S., Olivotto I. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm. 2020;17:142&#x2013;151. doi: 10.1016/j.hrthm.2019.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.07.019</ArticleId><ArticleId IdType="pubmed">31349064</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J.V., Harris K.M., Casey S.A., Zenovich A.G., Maron B.J. Relation of Electrocardiographic Patterns to Phenotypic Expression and Clinical Outcome in Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2005;96:270&#x2013;275. doi: 10.1016/j.amjcard.2005.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.03.058</ArticleId><ArticleId IdType="pubmed">16018856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh N., Papadakis M., Panoulas V.F., Prakash K., Millar L., Adami P., Zaidi A., Gati S., Wilson M., Carr-White G., et al. Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK. Heart. 2016;102:1797&#x2013;1804. doi: 10.1136/heartjnl-2016-309843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2016-309843</ArticleId><ArticleId IdType="pubmed">27679836</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod C.J., Ackerman M.J., Nishimura R.A., Tajik A.J., Gersh B.J., Ommen S.R. Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram. J. Am. Coll. Cardiol. 2009;54:229&#x2013;233. doi: 10.1016/j.jacc.2009.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.071</ArticleId><ArticleId IdType="pubmed">19589435</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcr&#xe8; S.D.L., Di Donna P., Leuzzi S., Miceli S., Bisi M., Scaglione M., Caponi D., Conte M.R., Cecchi F., Olivotto I., et al. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: A cardiac magnetic resonance study. Int. J. Cardiol. 2013;167:1038&#x2013;1045. doi: 10.1016/j.ijcard.2012.03.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.03.074</ArticleId><ArticleId IdType="pubmed">22464482</ArticleId></ArticleIdList></Reference><Reference><Citation>Calore C., Melacini P., Pelliccia A., Cianfrocca C., Schiavon M., Di Paolo F.M., Bovolato F., Quattrini F.M., Basso C., Thiene G., et al. Prevalence and clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete&#x2019;s heart: Relevance to athletic screening. Int. J. Cardiol. 2013;168:4494&#x2013;4497. doi: 10.1016/j.ijcard.2013.06.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.06.123</ArticleId><ArticleId IdType="pubmed">23928341</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin E.J., Maron B.J., Appelbaum E., Link M.S., Gibson C.M., Lesser J.R., Haas T.S., Udelson J.E., Manning W.J., Maron M.S. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am. J. Cardiol. 2012;110:1027&#x2013;1032. doi: 10.1016/j.amjcard.2012.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.05.035</ArticleId><ArticleId IdType="pubmed">22809754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang N., Yamauchi K. Using a neural network to diagnose the hypertrophic portions of hypertrophic cardiomyopathy. MD Comput. 1998;15:106&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">9540323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko W.Y., Siontis K.C., Attia Z.I., Carter R.E., Kapa S., Ommen S.R., Demuth S.J., Ackerman M.J., Gersh B.J., Arruda-Olson A.M., et al. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram. J. Am. Coll. Cardiol. 2020;75:722&#x2013;733. doi: 10.1016/j.jacc.2019.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.12.030</ArticleId><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota N., Suzuki S., Motogi J., Umemoto T., Nakai H., Matsuzawa W., Takayanagi T., Hyodo A., Satoh K., Arita T., et al. Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting. Heart Vessels. 2024;39:524&#x2013;538. doi: 10.1007/s00380-024-02367-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-024-02367-9</ArticleId><ArticleId IdType="pubmed">38553520</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison G.H., Zhang J., Delling F.N., Deo R.C. Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery. Circ. Cardiovasc. Qual. Outcomes. 2019;12:e005289. doi: 10.1161/CIRCOUTCOMES.118.005289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.118.005289</ArticleId><ArticleId IdType="pmc">PMC6951431</ArticleId><ArticleId IdType="pubmed">31525078</ArticleId></ArticleIdList></Reference><Reference><Citation>Maanja M., Noseworthy P.A., Geske J.B., Ackerman M.J., Arruda-Olson A.M., Ommen S.R., Attia Z.I., Friedman P.A., Siontis K.C. Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice. Cardiovasc. Digit. Health J. 2022;3:289&#x2013;296. doi: 10.1016/j.cvdhj.2022.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2022.10.002</ArticleId><ArticleId IdType="pmc">PMC9795257</ArticleId><ArticleId IdType="pubmed">36589312</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon D.M., Sehrawat O., Maanja M., Wight J., Noseworthy P.A. Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation. Arrhythm. Electrophysiol. Rev. 2023;12:e12. doi: 10.15420/aer.2022.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/aer.2022.31</ArticleId><ArticleId IdType="pmc">PMC10326669</ArticleId><ArticleId IdType="pubmed">37427304</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhang L., Sun W., Zhu Y., Zhang Z., Chen L., Xie M., Zhang L. Artificial Intelligence in Diagnosis of Heart Failure. J. Am. Heart Assoc. 2025;14:e039511. doi: 10.1161/JAHA.124.039511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.124.039511</ArticleId><ArticleId IdType="pmc">PMC12132872</ArticleId><ArticleId IdType="pubmed">40207505</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi S.A.J., Ghafoor A., Kim J., Abbas Z., Lee S.W. HeartEnsembleNet: An Innovative Hybrid Ensemble Learning Approach for Cardiovascular Risk Prediction. Healthcare. 2025;13:507. doi: 10.3390/healthcare13050507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare13050507</ArticleId><ArticleId IdType="pmc">PMC11898877</ArticleId><ArticleId IdType="pubmed">40077069</ArticleId></ArticleIdList></Reference><Reference><Citation>Petretto G., Porcheddu T., Isgender M., Merella P., Talanas G., Casu G., Navarese E.P., Bilotta F. An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: Heartguardai. Eur. Heart J. 2024;45((Suppl. 1)):ehae666.1545. doi: 10.1093/eurheartj/ehae666.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae666.1545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40162910</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1942-0080</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Circulation. Cardiovascular imaging</Title><ISOAbbreviation>Circ Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>AI-Quantitative CT Coronary Plaque Features Associate With a Higher Relative Risk in Women: CONFIRM2 Registry.</ArticleTitle><Pagination><StartPage>e018235</StartPage><MedlinePgn>e018235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCIMAGING.125.018235</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Coronary plaque features are imaging biomarkers of cardiovascular risk, but less is known about sex-specific patterns in their prognostic value. This study aimed to define sex differences in the coronary atherosclerotic phenotypes assessed by artificial intelligence-based quantitative computed tomography (AI-QCT) and the associated risk of major adverse cardiovascular events (MACEs).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Global multicenter registry including symptomatic patients with suspicion of coronary artery disease referred for coronary computed tomography angiography. AI-QCT analyzed 16 coronary artery disease features. The primary end point was MACE defined as death, myocardial infarction, late revascularization, cerebrovascular events, unstable angina, and congestive heart failure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 3551 patients (mean age, 59&#xb1;12 years; 49.5% women), MACE occurred in 3.2% of women and 6.1% of men during an average follow-up of 4.8&#xb1;2.2 years. The AI-QCT features total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume were significantly higher in men (<i>P</i>&lt;0.001), and high-risk plaques were more prevalent (9.2% versus 2.5%; <i>P</i>&lt;0.0001). Independent of age and cardiovascular risk factors, the AI-QCT-derived features of total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume conferred a higher relative risk of MACE in women than men. For every 50-mm<sup>3</sup> increase in total plaque volume, relative risk increased by 17.7% (95% CI, 1.12-1.24) in women versus 5.3% (95% CI, 1.03-1.07) in men (<i>P</i><sub>interaction</sub>&lt;0.001); for noncalcified plaque, relative risk increased by 27.1% (95% CI, 1.17-1.38) versus 11.6% (95% CI, 1.08-1.15; <i>P</i><sub>interaction</sub>=0.0015); and for calcified plaque, relative risk increased by 22.9% (95% CI, 1.14-1.33) versus 5.4% (95% CI, 1.01-1.10; <i>P</i><sub>interaction</sub>=0.0012), respectively. Similarly, for percentage atheroma volume, the risk was higher in women. The findings remained unchanged when restricted to a secondary composite end point (death and myocardial infarction).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The AI-QCT plaque features, total plaque volume, noncalcified plaque, calcified plaque, and percentage atheroma volume, conferred a higher relative MACE risk in women and may prompt more aggressive antiatherosclerotic therapy and reinforced preventive interventions.</AbstractText><AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">URL: https://www.clinicaltrials.gov; Unique identifier: NCT04279496.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feuchtner</LastName><ForeName>Gudrun M</ForeName><Initials>GM</Initials><Identifier Source="ORCID">0000-0001-6755-4399</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Medical University of Innsbruck, Austria (G.M.F., P.G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacaita</LastName><ForeName>Pietro G</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Department of Radiology, Medical University of Innsbruck, Austria (G.M.F., P.G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bax</LastName><ForeName>Jeroen J</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0001-7368-0500</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B., A.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5226-0723</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Stanford University School of Medicine, Paolo Alto, CA (F.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakanishi</LastName><ForeName>Rine</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4237-3927</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Tokyo, Japan (R.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pontone</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1339-6679</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS), Milan, Italy (G.P.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy (G.P.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mushtaq</LastName><ForeName>Saima</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4168-2207</Identifier><AffiliationInfo><Affiliation>Perioperative Cardiology and Cardiovascular Imaging Department, Centro Cardiologico Monzino IRCCS, Milan, Italy (S.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buechel</LastName><ForeName>Ronny R</ForeName><Initials>RR</Initials><Identifier Source="ORCID">0000-0001-8064-8904</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Cardiac Imaging, University Hospital and University of Zurich, Switzerland (R.R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;ni</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-6029-0597</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland (C.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Amit R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-7621-6463</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Virginia, Charlottesville (A.R.P., C.C.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singulane</LastName><ForeName>Cristiane C</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0002-8561-4276</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Virginia, Charlottesville (A.R.P., C.C.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Andrew D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Radiology, George Washington University, Washington, DC (A.D.C., ).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mallah</LastName><ForeName>Mouaz</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2348-0484</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Houston Methodist, TX (M.A.-M.,.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreini</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of University Cardiology, IRCCS Galeazzi Sant'Ambrogio, Department of Biomedical and Clinical Sciences, University of Milan, Italy (D.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsberg</LastName><ForeName>Ronald P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0003-4695-9092</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Foundation of Southern California, Cedars-Sinai Heart, David Geffen School of Medicine, University of California Los Angeles (R.P.K., G.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Geoffrey</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4438-2093</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Foundation of Southern California, Cedars-Sinai Heart, David Geffen School of Medicine, University of California Los Angeles (R.P.K., G.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rochitte</LastName><ForeName>Carlos E</ForeName><Initials>CE</Initials><Identifier Source="ORCID">0000-0003-4505-3344</Identifier><AffiliationInfo><Affiliation>Heart Institute, InCor, University of S&#xe3;o Paulo Medical School, Brazil (C.E.R.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alasnag</LastName><ForeName>Mirvat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiac Center, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia (M. Alasnag).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamdan</LastName><ForeName>Ashraf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rabin Medical Center, Petah Tikva and Tel Aviv University, Israel (A.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cademartiri</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-0579-3279</Identifier><AffiliationInfo><Affiliation>IRCCS SYNLAB SDN, Naples, Italy (F.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maffei</LastName><ForeName>Erica</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0388-4433</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Istituto di Ricovero e Cura a Carattere (IRCCS) SYNLAB SDN, Naples, Italy (E. Maffei).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marques</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal (H.M., P.M.G.F).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gon&#xe7;alves Pereira</LastName><ForeName>Pedro M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-4301-3090</Identifier><AffiliationInfo><Affiliation>UNICA, Unit of Cardiovascular Imaging, Hospital da Luz, Lisboa, Portugal (H.M., P.M.G.F).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Himanshu</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-9428-4988</Identifier><AffiliationInfo><Affiliation>Cardiac Imaging, Heart and Vascular Institute, Valley Health System, Paramus, NJ (H.G.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadamitzky</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology and Nuclear Medicine, German Heart Center Munich, Germany (M.H.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalique</LastName><ForeName>Omar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0003-1850-8665</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Imaging, St. Francis Hospital and Heart Center, Roslyn, NY (O.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Dinesh</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5254-4067</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Louisville School of Medicine, KY (D.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>James D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0009-0000-8061-7462</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West Virginia University Heart and Vascular Institute, Morgantown (J.D.M.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nurmohamed</LastName><ForeName>Nick S</ForeName><Initials>NS</Initials><Identifier Source="ORCID">0000-0001-9045-6009</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Department of Vascular Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands (N.S.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knaapen</LastName><ForeName>Paul</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-8038-7898</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, the Netherlands (P.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Budoff</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9616-1946</Identifier><AffiliationInfo><Affiliation>The Lundquist Institute, Torrance, CA (M. Budoff).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaikh</LastName><ForeName>Kashif</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Tennessee Medical Center, Knoxville (K.S.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cardiology, MercyOne-Iowa Heart Center, Des Moines, IA (E. Martin).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>German</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Knight Cardiovascular Institute, Oregon Health &amp; Science University, Portland (D.M.G., M.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferencik</LastName><ForeName>Maros</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5872-2223</Identifier><AffiliationInfo><Affiliation>Knight Cardiovascular Institute, Oregon Health &amp; Science University, Portland (D.M.G., M.F.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oehler</LastName><ForeName>Andrew C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-2329-8845</Identifier><AffiliationInfo><Affiliation>Allegheny Health Network Cardiovascular Institute, Allegheny Health Network, Pittsburgh, PA (A.C.O.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dea&#xf1;o</LastName><ForeName>Roderick</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0325-8002</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison (R.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagpal</LastName><ForeName>Prashant</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2347-034X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison (P.N.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Assen</LastName><ForeName>Marly</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4044-4426</Identifier><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA (M.V.A., C.N.D.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cecco</LastName><ForeName>Carlo Nicola</ForeName><Initials>CN</Initials><Identifier Source="ORCID">0000-0002-2956-3101</Identifier><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA (M.V.A., C.N.D.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foldyna</LastName><ForeName>Borek</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-2466-4827</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Cardiovascular Imaging and Research Center, Massachusetts General Hospital and Harvard Medical School, Boston (B.F., J.M.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brendel</LastName><ForeName>Jan Michael</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-2729-610X</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Cardiovascular Imaging and Research Center, Massachusetts General Hospital and Harvard Medical School, Boston (B.F., J.M.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Victor Y</ForeName><Initials>VY</Initials><AffiliationInfo><Affiliation>Minneapolis Heart Institute, MN (V.Y.C.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branch</LastName><ForeName>Kelley</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2362-6498</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Cardiovascular Clinical Trials, University of Washington, Seattle (K.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bittencourt</LastName><ForeName>Marcio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-3711-1754</Identifier><AffiliationInfo><Affiliation>Heart and Vascular Institute, University of Pittsburgh Medical Center, PA (M. Bittencourt).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatti</LastName><ForeName>Sabha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Institute of Cardiovascular Diseases, Karachi, Pakistan (S. Bhatti).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polsani</LastName><ForeName>Venkateshwar</ForeName><Initials>V</Initials><Identifier Source="ORCID">0009-0004-6576-1297</Identifier><AffiliationInfo><Affiliation>Piedmont Heart Institute, Atlanta, GA (V.P.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wesbey</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Computed Tomography, Scripps Clinic, La Jolla, CA (G.W.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Rhanderson</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (R.C., R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Ron</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8393-6562</Identifier><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (R.C., R.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delago</LastName><ForeName>Augustin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Data Research Collaborative, United Kingdom (A.D.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA (A.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pursnani</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5616-8839</Identifier><AffiliationInfo><Affiliation>Cardiology, Endeavor NorthShore Cardiovascular Institute, Evanston, IL (A.P.).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pritzker School of Medicine, University of Chicago, IL (A.P.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsaid</LastName><ForeName>Amro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6466-2615</Identifier><AffiliationInfo><Affiliation>Department of Cardiac Imaging, Baylor Scott &amp; White The Heart Hospital Plano, TX (A.A.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Midwest Heart and Vascular Associates, Kansas City, MO (S. Bloom).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamperidis</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-8424-6718</Identifier><AffiliationInfo><Affiliation>1st Cardiology Department, Medical School, Aristotle University of Thessaloniki, Greece (V.K.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbieri</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4456-1822</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charit&#xe9;, Berlin, Germany (F.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aquino</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cleerly Health, Denver, CO (M. Aquino).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danad</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands (I.D.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Rosendael</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Leiden University Medical Center, the Netherlands (J.J.B., A.R.).</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04279496</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Cardiovasc Imaging</MedlineTA><NlmUniqueID>101479935</NlmUniqueID><ISSNLinking>1941-9651</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Circ Cardiovasc Imaging. 2025 Jun;18(6):e018438. doi: 10.1161/CIRCIMAGING.125.018438.</RefSource><PMID Version="1">40444358</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="Y">Coronary Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="Y">Plaque, Atherosclerotic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">atherosclerosis</Keyword><Keyword MajorTopicYN="N">computed tomography</Keyword><Keyword MajorTopicYN="N">computed tomography angiography</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">women&#x2019;s health</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships that may be considered potential competing interests. Dr van Rosendael is a member of the Cleerly Scientific Advisory Board. Dr Pontone received an honorarium as a speaker/consultant and an institutional research grant from GE Healthcare, Bracco, Medtronic, and Novartis. Dr Buechel reports receiving speaking honoraria from GE Healthcare, Pfizer, Gilead, and IBA. Dr Gr&#xe4;ni received funding from the Swiss National Science Foundation, InnoSuisse, the CAIM Foundation, the GAMBIT Foundation, and the Novartis Foundation for biomedical research, outside of the submitted work. Dr Choi is a consultant for Siemens, holds equity in Cleerly, and receives grant support from the George Washington Heart and Vascular Institute. Dr Rochitte reports receiving speaking honoraria for Pfizer, Edwards, GE, and Manole. Dr Khalique is a consultant for Edwards, Croivalve, and Restore Medical, holds equity in Triflo, and received honoraria for educational programs from Heartflow. Udo Hoffmann is an employee and equity holder in Cleerly, Inc, and received honoraria from Stanford University, Clinical Cardiovascular Sciences, Rapid AI, and MedTrace. Dr Danad is a member of the Cleerly Scientific Advisory Board. Dr Marques is a consultant for Cleerly, Inc. The other authors report no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>17</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>21</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>31</Day><Hour>10</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40162910</ArticleId><ArticleId IdType="pmc">PMC12173162</ArticleId><ArticleId IdType="doi">10.1161/CIRCIMAGING.125.018235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Bansal N, Beaton AZ, et al. ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. 2025 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association. Circulation. 2025;151:e41&#x2013;e660. doi: 10.1161/CIR.0000000000001303</Citation><ArticleIdList><ArticleId IdType="pubmed">39866113</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Lozano PF, Rrapo Kaso E, Bourque JM, Morsy M, Taylor AM, Villines TC, Kramer CM, Salerno M. Cardiovascular imaging for ischemic heart disease in women: time for a paradigm shift. JACC Cardiovasc Imaging. 2022;15:1488&#x2013;1501. doi: 10.1016/j.jcmg.2022.01.006</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9355915</ArticleId><ArticleId IdType="pubmed">35331658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagidipati NJ, Coles A, Hemal K, Lee KL, Dolor RJ, Pellikka PA, Mark DB, Patel MR, Litwin SE, Daubert MA, et al. ; PROMISE Investigators. Sex differences in management and outcomes of patients with stable symptoms suggestive of coronary artery disease: insights from the PROMISE trial. Am Heart J. 2019;208:28&#x2013;36. doi: 10.1016/j.ahj.2018.11.002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382571</ArticleId><ArticleId IdType="pubmed">30529930</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds HR, Shaw LJ, Min JK, Spertus JA, Chaitman BR, Berman DS, Picard MH, Kwong RY, Bairey-Merz CN, Cyr DD, et al. ; ISCHEMIA Research Group. Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial. JAMA Cardiol. 2020;5:773&#x2013;786. doi: 10.1001/jamacardio.2020.0822</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7105951</ArticleId><ArticleId IdType="pubmed">32227128</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael SE, Bax AM, Lin FY, Achenbach S, Andreini D, Budoff MJ, Cademartiri F, Callister TQ, Chinnaiyan K, Chow BJW, et al. Sex and age-specific interactions of coronary atherosclerotic plaque onset and prognosis from coronary computed tomography. Eur Heart J Cardiovasc Imaging. 2023;24:1180&#x2013;1189. doi: 10.1093/ehjci/jead094</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10445263</ArticleId><ArticleId IdType="pubmed">37165981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyer RP, Ranasinghe I, Wang Y, Dharmarajan K, Murugiah K, Nuti SV, Hsieh AF, Spertus JA, Krumholz HM. Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation. 2015;132:158&#x2013;166. doi: 10.1161/CIRCULATIONAHA.114.014776</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5322973</ArticleId><ArticleId IdType="pubmed">26085455</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Min JK, Nasir K, Xie JX, Berman DS, Miedema MD, Whelton SP, Dardari ZA, Rozanski A, Rumberger J, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC consortium. Eur Heart J. 2018;39:3727&#x2013;3735. doi: 10.1093/eurheartj/ehy534</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6209852</ArticleId><ArticleId IdType="pubmed">30212857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C, McCarthy CP, Mohebi R, Liu Y, Blankstein R, Murphy SP, Miksenas H, Rogers C, Amponsah DK, Rambarat PK, et al. Sex differences in coronary artery disease characteristics among patients with type 2 myocardial infarction. JACC Adv. 2023;3:100795. doi: 10.1016/j.jacadv.2023.100795</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11198490</ArticleId><ArticleId IdType="pubmed">38939381</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, et al. ; Peer Review Committee Members. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9&#x2013;e119. doi: 10.1161/CIR.0000000000001168</Citation><ArticleIdList><ArticleId IdType="pubmed">37471501</ArticleId></ArticleIdList></Reference><Reference><Citation>Min JK, Chang HJ, Andreini D, Pontone G, Guglielmo M, Bax JJ, Knaapen P, Raman SV, Chazal RA, Freeman AM, et al. Coronary CTA plaque volume severity stages according to invasive coronary angiography and FFR. J Cardiovasc Comput Tomogr. 2022;16:415&#x2013;422. doi: 10.1016/j.jcct.2022.03.001</Citation><ArticleIdList><ArticleId IdType="pubmed">35379596</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmohamed NS, Danad I, Jukema RA, de Winter RW, de Groot RJ, Driessen RS, Bom MJ, van Diemen P, Pontone G, Andreini D, et al. ; CREDENCE and PACIFIC-1 Investigators. Development and validation of a quantitative coronary CT angiography model for diagnosis of vessel-specific coronary ischemia. JACC Cardiovasc Imaging. 2024;17:894&#x2013;906. doi: 10.1016/j.jcmg.2024.01.007</Citation><ArticleIdList><ArticleId IdType="pubmed">38483420</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurmohamed NS, Min JK, Anthopolos R, Reynolds HR, Earls JP, Crabtree T, Mancini GBJ, Leipsic J, Budoff MJ, Hague CJ, et al. Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial. Eur Heart J. 2024;45:3735&#x2013;3747. doi: 10.1093/eurheartj/ehae471</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11439108</ArticleId><ArticleId IdType="pubmed">39101625</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MC, Kwiecinski J, Doris M, McElhinne P, D&#x2019;Souza MS, Cadet S, Adamson PD, Moss A, Alam S, Hunter A, et al. Low-attenuation noncalcified plaque on coronary computed tomography angiography predicts myocardial infarction: results from the multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Circulation. 2020;141:1452&#x2013;1462. doi: 10.1161/CIRCULATIONAHA.119.044720</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195857</ArticleId><ArticleId IdType="pubmed">32174130</ArticleId></ArticleIdList></Reference><Reference><Citation>Foldyna B, Mayrhofer T, Lu MT, Kar&#xe1;dy J, Kolossv&#xe1;ry M, Ferencik M, Shah SH, Pagidipati NJ, Douglas PS, Hoffmann U. Prognostic value of CT-derived coronary artery disease characteristics varies by ASCVD risk: insights from the PROMISE trial. Eur Radiol. 2023;33:4657&#x2013;4667. doi: 10.1007/s00330-023-09430-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10765563</ArticleId><ArticleId IdType="pubmed">36719496</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael AR, Crabtree T, Bax JJ, Nakanishi R, Mushtaq S, Pontone G, Andreini D, Buechel RR, Gr&#xe4;ni C, Feuchtner G, et al. ; CONFIRM 2 Investigators. Rationale and design of the CONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) study. J Cardiovasc Comput Tomogr. 2024;18:11&#x2013;17. doi: 10.1016/j.jcct.2023.10.004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10923095</ArticleId><ArticleId IdType="pubmed">37951725</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618&#x2013;e651. doi: 10.1161/CIR.0000000000000617</Citation><ArticleIdList><ArticleId IdType="pubmed">30571511</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin WF, Choi AD, Riess JS, Marques H, Chang HJ, Choi JH, Doh JH, Her AY, Koo BK, Nam CW, et al. AI evaluation of stenosis on coronary CTA, comparison with quantitative coronary angiography and fractional flow reserve: a CREDENCE trial substudy. JACC Cardiovasc Imaging. 2023;16:193&#x2013;205. doi: 10.1016/j.jcmg.2021.10.020</Citation><ArticleIdList><ArticleId IdType="pubmed">35183478</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi AD, Marques H, Kumar V, Griffin WF, Rahban H, Karlsberg RP, Zeman RK, Katz RJ, Earls JP. CT Evaluation by Artificial Intelligence for Atherosclerosis, Stenosis and Vascular Morphology (CLARIFY): a multi-center, international study. J Cardiovasc Comput Tomogr. 2021;15:470&#x2013;476. doi: 10.1016/j.jcct.2021.05.004</Citation><ArticleIdList><ArticleId IdType="pubmed">34127407</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas R, Earls J, Marques H, Chang HJ, Choi JH, Doh JH, Her AY, Koo BK, Nam CW, Park HB, et al. Relationship of age, atherosclerosis and angiographic stenosis using artificial intelligence. Open Heart. 2021;8:e001832. doi: 10.1136/openhrt-2021-001832</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8596051</ArticleId><ArticleId IdType="pubmed">34785589</ArticleId></ArticleIdList></Reference><Reference><Citation>Omori H, Matsuo H, Fujimoto S, Sobue Y, Nozaki Y, Nakazawa G, Takahashi K, Osawa K, Okubo R, Kaneko U, et al. Determination of lipid-rich plaques by artificial intelligence-enabled quantitative computed tomography using near-infrared spectroscopy as reference. Atherosclerosis. 2023;386:117363. doi: 10.1016/j.atherosclerosis.2023.117363</Citation><ArticleIdList><ArticleId IdType="pubmed">37944269</ArticleId></ArticleIdList></Reference><Reference><Citation>Ihdayhid AR, Tzimas G, Peterson K, Ng N, Mirza S, Maehara A, Safian RD. Diagnostic performance of AI-enabled plaque quantification from coronary CT angiography compared with intravascular ultrasound. Radiol Cardiothorac Imaging. 2024;6:e230312. doi: 10.1148/ryct.230312</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11683154</ArticleId><ArticleId IdType="pubmed">39540820</ArticleId></ArticleIdList></Reference><Reference><Citation>Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ, Nieman K, Pontone G, Raff GL. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr. 2014;8:342&#x2013;358. doi: 10.1016/j.jcct.2014.07.003</Citation><ArticleIdList><ArticleId IdType="pubmed">25301040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cury RC, Leipsic J, Abbara S, Achenbach S, Berman D, Bittencourt M, Budoff M, Chinnaiyan K, Choi AD, Ghoshhajra B, et al. CAD-RADS&#x2122; 2.0 - 2022 coronary artery disease-reporting and data system: an expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the American College of Radiology (ACR), and the North America Society of Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr. 2022;16:536&#x2013;557. doi: 10.1016/j.jcct.2022.07.002</Citation><ArticleIdList><ArticleId IdType="pubmed">35864070</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Blankstein R, Bax JJ, Ferencik M, Bittencourt MS, Min JK, Berman DS, Leipsic J, Villines TC, Dey D, et al. Society of Cardiovascular Computed Tomography/North American Society of Cardiovascular Imaging - expert consensus document on coronary CT imaging of atherosclerotic plaque. J Cardiovasc Comput Tomogr. 2021;15:93&#x2013;109. doi: 10.1016/j.jcct.2020.11.002</Citation><ArticleIdList><ArticleId IdType="pubmed">33303383</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael AR, Lin FY, Ma X, van den Hoogen IJ, Gianni U, Al Hussein O, Al&#x2019;Aref SJ, Pe&#xf1;a JM, Andreini D, Al-Mallah MH, et al. Percent atheroma volume: optimal variable to report whole-heart atherosclerotic plaque burden with coronary CTA, the PARADIGM study. J Cardiovasc Comput Tomogr. 2020;14:400&#x2013;406. doi: 10.1016/j.jcct.2020.01.012</Citation><ArticleIdList><ArticleId IdType="pubmed">32063545</ArticleId></ArticleIdList></Reference><Reference><Citation>Onnis C, Virmani R, Madra A, Nardi V, Salgado R, Montisci R, Cau R, Boi A, Lerman A, De Cecco CN, et al. Whys and wherefores of coronary arterial positive remodeling. Arterioscler Thromb Vasc Biol. 2024;44:2416&#x2013;2427. doi: 10.1161/ATVBAHA.124.321504</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11594009</ArticleId><ArticleId IdType="pubmed">39479766</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979;300:1350&#x2013;1358. doi: 10.1056/nejm197906143002402</Citation><ArticleIdList><ArticleId IdType="pubmed">440357</ArticleId></ArticleIdList></Reference><Reference><Citation>Goff DC, Jr, Lloyd-Jones DM, Bennett G, Coady S, D&#x2019;Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O&#x2019;Donnell CJ, et al. ; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:S49&#x2013;S73. doi: 10.1161/01.cir.0000437741.48606.98</Citation><ArticleIdList><ArticleId IdType="pubmed">24222018</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas G, Gulsin GS, Everett RJ, Akodad M, Meier D, Sewnarain K, Ally Z, Alnamasy R, Ng N, Mullen S, et al. Age- and sex-specific nomographic CT quantitative plaque data from a large international cohort. JACC Cardiovasc Imaging. 2024;17:165&#x2013;175. doi: 10.1016/j.jcmg.2023.05.011</Citation><ArticleIdList><ArticleId IdType="pubmed">37410009</ArticleId></ArticleIdList></Reference><Reference><Citation>Plank F, Beyer C, Friedrich G, Wildauer M, Feuchtner G. Sex differences in coronary artery plaque composition detected by coronary computed tomography: quantitative and qualitative analysis. Neth Heart J. 2019;27:272&#x2013;280. doi: 10.1007/s12471-019-1234-5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6470243</ArticleId><ArticleId IdType="pubmed">30734147</ArticleId></ArticleIdList></Reference><Reference><Citation>Theofilatos K, Stojkovic S, Hasman M, van der Laan SW, Baig F, Barallobre-Barreiro J, Schmidt LE, Yin S, Yin X, Burnap S, et al. Proteomic atlas of atherosclerosis: the contribution of proteoglycans to sex differences, plaque phenotypes, and outcomes. Circ Res. 2023;133:542&#x2013;558. doi: 10.1161/CIRCRESAHA.123.322590</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10498884</ArticleId><ArticleId IdType="pubmed">37646165</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael AR, Narula J, Lin FY, van den Hoogen IJ, Gianni U, Al Hussein Alawamlh O, Dunham PC, Pe&#xf1;a JM, Lee SE, Andreini D, et al. Association of high-density calcified 1K plaque with risk of acute coronary syndrome. JAMA Cardiol. 2020;5:282&#x2013;290. doi: 10.1001/jamacardio.2019.5315</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6990946</ArticleId><ArticleId IdType="pubmed">31968065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SE, Chang HJ, Sung JM, Park HB, Heo R, Rizvi A, Lin FY, Kumar A, Hadamitzky M, Kim YJ, et al. Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging. 2018;11:1475&#x2013;1484. doi: 10.1016/j.jcmg.2018.04.015</Citation><ArticleIdList><ArticleId IdType="pubmed">29909109</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HB, Arsanjani R, Sung JM, Heo R, Lee BK, Lin FY, Hadamitzky M, Kim YJ, Conte E, Andreini D, et al. Impact of statins based on high-risk plaque features on coronary plaque progression in mild stenosis lesions: results from the PARADIGM study. Eur Heart J Cardiovasc Imaging. 2023;24:1536&#x2013;1543. doi: 10.1093/ehjci/jead110</Citation><ArticleIdList><ArticleId IdType="pubmed">37232393</ArticleId></ArticleIdList></Reference><Reference><Citation>Puri R, Nicholls SJ, Shao M, Kataoka Y, Uno K, Kapadia SR, Tuzcu EM, Nissen SE. Impact of statins on serial coronary calcification during atheroma progression and regression. J Am Coll Cardiol. 2015;65:1273&#x2013;1282. doi: 10.1016/j.jacc.2015.01.036</Citation><ArticleIdList><ArticleId IdType="pubmed">25835438</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MC, Kwiecinski J, Doris M, McElhinney P, D&#x2019;Souza MS, Cadet S, Adamson PD, Moss AJ, Alam S, Hunter A, et al. Sex-specific computed tomography coronary plaque characterization and risk of myocardial infarction. JACC Cardiovasc Imaging. 2021;14:1804&#x2013;1814. doi: 10.1016/j.jcmg.2021.03.004</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435010</ArticleId><ArticleId IdType="pubmed">33865779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferencik M, Mayrhofer T, Bittner DO, Emami H, Puchner SB, Lu MT, Meyersohn NM, Ivanov AV, Adami EC, Patel MR, et al. Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol. 2018;3:144&#x2013;152. doi: 10.1001/jamacardio.2017.4973</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5838601</ArticleId><ArticleId IdType="pubmed">29322167</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuchtner G, Beyer C, Barbieri F, Spitaler P, Dichtl W, Friedrich G, Widmann G, Plank F. The atherosclerosis profile by coronary computed tomography angiography (CTA) in symptomatic patients with coronary artery calcium score zero. Diagnostics (Basel). 2022;12:2042. doi: 10.3390/diagnostics12092042</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9498007</ArticleId><ArticleId IdType="pubmed">36140444</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir K, Cainzos-Achirica M, Valero-Elizondo J, Ali SS, Havistin R, Lakshman S, Blaha MJ, Blankstein R, Shapiro MD, Arias L, et al. Coronary atherosclerosis in an asymptomatic U.S. population. JACC Cardiovasc Imaging. 2022;15:1604&#x2013;1618. doi: 10.1016/j.jcmg.2022.03.010</Citation><ArticleIdList><ArticleId IdType="pubmed">36075621</ArticleId></ArticleIdList></Reference><Reference><Citation>Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332:73&#x2013;78. doi: 10.1136/bmj.38678.389583.7C</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1326926</ArticleId><ArticleId IdType="pubmed">16371403</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, O&#x2019;Neil A, Jiao Y, Wang L, Huang J, Lan Y, Zhu Y, Yu C. Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants. BMC Med. 2019;17:136. doi: 10.1186/s12916-019-1355-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625042</ArticleId><ArticleId IdType="pubmed">31296205</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold SV, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Mues KE, Alam S, Elliott-Davey M, Bhatt DL, Cannon CP, et al. ; GOULD Investigators. Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease. Circulation. 2019;140:618&#x2013;620. doi: 10.1161/CIRCULATIONAHA.119.041730</Citation><ArticleIdList><ArticleId IdType="pubmed">31174429</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahoual G, Zeitouni M, Charpentier E, Ritvo PG, Rouanet S, Procopi N, Boukhelifa S, Charleux P, Guedeney P, Kerneis M, et al. Phenotyping coronary plaque by computed tomography in premature coronary artery disease. Eur Heart J Cardiovasc Imaging. 2024;25:257&#x2013;266. doi: 10.1093/ehjci/jead212</Citation><ArticleIdList><ArticleId IdType="pubmed">37597177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kral BG, Becker LC, Vaidya D, Yanek LR, Qayyum R, Zimmerman SL, Dey D, Berman DS, Moy TF, Fishman EK, et al. Noncalcified coronary plaque volumes in healthy people with a family history of early onset coronary artery disease. Circ Cardiovasc Imaging. 2014;7:446&#x2013;453. doi: 10.1161/CIRCIMAGING.113.000980</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4419782</ArticleId><ArticleId IdType="pubmed">24577355</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis EM, Collins BL, Singh A, Biery DW, Fatima A, Qamar A, Berman AN, Gupta A, Cawley M, Wood MJ, et al. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registry. Eur Heart J. 2020;41:4127&#x2013;4137. doi: 10.1093/eurheartj/ehaa662</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7700756</ArticleId><ArticleId IdType="pubmed">33049774</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082&#x2013;e1143. doi: 10.1161/CIR.0000000000000625</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403606</ArticleId><ArticleId IdType="pubmed">30586774</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596&#x2013;e646. doi: 10.1161/CIR.0000000000000678</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7734661</ArticleId><ArticleId IdType="pubmed">30879355</ArticleId></ArticleIdList></Reference><Reference><Citation>Banach M, Serban C, Sahebkar A, Mikhailidis DP, Ursoniu S, Ray KK, Rysz J, Toth PP, Muntner P, Mosteoru S, et al. ; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies. BMC Med. 2015;13:229. doi: 10.1186/s12916-015-0459-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4575433</ArticleId><ArticleId IdType="pubmed">26385210</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rosendael AR, van den Hoogen IJ, Gianni U, Ma X, Tantawy SW, Bax AM, Lu Y, Andreini D, Al-Mallah MH, Budoff MJ, et al. Association of statin treatment with progression of coronary atherosclerotic plaque composition. JAMA Cardiol. 2021;6:1257&#x2013;1266. doi: 10.1001/jamacardio.2021.3055</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8374741</ArticleId><ArticleId IdType="pubmed">34406326</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong Y, Giovannucci J, Pang SN, Hong W, Han D, Berman DS, Dey D, Nicholls SJ, Nerlekar N, Lin A. Coronary artery calcium density and risk of cardiovascular events: a systematic review and meta-analysis. JACC Cardiovasc Imaging. 2025;18:294&#x2013;304. doi: 10.1016/j.jcmg.2024.07.024</Citation><ArticleIdList><ArticleId IdType="pubmed">39243235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacaita PG, Luger A, Troger F, Widmann G, Feuchtner GM. Photon-counting detector computed tomography (PCD-CT): a new era for cardiovascular imaging? current status and future outlooks. J Cardiovasc Dev Dis. 2024;11:127. doi: 10.3390/jcdd11040127</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11050624</ArticleId><ArticleId IdType="pubmed">38667745</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40216258</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2472-6311</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>SLAS technology</Title><ISOAbbreviation>SLAS Technol</ISOAbbreviation></Journal><ArticleTitle>AI driven cardiovascular risk prediction using NLP and Large Language Models for personalized medicine in athletes.</ArticleTitle><Pagination><StartPage>100286</StartPage><MedlinePgn>100286</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.slast.2025.100286</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2472-6303(25)00044-5</ELocationID><Abstract><AbstractText>The performance and long-term health of athletes are significantly influenced by their cardiovascular resilience and associated risk factors. This study explores the innovative applications of Natural Language Processing (NLP) and Large Language Models (LLMs) in biomedical diagnostics, particularly for AI-driven arrhythmia detection, hypertrophic cardiomyopathy (HCM) in athletes, and personalized medicine. The complexity of analysing diverse biomedical datasets, such as electrocardiograms (ECG), clinical records, genetic screening reports, and imaging results, poses challenges in obtaining precise early diagnoses. To address these issues, we introduce a hybrid machine learning (ML) framework that integrates the Wolf Pack Search Algorithm Dynamic Random Forest (WPSA-DRF) with a RoBERTa-based LLM to enhance the accuracy of cardiovascular disease predictions. Using advanced NLP techniques, including biomedical text mining, entity recognition, and feature extraction, the system processes structured and unstructured clinical data to detect abnormalities associated with sudden cardiac arrest (SCA), arrhythmias, and genetic cardiomyopathies. The proposed system achieves a diagnostic accuracy of 92.5 %, precision of 92.7 %, recall of 99.23 %, and F1-score of 95.6 %, outperforming traditional diagnostic methodologies. Furthermore, the research underscores the role of LLMs in personalized medicine, identifying patient-specific risk factors and optimizing treatment pathways for cardiac patients. This work highlights how NLP-driven AI solutions are transforming biomedical research, accelerating early disease detection, and improving clinical decision-making for both athletes and the general population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ang</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Graduate School of Arts and Science, Dongshin University, Naju, 58245, South Korea. Electronic address: liang95965@Gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yunxin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Basic Teaching and Research, Jilin Sport University, Changchun, Jilin, 130022, China. Electronic address: 18737012812@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hongxu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Physical Education, Zhengzhou University of Science and Technology, Zhengzhou, Henan, 450064, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>SLAS Technol</MedlineTA><NlmUniqueID>101697564</NlmUniqueID><ISSNLinking>2472-6303</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="Y">Precision Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056352" MajorTopicYN="Y">Athletes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009323" MajorTopicYN="Y">Natural Language Processing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000098342" MajorTopicYN="N">Large Language Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmia Detection</Keyword><Keyword MajorTopicYN="N">Artificial Intelligence in Healthcare</Keyword><Keyword MajorTopicYN="N">Biomedical Text Mining</Keyword><Keyword MajorTopicYN="N">Hypertrophic Cardiomyopathy in Athletes</Keyword><Keyword MajorTopicYN="N">Large Language Models (LLMs)</Keyword><Keyword MajorTopicYN="N">Natural Language Processing (NLP)</Keyword><Keyword MajorTopicYN="N">Personalized Medicine</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>11</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40216258</ArticleId><ArticleId IdType="doi">10.1016/j.slast.2025.100286</ArticleId><ArticleId IdType="pii">S2472-6303(25)00044-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40040169</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2694-0604</ISSN><JournalIssue CitedMedium="Internet"><Volume>2024</Volume><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference</Title><ISOAbbreviation>Annu Int Conf IEEE Eng Med Biol Soc</ISOAbbreviation></Journal><ArticleTitle>Can Generative AI Learn Physiological Waveform Morphologies? A Study on Denoising Intracardiac Signals in Ischemic Cardiomyopathy.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>4</EndPage><MedlinePgn>1-4</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1109/EMBC53108.2024.10782966</ELocationID><Abstract><AbstractText>Reducing electrophysiological (EP) signal noise is essential for diagnosis, mapping, and ablation, yet traditional approaches are suboptimal. This study tests the hypothesis that generative artificial intelligence (AI), specifically Variational Autoencoders (VAEs), can effectively denoise these signals by forming robust internal representations of 'clean' signals. Utilizing a dataset of 5706 time series from 42 patients with ischemic cardiomyopathy at risk of cardiac sudden death, we set out to apply a &#x3b2;-VAE model to denoise and reconstruct intra-ventricular monophasic action potential (MAP) signals, which have verifiable morphology. The &#x3b2;-VAE model is evaluated against various noise types, including EP noise, demonstrating superior denoising performance compared to traditional methods (Pearson's Correlation of denoised vs original of 0.967 &#xb1; 0.009 for our proposed model vs 0.879 &#xb1; 0.022 for the best performing baseline). Results indicate that the model effectively reduces a wide array of noise types, particularly EP noise. We conclude that generative AI provides powerful tools that can eliminate diverse sources of noise in single beats by learning essential signal features without manual annotation, outperforming state-of-the-art denoising techniques.Clinical Relevance- The proposed &#x3b2;-VAE model's ability to effectively denoise and reconstruct intracardiac signals, particularly in the challenging context of arrhythmias, can significantly enhance diagnostic accuracy across a variety of heart rhythm disorders and improve treatment efficacy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruiperez-Campillo</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Ryser</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sutter</LastName><ForeName>Thomas M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Ruibin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Prasanth</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Deb</LastName><ForeName>Brototo</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Brennan</LastName><ForeName>Kelly A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Kolk</LastName><ForeName>Maarten Z H</ForeName><Initials>MZH</Initials></Author><Author ValidYN="Y"><LastName>Tjong</LastName><ForeName>Fleur V Y</ForeName><Initials>FVY</Initials></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Albert J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Narayan</LastName><ForeName>Sanjiv M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Vogt</LastName><ForeName>Julia E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL149134</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL162260</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Int Conf IEEE Eng Med Biol Soc</MedlineTA><NlmUniqueID>101763872</NlmUniqueID><ISSNLinking>2375-7477</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012815" MajorTopicYN="Y">Signal Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059629" MajorTopicYN="N">Signal-To-Noise Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>5</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40040169</ArticleId><ArticleId IdType="mid">NIHMS2075097</ArticleId><ArticleId IdType="pmc">PMC12061072</ArticleId><ArticleId IdType="doi">10.1109/EMBC53108.2024.10782966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Starreveld Roeliene, et al. &#x201c;The impact of filter settings on morphology of unipolar fibrillation potentials.&#x201d; Journal of Cardiovascular Translational Research 13 (2020): 953&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7708344</ArticleId><ArticleId IdType="pubmed">32410210</ArticleId></ArticleIdList></Reference><Reference><Citation>Groot De, Natasja MS, et al. &#x201c;Critical appraisal of technologies to assess electrical activity during atrial fibrillation: a position paper from the European heart rhythm association and european society of cardiology working group on ecardiology in collaboration with the heart rhythm society, asia pacific heart rhythm society, latin American heart rhythm society and computing in cardiology.&#x201d; EP Europace 24.2 (2022): 313&#x2013;330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11636570</ArticleId><ArticleId IdType="pubmed">34878119</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingma Diederik P., and Max Welling. &#x201c;Auto-encoding variational bayes.&#x201d; arXiv preprint arXiv:1312.6114 (2013).</Citation></Reference><Reference><Citation>Vincent Pascal, et al. &#x201c;Extracting and composing robust features with denoising autoencoders.&#x201d; Proceedings of the 25th international conference on Machine learning. 2008.</Citation></Reference><Reference><Citation>Higgins Irina, et al. &#x201c;beta-vae: Learning basic visual concepts with a constrained variational framework.&#x201d; International conference on learning representations. 2016.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40093989</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Performance of an AI prediction tool for new-onset atrial fibrillation after coronary artery bypass grafting.</ArticleTitle><Pagination><StartPage>103131</StartPage><MedlinePgn>103131</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">103131</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2025.103131</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There is lack of tools to predict new-onset postoperative atrial fibrillation (NOAF) after coronary artery bypass grafting (CABG). We aimed to develop and validate a novel AI-based bedside tool that accurately predicts predict NOAF after CABG.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Data from 2994 patients who underwent CABG between March 2015 and July 2024&#xa0;at two tertiary hospitals in China were retrospectively analyzed. 2486 patients from one hospital formed the derivation cohort, split 7:3 into training and test sets, while the 508 patients from a separate hospital formed the external validation cohort. A stacking model integrating 11 base learners was developed and evaluated using Accuracy, Precision, Recall, F1 score, and Area Under Curve (AUC). SHapley Additive exPlanations (SHAP) values were calculated and plotted to interpret the contributions of individual characteristics to the model's predictions.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">Seventy-seven predictive characteristics were analyzed. The stacking model achieved superior performance with AUCs 0&#xb7;931 and F1 scores 0&#xb7;797 in the independent external validation, outperforming CHA2DS2-VASc, HATCH, and POAF scores (AUC 0&#xb7;931 vs. 0&#xb7;713, 0&#xb7;708, and 0&#xb7;667; <i>p</i>&#xa0;&lt;&#xa0;0&#xb7;05). SHAP value indicate that the importance of predictive features for NOAF, in descending order, include: Brain natriuretic peptide, Left ventricular end-diastolic diameter, Ejection fraction, BMI, &#x3b2;-receptor blockers, Duration of surgery, Age, Neutrophil percentage-to-albumin ratio, Myocardial infarction, Left atrial diameter, Hypertension, and smoking status. Subsequently, we constructed an easy-to-use bedside clinical tool for NOAF risk assessment leveraging these characteristics.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">The AI-based tool offers superior prediction of NOAF, outperforming three existing predictive tools. Future studies should further explore how various patient characteristics influence the timing of NOAF onset, whether early or late.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This work was funded by Lingnan Nightingale Nursing Research Institute of Guangdong Province, and Guangdong Nursing Society (GDHLYJYZ202401).</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Hualong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jinan University School of Nursing, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dalong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Yunfu People's Hospital, Yunfu, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Weitao</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Qiuying</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Qingyuan People's Hospital, Qingyuan, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Qinai</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Laboratory Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Lizhen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoge</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Jinan University School of Nursing, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qinyang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Jinan University School of Nursing, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xianliang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Nursing and Health Studies, Hong Kong Metropolitan University, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Qiaohong</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Jinan University School of Nursing, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Coronary artery bypass grafting</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Postoperative atrial fibrillation</Keyword><Keyword MajorTopicYN="N">Prediction model</Keyword><Keyword MajorTopicYN="N">Web tool</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>17</Day><Hour>15</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>17</Day><Hour>15</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40093989</ArticleId><ArticleId IdType="pmc">PMC11908608</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2025.103131</ArticleId><ArticleId IdType="pii">S2589-5370(25)00063-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eikelboom R., Sanjanwala R., Le M.-L., Yamashita M.H., Arora R.C. Postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis. Ann Thorac Surg. 2021;111:544&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">32687821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Qiao H., Yang B., et al. Development and validation of a diagnostic model based on left atrial diameter to predict postoperative atrial fibrillation after off-pump coronary artery bypass grafting. J&#xa0;Thorac Dis. 2023;15:3708&#x2013;3725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10407488</ArticleId><ArticleId IdType="pubmed">37559620</ArticleId></ArticleIdList></Reference><Reference><Citation>Engin M., Ayd&#x131;n C. Investigation of the effect of HATCH score and coronary artery disease complexity on atrial fibrillation after on-pump coronary artery bypass graft surgery. Med Princ Pract. 2020;30:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7923874</ArticleId><ArticleId IdType="pubmed">32422635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotter K., Yadav S., Saxena P., Vangaveti V., John B. Predictors of atrial fibrillation post coronary artery bypass graft surgery: new scoring system. Open Heart. 2023;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10277528</ArticleId><ArticleId IdType="pubmed">37316327</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedetto U., Gaudino M.F., Dimagli A., et al. Postoperative atrial fibrillation and long-term risk of stroke after isolated coronary artery bypass graft surgery. Circulation. 2020;142:1320&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7845484</ArticleId><ArticleId IdType="pubmed">33017213</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Lall S., Zheng V., Buckley P., Damiano R.J., Schuessler R.B. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J&#xa0;Thorac Cardiovasc Surg. 2011;141:559&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917532</ArticleId><ArticleId IdType="pubmed">20434173</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan K., Chen L., Liu F., et al. Predicting new-onset postoperative atrial fibrillation following isolated coronary artery bypass grafting: development and validation of a novel nomogram. Int J Gen Med. 2022;15:937&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801512</ArticleId><ArticleId IdType="pubmed">35115819</ArticleId></ArticleIdList></Reference><Reference><Citation>Arslan A.K., Erdil N., Guldogan E., Colak C., Akca B., Colak M.C. Prediction of postcoronary artery bypass grafting atrial fibrillation: POAFRiskScore tool. Thorac Cardiovasc Surg. 2023;71:282&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">34894632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.-L., Zeng M., Liu Y., et al. CHA2DS2-VASc score for identifying patients at high risk of postoperative atrial fibrillation after cardiac surgery: a meta-analysis. Ann Thorac Surg. 2020;109:1210&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pubmed">31521590</ArticleId></ArticleIdList></Reference><Reference><Citation>Emren V., Aldemir M., Duygu H., et al. Usefulness of HATCH score as a predictor of atrial fibrillation after coronary artery bypass graft. Kardiol Pol. 2016;74:749&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040011</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscalco G., Biancari F., Zanobini M., et al. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac surgery: the POAF score. J&#xa0;Am Heart Assoc. 2014;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187480</ArticleId><ArticleId IdType="pubmed">24663335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin T.H., Ashley S.W., Tsai T.C. Defining the role of machine learning in optimizing surgical outcomes. JAMA Surg. 2024;159(12):1432. doi: 10.1001/jamasurg.2024.4297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2024.4297</ArticleId><ArticleId IdType="pubmed">39382866</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Society of Cardiology, Chinese Medical Association, Heart Rhythm Committee of Chinese Society of Biomedical Engineering Chinese guidelines on diagnosis and management of atrial fibrillation. Chinese J Cardiovasc Dis. 2023;51:572&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">37312479</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinkels B.M., de Mol B.A., Kelder J.C., Vermeulen F.E., Ten Berg J.M. New-onset postoperative atrial fibrillation after aortic valve replacement: effect on long-term survival. J&#xa0;Thorac Cardiovasc Surg. 2017;154:492&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">28390762</ArticleId></ArticleIdList></Reference><Reference><Citation>A C., Vm C., Yh O., et al. Association of intracranial aneurysm rupture with smoking duration, intensity, and cessation. Neurology. 2017;89 doi: 10.1212/WNL.0000000000004419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004419</ArticleId><ArticleId IdType="pmc">PMC5649762</ArticleId><ArticleId IdType="pubmed">28855408</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane J., Chen H., Conigrave K.M., Hao W. Alcohol use in China. Alcohol Alcohol. 2003;38:537&#x2013;542.</Citation><ArticleIdList><ArticleId IdType="pubmed">14633640</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T., Shen H., Guo Q., et al. Association between neutrophil percentage-to-albumin ratio and all-cause mortality in critically Ill patients with coronary artery disease. Biomed Res Int. 2020;2020</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479485</ArticleId><ArticleId IdType="pubmed">32934964</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley R.D., Ensor J., Snell K.I.E., et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441.</Citation><ArticleIdList><ArticleId IdType="pubmed">32188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Chokengarmwong N., Yeh D.D., Chang Y., et al. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients. J&#xa0;Trauma Acute Care Surg. 2017;83:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">28463935</ArticleId></ArticleIdList></Reference><Reference><Citation>Akazawa T., Nishihara H., Iwata H., Warabi K., Ohshima M., Inada E. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J&#xa0;Anesth. 2008;22:347&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">19011771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochetkov A.I., Iyu Orlova, Ostroumova O.D., et al. Connection between &#x441;ardiac fibrosis biomarkers and echocardiography parameters in patients with various forms of atrial fibrillation. Medicinskij Sovet. 2024;6:170&#x2013;179.</Citation></Reference><Reference><Citation>Zhang J., Zhu C., Nie C., et al. Impact of body mass index on postoperative atrial fibrillation in patients with hypertrophic cardiomyopathy undergoing septal Myectomy. J&#xa0;Am Heart Assoc. 2022;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238498</ArticleId><ArticleId IdType="pubmed">35043680</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco A.C., Awata W.M.C., Lima T.S., et al. Three generation &#x3b2;-blockers for atrial fibrillation treatment. Curr Hypertens Rev. 2023;19:34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">35692167</ArticleId></ArticleIdList></Reference><Reference><Citation>Dave S. Incidence and risk factors for development of atrial fibrillation after cardiac surgery under cardiopulmonary bypass. Indian J Anaesth. 2019;63:512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573053</ArticleId><ArticleId IdType="pubmed">31263313</ArticleId></ArticleIdList></Reference><Reference><Citation>Akintoye E., Sellke F., Marchioli R., Tavazzi L., Mozaffarian D. Factors associated with postoperative atrial fibrillation and other adverse events after cardiac surgery. J&#xa0;Thorac Cardiovasc Surg. 2018;155:242&#x2013;251.e10.</Citation><ArticleIdList><ArticleId IdType="pubmed">28890081</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai Y. Inflammation and atrial fibrillation. J&#xa0;Arrythm. 2024;40:26&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10848572</ArticleId><ArticleId IdType="pubmed">38333377</ArticleId></ArticleIdList></Reference><Reference><Citation>Plakht Y., Gilutz H., Shiyovich A. Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project. Int J Cardiol. 2016;219:20&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">27257851</ArticleId></ArticleIdList></Reference><Reference><Citation>Creavin S.T., Noel-Storr A.H., Langdon R.J., et al. Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people. Cochrane Database Syst Rev. 2022;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9202995</ArticleId><ArticleId IdType="pubmed">35709018</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40328810</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>06</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Comparison of different AI systems for diagnosing sepsis, septic shock, and cardiogenic shock: a retrospective study.</ArticleTitle><Pagination><StartPage>15850</StartPage><MedlinePgn>15850</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15850</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-00830-9</ELocationID><Abstract><AbstractText>Sepsis, septic shock, and cardiogenic shock are life-threatening conditions associated with high mortality rates, but differentiating them is complex because they share certain symptoms. Using the Medical Information Mart for Intensive Care (MIMIC)-III database and artificial intelligence (AI), we aimed to increase diagnostic precision, focusing on Bayesian network classifiers (BNCs) and comparing them with other AI methods. Data from 5970 adults, including 950 patients with cardiogenic shock, 1946 patients with septic shock, and 3074 patients with sepsis, were extracted for this study. Of the original 51 variables included in the data records, 12 were selected for constructing the predictive model. The data were divided into training and validation sets at an 80:20 ratio, and the performance of the BNCs was evaluated and compared with that of other AI models, such as the one rule classifier (OneR), classification and regression tree (CART), and an artificial neural network (ANN), in terms of accuracy, sensitivity, specificity, precision, and F1-score. The BNCs exhibited an accuracy of 87.6% to 91.5%. The CART model demonstrated a notable 91.6% accuracy when only three decision levels were used, whereas the intricate ANN model reached 90.5% accuracy. Both the BNCs and the CART model allowed clear interpretation of the predictions. BNCs have the potential to be valuable tools in diagnostic tasks, with an accuracy, sensitivity, and precision comparable, in some cases, to those of ANNs while demonstrating superior interpretability.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Obmann</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, Klinikum Aschaffenburg-Alzenau, Aschaffenburg, Germany. dirk.obmann@klinikum-ab-alz.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, University of Regensburg, Regensburg, Germany. dirk.obmann@klinikum-ab-alz.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;nch</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Engineering, Competence Centre for Artificial Intelligence, TH Aschaffenburg (University of Applied Sciences), Aschaffenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graf</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University of Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Jouanne-Diedrich</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Faculty of Engineering, Competence Centre for Artificial Intelligence, TH Aschaffenburg (University of Applied Sciences), Aschaffenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zausig</LastName><ForeName>York A</ForeName><Initials>YA</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care, Klinikum Aschaffenburg-Alzenau, Aschaffenburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, University of Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016571" MajorTopicYN="N">Neural Networks, Computer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="N">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ai</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Cardiogenic shock</Keyword><Keyword MajorTopicYN="N">Decision support systems</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: An inquiry was submitted to the Ethics Committee of the Bavarian Medical Association. Following an internal review, no further consultation with the ethics committee was deemed necessary. The data are widely accessible to researchers under a data use agreement, so the study was exempt from the need for specific ethical review. Nevertheless, we adhered to fundamental ethical principles and ensured the validity and fairness of the study process.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>7</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>6</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40328810</ArticleId><ArticleId IdType="pmc">PMC12056228</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-00830-9</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-00830-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA315, 801&#x2013;810 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med.47, 1181&#x2013;1247 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahdatpour, C., Collins, D. &amp; Goldberg, S. Cardiogenic shock. J. Am. Heart Assoc.8, e011991 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6507212</ArticleId><ArticleId IdType="pubmed">30947630</ArticleId></ArticleIdList></Reference><Reference><Citation>Werdan, K. et al. Kurzversion der 2. Auflage der deutsch-&#xf6;sterreichischen S3-Leitlinie infarkt-bedingter kardiogener schock&#x2014;Diagnose, monitoring und therapie. Kardiologe14, 364&#x2013;395 (2020).</Citation></Reference><Reference><Citation>Standl, T. et al. The nomenclature, definition and distinction of types of shock. Dtsch Arztebl Int.115, 757&#x2013;768 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323133</ArticleId><ArticleId IdType="pubmed">30573009</ArticleId></ArticleIdList></Reference><Reference><Citation>Carbone, F., Liberale, L., Preda, A., Schindler, T. H. &amp; Montecucco, F. Septic cardiomyopathy: From pathophysiology to the clinical setting. Cells11, 2833 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9496713</ArticleId><ArticleId IdType="pubmed">36139408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom, J. E. et al. Incidence and outcomes of nontraumatic shock in adults using emergency medical services in Victoria, Australia. JAMA Netw Open5, e2145179 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792885</ArticleId><ArticleId IdType="pubmed">35080603</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport, T. &amp; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J.6, 94&#x2013;98 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6616181</ArticleId><ArticleId IdType="pubmed">31363513</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, K. H., Beam, A. L. &amp; Kohane, I. S. Artificial intelligence in healthcare. Nat. Biomed. Eng.2, 719&#x2013;731 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">31015651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zihni, E. et al. Opening the black box of artificial intelligence for clinical decision support: A study predicting stroke outcome. PLoS ONE15, e0231166 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135268</ArticleId><ArticleId IdType="pubmed">32251471</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, A., Pollard, T. &amp; Mark, R. MIMIC-III clinical database. PhysioNet (2023).</Citation></Reference><Reference><Citation>Johnson, A., Pollard, T., Blundell, J., Gow, B., Erinhong, Paris, N., et al. MIT-LCP/Mimic-Code: MIMIC Code v2.2.1. Zenodo; (2022).</Citation></Reference><Reference><Citation>Elixhauser, A., Steiner, C., Harris, D. R. &amp; Coffey, R. M. Comorbidity measures for use with administrative data. Med. Care36, 8&#x2013;27 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan, H. et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care43, 1130&#x2013;1139 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaik, N. B., Pedapati, S. R., Taqvi, S. A. A., Othman, A. R. &amp; Dzubir, F. A. A. A feed-forward back propagation neural network approach to predict the life condition of crude oil pipeline. Processes8, 661 (2020).</Citation></Reference><Reference><Citation>Breiman, L. Classification and Regression Trees (Routledge, 1984).</Citation></Reference><Reference><Citation>Hand, D. J. &amp; Till, R. J. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach. Learn.45, 171&#x2013;186 (2001).</Citation></Reference><Reference><Citation>Mihaljevic, B., Bielza, C. &amp; Larranaga, P. bnclassify: Learning Bayesian network classifiers. R J.10, 455 (2018).</Citation></Reference><Reference><Citation>Jouanne-Diedrich, H. V. OneR: one rule machine learning classification algorithm with enhancements (2017). https://CRAN.R-project.org/package=OneR. Accessed 23 Feb 2024.</Citation></Reference><Reference><Citation>Venables, B. &amp; Ripley, B. Modern Applied Statistics with S (Springer, 2002).</Citation></Reference><Reference><Citation>Kuhn, M. caret: Classification and regression training. 2022. https://CRAN.R-project.org/package=caret. Accessed 12 May 2024.</Citation></Reference><Reference><Citation>Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf.10.1186/1471-2105-12-77 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau, T. &amp; Atkinson, B. rpart: Recursive partitioning and regression trees (2022). https://CRAN.R-project.org/package=rpart. Accessed 12 Feb 2024.</Citation></Reference><Reference><Citation>Wu, M., Du, X., Gu, R. &amp; Wei, J. Artificial intelligence for clinical decision support in sepsis. Front Med.8, 665464 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155362</ArticleId><ArticleId IdType="pubmed">34055839</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, Z. et al. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction. Ann. Transl. Med.9, 1162 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350690</ArticleId><ArticleId IdType="pubmed">34430603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, Y. et al. Early prediction of cardiogenic shock using machine learning. Front Cardiovasc. Med.9, 862424 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9326048</ArticleId><ArticleId IdType="pubmed">35911549</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Y., Lui, A., Goldstein, M., Sudarshan, M., Tinsay, A., Tsui, C., et al. A dynamic risk score for early prediction of cardiogenic shock using machine learning. arXiv 10.48550/arXiv.2303.12888 (2023).</Citation></Reference><Reference><Citation>Rahman, F. et al. Using machine learning for early prediction of cardiogenic shock in patients with acute heart failure. J. Soc. Cardiovasc. Angiogr. Interv.1, 100308 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11307874</ArticleId><ArticleId IdType="pubmed">39131966</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, M. &amp; Islam, A. K. M. N. Deep learning: Hope or hype. Ann. Data Sci.7, 427&#x2013;432 (2020).</Citation></Reference><Reference><Citation>Johansson, U., S&#xf6;nstr&#xf6;d, C., Norinder, U. &amp; Bostr&#xf6;m, H. Trade-off between accuracy and interpretability for predictive in silico modeling. Future Med. Chem.3, 647&#x2013;663 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21554073</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng, R. &amp; Yeghiazarians, Y. Post myocardial infarction cardiogenic shock: A review of current therapies. J. Intensive Care Med.28, 151&#x2013;165. 10.1177/0885066611411407 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">21747126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato, R., Hasegawa, D., Guo, S., Nuqali, A. E. &amp; Moreno, J. E. P. Sepsis-induced cardiogenic shock: Controversies and evidence gaps in diagnosis and management. J. Intensive Care13, 1. 10.1186/s40560-024-00770-y (2025).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11694368</ArticleId><ArticleId IdType="pubmed">39748440</ArticleId></ArticleIdList></Reference><Reference><Citation>Soussi, S. et al. Identifying biomarker-driven subphenotypes of cardiogenic shock: Analysis of prospective cohorts and randomized controlled trials. EClinicalMedicine79, 103013. 10.1016/j.eclinm.2024.103013 (2025).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11718329</ArticleId><ArticleId IdType="pubmed">39802301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zweck, E. et al. Phenotyping cardiogenic shock. J. Am. Heart Assoc.10, e020085. 10.1161/JAHA.120.020085 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8483502</ArticleId><ArticleId IdType="pubmed">34227396</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentzer, J. C. et al. Machine learning approaches for phenotyping in cardiogenic shock and critical illness: Part 2 of 2. JACC Adv.1, 100126. 10.1016/j.jacadv.2022.100126 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11198618</ArticleId><ArticleId IdType="pubmed">38939698</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, C., Li, Y., Wang, F. &amp; Peng, Z. Application of machine learning for clinical subphenotype identification in sepsis. Infect. Dis. Ther.11, 1949&#x2013;1964. 10.1007/s40121-022-00684-y (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9617989</ArticleId><ArticleId IdType="pubmed">36006560</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour, C. W. et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA321, 2003&#x2013;2017. 10.1001/jama.2019.5791 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. et al. Identification of clinical subphenotypes of sepsis after laparoscopic surgery. Laparosc. Endosc. Robot. Surg.7, 16&#x2013;26. 10.1016/j.lers.2024.02.001 (2024).</Citation></Reference><Reference><Citation>Subbaswamy, A. et al. A data-driven framework for identifying patient subgroups on which an AI/machine learning model may underperform. NPJ Digit. Med.7, 334. 10.1038/s41746-024-01275-6 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11582698</ArticleId><ArticleId IdType="pubmed">39572755</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40287120</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6744</ISSN><JournalIssue CitedMedium="Internet"><Volume>288</Volume><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>American heart journal</Title><ISOAbbreviation>Am Heart J</ISOAbbreviation></Journal><ArticleTitle>Opportunistic assessment of abdominal aortic calcification using artificial intelligence (AI) predicts coronary artery disease and cardiovascular events.</ArticleTitle><Pagination><StartPage>122</StartPage><EndPage>130</EndPage><MedlinePgn>122-130</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahj.2025.04.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-8703(25)00137-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Abdominal computed tomography (CT) is commonly performed in adults. Abdominal aortic calcification (AAC) can be visualized and quantified using artificial intelligence (AI) on CTs performed for other clinical purposes (opportunistic CT). We sought to investigate the value of AI-enabled AAC quantification as a predictor of coronary artery disease and its association with cardiovascular events.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A fully automated AI algorithm to quantify AAC from the diaphragm to aortic bifurcation using the Agatston score was retrospectively applied to a cohort of patient that underwent both noncontrast abdominal CT for routine clinical care and cardiac CT for coronary artery calcification (CAC) assessment. Subjects were followed for a median of 36 months for major adverse cardiovascular events (MACE, composite of death, myocardial infarction [MI], ischemic stroke, coronary revascularization) and major coronary events (MCE, MI or coronary revascularization). The 10-year Predicting Risk of cardiovascular disease EVENTs (PREVENT) cardiovascular risk score was calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our cohort included 3599 patients (median age 61 years, 49% female, 73% white) with an evaluable abdominal and cardiac CT. There was a positive correlation between presence and severity of AAC and CAC (r = 0.56, P &lt; .001). AAC showed excellent discriminatory power for detecting or ruling out any CAC (AUC for PREVENT risk score 0.701 [0.683-0.718]; AUC for PREVENT plus AAC 0.782 [0.767-0.797]; P &lt; .001). There were 324 MACE, of which 246 were MCE. Following adjustment for the PREVENT score, the presence of AAC was associated with a significant risk of MACE (adjHR 2.26, 95% CI 1.67-3.07, P &lt; .001) and MCE (adjHR 2.58, 95% CI 1.80-3.71, P &lt; .001). A doubling of the AAC score resulted in an 11% increase in the risk of MACE and a 13% increase in the risk of MCE.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using opportunistic abdominal CTs, assessment of AAC using a fully automated AI algorithm, predicted CAC and was independently associated with cardiovascular events. These data support the use of opportunistic imaging for cardiovascular risk assessment. Future studies should investigate whether opportunistic imaging can help guide appropriate cardiovascular prevention strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berger</LastName><ForeName>Jeffrey S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Cardiology Division, Department of Medicine, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Department of Population Health, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iturrate</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westerhoff</LastName><ForeName>Malte</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Visage Imaging, GmbH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gyftopoulos</LastName><ForeName>Soterios</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dane</LastName><ForeName>Bari</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Judy</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Biostatistics, Department of Population Health, NYU Langone Health and Grossman School of Medicine, New York, NY; Division of Biostatistics, Weill Cornell Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Recht</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bredella</LastName><ForeName>Miriam A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Radiology, NYU Langone Health and Grossman School of Medicine, New York, NY. Electronic address: Miriam.Bredella@nyulangone.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG065330</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM013344</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL144993</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J</MedlineTA><NlmUniqueID>0370465</NlmUniqueID><ISSNLinking>0002-8703</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061205" MajorTopicYN="Y">Vascular Calcification</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001012" MajorTopicYN="Y">Aorta, Abdominal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="Y">Aortic Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of competing interest MW: Dr. Westerhoff is an employee of Visage Imaging and shareholder of its parent company Promedicus Ltd. BD: Dr. Dane received speaker honorarium, research support, and travel from Siemens Healthineers.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>7</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>3</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>26</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40287120</ArticleId><ArticleId IdType="mid">NIHMS2077269</ArticleId><ArticleId IdType="pmc">PMC12145238</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2025.04.019</ArticleId><ArticleId IdType="pii">S0002-8703(25)00137-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>North BJ, Sinclair DA. The intersection between aging and cardiovascular disease. Circ Res. 2012;110(8):1097&#x2013;108. doi: 10.1161/CIRCRESAHA.111.246876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.246876</ArticleId><ArticleId IdType="pmc">PMC3366686</ArticleId><ArticleId IdType="pubmed">22499900</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanyar A, Newman AB. The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med. 2009;25(4):563&#x2013;77, vii. doi: 10.1016/j.cger.2009.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2009.07.007</ArticleId><ArticleId IdType="pmc">PMC2797320</ArticleId><ArticleId IdType="pubmed">19944261</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: A review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211. Epub 20170101. doi: 10.1177/2048004016687211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048004016687211</ArticleId><ArticleId IdType="pmc">PMC5331469</ArticleId><ArticleId IdType="pubmed">28286646</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107(3):490&#x2013;7. doi: 10.1161/01.cir.0000048894.99865.02.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000048894.99865.02</ArticleId><ArticleId IdType="pubmed">12551876</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E, Amadi C, Williams MC, Agarwal PP. Coronary Artery Disease: Role of Computed Tomography and Recent Advances. Radiol Clin North Am. 2024;62(3):385&#x2013;98. Epub 20240120. doi: 10.1016/j.rcl.2023.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rcl.2023.12.017</ArticleId><ArticleId IdType="pubmed">38553176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A, Pandey A, Ayers CR, Khera A, Sperling LS, Szklo MS, Gottesman RF, Budoff MJ, Blaha MJ, Blumenthal RS, Nasir K, Joshi PH. Predictive Value of Coronary Artery Calcium Score Categories for Coronary Events Versus Strokes: Impact of Sex and Race: MESA and DHS. Circ Cardiovasc Imaging. 2020;13(8):e010153. Epub 20200818. doi: 10.1161/CIRCIMAGING.119.010153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.119.010153</ArticleId><ArticleId IdType="pmc">PMC7440773</ArticleId><ArticleId IdType="pubmed">32806939</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzlin N, Chapel A, Adefisoye J, Garg K, Zlochiver V, Walczak S, Plautz D, Peterson M, Muthukumar L, Harland DR, Jain R, Port S, Galazka P. Differences and Disparities Among Self-Referred and Physician-Referred Populations Undergoing Coronary Artery Calcium Scanning. Circ Cardiovasc Imaging. 2024;17(2):e015712. Epub 20240220. doi: 10.1161/CIRCIMAGING.123.015712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.123.015712</ArticleId><ArticleId IdType="pubmed">38377241</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Munoz D, Smith SC Jr., Virani SS, Williams KA Sr., Yeboah J, Ziaeian B 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e563&#x2013;e95. Epub 20190317. doi: 10.1161/CIR.0000000000000677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000677</ArticleId><ArticleId IdType="pmc">PMC8351755</ArticleId><ArticleId IdType="pubmed">30879339</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickhardt PJ. Value-added Opportunistic CT Screening: State of the Art. Radiology. 2022;303(3):E41. doi: 10.1148/radiol.229010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.229010</ArticleId><ArticleId IdType="pmc">PMC9083232</ArticleId><ArticleId IdType="pubmed">35289661</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickhardt PJ, Graffy PM, Perez AA, Lubner MG, Elton DC, Summers RM. Opportunistic Screening at Abdominal CT: Use of Automated Body Composition Biomarkers for Added Cardiometabolic Value. Radiographics. 2021;41(2):524&#x2013;42. doi: 10.1148/rg.2021200056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2021200056</ArticleId><ArticleId IdType="pmc">PMC7924410</ArticleId><ArticleId IdType="pubmed">33646902</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredella MA. Opportunistic Imaging: Point-Increasing the Value of Diagnostic Imaging. AJR Am J Roentgenol. 2023;221(2):171&#x2013;2. Epub 20230111. doi: 10.2214/AJR.22.28851.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.22.28851</ArticleId><ArticleId IdType="pubmed">36629309</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF. Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA. 1999;281(8):727&#x2013;35. doi: 10.1001/jama.281.8.727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.281.8.727</ArticleId><ArticleId IdType="pubmed">10052443</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor SD, Graffy PM, Zea R, Pickhardt PJ. Does Nonenhanced CT-based Quantification of Abdominal Aortic Calcification Outperform the Framingham Risk Score in Predicting Cardiovascular Events in Asymptomatic Adults? Radiology. 2019;290(1):108&#x2013;15. Epub 20181002. doi: 10.1148/radiol.2018180562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2018180562</ArticleId><ArticleId IdType="pubmed">30277443</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle K, Neeland IJ, Chow SL, Rangaswami J, Pencina MJ, Ndumele CE, Coresh J, Chronic Kidney Disease Prognosis C, the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory G. Development and Validation of the American Heart Association&#x2019;s PREVENT Equations. Circulation. 2024;149(6):430&#x2013;49. Epub 20231110. doi: 10.1161/CIRCULATIONAHA.123.067626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.067626</ArticleId><ArticleId IdType="pmc">PMC10910659</ArticleId><ArticleId IdType="pubmed">37947085</ArticleId></ArticleIdList></Reference><Reference><Citation>Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr., Detrano R Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827&#x2013;32. doi: 10.1016/0735-1097(90)90282-t.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(90)90282-t</ArticleId><ArticleId IdType="pubmed">2407762</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;i&#xe7;ek &#xd6;, Abdulkadir A, Lienkamp SS, Brox T, Ronneberger O, editors. 3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation2016; Cham: Springer International Publishing.</Citation></Reference><Reference><Citation>Graffy PM, Liu J, O&#x2019;Connor S, Summers RM, Pickhardt PJ. Automated segmentation and quantification of aortic calcification at abdominal CT: application of a deep learning-based algorithm to a longitudinal screening cohort. Abdom Radiol (NY). 2019;44(8):2921&#x2013;8. doi: 10.1007/s00261-019-02014-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00261-019-02014-2</ArticleId><ArticleId IdType="pubmed">30976827</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers RM, Elton DC, Lee S, Zhu Y, Liu J, Bagheri M, Sandfort V, Grayson PC, Mehta NN, Pinto PA, Linehan WM, Perez AA, Graffy PM, O&#x2019;Connor SD, Pickhardt PJ. Atherosclerotic Plaque Burden on Abdominal CT: Automated Assessment With Deep Learning on Noncontrast and Contrast-enhanced Scans. Acad Radiol. 2021;28(11):1491&#x2013;9. Epub 20200918. doi: 10.1016/j.acra.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acra.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7969468</ArticleId><ArticleId IdType="pubmed">32958429</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo-Kioeng-Shioe MS, Vavere AL, Arbab-Zadeh A, Schuijf JD, Rochitte CE, Chen MY, Rief M, Kofoed KF, Clouse ME, Scholte AJ, Miller JM, Betoko A, Blaha MJ, Cox C, Deckers JW, Lima JAC. Coronary Calcium Characteristics as Predictors of Major Adverse Cardiac Events in Symptomatic Patients: Insights From the CORE 320 Multinational Study. J Am Heart Assoc. 2019;8(6):e007201. doi: 10.1161/JAHA.117.007201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.007201</ArticleId><ArticleId IdType="pmc">PMC6475072</ArticleId><ArticleId IdType="pubmed">30879377</ArticleId></ArticleIdList></Reference><Reference><Citation>American Heart Association. Available from: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator.</Citation></Reference><Reference><Citation>Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC Jr., Sperling LS, Virani SS, Blumenthal RS. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019;139(25):e1162&#x2013;e77. Epub 20181110. doi: 10.1161/CIR.0000000000000638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000638</ArticleId><ArticleId IdType="pubmed">30586766</ArticleId></ArticleIdList></Reference><Reference><Citation>Onnis C, Virmani R, Kawai K, Nardi V, Lerman A, Cademartiri F, Scicolone R, Boi A, Congiu T, Faa G, Libby P, Saba L. Coronary Artery Calcification: Current Concepts and Clinical Implications. Circulation. 2024;149(3):251&#x2013;66. Epub 20240116. doi: 10.1161/CIRCULATIONAHA.123.065657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.065657</ArticleId><ArticleId IdType="pmc">PMC10794033</ArticleId><ArticleId IdType="pubmed">38227718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson E. Accuracy and Equity in Clinical Risk Prediction. N Engl J Med. 2024;390(2):100&#x2013;2. Epub 20240106. doi: 10.1056/NEJMp2311050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2311050</ArticleId><ArticleId IdType="pubmed">38198167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang ML, Massaro JM, Levitzky YS, Fox CS, Manders ES, Hoffmann U, O&#x2019;Donnell CJ. Prevalence and distribution of abdominal aortic calcium by gender and age group in a community-based cohort (from the Framingham Heart Study). Am J Cardiol. 2012;110(6):891&#x2013;6. Epub 20120620. doi: 10.1016/j.amjcard.2012.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.05.020</ArticleId><ArticleId IdType="pmc">PMC3432173</ArticleId><ArticleId IdType="pubmed">22727181</ArticleId></ArticleIdList></Reference><Reference><Citation>An C, Lee HJ, Lee HS, Ahn SS, Choi BW, Kim MJ, Chung YE. CT-based abdominal aortic calcification score as a surrogate marker for predicting the presence of asymptomatic coronary artery disease. Eur Radiol. 2014;24(10):2491&#x2013;8. Epub 20140717. doi: 10.1007/s00330-014-3298-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-014-3298-3</ArticleId><ArticleId IdType="pubmed">25030461</ArticleId></ArticleIdList></Reference><Reference><Citation>Oishi H, Horibe H, Yamase Y, Ueyama C, Takemoto Y, Shigeta T, Hibino T, Kondo T, Suzuki S, Ishii H, Murohara T. Predictive value of abdominal aortic calcification index for mid-term cardiovascular events in patients with acute coronary syndrome. Heart Vessels. 2020;35(5):620&#x2013;9. Epub 20191109. doi: 10.1007/s00380-019-01527-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-019-01527-6</ArticleId><ArticleId IdType="pubmed">31707516</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong ND, Lopez VA, Allison M, Detrano RC, Blumenthal RS, Folsom AR, Ouyang P, Criqui MH. Abdominal aortic calcium and multi-site atherosclerosis: the Multiethnic Study of Atherosclerosis. Atherosclerosis. 2011;214(2):436&#x2013;41. Epub 20100918. doi: 10.1016/j.atherosclerosis.2010.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2010.09.011</ArticleId><ArticleId IdType="pmc">PMC3040451</ArticleId><ArticleId IdType="pubmed">21035803</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow K, Szulc P, Schousboe JT, Kiel DP, Teixeira-Pinto A, Shaikh H, Sawang M, Sim M, Bondonno N, Hodgson JM, Sharma A, Thompson PL, Prince RL, Craig JC, Lim WH, Wong G, Lewis JR. Prognostic Value of Abdominal Aortic Calcification: A Systematic Review and Meta-Analysis of Observational Studies. J Am Heart Assoc. 2021;10(2):e017205. Epub 20210113. doi: 10.1161/JAHA.120.017205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017205</ArticleId><ArticleId IdType="pmc">PMC7955302</ArticleId><ArticleId IdType="pubmed">33439672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40483710</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1540-8175</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Echocardiography (Mount Kisco, N.Y.)</Title><ISOAbbreviation>Echocardiography</ISOAbbreviation></Journal><ArticleTitle>From Acquisition to Prognosis: The Role of AI in Cardiac Magnetic Resonance Imaging Evaluation of Ischemic Cardiomyopathy.</ArticleTitle><Pagination><StartPage>e70201</StartPage><MedlinePgn>e70201</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/echo.70201</ELocationID><Abstract><AbstractText>Acute and chronic ischemic cardiomyopathy (ICM) still represents a leading cause of morbidity and mortality. Cardiac magnetic resonance (CMR) imaging plays a central role in the diagnosis and management of ICM, offering detailed visualization of cardiac structures and function. The evolving role of artificial intelligence (AI) in enhancing CMR exams, from acquisition to prognosis, is rapidly expanding in clinical practice, particularly in CMR of patients with ICM, emphasizing the integration of AI algorithms to optimize imaging workflows in standard protocols. Advanced AI models enable more efficient and faster image acquisition, reducing artifacts and enhancing accuracy, even offering free-breathing sequences. In post-processing, AI allows for the segmentation and quantification of cardiac parameters, facilitating precise assessment of volumes, myocardial scarring, and perfusion abnormalities, which are critical parameters in ICM. Moreover, AI-driven analysis provides robust prognostic insights by predicting adverse outcomes, such as heart failure and arrhythmias, through comprehensive data integration and pattern recognition. Looking forward, the future of AI in CMR promises further advancements in personalized medicine, with AI algorithms continually improving in accuracy and clinical applicability. This review will analyze the role of AI in increasing diagnostic accuracy, optimizing workflows, and improving prognosis in patients with ICM.</AbstractText><CopyrightInformation>&#xa9; 2025 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Muscogiuri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-4757-2420</Identifier><AffiliationInfo><Affiliation>Department of Radiology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pegoraro</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0007-3637-0109</Identifier><AffiliationInfo><Affiliation>Department of Translational Medicine - Section of Radiology, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cossu</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology and Laboratory Medicine, University Hospital of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caruso</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casartelli</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gershon</LastName><ForeName>Gabrielle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Assen</LastName><ForeName>Marly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Cecco</LastName><ForeName>Carlo N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Radiology and Imaging Sciences, Emory University, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guglielmo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1718-9949</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Angelo</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0004-6378</Identifier><AffiliationInfo><Affiliation>Diagnostic and Interventional Radiology Unit, Department of Dental and Morphological and Functional Imaging, University Hospital Messina, Messina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saba</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, Azienda Ospedaliero Universitaria of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cau</LastName><ForeName>Riccardo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7910-1087</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Azienda Ospedaliero Universitaria of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marra</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnevale</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine - Section of Radiology, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giganti</LastName><ForeName>Melchiore</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Translational Medicine - Section of Radiology, University of Ferrara, Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sironi</LastName><ForeName>Sandro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Echocardiography</MedlineTA><NlmUniqueID>8511187</NlmUniqueID><ISSNLinking>0742-2822</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017202" MajorTopicYN="Y">Myocardial Ischemia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="Y">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">late gadolinium enhancement</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>8</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>8</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>8</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40483710</ArticleId><ArticleId IdType="doi">10.1111/echo.70201</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>P. Pastena, J. T. Frye, C. Ho, M. E. Goldschmidt, and A. P. Kalogeropoulos, &#x201c;Ischemic Cardiomyopathy: Epidemiology, Pathophysiology, Outcomes, and Therapeutic Options,&#x201d; Heart Failure Reviews 29 (2024): 287&#x2013;299.</Citation></Reference><Reference><Citation>G. Muscogiuri, J. R. Weir&#x2010;McCall, M. Tregubova, et&#xa0;al., &#x201c;ESR Essentials: Imaging in Stable Chest Pain &#x2013; Practice Recommendations by ESCR,&#x201d; European Radiology 34 (2024): 6559&#x2013;6567.</Citation></Reference><Reference><Citation>A. M. West and C. M. Kramer, &#x201c;Comprehensive Cardiac Magnetic Resonance Imaging,&#x201d; Journal of Invasive Cardiology 21 (2009): 339&#x2013;345.</Citation></Reference><Reference><Citation>P. S. Rajiah, F. CJ, and T. Leiner, &#x201c;M. R. I. Cardiac: State of the Art,&#x201d; Radiology 307 (2023): e223008.</Citation></Reference><Reference><Citation>K. L. Nguyen, P. Hu, and J. P. Finn, &#x201c;Cardiac Magnetic Resonance Quantification of Structure&#x2010;Function Relationships in Heart Failure,&#x201d; Heart Failure Clinics 17 (2021): 9&#x2013;24.</Citation></Reference><Reference><Citation>V. Sharma, S. Binukrishnan, U. J. Schoepf, and B. Ruzsics, &#x201c;Myocardial Tissue Characterization With Magnetic Resonance Imaging,&#x201d; Journal of Thoracic Imaging 29 (2014): 318&#x2013;330.</Citation></Reference><Reference><Citation>M. M. Bissell, F. Raimondi, L. Ait Ali, et&#xa0;al., &#x201c;4D Flow Cardiovascular Magnetic Resonance Consensus Statement: 2023 update,&#x201d; Journal of Cardiovascular Magnetic Resonance 25 (2023): 40.</Citation></Reference><Reference><Citation>G. Muscogiuri, F. Ricci, S. Scafuri, et&#xa0;al., &#x201c;Cardiac Magnetic Resonance Tissue Characterization in Ischemic Cardiomyopathy,&#x201d; Journal of Thoracic Imaging 37 (2022): 2&#x2013;16.</Citation></Reference><Reference><Citation>G. Muscogiuri, M. Guglielmo, A. Serra, et&#xa0;al., &#x201c;Multimodality Imaging in Ischemic Chronic Cardiomyopathy,&#x201d; Journal of Imaging 8 (2022): 35.</Citation></Reference><Reference><Citation>K. Laubrock, T. von Loesch, M. Steinmetz, et&#xa0;al., &#x201c;Imaging of Arrhythmia: Real&#x2010;Time Cardiac Magnetic Resonance Imaging in Atrial Fibrillation,&#x201d; European Journal of Radiology Open 9 (2022): 100404.</Citation></Reference><Reference><Citation>N. G. Bellenger, P. D. Gatehouse, K. Rajappan, J. Keegan, D. N. Firmin, and D. J. Pennell, &#x201c;Left Ventricular Quantification in Heart Failure by Cardiovascular MR Using Prospective Respiratory Navigator Gating: Comparison With Breath&#x2010;Hold Acquisition,&#x201d; Journal of Magnetic Resonance Imaging 11 (2000): 411&#x2013;417.</Citation></Reference><Reference><Citation>S. J. Backhaus, G. Metschies, M. Billing, et&#xa0;al., &#x201c;Defining the Optimal Temporal and Spatial Resolution for Cardiovascular Magnetic Resonance Imaging Feature Tracking,&#x201d; Journal of Cardiovascular Magnetic Resonance 23 (2021): 60.</Citation></Reference><Reference><Citation>D. M. Adams, R. Boubertakh, and M. ME, &#x201c;Effects of Spatial and Temporal Resolution on Cardiovascular Magnetic Resonance Feature Tracking Measurements Using A Simple Realistic Numerical Phantom,&#x201d; British Journal of Radiology 96 (2023): 20220233.</Citation></Reference><Reference><Citation>G. Muscogiuri, V. Volpato, R. Cau, et&#xa0;al., &#x201c;Application of AI in Cardiovascular Multimodality Imaging,&#x201d; Heliyon 8 (2022): e10872.</Citation></Reference><Reference><Citation>C. J. Harrison and S.&#x2010;G. CJ, &#x201c;Machine Learning in Medicine: A Practical Introduction to Natural Language Processing,&#x201d; BMC Medical Research Methodology 21 (2021): 158.</Citation></Reference><Reference><Citation>Y. LeCun, Y. Bengio, and G. Hinton, &#x201c;Deep Learning,&#x201d; Nature 521 (2015): 436&#x2013;444.</Citation></Reference><Reference><Citation>H. P. Chan, R. K. Samala, L. M. Hadjiiski, and C. Zhou, &#x201c;Deep Learning in Medical Image Analysis,&#x201d; Advances in Experimental Medicine Biology 1213 (2020): 3&#x2013;21.</Citation></Reference><Reference><Citation>L. R. M. Lanzafame, G. M. Bucolo, G. Muscogiuri, et&#xa0;al., &#x201c;Artificial Intelligence in Cardiovascular CT and MR Imaging,&#x201d; Life 13 (2023): 507.</Citation></Reference><Reference><Citation>M. van Assen, G. Muscogiuri, D. Caruso, S. J. Lee, A. Laghi, and C. N. De Cecco, &#x201c;Artificial Intelligence in Cardiac Radiology,&#x201d; Radiologia Medica 125 (2020): 1186&#x2013;1199.</Citation></Reference><Reference><Citation>L. Cui, Y. Song, Y. Wang, et&#xa0;al., &#x201c;Motion Artifact Reduction for Magnetic Resonance Imaging With Deep Learning and k&#x2010;Space Analysis,&#x201d; PLOS One 18 (2023): e0278668.</Citation></Reference><Reference><Citation>I. Oksuz, J. R. Clough, B. Ruijsink, et&#xa0;al., &#x201c;Deep Learning&#x2010;Based Detection and Correction of Cardiac MR Motion Artefacts During Reconstruction for High&#x2010;Quality Segmentation,&#x201d; IEEE Transactions on Medical Imaging 39 (2020): 4001&#x2013;4010.</Citation></Reference><Reference><Citation>H. Abdeltawab, F. Khalifa, F. Taher, et&#xa0;al., &#x201c;A Deep Learning&#x2010;Based Approach for Automatic Segmentation and Quantification of the Left Ventricle From Cardiac Cine MR Images,&#x201d; Computerized Medical Imaging and Graphics 81 (2020): 101717.</Citation></Reference><Reference><Citation>J. Schulz&#x2010;Menger, D. A. Bluemke, J. Bremerich, et&#xa0;al., &#x201c;Standardized Image Interpretation and Post&#x2010;Processing in Cardiovascular Magnetic Resonance &#x2010; 2020 Update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post&#x2010;Processing,&#x201d; Journal of Cardiovascular Magnetic Resonance 22 (2020): 19.</Citation></Reference><Reference><Citation>G. Choy, O. Khalilzadeh, M. Michalski, et&#xa0;al., &#x201c;Current Applications and Future Impact of Machine Learning in Radiology,&#x201d; Radiology 288 (2018): 318&#x2013;328.</Citation></Reference><Reference><Citation>F. Catapano, L. J. Moser, M. Francone, et&#xa0;al., &#x201c;Competence of Radiologists In Cardiac CT and MR Imaging in Europe: Insights From the ESCR Registry,&#x201d; European Radiology 34 (2024): 5666&#x2013;5677.</Citation></Reference><Reference><Citation>M. A. Griswold, P. M. Jakob, R. M. Heidemann, et&#xa0;al., &#x201c;Generalized Autocalibrating Partially Parallel Acquisitions (GRAPPA),&#x201d; Magnetic Resonance Medicine 47 (2002): 1202&#x2013;1210.</Citation></Reference><Reference><Citation>M. Blaimer, F. A. Breuer, N. Seiberlich, et&#xa0;al., &#x201c;Accelerated Volumetric MRI With a SENSE/GRAPPA Combination,&#x201d; Journal of Magnetic Resonance Imaging 24 (2006): 444&#x2013;450.</Citation></Reference><Reference><Citation>J. Craft, Y. Li, N. F. Nashta, and J. Weber, &#x201c;Comparison Between Compressed Sensing and Segmented Cine Cardiac Magnetic Resonance: A Meta&#x2010;Analysis,&#x201d; BMC Cardiovascular Disorders 23 (2023): 473.</Citation></Reference><Reference><Citation>N. K. Naresh, L. Malone, T. Fujiwara, et&#xa0;al., &#x201c;Use of Compressed Sensing to Reduce Scan Time and Breath&#x2010;Holding for Cardiac Cine Balanced Steady&#x2010;State Free Precession Magnetic Resonance Imaging In Children and Young Adults,&#x201d; Pediatric Radiology 51 (2021): 1192&#x2013;1201.</Citation></Reference><Reference><Citation>A. D. Curtis and H. M. Cheng, &#x201c;Primer and Historical Review on Rapid Cardiac CINE MRI,&#x201d; Journal of Magnetic Resonance Imaging 55 (2022): 373&#x2013;388.</Citation></Reference><Reference><Citation>G. Muscogiuri, M. Gatti, S. Dell'Aversana, et&#xa0;al., &#x201c;Diagnostic Accuracy of Single&#x2010;Shot 2&#x2010;Dimensional Multisegment Late Gadolinium Enhancement in Ischemic and Nonischemic Cardiomyopathy,&#x201d; Journal of Thoracic Imaging 35 (2020): 56&#x2013;63.</Citation></Reference><Reference><Citation>M. Henningsson, S. Malik, R. Botnar, D. Castellanos, T. Hussain, and T. Leiner, &#x201c;Black&#x2010;Blood Contrast in Cardiovascular MRI,&#x201d; Journal of Magnetic Resonance Imaging 55 (2022): 61&#x2013;80.</Citation></Reference><Reference><Citation>N. Y. Pan, T. Y. Huang, J. J. Yu, et&#xa0;al., &#x201c;Virtual MOLLI Target: Generative Adversarial Networks Toward Improved Motion Correction in MRI Myocardial T1 Mapping,&#x201d; Journal of Magnetic Resonance Imaging 61 (2025): 209&#x2013;219.</Citation></Reference><Reference><Citation>N. Jin, J. S. da Silveira, M. P. Jolly, et&#xa0;al., &#x201c;Free&#x2010;Breathing Myocardial T2* Mapping Using GRE&#x2010;EPI and Automatic Non&#x2010;Rigid Motion Correction,&#x201d; Journal of Cardiovascular Magnetic Resonance 17 (2015): 113.</Citation></Reference><Reference><Citation>G. Captur, I. Lobascio, Y. Ye, et&#xa0;al., &#x201c;Motion&#x2010;Corrected Free&#x2010;Breathing LGE Delivers High Quality Imaging and Reduces Scan Time by Half: An Independent Validation Study,&#x201d; International Journal of Cardiovascular Imaging 35 (2019): 1893&#x2013;1901.</Citation></Reference><Reference><Citation>A. Argentiero, G. Muscogiuri, M. G. Rabbat, et&#xa0;al., &#x201c;The Applications of Artificial Intelligence in Cardiovascular Magnetic Resonance&#x2010;A Comprehensive Review,&#x201d; Journal of Clinical Medicine 11 (2022): 2866.</Citation></Reference><Reference><Citation>G. Pontone, A. I. Guaricci, L. Fusini, et&#xa0;al., &#x201c;Cardiac Magnetic Resonance for Prophylactic Implantable&#x2010;Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE&#x2010;ICM International Registry,&#x201d; JACC Cardiovascular Imaging 16 (2023): 1387&#x2013;1400.</Citation></Reference><Reference><Citation>W. Shi, J. Caballero, F. Husz&#xe1;r, et&#xa0;al., &#x201c;Real&#x2010;Time Single Image and Video Super&#x2010;Resolution Using an Efficient Sub&#x2010;Pixel Convolutional Neural Network,&#x201d; in 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR) (IEEE, 2016), 1874&#x2013;1883.</Citation></Reference><Reference><Citation>J. Schlemper, J. Caballero, J. Hajnal, A. Price, and D. Rueckert, &#x201c;A Deep Cascade of Convolutional Neural Networks for Dynamic MR Image Reconstruction,&#x201d; IEEE Transactions on Medical Imaging 37 (2017): 491&#x2013;503.</Citation></Reference><Reference><Citation>K. Hammernik, T. Klatzer, E. Kobler, et&#xa0;al., &#x201c;Learning a Variational Network for Reconstruction of Accelerated MRI Data,&#x201d; Magnetic Resonance in Medicine 79 (2018): 3055&#x2013;3071.</Citation></Reference><Reference><Citation>C. M. Sandino, P. Lai, S. S. Vasanawala, and J. Y. Cheng, &#x201c;Accelerating Cardiac Cine MRI Using a Deep Learning&#x2010;Based ESPIRiT Reconstruction,&#x201d; Magnetic Resonance in Medicine 85 (2021): 152&#x2013;167.</Citation></Reference><Reference><Citation>A. Hauptmann, S. Arridge, F. Lucka, V. Muthurangu, and J. A. Steeden, &#x201c;Real&#x2010;Time Cardiovascular MR With Spatio&#x2010;Temporal Artifact Suppression Using Deep Learning&#x2010;Proof of Concept in Congenital Heart Disease,&#x201d; Magnetic Resonance in Medicine 81 (2019): 1143&#x2013;1156.</Citation></Reference><Reference><Citation>G. Yang, S. Yu, H. Dong, et&#xa0;al., &#x201c;DAGAN: Deep De&#x2010;Aliasing Generative Adversarial Networks for Fast Compressed Sensing MRI Reconstruction,&#x201d; IEEE Transactions on Medical Imaging 37 (2018): 1310&#x2013;1321.</Citation></Reference><Reference><Citation>G. Yang, J. Lyu, Y. Chen, J. Huang, and J. Zhu, &#x201c;Generative Adversarial Networks (GAN) Powered Fast Magnetic Resonance Imaging &#x2013; Mini Review, Comparison and Perspectives,&#x201d; preprint, arXiv May 4, 2021.</Citation></Reference><Reference><Citation>R. Patel Amit, M. Salerno, Y. Kwong Raymond, A. Singh, B. Heydari, and M. Kramer Christopher, &#x201c;Stress Cardiac Magnetic Resonance Myocardial Perfusion Imaging,&#x201d; Journal of the American College of Cardiology 78 (2021): 1655&#x2013;1668.</Citation></Reference><Reference><Citation>M. A. Morales, S. Assana, X. Cai, et&#xa0;al., &#x201c;An Inline Deep Learning Based Free&#x2010;Breathing ECG&#x2010;Free Cine for Exercise Cardiovascular Magnetic Resonance,&#x201d; Journal of Cardiovascular Magnetic Resonance 24 (2022): 47.</Citation></Reference><Reference><Citation>D. Radenkovic, S. Weing&#xe4;rtner, L. Ricketts, J. C. Moon, and G. Captur, &#x201c;T(1) Mapping in Cardiac MRI,&#x201d; Heart Failure Reviews 22 (2017): 415&#x2013;430.</Citation></Reference><Reference><Citation>C. D. Sheagren, T. Cao, J. H. Patel, et&#xa0;al., &#x201c;Motion&#x2010;Compensated T(1) Mapping in Cardiovascular Magnetic Resonance Imaging: A Technical Review,&#x201d; Frontiers in Cardiovascular Medicine 10 (2023): 1160183.</Citation></Reference><Reference><Citation>E. R. Jenista, D. C. Wendell, C. F. Azevedo, et&#xa0;al., &#x201c;Revisiting How We Perform Late Gadolinium Enhancement CMR: Insights Gleaned Over 25 Years of Clinical Practice,&#x201d; Journal of Cardiovascular Magnetic Resonance 25 (2023): 18.</Citation></Reference><Reference><Citation>R. A. Gonzales, Q. Zhang, B. W. Papie&#x17c;, et&#xa0;al., &#x201c;MOCOnet: Robust Motion Correction of Cardiovascular Magnetic Resonance T1 Mapping Using Convolutional Neural Networks,&#x201d; Frontiers in Cardiovascular Medicine 8 (2021): 768245.</Citation></Reference><Reference><Citation>R. Guo, H. El&#x2010;Rewaidy, S. Assana, et&#xa0;al., &#x201c;Accelerated Cardiac T1 Mapping in Four Heartbeats With Inline MyoMapNet: A Deep Learning&#x2010;Based T1 Estimation Approach,&#x201d; Journal of Cardiovascular Magnetic Resonance 24 (2022): 6.</Citation></Reference><Reference><Citation>J. I. Hamilton, D. Currey, S. Rajagopalan, and N. Seiberlich, &#x201c;Deep Learning Reconstruction for Cardiac Magnetic Resonance Fingerprinting T(1) and T(2) Mapping,&#x201d; Magnetic Resonance in Medicne 85 (2021): 2127&#x2013;2135.</Citation></Reference><Reference><Citation>C. M. Kramer, J. Barkhausen, C. Bucciarelli&#x2010;Ducci, S. D. Flamm, R. J. Kim, and E. Nagel, &#x201c;Standardized Cardiovascular Magnetic Resonance Imaging (CMR) Protocols: 2020 Update,&#x201d; Journal of Cardiovascular Magnetic Resonance 22 (2020): 17.</Citation></Reference><Reference><Citation>C. Xie, R. Zhang, S. Mensink, et&#xa0;al., &#x201c;Automated Inversion Time Selection for Late Gadolinium&#x2010;Enhanced Cardiac Magnetic Resonance Imaging,&#x201d; European Radiology 34 (2024): 5186&#x2013;5828.</Citation></Reference><Reference><Citation>G. Muscogiuri, C. Martini, M. Gatti, et&#xa0;al., &#x201c;Feasibility of Late Gadolinium Enhancement (LGE) in Ischemic Cardiomyopathy Using 2D&#x2010;Multisegment LGE Combined With Artificial Intelligence Reconstruction Deep Learning Noise Reduction Algorithm,&#x201d; International Journal of Cardiology 343 (2021): 164&#x2013;170.</Citation></Reference><Reference><Citation>N. van der Velde, H. C. Hassing, B. J. Bakker, et&#xa0;al., &#x201c;Improvement of Late Gadolinium Enhancement Image Quality Using a Deep Learning&#x2010;Based Reconstruction Algorithm and Its Influence on Myocardial Scar Quantification,&#x201d; European Radiology 31 (2021): 3846&#x2013;3855.</Citation></Reference><Reference><Citation>S. Shit, J. Zimmermann, I. Ezhov, et&#xa0;al., &#x201c;SRflow: Deep Learning Based Super&#x2010;Resolution of 4D&#x2010;Flow MRI Data,&#x201d; Frontiers in Artificial Intelligence 5 (2022): 928181.</Citation></Reference><Reference><Citation>G. Milotta, C. Munoz, K. P. Kunze, et&#xa0;al., &#x201c;3D Whole&#x2010;Heart Grey&#x2010;Blood Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Imaging,&#x201d; Journal of Cardiovascular Magnetic Resonance 23 (2021): 62.</Citation></Reference><Reference><Citation>J. A. Oscanoa, M. J. Middione, C. Alkan, et&#xa0;al., &#x201c;Deep Learning&#x2010;Based Reconstruction for Cardiac MRI: A Review,&#x201d; Bioengineering 10 (2023): 334.</Citation></Reference><Reference><Citation>T. Leiner, D. Rueckert, A. Suinesiaputra, et&#xa0;al., &#x201c;Machine Learning In Cardiovascular Magnetic Resonance: Basic Concepts and Applications,&#x201d; Journal of Cardiovascular Magnetic Resonance 21 (2019): 61.</Citation></Reference><Reference><Citation>N. Kawel&#x2010;Boehm, S. J. Hetzel, B. Ambale&#x2010;Venkatesh, et&#xa0;al., &#x201c;Reference Ranges (&#x2018;Normal Values&#x2019;) for Cardiovascular Magnetic Resonance (CMR) In Adults and Children: 2020 Update,&#x201d; Journal of Cardiovascular Magnetic Resonance 22 (2020): 87.</Citation></Reference><Reference><Citation>Y.&#x2010;R. Wang, K. Yang, Y. Wen, et&#xa0;al., &#x201c;Screening and Diagnosis of Cardiovascular Disease Using Artificial Intelligence&#x2010;Enabled Cardiac Magnetic Resonance Imaging,&#x201d; Nature Medicine 30 (2024): 1471&#x2013;1480.</Citation></Reference><Reference><Citation>S. Tayebi Arasteh, J. Romanowicz, D. F. Pace, et&#xa0;al., &#x201c;Automated Segmentation of 3D Cine Cardiovascular Magnetic Resonance Imaging,&#x201d; Frontiers in Cardiovascular Medicine 10 (2023): 1167500.</Citation></Reference><Reference><Citation>M. Penso, S. Moccia, S. Scafuri, et&#xa0;al., &#x201c;Automated Left and Right Ventricular Chamber Segmentation in Cardiac Magnetic Resonance Images Using Dense Fully Convolutional Neural Network,&#x201d; Computer Methods and Programs in Biomedicine 204 (2021): 106059.</Citation></Reference><Reference><Citation>F. Yang, Y. Zhang, P. Lei, et&#xa0;al., &#x201c;A Deep Learning Segmentation Approach in Free&#x2010;Breathing Real&#x2010;Time Cardiac Magnetic Resonance Imaging,&#x201d; BioMed Research International 2019 (2019): 5636423.</Citation></Reference><Reference><Citation>D. Chen, H. Bhopalwala, N. Dewaswala, et&#xa0;al., &#x201c;Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation,&#x201d; Journal of Imaging 8 (2022): 149.</Citation></Reference><Reference><Citation>M. Schilling, C. Unterberg&#x2010;Buchwald, J. Lotz, and M. Uecker, &#x201c;Assessment of Deep Learning Segmentation for Real&#x2010;Time Free&#x2010;Breathing Cardiac Magnetic Resonance Imaging At Rest and Under Exercise Stress,&#x201d; Scientific Reports 14 (2024): 3754.</Citation></Reference><Reference><Citation>N. Zhang, G. Yang, Z. Gao, et&#xa0;al., &#x201c;Deep Learning for Diagnosis of Chronic Myocardial Infarction on Nonenhanced Cardiac Cine MRI,&#x201d; Radiology 291 (2019): 606&#x2013;617.</Citation></Reference><Reference><Citation>C. Xu, J. Howey, P. Ohorodnyk, M. Roth, H. Zhang, and S. Li, &#x201c;Segmentation and Quantification of Infarction Without Contrast Agents Via Spatiotemporal Generative Adversarial Learning,&#x201d; Medical Image Analysis 59 (2020): 101568.</Citation></Reference><Reference><Citation>G. Muscogiuri, P. Suranyi, U. J. Schoepf, et&#xa0;al., &#x201c;Cardiac Magnetic Resonance T1&#x2010;Mapping of the Myocardium: Technical Background and Clinical Relevance,&#x201d; Journal of Thoracic Imaging 33 (2018): 71&#x2013;80.</Citation></Reference><Reference><Citation>J. Wright, T. Adriaenssens, S. Dymarkowski, W. Desmet, and J. Bogaert, &#x201c;Quantification of Myocardial Area at Risk With T2&#x2010;Weighted CMR: Comparison With Contrast&#x2010;Enhanced CMR and Coronary Angiography,&#x201d; JACC Cardiovascular Imaging 2 (2009): 825&#x2013;831.</Citation></Reference><Reference><Citation>G. Muscogiuri, A. I. Guaricci, R. Cau, et&#xa0;al., &#x201c;Multimodality Imaging in Acute Myocarditis,&#x201d; Journal of Clinical Ultrasound 50 (2022): 1097&#x2013;1109.</Citation></Reference><Reference><Citation>A. A. Kammerlander, B. A. Marzluf, C. Zotter&#x2010;Tufaro, et&#xa0;al., &#x201c;T1 Mapping by CMR Imaging: From Histological Validation to Clinical Implication,&#x201d; JACC Cardiovasc Imaging 9 (2016): 14&#x2013;23.</Citation></Reference><Reference><Citation>D. R. Messroghli, J. C. Moon, V. M. Ferreira, et&#xa0;al., &#x201c;Clinical Recommendations for Cardiovascular Magnetic Resonance Mapping of T1, T2, T2* and Extracellular Volume: A Consensus Statement By The Society for Cardiovascular Magnetic Resonance (SCMR) Endorsed by the European Association for Cardiovascular Imaging (EACVI),&#x201d; Journal of Cardiovascular Magnetic Resonance 19 (2017): 75.</Citation></Reference><Reference><Citation>S. Chang, K. Han, S. Lee, et&#xa0;al., &#x201c;Automated Measurement of Native T1 and Extracellular Volume Fraction in Cardiac Magnetic Resonance Imaging Using a Commercially Available Deep Learning Algorithm,&#x201d; Korean Journal of Radiology 23 (2022): 1251&#x2013;1259.</Citation></Reference><Reference><Citation>A. Kalapos, L. Szab&#xf3;, Z. Dohy, et&#xa0;al., &#x201c;Automated T1 and T2 Mapping Segmentation on Cardiovascular Magnetic Resonance Imaging Using Deep Learning,&#x201d; Frontiers in Cardiovascular Medicine 10 (2023): 1147581.</Citation></Reference><Reference><Citation>Q. Zhang, E. Hann, K. Werys, et&#xa0;al., &#x201c;Deep Learning With Attention Supervision for Automated Motion Artefact Detection In Quality Control of Cardiac T1&#x2010;Mapping,&#x201d; Artifical Intelligence in Medicine 110 (2020): 101955.</Citation></Reference><Reference><Citation>M. C. Carminati, C. Boniotti, and L. Fusini, &#x201c;Comparison of Image Processing Techniques for Nonviable Tissue Quantification in Late Gadolinium Enhancement Cardiac Magnetic Resonance Images,&#x201d; Journal of Thoracic Imaging 31 (2016): 168&#x2013;176.</Citation></Reference><Reference><Citation>S. Moccia, R. Banali, C. Martini, et&#xa0;al., &#x201c;Development and Testing of a Deep Learning&#x2010;Based Strategy for Scar Segmentation on CMR&#x2010;LGE Images,&#x201d; MAGMA 32 (2019): 187&#x2013;195.</Citation></Reference><Reference><Citation>A. S. Fahmy, J. Rausch, U. Neisius, et&#xa0;al., &#x201c;Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks,&#x201d; JACC Cardiovascular Imaging 11 (2018): 1917&#x2013;1918.</Citation></Reference><Reference><Citation>D. M. Popescu, H. G. Abramson, R. Yu, et&#xa0;al., &#x201c;Anatomically Informed Deep Learning on Contrast&#x2010;Enhanced Cardiac Magnetic Resonance Imaging for Scar Segmentation and Clinical Feature Extraction,&#x201d; Cardiovascular Digital Health Journal 3 (2022): 2&#x2013;13.</Citation></Reference><Reference><Citation>A. S. Fahmy, E. J. Rowin, R. H. Chan, W. J. Manning, M. S. Maron, and R. Nezafat, &#x201c;Improved Quantification of Myocardium Scar in Late Gadolinium Enhancement Images: Deep Learning Based Image Fusion Approach,&#x201d; Journal of Magnetic Resonance Imaging 54 (2021): 303&#x2013;312.</Citation></Reference><Reference><Citation>Q. Zhang, A. Fotaki, S. Ghadimi, et&#xa0;al., &#x201c;Improving the Efficiency and Accuracy of CMR With AI &#x2010; Review of Evidence and Proposition of a Roadmap to Clinical Translation,&#x201d; Journal of Cardiovascular Magnetic Resonance 26 (2024): 101051.</Citation></Reference><Reference><Citation>O. B. Demirel, B. Yaman, C. Shenoy, S. Moeller, S. Weing&#xe4;rtner, and M. Ak&#xe7;akaya, &#x201c;Signal Intensity Informed Multi&#x2010;Coil Encoding Operator for Physics&#x2010;Guided Deep Learning Reconstruction of Highly Accelerated Myocardial Perfusion CMR,&#x201d; Magnetic Resonance in Medicine 89 (2023): 308&#x2013;321.</Citation></Reference><Reference><Citation>J. H. Chong, M. Abdulkareem, S. E. Petersen, and M. Y. Khanji, &#x201c;Artificial Intelligence and Cardiovascular Magnetic Resonance Imaging in Myocardial Infarction Patients,&#x201d; Current Problems in Cardiology 47 (2022): 101330.</Citation></Reference><Reference><Citation>B. P. Halliday, A. Gulati, A. Ali, et&#xa0;al., &#x201c;Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction,&#x201d; Circulation 135 (2017): 2106&#x2013;2115.</Citation></Reference><Reference><Citation>B. Ambale&#x2010;Venkatesh, X. Yang, C. O. Wu, et&#xa0;al., &#x201c;Cardiovascular Event Prediction by Machine Learning: The Multi&#x2010;Ethnic Study of Atherosclerosis,&#x201d; Circulation Research 121 (2017): 1092&#x2013;1101.</Citation></Reference><Reference><Citation>L. P. Kotu, K. Engan, R. Borhani, et&#xa0;al., &#x201c;Cardiac Magnetic Resonance Image&#x2010;Based Classification of the Risk of Arrhythmias in Post&#x2010;Myocardial Infarction Patients,&#x201d; Artificial Intelligence in Medicine 64 (2015): 205&#x2013;215.</Citation></Reference><Reference><Citation>F. Ghanbari, T. Joyce, V. Lorenzoni, et&#xa0;al., &#x201c;AI Cardiac MRI Scar Analysis Aids Prediction of Major Arrhythmic Events in the Multicenter DERIVATE Registry,&#x201d; Radiology 307 (2023): e222239.</Citation></Reference><Reference><Citation>A. Schuster, T. Lange, S. J. Backhaus, et&#xa0;al., &#x201c;Fully Automated Cardiac Assessment for Diagnostic and Prognostic Stratification Following Myocardial Infarction,&#x201d; Journal of American Heart Association 9 (2020): e016612.</Citation></Reference><Reference><Citation>H. Assadi, S. Alabed, A. Maiter, et&#xa0;al., &#x201c;The Role of Artificial Intelligence in Predicting Outcomes by Cardiovascular Magnetic Resonance: A Comprehensive Systematic Review,&#x201d; Medicina 58 (2022): 1087.</Citation></Reference><Reference><Citation>F. Ricci, A. Barison, G. Todiere, et&#xa0;al., &#x201c;Prognostic Value of Pulmonary Blood Volume by First&#x2010;Pass Contrast&#x2010;Enhanced CMR in Heart Failure Outpatients: The PROVE&#x2010;HF Study,&#x201d; European Heart Journal &#x2010; Cardiovascular Imaging 19 (2018): 896&#x2013;904.</Citation></Reference><Reference><Citation>K. D. Knott, A. Seraphim, J. B. Augusto, et&#xa0;al., &#x201c;The Prognostic Significance of Quantitative Myocardial Perfusion: An Artificial Intelligence&#x2010;Based Approach Using Perfusion Mapping,&#x201d; Circulation 141 (2020): 1282&#x2013;1291.</Citation></Reference><Reference><Citation>G. Iacobellis, &#x201c;Epicardial Adipose Tissue in Contemporary Cardiology,&#x201d; Nature Reviews Cardiology 19 (2022): 593&#x2013;606.</Citation></Reference><Reference><Citation>M. Guglielmo, M. Penso, M. L. Carerj, et&#xa0;al., &#x201c;DEep LearnIng&#x2010;Based Quantification of Epicardial Adipose Tissue Predicts MACE in Patients Undergoing Stress CMR,&#x201d; Atherosclerosis 397 (2024): 117549.</Citation></Reference><Reference><Citation>O. S. Patrascanu, D. Tutunaru, C. L. Musat, et&#xa0;al., &#x201c;Future Horizons: The Potential Role of Artificial Intelligence in Cardiology,&#x201d; Journal of Personalized Medicine 14 (2024): 656.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40587410</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>220</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/67525</ELocationID><Abstract><AbstractText>The scale of biomedical knowledge, spanning scientific literature and curated knowledge bases, poses a significant challenge for investigators in processing, evaluating, and interpreting findings effectively. Large Language Models (LLMs) have emerged as powerful tools for navigating this complex knowledge landscape but may produce hallucinatory responses. Retrieval-Augmented Generation (RAG) is essential for identifying relevant information to enhance accuracy and reliability. This protocol introduces RUGGED (Retrieval Under Graph-Guided Explainable disease Distinction), a comprehensive workflow designed to support knowledge integration, to mitigate bias, and to explore and validate new research directions. Biomedical information from publications and knowledge bases are synthesized and analyzed through text-mining association analysis and explainable graph prediction models to uncover potential drug-disease relationships. These findings, along with the source text corpus and knowledge bases, are incorporated into a framework that employs RAG-enhanced LLMs to enables users to explore hypotheses and investigate underlying mechanisms. A clinical use case demonstrates RUGGED's capability in evaluating and recommending therapeutics for Arrhythmogenic Cardiomyopathy (ACM) and Dilated Cardiomyopathy (DCM), analyzing prescribed drugs for molecular interactions and potential new applications. The platform reduces LLM hallucinations, highlights actionable insights, and streamlines the investigation of novel therapeutics.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pelletier</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Scalable Analytics Institute (ScAi) at Department of Computer Science, UCLA School of Engineering; arpelletier@g.ucla.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sankar</LastName><ForeName>Baradwaj Simha</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adam</LastName><ForeName>Irsyad</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Department of Medicine (Cardiology), UCLA School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Medical Informatics, University of California at Los Angeles (UCLA).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinecke</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Medical Informatics, University of California at Los Angeles (UCLA).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Scalable Analytics Institute (ScAi) at Department of Computer Science, UCLA School of Engineering.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Karol E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Medical Informatics, University of California at Los Angeles (UCLA); Department of Medicine (Cardiology), UCLA School of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ping</LastName><ForeName>Peipei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Physiology, UCLA School of Medicine; Scalable Analytics Institute (ScAi) at Department of Computer Science, UCLA School of Engineering; Medical Informatics, University of California at Los Angeles (UCLA); Department of Medicine (Cardiology), UCLA School of Medicine; pping38@g.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051188" MajorTopicYN="Y">Knowledge Bases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057225" MajorTopicYN="N">Data Mining</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>30</Day><Hour>13</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40587410</ArticleId><ArticleId IdType="doi">10.3791/67525</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40230669</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-9303</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>3Part B</Issue><PubDate><Year>2025</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of the Society for Cardiovascular Angiography &amp; Interventions</Title><ISOAbbreviation>J Soc Cardiovasc Angiogr Interv</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence-Powered Electrocardiogram Detecting Culprit Vessel Blood Flow Abnormality: AI-ECG TIMI Study Design and Rationale.</ArticleTitle><Pagination><StartPage>102494</StartPage><MedlinePgn>102494</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102494</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jscai.2024.102494</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The 12-lead electrocardiogram (ECG) is the gold standard for detecting patients who will benefit from emergent revascularization due to occlusive myocardial infarction (OMI). However, the pathophysiology of acute coronary syndromes (ACS) is dynamic, and nearly half of patients with OMI do not present with typical ST elevation or have dynamic ECG changes due to spontaneous recanalization before invasive coronary angiography (ICA). Recently, an ECG-based artificial intelligence (AI) model was developed using expert interpretation of OMI. However, its performance is limited to retrospective evaluation of ECGs recorded minutes to hours before ICA.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The AI-ECG thrombolysis in myocardial infarction (TIMI) study is an investigator-initiated prospective multicenter registry planning to enroll over 700 consecutive patients with ACS undergoing ICA in 9 centers across Europe. For all participants, a standard 10-second 12-lead ECG will be recorded at the time of coronary angiography. The primary end point is the AI model's ability to identify patients with an actively occluded (TIMI 0-1) culprit coronary artery at the time of invasive coronary angiography using only single-standard 12-lead ECGs. Standardized angiograms will be used as a reference standard.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">AI-ECG TIMI is the first prospective registry of consecutive patients with ACS with standard 12-lead ECGs recorded at the very moment of ICA. This study will help characterize ECG findings of abnormal myocardial perfusion due to acute active ischemia and prospectively validate an AI model's ability to detect them.</AbstractText><CopyrightInformation>&#xa9; 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Centre Aalst, Aalst, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Powerful Medical, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisova</LastName><ForeName>Timea</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Powerful Medical, Bratislava, Slovakia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belmonte</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilgenhof</LastName><ForeName>Adriaan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Centre Aalst, Aalst, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toth</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demolder</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Centre Aalst, Aalst, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Powerful Medical, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafajdus</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Powerful Medical, Bratislava, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Minnesota, Minneapolis, Minnesota.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartunek</LastName><ForeName>Jozef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Centre Aalst, Aalst, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbato</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sapienza University of Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Soc Cardiovasc Angiogr Interv</MedlineTA><NlmUniqueID>9918419271306676</NlmUniqueID><ISSNLinking>2772-9303</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary pathophysiology</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">non&#x2013;ST-elevation myocardial infarction</Keyword></KeywordList><CoiStatement>Robert Herman, Timea Kisova, Anthony Demolder, Adam Rafajdus, H. Pendell Meyers, Stephen W. Smith, Jozef Bartunek, and Emanuele Barbato are shareholders of Powerful Medical. All other contributing authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>4</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40230669</ArticleId><ArticleId IdType="pmc">PMC11993865</ArticleId><ArticleId IdType="doi">10.1016/j.jscai.2024.102494</ArticleId><ArticleId IdType="pii">S2772-9303(24)02183-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ibanez B., James S., Agewall S., et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39(2):119&#x2013;177. doi: 10.1093/eurheartj/ehx393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx393</ArticleId><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A.R., Golwala H., Tripathi A., et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2017;38(41):3082&#x2013;3089.</Citation><ArticleIdList><ArticleId IdType="pubmed">29020244</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanger E.K., Yildirimturk O., Simsek B., et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study) Int J Cardiol Heart Vasc. 2020;30 doi: 10.1016/j.ijcha.2020.100603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100603</ArticleId><ArticleId IdType="pmc">PMC7399112</ArticleId><ArticleId IdType="pubmed">32775606</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers H.P., Bracey A., Lee D., et al. Comparison of the ST-elevation myocardial infarction (STEMI) vs. NSTEMI and occlusion MI (OMI) vs. NOMI paradigms of acute MI. J&#xa0;Emerg Med. 2021;60(3):273&#x2013;284. doi: 10.1016/j.jemermed.2020.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2020.10.026</ArticleId><ArticleId IdType="pubmed">33308915</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R.A., Rossello X., Coughlan J., et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) Eur Heart J Acute Cardiovasc Care. 2024;13(1):55&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">37740496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.-S., Chen Y.-H., Huang C.-C., et al. Prevalence and outcome of patients with non-ST segment elevation myocardial infarction with occluded &#x201c;culprit&#x201d; artery&#x2014;a systemic review and meta-analysis. Crit Care. 2018;22(1):34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806289</ArticleId><ArticleId IdType="pubmed">29422071</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers H.P., Bracey A., Lee D., et al. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction. Int J Cardiol Heart Vasc. 2021;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8065286</ArticleId><ArticleId IdType="pubmed">33912650</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd K.W., Zvosec D.L., Hart M.A., et al. Electrocardiographic diagnosis of acute coronary occlusion myocardial infarction in ventricular paced rhythm using the modified Sgarbossa criteria. Ann Emerg Med. 2021;78(4):517&#x2013;529. doi: 10.1016/j.annemergmed.2021.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2021.03.036</ArticleId><ArticleId IdType="pubmed">34172301</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren J., de Alencar J.N., Aslanger E.K., Meyers H.P., Smith S.W. From ST-segment elevation MI to occlusion MI: the new paradigm shift in acute myocardial infarction. JACC: Adv. 2024;3(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11492056</ArticleId><ArticleId IdType="pubmed">39435181</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N&#xa0;Engl J Med. 2002;346(13):957&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">11919304</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone G.W., Cox D., Garcia E., et al. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation. 2001;104(6):636&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">11489767</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman R., Meyers H.P., Smith S.W., et al. International evaluation of an artificial&#xa0;intelligence&#x2013;powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health. 2024;5(2):123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10944682</ArticleId><ArticleId IdType="pubmed">38505483</ArticleId></ArticleIdList></Reference><Reference><Citation>Korosoglou G., Haars A., Michael G., et al. Quantitative evaluation of myocardial blush to assess tissue level reperfusion in patients with acute ST-elevation myocardial infarction: incremental prognostic value compared with visual assessment. Am Heart J. 2007;153(4):612&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">17383301</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson R.W. An introduction to the bootstrap. Teach Stat. 2001;23(2):49&#x2013;54.</Citation></Reference><Reference><Citation>Khera R., Oikonomou E.K., Nadkarni G.N., et al. Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC state-of-the-art review. J&#xa0;Am Coll Cardiol. 2024;84(1):97&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">38925729</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman R., Demolder A., Vavrik B., et al. Validation of an automated artificial intelligence system for 12-lead ECG interpretation. J&#xa0;Electrocardiol. 2024;82:147&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">38154405</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Z.I., Kapa S., Lopez-Jimenez F., et al. Screening for cardiac contractile dysfunction using an artificial intelligence&#x2013;enabled electrocardiogram. Nat Med. 2019;25(1):70&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Shelly M., Attia Z.I., Friedman P.A., et al. Electrocardiogram screening for aortic valve stenosis using artificial intelligence. Eur Heart J. 2021;42(30):2885&#x2013;2896.</Citation><ArticleIdList><ArticleId IdType="pubmed">33748852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko W.-Y., Siontis K.C., Attia Z.I., et al. Detection of hypertrophic cardiomyopathy using a convolutional neural network-enabled electrocardiogram. J&#xa0;Am Coll Cardiol. 2020;75(7):722&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner P., Strodthoff N., Bousseljot R.-D., et al. PTB-XL, a large publicly available electrocardiography dataset. Sci Data. 2020;7(1):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7248071</ArticleId><ArticleId IdType="pubmed">32451379</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe J.M., Armstrong E.J., Ku I., et al. Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J&#xa0;Am Heart Assoc. 2013;2(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835230</ArticleId><ArticleId IdType="pubmed">24096575</ArticleId></ArticleIdList></Reference><Reference><Citation>de Winter R.J., Verouden N.J., Wellens H.J., Wilde A.A. A&#xa0;new ECG sign of proximal LAD occlusion. N&#xa0;Engl J Med. 2008;359(19):2071&#x2013;2073.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987380</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez J.P., Pahlm O., Ringborn M., Warren S., Laguna P., S&#xf6;rnmo L. The STAFF III database: ECGs recorded during acutely induced myocardial ischemia. IEEE. 2017:1&#x2013;4.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40539261</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1942-0080</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Circulation. Cardiovascular imaging</Title><ISOAbbreviation>Circ Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Harvesting the Richness of CMR With Multimodal AI: A New Dawn to Differentiate HCM and Subtype Cardiac Amyloidosis?</ArticleTitle><Pagination><StartPage>e018600</StartPage><MedlinePgn>e018600</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCIMAGING.125.018600</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Parker</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology (P.M.), The Ohio State University Wexner Medical Center, Columbus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yuchi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-7582-1848</Identifier><AffiliationInfo><Affiliation>Cardiovascular Division (Y.H.), The Ohio State University Wexner Medical Center, Columbus.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Circ Cardiovasc Imaging</MedlineTA><NlmUniqueID>101479935</NlmUniqueID><ISSNLinking>1941-9651</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Circ Cardiovasc Imaging. 2025 Jul;18(7):e017761. doi: 10.1161/CIRCIMAGING.124.017761.</RefSource><PMID Version="1">40464070</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Editorials</Keyword><Keyword MajorTopicYN="N">amyloidosis</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiomyopathy, hypertrophic</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>11</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>11</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40539261</ArticleId><ArticleId IdType="doi">10.1161/CIRCIMAGING.125.018600</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40774461</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>440</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Generative AI-powered explainable prediction model: Enhancing early in-hospital mortality alert for patients with acute myocardial infarction.</ArticleTitle><Pagination><StartPage>133649</StartPage><MedlinePgn>133649</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2025.133649</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(25)00692-8</ELocationID><Abstract><AbstractText>Early identification of patients with acute myocardial infarction (AMI) at high risk of in-hospital mortality is crucial for optimizing treatment strategies. However, the urgent nature of these clinical scenarios often limits the ability to gather the comprehensive data necessary for accurate risk assessment. Missing data presents a substantial challenge to timely and effective risk evaluation METHODS: We developed MortiGen, an end-to-end model designed to address the dual challenges of missing data imputation and mortality risk prediction in patients with AMI. The model was trained using data from 9163 admissions in the eICU collaborative research database and externally tested on 12,166 admissions from the medical information Mart for intensive care and 2142 admissions from the Chongqing University central hospital. The performance of the MortiGen was compared with other ten models using multiple evaluation metrics RESULTS: MortiGen demonstrated robust performance in predicting in-hospital mortality using data available at 3&#xa0;h, 12&#xa0;h, 24&#xa0;h, and throughout the entire hospital stay (ranging from 47.2&#xa0;% to 89.5&#xa0;% of the data available), with receiver operating characteristic curve ranging from 0.794 to 0.855. MortiGen outperformed other ten models. Notably, when relying solely on data available within the first 3&#xa0;h of admission, MortiGen achieving performance better than some comparison models, which used data from the entire hospitalization CONCLUSIONS: MortiGen effectively predicts in-hospital mortality among patients with AMI, even in the early stages of hospital admission, overcoming challenges related to limited data availability due to time constraints and variability in laboratory testing conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Puguang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chongqing Emergency Medical Centre, Chongqing University Central Hospital, School of Medicine, College of Bioengineering, Chongqing University, Chongqing 400014, China; Bio-Med Informatics Research Centre &amp; Clinical Research Centre, Xinqiao Hospital, Army Medical University, Chongqing 40037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Chongqing Emergency Medical Centre, Chongqing University Central Hospital, School of Medicine, College of Bioengineering, Chongqing University, Chongqing 400014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chongqing Emergency Medical Centre, Chongqing University Central Hospital, School of Medicine, College of Bioengineering, Chongqing University, Chongqing 400014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurocritical Care Unit, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230026, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Bingbing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bio-Med Informatics Research Centre &amp; Clinical Research Centre, Xinqiao Hospital, Army Medical University, Chongqing 40037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Bio-Med Informatics Research Centre &amp; Clinical Research Centre, Xinqiao Hospital, Army Medical University, Chongqing 40037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Ruiyan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Xinqiao Hospital, Chongqing 40037, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Biomedical Imaging Research, School of Biomedical Engineering, Tsinghua University, Beijing 100084, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chongqing Emergency Medical Centre, Chongqing University Central Hospital, School of Medicine, College of Bioengineering, Chongqing University, Chongqing 400014, China. Electronic address: 81846846@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Bio-Med Informatics Research Centre &amp; Clinical Research Centre, Xinqiao Hospital, Army Medical University, Chongqing 40037, China. Electronic address: shine636363@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Diffusion model</Keyword><Keyword MajorTopicYN="N">Missing value</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors report no potential conflicts of interest relevant to this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>19</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40774461</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2025.133649</ArticleId><ArticleId IdType="pii">S0167-5273(25)00692-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40146672</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1466-187X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>Medical teacher</Title><ISOAbbreviation>Med Teach</ISOAbbreviation></Journal><ArticleTitle>Evaluating the value of AI-generated questions for USMLE step 1 preparation: A study using ChatGPT-3.5.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>9</EndPage><MedlinePgn>1-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/0142159X.2025.2478872</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Students are increasingly relying on artificial intelligence (AI) for medical education and exam preparation. However, the factual accuracy and content distribution of AI-generated exam questions for self-assessment have not been systematically investigated.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Curated prompts were created to generate multiple-choice questions matching the USMLE Step 1 examination style. We utilized ChatGPT-3.5 to generate 50 questions and answers based upon each prompt style. We manually examined output for factual accuracy, Bloom's Taxonomy, and category within the USMLE Step 1 content outline.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">ChatGPT-3.5 generated 150 multiple-choice case-style questions and selected an answer. Overall, 83% of generated multiple questions had no factual inaccuracies and 15% contained one to two factual inaccuracies. With simple prompting, common themes included deep venous thrombosis, myocardial infarction, and thyroid disease. Topic diversity improved by separating content topic generation from question generation, and specificity to Step 1 increased by indicating that "treatment" questions were not desired.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">We demonstrate that ChatGPT-3.5 can successfully generate Step 1 style questions with reasonable factual accuracy, and this method may be used by medical students preparing for USMLE examinations. While AI-generated questions demonstrated adequate factual accuracy, targeted prompting techniques should be used to overcome ChatGPT's bias towards particular medical conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balu</LastName><ForeName>Alan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9974-906X</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Georgetown University School of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prvulovic</LastName><ForeName>Stefan T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Georgetown University School of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez Perez</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Georgetown University School of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Georgetown University School of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donoho</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Children's National Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keating</LastName><ForeName>Gregory</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, MedStar Georgetown University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Med Teach</MedlineTA><NlmUniqueID>7909593</NlmUniqueID><ISSNLinking>0142-159X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ChatGPT</Keyword><Keyword MajorTopicYN="N">LLM</Keyword><Keyword MajorTopicYN="N">Step 1</Keyword><Keyword MajorTopicYN="N">USMLE</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>27</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>27</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>27</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40146672</ArticleId><ArticleId IdType="doi">10.1080/0142159X.2025.2478872</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40134980</PMID><DateRevised><Year>2025</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Contextual challenges in implementing artificial intelligence for healthcare in low-resource environments: insights from the SPEC-AI Nigeria trial.</ArticleTitle><Pagination><StartPage>1516088</StartPage><MedlinePgn>1516088</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1516088</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2025.1516088</ELocationID><Abstract><AbstractText>Nigeria is the most populous country in Africa with the highest gross domestic product (GDP) as of 2022. However, Nigeria is burdened by significant health challenges including an extremely high maternal mortality ratio, inadequate human resources, poor healthcare infrastructure, and population-level poverty rates as high as 40%. Nigeria also has the highest reported prevalence of peripartum cardiomyopathy worldwide which contributes to maternal mortality. Unfortunately, the diagnosis of peripartum cardiomyopathy is often delayed and mortality rates following diagnosis are extremely high (approximately 50%). Thus, there is a huge unmet need for simple, effective, and accessible solutions for cardiomyopathy detection in this population. To address maternal mortality through screening and early diagnosis, we designed and conducted a randomized controlled clinical trial (NCT05438576) of an artificial intelligence (AI) technology in Nigeria. The objective of the study was to evaluate the impact of AI-guided screening on cardiomyopathy detection in obstetric patients. The study findings showed AI-guided screening doubled the detection of cardiomyopathy (defined as left ventricular ejection fraction &lt;50%) when compared to usual care with a number needed to screen of 47. As we explore next steps in relation to deploying this technology for clinical use in Nigeria, we sought to gather contextual information and broadly share lessons learned from the recently completed trial. To that end, we convened a round table discussion with all study site investigators aimed at identifying site-specific contextual challenges related to the development and conduct of the study. The SPEC-AI Nigeria study is the first published randomized controlled clinical trial of a health AI intervention in Nigeria. Insights gained from this study can inform future AI intervention studies in clinical care, guide the development of implementation strategies to ensure effective interventions are successfully incorporated into clinical care, and provide a roadmap for key stakeholders to consider when evaluating AI-technologies for use in low-resource settings.</AbstractText><CopyrightInformation>&#xa9; 2025 Adedinsewo, Onietan, Morales-Lara, Moideen Sheriff, Afolabi, Kushimo, Mbakwem, Ibiyemi, Ogunmodede, Raji, Ringim, Habib, Hamza, Ogah, Obajimi, Saanu, Aborisade, Jagun, Inofomoh, Adeolu, Karaye, Gaya, Sa&#x2019;ad, Alfa, Yohanna, Noseworthy and Carter.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Adedinsewo</LastName><ForeName>Demilade A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onietan</LastName><ForeName>Damilola</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, College of Medicine and Centre for Clinical Trials, Research and Implementation Science, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-Lara</LastName><ForeName>Andrea Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moideen Sheriff</LastName><ForeName>Serin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afolabi</LastName><ForeName>Bosede B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, College of Medicine and Centre for Clinical Trials, Research and Implementation Science, University of Lagos, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushimo</LastName><ForeName>Oyewole A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbakwem</LastName><ForeName>Amam C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Department of Medicine, Lagos University Teaching Hospital, Lagos, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibiyemi</LastName><ForeName>Kehinde F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynaecology, University of Ilorin Teaching Hospital, Ilorin, Kwara, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogunmodede</LastName><ForeName>James Ayodele</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ilorin, Ilorin, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raji</LastName><ForeName>Hadijat Olaide</ForeName><Initials>HO</Initials><AffiliationInfo><Affiliation>Department of Obstetrics &amp; Gynaecology, University of Ilorin Teaching Hospital, Ilorin, Kwara, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringim</LastName><ForeName>Sadiq H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rasheed Shekoni Specialist Hospital, Dutse, Jigawa, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habib</LastName><ForeName>Abdullahi A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Rasheed Shekoni Teaching Hospital, Dutse, Jigawa, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamza</LastName><ForeName>Sabiu M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rasheed Shekoni Specialist Hospital, Dutse, Jigawa, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogah</LastName><ForeName>Okechukwu S</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ibadan, Oyo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obajimi</LastName><ForeName>Gbolahan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University College Hospital Ibadan, Oyo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saanu</LastName><ForeName>Olugbenga Oluseun</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, University College Hospital Ibadan, Oyo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aborisade</LastName><ForeName>Solomon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Ibadan, Oyo, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagun</LastName><ForeName>Olusoji E</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inofomoh</LastName><ForeName>Francisca O</ForeName><Initials>FO</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Department of Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adeolu</LastName><ForeName>Temitope</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Department of Medicine, Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karaye</LastName><ForeName>Kamilu M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaya</LastName><ForeName>Sule A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sa'ad</LastName><ForeName>Yahya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfa</LastName><ForeName>Isiaka</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medicine, Bayero University and Aminu Kano Teaching Hospital, Kano, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yohanna</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lakeside Healthcare at Yaxley, the Health Centre, Peterborough, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noseworthy</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Rickey E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Nigeria</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">implementation science</Keyword><Keyword MajorTopicYN="N">pregnancy</Keyword><Keyword MajorTopicYN="N">resource-limited settings</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>26</Day><Hour>13</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>26</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>26</Day><Hour>4</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40134980</ArticleId><ArticleId IdType="pmc">PMC11932990</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2025.1516088</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Global Health Emergency Appeal: Nigeria. (2022). Available online at:
https://www.who.int/publications/m/item/who-global-health-emergency-appeal-nigeria (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>UNICEF. Country Office Annual Report 2023: Nigeria. (2023). Available online at:
https://www.unicef.org/media/152961/file/Nigeria-2023-COAR.pdf (Accessed October 03, 2024).</Citation></Reference><Reference><Citation>Abubakar I, Dalglish SL, Angell B, Sanuade O, Abimbola S, Adamu AL, et al. The Lancet Nigeria commission: investing in health and the future of the nation. Lancet. (2022) 399(10330):1155&#x2013;200. 10.1016/S0140-6736(21)02488-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02488-0</ArticleId><ArticleId IdType="pmc">PMC8943278</ArticleId><ArticleId IdType="pubmed">35303470</ArticleId></ArticleIdList></Reference><Reference><Citation>The L. Nigeria: rightly taking its place on the world stage. Lancet. (2022) 399(10330):1093. 10.1016/S0140-6736(22)00511-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00511-6</ArticleId><ArticleId IdType="pubmed">35303468</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Trends in maternal mortality 2000 to 2020: estimates by WHO, UNICEF, UNFPA, World Bank Group and UNDESA/Population Division. (2023). September 30, 2024. Available online at:
https://www.who.int/publications/i/item/9789240068759 (Accessed September 30, 2024).</Citation></Reference><Reference><Citation>Karaye KM, Ishaq NA, Sa'idu H, Balarabe SA, Talle MA, Isa MS, et al. Incidence, clinical characteristics, and risk factors of peripartum cardiomyopathy in Nigeria: results from the PEACE registry. ESC Heart Fail. (2020) 7(1):235&#x2013;43. 10.1002/ehf2.12562</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12562</ArticleId><ArticleId IdType="pmc">PMC7083508</ArticleId><ArticleId IdType="pubmed">31990449</ArticleId></ArticleIdList></Reference><Reference><Citation>Adesola RO, Opuni E, Idris I, Okesanya OJ, Igwe O, Abdulazeez MD, et al. Navigating Nigeria&#x2019;s health landscape: population growth and its health implications. Environ Health Insights. (2024) 18:11786302241250211. 10.1177/11786302241250211</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11786302241250211</ArticleId><ArticleId IdType="pmc">PMC11064746</ArticleId><ArticleId IdType="pubmed">38698838</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunleye I. Artificial Intelligence for Economic Development in Nigeria. (2021). Available online at:
https://citrispolicylab.org/wp-content/uploads/2021/12/Artificial-Intelligence-for-Economic-Development-in-Nigeria_Ifejesu-Ogunleye.pdf (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>Co-creating a National Artificial Intelligence Strategy for Nigeria: Federal Ministry of Communications, Innovation, and Digital Economy. (2023). Available online at:
https://fmcide.gov.ng/initiative/nais/ (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>Heldreth C, Vi&#xe9;gas F, Akinsanmi T, Akrong D. AI in Nigeria: Google Whitepaper Policy Perspectives+People Insights. (2019). Available online at:
https://research.google/pubs/ai-in-nigeria/ (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>Broadband Access For All: Deepening Nigeria&#x2019;s National Backbone and Middle Mile Infrastructure. (2024). Available online at:
https://drive.google.com/file/d/1fpXV5y1GGePQrHCarw_hy6tEc9W7-T3f/view (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>Adedinsewo DA, Morales-Lara AC, Dugan J, Garzon-Siatoya WT, Yao X, Johnson PW, et al. Screening for peripartum cardiomyopathies using artificial intelligence in Nigeria (SPEC-AI Nigeria): clinical trial rationale and design. Am Heart J. (2023) 261:64&#x2013;74. 10.1016/j.ahj.2023.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2023.03.008</ArticleId><ArticleId IdType="pubmed">36966922</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Morales-Lara AC, Afolabi BB, Kushimo OA, Mbakwem AC, Ibiyemi KF, et al. Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial. Nat Med. (2024) 30(10):2897&#x2013;906. 10.1038/s41591-024-03243-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-03243-9</ArticleId><ArticleId IdType="pmc">PMC11485252</ArticleId><ArticleId IdType="pubmed">39223284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor-Avi V, Khandheria B, Klempfner R, Cotella JI, Moreno M, Ignatowski D, et al. Real-time artificial intelligence&#x2013;based guidance of echocardiographic imaging by novices: image quality and suitability for diagnostic interpretation and quantitative analysis. Circ Cardiovasc Imaging. (2023) 16(11):e015569. 10.1161/CIRCIMAGING.123.015569</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.123.015569</ArticleId><ArticleId IdType="pmc">PMC10659245</ArticleId><ArticleId IdType="pubmed">37955139</ArticleId></ArticleIdList></Reference><Reference><Citation>Narang A, Bae R, Hong H, Thomas Y, Surette S, Cadieu C, et al. Utility of a deep-learning algorithm to guide novices to acquire echocardiograms for limited diagnostic use. JAMA Cardiology. (2021) 6(6):624&#x2013;32. 10.1001/jamacardio.2021.0185</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0185</ArticleId><ArticleId IdType="pmc">PMC8204203</ArticleId><ArticleId IdType="pubmed">33599681</ArticleId></ArticleIdList></Reference><Reference><Citation>Motazedian P, Marbach JA, Prosperi-Porta G, Parlow S, Di Santo P, Abdel-Razek O, et al. Diagnostic accuracy of point-of-care ultrasound with artificial intelligence-assisted assessment of left ventricular ejection fraction. NPJ Digital Medicine. (2023) 6(1):201. 10.1038/s41746-023-00945-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-023-00945-1</ArticleId><ArticleId IdType="pmc">PMC10613290</ArticleId><ArticleId IdType="pubmed">37898711</ArticleId></ArticleIdList></Reference><Reference><Citation>Toesland F. Start-ups powering up Africa&#x2019;s solar energy ecosystem. (2024). Available online at:
https://www.un.org/africarenewal/magazine/january-2024/start-ups-powering-africa&#x2019;s-solar-energy-ecosystem
(updated January 25, 2024).</Citation></Reference><Reference><Citation>Hom J, Nikowitz J, Ottesen R, Niland JC. Facilitating clinical research through automation: combining optical character recognition with natural language processing. Clinical Trials. (2022) 19(5):504&#x2013;11. 10.1177/17407745221093621</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17407745221093621</ArticleId><ArticleId IdType="pubmed">35608136</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler Tobah YS, LeBlanc A, Branda ME, Inselman JW, Morris MA, Ridgeway JL, et al. Randomized comparison of a reduced-visit prenatal care model enhanced with remote monitoring. Am J Obstet Gynecol. (2019) 221(6):638.e1&#x2013;.e8. 10.1016/j.ajog.2019.06.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2019.06.034</ArticleId><ArticleId IdType="pubmed">31228414</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler Tobah YS, LeBlanc A, Branda M, Inselman J, Gostout B, Famuyide A. OB Nest&#x2014;a novel approach to prenatal care [21]. Obstet Gynecol. (2016) 127:7S&#x2013;8. 10.1097/01.AOG.0000483637.05137.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.AOG.0000483637.05137.18</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogah OS, Orimolade OA, Jinadu TO. Cardiovascular diseases in Nigeria: current Status, threats, and opportunities. Circulation. (2023) 148(19):1441&#x2013;4. 10.1161/CIRCULATIONAHA.123.063671</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.063671</ArticleId><ArticleId IdType="pubmed">37931020</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeshokan O, Obumselu C. Nigeria Debates mandatory domestic service to stem the medical brain drain. Br Med J. (2023) 383:p2064. 10.1136/bmj.p2064</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p2064</ArticleId><ArticleId IdType="pubmed">37871942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad JI. The imperative of medical entrepreneurship in addressing Physicians&#x2019; brain drain and health system strengthening in Nigeria. Economic and Policy Review. (2023) 21(1):19&#x2013;27. Available online at: https://www.ajol.info/index.php/epr/article/view/252753</Citation></Reference><Reference><Citation>Nnoruga JN, Osigwe CN. Brain drain in Nigeria: a challenge to human capital development. Nigerian J Afr Stud (NJAS). (2023) 5(2). Available online at:
https://nigerianjournalsonline.com/index.php/NJAS/article/view/3366</Citation></Reference><Reference><Citation>Commodore-Mensah Y, Turkson-Ocran R-AN, Foti K, Dennison Himmelfarb CR, Carson K, Appiah LT, et al. Abstract 15333: the addressing hypertension care in Africa (ADHINCRA) study: a multi-level nurse-led, Mobile-health enhanced intervention to improve hypertension control in Ghana. Circulation. (2023) 148(Suppl_1):A15333-A. 10.1161/circ.148.suppl_1.15333</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.148.suppl_1.15333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogbonna N. Why Nigeria&#x2019;s economy is in such a mess. BBC News. (2024) February 27, 2024).</Citation></Reference><Reference><Citation>The World Bank in Nigeria: Overview and Context: World Bank Group. (2024). Available online at:
https://www.worldbank.org/en/country/nigeria/overview (Accessed September 17, 2024).</Citation></Reference><Reference><Citation>Begazo T, Moussa P. Blimpo, and Mark A. Dutz. Digital Africa: Technological Transformation for Jobs. Washington, DC: World Bank;  (2023). Available online at:
https://www.worldbank.org/en/region/afr/publication/digital-africa
(cited March 13, 2023).</Citation></Reference><Reference><Citation>The Mobile Economy Sub-Saharan Africa 2023: Global System for Mobile Communications (GSMA). (2023). Available online at:
https://www.gsma.com/solutions-and-impact/connectivity-for-good/mobile-economy/sub-saharan-africa/ (Accessed July 02, 2024).</Citation></Reference><Reference><Citation>Ogunode NJ, Olofu PA, Bassey UO. Barriers to effective usage of artificial intelligence in tertiary institution in north-central, Nigeria. Web of Semantics: J Interdiscipli Sci. (2023) 1(1):38&#x2013;43. Available online at: http://web.semanticjournals.org/index.php/wos/article/view/13</Citation></Reference><Reference><Citation>Adigwe OP, Onavbavba G, Sanyaolu SE. Exploring the matrix: knowledge, perceptions and prospects of artificial intelligence and machine learning in Nigerian healthcare. Front Artif Intell. (2023) 6:1293297. 10.3389/frai.2023.1293297</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frai.2023.1293297</ArticleId><ArticleId IdType="pmc">PMC10834749</ArticleId><ArticleId IdType="pubmed">38314120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogolodom MP, Mbaba AN, Johnson J, Chiegwu HU, Ordu KS, Okej MC, et al. Knowledge and perception of healthcare workers towards the adoption of artificial intelligence in healthcare service delivery in Nigeria. AG Salud. (2023) 1:16. 10.62486/agsalud202316</Citation><ArticleIdList><ArticleId IdType="doi">10.62486/agsalud202316</ArticleId></ArticleIdList></Reference><Reference><Citation>Access to medicines: making market forces serve the poor. (2017). September 23, 2024. Available online at:
https://cdn.who.int/media/docs/default-source/essential-medicines/fair-price/chapter-medicines.pdf?sfvrsn=adcffc8f_4&amp;download=true (Accessed September 23, 2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40507459</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>AI-Based Predictive Models for Cardiogenic Shock in STEMI: Real-World Data for Early Risk Assessment and Prognostic Insights.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3698</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14113698</ELocationID><Abstract><AbstractText><b>Background:</b> Cardiogenic shock (CS) is a life-threatening complication of ST-elevation myocardial infarction (STEMI) and remains the leading cause of in-hospital mortality, with rates ranging from 5 to 10% despite advances in reperfusion strategies. Early identification and timely intervention are critical for improving outcomes. This study investigates the utility of machine learning (ML) models for predicting the risk of CS during the early phases of care-prehospital, emergency department (ED), and cardiology-on-call-with a focus on accurate triage and prioritization for urgent angiography. <b>Results:</b> In the prehospital phase, the Extra Trees classifier demonstrated the highest overall performance. It achieved an accuracy (ACC) of 0.9062, precision of 0.9078, recall of 0.9062, F1-score of 0.9061, and Matthews correlation coefficient (MCC) of 0.8140, indicating both high predictive power and strong generalization. In the ED phase, the support vector machine model outperformed others with an ACC of 78.12%. During the cardiology-on-call phase, Random Forest showed the best performance with an ACC of 81.25% and consistent values across other metrics. Quadratic discriminant analysis showed consistent and generalizable performance across all early care stages. Key predictive features included the Killip class, ECG rhythm, creatinine, potassium, and markers of renal dysfunction-parameters readily available in routine emergency settings. The greatest clinical utility was observed in prehospital and ED phases, where ML models could support the early identification of critically ill patients and could prioritize coronary catheterization, especially important for centers with limited capacity for angiography. <b>Conclusions:</b> Machine learning-based predictive models offer a valuable tool for early risk stratification in STEMI patients at risk for cardiogenic shock. These findings support the implementation of ML-driven tools in early STEMI care pathways, potentially improving survival through faster and more accurate decision-making, especially in time-sensitive clinical environments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stamate</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-5056-1015</Identifier><AffiliationInfo><Affiliation>Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Culea-Florescu</LastName><ForeName>Anisia-Luiza</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Electronics and Telecommunications, "Dunarea de Jos" University of Gala&#x21b;i, 800008 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miron</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4536-1574</Identifier><AffiliationInfo><Affiliation>Department of Computer Science and Information Technology, "Dunarea de Jos" University of Gala&#x21b;i, 800008 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piraianu</LastName><ForeName>Alin-Ionut</ForeName><Initials>AI</Initials><Identifier Source="ORCID">0000-0001-9664-2128</Identifier><AffiliationInfo><Affiliation>Department of Morphological and Functional Sciences, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dumitrascu</LastName><ForeName>Adrian George</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0003-1557-9791</Identifier><AffiliationInfo><Affiliation>Division of Hospital Internal Medicine, Department of Medicine, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fulga</LastName><ForeName>Iuliu</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Medical, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fulga</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Surgical, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patrascanu</LastName><ForeName>Octavian Stefan</ForeName><Initials>OS</Initials><Identifier Source="ORCID">0000-0002-5853-393X</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 AL Cuza St, 800010 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iancu</LastName><ForeName>Doriana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Dunarea de Jos University of Galati, 35 AL Cuza St, 800010 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciobotaru</LastName><ForeName>Octavian Catalin</ForeName><Initials>OC</Initials><Identifier Source="ORCID">0000-0003-4568-5237</Identifier><AffiliationInfo><Affiliation>Department of Clinical Surgical, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciobotaru</LastName><ForeName>Oana Roxana</ForeName><Initials>OR</Initials><Identifier Source="ORCID">0000-0001-9173-6205</Identifier><AffiliationInfo><Affiliation>Department of Clinical Medical, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 35, Al. I. Cuza Street, 800216 Galati, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VAT RO50411550</GrantID><Agency>"Dunarea de Jos" University of Galati</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">angiography prioritization</Keyword><Keyword MajorTopicYN="N">cardiogenic shock</Keyword><Keyword MajorTopicYN="N">early triage</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">predictive models</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40507459</ArticleId><ArticleId IdType="pmc">PMC12156923</ArticleId><ArticleId IdType="doi">10.3390/jcm14113698</ArticleId><ArticleId IdType="pii">jcm14113698</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>So D.Y., Boudreau R., Chih S. The Role of a Cardiogenic Shock Team in Decision Making Surrounding Mechanical Circulatory Support. Can. J. Cardiol. 2025;41:682&#x2013;690. doi: 10.1016/j.cjca.2025.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2025.02.002</ArticleId><ArticleId IdType="pubmed">39922308</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen T., Senaratne J.M. Definition, Classification, and Management of Primary Noncardiac Causes of Cardiogenic Shock. Can. J. Cardiol. 2024;41:587&#x2013;604. doi: 10.1016/j.cjca.2024.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2024.12.014</ArticleId><ArticleId IdType="pubmed">39675467</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;sebrink E., Binzenh&#xf6;fer L., Adamo M., Lorusso R., Mebazaa A., Morrow D.A., Price S., Jentzer J.C., Brodie D., Combes A., et al. Cardiogenic shock. Lancet. 2024;404:2006&#x2013;2020. doi: 10.1016/S0140-6736(24)01818-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01818-X</ArticleId><ArticleId IdType="pubmed">39550175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanhouche G., Nicolau J.C., Furtado R.H.d.M., Carvalho L.S., Dal&#xe7;oquio T.F., Pileggi B., Marchi M.F.d.S., Abi-Kair P., Lopes N., Giraldez R.R., et al. Long-term outcomes of cardiogenic shock and cardiac arrest complicating ST-elevation myocardial infarction according to timing of occurrence. Eur. Heart J. Open. 2024;4:oeae075. doi: 10.1093/ehjopen/oeae075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjopen/oeae075</ArticleId><ArticleId IdType="pmc">PMC11430270</ArticleId><ArticleId IdType="pubmed">39346895</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.H., Harrison W., Chow K.L., Lee M., Kerr A.J. Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73) Heart Lung Circ. 2024;33:450&#x2013;459. doi: 10.1016/j.hlc.2024.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2024.01.009</ArticleId><ArticleId IdType="pubmed">38453606</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;ss J., Desch S., Thiele H. Shock management in acute myocardial infarction. EuroIntervention. 2014;10:T74&#x2013;T82. doi: 10.4244/EIJV10STA12.</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJV10STA12</ArticleId><ArticleId IdType="pubmed">25256538</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamis-Holland J.E., Abbott J.D., Al-Azizi K., Barman N., Bortnick A.E., Cohen M.G., Dehghani P., Henry T.D., Latif F., Madjid M., et al. SCAI Expert Consensus Statement on the Management of Patients with STEMI Referred for Primary PCI. J. Soc. Cardiovasc. Angiogr. Interv. 2024;3:102294. doi: 10.1016/j.jscai.2024.102294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2024.102294</ArticleId><ArticleId IdType="pmc">PMC11624394</ArticleId><ArticleId IdType="pubmed">39649824</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlow S., Fernando S.M., Pugliese M., Qureshi D., Talarico R., Sterling L.H., van Diepen S., Herridge M.S., Price S., Brodie D., et al. Resource Utilization and Costs Associated with Cardiogenic Shock Complicating Myocardial Infarction: A Population-Based Cohort Study. JACC Adv. 2024;3:101047. doi: 10.1016/j.jacadv.2024.101047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101047</ArticleId><ArticleId IdType="pmc">PMC11268098</ArticleId><ArticleId IdType="pubmed">39050814</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamil Y., Park D.Y., Rao S.V., Ahmad Y., Sikand N.V., Bosworth H.B., Coles T., Damluji A.A., Nanna M.G., Samsky M.D. Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock. JACC Adv. 2024;3:100949. doi: 10.1016/j.jacadv.2024.100949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.100949</ArticleId><ArticleId IdType="pmc">PMC11198471</ArticleId><ArticleId IdType="pubmed">38938859</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren A.F., Rosner C., Gattani R., Truesdell A.G., Proudfoot A.G. Cardiogenic Shock: Protocols, Teams, Centers, and Networks. US Cardiol. Rev. 2021;15:e18. doi: 10.15420/usc.2021.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/usc.2021.10</ArticleId><ArticleId IdType="pmc">PMC11664751</ArticleId><ArticleId IdType="pubmed">39720489</ArticleId></ArticleIdList></Reference><Reference><Citation>Shenoy N., Devasia T. Comparison of Outcomes between Early and Late Presentation of ST-elevation Myocardial Infarction in Patients with Cardiogenic Shock. Int. J. Cardiovasc. Acad. 2024;10:53&#x2013;59. doi: 10.4274/ijca.2024.41861.</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/ijca.2024.41861</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdeva P., Kaur K., Fatima S., Mahak F., Noman M., Siddenthi S.M., Surksha M.A., Munir M., Fatima F., Sultana S.S., et al. Advancements in Myocardial Infarction Management: Exploring Novel Approaches and Strategies. Cureus. 2023;15:e45578. doi: 10.7759/cureus.45578.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45578</ArticleId><ArticleId IdType="pmc">PMC10587445</ArticleId><ArticleId IdType="pubmed">37868550</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.V., O&#x2019;Donoghue M.L., Ruel M., Rab T., Tamis-Holland J.E., Alexander J.H., Baber U., Baker H., Cohen M.G., Cruz-Ruiz M., et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients with Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151:e771&#x2013;e862.</Citation><ArticleIdList><ArticleId IdType="pubmed">40014670</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.S., Baran D.A., Jentzer J.C., Hollenberg S.M., van Diepen S., Basir M.B., Grines C.L., Diercks D.B., Hall S., Kapur N.K., et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies. J. Soc. Cardiovasc. Angiogr. Interv. 2022;1:100008. doi: 10.1016/j.jscai.2021.100008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2021.100008</ArticleId><ArticleId IdType="pmc">PMC11308837</ArticleId><ArticleId IdType="pubmed">39130139</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung C., Fong Y.H., Chiang M.C.S., Wong I.M.H., Ho C.B., Yeung Y.K., Leung C.Y., Lee P.H., So T.C., Cheng Y.W., et al. Protocol-Driven Best Practices and Cardiogenic Shock Survival in Asian Patients. J. Am. Hear. Assoc. 2025;14:e037742. doi: 10.1161/JAHA.124.037742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.124.037742</ArticleId><ArticleId IdType="pmc">PMC12132677</ArticleId><ArticleId IdType="pubmed">40008554</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhaddad M., Hamam S. AI-Driven Clinical Decision Support Systems: An Ongoing Pursuit of Potential. Cureus. 2024;16:e57728. doi: 10.7759/cureus.57728.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.57728</ArticleId><ArticleId IdType="pmc">PMC11073764</ArticleId><ArticleId IdType="pubmed">38711724</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial Intelligence in Healthcare&#x2014;European Commission.  [(accessed on 15 March 2025)].  Available online:  https://health.ec.europa.eu/ehealth-digital-health-and-care/artificial-intelligence-healthcare_en.</Citation></Reference><Reference><Citation>Niculet E., Bobeica C., Stefanopol I.A., Pelin A.M., Nechifor A., Onisor C., Tatu A.L. Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives. Ther. Clin. Risk Manag. 2022;18:399&#x2013;407. doi: 10.2147/TCRM.S338661.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TCRM.S338661</ArticleId><ArticleId IdType="pmc">PMC9014825</ArticleId><ArticleId IdType="pubmed">35444421</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;hm A., Segev A., Jajcay N., Krychtiuk K.A., Tavazzi G., Spartalis M., Kollarova M., Berta I., Jankova J., Guerra F., et al. Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome. Eur. Heart J.-Digit. Heal. 2025;6:240&#x2013;251. doi: 10.1093/ehjdh/ztaf002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztaf002</ArticleId><ArticleId IdType="pmc">PMC11914733</ArticleId><ArticleId IdType="pubmed">40110217</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamate E., Piraianu A.-I., Ciobotaru O.R., Crassas R., Duca O., Fulga A., Grigore I., Vintila V., Fulga I., Ciobotaru O.C. Revolutionizing Cardiology through Artificial Intelligence&#x2014;Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment&#x2014;A Comprehensive Review of the Past 5 Years. Diagnostics. 2024;14:1103. doi: 10.3390/diagnostics14111103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14111103</ArticleId><ArticleId IdType="pmc">PMC11172021</ArticleId><ArticleId IdType="pubmed">38893630</ArticleId></ArticleIdList></Reference><Reference><Citation>Patrascanu O.S., Tutunaru D., Musat C.L., Dragostin O.M., Fulga A., Nechita L., Ciubara A.B., Piraianu A.I., Stamate E., Poalelungi D.G., et al. Future Horizons: The Potential Role of Artificial Intelligence in Cardiology. J. Pers. Med. 2024;14:656. doi: 10.3390/jpm14060656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm14060656</ArticleId><ArticleId IdType="pmc">PMC11204977</ArticleId><ArticleId IdType="pubmed">38929877</ArticleId></ArticleIdList></Reference><Reference><Citation>Piraianu A.-I., Fulga A., Musat C.L., Ciobotaru O.-R., Poalelungi D.G., Stamate E., Ciobotaru O., Fulga I. Enhancing the Evidence with Algorithms: How Artificial Intelligence Is Transforming Forensic Medicine. Diagnostics. 2023;13:2992. doi: 10.3390/diagnostics13182992.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13182992</ArticleId><ArticleId IdType="pmc">PMC10529115</ArticleId><ArticleId IdType="pubmed">37761359</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto A., Nakamura Y., Sato E., Kagiyama N. Artificial Intelligence in Clinics: Enhancing Cardiology Practice. JMA J. 2025;8:131&#x2013;140. doi: 10.31662/jmaj.2024-0190.</Citation><ArticleIdList><ArticleId IdType="doi">10.31662/jmaj.2024-0190</ArticleId><ArticleId IdType="pmc">PMC11799705</ArticleId><ArticleId IdType="pubmed">39926098</ArticleId></ArticleIdList></Reference><Reference><Citation>Alowais S.A., Alghamdi S.S., Alsuhebany N., Alqahtani T., Alshaya A.I., Almohareb S.N., Aldairem A., Alrashed M., Bin Saleh K., Badreldin H.A., et al. Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Med. Educ. 2023;23:689. doi: 10.1186/s12909-023-04698-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12909-023-04698-z</ArticleId><ArticleId IdType="pmc">PMC10517477</ArticleId><ArticleId IdType="pubmed">37740191</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A., Vavilin I., Nguyen A.H., Batchelor W.B., Blumer V., Cilia L., Dewanjee A., Desai M., Desai S.S., Flanagan M.C., et al. Contemporary approach to cardiogenic shock care: A state-of-the-art review. Front. Cardiovasc. Med. 2024;11:1354158. doi: 10.3389/fcvm.2024.1354158.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1354158</ArticleId><ArticleId IdType="pmc">PMC10965643</ArticleId><ArticleId IdType="pubmed">38545346</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolub G., Khurshid S., Theriault-Lauzier P., Lapalme A.N., Tastet O., So D., Langlais E.L., Cobin D., Avram R. Revolutionising Acute Cardiac Care with Artificial Intelligence: Opportunities and Challenges. Can. J. Cardiol. 2024;40:1813&#x2013;1827. doi: 10.1016/j.cjca.2024.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2024.06.011</ArticleId><ArticleId IdType="pmc">PMC12131165</ArticleId><ArticleId IdType="pubmed">38901544</ArticleId></ArticleIdList></Reference><Reference><Citation>Karalis V.D. The Integration of Artificial Intelligence into Clinical Practice. Appl. Biosci. 2024;3:14&#x2013;44. doi: 10.3390/applbiosci3010002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/applbiosci3010002</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamate E., Ciobotaru O.R., Arbune M., Piraianu A.I., Duca O.M., Fulga A., Fulga I., Balta A.A.S., Dumitrascu A.G., Ciobotaru O.C. Multidisciplinary Perspectives of Challenges in Infective Endocarditis Complicated by Septic Embolic-Induced Acute Myocardial Infarction. Antibiotics. 2024;13:513. doi: 10.3390/antibiotics13060513.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13060513</ArticleId><ArticleId IdType="pmc">PMC11201065</ArticleId><ArticleId IdType="pubmed">38927180</ArticleId></ArticleIdList></Reference><Reference><Citation>Totolici G., Miron M., Culea-Florescu A.-L. Automatic Segmentation and Statistical Analysis of the Foveal Avascular Zone. Technologies. 2024;12:235. doi: 10.3390/technologies12120235.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/technologies12120235</ArticleId></ArticleIdList></Reference><Reference><Citation>Recommendations on Digital Interventions for Health System Strengthening.  [(accessed on 5 April 2025)].  Available online:  https://iris.who.int/bitstream/handle/10665/311941/9789241550505-eng.pdf.</Citation></Reference><Reference><Citation>Johnson K.B., Horn I.B., Horvitz E. Pursuing Equity with Artificial Intelligence in Health Care. JAMA Healt Forum. 2025;6:e245031. doi: 10.1001/jamahealthforum.2024.5031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2024.5031</ArticleId><ArticleId IdType="pubmed">39888636</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmark B.A., Mathenge N., Merlini P.A., Lawrence-Wright M.B., Giugliano R.P. Acute coronary syndromes. Lancet. 2022;399:1347&#x2013;1358. doi: 10.1016/S0140-6736(21)02391-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02391-6</ArticleId><ArticleId IdType="pmc">PMC8970581</ArticleId><ArticleId IdType="pubmed">35367005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammirati E., Frigerio M., Adler E.D., Basso C., Birnie D.H., Brambatti M., Friedrich M.G., Klingel K., Lehtonen J., Moslehi J.J., et al. Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy. Circ. Heart Fail. 2020;13:e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.007405</ArticleId><ArticleId IdType="pmc">PMC7673642</ArticleId><ArticleId IdType="pubmed">33176455</ArticleId></ArticleIdList></Reference><Reference><Citation>Borger M., de Waha S., Marsan N.A., Z&#xfc;hlke L., Mestres C.A., Fosbol E., Bonaros N., Pizzi M.N., Brida M., Sionis A., et al. Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings. Eur. Heart J.-Qual. Care Clin. Outcomes. 2025 doi: 10.1093/ehjqcco/qcae106. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcae106</ArticleId><ArticleId IdType="pubmed">40152919</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd K.E., Johnson S.C., Agesa K.M., Shackelford K.A., Tsoi D., Kievlan D.R., Colombara D.V., Ikuta K.S., Kissoon N., Finfer S., et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: Analysis for the Global Burden of Disease Study. Lancet. 2020;395:200&#x2013;211. doi: 10.1016/S0140-6736(19)32989-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mello B.H.G., Oliveira G.B.F., Ramos R.F., Lopes B.B.C., Barros C.B.S., de Oliveira Carvalho E., Teixeira F.B.P., Arruda A.S., Revelo M.S.C., Piegas L.S. Validation of the Killip-Kimball Classification and Late Mortality after Acute Myocardial Infarction. Arq. Bras. Cardiol. 2014;103:107. doi: 10.5935/abc.20140091.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/abc.20140091</ArticleId><ArticleId IdType="pmc">PMC4150661</ArticleId><ArticleId IdType="pubmed">25014060</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee. ElSayed N.A., Aleppo G., Bannuru R.R., Bruemmer D., Collins B.S., Ekhlaspour L., Gaglia J.L., Hilliard M.E., Johnson E.L., et al. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes&#x2014;2024. Diabetes Care. 2023;47:S20&#x2013;S42. doi: 10.2337/dc24-s002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc24-s002</ArticleId><ArticleId IdType="pmc">PMC10725812</ArticleId><ArticleId IdType="pubmed">38078589</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvoy J.W., McCarthy C.P., Bruno R.M., Brouwers S., Canavan M.D., Ceconi C., Christodorescu R.M., Daskalopoulou S.S., Ferro C.J., Gerdts E., et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur. Heart J. 2024;45:3912&#x2013;4018. doi: 10.1093/eurheartj/ehae178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae178</ArticleId><ArticleId IdType="pubmed">39210715</ArticleId></ArticleIdList></Reference><Reference><Citation>Mach F., Baigent C., Catapano A.L., Koskinas K.C., Casula M., Badimon L., Chapman M.J., De Backer G.G., Delgado V., Ference B.A., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Eur. Heart J. 2020;41:111&#x2013;188. doi: 10.1093/eurheartj/ehz455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz455</ArticleId><ArticleId IdType="pubmed">31504418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox K.A.A., Dabbous O.H., Goldberg R.J., Pieper K.S., Eagle K.A., Van de Werf F., Avezum &#xc1;., Goodman S.G., Flather M.D., Anderson F.A., et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: Prospective multinational observational study (GRACE) BMJ. 2006;333:1091. doi: 10.1136/bmj.38985.646481.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38985.646481.55</ArticleId><ArticleId IdType="pmc">PMC1661748</ArticleId><ArticleId IdType="pubmed">17032691</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele H., Zeymer U., Neumann F.-J., Ferenc M., Olbrich H.-G., Hausleiter J., Richardt G., Hennersdorf M., Empen K., Fuernau G., et al. Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock. N. Engl. J. Med. 2012;367:1287&#x2013;1296. doi: 10.1056/NEJMoa1208410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1208410</ArticleId><ArticleId IdType="pubmed">22920912</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaji H., Iwasaki K., Kusachi S., Murakami T., Hirami R., Hamamoto H., Hina K., Kita T., Sakakibara N., Tsuji T. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography: ST segment elevation in lead aVR with less ST segment elevation in lead V1. J. Am. Coll. Cardiol. 2001;38:1348&#x2013;1354. doi: 10.1016/S0735-1097(01)01563-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01563-7</ArticleId><ArticleId IdType="pubmed">11691506</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R., Coughlan J.J., Rossello X., Ibanez B., Members of the Task Force for the 2023 ESC Guidelines for the Management of Acute Coronary Syndromes. Barbato E., Berry C., Chieffo A., Claeys M.J., Dan G.-A., et al. Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings. Eur. Heart J.-Qual. Care Clin. Outcomes. 2025 doi: 10.1093/ehjqcco/qcae107. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcae107</ArticleId><ArticleId IdType="pubmed">40152902</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R., Rossello X., Coughlan J.J., Barbato E., Berry C., Chieffo A., Claeys M.J., Dan G.-A., Dweck M.R., Galbraith M., et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) Eur. Heart J. Acute Cardiovasc. Care. 2023;13:55&#x2013;161. doi: 10.1093/ehjacc/zuad107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjacc/zuad107</ArticleId><ArticleId IdType="pubmed">37740496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochman J.S., Sleeper L.A., Webb J.G., Dzavik V., Buller C.E., Aylward P., Col J., White H.D., for the SHOCK Investigators Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial Infarction. JAMA. 2006;295:2511&#x2013;2515. doi: 10.1001/jama.295.21.2511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.21.2511</ArticleId><ArticleId IdType="pmc">PMC1782030</ArticleId><ArticleId IdType="pubmed">16757723</ArticleId></ArticleIdList></Reference><Reference><Citation>Emilia Babe E., Florin Pop C., Alexandra Coad&#x103; C., Lupu M., Florin Ferent I., Ioana Hodas R., Ursu M.-&#x15e;. Factors Associated with Mortality Risk in Patients with Cardiogenic Shock Post-ST-Elevation Myocardial Infarction: Insights from a Regional Centre in Northwest Romania. Medicina. 2025;61:725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12029066</ArticleId><ArticleId IdType="pubmed">40283015</ArticleId></ArticleIdList></Reference><Reference><Citation>Syntila S., Chatzis G., Markus B., Ahrens H., Waechter C., Luesebrink U., Divchev D., Schuett H., Tsalouchidou P.-E., Jerrentrup A., et al. Comparison of Mechanical Support with Impella or Extracorporeal Life Support in Post-Cardiac Arrest Cardiogenic Shock: A Propensity Scoring Matching Analysis. J. Clin. Med. 2021;10:3583. doi: 10.3390/jcm10163583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163583</ArticleId><ArticleId IdType="pmc">PMC8396971</ArticleId><ArticleId IdType="pubmed">34441879</ArticleId></ArticleIdList></Reference><Reference><Citation>Taha H.S., Gohar A., Ammar W., Alhossary H., Adel A., Diab R., Mahfouz H., Shaker M.M., Samy M. Predictors of short-term mortality in cardiogenic shock: Insights from an Egyptian multicenter registry. Egypt. Heart J. 2024;76:94. doi: 10.1186/s43044-024-00525-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-024-00525-y</ArticleId><ArticleId IdType="pmc">PMC11282039</ArticleId><ArticleId IdType="pubmed">39060876</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Garc&#xed;a C., L&#xf3;pez-Sobrino T., Sanz-Girgas E., Cueto M.R., Aboal J., Pastor P., Buera I., Sionis A., Andrea R., Rodr&#xed;guez-L&#xf3;pez J., et al. Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock-CAT study. ESC Heart Fail. 2024;12:1336&#x2013;1345. doi: 10.1002/ehf2.15148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.15148</ArticleId><ArticleId IdType="pmc">PMC11911611</ArticleId><ArticleId IdType="pubmed">39587711</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzafarova T., Motovska Z., Hlinomaz O., Kala P., Hromadka M., Precek J., Mrozek J., Matejka J., Kettner J., Bis J., et al. The Prognosis of Cardiogenic Shock Following Acute Myocardial Infarction&#x2014;An Analysis of 2693 Cases from a Prospective Multicenter Registry. Dtsch. Aerzteblatt Online. 2023;120:538&#x2013;539. doi: 10.3238/arztebl.m2023.0102.</Citation><ArticleIdList><ArticleId IdType="doi">10.3238/arztebl.m2023.0102</ArticleId><ArticleId IdType="pmc">PMC10534133</ArticleId><ArticleId IdType="pubmed">37721142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Xu L., Xie Z., He W., Huang X. Machine learning-based prediction of mortality in acute myocardial infarction with cardiogenic shock. Front. Cardiovasc. Med. 2024;11:1402503. doi: 10.3389/fcvm.2024.1402503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1402503</ArticleId><ArticleId IdType="pmc">PMC11513311</ArticleId><ArticleId IdType="pubmed">39469130</ArticleId></ArticleIdList></Reference><Reference><Citation>Senman B., Jentzer J.C., Barnett C.F., Bartos J.A., Berg D.D., Chih S., Drakos S.G., Dudzinski D.M., Elliott A., Gage A., et al. Need for a Cardiogenic Shock Team Collaborative&#x2014;Promoting a Team-Based Model of Care to Improve Outcomes and Identify Best Practices. J. Am. Heart Assoc. 2024;13:e031979. doi: 10.1161/JAHA.123.031979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.031979</ArticleId><ArticleId IdType="pmc">PMC11009990</ArticleId><ArticleId IdType="pubmed">38456417</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe9;rion F.-X., Beurton A., Oddos C., Nubret K., Aguerreche C., Quessard A., Faure M., Gerbaud E., Pernot M., Imbault J., et al. Multidisciplinary cardiogenic shock team approach improves the long-term outcomes of patients suffering from refractory cardiogenic shock treated with short-term mechanical circulatory support. Eur. Heart J. Acute Cardiovasc. Care. 2023;12:821&#x2013;830. doi: 10.1093/ehjacc/zuad108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjacc/zuad108</ArticleId><ArticleId IdType="pubmed">37713615</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Mughayyar D., Marshall T., D&#x2019;souza K., MacLeod J.B., McCoy A., Morris S., Smith M., White C.W., Sarkar S., Brunt K.R., et al. Implementation of a Multidisciplinary Cardiogenic Shock Team in a Nonacademic Canadian Heart Centre: An Implementation Study. CJC Open. 2025;7:231&#x2013;238. doi: 10.1016/j.cjco.2024.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2024.11.007</ArticleId><ArticleId IdType="pmc">PMC11886362</ArticleId><ArticleId IdType="pubmed">40060208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuriditsky E., Horowitz J.M. Prioritizing Rapid Reperfusion in ST-Segment&#x2013;Elevation Myocardial Infarction Complicated by Cardiogenic Shock: Leveraging Regionalized Systems of Care. Circ. Cardiovasc. Interv. 2024;17:e013848. doi: 10.1161/CIRCINTERVENTIONS.123.013848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.123.013848</ArticleId><ArticleId IdType="pubmed">38293832</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz K.H., Friede T., Meyer T., Jacobshagen C., Lengenfelder B., Jung J., Fleischmann C., Moehlis H., Olbrich H.G., Ott R., et al. Prognostic significance of emergency department bypass in stable and unstable patients with ST-segment elevation myocardial infarction. Eur. Heart J. Acute Cardiovasc. Care. 2018;9:34&#x2013;44. doi: 10.1177/2048872618813907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872618813907</ArticleId><ArticleId IdType="pmc">PMC7047304</ArticleId><ArticleId IdType="pubmed">30477317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman F., Finkelstein N., Alyakin A., Gilotra N.A., Trost J., Schulman S.P., Saria S. Using Machine Learning for Early Prediction of Cardiogenic Shock in Patients with Acute Heart Failure. J. Soc. Cardiovasc. Angiogr. Interv. 2022;1:100308. doi: 10.1016/j.jscai.2022.100308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2022.100308</ArticleId><ArticleId IdType="pmc">PMC11307874</ArticleId><ArticleId IdType="pubmed">39131966</ArticleId></ArticleIdList></Reference><Reference><Citation>Couronn&#xe9; R., Probst P., Boulesteix A.L. Random forest versus logistic regression: A large-scale benchmark experiment. BMC Bioinf. 2018 doi: 10.1186/s12859-018-2264-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-018-2264-5</ArticleId><ArticleId IdType="pmc">PMC6050737</ArticleId><ArticleId IdType="pubmed">30016950</ArticleId></ArticleIdList></Reference><Reference><Citation>Eliakundu A.L., Bloom J.E., Ball J., Nehme E., Okyere D., Heritier S., Voskoboinik A., Dawson L., Cox S., Anderson D., et al. Prehospital factors predicting mortality in patients with shock: State-wide linkage study. Open Heart. 2024;11:e002799. doi: 10.1136/openhrt-2024-002799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2024-002799</ArticleId><ArticleId IdType="pmc">PMC11448143</ArticleId><ArticleId IdType="pubmed">39349049</ArticleId></ArticleIdList></Reference><Reference><Citation>Meertens M.M., Tichelb&#xe4;cker T., Macherey-Meyer S., Heyne S., Braumann S., Nie&#xdf;en S.F., Baldus S., Adler C., Lee S. Meta-analysis of extracorporeal membrane oxygenation in combination with intra-aortic balloon pump vs. extracorporeal membrane oxygenation only in patients with cardiogenic shock due to acute myocardial infarction. Front. Cardiovasc. Med. 2023;9:1104357. doi: 10.3389/fcvm.2022.1104357.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1104357</ArticleId><ArticleId IdType="pmc">PMC9889933</ArticleId><ArticleId IdType="pubmed">36741852</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage M.L., Hay K., Vollbon W., Doan T., Murdoch D.J., Hammett C., Poulter R., Walters D.L., Denman R., Ranasinghe I., et al. Prehospital Activation of the Cardiac Catheterization Laboratory in ST-Segment&#x2013;Elevation Myocardial Infarction for Primary Percutaneous Coronary Intervention. J. Am. Heart Assoc. 2023;12:e029346. doi: 10.1161/JAHA.122.029346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.029346</ArticleId><ArticleId IdType="pmc">PMC10382081</ArticleId><ArticleId IdType="pubmed">37449585</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C., Wang S., Huo R., Huang Y., Yang S. Comparison of machine learning and nomogram to predict 30-day in-hospital mortality in patients with acute myocardial infarction combined with cardiogenic shock: A retrospective study based on the eICU-CRD and MIMIC-IV databases. BMC Cardiovasc. Disord. 2025;25:197. doi: 10.1186/s12872-025-04628-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-025-04628-5</ArticleId><ArticleId IdType="pmc">PMC11924626</ArticleId><ArticleId IdType="pubmed">40108540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaskiewicz F., Zielinska M. Prehospital clinical presentation in patients with acute coronary syndrome complicated by cardiogenic shock: A single center study. Aust. Crit. Care. 2019;32:293&#x2013;298. doi: 10.1016/j.aucc.2018.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aucc.2018.08.002</ArticleId><ArticleId IdType="pubmed">30213588</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Z., Liu Y., Yuan Y.-Y., Wang X.-Y., Yu H.-Y., Gao W. Early identification of STEMI patients with emergency chest pain using lipidomics combined with machine learning. J. Geriatr. Cardiol. 2022;19:685&#x2013;695. doi: 10.11909/j.issn.1671-5411.2022.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2022.09.003</ArticleId><ArticleId IdType="pmc">PMC9548052</ArticleId><ArticleId IdType="pubmed">36284682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Lee T., Kochan A., Barker M., Roston T., Singer J., Grunau B., Helmer J., Wong G.C., Fordyce C. Abstract 14054: Pre-Hospital Predictors of Cardiogenic Shock Among ST-Segment Elevation Myocardial Infarction Patients with and without Cardiac Arrest: Implications for Shock Teams. Circulation. 2023;148((Suppl. S1)):4. doi: 10.1161/circ.148.suppl_1.14054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.148.suppl_1.14054</ArticleId></ArticleIdList></Reference><Reference><Citation>Krychtiuk K., Vrints C., Wojta J., Huber K., Speidl W.S. Basic mechanisms in cardiogenic shock: Part 2&#x2014;Biomarkers and treatment options. Eur. Heart J. Acute Cardiovasc. Care. 2022;11:366&#x2013;374. doi: 10.1093/ehjacc/zuac022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjacc/zuac022</ArticleId><ArticleId IdType="pubmed">35218355</ArticleId></ArticleIdList></Reference><Reference><Citation>Galusko V., Wenzl F.A., Vandenbriele C., Panoulas V., L&#xfc;scher T.F., Gorog D.A. Current and novel biomarkers in cardiogenic shock. Eur. J. Heart Fail. 2025 doi: 10.1002/ejhf.3531. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3531</ArticleId><ArticleId IdType="pubmed">39822053</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatu A.L., Nadasdy T., Arbune A., Chioncel V., Bobeica C., Niculet E., Iancu A.V., Dumitru C., Popa V.T., Kluger N., et al. Interrelationship and Sequencing of Interleukins 4, 13, 31, and 33&#x2014;An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives. J. Inflamm. Res. 2022;15:5163&#x2013;5184. doi: 10.2147/JIR.S374060.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S374060</ArticleId><ArticleId IdType="pmc">PMC9468867</ArticleId><ArticleId IdType="pubmed">36110506</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ntti T., Tarvasm&#xe4;ki T., Harjola V.-P., Parissis J., Pulkki K., Sionis A., Silva-Cardoso J., K&#xf8;ber L., Banaszewski M., Spinar J., et al. Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients with Cardiogenic Shock. Am. J. Cardiol. 2017;120:1090&#x2013;1097. doi: 10.1016/j.amjcard.2017.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2017.06.049</ArticleId><ArticleId IdType="pubmed">28821350</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Zhao Z., Jiang H., Jiang M., Yu G., Li X. Predictive value of elevated alanine aminotransferase for in-hospital mortality in patients with acute myocardial infarction. BMC Cardiovasc. Disord. 2021;21:82. doi: 10.1186/s12872-021-02257-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-021-02257-2</ArticleId><ArticleId IdType="pmc">PMC7874605</ArticleId><ArticleId IdType="pubmed">33563221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariefuddin W.W.A., Pramudyo M., Martha J.W. Shock index creatinine: A new predictor of mortality in acute coronary syndrome patients. BMC Cardiovasc. Disord. 2024;24:87. doi: 10.1186/s12872-024-03730-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-024-03730-4</ArticleId><ArticleId IdType="pmc">PMC10838412</ArticleId><ArticleId IdType="pubmed">38310219</ArticleId></ArticleIdList></Reference><Reference><Citation>Ran P., Wei X.-B., Lin Y.-W., Li G., Huang J.-L., He X.-Y., Yang J.-Q., Yu D.-Q., Chen J.-Y. Shock Index-C: An Updated and Simple Risk-Stratifying Tool in ST-Segment Elevation Myocardial Infarction. Front. Cardiovasc. Med. 2021;8:657817. doi: 10.3389/fcvm.2021.657817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.657817</ArticleId><ArticleId IdType="pmc">PMC8241092</ArticleId><ArticleId IdType="pubmed">34212012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanabar K., Sharma Y.P., Krishnappa D., Santosh K., Dhudasia M. A study of the predictive role of multiple variables for the incidence of acute kidney injury and its outcomes in Indian patients with ST-elevation myocardial infarction and cardiogenic shock. Egypt. Heart J. 2024;76:123. doi: 10.1186/s43044-024-00557-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-024-00557-4</ArticleId><ArticleId IdType="pmc">PMC11384670</ArticleId><ArticleId IdType="pubmed">39251455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H., Liu X., Sun D., Liu X., Wang Y., Zhang Z., Han Y., Wang X. CCC-ACS investigators Machine-learning models to predict serious adverse hospitalization events after ACS. Postgrad. Med. J. 2025 doi: 10.1093/postmj/qgae180. online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/postmj/qgae180</ArticleId><ArticleId IdType="pubmed">40037309</ArticleId></ArticleIdList></Reference><Reference><Citation>Zweck E., Thayer K.L., Helgestad O.K.L., Kanwar M., Ayouty M., Garan A.R., Hernandez-Montfort J., Mahr C., Wencker D., Sinha S.S., et al. Phenotyping cardiogenic shock. J. Am. Heart Assoc. 2021;10:e020085. doi: 10.1161/JAHA.120.020085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.020085</ArticleId><ArticleId IdType="pmc">PMC8483502</ArticleId><ArticleId IdType="pubmed">34227396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrero J.M., Gonzalez-Ascaso A., Matas J.F.R. The mechanisms of potassium loss in acute myocardial ischemia: New insights from computational simulations. Front. Physiol. 2023;14:1074160. doi: 10.3389/fphys.2023.1074160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2023.1074160</ArticleId><ArticleId IdType="pmc">PMC10009276</ArticleId><ArticleId IdType="pubmed">36923288</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft P.L., Newman S., Hanson D., Anderson W., Bastani A. Emergency physician discretion to activate the cardiac catheterization team decreases door-to-balloon time for acute ST-elevation myocardial infarction. Ann. Emerg. Med. 2007;50:520&#x2013;526. doi: 10.1016/j.annemergmed.2007.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2007.03.013</ArticleId><ArticleId IdType="pubmed">17583375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani B.N., Truesdell A.G., Sherwood M., Desai S., Tran H.A., Epps K.C., Singh R., Psotka M., Shah P., Cooper L.B., et al. Standardized Team-Based Care for Cardiogenic Shock. J. Am. Coll. Cardiol. 2019;73:1659&#x2013;1669. doi: 10.1016/j.jacc.2018.12.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.12.084</ArticleId><ArticleId IdType="pubmed">30947919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S.S., Morrow D.A., Kapur N.K., Kataria R., Roswell R.O. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Evaluation and Management of Cardiogenic Shock. J. Am. Coll. Cardiol. 2025;85:1618&#x2013;1641. doi: 10.1016/j.jacc.2025.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2025.02.018</ArticleId><ArticleId IdType="pubmed">40100174</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.S., Baran D.A., Jentzer J.C., Hollenberg S.M., van Diepen S., Basir M.B., Grines C.L., Diercks D.B., Hall S., Kapur N.K., et al. SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J. Am. Coll. Cardiol. 2022;79:933&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pubmed">35115207</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H.S., Gonz&#xe1;lez-Costello J., Belohlavek J., Zweck E., Blumer V., Schrage B., Hanff T.C. Hemodynamic management of cardiogenic shock in the intensive care unit. J. Heart Lung Transplant. 2024;43:1059&#x2013;1073. doi: 10.1016/j.healun.2024.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.healun.2024.03.009</ArticleId><ArticleId IdType="pmc">PMC11148863</ArticleId><ArticleId IdType="pubmed">38518863</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwak M.J., Kim K., Joong E.R., Jung H.S., Gil J.S., Jo Y.S., Youn T.-J., Chung W.-Y., Chae I.-H., Choi D.-J., et al. The Effect of Direct Communication Between Emergency Physicians and Interventional Cardiologists on Door to Balloon Times in STEMI. J. Korean Med. Sci. 2008;23:706. doi: 10.3346/jkms.2008.23.4.706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2008.23.4.706</ArticleId><ArticleId IdType="pmc">PMC2526406</ArticleId><ArticleId IdType="pubmed">18756061</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Z., Hu S., Wang Y., Deng W., Gu N., Zhao R., Zhang W., Ma Y., Wang Z., Liu Z., et al. Development of a machine learning model to predict the risk of late cardiogenic shock in patients with ST-segment elevation myocardial infarction. Ann. Transl. Med. 2021;9:1162. doi: 10.21037/atm-21-2905.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-2905</ArticleId><ArticleId IdType="pmc">PMC8350690</ArticleId><ArticleId IdType="pubmed">34430603</ArticleId></ArticleIdList></Reference><Reference><Citation>Laghlam D., Benghanem S., Ortuno S., Bouabdallaoui N., Manzo-Silberman S., Hamzaoui O., Aissaoui N. Management of cardiogenic shock: A narrative review. Ann. Intensiv. Care. 2024;14:45. doi: 10.1186/s13613-024-01260-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-024-01260-y</ArticleId><ArticleId IdType="pmc">PMC10980676</ArticleId><ArticleId IdType="pubmed">38553663</ArticleId></ArticleIdList></Reference><Reference><Citation>Djakpo D.K., Wang Z.Q., Shrestha M. The significance of transaminase ratio (AST/ALT) in acute myocardial infarction. Arch. Med. Sci.-Atheroscler. Dis. 2020;5:279&#x2013;283. doi: 10.5114/amsad.2020.103028.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/amsad.2020.103028</ArticleId><ArticleId IdType="pmc">PMC7885810</ArticleId><ArticleId IdType="pubmed">33644486</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundermeyer J., Kellner C., Beer B.N., Besch L., Dettling A., Bertoldi L.F., Blankenberg S., Dauw J., Dindane Z., Eckner D., et al. Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock. Clin. Res. Cardiol. 2023;113:570&#x2013;580. doi: 10.1007/s00392-023-02332-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-023-02332-y</ArticleId><ArticleId IdType="pmc">PMC10954940</ArticleId><ArticleId IdType="pubmed">37982863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundermeyer J., Beer B.N., Blankenberg S., Kirchhof P., Luedike P., Mangner N., Nordbeck P., Orban M., Pazdernik M., Proudfoot A., et al. Impact of left ventricular ejection fraction on mortality and use of mechanical circulatory support in non-ischaemic cardiogenic shock. Eur. Heart J. 2022;43((Suppl. S2)):ehac544.1013. doi: 10.1093/eurheartj/ehac544.1013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.1013</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J.H., Kook H., Lee S.H., Joo H.J., Park J.H., Hong S.J., Kim M.-N., Park S.-M., Jung J.S., Yang J.H., et al. Prediction of In-Hospital Mortality for Ischemic Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2024;13:e032701. doi: 10.1161/JAHA.123.032701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.032701</ArticleId><ArticleId IdType="pmc">PMC11010074</ArticleId><ArticleId IdType="pubmed">38362865</ArticleId></ArticleIdList></Reference><Reference><Citation>Yogyakarta I., Bagaswoto H.P., Dinarti L.K. Left Ventricle Ejection Fraction as a Predictor of Cardiogenic Shock in Patients with ST Elevation Myocardial Infarct at Dr. Sardjito General Hospital Yogyakarta; Proceedings of the International Conference on Medical Science and Health (ICOMESH 2024); Bandar Lampung, Indonesia. 7&#x2013;8 August 2024; pp. 104&#x2013;118.</Citation></Reference><Reference><Citation>Moreira A., Crispim J. The importance of the health information systems in value-based healthcare initiatives: A scoping review. Procedia Comput. Sci. 2024;239:1476&#x2013;1482. doi: 10.1016/j.procs.2024.06.321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.procs.2024.06.321</ArticleId></ArticleIdList></Reference><Reference><Citation>Brahmbhatt D.H., Kalra S., Luk A., Billia F. From Escalate to Elevate: A New Paradigm for Comprehensive Cardiogenic Shock Management. Can. J. Cardiol. 2025;41:630&#x2013;644. doi: 10.1016/j.cjca.2024.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2024.12.036</ArticleId><ArticleId IdType="pubmed">39798668</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh E., Gallo R., Hom J., Strong E., Weng Y., Kerman H., Cool J.A., Kanjee Z., Parsons A.S., Ahuja N., et al. Large Language Model Influence on Diagnostic Reasoning: A Randomized Clinical Trial. JAMA Netw. Open. 2024;7:e2440969. doi: 10.1001/jamanetworkopen.2024.40969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.40969</ArticleId><ArticleId IdType="pmc">PMC11519755</ArticleId><ArticleId IdType="pubmed">39466245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mebazaa A., Soussi S. Precision Medicine in Cardiogenic Shock: We Are Almost There! JACC Heart Fail. 2023;11:1316&#x2013;1319. doi: 10.1016/j.jchf.2023.06.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2023.06.024</ArticleId><ArticleId IdType="pubmed">37589609</ArticleId></ArticleIdList></Reference><Reference><Citation>Soussi S., Tarvasm&#xe4;ki T., Kimmoun A., Ahmadiankalati M., Azibani F., dos Santos C.C., Duarte K., Gayat E., Jentzer J.C., Harjola V.-P., et al. Identifying biomarker-driven subphenotypes of cardiogenic shock: Analysis of prospective cohorts and randomized controlled trials. eClinicalMedicine. 2024;79:103013. doi: 10.1016/j.eclinm.2024.103013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2024.103013</ArticleId><ArticleId IdType="pmc">PMC11718329</ArticleId><ArticleId IdType="pubmed">39802301</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40763602</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2025</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio).</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>199</EndPage><MedlinePgn>193-199</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2025.07.061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(25)00523-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Accurate ECG interpretation is crucial to identify occlusive myocardial infarction (OMI) to determine the need for immediate catheterization laboratory activation (CLA). STEMI-equivalent and STEMI-mimic ECG patterns deviate from conventional STEMI criteria, risking misclassification of OMI cases. The diagnostic accuracy for these complex ECGs is unknown.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to measure physician accuracy for interpreting STEMI-equivalent and STEMI-mimic ECGs for catheterization laboratory activation (CLA) and compare their performance to a machine learning-based artificial intelligence algorithm, Queen of Hearts AI (QoH AI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-three EPs and 42 cardiologists interpreted 18 ECGs (eight STEMI-equivalents, eight STEMI-mimics, with one STEMI, and a normal ECG as controls) to determine the presence of OMI requiring immediate CLA. The same ECGs were analyzed by QoH AI. Interpretations were compared against a reference standard based on angiography, troponin, echocardiography, and clinical follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Interpretation accuracies were similar between EPs and cardiologists (65.6&#xa0;%, 95&#xa0;% CI [51, 78]; 65.5&#xa0;%, 95&#xa0;% CI [51, 77], respectively; p&#xa0;=&#xa0;0.969), and significantly lower than QoH AI (88.9&#xa0;%, 95&#xa0;% CI [82, 93]) vs. physicians overall, 65.6&#xa0;%, 95&#xa0;% CI [52, 77]; p&#xa0;&lt;&#xa0;0.001). Physicians most frequently misclassified de Winter, Transient STEMI, Hyperacute T-wave OMI, and bundle branch block ECGs. QoH AI only misclassified left bundle branch block with OMI and left ventricular aneurysm without OMI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Physicians frequently misinterpret STEMI-equivalent and STEMI-mimic ECGs, potentially impacting CLA decisions. QoH AI demonstrated superior accuracy, suggesting a potential to reduce missed OMIs and unnecessary catheterization laboratory activations. Prospective studies are needed to validate these findings in clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shroyer</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Greater San Antonio Emergency Physicians, Methodist Hospital System, San Antonio, TX, USA. Electronic address: stevenshroyerMD@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Sumeru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Greater San Antonio Emergency Physicians, Methodist Hospital System, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thukral</LastName><ForeName>Nandish</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiology Clinic of San Antonio, Methodist Hospital System, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smiley</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Brooke Army Medical Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercaldo</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin County Medical Center, and Department of Emergency Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA. Electronic address: smith253@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cath lab activation</Keyword><Keyword MajorTopicYN="N">ECG accuracy</Keyword><Keyword MajorTopicYN="N">Myocardical infarction</Keyword><Keyword MajorTopicYN="N">PCI</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">STEMI equivalent</Keyword><Keyword MajorTopicYN="N">STEMI mimic</Keyword></KeywordList><CoiStatement>Declaration of competing interest Authors SRS, SM, KS, NM and NT report no conflicts of interest, including financial support from the PMcardio&#x2014;Queen of Hearts App developer, Powerful Medical. SWS reports stock ownership in Powerful Medical and has consulted with Rapid AI; HPM reports stock ownership in Powerful Medical and has consulted with Rapid AI.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>18</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40763602</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2025.07.061</ArticleId><ArticleId IdType="pii">S0735-6757(25)00523-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40127777</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6551</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</Title><ISOAbbreviation>J Nucl Cardiol</ISOAbbreviation></Journal><ArticleTitle>AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis.</ArticleTitle><Pagination><StartPage>102195</StartPage><MedlinePgn>102195</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nuclcard.2025.102195</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1071-3581(25)00069-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">[18F]-fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET) plays a central role in diagnosing and managing cardiac sarcoidosis. We propose a fully automated pipeline for quantification of [18F]FDG PET activity using deep learning (DL) segmentation of cardiac chambers on computed tomography (CT) attenuation maps and evaluate quantitative approaches based on this framework.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included consecutive patients undergoing [18F]FDG PET/CT for suspected cardiac sarcoidosis. DL segmented left atrium, left ventricle (LV), right atrium, right ventricle, aorta, LV myocardium, and lungs from CT attenuation scans. CT-defined anatomical regions were applied to [18F]FDG PET images automatically to quantify target to background ratio (TBR), volume of inflammation (VOI) and cardiometabolic activity (CMA) using full sized and shrunk segmentations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 69 patients were included, with mean age of 56.1 &#xb1; 13.4 and cardiac sarcoidosis present in 29 (42 %). CMA had highest prediction performance (area under the receiver operating characteristic curve [AUC] .919, 95 % confidence interval [CI] .858 - .980) followed by VOI (AUC .903, 95 % CI .834 - .971), TBR (AUC .891, 95 % CI .819 - .964), and maximum standardized uptake value (AUC .812, 95 % CI .701 - .923). Abnormal CMA (&#x2265;1) had a sensitivity of 100 % and specificity 65 % for cardiac sarcoidosis. Lung quantification was able to identify patients with pulmonary abnormalities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We demonstrate that fully automated volumetric quantification of [18F]FDG PET for cardiac sarcoidosis based on CT attenuation map-derived volumetry is feasible, rapid, and has high prediction performance. This approach provides objective measurements of cardiac inflammation with consistent definition of myocardium and background region.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert Jh</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Cardiac Sciences, University of Calgary, Calgary AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanbhag</LastName><ForeName>Aakash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA; Signal and Image Processing Institute, Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcinkiewicz</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA; Center of Radiological Diagnostics, National Medical Institute of the Ministry of the Interior and Administration, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Struble</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gransar</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijazi</LastName><ForeName>Waseem</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujito</LastName><ForeName>Hidesato</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kransdorf</LastName><ForeName>Evan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavanagh</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Joanna X</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Builoff</LastName><ForeName>Valerie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Damini</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slomka</LastName><ForeName>Piotr J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging and Biomedical Sciences Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Piotr.Slomka@cshs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 HL161195</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Nucl Cardiol</MedlineTA><NlmUniqueID>9423534</NlmUniqueID><ISSNLinking>1071-3581</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 Sep 23:2024.09.20.24314081. doi: 10.1101/2024.09.20.24314081.</RefSource><PMID Version="1">39399046</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="Y">Positron Emission Tomography Computed Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac sarcoidosis</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Hypermetabolism</Keyword><Keyword MajorTopicYN="N">Positron emission tomography</Keyword><Keyword MajorTopicYN="N">Quantification</Keyword></KeywordList><CoiStatement>CONFLICT OF INTEREST. Dr. Miller reports research and consulting support from Pfizer. Mr. Kavanagh, Drs. Berman and Slomka participate in software royalties for QPS software at Cedars-Sinai Medical Center. Dr. Slomka has received research grant support from Siemens Medical Systems and consulting fees from Synektik. Dr. Berman has served as a consultant for GE Healthcare. Dr. Hidesato Fujito received research funding support from the Fukuda Foundation for Medical Technology, the Nihon University School of Medicine Alumni Association Research Grant and the Society of Nuclear Medicine and Molecular Imaging Wagner-Torizuka Fellowship grant. The authors have no other relevant disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>9</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>25</Day><Hour>0</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>24</Day><Hour>20</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40127777</ArticleId><ArticleId IdType="mid">NIHMS2067882</ArticleId><ArticleId IdType="pmc">PMC12147654</ArticleId><ArticleId IdType="doi">10.1016/j.nuclcard.2025.102195</ArticleId><ArticleId IdType="pii">S1071-3581(25)00069-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lehtonen J, Uusitalo V, P&#xf6;yh&#xf6;nen P, M&#xe4;yr&#xe4;np&#xe4;&#xe4; MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J 2023;44:1495&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10149532</ArticleId><ArticleId IdType="pubmed">36924191</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazelpour S, Sadek MM, Nery PB, Beanlands RS, Tzemos N, Toma M et al. Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis. J Am Heart Ass 2021;10:e021183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8649244</ArticleId><ArticleId IdType="pubmed">34472360</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshankar G, Zhang JY, Parekh D, Lyons K, Isaac D, Miller RJH. Steroid Sparing Immunosuppression in Management of Cardiac Sarcoidosis. Health Sci Rev 2022;4:100034.</Citation></Reference><Reference><Citation>Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis. J Cardiovasc Electrophysiol 2009;20:578&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19175448</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24819193</ArticleId></ArticleIdList></Reference><Reference><Citation>Skali H, Schulman AR, Dorbala S. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep 2013;15:352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4009625</ArticleId><ArticleId IdType="pubmed">23544184</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL et al. Joint SNMMI&#x2013;ASNC expert consensus document on the role of 18 F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol 2017;24(5):1741&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pubmed">28770463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperry BW, Bateman TM, Akin EA, Bravo PE, Chen W, Dilsizian V et al. Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM. J Nucl Cardiol 2023;30(2):626&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">35864433</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian A, Brogan A, Berman J, Sverdlov AL, Mercier G, Mazzini M et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014;21:925&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">24879453</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian M, Swapna N, Ali AZ, Saggu DK, Yalagudri S, Kishore J et al. Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging 2021;14:2008&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">33454258</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RJH, Cadet S, Pournazari P, Pope A, Kransdorf E, Hamilton MA et al. Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis. J Nucl Cardiol 2022;29:86&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">32462631</ArticleId></ArticleIdList></Reference><Reference><Citation>MIller R, Shanbhag A, Killekar A, Lemley M, Bednarski B, Kavanagh P et al. AI-defined cardiac anatomy Improves Risk Stratification of Hybrid Perfusion Imaging. JACC Cardiovasc Imaging 2024,17(7):780&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11222053</ArticleId><ArticleId IdType="pubmed">38456877</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasserthal J, Breit H-C, Meyer MT, Pradella M, Hinck D, Sauter AW et al. TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images. Radiol Artific Intell 2023;5:e230024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10546353</ArticleId><ArticleId IdType="pubmed">37795137</ArticleId></ArticleIdList></Reference><Reference><Citation>Betensky BP, Tschabrunn CM, Zado ES, Goldberg LR, Marchlinski FE, Garcia FC et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 2012;9:884&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">22338670</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:1187&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">27392702</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekemp RA, Declerck J, Klein R, Pan XB, Nakazato R, Tonge C et al. Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET/CT and a 1-tissue-compartment model of 82Rb kinetics. J Nucl Med 2013;54:571&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">23447656</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakazato R, Berman DS, Dey D, Le Meunier L, Hayes SW, Fermin JS et al. Automated quantitative Rb-82 3D PET/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography. J Nucl Cardiol 2012;19:265&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3383786</ArticleId><ArticleId IdType="pubmed">22203445</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishiyama M, Soine LA, Vesselle HJ. Semi-quantitative metabolic values on FDG PET/CT including extracardiac sites of disease as a predictor of treatment course in patients with cardiac sarcoidosis. EJNMMI Res 2017;7:67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5561746</ArticleId><ArticleId IdType="pubmed">28822108</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuominen H, Haarala A, Tikkakoski A, K&#xe4;h&#xf6;nen M, Nikus K, Sipil&#xe4; K. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events. J Nucl Cardiol 2021;28:199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7920884</ArticleId><ArticleId IdType="pubmed">30815833</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL et al. Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis. J Am Coll Cardiol 2014;63:329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3955730</ArticleId><ArticleId IdType="pubmed">24140661</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemel&#xe4; M, Uusitalo V, P&#xf6;yh&#xf6;nen P, Schildt J, Lehtonen J, Kupari M. Incidence and predictors of atrial fibrillation in cardiac sarcoidosis. JACC Cardiovasc Imaging 2022;15:1622&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">36075623</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mallah MH, Bateman TM, Branch KR, Crean A, Gingold EL, Thompson RC et al. 2022 ASNC/AAPM/SCCT/SNMMI guideline for the use of CT in hybrid nuclear/CT cardiac imaging. J Nucl Cardiol 2022;29:3491&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">36056224</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne MT, Hulten EA, Singh A, Waller AH, Bittencourt MS, Stewart GC et al. Reduction in &#xb9;&#x2078;F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol 2014;21:166&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">24307261</ArticleId></ArticleIdList></Reference><Reference><Citation>Sperry BW, Vranian MN, Tower-Rader A, Hachamovitch R, Hanna M, Brunken R et al. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality. JACC Cardiovasc Imaging 2018;11:234&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28917675</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera R, Ananthasubramaniam K. Diagnosis, therapeutic response assessment, and detection of disease recurrence in cardiac sarcoidosis: Integral role of cardiac PET. J Nucl Cardiol 2016;23:850&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26809438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonthaitawee P, Bois John P. Quantitative FDG PET/CT to Guide Treatment of Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2021;14:2017&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33744154</ArticleId></ArticleIdList></Reference><Reference><Citation>Manabe O, Takahashi K, Kawakami H, Ohtsuka A, Aikawa T, Maki H et al. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis. Ann Nucl Med 2023;37:535&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">37418117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40397500</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1929-0748</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2025</Year><Month>May</Month><Day>21</Day></PubDate></JournalIssue><Title>JMIR research protocols</Title><ISOAbbreviation>JMIR Res Protoc</ISOAbbreviation></Journal><ArticleTitle>Coronary Computed Tomographic Angiography to Optimize the Diagnostic Yield of Invasive Angiography for Low-Risk Patients Screened With Artificial Intelligence: Protocol for the CarDIA-AI Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>e71726</StartPage><MedlinePgn>e71726</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e71726</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/71726</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Invasive coronary angiography (ICA) is the gold standard in the diagnosis of coronary artery disease (CAD). Being invasive, it carries rare but serious risks including myocardial infarction, stroke, major bleeding, and death. A large proportion of elective outpatients undergoing ICA have nonobstructive CAD, highlighting the suboptimal use of this test. Coronary computed tomographic angiography (CCTA) is a noninvasive option that provides similar information with less risk and is recommended as a first-line test for patients with low-to-intermediate risk of CAD. Leveraging artificial intelligence (AI) to appropriately direct patients to ICA or CCTA based on the predicted probability of disease may improve the efficiency and safety of diagnostic pathways.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">he CarDIA-AI (Coronary computed tomographic angiography to optimize the Diagnostic yield of Invasive Angiography for low-risk patients screened with Artificial Intelligence) study aims to evaluate whether AI-based risk assessment for obstructive CAD implemented within a centralized triage process can optimize the use of ICA in outpatients referred for nonurgent ICA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">CarDIA-AI is a pragmatic, open-label, superior randomized controlled trial involving 2 Canadian cardiac centers. A total of 252 adults referred for elective outpatient ICA will be randomized 1:1 to usual care (directly proceeding to ICA) or to triage using an AI-based decision support tool. The AI-based decision support tool was developed using referral information from over 37,000 patients and uses a light gradient boosting machine model to predict the probability of obstructive CAD based on 42 clinically relevant predictors, including patient referral information, demographic characteristics, risk factors, and medical history. Participants in the intervention arm will have their ICA referral forms and medical charts reviewed, and select details entered into the decision support tool, which recommends CCTA or ICA based on the patient's predicted probability of obstructive CAD. All patients will receive the selected imaging modality within 6 weeks of referral and will be subsequently followed for 90 days. The primary outcome is the proportion of normal or nonobstructive CAD diagnosed via ICA and will be assessed using a 2-sided z test to compare the patients referred for cardiac investigation with normal or nonobstructive CAD diagnosed through ICA between the intervention and control groups. Secondary outcomes include the number of angiograms avoided and the diagnostic yield of ICA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Recruitment began on January 9, 2025, and is expected to conclude in mid to late 2025. As of April 14, 2025, we have enrolled 81 participants. Data analysis will begin once data collection is completed. We expect to submit the results for publication in 2026.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CarDIA-AI will be the first randomized controlled trial using AI to optimize patient selection for CCTA versus ICA, potentially improving diagnostic efficiency, avoiding unnecessary complications of ICA, and improving health care resource usage.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT06648239; https://clinicaltrials.gov/study/NCT06648239/.</AbstractText><AbstractText Label="INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID)" NlmCategory="UNASSIGNED">DERR1-10.2196/71726.</AbstractText><CopyrightInformation>&#xa9;Jeremy Petch, Juan Pablo Tabja Bortesi, Tej Sheth, Madhu Natarajan, Natalia Pinilla-Echeverri, Shuang Di, Shrikant I Bangdiwala, Karen Mosleh, Omar Ibrahim, Kevin R Bainey, Julian Dobranowski, Maria P Becerra, Katie Sonier, Jon-David Schwalm. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 21.05.2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petch</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1614-1046</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabja Bortesi</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0009-0002-1631-5165</Identifier><AffiliationInfo><Affiliation>Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheth</LastName><ForeName>Tej</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0001-4651-8310</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Madhu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6372-1348</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinilla-Echeverri</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7784-0348</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1707-7613</Identifier><AffiliationInfo><Affiliation>Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangdiwala</LastName><ForeName>Shrikant I</ForeName><Initials>SI</Initials><Identifier Source="ORCID">0000-0002-3111-0689</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosleh</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9009-3452</Identifier><AffiliationInfo><Affiliation>Centre for Evidence-Based Implementation, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Omar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-7095-182X</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bainey</LastName><ForeName>Kevin R</ForeName><Initials>KR</Initials><Identifier Source="ORCID">0000-0002-5458-4617</Identifier><AffiliationInfo><Affiliation>Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dobranowski</LastName><ForeName>Julian</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5613-3502</Identifier><AffiliationInfo><Affiliation>Department of Medical Imaging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Integrated and Advanced Medical Imaging, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Niagara Health System, Saint Catharines, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Becerra</LastName><ForeName>Maria P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-4127-4660</Identifier><AffiliationInfo><Affiliation>Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonier</LastName><ForeName>Katie</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0000-2590-4098</Identifier><AffiliationInfo><Affiliation>Centre for Data Science and Digital Health, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwalm</LastName><ForeName>Jon-David</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-2516-4952</Identifier><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Evidence-Based Implementation, Hamilton Health Sciences, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06648239</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Res Protoc</MedlineTA><NlmUniqueID>101599504</NlmUniqueID><ISSNLinking>1929-0748</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="Y">Coronary Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">clinical decision support</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">coronary computed tomographic angiography</Keyword><Keyword MajorTopicYN="N">invasive coronary angiography</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40397500</ArticleId><ArticleId IdType="pmc">PMC12138305</ArticleId><ArticleId IdType="doi">10.2196/71726</ArticleId><ArticleId IdType="pii">v14i1e71726</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality from ischemic heart disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):005375. doi: 10.1161/circoutcomes.118.005375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circoutcomes.118.005375</ArticleId><ArticleId IdType="pmc">PMC6613716</ArticleId><ArticleId IdType="pubmed">31163980</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, Brindis RG, Douglas PS. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886&#x2013;895. doi: 10.1056/nejmoa0907272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa0907272</ArticleId><ArticleId IdType="pmc">PMC3920593</ArticleId><ArticleId IdType="pubmed">20220183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley SM, Maddox TM, Stanislawski MA, O'Donnell CI, Grunwald GK, Tsai TT, Ho PM, Peterson ED, Rumsfeld JS. Normal coronary rates for elective angiography in the veterans affairs healthcare system: insights from the VA CART program (veterans affairs clinical assessment reporting and tracking) J Am Coll Cardiol. 2014;63(5):417&#x2013;426. doi: 10.1016/j.jacc.2013.09.055. 
 
S0735-1097(13)05733-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.09.055</ArticleId><ArticleId IdType="pubmed">24184244</ArticleId></ArticleIdList></Reference><Reference><Citation>The relative cost-effectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario. Toronto Health Economics and Technology Assessment Collaborative. 2010.  [2025-01-10].  
 https://www.hqontario.ca/Portals/0/Documents/evidence/special-reports/theta-cardiac-imaging-1003-en.pdf
.</Citation></Reference><Reference><Citation>Oseran AS, Ati S, Feldman WB, Gondi S, Yeh RW, Wadhera RK. Assessment of prices for cardiovascular tests and procedures at top-ranked US hospitals. JAMA Intern Med. 2022;182(9):996&#x2013;999. doi: 10.1001/jamainternmed.2022.2602. 
 
2794393</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2022.2602</ArticleId><ArticleId IdType="pmc">PMC9295022</ArticleId><ArticleId IdType="pubmed">35849412</ArticleId></ArticleIdList></Reference><Reference><Citation>Darlington M, Gueret P, Laissy JP, Pierucci AF, Maoulida H, Quelen C, Niarra R, Chatellier G, Durand-Zaleski I. Cost-effectiveness of computed tomography coronary angiography versus conventional invasive coronary angiography. Eur J Health Econ. 2015;16(6):647&#x2013;655. doi: 10.1007/s10198-014-0616-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-014-0616-2</ArticleId><ArticleId IdType="pubmed">24990117</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavakol M, Ashraf S, Brener SJ. Risks and complications of coronary angiography: a comprehensive review. Global J Health Sci. 2012;4(1):65&#x2013;93. doi: 10.5539/gjhs.v4n1p65. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.5539/gjhs.v4n1p65</ArticleId><ArticleId IdType="pmc">PMC4777042</ArticleId><ArticleId IdType="pubmed">22980117</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase R, Schlattmann P, Gueret P, Andreini D, Pontone G, Alkadhi H, Hausleiter J, Garcia MJ, Leschka S, Meijboom WB, Zimmermann E, Gerber B, Schoepf UJ, Shabestari AA, N&#xf8;rgaard BL, Meijs MFL, Sato A, Ovrehus KA, Diederichsen ACP, Jenkins SMM, Knuuti J, Hamdan A, Halvorsen BA, Mendoza-Rodriguez V, Rochitte CE, Rixe J, Wan YL, Langer C, Bettencourt N, Martuscelli E, Ghostine S, Buechel RR, Nikolaou K, Mickley H, Yang L, Zhang Z, Chen MY, Halon DA, Rief M, Sun K, Hirt-Moch B, Niinuma H, Marcus RP, Muraglia S, Jakamy R, Chow BJ, Kaufmann PA, Tardif J, Nomura C, Kofoed KF, Laissy J, Arbab-Zadeh A, Kitagawa K, Laham R, Jinzaki M, Hoe J, Rybicki FJ, Scholte A, Paul N, Tan SY, Yoshioka K, R&#xf6;hle R, Schuetz GM, Schueler S, Coenen MH, Wieske V, Achenbach S, Budoff MJ, Laule M, Newby DE, Dewey M. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ. 2019;365:l1945. doi: 10.1136/bmj.l1945. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l1945</ArticleId><ArticleId IdType="pmc">PMC6561308</ArticleId><ArticleId IdType="pubmed">31189617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth T, Amlani S, Ellins ML, Mehta S, Velianou J, Cappelli G, Yang S, Natarajan M. Computed tomographic coronary angiographic assessment of high-risk coronary anatomy in patients with suspected coronary artery disease and intermediate pretest probability. Am Heart J. 2008;155(5):918&#x2013;923. doi: 10.1016/j.ahj.2007.11.035.S0002-8703(07)00993-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.11.035</ArticleId><ArticleId IdType="pubmed">18440342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini GBJ, Leipsic J, Budoff MJ, Hague CJ, Min JK, Stevens SR, Reynolds HR, O'Brien SM, Shaw LJ, Manjunath CN, Mavromatis K, Demkow M, Lopez-Sendon JL, Chernavskiy AM, Gosselin G, Schuchlenz H, Devlin GP, Chauhan A, Bangalore S, Hochman JS, Maron DJ. CT Angiography followed by invasive angiography in patients with moderate or severe ischemia-insights from the ISCHEMIA trial. JACC Cardiovasc Imaging. 2021;14(7):1384&#x2013;1393. doi: 10.1016/j.jcmg.2020.11.012. 
 
S1936-878X(20)31019-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.11.012</ArticleId><ArticleId IdType="pmc">PMC8260655</ArticleId><ArticleId IdType="pubmed">33454249</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407&#x2013;477. doi: 10.1093/eurheartj/ehz425. 
 
5556137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz425</ArticleId><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021;144(22):e368&#x2013;e454. doi: 10.1161/CIR.0000000000001029. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001029?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1161/CIR.0000000000001029</ArticleId><ArticleId IdType="pubmed">34709879</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J. 2017;38(23):1805&#x2013;1814. doi: 10.1093/eurheartj/ehw302. 
 
ehw302</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw302</ArticleId><ArticleId IdType="pmc">PMC5837244</ArticleId><ArticleId IdType="pubmed">27436868</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalm JD, Di S, Sheth T, Natarajan MK, O'Brien E, McCready T, Petch J. A machine learning-based clinical decision support algorithm for reducing unnecessary coronary angiograms. Cardiovasc Digital Health J. 2022;3(1):21&#x2013;30. doi: 10.1016/j.cvdhj.2021.12.001. 
 
S2666-6936(21)00144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2021.12.001</ArticleId><ArticleId IdType="pmc">PMC8890355</ArticleId><ArticleId IdType="pubmed">35265932</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalm JD, Bouck Z, Natarajan MK, Pinilla N, Walker D, Syed N, Landry D, Sabri A, Tandon V, Nkurunziza J, Taljaard M, Sheth T. Centralized triage of suspected coronary artery disease using coronary computed tomographic angiography to optimize the diagnostic yield of invasive angiography. CJC Open. 2023;5(2):148&#x2013;157. doi: 10.1016/j.cjco.2022.10.009. 
 
S2589-790X(22)00252-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2022.10.009</ArticleId><ArticleId IdType="pmc">PMC9984898</ArticleId><ArticleId IdType="pubmed">36880068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong JCC, Erdman L, Khondker A, Skreta M, Goldenberg A, McCradden MD, Lorenzo AJ, Rickard M. The silent trial&#x2014;the bridge between bench-to-bedside clinical AI applications. Front Digital Health. 2022;4:929508. doi: 10.3389/fdgth.2022.929508. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2022.929508</ArticleId><ArticleId IdType="pmc">PMC9424628</ArticleId><ArticleId IdType="pubmed">36052317</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera SC, Liu X, Chan AW, Denniston AK, Calvert MJ, The SPIRIT-AI and CONSORT-AI Working Group  Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension. BMJ. 2020;370:m3210. doi: 10.1136/bmj.m3210. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3210</ArticleId><ArticleId IdType="pmc">PMC7490785</ArticleId><ArticleId IdType="pubmed">32907797</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittes J. Sample size calculations for randomized controlled trials. Epidemiol Rev. 2002;24(1):39&#x2013;53. doi: 10.1093/epirev/24.1.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/epirev/24.1.39</ArticleId><ArticleId IdType="pubmed">12119854</ArticleId></ArticleIdList></Reference><Reference><Citation>Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75. doi: 10.1186/s13012-022-01245-0. 
 
10.1186/s13012-022-01245-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-022-01245-0</ArticleId><ArticleId IdType="doi">10.1186/s13012-022-01245-0</ArticleId><ArticleId IdType="pmc">PMC9617234</ArticleId><ArticleId IdType="pubmed">36309746</ArticleId></ArticleIdList></Reference><Reference><Citation>Waltz TJ, Powell BJ, Fern&#xe1;ndez ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019;14(1):42. doi: 10.1186/s13012-019-0892-4. 
 
10.1186/s13012-019-0892-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-019-0892-4</ArticleId><ArticleId IdType="doi">10.1186/s13012-019-0892-4</ArticleId><ArticleId IdType="pmc">PMC6489173</ArticleId><ArticleId IdType="pubmed">31036028</ArticleId></ArticleIdList></Reference><Reference><Citation>Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman &amp; Hall; 1993.</Citation></Reference><Reference><Citation>Maffei E, Seitun S, Martini C, Palumbo A, Tarantini G, Berti E, Grilli R, Tedeschi C, Messalli G, Guaricci A, Weustink AC, Mollet NR, Cademartiri F. CT coronary angiography and exercise ECG in a population with chest pain and low-to-intermediate pre-test likelihood of coronary artery disease. Heart. 2010;96(24):1973&#x2013;1979. doi: 10.1136/hrt.2009.191361.hrt.2009.191361</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2009.191361</ArticleId><ArticleId IdType="pubmed">21051457</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen LH, Ortner N, N&#xf8;rgaard BL, Achenbach S, Leipsic J, Abdulla J. The diagnostic accuracy and outcomes after coronary computed tomography angiography vs. conventional functional testing in patients with stable angina pectoris: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2014;15(9):961&#x2013;971. doi: 10.1093/ehjci/jeu027.jeu027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeu027</ArticleId><ArticleId IdType="pubmed">24618659</ArticleId></ArticleIdList></Reference><Reference><Citation>Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol. 2008;52(21):1724&#x2013;1732. doi: 10.1016/j.jacc.2008.07.031. 
 
S0735-1097(08)02609-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.07.031</ArticleId><ArticleId IdType="pubmed">19007693</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrodicasa D, van Assen M, Huisman M, Leiner T, Williamson EE, Nicol ED, Allen BD, Saba L, Vliegenthart R, Hanneman K. Use of AI in cardiac CT and MRI: a scientific statement from the ESCR, EuSoMII, NASCI, SCCT, SCMR, SIIM, and RSNA. Radiology. 2025;314(1):e240516. doi: 10.1148/radiol.240516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.240516</ArticleId><ArticleId IdType="pmc">PMC11783164</ArticleId><ArticleId IdType="pubmed">39873607</ArticleId></ArticleIdList></Reference><Reference><Citation>He T, Liu X, Xu N, Li Y, Wu Q, Liu M, Yuan H. Diagnostic models of the pre-test probability of stable coronary artery disease: a systematic review. Clinics (Sao Paulo) 2017;72(3):188&#x2013;196. doi: 10.6061/clinics/2017(03)10. 
 
S1807-5932(22)00998-X</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2017(03)10</ArticleId><ArticleId IdType="pmc">PMC5350262</ArticleId><ArticleId IdType="pubmed">28355366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mincarone P, Bodini A, Tumolo MR, Vozzi F, Rocchiccioli S, Pelosi G, Caselli C, Sabina S, Leo CG. Discrimination capability of pretest probability of stable coronary artery disease: a systematic review and meta-analysis suggesting how to improve validation procedures. BMJ Open. 2021;11(7):e047677. doi: 10.1136/bmjopen-2020-047677. 
 
bmjopen-2020-047677</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-047677</ArticleId><ArticleId IdType="pmc">PMC8268916</ArticleId><ArticleId IdType="pubmed">34244268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YC, Chen KW, Tsai BY, Wu M, Hsieh P, Wei J, Shih ES, Shiao Y, Hwang M, Chang K. Implementation of an all-day artificial intelligence-based triage system to accelerate door-to-balloon times. Mayo Clin Proc. 2022;97(12):2291&#x2013;2303. doi: 10.1016/j.mayocp.2022.05.014.S0025-6196(22)00302-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2022.05.014</ArticleId><ArticleId IdType="pubmed">36336511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson JS, Taylor RA, Venkatesh A, Steinhart BD, Chmura C, Sangal RB, Levin SR. Accelerated chest pain treatment with artificial intelligence-informed, risk-driven triage. JAMA Intern Med. 2024;184(9):1125&#x2013;1127. doi: 10.1001/jamainternmed.2024.3219.2821363</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2024.3219</ArticleId><ArticleId IdType="pmc">PMC11264065</ArticleId><ArticleId IdType="pubmed">39037785</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton R, Akerman AP, Marwick TH, Johnson CL, Piotrowska H, Bajre M, Breen M, Dawes H, Dehbi H, Descamps T, Harris V, Hawkes W, Krasner S, Sanderson E, Savage N, Thompson B, Williamson V, Woodward W, Sarwar R, O&#x2019;Driscoll J, Sharma R, Chiocchia V, Petersen SE, Frangou E, Ridgway G, Bhattacharyya S, Ripley DP, Woodward G, Leeson P. PROTEUS: a prospective RCT evaluating use of AI in stress echocardiography. NEJM AI. 2024;1(11):2400865. doi: 10.1056/aioa2400865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/aioa2400865</ArticleId></ArticleIdList></Reference><Reference><Citation>Moosavi A, Huang S, Vahabi M, Motamedivafa B, Tian N, Mahmood R, Liu P, Sun CL. Prospective human validation of artificial intelligence interventions in&#xa0;cardiology: a scoping review. JACC Adv. 2024;3(9):101202. doi: 10.1016/j.jacadv.2024.101202. 
 
S2772-963X(24)00433-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101202</ArticleId><ArticleId IdType="pmc">PMC11450923</ArticleId><ArticleId IdType="pubmed">39372457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang D, Hogan J. We need more randomized clinical trials of AI. NEJM AI. 2024;1(11):2400881. doi: 10.1056/aie2400881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/aie2400881</ArticleId></ArticleIdList></Reference><Reference><Citation>The DISCHARGE Trial Group CT or invasive coronary angiography in stable chest pain. N Engl J Med. 2022;386(17):1591&#x2013;1602. doi: 10.1056/nejmoa2200963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2200963</ArticleId><ArticleId IdType="pubmed">35240010</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey M, Rief M, Martus P, Kendziora B, Feger S, Dreger H, Priem S, Knebel F, B&#xf6;hm M, Schlattmann P, Hamm B, Sch&#xf6;nenberger E, Laule M, Zimmermann E. Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial. BMJ. 2016;355:i5441. doi: 10.1136/bmj.i5441. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5441</ArticleId><ArticleId IdType="pmc">PMC5076567</ArticleId><ArticleId IdType="pubmed">27777234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudzi&#x144;ski PN, Kruk M, Demkow M, Oleksiak A, Schoepf JU, Mach M, Dzieli&#x144;ska Z, Pr&#x119;gowski J, Witkowski A, Ru&#x17c;y&#x142;&#x142;o W, K&#x119;pka C. Efficacy and safety of coronary computed tomography angiography in patients with a high clinical likelihood of obstructive coronary artery disease. Kardiol Pol. 2022;80(1):56&#x2013;63. doi: 10.33963/kp.a2021.0185.</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/kp.a2021.0185</ArticleId><ArticleId IdType="pubmed">34923618</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang HJ, Lin FY, Gebow D, An HY, Andreini D, Bathina R, Baggiano A, Beltrama V, Cerci R, Choi E, Choi J, Choi S, Chung N, Cole J, Doh J, Ha S, Her A, Kepka C, Kim J, Kim J, Kim S, Kim W, Pontone G, Valeti U, Villines TC, Lu Y, Kumar A, Cho I, Danad I, Han D, Heo R, Lee S, Lee JH, Park H, Sung J, Leflang D, Zullo J, Shaw LJ, Min JK. Selective referral using CCTA versus direct referral for individuals referred to&#xa0;invasive coronary angiography for&#xa0;suspected CAD: a randomized, controlled, open-label trial. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1303&#x2013;1312. doi: 10.1016/j.jcmg.2018.09.018. 
 
S1936-878X(18)30921-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.09.018</ArticleId><ArticleId IdType="pubmed">30553687</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39993551</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6744</ISSN><JournalIssue CitedMedium="Internet"><Volume>285</Volume><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>American heart journal</Title><ISOAbbreviation>Am Heart J</ISOAbbreviation></Journal><ArticleTitle>Re-engineering the clinical approach to suspected cardiac chest pain assessment in the emergency department by expediting research evidence to practice using artificial intelligence. (RAPIDx AI)-a cluster randomized study design.</ArticleTitle><Pagination><StartPage>106</StartPage><EndPage>118</EndPage><MedlinePgn>106-118</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahj.2025.02.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-8703(25)00054-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Clinical work-up for suspected cardiac chest pain is resource intensive. Despite expectations, high-sensitivity cardiac troponin assays have not made decision making easier. The impact of recently validated rapid triage protocols including the 0-hour/1-hour hs-cTn protocols on care and outcomes may be limited by the heterogeneity in interpretation of troponin profiles by clinicians. We have developed machine learning (ML) models which digitally phenotype myocardial injury and infarction with a high predictive performance and provide accurate risk assessment among patients presenting to EDs with suspected cardiac symptoms. The use of these models may support clinical decision-making and allow the synthesis of an evidence base particularly in non-T1MI patients however prospective validation is required.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We propose that integrating validated real-time artificial intelligence (AI) methods into clinical care may better support clinical decision-making and establish the foundation for a self-learning health system.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">This prospective, multicenter, open-label, cluster-randomized clinical trial within blinded endpoint adjudication across 12 hospitals (n = 20,000) will randomize sites to the clinical decision-support tool or continue current standard of care. The clinical decision support tool will utilize ML models to provide objective patient-specific diagnostic probabilities (ie, likelihood for Type 1 myocardial infarction [MI] versus Type 2 MI/Acute Myocardial Injury versus Chronic Myocardial Injury etc.) and prognostic assessments. The primary outcome is the composite of cardiovascular mortality, new or recurrent MI and unplanned hospital re-admission at 12 months post index presentation.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Supporting clinicians with a decision support tool that utilizes AI has the potential to provide better diagnostic and prognostic assessment thereby improving clinical efficiency and establish a self-learning health system continually improving risk assessment, quality and safety.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ANZCTR, Registration Number: ACTRN12620001319965, https://www.anzctr.org.au/.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Ehsan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia; Department of Health, SA Health, South Australian, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambrakis</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia; Department of Health, SA Health, South Australian, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briffa</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Population and Global Health, University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cullen</LastName><ForeName>Louise A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Australia; School of Public Health, Queensland University of Technology, Brisbane, Australia; School of Medicine, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karnon</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papendick</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Health, SA Health, South Australian, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinn</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Statistics, Department of Health Science and Biostatistics, Swinburne University of Technology, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tideman</LastName><ForeName>Phil</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia; Department of Health, SA Health, South Australian, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hengel</LastName><ForeName>Anton Van Den</ForeName><Initials>AVD</Initials><AffiliationInfo><Affiliation>Australian Institute for Machine Learning (AIML), The University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verjans</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Health, SA Health, South Australian, Adelaide, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Derek P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>College of Medicine and Public Health, Flinders University of South Australia, Adelaide, Australia; South Australian Health and Medical Research Institute, Adelaide, Australia; Department of Health, SA Health, South Australian, Adelaide, Australia. Electronic address: derek.chew@flinders.edu.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J</MedlineTA><NlmUniqueID>0370465</NlmUniqueID><ISSNLinking>0002-8703</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="Y">Chest Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="N">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="Y">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014218" MajorTopicYN="N">Triage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of interest None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>10</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>25</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>24</Day><Hour>19</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39993551</ArticleId><ArticleId IdType="doi">10.1016/j.ahj.2025.02.016</ArticleId><ArticleId IdType="pii">S0002-8703(25)00054-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40703113</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2634-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European heart journal. Digital health</Title><ISOAbbreviation>Eur Heart J Digit Health</ISOAbbreviation></Journal><ArticleTitle>Novel artificial intelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularization.</ArticleTitle><Pagination><StartPage>608</StartPage><EndPage>618</EndPage><MedlinePgn>608-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjdh/ztaf049</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">Rapid myocardial revascularization in patients with acute myocardial infarction (AMI) is essential to improve clinical outcomes. There is still room for improvement in the timely diagnosis of AMI. This study aimed to develop an artificial intelligence (AI) model using electrocardiograms (ECGs) for detecting AMI needing revascularization.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="UNASSIGNED">A total of 723 389 ECGs from 300 627 patients in the derivation cohort at a single centre between 2013 and 2020, including 5872 patients with AMI (1.95%) who underwent revascularization, were used for model training and internal testing. A transformer-based deep learning model, initially trained on about one million unlabelled ECGs through self-supervised learning, was fine-tuned for AMI detection. The model's final performance was evaluated in the internal test and the external validation set. The external validation was conducted at an independent centre between 2002 and 2020 using 261 429 ECGs from 259 454 patients, including 1095 patients with AMI (0.42%). By integrating self-supervised learning to train the AI model, we enhanced the AMI detection performance, as demonstrated by an increase in the area under the receiver operating characteristic curve (AUROC) from 0.910 (95% CI, 0.904-0.915) to 0.968 (95% CI, 0.965-0.971) in the external validation set. For ST-elevation myocardial infarction and non-ST-elevation myocardial infarction detection, the AUROCs were 0.991 (95% CI, 0.989-0.993) and 0.947 (95% CI, 0.942-0.952) in the external validation set, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This novel ECG-based AI model may be beneficial for the timely identification of patients with AMI needing revascularization.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Kyung Hoon</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Victorian Heart Institute, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Young Hoon</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Mineok</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4569-6326</Identifier><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Yongwhan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Joon Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Hun</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-2337-7826</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyun</LastName><ForeName>Dae Young</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Namho</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seonghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jung Rae</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Min-Kyung</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Dong-Geum</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yeha</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Chul</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Doo Sun</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Young Joon</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ju Han</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Youngkeun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2022-9366</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Donghoon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Myung Ho</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-2424-810X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Gwangju Veterans Hospital, 99 Cheomdanwolbong-ro, Gwangsan-gu, Gwangju 62284, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Digit Health</MedlineTA><NlmUniqueID>101778323</NlmUniqueID><ISSNLinking>2634-3916</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Myocardial revascularization</Keyword><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">Self-supervised learning</Keyword></KeywordList><CoiStatement>Conflict of interest: K.H.C. and D.H. received the institutional research grant from VUNO Corporation. Y.Lee is the co-founder and shareholder of VUNO Corporation. Y.H.J, S.J, and M.C. received salaries from VUNO Corporation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40703113</ArticleId><ArticleId IdType="pmc">PMC12282381</ArticleId><ArticleId IdType="doi">10.1093/ehjdh/ztaf049</ArticleId><ArticleId IdType="pii">ztaf049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McClellan &#xa0;M, Brown &#xa0;N, Califf &#xa0;RM, Warner &#xa0;JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation &#xa0;2019;139:e44&#x2013;e54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30674212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nallamothu &#xa0;BK, Normand &#xa0;S-LT, Wang &#xa0;Y, Hofer &#xa0;TP, Brush &#xa0;JE &#xa0;Jr, Messenger &#xa0;JC, et al. &#xa0;Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet &#xa0;2015;385:1114&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409657</ArticleId><ArticleId IdType="pubmed">25467573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho &#xa0;KH, Han &#xa0;X, Ahn &#xa0;JH, Hyun &#xa0;DY, Kim &#xa0;MC, Sim &#xa0;DS, et al. &#xa0;Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol &#xa0;2021;77:1859&#x2013;1870.</Citation><ArticleIdList><ArticleId IdType="pubmed">33858622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha &#xa0;JJ, Bae &#xa0;S, Park &#xa0;DW, Park &#xa0;JH, Hong &#xa0;SJ, Park &#xa0;SM, et al. &#xa0;Clinical outcomes in patients with delayed hospitalization for non-ST-segment elevation myocardial infarction. J Am Coll Cardiol &#xa0;2022;79:311&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">35086652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;J, Gale &#xa0;CP, Hall &#xa0;M, Dondo &#xa0;TB, Metcalfe &#xa0;E, Oliver &#xa0;G, et al. &#xa0;Editor's choice&#x2014;impact of initial hospital diagnosis on mortality for acute myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovasc Care &#xa0;2018;7:139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614828</ArticleId><ArticleId IdType="pubmed">27574333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson &#xa0;M, Welch &#xa0;J, Schuur &#xa0;J, O'Laughlin &#xa0;K, Cutler &#xa0;D. Hospital and emergency department factors associated with variations in missed diagnosis and costs for patients age 65 years and older with acute myocardial infarction who present to emergency departments. Acad Emerg Med &#xa0;2014;21:1101&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285372</ArticleId><ArticleId IdType="pubmed">25308132</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy &#xa0;E, Barrett &#xa0;M, Coffey &#xa0;R, Hines &#xa0;AL, Newman-Toker &#xa0;DE. Missed diagnoses of acute myocardial infarction in the emergency department: variation by patient and facility characteristics. Diagnosis (Berl) &#xa0;2015;2:29&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">29540019</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams &#xa0;T, Savage &#xa0;L, Whitehead &#xa0;N, Orvad &#xa0;H, Cummins &#xa0;C, Faddy &#xa0;S, et al. &#xa0;Missed acute myocardial infarction (MAMI) in a rural and regional setting. Int J Cardiol Heart Vasc &#xa0;2019;22:177&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411579</ArticleId><ArticleId IdType="pubmed">30906847</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias &#xa0;P, Poterucha &#xa0;TJ, Rajaram &#xa0;V, Moller &#xa0;LM, Rodriguez &#xa0;V, Bhave &#xa0;S, et al. &#xa0;Deep learning electrocardiographic analysis for detection of left-sided valvular heart disease. J Am Coll Cardiol &#xa0;2022;80:613&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">35926935</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway &#xa0;CD, Valys &#xa0;AV, Shreibati &#xa0;JB, Treiman &#xa0;DL, Petterson &#xa0;FL, Gundotra &#xa0;VP, et al. &#xa0;Development and validation of a deep-learning model to screen for hyperkalemia from the electrocardiogram. JAMA Cardiol &#xa0;2019;4:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537816</ArticleId><ArticleId IdType="pubmed">30942845</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi &#xa0;J, Lee &#xa0;S, Chang &#xa0;M, Lee &#xa0;Y, Oh &#xa0;GC, Lee &#xa0;HY. Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction. Sci Rep &#xa0;2022;12:14235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392508</ArticleId><ArticleId IdType="pubmed">35987961</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia &#xa0;ZI, Noseworthy &#xa0;PA, Lopez-Jimenez &#xa0;F, Asirvatham &#xa0;SJ, Deshmukh &#xa0;AJ, Gersh &#xa0;BJ, et al. &#xa0;An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet &#xa0;2019;394:861&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">31378392</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu &#xa0;W-C, Lin &#xa0;C-S, Tsai &#xa0;C-S, Tsao &#xa0;T-P, Cheng &#xa0;C-C, Liou &#xa0;J-T, et al. &#xa0;A deep learning algorithm for detecting acute myocardial infarction. EuroIntervention &#xa0;2021;17:765&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724911</ArticleId><ArticleId IdType="pubmed">33840640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson &#xa0;S, Gedon &#xa0;D, Lampa &#xa0;E, Ribeiro &#xa0;AH, Holzmann &#xa0;MJ, Sch&#xf6;n &#xa0;TB, et al. &#xa0;Development and validation of deep learning ECG-based prediction of myocardial infarction in emergency department patients. Sci Rep &#xa0;2022;12:19615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666471</ArticleId><ArticleId IdType="pubmed">36380048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;BT, Kwon &#xa0;J-M, Cho &#xa0;J, Bae &#xa0;W, Park &#xa0;H, Seo &#xa0;W-W, et al. &#xa0;Usefulness of deep-learning algorithm for detecting acute myocardial infarction using electrocardiogram alone in patients with chest pain at emergency department: DAMI-ECG study. J Cardiovasc Interv &#xa0;2023;2:100&#x2013;112.</Citation></Reference><Reference><Citation>Chang &#xa0;K-C, Hsieh &#xa0;P-H, Wu &#xa0;M-Y, Wang &#xa0;Y-C, Wei &#xa0;J-T, Shih &#xa0;ESC, et al. &#xa0;Usefulness of multi-labelling artificial intelligence in detecting rhythm disorders and acute ST-elevation myocardial infarction on 12-lead electrocardiogram. Eur Heart J Digit Health &#xa0;2021;2:299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708016</ArticleId><ArticleId IdType="pubmed">36712388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid &#xa0;A, Jiang &#xa0;J, Sawant &#xa0;A, Lerakis &#xa0;S, Argulian &#xa0;E, Ahuja &#xa0;Y, et al. &#xa0;A foundational vision transformer improves diagnostic performance for electrocardiograms. NPJ Digit Med &#xa0;2023;6:108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242218</ArticleId><ArticleId IdType="pubmed">37280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawano &#xa0;S, Kodera &#xa0;S, Setoguchi &#xa0;N, Tanabe &#xa0;K, Kushida &#xa0;S, Kanda &#xa0;J, et al. &#xa0;Applying masked autoencoder-based self-supervised learning for high-capability vision transformers of electrocardiographies. PLoS One &#xa0;2024;19:e0307978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11324121</ArticleId><ArticleId IdType="pubmed">39141600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai &#xa0;J, Tan &#xa0;H, Wang &#xa0;J, Ji &#xa0;L, Guo &#xa0;J, Han &#xa0;B, et al. &#xa0;Practical intelligent diagnostic algorithm for wearable 12-lead ECG via self-supervised learning on large-scale dataset. Nat Commun &#xa0;2023;14:3741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290151</ArticleId><ArticleId IdType="pubmed">37353501</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen &#xa0;K, Alpert &#xa0;JS, Jaffe &#xa0;AS, Chaitman &#xa0;BR, Bax &#xa0;JJ, Morrow &#xa0;DA, et al. &#xa0;Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol &#xa0;2018;72:2231&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>

Dosovitskiy &#xa0;A, Beyer &#xa0;L, Kolesnikov &#xa0;A, Weissenborn &#xa0;D, Zhai &#xa0;X, Unterthiner &#xa0;T, et al.  &#xa0;An image is worth 16&#xd7;16 words: Transformers for image recognition at scale. In: <i>9th International Conference on Learning Representations (ICLR), Virtual Conference</i>, 2021. https://openreview.net/forum?id=YicbFdNTTy.</Citation></Reference><Reference><Citation>

He &#xa0;K, Chen &#xa0;X, Xie &#xa0;S, Li &#xa0;Y, Doll&#xe1;r &#xa0;P, Girshick &#xa0;R. &#xa0;Masked autoencoders are scalable vision learners. In: <i>2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), New Orleans, Louisiana, USA</i>, 2022, p.16000&#x2013;16009. IEEE, Piscataway, New Jersey, USA.</Citation></Reference><Reference><Citation>
World Health Organization . Cardiovascular diseases (CVDs). https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (29 January 2024).</Citation></Reference><Reference><Citation>Hayashi &#xa0;M, Shimizu &#xa0;W, Albert &#xa0;CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res &#xa0;2015;116:1887&#x2013;1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929621</ArticleId><ArticleId IdType="pubmed">26044246</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne &#xa0;RA, Rossello &#xa0;X, Coughlan &#xa0;J, Barbato &#xa0;E, Berry &#xa0;C, Chieffo &#xa0;A, et al. &#xa0;2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J &#xa0;2023;44:3720&#x2013;3826.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto &#xa0;JG, Shlipak &#xa0;MG, Rogers &#xa0;WJ, Malmgren &#xa0;JA, Frederick &#xa0;PD, Lambrew &#xa0;CT, et al. &#xa0;Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA &#xa0;2000;283:3223&#x2013;3229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10866870</ArticleId></ArticleIdList></Reference><Reference><Citation>Han &#xa0;X, Bai &#xa0;L, Jeong &#xa0;MH, Ahn &#xa0;JH, Hyun &#xa0;DY, Cho &#xa0;KH, et al. &#xa0;Higher long-term mortality in patients with non-ST-elevation myocardial infarction than ST-elevation myocardial infarction after discharge. Yonsei Med J &#xa0;2021;62:400&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084695</ArticleId><ArticleId IdType="pubmed">33908210</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe &#xa0;JM, Armstrong &#xa0;EJ, Ku &#xa0;I, Kulkarni &#xa0;A, Hoffmayer &#xa0;KS, Bhave &#xa0;PD, et al. &#xa0;Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J Am Heart Assoc &#xa0;2013;2:e000268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835230</ArticleId><ArticleId IdType="pubmed">24096575</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho &#xa0;KH, Shin &#xa0;MH, Kim &#xa0;MC, Sim &#xa0;DS, Hong &#xa0;YJ, Kim &#xa0;JH, et al. &#xa0;Incidence, relevant patient factors, and clinical outcomes of the misdiagnosis of ST-segment-elevation myocardial infarction: results from the Korea acute myocardial infarction registry. J Am Heart Assoc &#xa0;2023;12:e029728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10356100</ArticleId><ArticleId IdType="pubmed">37345749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taggart &#xa0;C, Roos &#xa0;A, Kadesjo &#xa0;E, Anand &#xa0;A, Li &#xa0;Z, Doudesis &#xa0;D, et al. &#xa0;Application of the universal definition of myocardial infarction in clinical practice in Scotland and Sweden. JAMA Netw Open &#xa0;2024;7:e245853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11002705</ArticleId><ArticleId IdType="pubmed">38587840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin &#xa0;C, Liu &#xa0;W-T, Chang &#xa0;C-H, Lee &#xa0;C-C, Hsing &#xa0;S-C, Fang &#xa0;W-H, et al. &#xa0;Artificial intelligence&#x2013;powered rapid identification of ST-elevation myocardial infarction via electrocardiogram (ARISE)&#x2014;a pragmatic randomized controlled trial. NEJM AI &#xa0;2024;1. doi: 10.1056/AIoa2400190</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/AIoa2400190</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti &#xa0;SS, Martin-Gill &#xa0;C, Zegre-Hemsey &#xa0;JK, Bouzid &#xa0;Z, Faramand &#xa0;Z, Alrawashdeh &#xa0;MO, et al. &#xa0;Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med &#xa0;2023;29:1804&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani &#xa0;V, Nabi &#xa0;ST, Kumar &#xa0;M, Mittal &#xa0;A, Kumar &#xa0;K. Self-supervised learning: a succinct review. Arch Comput Methods Eng &#xa0;2023;30:2761&#x2013;2775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857922</ArticleId><ArticleId IdType="pubmed">36713767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulluck &#xa0;H, Hammond-Haley &#xa0;M, Weinmann &#xa0;S, Martinez-Macias &#xa0;R, Hausenloy &#xa0;DJ. Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials. JACC Cardiovasc Imaging &#xa0;2017;10:230&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348096</ArticleId><ArticleId IdType="pubmed">28279370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40684845</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Risk Stratification of CABG Patients Using an Artificial Intelligence ECG-Derived Age.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(25)00569-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2025.06.037</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the prognostic value of artificial intelligence electrocardiogram-derived (AI ECG) age in predicting outcomes following isolated CABG.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used preoperative ECGs (within 30 days from surgery) from 13,808 isolated CABG patients to calculate AI ECG-derived age using convolutional neural networks. The age gap was calculated as AI ECG-derived age minus chronological age. The associations of age gap with baseline comorbidities, operative outcomes, and long-term survival were analyzed using multivariable regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median chronological age was 68 (60-74) years, and the AI ECG-derived age was 67 (61-72) years. Mean age gap was -1&#xb1;8 year (range -39 to +35 years). In 44% of patients, the AI ECG-derived age was older than the chronological age (positive age gap of 6(&#xb1;5) years), and in 21.4% this gap was greater than 5 years. Patients with age gap&gt;5 years were more likely to have renal failure, congestive heart failure, history of myocardial infarction, higher BMI, and lower ejection fraction. Postoperatively, they were at higher risk of atrial fibrillation (OR=1.15(95% confidence interval [95% CI] 1.05-1.30), p=0.042), prolonged ventilation (OR=1.2 (95% CI 1.1-1.5), p=0.047), blood transfusion (OR=1.15(95% CI 1.1-1.30), p=0.017), postoperative creatinine(B-coefficient=+0.15 units, p&lt;0.001), and hospital stay (B-coefficient=+0.7 days, p=0.001). Long-term survival was lower in patients with age gap&gt;5 years compared to those with gap&#x2264;5 (Hazard Ratio=1.4(95% CI 1.2-1.5), p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Higher age gap identifies a cohort of CABG patients with increased comorbidities and advanced physiological age. Advanced physiological age identified by AI ECG is independently associated with worse operative outcomes and long-term mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sawma</LastName><ForeName>Tedy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: sawma.tedy@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arghami</LastName><ForeName>Arman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaff</LastName><ForeName>Hartzell V</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslahishahri</LastName><ForeName>Masoomeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangold</LastName><ForeName>Kathryn E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dearani</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stulak</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagameri</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villavicencio</LastName><ForeName>Mauricio A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greason</LastName><ForeName>Kevin L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Jimenez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attia</LastName><ForeName>Zachi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crestanello</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: crestanello.juan@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI ECG</Keyword><Keyword MajorTopicYN="N">AI ECG age</Keyword><Keyword MajorTopicYN="N">CABG</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">artificial intelligence ECG-derived age</Keyword><Keyword MajorTopicYN="N">chronological age</Keyword><Keyword MajorTopicYN="N">physiological age</Keyword><Keyword MajorTopicYN="N">revascularization</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>20</Day><Hour>19</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40684845</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2025.06.037</ArticleId><ArticleId IdType="pii">S0022-5223(25)00569-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40717627</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2048-8734</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>European heart journal. Acute cardiovascular care</Title><ISOAbbreviation>Eur Heart J Acute Cardiovasc Care</ISOAbbreviation></Journal><ArticleTitle>Failure of standard contemporary ST-elevation myocardial infarction electrocardiogram criteria to reliably identify acute occlusion of the left anterior descending coronary artery.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>411</EndPage><MedlinePgn>403-411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjacc/zuaf037</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">ST-elevation (STE) criteria on the electrocardiogram (ECG) are poorly sensitive for acute coronary occlusion myocardial infarction (ACOMI or OMI). This study evaluates the sensitivity of STE criteria on serial ECGs for total left anterior descending (LAD) coronary artery occlusion. We compared STE criteria with expert interpretation and a validated artificial intelligence (AI) ECG model for diagnosing LAD OMI.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a retrospective sub-study of the DOMI-ARIGATO case-control study of OMI (808 patients, 265 with OMI). All cases of total (TIMI-0 flow) LAD occlusion were assessed for STE criteria. An OMI ECG expert blindly interpreted all serial ECGs. An AI model (PMCardio Queen of Hearts) was applied to the first available 12-lead ECG. Among the 53 cases of acute LAD OMI with TIMI-0 flow, 20 (38%) did not meet STE myocardial infarction (STEMI) criteria on any pre-angiography ECG; 16/20 had at least two ECGs before angiography. Both the expert and AI model had 100% sensitivity for diagnosing LAD OMI on the first ECG in these 20 cases. Door-to-balloon time (DBT) was significantly shorter for those meeting STEMI criteria. Infarct size, measured by ejection fraction and peak troponin, did not differ between cases with and without STEMI criteria.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The STEMI criteria missed 38% of acute total LAD occlusions on all serial ECGs. Both expert interpretation and the AI model demonstrated 100% sensitivity on the first ECG for all cases. Despite the lack of STEMI criteria, these cases had similar infarct sizes but were associated with longer DBTs.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><Identifier Source="ORCID">0000-0001-7484-2022</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, 1000 Blythe Blvd, Charlotte, NC 28203, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharkey</LastName><ForeName>Scott W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Minneapolis Heart Institute, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Alencar</LastName><ForeName>Jos&#xe9; Nunes</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dante Pazzanese Institute of Cardiology, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shroff</LastName><ForeName>Gautam R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Hennepin Healthcare and University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frick</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, SSM Health St. Louis University Hospital, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin Healthcare and the University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Acute Cardiovasc Care</MedlineTA><NlmUniqueID>101591369</NlmUniqueID><ISSNLinking>2048-8726</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054059" MajorTopicYN="Y">Coronary Occlusion</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndromes</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">LAD occlusion</Keyword><Keyword MajorTopicYN="N">OMI</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">STEMI criteria</Keyword></KeywordList><CoiStatement>Conflict of interest: H.P.M. is a consultant of Powerful Medical. R.H. is the Chief Medical Officer of Powerful Medical. H.P.M., R.H., and S.W.S. all own stock in Powerful Medical.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40717627</ArticleId><ArticleId IdType="doi">10.1093/ehjacc/zuaf037</ArticleId><ArticleId IdType="pii">8214322</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40718295</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Decoding Hidden Pathways: A Comprehensive Exploration of Anomalous Coronary Arteries.</ArticleTitle><Pagination><StartPage>e86852</StartPage><MedlinePgn>e86852</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86852</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86852</ELocationID><Abstract><AbstractText>Introduction Coronary artery anomalies (CAA) are congenital anomalies affecting the origin, course, structure, or number of coronary arteries; certain high-risk configurations, particularly those involving interarterial or intramural segments, can predispose individuals to ischemia, arrhythmias, or sudden cardiac death (SCD). Populations at particular risk include young athletes and individuals with anomalies exhibiting interarterial or intramural courses. This study aimed to characterize the prevalence, imaging features, management strategies, and outcomes of CAAs, including rare variants such as anomalous left coronary artery from the pulmonary artery (ALCAPA), and interarterial left main in a single tertiary care center cohort. Methods We retrospectively analyzed 8,000 patients who underwent coronary angiography between January 2012 and December 2021 and identified 133 patients with CAAs. Diagnostic modalities included invasive coronary angiography (CAG)&#xa0;for typical ischemic or acute presentations and coronary CT angiography (CTA) for atypical or lower-risk cases; MRI was unavailable. Demographic data, clinical features, anomaly subtypes, and management strategies [medical therapy, percutaneous coronary intervention (PCI), or surgery] were documented. Outcomes at a median 36-month follow-up included symptom resolution and adverse events clearly defined as myocardial infarction (Fourth Universal Definition), revascularization [PCI/coronary artery bypass grafting (CABG) for stenosis &gt;60%], and cardiac death. Results A total of 133 patients (mean age: 52.3&#x202f;&#xb1;&#x202f;10.5 years; 62% male) were included. Chest pain (60%) was the most common symptom, with 10% asymptomatic. The most frequent anomalies were classified as&#xa0;benign variants, including anomalous right coronary artery (RCA)&#xa0;from the left sinus (37.6%) and left circumflex artery (LCx) from the right sinus (30.1%).&#xa0;Malignant variants&#xa0;included five cases of ALCAPA (3.8%), two interarterial left main origins (1.5%), and two single coronary artery cases (1.5%). One patient with an interarterial left main died of SCD during follow-up. Other less common forms (e.g., high takeoff, fistulas, significant myocardial bridging) were grouped under "Other" (7.5%). Significant concomitant coronary artery disease (CAD) (&gt;50% stenosis) was present in 17.5%. Management strategies included medical therapy (60%), PCI (22.5%), and surgical correction (17.5%). Symptom resolution occurred in 70% of medically treated, 80% of PCI-treated, and 100% of surgically treated patients. Adverse events (overall 10%) - defined as myocardial infarction, revascularization, or cardiac death - occurred in 5% of the medical group, 8.9% of PCI, and 4.3% of surgical cases. Outcome data for rare variants were limited due to low sample size, but suggest higher risk with malignant anatomies. Conclusions Anomalous coronary arteries show wide clinical variability; high-risk types like interarterial left main and ALCAPA warrant careful follow-up. While most patients achieve good outcomes, SCD in one case in our cohort highlights the need for timely intervention. Current challenges include limited awareness, lack of standardized screening, inconsistent risk assessment, and absence of personalized treatment protocols. Advancements in imaging, genetics, and artificial intelligence (AI)-driven risk models may enhance early detection and tailored management of CAAs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Vallurupalli et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vallurupalli</LastName><ForeName>Aineesh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Of Cardiology, Amrita Institute of Medical Sciences and Research Centre, Kochi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thachathodiyl</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amrita Institute of Medical Sciences and Research Centre, Kochi, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">alcapa</Keyword><Keyword MajorTopicYN="N">computed tomography angiography (cta)</Keyword><Keyword MajorTopicYN="N">coronary artery anomalies</Keyword><Keyword MajorTopicYN="N">interarterial left main</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40718295</ArticleId><ArticleId IdType="pmc">PMC12296873</ArticleId><ArticleId IdType="doi">10.7759/cureus.86852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Yamanaka O, Hobbs RE. Cathet Cardiovasc Diagn. 1990;21:28&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">2208265</ArticleId></ArticleIdList></Reference><Reference><Citation>Detection of coronary artery anomalies by dual-source CT coronary angiography. Cheng Z, Wang X, Duan Y, et al. Clin Radiol. 2010;65:815&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">20797468</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of coronary artery anomalies in 12,457 adult patients who underwent coronary angiography. Yildiz A, Okcun B, Peker T, Arslan C, Olcay A, Bulent Vatan M. Clin Cardiol. 2010;33:0&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6653639</ArticleId><ArticleId IdType="pubmed">21184546</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary artery anomalies: an entity in search of an identity. Angelini P. Circulation. 2007;115:1296&#x2013;1305.</Citation><ArticleIdList><ArticleId IdType="pubmed">17353457</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. Basso C, Maron BJ, Corrado D, Thiene G. J Am Coll Cardiol. 2000;35:1493&#x2013;1501.</Citation><ArticleIdList><ArticleId IdType="pubmed">10807452</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert consensus guidelines: anomalous aortic origin of a coronary artery. Brothers JA, Frommelt MA, Jaquiss RD, Myerburg RJ, Fraser CD Jr, Tweddell JS. J Thorac Cardiovasc Surg. 2017;153:1440&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">28274557</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and management of anomalous coronary arteries with a malignant course. Gr&#xe4;ni C, Kaufmann PA, Windecker S, Buechel RR. Interv Cardiol. 2019;14:83&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6545977</ArticleId><ArticleId IdType="pubmed">31178934</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence and characteristics of coronary artery anomalies detected by coronary computed tomography angiography in 5&#x200a;634 consecutive patients in a single centre in Switzerland. Gr&#xe4;ni C, Benz DC, Schmied C, et al. Swiss Med Wkly. 2016;146:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">27124568</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of anomalous origin of coronary artery in 1879 Chinese adults on dual-source CT angiography. Zhang LJ, Yang GF, Huang W, Zhou CS, Chen P, Lu GM. Neth Heart J. 2010;18:466&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2954298</ArticleId><ArticleId IdType="pubmed">20978590</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary artery anomalies: classification and ECG-gated multi-detector row CT findings with angiographic correlation. Kim SY, Seo JB, Do KH, et al. Radiographics. 2006;26:317&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">16549600</ArticleId></ArticleIdList></Reference><Reference><Citation>The registry of anomalous aortic origin of the coronary artery of the Congenital Heart Surgeons' Society. Brothers JA, Gaynor JW, Jacobs JP, Caldarone C, Jegatheeswaran A, Jacobs ML. Cardiol Young. 2010;20:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21087560</ArticleId></ArticleIdList></Reference><Reference><Citation>Anomalous aortic origin of a coronary artery from the inappropriate sinus of Valsalva. Cheezum MK, Liberthson RR, Shah NR, Villines TC, O'Gara PT, Landzberg MJ, Blankstein R. J Am Coll Cardiol. 2017;69:1592&#x2013;1608.</Citation><ArticleIdList><ArticleId IdType="pubmed">28335843</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary artery anomalies and their clinical relevance. Misuraca L, Benedetti G, Petronio AS, De Carlo M, Chella P, Pieroni A, Balbarini A. Monaldi Arch Chest Dis. 2011;76:66&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">22128609</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary artery fistulas: clinical and therapeutic considerations. Gowda RM, Vasavada BC, Khan IA. Int J Cardiol. 2006;107:7&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">16125261</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiac imaging: MR or CT? Which to use when. Taylor AM. Pediatr Radiol. 2008;38:0&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18470452</ArticleId></ArticleIdList></Reference><Reference><Citation>Congenital anomalies of the coronary arteries: imaging with contrast-enhanced, multidetector computed tomography. Schmitt R, Froehner S, Brunn J, et al. Eur Radiol. 2005;15:1110&#x2013;1121.</Citation><ArticleIdList><ArticleId IdType="pubmed">15756551</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary anomalies: incidence, pathophysiology, and clinical relevance. Angelini P, Velasco JA, Flamm S. Circulation. 2002;105:2449&#x2013;2454.</Citation><ArticleIdList><ArticleId IdType="pubmed">12021235</ArticleId></ArticleIdList></Reference><Reference><Citation>Primary congenital anomalies of the coronary arteries: a coronary: arteriographic study. Garg N, Tewari S, Kapoor A, Gupta DK, Sinha N. Int J Cardiol. 2000;12:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">10854679</ArticleId></ArticleIdList></Reference><Reference><Citation>Congenital coronary artery anomalies as an important cause of sudden death in the young. Basso C, Corrado D, Thiene G. Cardiol Rev. 2001;9:312&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pubmed">11696258</ArticleId></ArticleIdList></Reference><Reference><Citation>Anomalous aortic origin of a coronary artery: toward a standardized approach. Mery CM, Lawrence SM, Krishnamurthy R, Sexson-Tejtel SK, Carberry KE, McKenzie ED, Fraser CD Jr. Semin Thorac Cardiovasc Surg. 2014;26:110&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">25441002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40770243</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Revolutionizing clinical decision making through deep learning and topic modeling for pathway optimization.</ArticleTitle><Pagination><StartPage>28787</StartPage><MedlinePgn>28787</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">28787</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-12679-z</ELocationID><Abstract><AbstractText>Optimizing clinical pathways is pivotal for enhancing healthcare delivery, yet traditional methods are increasingly insufficient in the face of complex, personalized medical demands. This paper introduces an innovative optimization framework that fuses Latent Dirichlet Allocation (LDA) topic modeling with Bidirectional Long Short-Term Memory (BiLSTM) networks to address the complexities of modern healthcare. The LDA component elucidates key diagnostic and treatment patterns from clinical narratives, while the BiLSTM network adeptly captures the temporal progression of patient care. Our model was validated against a real-world medical dataset, achieving remarkable results with an accuracy of over 90%, precision exceeding 28% improvement, recall with a 21% enhancement, and an F1 score that reflects a 25% increase over existing models. These results were obtained through comparative analysis with established models such as DeepCare, Doctor AI, and LSTM variants, showcasing the superior predictive capabilities of our LDA-BiLSTM integrated approach. This study not only advances the academic discourse on clinical pathway management but also presents a tangible tool for healthcare practitioners, promising a significant impact on the customization and efficacy of clinical pathways, thereby enhancing patient care and satisfaction.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tianzhao</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Resources and Environment, Shensi Lab, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking University Shenzhen Hospital, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jinzhi</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Resources and Environment, Shensi Lab, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Resources and Environment, Shensi Lab, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jun</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hong Kong Baptist University, KLN, Hong Kong, China. junsong@hkbu.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hailong</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Resources and Environment, Shensi Lab, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Wuyi University, Jiangmen, China. yanliang@wyu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sino-European Center of Biomedicine and Health, Shenzhen, China. yanliang@wyu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>42077395</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>JCYJ2021018</GrantID><Agency>Peking University Shenzhen Hospital, Shenzhen</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019091" MajorTopicYN="Y">Critical Pathways</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical pathways</Keyword><Keyword MajorTopicYN="N">Data-driven methods</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Elevated myocardial infarction</Keyword><Keyword MajorTopicYN="N">Recurrent neural networks</Keyword><Keyword MajorTopicYN="N">Topic modeling</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>23</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40770243</ArticleId><ArticleId IdType="pmc">PMC12328816</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-12679-z</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-12679-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lin, F., Chou, S., Pan, S. &amp; Chen, Y. Mining time dependency patterns in clinical pathways. <i>Int. J. Med. Inf.</i><b>62</b>(1), 11&#x2013;25. 10.1016/S1386-5056(01)00126-5 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11340003</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, H., Jin, T. &amp; Wang, J. Clinical-event packing method based on conditional probability. <i>CIMS</i><b>23</b>(5), 1031&#x2013;1039. 10.13196/j.cims.2017.05.014 (2017).</Citation></Reference><Reference><Citation>Yin, L., Dong, W., Huang, Z., Ji, L. &amp; Lv, X. On detecting the changes of medical behaviors in clinical pathways. <i>Chin. J. Biomedical Eng.</i><b>34</b>(3), 272&#x2013;280 (2015).</Citation></Reference><Reference><Citation>Prokofyeva, E. S. &amp; Zaytsev, R. D. Clinical pathways analysis of patients in medical institutions based on hard and fuzzy clustering methods. <i>&#x411;&#x438;&#x437;&#x43d;&#x435;&#x441;-&#x438;&#x43d;&#x444;&#x43e;&#x440;&#x43c;&#x430;&#x442;&#x438;&#x43a;&#x430;</i><b>14</b>(1(eng)), 19&#x2013;31. 10.17323/2587-814X.2020.1.19.31 (2020).</Citation></Reference><Reference><Citation>Minsu, C. et al. Developing data-driven clinical pathways using electronic health records: the cases of total laparoscopic hysterectomy and rotator cuff tears. <i>Int. J. Med. Informatics</i>. <b>133</b>(104015), 1386&#x2013;5056. 10.1016/j.ijmedinf.2019.104015 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31683142</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, X., Jin, T., Wei, Z., Lv, C. &amp; Wang, J. TCPM: topic-based clinical pathway mining. <i>CHASE</i> 27&#x2013;29 10.1109/CHASE.2016.17 (2016).</Citation></Reference><Reference><Citation>Xu, X., Jin, T. &amp; Wang, J. Optimized topic model for clinical pathway mining. <i>J. Softw.</i><b>29</b>(11), 3295&#x2013;3305. 10.13328/j.cnki.jos.005481 (2018).</Citation></Reference><Reference><Citation>Kobayashi, S. Contextual augmentation: data augmentation by words with paradigmatic relations. <i>Conf. North. Am. Chapter Association Comput. Linguistics: Hum. Lang. Technol.</i><b>2</b>, 452&#x2013;457. 10.18653/v1/N18-2072 (2018).</Citation></Reference><Reference><Citation>Quteineh, H., Samothrakis, S. &amp; Sutcliffe, R. Textual data augmentation for efficient active learning on tiny datasets. <i>EMNLP</i><b>2020</b>, 7400&#x2013;7410. 10.18653/v1/2020.emnlp-main.600 (2020).</Citation></Reference><Reference><Citation>Pham, T., Tran, T. &amp; Phung, D. Q. DeepCare: A deep dynamic memory model for predictive medicine. <i>PAKDD</i> 30&#x2013;41. 10.1007/978-3-319-31750-2_3 (2016).</Citation></Reference><Reference><Citation>Choi, E., Bahadori, M. T., Schuetz, A., Stewart, W. F. &amp; Sun, J. Doctor AI: predicting clinical events via recurrent neural networks. <i>JMLR Workshop and Conference Proceedings</i><b>56</b>, 301&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5341604</ArticleId><ArticleId IdType="pubmed">28286600</ArticleId></ArticleIdList></Reference><Reference><Citation>Yufang, Y., Kui, Z., Jilong, C. &amp; Huimin, M. Prediction research of cervical cancer clinical events based on recurrent neural network. <i>Procedia Comput. Sci.</i><b>183</b>, 221&#x2013;229. 10.1016/j.procs.2021.02.052 (2021).</Citation></Reference><Reference><Citation>Li, W., Min, X., Ye, P. &amp; Xie, W. Temporal topic model for clinical pathway mining from electronic medical records. <i>BMC Med. Inf. Decis. Mak.</i><b>24</b>, 20. 10.1186/s12911-024-02418-1 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10804581</ArticleId><ArticleId IdType="pubmed">38263007</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhdanova, E., Korneev, I. &amp; Kovalchuk, S. Predictive modeling of multistep clinical pathways: application to infertility treatment process. <i>Procedia Comput. Sci.</i><b>229</b>, 272&#x2013;283. 10.1016/j.procs.2023.12.029 (2023).</Citation></Reference><Reference><Citation>Wani, N. A., Bedi, J., Kumar, R., Khan, M. A. &amp; Rida, I. Synergizing fusion modelling for accurate cardiac prediction through explainable artificial intelligence. <i>IEEE Trans. Consum. Electron.</i>10.1109/TCE.2024.3419814 (2024).</Citation></Reference><Reference><Citation>Wani, N. A., Kumar, R., Bedi, J. &amp; DeepXplainer An interpretable deep learning based approach for lung cancer detection using explainable artificial intelligence. <i>Comput. Methods Programs Biomed.</i><b>243</b>, 107879. 10.1016/j.cmpb.2023.107879 (2023).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37897989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani, N. A., Kumar, R. &amp; Bedi, J. Explainable AI-driven IoMT fusion: unravelling techniques, opportunities, and challenges with explainable AI in healthcare. <i>Inform. Fusion</i>. <b>110</b>, 1566&#x2013;2535. 10.1016/j.inffus.2024.102472 (2024).</Citation></Reference><Reference><Citation>Wang, L. et al. Research on intelligent diagnosis sequence prediction based on FT-LSTM model. <i>Appl. Res. Comput.</i><b>37</b>(10), 2961&#x2013;2965. 10.19734/j.issn.1001-3695.2019.04.0192 (2020).</Citation></Reference><Reference><Citation>Liu, L. et al. Learning the joint representation of heterogeneous Temporal events for clinical endpoint prediction. <i>Proc. Thirty-Second AAAI Conf. Artif. Intell.</i><b>32</b>(1). 10.1609/aaai.v32i1.11307 (2018).</Citation></Reference><Reference><Citation>Niyaz, A., Ravinder, K. &amp; Jatin, B. Harnessing fusion modeling for enhanced breast cancer classification through interpretable artificial intelligence and in-depth explanations. <i>Eng. Appl. Artif. Intell.</i>10.1016/j.engappai.2024.108939 (2024).</Citation></Reference><Reference><Citation>Niyaz, A., Ravinder, K., Mamta, J. B. &amp; Imad, R. explainable AI-driven IoMT fusion: unravelling techniques, opportunities, and challenges with explainable AI in healthcare. <i>Inform. Fusion</i>. <b>110</b> (102472), 1566&#x2013;2535. 10.1016/j.inffus.2024.102472 (2024).</Citation></Reference><Reference><Citation>Niyaz, A., Ravinder, K. &amp; Jatin, B. DeepXplainer: An interpretable deep learning based approach for lung cancer detection using explainable artificial intelligence. <i>Comput. Methods Programs Biomed.</i><b>243</b>, 107879. 10.1016/j.cmpb.2023.107879 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">37897989</ArticleId></ArticleIdList></Reference><Reference><Citation>Blei, D. M., Ng, A. Y. &amp; Jordan, M. I. Latent dirichlet allocation. <i>J. Mach. Learn. Res.</i><b>3</b>, 993&#x2013;1022. 10.5555/944919.944937 (2003). https://dl.acm.org/doi/</Citation></Reference><Reference><Citation>R&#xf6;der, M., Both, A. &amp; Hinneburg, A. Exploring the space of topic coherence measures. <i>WSDM &#x2018;15: Proc. Eighth ACM Int. Conf. Web Search. Data Min.</i> 399&#x2013;408 10.1145/2684822.2685324 (2015).</Citation></Reference><Reference><Citation>Hochreiter, S. &amp; Schmidhuber, J. Long short-term memory. <i>Neural Comput.</i><b>9</b>(8), 1735&#x2013;1780. 10.1162/neco.1997.9.8.1735 (1997).
</Citation><ArticleIdList><ArticleId IdType="pubmed">9377276</ArticleId></ArticleIdList></Reference><Reference><Citation>Gers, F. A., Schmidhuber, J. &amp; Cummins, F. Learning to forget: continual prediction with LSTM. <i>Neural Comput.</i><b>12</b>(10), 2451&#x2013;2471. 10.1049/cp:19991218 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">11032042</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster, M. &amp; Paliwal, K. K. Bidirectional recurrent neural networks. <i>IEEE Trans. Signal. Process.</i><b>45</b>(11), 2673&#x2013;2681. 10.1109/78.650093 (1997).</Citation></Reference><Reference><Citation>Gu, Y., Cao, J., Zhu, N., Chen, X. &amp; Shen, K. Personalized clinical pathway recommendation via attention based pre-training. <i>IEEE BIBM</i><b>2021</b>, 980&#x2013;987. 10.1109/BIBM52615.2021.9669809 (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40774620</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6551</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</Title><ISOAbbreviation>J Nucl Cardiol</ISOAbbreviation></Journal><ArticleTitle>The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET(REFINE PET): Rationale and Design.</ArticleTitle><Pagination><StartPage>102449</StartPage><MedlinePgn>102449</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nuclcard.2025.102449</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1071-3581(25)00323-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The REgistry of Flow and Perfusion Imaging for Artificial Intelligence with PET (REFINE PET) was established to collect multicenter PET and associated computed tomography (CT) images, together with clinical data and outcomes, into a comprehensive research resource. REFINE PET will enable validation and development of both standard and novel cardiac PET/CT processing methods.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">REFINE PET is a multicenter, international registry that contains both clinical and imaging data. The PET scans were processed using QPET software (Cedars-Sinai Medical Center, Los Angeles, CA), while the CT scans were processed using deep learning (DL) to detect coronary artery calcium (CAC). Patients were followed up for the occurrence of major adverse cardiovascular events (MACE), which include death, myocardial infarction, unstable angina, and late revascularization (&gt;90 days from PET).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The REFINE PET registry currently contains data for 35,588 patients from 14 sites, with additional patient data and sites anticipated. Comprehensive clinical data (including demographics, medical history, and stress test results) were integrated with more than 2200 imaging variables across 42 categories. The registry is poised to address a broad range of clinical questions, supported by correlating invasive angiography (within 6 months of MPI) in 5972 patients and a total of 9252 major adverse cardiovascular events during a median follow-up of 4.2 years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The REFINE PET registry leverages the integration of clinical, multimodality imaging, and novel quantitative and AI tools to advance the role of PET/CT MPI in diagnosis and risk stratification.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Giselle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemley</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanbhag</LastName><ForeName>Aakash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Signal and Image Processing Institute, Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwiecinski</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert J H</ForeName><Initials>RJH</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavanagh</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Joanna X</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Damini</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slipczuk</LastName><ForeName>Leandro</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Division, Montefiore Health System/Albert Einstein College of Medicine, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travin</LastName><ForeName>Mark I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Radiology (Nuclear Medicine), Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexanderson</LastName><ForeName>Erick</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nuclear Cardiology, Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico; Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvajal-Juarez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nuclear Cardiology, Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Packard</LastName><ForeName>Ren&#xe9; R S</ForeName><Initials>RRS</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; West Los Angeles Veterans Affairs Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mallah</LastName><ForeName>Mouaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart &amp; Vascular Center, Houston Methodist Academic Institute, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einstein</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feher</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acampa</LastName><ForeName>Wanda</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA; Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Viet T</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanghani</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wopperer</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chareonthaitawee</LastName><ForeName>Panithaya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buechel</LastName><ForeName>Ronny R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosamond</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>deKemp</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Carli</LastName><ForeName>Marcelo F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Cardiovascular Imaging Program, Departments of Radiology and Medicine; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slomka</LastName><ForeName>Piotr J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: Piotr.Slomka@cshs.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Nucl Cardiol</MedlineTA><NlmUniqueID>9423534</NlmUniqueID><ISSNLinking>1071-3581</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2025 Jul 11:2025.07.10.25330435. doi: 10.1101/2025.07.10.25330435.</RefSource><PMID Version="1">40672503</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">myocardial perfusion imaging</Keyword><Keyword MajorTopicYN="N">quantitative analysis</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest &#x2612; The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Piotr Slomka reports financial support was provided by National Institutes of Health. Piotr Slomka reports a relationship with APQ Health Inc that includes: equity or stocks. Piotr Slomka reports a relationship with Synektik SA that includes: consulting or advisory. Piotr Slomka reports a relationship with Novo Nordisk that includes: consulting or advisory. RM received consulting fees from Pfizer and research support from Pfizer and Alberta Innovates. DB and PS participated in software royalties for QPS software at Cedars-Sinai Medical Center. DB, DD, and PS reported equity in APQ Health Inc. DB received research grant support from The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation and consulting fees from GE Healthcare. PS received research grant support from Siemens Medical Systems, and consulting fees from Synektik SA and Novo Nordisk. PC reported consulting for Clario. MDC reported consulting fees from MedTrace, Valo Health, GE, Bitterroot Bio, and IBA, investigator-initiated research support from Amgen, and institutional research grant support from Sun Pharma, Xylocor, Alnylam, and Intellia. AJE reported consulting for Artrya, authorship fees from Wolters Kluwer Healthcare&#x2014;UpToDate and serving on scientific advisory boards for Axcellant and Canon Medical Systems USA; his institution has grants/grants pending from Alexion, Attralus, BridgeBio, Canon Medical Systems USA, GE HealthCare, Intellia Therapeutics, International Atomic Energy Agency, Ionis Pharmaceuticals, National Institutes of Health, Pfizer, and Shockware Medical. RRSP serves as a consultant for GE HealthCare. RS reported being a consultant for GE Healthcare. MA-M received research support from Siemens and GE Healthcare and is a consultant to Jubilant, Medtrace, GE Healthcare, and Pfizer. LS received grant support/consulting honorarium from Amgen and Philips and served as site PI for V-INITIATE and Ocean(a) trials. The remaining authors declare no conflict of interest. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>19</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40774620</ArticleId><ArticleId IdType="doi">10.1016/j.nuclcard.2025.102449</ArticleId><ArticleId IdType="pii">S1071-3581(25)00323-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40615329</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence for electrocardiographic diagnosis of perioperative myocardial ischaemia: a scoping review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(25)00353-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2025.05.037</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative electrocardiographic monitoring can offer immediate detection of myocardial ischaemia, yet its application in perioperative and remote monitoring settings is hampered by frequent false alarms and signal contamination. We performed a scoping review for the current state of artificial intelligence (AI) in perioperative ECG interpretation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search in Ovid MEDLINE, EMBASE, Compendex, and CINAHL databases was performed from inception to May 10, 2023. All original research of ECG monitoring for myocardial ischaemia, myocardial infarction, or both was included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 182 original research articles published between 1991 and 2023 were included. Most studies (n=132) used a pre-existing ECG database to develop AI algorithms retrospectively, and the rest did not specify their sources. Processing filters were used in 58% of the studies to remove ECG noises/artifacts before AI algorithm development. Amongst the AI technologies used, ResNet demonstrated the highest median sensitivity, precision, and specificity at 98.4%, 99.8%, and 99.1%, respectively. There are only five studies with intermittent prospective ECG collection on ST-segment elevation myocardial infarction. No studies prospectively collected continuous ECG perioperatively, with frequent false alarms and signal contamination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AI technology can achieve high diagnostic accuracy for myocardial ischaemia detection in clean intermittent electrocardiograms. However, almost all these algorithms were developed from a few open-source clean ECG databases without testing on 'noisy data', which limited their clinical applicability in the perioperative setting where signal contamination is frequent. AI algorithms on perioperative electrocardiography, tested in a noisy perioperative and remote monitoring environment, including wearable devices, are needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iansavitchene</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London Health Science Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komeili</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Adrian D C</ForeName><Initials>ADC</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Homer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chui</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, University of Western Ontario, London, ON, Canada. Electronic address: Jason.chui@lhsc.on.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">myocardial ischaemia</Keyword><Keyword MajorTopicYN="N">remote home monitoring</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>4</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40615329</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2025.05.037</ArticleId><ArticleId IdType="pii">S0007-0912(25)00353-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40623633</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>438</Volume><PubDate><Year>2025</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Interpretable hybrid-ensemble acute myocardial infarction diagnosis with clinical transparency.</ArticleTitle><Pagination><StartPage>133598</StartPage><MedlinePgn>133598</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2025.133598</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(25)00641-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Single-algorithm machine learning models for acute myocardial infarction (AMI) often struggle with heterogeneous clinical data and lack transparency, limiting their clinical adoption.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We propose a novel interpretable hybrid-ensemble AMI diagnosis method with clinical transparency. Our method performs nested iteration and global hyperparameter optimization via data reuse, which can improve the generalizability of single-algorithms to a certain extent. By balance criterion between ensemble robustness and performance optimization, some improved pre-ensemble algorithms and optimal ensemble strategy are determined to coordinate multiple algorithms in constructing our hybrid-ensemble model. A game-theoretic marginal contribution analysis (GMCA) framework was established to quantify the feature contribution of prediction results in global and local levels&#xff0c;which can improve the interpretability and clinical transparency of our hybrid-ensemble model. Based on the framework, data-driven dimensionality reduction of clinical feature is performed, while ensuring clinical effectiveness through expert guided validation. Additionally, a series of extended experiments were conducted to further validate the adaptability and generalizability of our proposed method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our hybrid-ensemble model achieved 0.944 accuracy and 0.94&#xa0;F1-score in binary classification, outperforming single-algorithms. The GMCA framework identified six features, achieving dual optimization of data-driven selection and domain knowledge consistency. Extended experiments confirm the model's robust accuracy and generalizability across diverse configurations.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study presents a replicable method for developing transparent and clinically actionable AI systems in emergency cardiology. By harmonizing algorithmic diversity with interpretability, our hybrid-ensemble method not only enhances diagnostic accuracy but also fosters clinician trust.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yanmin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Joint Research Center for Occupational Medicine and Health of IHM, Anhui University of Science &amp; Technology, Huainan 232001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xian</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Computer Science and Engineering, Anhui University of Science &amp; Technology, Huainan, Anhui 232001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Shuzhi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Joint Research Center for Occupational Medicine and Health of IHM, Anhui University of Science &amp; Technology, Huainan 232001, China; The First Hospital, Anhui University of Science &amp; Technology, Huainan 232001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiao</LastName><ForeName>Zengyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, the Sixth People's Hospital South Campus, Shanghai Jiao Tong University School of Medicine, Shanghai 201400, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Mingquan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Anhui University of Science &amp; Technology, Huainan 232001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>KeXue</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>School of Computer Science and Engineering, Anhui University of Science &amp; Technology, Huainan, Anhui 232001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, Anhui University of Science &amp; Technology, Huainan 232001, China. Electronic address: daiyong22@aust.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">Ensemble learning</Keyword><Keyword MajorTopicYN="N">Feature importance analysis</Keyword><Keyword MajorTopicYN="N">Interpretable machine learning</Keyword><Keyword MajorTopicYN="N">Predictive cardiology</Keyword></KeywordList><CoiStatement>Declaration of competing interest We have nothing to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>18</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40623633</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2025.133598</ArticleId><ArticleId IdType="pii">S0167-5273(25)00641-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40624386</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1863-6713</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>General thoracic and cardiovascular surgery</Title><ISOAbbreviation>Gen Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>A new strategy for open surgery of giant aortoiliac aneurysms with preservation of the hypogastric artery.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11748-025-02179-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">We present a new approach for open surgical repair of giant aortoiliac (AI) aneurysms that prioritizes preservation of the hypogastric artery (HA). In cases where the aneurysm extends to the iliac bifurcation and involves both HAs, traditional open repair techniques often require an aortobifemoral bypass with HA exclusion, posing challenges for maintaining pelvic perfusion.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis of 10 patients treated between 07/2021 and 07/2023 was conducted. The aneurysms extended to both HA in all cases. Patients were followed up at 30-day and in 6-month intervals thereafter. A total of 10 HA revascularization procedures were performed in 10 patients undergoing open surgical AI aneurysms repair (9 men and 1 woman; median age 68 [65; 70]&#xa0;years). Six-mm polyester grafts were used for aortic tube graft to HA bypass in 10 cases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Successful open surgical repair of giant AI aneurysms, including those involving the iliac bifurcation, was achieved in all cases. There was one case of perioperative myocardial infarction with pulmonary edema. No instances of gluteal claudication, colon ischemia, or perineal ischemia were observed. Eight patients reported no change in sexual function, while one patient experienced a reduction in erectile function. One patient died in the ICU 2&#xa0;weeks postoperatively. During a follow-up period of 6-18&#xa0;months, graft patency was maintained in nine patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">An additional branch to the HA can reliably maintain pelvic circulation in the short to intermediate term, helping to prevent ischemia in patients requiring extended open surgical repair that involves both HAs.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to The Japanese Association for Thoracic Surgery.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piljic</LastName><ForeName>Dragan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4675-2633</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Clinical Center Tuzla, Trnovac bb, 75000, Tuzla, Bosnia and Herzegovina. dragan.piljic@dr.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sehic</LastName><ForeName>Nail</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Clinical Center Tuzla, Trnovac bb, 75000, Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ksela</LastName><ForeName>Jus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardicascular Surgery, University Clinical Center Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lescan</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, University Heart Center Freiburg-Bad Krozingen, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Gen Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>101303952</NlmUniqueID><ISSNLinking>1863-6705</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aneurysm</Keyword><Keyword MajorTopicYN="N">Hypogastric artery</Keyword><Keyword MajorTopicYN="N">Iliac</Keyword><Keyword MajorTopicYN="N">Open aneurysm repair</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: The authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40624386</ArticleId><ArticleId IdType="doi">10.1007/s11748-025-02179-2</ArticleId><ArticleId IdType="pii">10.1007/s11748-025-02179-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Czerny M, Grabenwoger M, Berger T, Aboyans V, Della Corte A, Chen EP, et al. EACTS/STS guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. Eur J Cardiothorac Surg. 2024;65:ezad426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezad426</ArticleId><ArticleId IdType="pubmed">38408364</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun JY, Mailli L, Abbasi MA, Belli AM, Gonsalves M, Munneke G, et al. Embolization of the internal iliac artery before evar: is it effective? Is it safe? Which technique should be used? Cardiovasc Intervent Radiol. 2014;37:329&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-013-0659-2</ArticleId><ArticleId IdType="pubmed">23771327</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonorden C, Shoura M, Andic M, Hahn JK, Mustafi M, Schlensak C, et al. Mid-term outcomes of a pre-cannulated iliac branched device in the treatment of abdominal aortoiliac aneurysms: a retrospective analysis from a single center. J Clin Med. 2023;12:6395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12196395</ArticleId><ArticleId IdType="pubmed">37835039</ArticleId><ArticleId IdType="pmc">10573636</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Oria M, Lima GBB, Dias N, Parlani G, Farber M, Tsilimparis N, et al. Outcomes of &#x201c;anterior versus posterior divisional branches of the hypogastric artery as distal landing zone for iliac branch devices&#x201d;: the international multicentric r3oyal registry. J Endovasc Ther. 2024;31:282&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15266028221120513</ArticleId><ArticleId IdType="pubmed">36113081</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A, Khan YS. Anatomy, abdomen and pelvis: arteries and veins. Treasure Islan: Statpearls; 2024.</Citation></Reference><Reference><Citation>Sfyroeras GS, Koutsias S, Karathanos C, Stamoulis K, Giannoukas AD. Colonic ischemia after endovascular exclusion of an aortoiliac aneurysm using an iliac branch device. Vasc Endovasc Surg. 2010;44:597&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1538574410369388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosanquet DC, Wilcox C, Whitehurst L, Cox A, Williams IM, Twine CP, et al. Systematic review and meta-analysis of the effect of internal iliac artery exclusion for patients undergoing evar. Eur J Vasc Endovasc Surg. 2017;53:534&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejvs.2017.01.009</ArticleId><ArticleId IdType="pubmed">28242154</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi M, Ceragioli S, Mocellin DM, Alberti A, Tomei F, Adami D, et al. Open surgical management of hypogastric artery during aortic surgery: ligate or not ligate? Ann Vasc Surg. 2015;29:780&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2014.12.025</ArticleId><ArticleId IdType="pubmed">25733215</ArticleId></ArticleIdList></Reference><Reference><Citation>King B, Rockman C, Han S, Siracuse JJ, Patel VI, Johnson WS, et al. Aortobifemoral reconstruction in open abdominal aortic aneurysm repair is associated with increased morbidity and mortality. J Vasc Surg. 2023;78(77&#x2013;88): e3.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40626266</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2047-2501</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Health information science and systems</Title><ISOAbbreviation>Health Inf Sci Syst</ISOAbbreviation></Journal><ArticleTitle>CnnBoost: a multilevel explainable stacked ensemble framework for effective detection of Myocardial Infarction from 12-lead ECG images using a transformational approach.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">40</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13755-025-00357-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Electrocardiogram (ECG) is the most commonly used non-invasive diagnostic tool for cardiovascular diseases. However, its interpretation requires significant expertise, which may not be available across all medical specializations. Automated detection of heart abnormalities can assist clinicians in making accurate and efficient diagnoses. This study aims to develop an explainable machine-learning framework for classifying myocardial infarction (MI) and other heart abnormalities using ECG images.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Publicly available ECG images from health centers in South Asia were used for this study. The dataset consists of four classes: Normal, Abnormal, Myocardial Infarction (MI), and Previous History of MI. The ECG images were preprocessed and transformed into time-series signals for efficient computation. These signals were then used to train an ensemble model, XGBoost, and a deep learning model, Convolutional Neural Network (CNN). To enhance learning of both spatial and temporal features, we proposed CNNBoost, a Multilevel Explainable Stacked Ensemble model where CNN-extracted spatial features were concatenated with time-series data and processed by XGBoost. SHapley Additive Explanations (SHAP) were used to identify diagnostically significant ECG leads, validated by a senior cardiologist.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The proposed framework achieved 99% accuracy, 98.58% AUC, and 96.47% AUPRC, demonstrating effective MI classification. The explainability component identified critical ECG leads, reinforcing model trustworthiness.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">By integrating deep learning and ensemble learning, our approach enhances ECG classification while ensuring clinical relevance. CNNBoost's ability to learn spatial and temporal features improves interpretability and decision support. Cardiologist validation confirms its potential for real-world healthcare applications, reducing misdiagnoses and aiding clinical decision-making.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Nature Switzerland AG 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashokan</LastName><ForeName>Pillai Lekshmi</ForeName><Initials>PL</Initials><Identifier Source="ORCID">0000-0002-9556-396X</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathya</LastName><ForeName>S Siva</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantari Nagar, Puducherry, 605006 India.</Affiliation><Identifier Source="ROR">https://ror.org/02fq2px14</Identifier><Identifier Source="GRID">grid.414953.e</Identifier><Identifier Source="ISNI">0000000417678301</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satheesh</LastName><ForeName>Santhosh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Inf Sci Syst</MedlineTA><NlmUniqueID>101638060</NlmUniqueID><ISSNLinking>2047-2501</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Convolutional neural network</Keyword><Keyword MajorTopicYN="N">ECG images</Keyword><Keyword MajorTopicYN="N">EXplainable AI (XAI)</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">SHAP</Keyword><Keyword MajorTopicYN="N">XGBoost</Keyword></KeywordList><CoiStatement>Conflict of interestThe authors have no Conflict of interest to declare that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40626266</ArticleId><ArticleId IdType="pmc">PMC12229351</ArticleId><ArticleId IdType="doi">10.1007/s13755-025-00357-3</ArticleId><ArticleId IdType="pii">357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tr&#xe4;g&#xe5;rdh E, Engblom H, Pahlm O. How many ecg leads do we need? Cardiol Clin. 2006;24(3):317&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16939826</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane P, Devine B, Clark E. The university of glasgow (uni-g) ecg analysis program. In: Computers in Cardiology, pp&#xa0;451&#x2013; 454; 2005. IEEE</Citation></Reference><Reference><Citation>Ojha N, Dhamoon AS. Myocardial Infarction. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2024. http://www.ncbi.nlm.nih.gov/books/NBK537076/ Accessed 2024-03-04</Citation></Reference><Reference><Citation>Kwok CS, Bennett S, Azam Z, Welsh V, Potluri R, Loke YK, Mallen CD. Misdiagnosis of acute myocardial infarction: a systematic review of the literature. Crit Pathw Cardiol. 2021;20(3):155&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">33606411</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AH, Hussain M, Malik MK. Ecg images dataset of cardiac and covid-19 patients. Data Brief. 2021;34:106762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820911</ArticleId><ArticleId IdType="pubmed">33521183</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubaker MB, Babayi&#x11f;it B. Detection of cardiovascular diseases in ecg images using machine learning and deep learning methods. IEEE Trans Artif Intell. 2022;4(2):373&#x2013;82.</Citation></Reference><Reference><Citation>Anand A, Kadian T, Shetty MK, Gupta A. Explainable ai decision model for ecg data of cardiac disorders. Biomed Signal Process Control. 2022;75:103584.</Citation></Reference><Reference><Citation>Goldberger AL, Goldberger ZD, Shvilkin A. ECG Leads. In: Goldberger&#x2019;s Clinical Electrocardiography, pp. 21&#x2013; 31. Elsevier, Amsterdam, 2018. 10.1016/B978-0-323-40169-2.00004-4. https://linkinghub.elsevier.com/retrieve/ pii/B9780323401692000044 Accessed 2024-03-01</Citation></Reference><Reference><Citation>Ashley EA, Niebauer J. Conquering the ecg. cardiology explained, 15&#x2013;33; 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">20821845</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Qu Q, Wang M, Yu L, Wang J, Shen L, He K. Deep learning for digitizing highly noisy paper-based ecg records. Comput Biol Med. 2020;127:104077.</Citation><ArticleIdList><ArticleId IdType="pubmed">33171291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S, Khatwani G, Patil R, Sapariya D, Shah V, Parmar D, Dinesh S, Daphal P, Mehendale N. Ecg paper record digitization and diagnosis using deep learning. J Med Biol Eng. 2021;41(4):422&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204064</ArticleId><ArticleId IdType="pubmed">34149335</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortune JD, Coppa NE, Haq KT, Patel H, Tereshchenko LG. Digitizing ecg image: a new method and open-source software code. Comput Methods Programs Biomed. 2022;221:106890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9286778</ArticleId><ArticleId IdType="pubmed">35598436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Patel KHK, Li X, Zhang B, Galazis C, Bajaj N, Sau A, Shi X, Sun L, Tao Y, et al. A fully-automated paper ecg digitisation algorithm using deep learning. Sci Rep. 2022;12(1):20963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9722713</ArticleId><ArticleId IdType="pubmed">36471089</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathail I, Bhagile VD. Ecg paper digitization and r peaks detection using fft. Appl Comput Intell Soft Comput. 2022;2022(1):1238864.</Citation></Reference><Reference><Citation>Hannun AY, Rajpurkar P, Haghpanahi M, Tison GH, Bourn C, Turakhia MP, Ng AY. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25(1):65&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6784839</ArticleId><ArticleId IdType="pubmed">30617320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro AH, Ribeiro MH, Paix&#xe3;o GM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MP, Andersson CR, Macfarlane PW, Meira W Jr, et al. Automatic diagnosis of the 12-lead ecg using a deep neural network. Nat Commun. 2020;11(1):1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145824</ArticleId><ArticleId IdType="pubmed">32273514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganeshkumar M, Ravi V, Sowmya V, Gopalakrishnan E, Soman K. Explainable deep learning-based approach for multilabel classification of electrocardiogram. IEEE Trans Eng Manag. 2021;70(8):2787&#x2013;99.</Citation></Reference><Reference><Citation>Sangha V, Mortazavi BJ, Haimovich AD, Ribeiro AH, Brandt CA, Jacoby DL, Schulz WL, Krumholz HM, Ribeiro ALP, Khera R. Automated multilabel diagnosis on electrocardiographic images and signals. Nat Commun. 2022;13(1):1583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948243</ArticleId><ArticleId IdType="pubmed">35332137</ArticleId></ArticleIdList></Reference><Reference><Citation>Le KH, Pham HH, Nguyen TB, Nguyen TA, Thanh TN, Do CD. Lightx3ecg: a lightweight and explainable deep learning system for 3-lead electrocardiogram classification. Biomed Signal Process Control. 2023;85:104963.</Citation></Reference><Reference><Citation>Han C, Sun J, Bian Y, Que W, Shi L. Automated detection and localization of myocardial infarction with interpretability analysis based on deep learning. IEEE Trans Instrum Meas. 2023;72:1&#x2013;12.</Citation></Reference><Reference><Citation>Qiang Y, Dong X, Yang Y. Automatic detection and localisation of myocardial infarction using multi-channel dense attention neural network. Biomed Signal Process Control. 2024;89:105766.</Citation></Reference><Reference><Citation>Alamatsaz N, Tabatabaei L, Yazdchi M, Payan H, Alamatsaz N, Nasimi F. A lightweight hybrid cnn-lstm explainable model for ecg-based arrhythmia detection. Biomed Signal Process Control. 2024;90:105884.</Citation></Reference><Reference><Citation>Abagaro AM, Barki H, Ayana G, Dawud AA, Thamineni BL, Jemal T, Choe S-W. Automated ecg signals analysis for cardiac abnormality detection and classification. J Electr Eng Technol. 2024;19(5):3353&#x2013;71.</Citation></Reference><Reference><Citation>Saha A, Bristy EJ, Islam MR, Afzal R, Ridita SA et al. Lime-based explainable ai models for predicting disease from patient&#x2019;s symptoms. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013;6; 2023. IEEE</Citation></Reference><Reference><Citation>Sanim MS, Hasan KM, et al. Identification of covid-19 from other upper respiratory tract infections using random undersampling and lime-based xai model. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Akhtar M, Ahmed KA, et al. An improved prediction of polycystic ovary syndrome using smote-based oversampling and stacking classifier. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Robbani R, Alam MM, Sanim MS, Hasan KM. Adaseml: Hospitalization period prediction of covid-19 patients using adasyn and stacking based ensemble learning. In: International Conference on Advanced Network Technologies and Intelligent Computing, pp&#xa0;3&#x2013;15; 2022. Springer</Citation></Reference><Reference><Citation>Xiong P, Lee SM-Y, Chan G. Deep learning for detecting and locating myocardial infarction by electrocardiogram: A literature review. Front Cardiovasc Med. 2022;9:860032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990170</ArticleId><ArticleId IdType="pubmed">35402563</ArticleId></ArticleIdList></Reference><Reference><Citation>Denysyuk HV, Pinto RJ, Silva PM, Duarte RP, Marinho FA, Pimenta L, Gouveia AJ, Gon&#xe7;alves NJ, Coelho PJ, Zdravevski E, et al. Algorithms for automated diagnosis of cardiovascular diseases based on ecg data: a comprehensive systematic review. Heliyon. 2023;9(2):e13601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9958295</ArticleId><ArticleId IdType="pubmed">36852052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodner E, Simon M, Fisher RB, Denzler J. Fine-grained recognition in the noisy wild: Sensitivity analysis of convolutional neural networks approaches; 2016. arXiv preprint arXiv:1610.06756</Citation></Reference><Reference><Citation>Grinsztajn L, Oyallon E, Varoquaux G. Why do tree-based models still outperform deep learning on typical tabular data? Adv Neural Inf Process Syst. 2022;35:507&#x2013;20.</Citation></Reference><Reference><Citation>Ashokan PL, Sathya SS. Comparing tree-based ensemble machine learning models and convolutional neural network for automatic classification of heart abnormalities from ecg images. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Anwar T, Zakir S. Effect of image augmentation on ecg image classification using deep learning. In: 2021 International Conference on Artificial Intelligence (ICAI), pp. 182&#x2013;186; 2021. IEEE</Citation></Reference><Reference><Citation>Meek S, Morris F. Introduction. i&#x2013;leads, rate, rhythm, and cardiac axis. BMJ. 2002;324(7334):415&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1122339</ArticleId><ArticleId IdType="pubmed">11850377</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AH, Hussain M, Malik MK. Cardiac disorder classification by electrocardiogram sensing using deep neural network. Complexity. 2021;2021:1&#x2013;8.</Citation></Reference><Reference><Citation>Goldberger AL, Goldberger ZD, Shvilkin A. Chapter 4&#x2014;ecg leads. In: Goldberger AL, Goldberger ZD, Shvilkin A (eds) Goldberger&#x2019;s clinical electrocardiography, 9th Edn, pp. 21&#x2013; 31. Elsevier, Amsterdam (2018). 10.1016/B978-0-323-40169-2.00004-4 . https://www.sciencedirect.com/science/article/pii/B9780323401692000044</Citation></Reference><Reference><Citation>Leong LH, Yap YC, Lo ZZ. Importance of lead avl in the diagnosis of inferior wall myocardial infarction: A case report. Malaysn Fam Phys. 2023;18:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337600</ArticleId><ArticleId IdType="pubmed">37449275</ArticleId></ArticleIdList></Reference><Reference><Citation>George A, Arumugham PS, Figueredo VM. avr-the forgotten lead. Exp Clin Cardiol. 2010;15(2):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898534</ArticleId><ArticleId IdType="pubmed">20631863</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40646014</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Congo red fluorescence enhances digital pathology workflow in cardiac amyloidosis.</ArticleTitle><Pagination><StartPage>25089</StartPage><MedlinePgn>25089</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25089</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-07157-5</ELocationID><Abstract><AbstractText>Despite advances in non-invasive methods, endomyocardial biopsy (EMB) remains essential for definitive diagnosis of amyloidosis in many cases. Traditionally, Congo red birefringence (CRB) has been crucial for identifying amyloid deposits but is challenging to capture digitally. Emerging fluorescent Congo red imaging (CRF) overcomes this problem and holds promise in image analysis and AI applications. The diagnostic performance of CRF on virtual slides was evaluated in a cohort of EMB and autopsy cases. The feasibility of developing AI algorithms applicable to centers lacking a fluorescence scanner was investigated leveraging a computational pipeline that enables fluorescence outcome visualization in brightfield.&#xa0;The study analyzed 43 digital myocardial slides stained with Congo Red, acquired using a fluorescent Texas Red filter. Among these, 28 (65%) were diagnosed with amyloidosis, with complete diagnostic agreement with original diagnosis. AI achieved an AUC-ROC of 0.87, 0.86 and 0.79 on the training, validation and test set, respectively, in tile-level classification for amyloidosis positivity and IoU and Dice scores indicating partial but reasonable overlap between predictions and ground truth in amyloid segmentation. The study underscores CRF's transformative impact on virtual slides and AI integration for diagnosing cardiac amyloidosis, showcasing high reliability and diagnostic accuracy. These advancements promise a more quantitative and precise approach, facilitating the histological study of the disease in the digital transition era of pathology labs.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cazzaniga</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5373-0611</Identifier><AffiliationInfo><Affiliation>Pathology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Gaspari</LastName><ForeName>Monica</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9528-4883</Identifier><AffiliationInfo><Affiliation>Cardiovascular Pathology Unit, Azienda Ospedaliera, Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L'Imperio</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-9284-2998</Identifier><AffiliationInfo><Affiliation>Pathology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beretta</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-9008-9317</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, ASST Papa Giovanni XXIII, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pathology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizzo</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-5969-4412</Identifier><AffiliationInfo><Affiliation>Cardiovascular Pathology Unit, Azienda Ospedaliera, Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basso</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0195-9753</Identifier><AffiliationInfo><Affiliation>Cardiovascular Pathology Unit, Azienda Ospedaliera, Department of Cardiac, Thoracic, and Vascular Sciences and Public Health, University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pagni</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-9625-1637</Identifier><AffiliationInfo><Affiliation>Pathology, IRCCS Fondazione San Gerardo dei Tintori, Monza, Italy. fabio.pagni@unimib.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy. fabio.pagni@unimib.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, Pathology IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Monza, Italy. fabio.pagni@unimib.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BIRD 240154</GrantID><Agency>Universit&#xe0; degli Studi di Padova</Agency><Country/></Grant><Grant><GrantID>Dipartimenti di Eccellenza 2023-2027 (l. 232/2016, art. 1, commi 314 - 337)</GrantID><Agency>Ministero dell'Universit&#xe0; e della Ricerca</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3U05FHG59S</RegistryNumber><NameOfSubstance UI="D003224">Congo Red</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003224" MajorTopicYN="Y">Congo Red</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="Y">Amyloidosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="N">Workflow</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005453" MajorTopicYN="N">Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061848" MajorTopicYN="Y">Optical Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">Cardiovascular pathology</Keyword><Keyword MajorTopicYN="N">Congo red</Keyword><Keyword MajorTopicYN="N">Digital pathology</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests. Ethics approval: Approval was obtained from the PNRR-MR1-2022-12375735, 03/16/23 (Fondazione IRCCS San Gerardo dei Tintori) and from the 280n/AO/22 (Azienda Ospedaliera di Padova) ethics committee. The study was conducted in compliance with the Declaration of Helsinki. All data were fully anonymized and informed consent was waived by the Fondazione IRCCS San Gerardo dei Tintori (PNRR-MR1-2022-12375735) and Azienda Ospedaliera di Padova (280n/AO/22) ethics committe in accordance with applicable ethical guidelines.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>16</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>23</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40646014</ArticleId><ArticleId IdType="pmc">PMC12254226</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-07157-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-07157-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garcia-Pavia, P. et al. 2021 diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. <i>Eur. Heart J.</i><b>42</b>(16) 1554&#x2013;1568. 10.1093/eurheartj/ehab072</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060056</ArticleId><ArticleId IdType="pubmed">33825853</ArticleId></ArticleIdList></Reference><Reference><Citation>Papingiotis&#x2019; [ &#x2019;georgios. Basmpana&#x2019; &#x2019;lamprini, Farmakis&#x2019;] &#x2019;dimitrios. Cardiac amyloidosis: epidemiology, diagnosis and therapy [Internet]. [cited 2024 Mar 10]. Available from: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-19/cardiac-amyloidosis-epidemiology-diagnosis-and-therapy</Citation></Reference><Reference><Citation>Palladini, G. &amp; Merlini, G. What is new in diagnosis and management of light chain amyloidosis? <i>Blood</i><b>128</b> (2), 159&#x2013;168. 10.1182/blood-2016-01-629790 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">27053535</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer, M. S., Elliott, P., Comenzo, R., Semigran, M. &amp; Rapezzi, C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. <i>Circulation</i><b>135</b> (14), 1357&#x2013;1377. 10.1161/CIRCULATIONAHA.116.024438 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5392416</ArticleId><ArticleId IdType="pubmed">28373528</ArticleId></ArticleIdList></Reference><Reference><Citation>Glass, C. et al. 2022 the role of machine learning in cardiovascular pathology. <i>Can. J. Cardiol.</i><b>38</b>(2) 234&#x2013;245. 10.1016/j.cjca.2021.11.008</Citation><ArticleIdList><ArticleId IdType="pubmed">34813876</ArticleId></ArticleIdList></Reference><Reference><Citation>Kveton, M. et al. Digital pathology in cardiac transplant diagnostics: from biopsies to algorithms. <i>Cardiovasc. Pathol.</i><b>68</b>, 107587. 10.1016/j.carpath.2023.107587 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37926351</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzaniga, G. et al.Congo red staining in digital pathology: the streamlined pipeline for amyloid detection through congo red fluorescence digital analysis. <i>Lab. Invest.</i><b>103</b> 100243. 10.1016/j.labinv.2023.100243</Citation><ArticleIdList><ArticleId IdType="pubmed">37634845</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gaspari, M., Finato, N. &amp; Basso, C. Cardiac amyloidosis: the pathologist&#x2019;s point of view. Vessel Plus. 6 57. (2022). Available from: https://www.oaepublish.com/articles/2574-1209.2022.05</Citation></Reference><Reference><Citation>L&#x2019;Imperio, V. et al. Improvements in digital pathology equipment for renal biopsies: updating the standard model. <i>J. Nephrol.</i><b>37</b>(1) 221&#x2013;229. 10.1007/s40620-023-01568-1 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">36786977</ArticleId></ArticleIdList></Reference><Reference><Citation>Adrogue, H. E. Amyloidosis of the heart and kidney. <i>Methodist Debakey Cardiovasc. J.</i><b>18</b> (4), 27&#x2013;33. 10.14797/mdcvj.1150 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9461691</ArticleId><ArticleId IdType="pubmed">36132587</ArticleId></ArticleIdList></Reference><Reference><Citation>Frag&#xe3;o-Marques, M. &amp; Ozben, T. Digital transformation and sustainability in healthcare and clinical laboratories. <i>Clin. Chem. Lab. Med.</i><b>28 61</b> (4), 627&#x2013;633. (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36473150</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee, S. S. et al. Optical spectroscopic detection and typing of cardiac amyloidosis. <i>Circulation</i><b>150</b>(16) 1299&#x2013;1301. 10.1161/CIRCULATIONAHA.124.069554 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11486296</ArticleId><ArticleId IdType="pubmed">39401277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. <i>Sci. Rep.</i><b>7</b> (1), 16878. 10.1038/s41598-017-17204-5 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5715110</ArticleId><ArticleId IdType="pubmed">29203879</ArticleId></ArticleIdList></Reference><Reference><Citation>Brailovsky, Y., Rajapreyar, I. &amp; Alvarez, R. TTR amyloidosis: current state of affairs and promise for the future. <i>JACC Case Rep. Doi</i><b>10</b> 101759. 10.1016/j.jaccas.2023.101759 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10039388</ArticleId><ArticleId IdType="pubmed">36974058</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto, H. &amp; Yokochi, T. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. <i>ESC Heart Fail.</i><b>6</b> (6), 1128&#x2013;1139. 10.1002/ehf2.12518 (2019).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6989279</ArticleId><ArticleId IdType="pubmed">31553132</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern, L. K. &amp; Patel, J. Cardiac amyloidosis treatment. <i>Methodist Debakey Cardiovasc. J.</i><b>18</b> (2), 59&#x2013;72. 10.14797/mdcvj.1050 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8932359</ArticleId><ArticleId IdType="pubmed">35414852</ArticleId></ArticleIdList></Reference><Reference><Citation>Banypersad, S. M. The evolving role of cardiovascular Magnetic resonance imaging in the evaluation of systemic amyloidosis.<i> Magn reson insights.</i><b> 12 </b>1178623X19843519. (2019). 10.1177/1178623X19843519</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6495435</ArticleId><ArticleId IdType="pubmed">31068754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillmore, J. D. et al. 2016 nonbiopsy diagnosis of cardiac transthyretin amyloidosis. <i>Circulation</i><b>133</b>(24) 2404&#x2013;2412. 10.1161/CIRCULATIONAHA.116.021612</Citation><ArticleIdList><ArticleId IdType="pubmed">27143678</ArticleId></ArticleIdList></Reference><Reference><Citation>Razvi, Y., Patel, R. K., Fontana, M. &amp; Gillmore, J. D. Cardiac amyloidosis: a review of current imaging techniques. <i>Front. Cardiovasc. Med.</i><b>8</b>, 751293. 10.3389/fcvm.2021.751293 (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8702802</ArticleId><ArticleId IdType="pubmed">34957240</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownrigg, J., Lorenzini, M., Lumley, M. &amp; Elliott, P. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis. <i>ESC Heart Fail.</i><b>6</b> (5), 1041&#x2013;1051. 10.1002/ehf2.12511 (2019).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6816075</ArticleId><ArticleId IdType="pubmed">31487121</ArticleId></ArticleIdList></Reference><Reference><Citation>Briasoulis, A. et al. 2023 invasive and non-invasive diagnostic pathways in the diagnosis of cardiac amyloidosis. <i>J. Cardiovasc. Dev. Dis.</i>10.3390/jcdd10060256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10299430</ArticleId><ArticleId IdType="pubmed">37367421</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelini, A. et al. Cardiac amyloidosis: a review of the literature and a practical approach for the clinicians. <i>Ital. J. Med.</i><b>13</b>(2) 73&#x2013;90 (2019).</Citation></Reference><Reference><Citation>Kiran, N. et al.Digital pathology: transforming diagnosis in the digital age. <i>Cureus</i><b>15</b>(9) e44620. 10.7759/cureus.44620(2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10547926</ArticleId><ArticleId IdType="pubmed">37799211</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, A. S., Calkins, E. &amp; Levene, C. I. Studies on experimental amyloidosis. I. Analysis of histology and staining reactions of casein-induced amyloidosis in the rabbit. <i>Am. J. Pathol.</i><b>35</b> (5), 971&#x2013;989 (1959).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1934842</ArticleId><ArticleId IdType="pubmed">13810917</ArticleId></ArticleIdList></Reference><Reference><Citation>Laury, A. R. et al. Opening the black box: Spatial transcriptomics and the relevance of artificial intelligence-detected prognostic regions in high-grade serous carcinoma. <i>Mod. Pathol.</i><b>37</b>(7) 100508 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38704029</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H., L&#x2019;Imperio, V., Rossi, M., Kapp, M. E. &amp; Paueksakon, P. Differences between &#x3ba; and &#x3bb; light chain amyloidosis analyzed by a pathologic scoring system. <i>Am. J. Clin. Pathol.</i><b>160</b> (2), 144&#x2013;149. 10.1093/ajcp/aqad017 (2023).
</Citation><ArticleIdList><ArticleId IdType="pubmed">36933186</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee, Kittleson, M. M. et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: A report of the American college of cardiology solution set oversight committee. <i>J. Am. Coll. Cardiol.</i><b>81</b>(11) 1076&#x2013;1126. 10.1016/j.jacc.2022.11.022</Citation><ArticleIdList><ArticleId IdType="pubmed">36697326</ArticleId></ArticleIdList></Reference><Reference><Citation>Girych, M. et al. Combined thioflavin T-Congo red fluorescence assay for amyloid fibril detection. <i>Methods Appl. Fluoresc</i>. <b>4</b> (3), 034010. 10.1088/2050-6120/4/3/034010 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">28355156</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, A. J. et al. Validating whole slide imaging systems for diagnostic purposes in pathology. <i>Arch. Pathol. Lab. Med.</i><b>146</b> (4), 440&#x2013;450 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34003251</ArticleId></ArticleIdList></Reference><Reference><Citation>Howie, A. J. Origins of a pervasive, erroneous idea: the green birefringence of congo red-stained amyloid. <i>Int. J. Exp. Pathol.</i><b>100</b> (4), 208&#x2013;221. 10.1111/iep.12330 (2019).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6877999</ArticleId><ArticleId IdType="pubmed">31515863</ArticleId></ArticleIdList></Reference><Reference><Citation>Howie, A. J., Brewer, D. B., Howell, D. &amp; Jones, A. P. Physical basis of colors seen in congo red-stained amyloid in polarized light. <i>Lab. Invest.</i><b>88</b> (3), 232&#x2013;242. 10.1038/labinvest.3700714 (2008).
</Citation><ArticleIdList><ArticleId IdType="pubmed">18166974</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana, R., Uversky, V. N., Nielsen, L. &amp; Fink, A. L. Is congo red an amyloid-specific dye? <i>J. Biol. Chem.</i><b>276</b> (25), 22715&#x2013;22721 (2001).
</Citation><ArticleIdList><ArticleId IdType="pubmed">11410601</ArticleId></ArticleIdList></Reference><Reference><Citation>Linke, R. P. Highly sensitive diagnosis of amyloid and various amyloid syndromes using congo red fluorescence. <i>Virchows Arch.</i><b>436</b> (5), 439&#x2013;448. 10.1007/s004280050471 (2000).
</Citation><ArticleIdList><ArticleId IdType="pubmed">10881737</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleszewski, J. J. Cardiac amyloidosis: pathology, nomenclature, and typing. <i>Cardiovasc. Pathol.</i><b>24</b> (6), 343&#x2013;350 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">26361138</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerance, A., Slavin, G. &amp; McWatt, J. Experience with the sodium sulphate-Alcian blue stain for amyloid in cardiac pathology. <i>J. Clin. Pathol.</i><b>29</b> (1), 22&#x2013;26 (1976).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC475937</ArticleId><ArticleId IdType="pubmed">55419</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen, B. T. et al. Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases. <i>Histopathology</i><b>68</b>(5) 648&#x2013;656 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26212778</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty, T. B., Li, C. Y., Edwards, W. D. &amp; Suman, V. J. Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. <i>Cardiovasc. Pathol.</i><b>4</b> (1), 39&#x2013;42 (1995).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25850778</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gaspari, M. et al. Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient. <i>Eur. Heart J. Cardiovasc. Imaging</i>. <b>24</b> (9), 1258&#x2013;1268 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10445246</ArticleId><ArticleId IdType="pubmed">37191052</ArticleId></ArticleIdList></Reference><Reference><Citation>Neben-Wittich, M. A. et al.Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. <i>Am. J. Med.</i><b>118</b>(11) 1287 ( 2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16271914</ArticleId></ArticleIdList></Reference><Reference><Citation>De Michieli, L. et al. Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance. <i>Int. J. Cardiol.</i><b>389</b>(131204) 131204 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37481000</ArticleId></ArticleIdList></Reference><Reference><Citation>Bindi, G. et al. Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies. <i>J. Clin. Pathol.</i><b>77</b> (6), 402&#x2013;410 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">36813560</ArticleId></ArticleIdList></Reference><Reference><Citation>Riefolo, M., Conti, M., Longhi, S., Fabbrizio, B. &amp; Leone, O. Amyloidosis: what does pathology offer? The evolving field of tissue biopsy. <i>Front. Cardiovasc. Med.</i><b>9</b>, 1081098. 10.3389/fcvm.2022.1081098 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9760761</ArticleId><ArticleId IdType="pubmed">36545023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, X. et al. Virtual birefringence imaging and histological staining of amyloid deposits in label-free tissue using autofluorescence microscopy and deep learning. <i>Nat. Commun.</i><b>15</b>(1) 7978 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11393327</ArticleId><ArticleId IdType="pubmed">39266547</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40631729</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>09</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ehaf387</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehaf387</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS">Accurate differentiation of cardiac amyloidosis (CA) from phenotypic mimics remains challenging using current clinical and echocardiographic techniques. The accuracy of a novel artificial intelligence (AI) screening algorithm for echocardiography-based CA detection was assessed.</AbstractText><AbstractText Label="METHODS">Utilizing a multisite, multiethnic dataset (n = 2612, 52% CA), a convolutional neural network was trained to differentiate CA from phenotypic controls using transthoracic apical four-chamber video clips. External validation was conducted globally across 18 sites including 597 CA cases and 2122 controls. Classification accuracy was assessed on the entire external validation dataset, and subgroup analyses were performed both on technetium pyrophosphate scintigraphy referrals, and individuals matched for age, sex, and wall thickness. Model accuracy was also compared with the transthyretin CA score and the increased wall thickness score within a subset of older heart failure with preserved ejection fraction patients with increased wall thickness.</AbstractText><AbstractText Label="RESULTS">Cardiac amyloidosis patients and controls displayed similar age, sex, race, and comorbidities. After the removal of uncertain AI predictions (13%), model discrimination and classification were excellent for the entire external validation dataset [area under the receiver operating characteristic curve (AUROC) 0.93, sensitivity 85%, specificity 93%], irrespective of CA subtype (sensitivity: light-chain = 84%, wild-type transthyretin = 85%, and hereditary transthyretin = 86%). Performance was maintained in subgroup analysis in patients clinically referred for technetium pyrophosphate scintigraphy imaging (AUROC 0.86, sensitivity 77%, specificity 86%) and matched patients (AUROC 0.92, sensitivity 84%, specificity 91%). The AI model (AUROC 0.93) also outperformed transthyretin CA score (AUROC 0.73) and increased wall thickness (AUROC 0.80) scores.</AbstractText><AbstractText Label="CONCLUSIONS">This AI screening model-using only an apical four-chamber view-effectively differentiated CA from other causes of increased left ventricular wall thickness.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Slivnick</LastName><ForeName>Jeremy A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hawkes</LastName><ForeName>Will</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliveira</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodward</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akerman</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamza</LastName><ForeName>Izhan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Viral K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrett-O'Keefe</LastName><ForeName>Zachary</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grogan</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dispenzieri</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0003-1340-0647</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davison</LastName><ForeName>Halley N</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotella</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurer</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Columbia University, 622 West 168th Street, PH12-134, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helmke</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Columbia University, 622 West 168th Street, PH12-134, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherrer-Crosbie</LastName><ForeName>Marielle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Pennsylvania, Hospital of the University of Pennsylvania, Room 11-131, 11th Floor South Pavilion, 3400 Civic Center Blvd., Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soltani</LastName><ForeName>Marwa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Pennsylvania, Hospital of the University of Pennsylvania, Room 11-131, 11th Floor South Pavilion, 3400 Civic Center Blvd., Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Akash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Ohio State University, 473 W. 12th Ave, Suite 200, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zareba</LastName><ForeName>Karolina M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Ohio State University, 473 W. 12th Ave, Suite 200, Columbus, OH 43210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Richard K</ForeName><Initials>RK</Initials><Identifier Source="ORCID">0000-0001-5994-5998</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of Washington, 1959 NE Pacific Street, Box 356422, Seattle, WA 98195-6422, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>James N</ForeName><Initials>JN</Initials><Identifier Source="ORCID">0000-0003-0877-7618</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of Washington, 1959 NE Pacific Street, Box 356422, Seattle, WA 98195-6422, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitano</LastName><ForeName>Tetsuji</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital of University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeuchi</LastName><ForeName>Masaaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital of University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hotta</LastName><ForeName>Viviane Tiemi</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Clinical Unity of Cardiomyopathies, Heart Institute (InCor), Av. Dr. En&#xe9;as Carvalho de Aguiar, 44, Cerqueira Cezar, Sao Paolo CEP: 05403/000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos Vieira</LastName><ForeName>Marcelo Luiz</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Clinical Unity of Cardiomyopathies, Heart Institute (InCor), Av. Dr. En&#xe9;as Carvalho de Aguiar, 44, Cerqueira Cezar, Sao Paolo CEP: 05403/000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elissamburu</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Imaging, ICBA, Blanco Encalada 1543 street - C1428DCO, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronderos</LastName><ForeName>Ricardo E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Imaging, ICBA, Blanco Encalada 1543 street - C1428DCO, CABA, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Centro Privado de Cardiolog&#xed;a, Virgen De La Merced 550, Tucuman, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutroumpakis</LastName><ForeName>Efstratios</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6757-6480</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 1451, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deswal</LastName><ForeName>Anita</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6147-9591</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 1451, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pursnani</LastName><ForeName>Amit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5616-8839</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Endeavor Health - NorthShore Cardiovascular Institute, Walgreen Building 3rd Floor, 2650 Ridge Ave, Evanston, IL 60201, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarswat</LastName><ForeName>Nitasha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Amit R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, University of Virginia Medical Center, 1215 Lee Street, PO Box Charlottesville, VA 800158, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addetia</LastName><ForeName>Karima</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruberg</LastName><ForeName>Frederick L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Boston University Chobanian &amp; Avedisian School of Medicine, 821 Collamore Building, 72 East Concord Street, Boston, MA 02118-2308, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randazzo</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asch</LastName><ForeName>Federico M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Core Labs, MedStar Health Research Institute, 100 Irving St NW, Ste EB5123, Washington, DC 20010, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Driscoll</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Diabetes Research Centre, College of Life Sciences, University of Leicester, Gwendolen Road, Leicester LE5 4PW, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Roub</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Richard A. and Susan F. SmithCenter for Outcomes Research in Cardiology, MASCO 4375 Longwood Ave., Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strom</LastName><ForeName>Jordan B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Richard A. and Susan F. SmithCenter for Outcomes Research in Cardiology, MASCO 4375 Longwood Ave., Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kidd</LastName><ForeName>Liam</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Brigham &amp; Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuddy</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Brigham &amp; Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Upton</LastName><ForeName>Ross</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Ultromics, Ltd., Cascade Way, Oxford Business Park, Oxford, OX4 2SU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lang</LastName><ForeName>Roberto M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>University of Chicago, Chicago, IL, 5758 South Maryland Avenue, M.C. 9067, Chicago, IL 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellikka</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0001-6800-3521</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Ultromics</Agency><Country/></Grant><Grant><Agency>Mayo Clinic</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyloid</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40631729</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaf387</ArticleId><ArticleId IdType="pii">8193027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40572638</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence Performance in Cardiac Magnetic Resonance Strain Analysis for Aortic Stenosis: Validation with Echocardiography and Healthy Controls.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">950</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina61060950</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: Aortic stenosis (AS) leads to progressive left ventricular (LV) dysfunction, making early detection crucial. Global longitudinal strain (GLS) is an echocardiographic marker of subclinical LV dysfunction; however, echocardiography has limitations, including operator dependency and acoustic variability. Cardiac magnetic resonance (CMR) is a valuable complementary tool, and artificial intelligence (AI) may enhance strain measurement accuracy, though its role in AS remains underexplored. To evaluate the performance of an AI-based CMR feature tracking tool for the assessment of LV global and segmental GLS in AS patients and compare results with the respective measurements from healthy volunteers (control group), as well as with the GLS obtained using the echocardiographic speckle tracking technique. <i>Materials and Methods</i>: This retrospective study analysed 111 CMR exams (70 AS patients, 41 healthy controls) from a single centre. AI-derived GLS values from gradient echo 2-, 3-, and 4-chamber CMR views were manually reviewed for accuracy. Error rates, segmental, and global myocardial strain differences were assessed between AS patients and the control group. <i>Results</i>: AI-based CMR GLS strongly correlated with echocardiographic GLS (r = 0.694, <i>p</i> &lt; 0.001) and showed lower variability. The AI-derived GLS from CMR was significantly lower in aortic stenosis patients compared to controls (-17.86 &#xb1; 3.47 vs. -20.70 &#xb1; 1.98). However, AI-based strain analysis had an overall error rate of 6%, which was significantly higher in AS patients (18.6%) compared to healthy controls (2.44%) (<i>p</i> = 0.0088). The 3-chamber CMR view was the most error-prone (50% of isolated errors). Segmental strain variability between AS patients and controls was most pronounced in basal segments, with smaller differences in middle and apical segments. CMR demonstrated greater precision than echocardiography, as indicated by a smaller standard deviation in GLS measurements (3.47 vs. 4.98). <i>Conclusions</i>: The AI-based CMR feature tracking technique provides accurate and reproducible GLS measurements, showing strong agreement with echocardiographic speckle tracking-based GLS. However, the higher error rates in AS patients compared to controls underscore the need for more advanced AI algorithms to improve performance in cardiac pathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abramikas</LastName><ForeName>&#x17d;ygimantas</ForeName><Initials>&#x17d;</Initials><Identifier Source="ORCID">0000-0003-3579-7913</Identifier><AffiliationInfo><Affiliation>Clinic of Cardiovascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jasiukevi&#x10d;i&#x16b;t&#x117;</LastName><ForeName>Ieva</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bal&#x10d;i&#x16b;nait&#x117;</LastName><ForeName>Giedr&#x117;</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Clinic of Cardiovascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glaveckait&#x117;</LastName><ForeName>Sigita</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5291-9954</Identifier><AffiliationInfo><Affiliation>Clinic of Cardiovascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palionis</LastName><ForeName>Darius</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital Santaros Klinikos, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valevi&#x10d;ien&#x117;</LastName><ForeName>Nomeda</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Vilnius University Hospital Santaros Klinikos, LT-03101 Vilnius, Lithuania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="N">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aortic stenosis</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiac MRI</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">global longitudinal strain</Keyword><Keyword MajorTopicYN="N">myocardial strain</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40572638</ArticleId><ArticleId IdType="pmc">PMC12194916</ArticleId><ArticleId IdType="doi">10.3390/medicina61060950</ArticleId><ArticleId IdType="pii">medicina61060950</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eveborn G.W., Schirmer H., Heggelund G., Lunde P., Rasmussen K. The Evolving Epidemiology of Valvular Aortic Stenosis. The Troms&#xf8; Study. Heart. 2013;99:396&#x2013;400. doi: 10.1136/heartjnl-2012-302265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-302265</ArticleId><ArticleId IdType="pubmed">22942293</ArticleId></ArticleIdList></Reference><Reference><Citation>Iung B., Vahanian A. Epidemiology of Acquired Valvular Heart Disease. Can. J. Cardiol. 2014;30:962&#x2013;970. doi: 10.1016/j.cjca.2014.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2014.03.022</ArticleId><ArticleId IdType="pubmed">24986049</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph J., Naqvi S.Y., Giri J., Goldberg S. Aortic Stenosis: Pathophysiology, Diagnosis, and Therapy. Am. J. Med. 2017;130:253&#x2013;263. doi: 10.1016/j.amjmed.2016.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2016.10.005</ArticleId><ArticleId IdType="pubmed">27810479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakkar M., Bryan A.J., Angelini G.D. Aortic Stenosis: Diagnosis and Management. BMJ. 2016;355:i5425. doi: 10.1136/bmj.i5425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5425</ArticleId><ArticleId IdType="pubmed">27760734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Majmundar M., Doshi R., Kansara T., Shariff M., Shah P., Adalja D., Gullapalli N., Vallabhajosyula S., Panaich S.S., et al. Meta-Analysis of Early Intervention Versus Conservative Management for Asymptomatic Severe Aortic Stenosis. Am. J. Cardiol. 2021;138:85&#x2013;91. doi: 10.1016/j.amjcard.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.10.013</ArticleId><ArticleId IdType="pubmed">33065088</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., Capodanno D., Conradi L., De Bonis M., De Paulis R., et al. 2021 ESC/EACTS Guidelines for the Management of Valvular Heart Disease: Developed by the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Rev. Esp. Cardiol. 2022;75:524. doi: 10.1016/j.rec.2022.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2022.05.006</ArticleId><ArticleId IdType="pubmed">35636831</ArticleId></ArticleIdList></Reference><Reference><Citation>Repanas T.I., Papanastasiou C.A., Efthimiadis G.K., Fragkakis N., Sachpekidis V., Klein R.M., Karvounis H., Karamitsos T.D. Cardiovascular Magnetic Resonance as a Complementary Method to Transthoracic Echocardiography for Aortic Valve Area Estimation in Patients with Aortic Stenosis: A Systematic Review and Meta-Analysis. Hell. J. Cardiol. 2021;62:107&#x2013;111. doi: 10.1016/j.hjc.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hjc.2020.05.008</ArticleId><ArticleId IdType="pubmed">32535246</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah S.M., Shah J., Lakey S.M., Garg P., Ripley D.P. Pathophysiology, Emerging Techniques for the Assessment and Novel Treatment of Aortic Stenosis. Open Heart. 2023;10:e002244. doi: 10.1136/openhrt-2022-002244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2022-002244</ArticleId><ArticleId IdType="pmc">PMC10040005</ArticleId><ArticleId IdType="pubmed">36963766</ArticleId></ArticleIdList></Reference><Reference><Citation>Villegas-Martinez M., De Villedon De Naide V., Muthurangu V., Bustin A. The Beating Heart: Artificial Intelligence for Cardiovascular Application in the Clinic. Magn. Reson. Mater. Phys. Biol. Med. 2024;37:369&#x2013;382. doi: 10.1007/s10334-024-01180-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10334-024-01180-9</ArticleId><ArticleId IdType="pmc">PMC11316708</ArticleId><ArticleId IdType="pubmed">38907767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanauskait&#x117; D., Bal&#x10d;i&#x16b;nait&#x117; G., Palionis D., Besusparis J., &#x17d;urauskas E., Janu&#x161;auskas V., Zorinas A., Valevi&#x10d;ien&#x117; N., Sogaard P., Glaveckait&#x117; S. The Relative Apical Sparing Strain Pattern in Severe Aortic Valve Stenosis: A Marker of Adverse Cardiac Remodeling. JPM. 2024;14:707. doi: 10.3390/jpm14070707.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm14070707</ArticleId><ArticleId IdType="pmc">PMC11277935</ArticleId><ArticleId IdType="pubmed">39063961</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameli M. Echocardiography Strain: Why Is It Used More and More? Eur. Heart J. Suppl. 2022;24:I38&#x2013;I42. doi: 10.1093/eurheartjsupp/suac070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartjsupp/suac070</ArticleId><ArticleId IdType="pmc">PMC9653139</ArticleId><ArticleId IdType="pubmed">36380779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor-Avi V., Lang R.M., Badano L.P., Belohlavek M., Cardim N.M., Derumeaux G., Galderisi M., Marwick T., Nagueh S.F., Sengupta P.P., et al. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications. J. Am. Soc. Echocardiogr. 2011;24:277&#x2013;313. doi: 10.1016/j.echo.2011.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2011.01.015</ArticleId><ArticleId IdType="pubmed">21338865</ArticleId></ArticleIdList></Reference><Reference><Citation>Claus P., Omar A.M.S., Pedrizzetti G., Sengupta P.P., Nagel E. Tissue Tracking Technology for Assessing Cardiac Mechanics. JACC Cardiovasc. Imaging. 2015;8:1444&#x2013;1460. doi: 10.1016/j.jcmg.2015.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2015.11.001</ArticleId><ArticleId IdType="pubmed">26699113</ArticleId></ArticleIdList></Reference><Reference><Citation>Smiseth O.A., Rider O., Cvijic M., Valkovi&#x10d; L., Remme E.W., Voigt J.-U. Myocardial Strain Imaging. JACC Cardiovasc. Imaging. 2025;18:340&#x2013;381. doi: 10.1016/j.jcmg.2024.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2024.07.011</ArticleId><ArticleId IdType="pubmed">39269417</ArticleId></ArticleIdList></Reference><Reference><Citation>Obokata M., Nagata Y., Wu V.C.-C., Kado Y., Kurabayashi M., Otsuji Y., Takeuchi M. Direct Comparison of Cardiac Magnetic Resonance Feature Tracking and 2D/3D Echocardiography Speckle Tracking for Evaluation of Global Left Ventricular Strain. Eur. Heart J. Cardiovasc. Imaging. 2016;17:525&#x2013;532. doi: 10.1093/ehjci/jev227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev227</ArticleId><ArticleId IdType="pubmed">26377901</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi T., Saha S.K., Ludwig D.R., Onishi T., Marek J.J., Cavalcante J.L., Schelbert E.B., Schwartzman D., Gorcsan J. Feature Tracking Measurement of Dyssynchrony from Cardiovascular Magnetic Resonance Cine Acquisitions: Comparison with Echocardiographic Speckle Tracking. J. Cardiovasc. Magn. Reson. 2013;15:95. doi: 10.1186/1532-429X-15-95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-15-95</ArticleId><ArticleId IdType="pmc">PMC4016574</ArticleId><ArticleId IdType="pubmed">24134158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C.-H., Takeuchi M., Nabeshima Y., Yamashita E., Izumo M., Ishizu T., Seo Y. Prognostic Value of Apical Sparing of Longitudinal Strain in Patients with Symptomatic Aortic Stenosis. Acta Cardiol. Sin. 2022;38:341&#x2013;351. doi: 10.6515/ACS.202205_38(3).20211209A.</Citation><ArticleIdList><ArticleId IdType="doi">10.6515/ACS.202205_38(3).20211209A</ArticleId><ArticleId IdType="pmc">PMC9121747</ArticleId><ArticleId IdType="pubmed">35673342</ArticleId></ArticleIdList></Reference><Reference><Citation>Abecasis J., Lopes P., Santos R.R., Malt&#xea;s S., Guerreiro S., Ferreira A., Freitas P., Ribeiras R., Andrade M.J., Manso R.T., et al. Prevalence and Significance of Relative Apical Sparing in Aortic Stenosis: Insights from an Echo and Cardiovascular Magnetic Resonance Study of Patients Referred for Surgical Aortic Valve Replacement. Eur. Heart J. Cardiovasc. Imaging. 2023;24:1033&#x2013;1042. doi: 10.1093/ehjci/jead032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jead032</ArticleId><ArticleId IdType="pubmed">36841934</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;chi M., Hess O.H., Murakami T., Krayenbuehl H.P. Left Ventricular Wall Stress Distribution in Chronic Pressure and Volume Overload: Effect of Normal and Depressed Contractility on Regional Stress-Velocity Relations. Basic. Res. Cardiol. 1990;85:367&#x2013;383. doi: 10.1007/BF01907129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01907129</ArticleId><ArticleId IdType="pubmed">2241767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryds K., Larsen A.H., Hansen M.S., Gr&#xf8;ndal A.Y.K., Tougaard R.S., Hansson N.H., Clemmensen T.S., L&#xf8;gstrup B.B., Wiggers H., Kim W.Y., et al. Myocardial Strain Assessed by Feature Tracking Cardiac Magnetic Resonance in Patients with a Variety of Cardiovascular Diseases&#x2014;A Comparison with Echocardiography. Sci. Rep. 2019;9:11296. doi: 10.1038/s41598-019-47775-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-47775-4</ArticleId><ArticleId IdType="pmc">PMC6683180</ArticleId><ArticleId IdType="pubmed">31383914</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrizzetti G., Claus P., Kilner P.J., Nagel E. Principles of Cardiovascular Magnetic Resonance Feature Tracking and Echocardiographic Speckle Tracking for Informed Clinical Use. J. Cardiovasc. Magn. Reson. 2016;18:51. doi: 10.1186/s12968-016-0269-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-016-0269-7</ArticleId><ArticleId IdType="pmc">PMC5000424</ArticleId><ArticleId IdType="pubmed">27561421</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi T., Saha S.K., Delgado-Montero A., Ludwig D.R., Onishi T., Schelbert E.B., Schwartzman D., Gorcsan J. Global Longitudinal Strain and Global Circumferential Strain by Speckle-Tracking Echocardiography and Feature-Tracking Cardiac Magnetic Resonance Imaging: Comparison with Left Ventricular Ejection Fraction. J. Am. Soc. Echocardiogr. 2015;28:587&#x2013;596. doi: 10.1016/j.echo.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.11.018</ArticleId><ArticleId IdType="pubmed">25577185</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichek N., Devereux R.B. Left Ventricular Hypertrophy: Relationship of Anatomic, Echocardiographic and Electrocardiographic Findings. Circulation. 1981;63:1391&#x2013;1398. doi: 10.1161/01.CIR.63.6.1391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.63.6.1391</ArticleId><ArticleId IdType="pubmed">6452972</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;schel J., Kuhnt J., Viezzer D., Hadler T., Hormes S., Barckow P., Schulz-Menger J., Blaszczyk E. Comparison of Manual and Artificial Intelligence Based Quantification of Myocardial Strain by Feature Tracking&#x2014;A Cardiovascular MR Study in Health and Disease. Eur. Radiol. 2023;34:1003&#x2013;1015. doi: 10.1007/s00330-023-10127-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-023-10127-y</ArticleId><ArticleId IdType="pmc">PMC10853310</ArticleId><ArticleId IdType="pubmed">37594523</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrovie M., B&#x117;zy S., &#xdc;nl&#xfc; S., Chakraborty B., Petrescu A., Duchenne J., Beela A.S., Voigt J.-U. How Does Regional Hypertrophy Affect Strain Measurements with Different Speckle-Tracking Methods? J. Am. Soc. Echocardiogr. 2019;32:1444&#x2013;1450. doi: 10.1016/j.echo.2019.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2019.06.008</ArticleId><ArticleId IdType="pubmed">31377070</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscogiuri G., Volpato V., Cau R., Chiesa M., Saba L., Guglielmo M., Senatieri A., Chierchia G., Pontone G., Dell&#x2019;Aversana S., et al. Application of AI in Cardiovascular Multimodality Imaging. Heliyon. 2022;8:e10872. doi: 10.1016/j.heliyon.2022.e10872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e10872</ArticleId><ArticleId IdType="pmc">PMC9576885</ArticleId><ArticleId IdType="pubmed">36267381</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Assen M., Muscogiuri G., Caruso D., Lee S.J., Laghi A., De Cecco C.N. Artificial Intelligence in Cardiac Radiology. Radiol. Med. 2020;125:1186&#x2013;1199. doi: 10.1007/s11547-020-01277-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11547-020-01277-w</ArticleId><ArticleId IdType="pubmed">32946002</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Patel H., Miller T., Ameyaw K., Narang A., Chauhan D., Anand S., Anyanwu E., Besser S.A., Kawaji K., et al. AI Based CMR Assessment of Biventricular Function. JACC Cardiovasc. Imaging. 2022;15:413&#x2013;427. doi: 10.1016/j.jcmg.2021.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.08.011</ArticleId><ArticleId IdType="pmc">PMC8917993</ArticleId><ArticleId IdType="pubmed">34656471</ArticleId></ArticleIdList></Reference><Reference><Citation>Elvas L.B., &#xc1;guas P., Ferreira J.C., Oliveira J.P., Dias M.S., Ros&#xe1;rio L.B. AI-Based Aortic Stenosis Classification in MRI Scans. Electronics. 2023;12:4835. doi: 10.3390/electronics12234835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics12234835</ArticleId></ArticleIdList></Reference><Reference><Citation>Evertz R., Lange T., Backhaus S.J., Schulz A., Beuthner B.E., Topci R., Toischer K., Puls M., Kowallick J.T., Hasenfu&#xdf; G., et al. Artificial Intelligence Enabled Fully Automated CMR Function Quantification for Optimized Risk Stratification in Patients Undergoing Transcatheter Aortic Valve Replacement. J. Interv. Cardiol. 2022;2022:1&#x2013;9. doi: 10.1155/2022/1368878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1368878</ArticleId><ArticleId IdType="pmc">PMC9046000</ArticleId><ArticleId IdType="pubmed">35539443</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto J.B., Davies R.H., Bhuva A.N., Knott K.D., Seraphim A., Alfarih M., Lau C., Hughes R.K., Lopes L.R., Shiwani H., et al. Diagnosis and Risk Stratification in Hypertrophic Cardiomyopathy Using Machine Learning Wall Thickness Measurement: A Comparison with Human Test-Retest Performance. Lancet Digit. Health. 2021;3:e20&#x2013;e28. doi: 10.1016/S2589-7500(20)30267-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30267-3</ArticleId><ArticleId IdType="pubmed">33735065</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Y., Zhao C., An J., Zhou J., Deng D., He Y. Progress in the Clinical Application of Artificial Intelligence for Left Ventricle Analysis in Cardiac Magnetic Resonance. Rev. Cardiovasc. Med. 2024;25:447. doi: 10.31083/j.rcm2512447.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2512447</ArticleId><ArticleId IdType="pmc">PMC11683706</ArticleId><ArticleId IdType="pubmed">39742214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C., Guo Z., Yuan J., Xia K., Yu H. Fine-Grained Calibrated Double-Attention Convolutional Network for Left Ventricular Segmentation. Phys. Med. Biol. 2022;67:055013. doi: 10.1088/1361-6560/ac5570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/1361-6560/ac5570</ArticleId><ArticleId IdType="pubmed">35168211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariscal-Harana J., Kifle N., Razavi R., King A.P., Ruijsink B., Puyol-Ant&#xf3;n E. Improved AI-Based Segmentation of Apical and Basal Slices from Clinical Cine CMR. Springer; Berlin/Heidelberg, Germany: 2021.</Citation></Reference><Reference><Citation>Assadi H., Alabed S., Li R., Matthews G., Karunasaagarar K., Kasmai B., Nair S., Mehmood Z., Grafton-Clarke C., Swoboda P.P., et al. Development and Validation of AI-Derived Segmentation of Four-Chamber Cine Cardiac Magnetic Resonance. Eur. Radiol. Exp. 2024;8:77. doi: 10.1186/s41747-024-00477-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41747-024-00477-7</ArticleId><ArticleId IdType="pmc">PMC11239622</ArticleId><ArticleId IdType="pubmed">38992116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuruvilla S., Adenaw N., Katwal A.B., Lipinski M.J., Kramer C.M., Salerno M. Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis. Circ. Cardiovasc. Imaging. 2014;7:250&#x2013;258. doi: 10.1161/CIRCIMAGING.113.001144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.001144</ArticleId><ArticleId IdType="pmc">PMC4007583</ArticleId><ArticleId IdType="pubmed">24363358</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R., Pisu F., Suri J.S., Mannelli L., Scaglione M., Masala S., Saba L. Artificial Intelligence Applications in Cardiovascular Magnetic Resonance Imaging: Are We on the Path to Avoiding the Administration of Contrast Media? Diagnostics. 2023;13:2061. doi: 10.3390/diagnostics13122061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13122061</ArticleId><ArticleId IdType="pmc">PMC10297403</ArticleId><ArticleId IdType="pubmed">37370956</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C., Howey J., Ohorodnyk P., Roth M., Zhang H., Li S. Segmentation and Quantification of Infarction without Contrast Agents via Spatiotemporal Generative Adversarial Learning. Med. Image Anal. 2020;59:101568. doi: 10.1016/j.media.2019.101568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2019.101568</ArticleId><ArticleId IdType="pubmed">31622838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Burrage M.K., Shanmuganathan M., Gonzales R.A., Lukaschuk E., Thomas K.E., Mills R., Leal Pelado J., Nikolaidou C., Popescu I.A., et al. Artificial Intelligence for Contrast-Free MRI: Scar Assessment in Myocardial Infarction Using Deep Learning&#x2013;Based Virtual Native Enhancement. Circulation. 2022;146:1492&#x2013;1503. doi: 10.1161/CIRCULATIONAHA.122.060137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060137</ArticleId><ArticleId IdType="pmc">PMC9662825</ArticleId><ArticleId IdType="pubmed">36124774</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayerhoefer M.E., Materka A., Langs G., H&#xe4;ggstr&#xf6;m I., Szczypi&#x144;ski P., Gibbs P., Cook G. Introduction to Radiomics. J. Nucl. Med. 2020;61:488&#x2013;495. doi: 10.2967/jnumed.118.222893.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.118.222893</ArticleId><ArticleId IdType="pmc">PMC9374044</ArticleId><ArticleId IdType="pubmed">32060219</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z., Izquierdo C., Campello V.M., Martin-Isla C., Jaggi A., Harvey N.C., Lekadir K., Petersen S.E. Cardiac Magnetic Resonance Radiomics: Basic Principles and Clinical Perspectives. Eur. Heart J. Cardiovasc. Imaging. 2020;21:349&#x2013;356. doi: 10.1093/ehjci/jeaa028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa028</ArticleId><ArticleId IdType="pmc">PMC7082724</ArticleId><ArticleId IdType="pubmed">32142107</ArticleId></ArticleIdList></Reference><Reference><Citation>Neisius U., El-Rewaidy H., Nakamori S., Rodriguez J., Manning W.J., Nezafat R. Radiomic Analysis of Myocardial Native T1 Imaging Discriminates Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy. JACC Cardiovasc. Imaging. 2019;12:1946&#x2013;1954. doi: 10.1016/j.jcmg.2018.11.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.11.024</ArticleId><ArticleId IdType="pmc">PMC7032053</ArticleId><ArticleId IdType="pubmed">30660549</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh Z., Martin-Isla C., Nissen L., Szabo L., Campello V.M., Escalera S., Winther S., B&#xf8;ttcher M., Lekadir K., Petersen S.E. Radiomics Analysis Enhances the Diagnostic Performance of CMR Stress Perfusion: A Proof-of-Concept Study Using the Dan-NICAD Dataset. Front. Cardiovasc. Med. 2023;10:1141026. doi: 10.3389/fcvm.2023.1141026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1141026</ArticleId><ArticleId IdType="pmc">PMC10541220</ArticleId><ArticleId IdType="pubmed">37781298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinuo L., Lu T. The Clinical Application of Radiomics Models Based on Cardiac Magnetic Resonance (CMR) Non-Contrast-Enhanced T1 Mapping for Discriminating Acute and Chronic Myocardial Infarction. J. Cardiovasc. Magn. Reson. 2025;27:101218. doi: 10.1016/j.jocmr.2024.101218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocmr.2024.101218</ArticleId></ArticleIdList></Reference><Reference><Citation>Avard E., Shiri I., Hajianfar G., Abdollahi H., Kalantari K.R., Houshmand G., Kasani K., Bitarafan-rajabi A., Deevband M.R., Oveisi M., et al. Non-Contrast Cine Cardiac Magnetic Resonance Image Radiomics Features and Machine Learning Algorithms for Myocardial Infarction Detection. Comput. Biol. Med. 2022;141:105145. doi: 10.1016/j.compbiomed.2021.105145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105145</ArticleId><ArticleId IdType="pubmed">34929466</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamori S., Amyar A., Fahmy A.S., Ngo L.H., Ishida M., Nakamura S., Omori T., Moriwaki K., Fujimoto N., Imanaka-Yoshida K., et al. Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy. Circulation. 2024;150:7&#x2013;18. doi: 10.1161/CIRCULATIONAHA.123.067107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.067107</ArticleId><ArticleId IdType="pmc">PMC11216881</ArticleId><ArticleId IdType="pubmed">38808522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushari N.A., Soultanidis G., Duff L., Trivieri M.G., Fayad Z.A., Robson P., Tsoumpas C. An Assessment of PET and CMR Radiomic Features for the Detection of Cardiac Sarcoidosis. Front. Nucl. Med. 2024;4:1324698. doi: 10.3389/fnume.2024.1324698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnume.2024.1324698</ArticleId><ArticleId IdType="pmc">PMC11460291</ArticleId><ArticleId IdType="pubmed">39381033</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Mui D., Chirinos J.A., Zamani P., Ferrari V.A., Chen Y., Han Y. Comparing Cardiovascular Magnetic Resonance Strain Software Packages by Their Abilities to Discriminate Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. J. Cardiovasc. Magn. Reson. 2021;23:55. doi: 10.1186/s12968-021-00747-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00747-y</ArticleId><ArticleId IdType="pmc">PMC8136221</ArticleId><ArticleId IdType="pubmed">34011382</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudgar P.D., Burkule N.J., Kamat N.V., Rege G.M., Jantre M.N. Myocardial Strain Imaging Using Feature Tracking Method of Cardiac MRI: Our Initial Experience of This Novel Parameter as an Additional Diagnostic Tool. Indian. J. Radiol. Imaging. 2022;32:479&#x2013;487. doi: 10.1055/s-0042-1748760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1748760</ArticleId><ArticleId IdType="pmc">PMC9705126</ArticleId><ArticleId IdType="pubmed">36451951</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Ven J.P.G., Van Genuchten W., Sadighy Z., Valsangiacomo Buechel E.R., Sarikouch S., Boersma E., Helbing W.A. Multivendor Evaluation of Automated MRI Postprocessing of Biventricular Size and Function for Children with and Without Congenital Heart Defects. Magn. Reson. Imaging. 2023;58:794&#x2013;804. doi: 10.1002/jmri.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.28568</ArticleId><ArticleId IdType="pubmed">36573004</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao X., Abdi M., Auger D.A., Sun C., Hanson C.A., Robinson A.A., Schumann C., Oomen P.J., Ratcliffe S., Malhotra R., et al. Cardiac Magnetic Resonance Assessment of Response to Cardiac Resynchronization Therapy and Programming Strategies. JACC Cardiovasc. Imaging. 2021;14:2369&#x2013;2383. doi: 10.1016/j.jcmg.2021.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.06.015</ArticleId><ArticleId IdType="pmc">PMC8671174</ArticleId><ArticleId IdType="pubmed">34419391</ArticleId></ArticleIdList></Reference><Reference><Citation>Gil K.E., Truong V., Liu C., Ibrahim D.Y., Mikrut K., Satoskar A., Varghese J., Kahwash R., Han Y. Distinguishing Hypertensive Cardiomyopathy from Cardiac Amyloidosis in Hypertensive Patients with Heart Failure: A CMR Study with Histological Confirmation. Int. J. Cardiovasc. Imaging. 2024;40:2559&#x2013;2570. doi: 10.1007/s10554-024-03262-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-024-03262-0</ArticleId><ArticleId IdType="pmc">PMC11618216</ArticleId><ArticleId IdType="pubmed">39417970</ArticleId></ArticleIdList></Reference><Reference><Citation>Backhaus S.J., Schuster A., Lange T., Stehning C., Billing M., Lotz J., Pieske B., Hasenfu&#xdf; G., Kelle S., Kowallick J.T. Impact of Fully Automated Assessment on Interstudy Reproducibility of Biventricular Volumes and Function in Cardiac Magnetic Resonance Imaging. Sci. Rep. 2021;11:11648. doi: 10.1038/s41598-021-90702-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90702-9</ArticleId><ArticleId IdType="pmc">PMC8172876</ArticleId><ArticleId IdType="pubmed">34078942</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40597894</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2407</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>BMC cancer</Title><ISOAbbreviation>BMC Cancer</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular risks associated with adjuvant endocrine therapy in women with breast cancer: a population-based cohort study.</ArticleTitle><Pagination><StartPage>1063</StartPage><MedlinePgn>1063</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1063</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12885-025-14280-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Endocrine therapies, including tamoxifen (TMX) and aromatase inhibitors (AIs), are widely used in breast cancer treatment. This study aims to evaluate the cardiovascular risks associated with these therapies in different age groups of non-metastatic breast cancer patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cohort study using data from patients newly diagnosed with non-metastatic breast cancer. Patients were categorized into two ages (&lt;&#x2009;45 years and &gt;&#x2009;55 years) and then divided into groups based on whether they were newly receiving either TMX or AI. Follow-up continued until the first occurrence of a study outcome, death, or the last date of data collection (December 31, 2022). Primary outcomes were coronary artery disease, myocardial infarction (MI), ischemic stroke, hospitalization for heart failure (HHF), atrial fibrillation (AF), cardiovascular mortality, all-cause mortality, and major adverse cardiovascular events (MACE).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among patients&#x2009;&lt;&#x2009;45 years old, 2837 were newly treated with TMX (n&#x2009;=&#x2009;2370) or AI (n&#x2009;=&#x2009;467). During a median follow-up of 8.4 years, the incidence rates of coronary artery disease (5.6 vs. 6.6 per 1000 person-years), myocardial infarction (1.0 vs. 1.7 per 1000 person-years), ischemic stroke (1.5 vs. 1.5 per 1000 person-years), and cardiovascular mortality (1.4 vs. 1.5 per 1000 person-years) were similar between TMX and AI users, with no significant differences in hazard ratios or cumulative incidence curves. However, AI users had a higher risk of HHF (Weighted HR, 3.08 [95% CI, 1.54-6.13], P&#x2009;=&#x2009;0.001) and AF (P&#x2009;=&#x2009;0.039) compared to TMX users. For MACE, there was a non-significant elevated risk (Weighted HR, 1.59 [95% CI, 0.90-2.81]), suggesting a trend toward increased risk. Among patients&#x2009;&gt;&#x2009;55 years old, 11,846 were newly treated with TMX (n&#x2009;=&#x2009;6577) or AI (n&#x2009;=&#x2009;5269). During a median follow-up of 5.0 years, AI users had a significantly increased risk of primary cardiovascular outcomes, including CAD, MI, ischemic stroke, HHF, AF, cardiovascular mortality, and MACE (all P&#x2009;&lt;&#x2009;0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study indicates that AIs are linked to a higher risk of cardiovascular events in post-menopausal patients compared to TMX. In younger patients, TMX's protective effect on cardiovascular outcomes may be less pronounced. Further large-scale studies are required to corroborate and address limitations related to menopausal status and residual confounding.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cheang</LastName><ForeName>Iokfai</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gue</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Mei-Zhen</ForeName><Initials>MZ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jia-Yi</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Qing-Wen</ForeName><Initials>QW</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ziqi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, 210029, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Yi-Kei</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hang-Long</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yap-Hang</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Hung-Fat</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xinli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Innovation and Transformation of Luobing Theory, Department of Cardiology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, 210029, China. xinli3267@njmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lip</LastName><ForeName>Gregory Y H</ForeName><Initials>GYH</Initials><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yiu</LastName><ForeName>Kai-Hang</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, The University of Hong Kong Shen Zhen Hospital, Shenzhen, 518009, China. khkyiu@hku.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong SAR, 999077, China. khkyiu@hku.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82370389, 81970339</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>SZSM201911020</GrantID><Agency>Sanming Project of Medicine in Shenzhen</Agency><Country/></Grant><Grant><GrantID>SZXK2020081</GrantID><Agency>HKU-SZH Fund for Shenzhen Key Medical Discipline</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cancer</MedlineTA><NlmUniqueID>100967800</NlmUniqueID><ISSNLinking>1471-2407</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047072">Aromatase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>094ZI81Y45</RegistryNumber><NameOfSubstance UI="D013629">Tamoxifen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047072" MajorTopicYN="Y">Aromatase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013629" MajorTopicYN="Y">Tamoxifen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018931" MajorTopicYN="Y">Antineoplastic Agents, Hormonal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000082742" MajorTopicYN="N">Heart Disease Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aromatase inhibitors</Keyword><Keyword MajorTopicYN="N">Breast Cancer</Keyword><Keyword MajorTopicYN="N">Cardio-oncology</Keyword><Keyword MajorTopicYN="N">Cardiovascular risk</Keyword><Keyword MajorTopicYN="N">Estrogen receptor</Keyword><Keyword MajorTopicYN="N">Tamoxifen</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The study was reviewed and approved by the Institutional Ethics Review Board of The University of Hong Kong and the Hong Kong West Cluster of the Hospital Authority (approval number: UW 21&#x2013;270), which waived the requirement for informed consent due to the retrospective and anonymized nature of the data used in this research. The study adhered strictly to the ethical guidelines outlined in the Declaration of Helsinki. Consent for publication: Not Applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>4</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40597894</ArticleId><ArticleId IdType="pmc">PMC12210659</ArticleId><ArticleId IdType="doi">10.1186/s12885-025-14280-z</ArticleId><ArticleId IdType="pii">10.1186/s12885-025-14280-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394&#x2013;424. 10.3322/caac.21492.</Citation><ArticleIdList><ArticleId IdType="pubmed">30207593</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardin S, Mora E, Varughese FM, D&#x2019;Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast Cancer survivorship, quality of life, and late toxicities. Front Oncol. 2020;10:864. 10.3389/fonc.2020.00864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308500</ArticleId><ArticleId IdType="pubmed">32612947</ArticleId></ArticleIdList></Reference><Reference><Citation>Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA. American Cancer society/american society of clinical oncology breast Cancer survivorship care guideline. J Clin Oncol. 2016;34(6):611&#x2013;35. 10.1200/JCO.2015.64.3809.</Citation><ArticleIdList><ArticleId IdType="pubmed">26644543</ArticleId></ArticleIdList></Reference><Reference><Citation>Barish R, Lynce F, Unger K, Barac A. Management of cardiovascular disease in women with breast Cancer. Circulation. 2019;139(8):1110&#x2013;20. 10.1161/CIRCULATIONAHA.118.039371.</Citation><ArticleIdList><ArticleId IdType="pubmed">30779651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumachi F, Brunello A, Maruzzo M, Basso U, Basso SM. Treatment of Estrogen receptor-positive breast cancer. Curr Med Chem. 2013;20(5):596&#x2013;604. 10.2174/092986713804999303.</Citation><ArticleIdList><ArticleId IdType="pubmed">23278394</ArticleId></ArticleIdList></Reference><Reference><Citation>Loibl S, Andr&#xe9; F, Bachelot T, Barrios CH, Bergh J, Burstein HJ, Cardoso LMJ, Carey LA, Dawood S, Del Mastro L, Denkert C, Fallenberg EM, Francis PA, Gamal-Eldin H, Gelmon K, Geyer CE, Gnant M, Guarneri V, Gupta S, Kim SB, Krug D, Martin M, Meattini I, Morrow M, Janni W, Paluch-Shimon S, Partridge A, Poortmans P, Pusztai L, Regan MM, Sparano J, Spanic T, Swain S, Tjulandin S, Toi M, Trapani D, Tutt A, Xu B, Curigliano G, Harbeck N, ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up&#x2020;. Ann Oncol. 2023. S0923-7534(23)05104-9. 10.1016/j.annonc.2023.11.016</Citation><ArticleIdList><ArticleId IdType="pubmed">38101773</ArticleId></ArticleIdList></Reference><Reference><Citation>Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godwin J, Davies C, Peto R. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus Tamoxifen. J Clin Oncol. 2010;28(3):509&#x2013;18. 10.1200/JCO.2009.23.1274.</Citation><ArticleIdList><ArticleId IdType="pubmed">19949017</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauri D, Pavlidis N, Polyzos NP, Ioannidis JP. Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst. 2006;98(18):1285&#x2013;91. 10.1093/jnci/djj357.</Citation><ArticleIdList><ArticleId IdType="pubmed">16985247</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Breast Cancer Trialists&#x2019; Collaborative Group (EBCTCG). Aromatase inhibitors versus Tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet Oncol. 2022;23(3):382&#x2013;92. 10.1016/S1470-2045(21)00758-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8885431</ArticleId><ArticleId IdType="pubmed">35123662</ArticleId></ArticleIdList></Reference><Reference><Citation>Okwuosa TM, Morgans A, Rhee JW, Reding KW, Maliski S, Plana JC, Volgman AS, Moseley KF, Porter CB, Ismail-Khan R, American Heart Association Cardio-Oncology Subcommittee of the Council on Clinical Cardiology and the Council on Genomic and Precision Medicine; Council on Arteriosclerosis, Thrombosis and Vascular Biology; and Council on Cardiovascular Radiology and Intervention. Impact of hormonal therapies for treatment of Hormone-Dependent cancers (Breast and Prostate) on the cardiovascular system: effects and modifications: A scientific statement from the American heart association. Circ Genom Precis Med. 2021;14(3):e000082. 10.1161/HCG.0000000000000082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33896190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo JJ, Jung EA, Kim Z, Kim BY. Risk of cardiovascular events and lipid profile change in patients with breast Cancer taking aromatase inhibitor: A systematic review and Meta-Analysis. Curr Oncol. 2023;30(2):1831&#x2013;43. 10.3390/curroncol30020142.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9955032</ArticleId><ArticleId IdType="pubmed">36826103</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, Smeeth L, Bhaskaran K. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 2018;363:k3845. 10.1136/bmj.k3845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174332</ArticleId><ArticleId IdType="pubmed">30297439</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JY, Tse YK, Li HL, Chen C, Zhao CT, Liu MY, Wu MZ, Ren QW, Yu SY, Hung D, Li XL, Tse HF, Lip GYH, Yiu KH. Prediabetes is associated with increased risk of heart failure among patients with atrial fibrillation. Diabetes Care. 2023;46(1):190&#x2013;6. 10.2337/dc22-1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">36251385</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren QW, Yu SY, Teng TK, Li X, Cheung KS, Wu MZ, Li HL, Wong PF, Tse HF, Lam CSP, Yiu KH. Statin associated lower cancer risk and related mortality in patients with heart failure. Eur Heart J. 2021;42(32):3049&#x2013;59. 10.1093/eurheartj/ehab325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380061</ArticleId><ArticleId IdType="pubmed">34157723</ArticleId></ArticleIdList></Reference><Reference><Citation>Law SWY, Lau WCY, Wong ICK, Lip GYH, Mok MT, Siu CW, Chan EW. Sex-Based differences in outcomes of oral anticoagulation in patients with atrial fibrillation. J Am Coll Cardiol. 2018;72(3):271&#x2013;82. 10.1016/j.jacc.2018.04.066.</Citation><ArticleIdList><ArticleId IdType="pubmed">30012320</ArticleId></ArticleIdList></Reference><Reference><Citation>Mc Menamin &#xda;C, Murray LJ, Hughes CM, Cardwell CR. Statin use and breast cancer survival: a nationwide cohort study in Scotland. BMC Cancer. 2016;16:600. 10.1186/s12885-016-2651-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4973520</ArticleId><ArticleId IdType="pubmed">27491389</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilli M, Ferdinandy P, Salvatorelli E, Menna P, Minotti G. Anthracyclines, diastolic dysfunction and the road to heart failure in Cancer survivors: an untold story. Prog Cardiovasc Dis. 2024;86(Sep&#x2013;Oct):38&#x2013;47. 10.1016/j.pcad.2024.07.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">39025347</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilli M, Cipolla CM, Dent S, Minotti G, Cardinale DM. Anthracycline cardiotoxicity in adult Cancer patients: JACC: cardiooncology State-of-the-Art review. JACC CardioOncol. 2024;6(5):655&#x2013;77. 10.1016/j.jaccao.2024.07.016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11520218</ArticleId><ArticleId IdType="pubmed">39479333</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L. Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: A Population-Based cohort study. Circulation. 2020;141(7):549&#x2013;59. 10.1161/CIRCULATIONAHA.119.044750.</Citation><ArticleIdList><ArticleId IdType="pubmed">32065766</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushman M, Costantino JP, Tracy RP, Song K, Buckley L, Roberts JD, Krag DN. Tamoxifen and cardiac risk factors in healthy women: suggestion of an anti-inflammatory effect. Arterioscler Thromb Vasc Biol. 2001;21(2):255&#x2013;61. 10.1161/01.atv.21.2.255.</Citation><ArticleIdList><ArticleId IdType="pubmed">11156862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, Neugebauer R, Rana JS, Nguyen-Huynh M, Shi Z, Laurent CA, Lee VS, Roh JM, Huang Y, Shen H, Hershman DL, Kushi LH, Greenlee H. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023;201(1):117&#x2013;26. 10.1007/s10549-023-06997-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10498727</ArticleId><ArticleId IdType="pubmed">37326764</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaris I, Asselah J, Aziz H, Bouganim N, Mousavi N. The cardiovascular risks associated with aromatase inhibitors, Tamoxifen, and GnRH agonists in women with breast Cancer. Curr Atheroscler Rep. 2023;25(4):145&#x2013;54. 10.1007/s11883-023-01085-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">36848014</ArticleId></ArticleIdList></Reference><Reference><Citation>Desautels DN, Blanchette PS, Pritchard KI. Do aromatase inhibitors increase cardiovascular risk? Piecing together the evidence. Eur J Cancer. 2016;68:176&#x2013;8. 10.1016/j.ejca.2016.09.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">27776294</ArticleId></ArticleIdList></Reference><Reference><Citation>Davezac M, Meneur C, Buscato M, Zahreddine R, Arnal JF, Dalenc F, Lenfant F, Fontaine C. The beneficial effects of Tamoxifen on arteries: A key player for cardiovascular health of breast cancer patient. Biochem Pharmacol. 2023;214:115677. 10.1016/j.bcp.2023.115677.</Citation><ArticleIdList><ArticleId IdType="pubmed">37419371</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauro E, Luc&#xe0; F, Tetta C, Parise O, Parrini I, Parise G, Rao CM, Matteucci F, Micali LR, Gulizia MM, La Meir M, Gelsomino S. Breast Cancer and atrial fibrillation. J Clin Med. 2022;11(5):1417. 10.3390/jcm11051417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8911432</ArticleId><ArticleId IdType="pubmed">35268508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho I, Wong CK, Wong YK, Lam TH, Sze-Him Leung I, Lin M, Tak-Wai Lui D, Kwok WC, Tam CC, Chan YH, Chan EWY, Tse HF. Aromatase inhibitor therapy increases the risk of New-Onset atrial fibrillation in patients with breast Cancer. JACC Asia. 2023;4(2):150&#x2013;60. 10.1016/j.jacasi.2023.09.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10866735</ArticleId><ArticleId IdType="pubmed">38371283</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon AR, L&#xf3;pez-Fern&#xe1;ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, Group ESD. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international Cardio-Oncology society (IC-OS): developed by the task force on cardio-oncology of the European society of cardiology (ESC). Eur Heart J. 2022;43:4229&#x2013;361. 10.1093/eurheartj/ehac244.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017568</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40557003</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Role of Machine Learning in Predicting Hospital Readmissions Among General Internal Medicine Patients: A Systematic Review.</ArticleTitle><Pagination><StartPage>e84761</StartPage><MedlinePgn>e84761</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e84761</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.84761</ELocationID><Abstract><AbstractText>Hospital readmissions contribute significantly to healthcare costs. While traditional regression models for predicting 30-day readmission risk offer modest accuracy, machine learning (ML) presents an opportunity to capture complex relationships in healthcare data, potentially enhancing predictions. This review assesses the role of ML in predicting 30-day readmissions for general internal medicine admissions in the U.S. Following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, a literature search of PubMed (2014-2023) was conducted using the keywords "artificial intelligence," "machine learning," and "readmission." The review focused on ML models predicting readmissions in general internal medicine patients in the U.S. Nine studies were reviewed, covering conditions like acute myocardial infarction (AMI), heart failure (HF), pneumonia (PNA), chronic obstructive pulmonary disease (COPD), and other general internal medicine cases. ML models such as artificial neural networks (ANN), random forests (RF), gradient boosting, logistic regression, and natural language processing (NLP) were used. ANN and RF models outperformed traditional regression methods, while NLP-based approaches showed limited success. Subgroup modeling provided marginal improvements in predictive accuracy. In conclusion, ML offers significant potential for improving 30-day readmission predictions by overcoming the limitations of traditional models. ANN and RF are particularly effective in predicting readmissions in general internal medicine. To advance predictive capabilities, future research should refine NLP, subgroup modeling, and focus on model generalizability, integration of diverse data sources, and the development of explainable AI for clinical adoption. Addressing these challenges could transform healthcare delivery, improve patient outcomes, and reduce costs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Sharda et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharda</LastName><ForeName>Mukul</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Saujas</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience, University of Michigan, Ann Arbor, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raikar</LastName><ForeName>Shaunak</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Chemical Engineering, University of Wisconsin-Madison, Madison, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verhagen</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wagle</LastName><ForeName>Janavi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Science, Brookfield East High School, Brookfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathur</LastName><ForeName>Ritisha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Science, Brookfield Academy, Brookfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gowda</LastName><ForeName>Saathvik</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Science, Brookfield Central High School, Brookfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kommu</LastName><ForeName>Sharath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Marshfield Clinic Health System, Marshfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prasad</LastName><ForeName>Rupesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, Aurora Sinai Medical Center, Milwaukee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhandari</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jha</LastName><ForeName>Pinky</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, Medical College of Wisconsin, Milwaukee, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">general internal medicine</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">readmission</Keyword><Keyword MajorTopicYN="N">us based</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>4</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40557003</ArticleId><ArticleId IdType="pmc">PMC12187041</ArticleId><ArticleId IdType="doi">10.7759/cureus.84761</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rehospitalizations among patients in the Medicare fee-for-service program. Jencks SF, Williams MV, Coleman EA. N Engl J Med. 2009;360:1418&#x2013;1428.</Citation><ArticleIdList><ArticleId IdType="pubmed">19339721</ArticleId></ArticleIdList></Reference><Reference><Citation>The patient protection and affordable care act: implications for public health policy and practice. Rosenbaum S. Public Health Rep. 2011;126:130&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001814</ArticleId><ArticleId IdType="pubmed">21337939</ArticleId></ArticleIdList></Reference><Reference><Citation>Patient Protection and Affordable Care Act.  [
Jan;
2025 
]. 2025. https://www.healthcare.gov/glossary/patient-protection-and-affordable-care-act/ https://www.healthcare.gov/glossary/patient-protection-and-affordable-care-act/</Citation></Reference><Reference><Citation>Readmission penalties and health insurance expansions: a dispatch from Massachusetts. Chen C, Scheffler G, Chandra A. https://doi.org/10.1002/jhm.2213. J Hosp Med. 2014;9:681&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">24945696</ArticleId></ArticleIdList></Reference><Reference><Citation>Differences in hospital readmission risk across all payer groups in South Carolina. Chakraborty H, Axon RN, Brittingham J, Lyons GR, Cole L, Turley CB. https://doi.org/10.1111/1475-6773.12579. Health Serv Res. 2017;52:1040&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441481</ArticleId><ArticleId IdType="pubmed">27678196</ArticleId></ArticleIdList></Reference><Reference><Citation>An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Krumholz HM, Lin Z, Drye EE, et al. Circ Cardiovasc Qual Outcomes. 2011;4:243&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3350811</ArticleId><ArticleId IdType="pubmed">21406673</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterns of readmissions for three common conditions among younger US adults. Sukul D, Sinha SS, Ryan AM, Sjoding MW, Hummel SL, Nallamothu BK. Am J Med. 2017;130:1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5699907</ArticleId><ArticleId IdType="pubmed">28606799</ArticleId></ArticleIdList></Reference><Reference><Citation>A comparison of models for predicting early hospital readmissions. Futoma J, Morris J, Lucas J. J Biomed Inform. 2015;56:229&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">26044081</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of machine learning techniques for heart failure readmissions. Mortazavi BJ, Downing NS, Bucholz EM, et al. Circ Cardiovasc Qual Outcomes. 2016;9:629&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5459389</ArticleId><ArticleId IdType="pubmed">28263938</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of 30-day all-cause readmissions in patients hospitalized for heart failure: comparison of machine learning and other statistical approaches. Frizzell JD, Liang L, Schulte PJ, et al. JAMA Cardiol. 2017;2:204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">27784047</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al.   https://doi.org/10.1136/bmj.n71 BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Development of electronic health record-based prediction models for 30-day readmission risk among patients hospitalized for acute myocardial infarction. Matheny ME, Ricket I, Goodrich CA, et al. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846941</ArticleId><ArticleId IdType="pubmed">33512518</ArticleId></ArticleIdList></Reference><Reference><Citation>Information extraction from electronic health records to predict readmission following acute myocardial infarction: does natural language processing using clinical notes improve prediction of readmission? Brown JR, Ricket IM, Reeves RM, et al. J Am Heart Assoc. 2022;11:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9075435</ArticleId><ArticleId IdType="pubmed">35322668</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting 30-day hospital readmissions using artificial neural networks with medical code embedding. Liu W, Stansbury C, Singh K, et al. PLoS One. 2020;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159221</ArticleId><ArticleId IdType="pubmed">32294087</ArticleId></ArticleIdList></Reference><Reference><Citation>Developing a parsimonious frailty index for older, multimorbid adults with heart failure using machine learning. Razjouyan J, Horstman MJ, Orkaby AR, et al. Am J Cardiol. 2023;190:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951585</ArticleId><ArticleId IdType="pubmed">36566620</ArticleId></ArticleIdList></Reference><Reference><Citation>Automated identification and predictive tools to help identify high-risk heart failure patients: pilot evaluation. Evans RS, Benuzillo J, Horne BD, et al. J Am Med Inform Assoc. 2016;23:872&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11741012</ArticleId><ArticleId IdType="pubmed">26911827</ArticleId></ArticleIdList></Reference><Reference><Citation>An AI-driven clinical care pathway to reduce 30-day readmission for chronic obstructive pulmonary disease (COPD) patients. Wang L, Li G, Ezeana CF, et al.  https://doi.org/10.1038/s41598-022-22434-3. Sci Rep. 2022;12:20633.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9712389</ArticleId><ArticleId IdType="pubmed">36450795</ArticleId></ArticleIdList></Reference><Reference><Citation>Man vs. machine: comparing physician vs. electronic health record-based model predictions for 30-day hospital readmissions. Nguyen OK, Washington C, Clark CR, Miller ME, Patel VA, Halm EA, Makam AN. https://doi.org/10.1007/s11606-020-06355-3. J Gen Intern Med. 2021;36:2555&#x2013;2562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8390613</ArticleId><ArticleId IdType="pubmed">33443694</ArticleId></ArticleIdList></Reference><Reference><Citation>A framework for modeling and interpreting patient subgroups applied to hospital readmission: visual analytical approach. Bhavnani SK, Zhang W, Visweswaran S, Raji M, Kuo YF. JMIR Med Inform. 2022;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9773032</ArticleId><ArticleId IdType="pubmed">35537203</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Fleuren LM, Klausch TL, Zwager CL, et al. Intensive Care Med. 2020;46:383&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7067741</ArticleId><ArticleId IdType="pubmed">31965266</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of machine learning techniques in the study of bipolar disorder: a systematic review. Librenza-Garcia D, Kotzian BJ, Yang J, et al. Neurosci Biobehav Rev. 2017;80:538&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">28728937</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning and microsimulation techniques on the prognosis of dementia: a systematic literature review. Dallora AL, Eivazzadeh S, Mendes E, Berglund J, Anderberg P. PLoS One. 2017;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5491044</ArticleId><ArticleId IdType="pubmed">28662070</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning applications in cancer prognosis and prediction. Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Comput Struct Biotechnol J. 2015;13:8&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4348437</ArticleId><ArticleId IdType="pubmed">25750696</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning and neurosurgical outcome prediction: a systematic review. Senders JT, Staples PC, Karhade AV, et al. World Neurosurg. 2018;109:476&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">28986230</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in major depression: from classification to treatment outcome prediction. Gao S, Calhoun VD, Sui J. CNS Neurosci Ther. 2018;24:1037&#x2013;1052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324186</ArticleId><ArticleId IdType="pubmed">30136381</ArticleId></ArticleIdList></Reference><Reference><Citation>Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review. Lee Y, Ragguett RM, Mansur RB, et al. J Affect Disord. 2018;1:519&#x2013;532.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153635</ArticleId></ArticleIdList></Reference><Reference><Citation>Application of machine learning in predicting hospital readmissions: a scoping review of the literature. Huang Y, Talwar A, Chatterjee S, Aparasu RR. BMC Med Res Methodol. 2021;21:96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101040</ArticleId><ArticleId IdType="pubmed">33952192</ArticleId></ArticleIdList></Reference><Reference><Citation>Use of electronic medical records in development and validation of risk prediction models of hospital readmission: systematic review. Mahmoudi E, Kamdar N, Kim N, Gonzales G, Singh K, Waljee AK. BMJ. 2020;369:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7249246</ArticleId><ArticleId IdType="pubmed">32269037</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictive models for hospital readmission risk: a systematic review of methods. Artetxe A, Beristain A, Gra&#xf1;a M. Comput Methods Programs Biomed. 2018;164:49&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30195431</ArticleId></ArticleIdList></Reference><Reference><Citation>A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models. Christodoulou E, Ma J, Collins GS, Steyerberg EW, Verbakel JY, Van Calster B. J Clin Epidemiol. 2019;110:12&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">30763612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40558656</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2308-3425</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of cardiovascular development and disease</Title><ISOAbbreviation>J Cardiovasc Dev Dis</ISOAbbreviation></Journal><ArticleTitle>The Role of Artificial Intelligence in Cardiac Amyloidosis: A Focus on Diagnosis and Clinical Application.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcdd12060221</ELocationID><Abstract><AbstractText>The aim of this review is to provide an update on contemporary and evolving artificial intelligence (AI) methods and their role in diagnosing and managing cardiac amyloidosis (CA). AI is the broadest term which describes a variety of different techniques that enable computers to mimic human intelligence. It is widely used across different diagnostic tests including electrocardiograms, echocardiography, scintigraphy and cardiac magnetic resonance (CMR). Through a comprehensive search among four databases, we identified several insights into clinical applications, diagnostic modalities and different utilization of AI in CA. The elusive nature of CA, which often makes early diagnosis challenging, can greatly benefit from the integration of AI into the diagnostic process. The variability in diagnostic strategies of CA underscores the need for more AI-focused prospective clinical trials to establish evidence-based guidelines for AI-driven diagnostic pathways. Our review highlights the capabilities of AI, particularly in the diagnosis of cardiac amyloidosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wardak</LastName><ForeName>Roshan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0005-9180-1704</Identifier><AffiliationInfo><Affiliation>Cleveland Clinic Florida, Weston, FL 33331, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snipelisky</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cleveland Clinic Florida, Weston, FL 33331, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Cardiovasc Dev Dis</MedlineTA><NlmUniqueID>101651414</NlmUniqueID><ISSNLinking>2308-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">neural networks</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40558656</ArticleId><ArticleId IdType="pmc">PMC12194601</ArticleId><ArticleId IdType="doi">10.3390/jcdd12060221</ArticleId><ArticleId IdType="pii">jcdd12060221</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goto S., Mahara K., Beussink-Nelson L., Ikura H., Katsumata Y., Endo J., Gaggin H.K., Shah S.J., Itabashi Y., MacRae C.A., et al. Artificial Intelligence-Enabled Fully Automated Detection of Cardiac Amyloidosis Using Electrocardiograms and Echocardiograms. Nat. Commun. 2021;12:2726. doi: 10.1038/s41467-021-22877-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22877-8</ArticleId><ArticleId IdType="pmc">PMC8113484</ArticleId><ArticleId IdType="pubmed">33976142</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan L., Benz D.C., Cuddy S.A.M., Dobner S., Shiri I., Caobelli F., Bernhard B., St&#xe4;mpfli S.F., O&#x2019;Sullivan C.J., Reyes M., et al. Current and Evolving Multimodality Cardiac Imaging in Managing Transthyretin Amyloid Cardiomyopathy. JACC Cardiovasc. Imaging. 2024;17:195&#x2013;211. doi: 10.1016/j.jcmg.2023.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.10.010</ArticleId><ArticleId IdType="pubmed">38099914</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Jimenez F., Attia Z., Arruda-Olson A.M., Carter R., Chareonthaitawee P., Jouni H., Kapa S., Lerman A., Luong C., Medina-Inojosa J.R., et al. Artificial Intelligence in Cardiology: Present and Future. Mayo Clin. Proc. 2020;95:1015&#x2013;1039. doi: 10.1016/j.mayocp.2020.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.01.038</ArticleId><ArticleId IdType="pubmed">32370835</ArticleId></ArticleIdList></Reference><Reference><Citation>Infante T., Francone M., De Rimini M.L., Cavaliere C., Canonico R., Catalano C., Napoli C., Salvatore M., Cademartiri F., Punzo B. Machine Learning and Network Medicine: A Novel Approach for Precision Medicine and Personalized Therapy in Cardiomyopathies. J. Cardiovasc. Med. 2020;22:429&#x2013;440. doi: 10.2459/JCM.0000000000001103.</Citation><ArticleIdList><ArticleId IdType="doi">10.2459/JCM.0000000000001103</ArticleId><ArticleId IdType="pubmed">32890235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahammed M.R., Ananya F.N. Cardiac Amyloidosis: A Comprehensive Review of Pathophysiology, Diagnostic Approach, Applications of Artificial Intelligence, and Management Strategies. Cureus. 2024;16:e63673. doi: 10.7759/cureus.63673.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.63673</ArticleId><ArticleId IdType="pmc">PMC11293487</ArticleId><ArticleId IdType="pubmed">39092395</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrudhula A., Stern L., Cheng P.C., Ricchiuto P., Daluwatte C., Witteles R., Patel J., Ouyang D., Kwan A.C., Cheng S.C. Impact of Case and Control Selection on Training Artificial Intelligence Screening of Cardiac Amyloidosis. JACC Adv. 2024;3:100998. doi: 10.1016/j.jacadv.2024.100998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.100998</ArticleId><ArticleId IdType="pmc">PMC11450940</ArticleId><ArticleId IdType="pubmed">39372462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison G.H., Zhang J., Delling F.N., Deo R.C., Attia Z., Carter R., Chareonthaitawee P., Jouni H., Kapa S., Lerman A., et al. Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery. Circ. Cardiovasc. Qual. Outcomes. 2019;12:e005289. doi: 10.1161/CIRCOUTCOMES.118.005289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.118.005289</ArticleId><ArticleId IdType="pmc">PMC6951431</ArticleId><ArticleId IdType="pubmed">31525078</ArticleId></ArticleIdList></Reference><Reference><Citation>Grogan M., Lopez-Jimenez F., Cohen-Shelly M., Dispenzieri A., Attia Z.I., Abou Ezzedine O.F., Lin G., Kapa S., Borgeson D.D., Friedman P.A. Artificial Intelligence&#x2013;Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin. Proc. 2021;96:2768&#x2013;2778. doi: 10.1016/j.mayocp.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.023</ArticleId><ArticleId IdType="pubmed">34218880</ArticleId></ArticleIdList></Reference><Reference><Citation>Haimovich J.S., Diamant N., Khurshid S., Di Achille P., Reeder C., Friedman S., Singh P., Spurlock W., Ellinor P.T., Philippakis A., et al. Artificial Intelligence&#x2013;Enabled Classification of Hypertrophic Heart Diseases Using Electrocardiograms. Cardiovasc. Digit. Health J. 2023;4:48&#x2013;59. doi: 10.1016/j.cvdhj.2023.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2023.03.001</ArticleId><ArticleId IdType="pmc">PMC10123506</ArticleId><ArticleId IdType="pubmed">37101945</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S., Solanki D., John J.E., Yagi R., Homilius M., Ichihara G., Katsumata Y., Gaggin H.K., Itabashi Y., MacRae C.A., et al. Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection. Circulation. 2022;146:755&#x2013;769. doi: 10.1161/CIRCULATIONAHA.121.058696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.058696</ArticleId><ArticleId IdType="pmc">PMC9439630</ArticleId><ArticleId IdType="pubmed">35916132</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon D.M., Mangold K., Baez Suarez A., Scott C.G., Murphree D.H., Malik A., Attia Z.I., Lopez-Jimenez F., Friedman P.A., Dispenzieri A., et al. Postdevelopment performance and validation of the artificial intelligence-enhanced electrocardiogram for detection of cardiac amyloidosis. JACC Adv. 2023;2:100612. doi: 10.1016/j.jacadv.2023.100612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2023.100612</ArticleId><ArticleId IdType="pmc">PMC11025724</ArticleId><ArticleId IdType="pubmed">38638999</ArticleId></ArticleIdList></Reference><Reference><Citation>Arana-Achaga X., Goena-Vives C., Villanueva-Benito I., Solla-Ruiz I., Rengel Jim&#xe9;nez A., Gaspar T.I., Urreta-Barallobre I., Barge-Caballero G., Seijas-Marcos S., Cabrera E., et al. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis. JACC Cardiovasc. Imaging. 2023;16:1567&#x2013;1580. doi: 10.1016/j.jcmg.2023.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.05.002</ArticleId><ArticleId IdType="pubmed">37389511</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Gajjala S., Agrawal P., Tison G.H., Hallock L.A., Beussink-Nelson L., Lassen M.H., Fan E., Aras M.A., Jordan C., et al. Fully Automated Echocardiogram Interpretation in Clinical Practice. Circulation. 2018;138:1623&#x2013;1635. doi: 10.1161/CIRCULATIONAHA.118.034338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.034338</ArticleId><ArticleId IdType="pmc">PMC6200386</ArticleId><ArticleId IdType="pubmed">30354459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C.-J., Jeong J., Arsanjani R., Kim K., Tsai Y.-L., Yu W.-C., Farina J.M., Mahmoud A.K., Ayoub C., Grogan M., et al. Echocardiography-Based Deep Learning Model to Differentiate Constrictive Pericarditis and Restrictive Cardiomyopathy. JACC Cardiovasc. Imaging. 2024;17:349&#x2013;360. doi: 10.1016/j.jcmg.2023.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.09.011</ArticleId><ArticleId IdType="pubmed">37943236</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy G., Cheng P.P., Yuan N., He B., Kwan A.C., Shun-Shin M.J., Alexander K.M., Ebinger J., Lungren M.P., Rader F., et al. High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy with Cardiovascular Deep Learning. JAMA Cardiol. 2022;7:386. doi: 10.1001/jamacardio.2021.6059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.6059</ArticleId><ArticleId IdType="pmc">PMC9008505</ArticleId><ArticleId IdType="pubmed">35195663</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Chao C.-J., Jeong J.J., Farina J.M., Seri A.R., Barry T., Newman H., Campany M., Abdou M., O&#x2019;Shea M., et al. Developing an Echocardiography-Based, Automatic Deep Learning Framework for the Differentiation of Increased Left Ventricular Wall Thickness Etiologies. J. Imaging. 2023;9:48. doi: 10.3390/jimaging9020048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging9020048</ArticleId><ArticleId IdType="pmc">PMC9964852</ArticleId><ArticleId IdType="pubmed">36826967</ArticleId></ArticleIdList></Reference><Reference><Citation>Narang A., Bae R., Hong H., Thomas Y., Surette S., Cadieu C., Chaudhry A., Martin R.P., McCarthy P.M., Rubenson D.S., et al. Utility of a Deep-Learning Algorithm to Guide Novices to Acquire Echocardiograms for Limited Diagnostic Use. JAMA Cardiol. 2021;6:624. doi: 10.1001/jamacardio.2021.0185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0185</ArticleId><ArticleId IdType="pmc">PMC8204203</ArticleId><ArticleId IdType="pubmed">33599681</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E.K., Vaid A., Holste G., Coppi A., McNamara R.L., Baloescu C., Krumholz H.M., Wang Z., Apakama D.J., Nadkarni G.N., et al. Artificial Intelligence-Guided Detection of Under-Recognised Cardiomyopathies on Point-of-Care Cardiac Ultrasonography: A Multicentre Study. Lancet Digit. Health. 2025;7:e113&#x2013;e123. doi: 10.1016/S2589-7500(24)00249-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(24)00249-8</ArticleId><ArticleId IdType="pmc">PMC12084816</ArticleId><ArticleId IdType="pubmed">39890242</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang D., He B., Ghorbani A., Yuan N., Ebinger J., Langlotz C.P., Heidenreich P.A., Harrington R.A., Liang D.H., Ashley E.A., et al. Video-Based AI for Beat-To-Beat Assessment of Cardiac Function. Nature. 2020;580:252&#x2013;256. doi: 10.1038/s41586-020-2145-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2145-8</ArticleId><ArticleId IdType="pmc">PMC8979576</ArticleId><ArticleId IdType="pubmed">32269341</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh C., Wright L., Baumann A., Seidel B., Yu C., Nolan M., Mylius T., Marwick T.H., AGILE-Echo Investigators An Artificial Intelligence-Guided Echocardiography in Primary Care Patients from Rural and Remote Communities: The AGILE-Echo Study. Heart Lung Circ. 2024;33:S161. doi: 10.1016/j.hlc.2024.06.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2024.06.083</ArticleId><ArticleId IdType="pubmed">39128659</ArticleId></ArticleIdList></Reference><Reference><Citation>Delbarre M.-A., Girardon F., Roquette L., Blanc-Durand P., Hubaut M.-A., Hachulla &#xc9;., Semah F., Huglo D., Garcelon N., Marchal E., et al. Deep Learning on Bone Scintigraphy to Detect Abnormal Cardiac Uptake at Risk of Cardiac Amyloidosis. JACC Cardiovasc. Imaging. 2023;16:1085&#x2013;1095. doi: 10.1016/j.jcmg.2023.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.01.014</ArticleId><ArticleId IdType="pubmed">37227330</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielvogel C.P., Haberl D., Mascherbauer K., Ning J., Kluge K., Traub-Weidinger T., Davies R.H., Pierce I., Patel K., Nakuz T., et al. Diagnosis and Prognosis of Abnormal Cardiac Scintigraphy Uptake Suggestive of Cardiac Amyloidosis Using Artificial Intelligence: A Retrospective, International, Multicentre, Cross-Tracer Development and Validation Study. Lancet Digit. Health. 2024;6:e251&#x2013;e260. doi: 10.1016/S2589-7500(23)00265-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00265-0</ArticleId><ArticleId IdType="pubmed">38519153</ArticleId></ArticleIdList></Reference><Reference><Citation>Halme H.-L., Ihalainen T., Suomalainen O., Loimaala A., M&#xe4;tzke S., Uusitalo V., Sipil&#xe4; O., Hippel&#xe4;inen E. Convolutional Neural Networks for Detection of Transthyretin Amyloidosis in 2D Scintigraphy Images. EJNMMI Res. 2022;12:27. doi: 10.1186/s13550-022-00897-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13550-022-00897-9</ArticleId><ArticleId IdType="pmc">PMC9079204</ArticleId><ArticleId IdType="pubmed">35524861</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggialetti N., Torrente A., Lorusso G., Villanova I., Ficco M., Gravina M., Ferrari C., Giordano L., Granata V., Rubini D., et al. Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review. J. Pers. Med. 2024;14:407. doi: 10.3390/jpm14040407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm14040407</ArticleId><ArticleId IdType="pmc">PMC11051560</ArticleId><ArticleId IdType="pubmed">38673034</ArticleId></ArticleIdList></Reference><Reference><Citation>Martini N., Aimo A., Barison A., Della Latta D., Vergaro G., Aquaro G.D., Ripoli A., Emdin M., Chiappino D., Chiappino S. Deep Learning to Diagnose Cardiac Amyloidosis from Cardiovascular Magnetic Resonance. J. Cardiovasc. Magn. Reson. 2020;22:84. doi: 10.1186/s12968-020-00690-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00690-4</ArticleId><ArticleId IdType="pmc">PMC7720569</ArticleId><ArticleId IdType="pubmed">33287829</ArticleId></ArticleIdList></Reference><Reference><Citation>Agibetov A., T&#xf6;rnquist K., Perez-Rodriguez D., Smistad E., Oliveira G.S., Rudd J., Rueckert D., J&#xf8;rstad O.K., &#xd8;stvik A., Blaschke T.F., et al. Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging. J. Pers. Med. 2021;11:1268. doi: 10.3390/jpm11121268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11121268</ArticleId><ArticleId IdType="pmc">PMC8705947</ArticleId><ArticleId IdType="pubmed">34945740</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckstein J., Moghadasi N., K&#xf6;rperich H., Weise Vald&#xe9;s E., Sciacca V., Paluszkiewicz L., Burchert W., Piran M. A Machine Learning Challenge: Detection of Cardiac Amyloidosis Based on Bi-Atrial and Right Ventricular Strain and Cardiac Function. Diagnostics. 2022;12:2693. doi: 10.3390/diagnostics12112693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12112693</ArticleId><ArticleId IdType="pmc">PMC9689404</ArticleId><ArticleId IdType="pubmed">36359536</ArticleId></ArticleIdList></Reference><Reference><Citation>Garofalo M., Piccoli L., Romeo M., Barzago M.M., Ravasio S., Foglierini M., Matkovic M., Sgrignani J., De Gasparo R., Prunotto M., et al. Machine Learning Analyses of Antibody Somatic Mutations Predict Immunoglobulin Light Chain Toxicity. Nat. Commun. 2021;12:3532. doi: 10.1038/s41467-021-23880-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23880-9</ArticleId><ArticleId IdType="pmc">PMC8192768</ArticleId><ArticleId IdType="pubmed">34112780</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R. Transforming Cardiovascular Care with Artificial Intelligence: From Discovery to Practice. J. Am. Coll. Cardiol. 2024;84:97&#x2013;114. doi: 10.1016/j.jacc.2024.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.05.003</ArticleId><ArticleId IdType="pubmed">38925729</ArticleId></ArticleIdList></Reference><Reference><Citation>Olawade D.B., Adertinto N., Olatunji G., Kokori E., David-Olawade A.C., Hadi M. Advancements and Applications of Artificial Intelligence in Cardiology: Current Trends and Future Prospects. J. Med. Surg. Public Health. 2024;3:100109. doi: 10.1016/j.glmedi.2024.100109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.glmedi.2024.100109</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40541228</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1361-6560</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Physics in medicine and biology</Title><ISOAbbreviation>Phys Med Biol</ISOAbbreviation></Journal><ArticleTitle>Analysis and generation of the fibrosis textures based on histology data of the human hearts with non-ischemic cardiomyopathy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1088/1361-6560/ade6bb</ELocationID><Abstract><AbstractText><i>Objective.</i>Cardiac arrhythmias, marked by irregular and/or fast heartbeats, can severely compromise heart function and pose serious health risks. Fibrosis alters the propagation of electrical signals in the heart and plays a critical role in arrhythmogenesis. The impact of fibrosis depends not only on its amount, but also on its geometric features and spatial distribution. Therefore, understanding and replicating the structural characteristics of fibrotic tissue is essential for accurate arrhythmia modeling, particularly in computational and AI-based studies.<i>Approach.</i>We analyzed a dataset of histological images from ten patients with non-ischemic cardiomyopathy (NICM) and sustained ventricular tachycardia. A statistical evaluation was performed on key geometric descriptors of fibrosis-size, elongation, orientation, and solidity-all of which influence the pro-arrhythmic potential of the tissue. To address the challenge of generating realistic fibrotic textures, we proposed the direct sampling (DS) method. This geostatistical image synthesis technique was used to produce large-scale synthetic fibrosis textures based on real data.<i>Main results.</i>Fibrotic cluster size spans six orders of magnitude within individual hearts. Fibrosis is generally elongated, with median elongation values between 2.19 and 2.63 depending on the patient and the myocardial layer. It has preferential alignment within the myocardial wall, especially in the midwall layers. The solidity of the clusters decreases nearly logarithmically with increasing fibrosis size. The DS method successfully reproduces the complexity and heterogeneity of real fibrotic patterns and generates diverse structurally realistic samples from a single input texture.<i>Significance.</i>This study provides a comprehensive quantitative characterization of the geometric variability of fibrosis in NICM and demonstrates the effectiveness of the DS method in generating realistic non-ischemic fibrotic patterns. This work contributes to the development of more realistic heart models, which can enhance computational studies of arrhythmias.</AbstractText><CopyrightInformation>&#xa9; 2025 Institute of Physics and Engineering in Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Okenov</LastName><ForeName>Arstanbek</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0008-8435-9921</Identifier><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nezlobinsky</LastName><ForeName>Timur</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0009-1542</Identifier><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glashan</LastName><ForeName>Claire A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeppenfeld</LastName><ForeName>Katja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Leiden University Medical Center, 2333ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandersickel</LastName><ForeName>Nele</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panfilov</LastName><ForeName>Alexander V</ForeName><Initials>AV</Initials><Identifier Source="ORCID">0000-0003-2643-642X</Identifier><AffiliationInfo><Affiliation>Department of Physics and Astronomy, Ghent University, 9000 Ghent, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Phys Med Biol</MedlineTA><NlmUniqueID>0401220</NlmUniqueID><ISSNLinking>0031-9155</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="Y">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="Y">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmias</Keyword><Keyword MajorTopicYN="N">cardiac fibrosis</Keyword><Keyword MajorTopicYN="N">cardiac modeling</Keyword><Keyword MajorTopicYN="N">direct sampling</Keyword><Keyword MajorTopicYN="N">image generation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>18</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40541228</ArticleId><ArticleId IdType="doi">10.1088/1361-6560/ade6bb</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40555010</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence for Detection of Prognostically Significant Left Ventricular Dysfunction From Echocardiography.</ArticleTitle><Pagination><StartPage>101891</StartPage><MedlinePgn>101891</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101891</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.101891</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00311-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identification of left ventricular (LV) dysfunction following echocardiographic investigations remains problematic, particularly when the ejection fraction (EF) is preserved.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The authors examined the operational characteristics of artificial intelligence LV dysfunction (AI-LVD) identification from routinely obtained echocardiographic measurements.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Following initial training in 126,136 (imputation cohort) and 254,735 (training cohort) cases from the National Echo Database of Australia, the AI-LVD was tested in 81,509 cases (last echo January 1, 2000-May 21, 2019) with no mitral valve intervention or pacemaker. This cohort comprised 41,796 men (51.3%) aged 62.3 &#xb1; 17.1 years and 39,713 women aged 63.2 &#xb1; 18.4 years, in whom 4,490 (5.5%), 3,734 (4.6%), and 59,297 (72.7%) had reduced, mildly reduced, and preserved EF, while 13,988 (17.2%) had no recorded EF and 39,940 (45.2%) had "indeterminate" filling pressures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, the AI-LVD generated a (sex-specific) output in decile distributions consistent with increasingly higher levels of LV dysfunction and mortality-actual 5-year mortality rising from 5.7% to 66.3% and 2.3% to 64.2% in men and women, respectively. The prognostic capacity of the AI-LVD persisted in preserved EF, when adjusting for age, year of echo, and missing echo parameters-with adjusted hazard for all-cause mortality during 1,541 (812-2,682) days follow-up 4.93-fold (95% CI: 4.35-5.59) and 7.11-fold (95% CI: 5.85-8.64) higher in the highest vs lowest decile group in men and women, respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A new AI-LVD algorithm using only echocardiographic measurements can reliably identify prognostically important LV dysfunction, including in preserved EF, even when key reporting parameters are missing. The AI-LVD can be used in real-time during routine echocardiography reporting.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Playford</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Health Research, The University of Notre Dame Australia, Fremantle, Western Australia, Australia. Electronic address: dplayford@neda.net.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Health Research, The University of Notre Dame Australia, Fremantle, Western Australia, Australia; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Echo IQ Ltd, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kezurer</LastName><ForeName>Dean</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Echo IQ Ltd, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Yih-Kai</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strange</LastName><ForeName>Geoff</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Health Research, The University of Notre Dame Australia, Fremantle, Western Australia, Australia; Heart Research Institute, University of Sydney, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">left ventricular dysfunction</Keyword><Keyword MajorTopicYN="N">systolic dysfunction</Keyword></KeywordList><CoiStatement>Funding support and author disclosures Dr Playford has received consulting fees from Echo IQ and investigator fees from NEDA. Dr Stewart is supported by the National Health and Medical Research Council of Australia (GNT1135894); has received consulting fees from Echo IQ and NEDA; and is the Director of Research for NEDA. Dr Watts is an employee of Echo IQ. Dr Strange has received consulting fees from Echo IQ and investigator fees from NEDA. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>25</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>18</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40555010</ArticleId><ArticleId IdType="pmc">PMC12240068</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.101891</ArticleId><ArticleId IdType="pii">S2772-963X(25)00311-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McDonagh T.A., Metra M., Adamo M., et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599&#x2013;3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich P.A., Bozkurt B., Aguilar D., et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79(17):e263&#x2013;e421.</Citation><ArticleIdList><ArticleId IdType="pubmed">35379503</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh T.A., Metra M., Adamo M., et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44:3627&#x2013;3639. doi: 10.1093/eurheartj/ehad195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad195</ArticleId><ArticleId IdType="pubmed">37622666</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddox T.M., Januzzi J.L., Allen L.A., et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction. J Am Coll Cardiol. 2024;83:1444&#x2013;1488. doi: 10.1016/j.jacc.2023.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.12.024</ArticleId><ArticleId IdType="pubmed">38466244</ArticleId></ArticleIdList></Reference><Reference><Citation>Anker S.D., Butler J., Filippatos G., et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385:1451&#x2013;1461. doi: 10.1056/NEJMoa2107038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107038</ArticleId><ArticleId IdType="pubmed">34449189</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M.E., Windsor S.L., Borlaug B.A., et al. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021;27:1954&#x2013;1960. doi: 10.1038/s41591-021-01536-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01536-x</ArticleId><ArticleId IdType="pmc">PMC8604725</ArticleId><ArticleId IdType="pubmed">34711976</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon S.D., McMurray J.J.V., Claggett B., et al. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med. 2022;387:1089&#x2013;1098. doi: 10.1056/nejmoa2206286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2206286</ArticleId><ArticleId IdType="pubmed">36027570</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasinska-Piadlo A., Campbell P. Management of patients with heart failure and preserved ejection fraction. Heart. 2023;109:874&#x2013;883. doi: 10.1136/heartjnl-2022-321097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2022-321097</ArticleId><ArticleId IdType="pmc">PMC10314029</ArticleId><ArticleId IdType="pubmed">36948571</ArticleId></ArticleIdList></Reference><Reference><Citation>Playford D., Strange G., Celermajer D.S., et al. Diastolic dysfunction and mortality in 436 360 men and women: the National Echo Database Australia (NEDA) Eur Heart J Cardiovasc Imag. 2020;22:505&#x2013;515. doi: 10.1093/ehjci/jeaa253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa253</ArticleId><ArticleId IdType="pmc">PMC8081414</ArticleId><ArticleId IdType="pubmed">33245344</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S., Playford D., Scalia G.M., et al. Ejection fraction and mortality: a nationwide register based cohort study of 499,153 women and men. Eur J Heart Fail. 2020;23:406&#x2013;416. doi: 10.1002/ejhf.2047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2047</ArticleId><ArticleId IdType="pubmed">33150657</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan S.S., Beach L.B., Yancy C.W. Sex-based differences in heart failure: JACC Focus Seminar 7/7. J Am Coll Cardiol. 2022;79:1530&#x2013;1541. doi: 10.1016/j.jacc.2022.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.02.013</ArticleId><ArticleId IdType="pubmed">35422249</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange G., Celermajer D.S., Marwick T., et al. The National Echocardiography Database Australia (NEDA): rationale and methodology. Am Heart J. 2018;204:186&#x2013;189. doi: 10.1016/j.ahj.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2018.07.001</ArticleId><ArticleId IdType="pubmed">30098706</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J.F., Korevaar D.A., Altman D.G., et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;6 doi: 10.1136/bmjopen-2016-012799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012799</ArticleId><ArticleId IdType="pmc">PMC5128957</ArticleId><ArticleId IdType="pubmed">28137831</ArticleId></ArticleIdList></Reference><Reference><Citation>Strange G., Stewart S., Watts A., Playford D. Enhanced detection of severe aortic stenosis via artificial intelligence: a clinical cohort study. Open Heart. 2023;10 doi: 10.1136/openhrt-2023-002265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2023-002265</ArticleId><ArticleId IdType="pmc">PMC10373677</ArticleId><ArticleId IdType="pubmed">37491129</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom J.B., Playford D., Stewart S., Strange G. An artificial intelligence algorithm for detection of severe aortic stenosis. JACC Adv. 2024;3 doi: 10.1016/j.jacadv.2024.101176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101176</ArticleId><ArticleId IdType="pmc">PMC11450902</ArticleId><ArticleId IdType="pubmed">39372458</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.M., Cikes M., Prasad N., et al. Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2019;74:2858&#x2013;2873. doi: 10.1016/j.jacc.2019.09.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.09.063</ArticleId><ArticleId IdType="pubmed">31806129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta P.P., Shrestha S., Berthon B., et al. Proposed requirements for cardiovascular imaging-related machine learning evaluation (PRIME): a checklist. JACC Cardiovasc Imaging. 2020;13:2017&#x2013;2035. doi: 10.1016/j.jcmg.2020.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.07.015</ArticleId><ArticleId IdType="pmc">PMC7953597</ArticleId><ArticleId IdType="pubmed">32912474</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein A., Kapelner A., Bleich J., Pitkin E. Peeking inside the black box: visualizing statistical learning with plots of individual conditional expectation. J Comput Graph Stat. 2015;24:44&#x2013;65. doi: 10.1080/10618600.2014.907095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10618600.2014.907095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233&#x2013;271. doi: 10.1093/ehjci/jev014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev014</ArticleId><ArticleId IdType="pubmed">25712077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S.F., Smiseth O.A., Appleton C.P., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321&#x2013;1360. doi: 10.1093/ehjci/jew082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jew082</ArticleId><ArticleId IdType="pubmed">27422899</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniades C., Oikonomou E.K. Artificial intelligence in cardiovascular imaging&#x2014;principles, expectations, and limitations. Eur Heart J. 2024;45:1322&#x2013;1326. doi: 10.1093/eurheartj/ehab678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab678</ArticleId><ArticleId IdType="pmc">PMC11015951</ArticleId><ArticleId IdType="pubmed">34557898</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer K.T., Arling B., Sevenster M., et al. Identifying errors and inconsistencies in real time while using facilitated echocardiographic reporting. J Am Soc Echocardiogr. 2015;28:88&#x2013;92.e81. doi: 10.1016/j.echo.2014.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.09.005</ArticleId><ArticleId IdType="pubmed">25441328</ArticleId></ArticleIdList></Reference><Reference><Citation>He B., Kwan A.C., Cho J.H., et al. Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature. 2023;616:520&#x2013;524. doi: 10.1038/s41586-023-05947-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05947-3</ArticleId><ArticleId IdType="pmc">PMC10115627</ArticleId><ArticleId IdType="pubmed">37020027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp J., Sarra C., Nidhal B., et al. Nurse-led home-based detection of cardiac dysfunction by ultrasound: results of the CUMIN pilot study. Eur Heart J Digit Health. 2024;5:163&#x2013;169. doi: 10.1093/ehjdh/ztad079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztad079</ArticleId><ArticleId IdType="pmc">PMC10944680</ArticleId><ArticleId IdType="pubmed">38505488</ArticleId></ArticleIdList></Reference><Reference><Citation>Onishi T., Saha S.K., Delgado-Montero A., et al. Global longitudinal strain and global circumferential strain by speckle-tracking echocardiography and feature-tracking cardiac magnetic resonance imaging: comparison with left ventricular ejection fraction. J Am Soc Echocardiogr. 2015;28:587&#x2013;596. doi: 10.1016/j.echo.2014.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.11.018</ArticleId><ArticleId IdType="pubmed">25577185</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S.F., Khan S.U. Left atrial strain for assessment of left ventricular diastolic function: focus on populations with normal LVEF. JACC Cardiovasc Imaging. 2023;16:691&#x2013;707. doi: 10.1016/j.jcmg.2022.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.10.011</ArticleId><ArticleId IdType="pubmed">36752445</ArticleId></ArticleIdList></Reference><Reference><Citation>Raafs A.G., Boscutti A., Henkens M.T.H.M., et al. Global longitudinal strain is incremental to left ventricular ejection fraction for the prediction of outcome in optimally treated dilated cardiomyopathy patients. J Am Heart Assoc. 2022;11 doi: 10.1161/jaha.121.024505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.121.024505</ArticleId><ArticleId IdType="pmc">PMC9075270</ArticleId><ArticleId IdType="pubmed">35253464</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenewegen A., Rutten F.H., Mosterd A., Hoes A.W. Epidemiology of heart failure. Eur J Heart Fail. 2020;22:1342&#x2013;1356. doi: 10.1002/ejhf.1858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1858</ArticleId><ArticleId IdType="pmc">PMC7540043</ArticleId><ArticleId IdType="pubmed">32483830</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy Y.N.V., Carter R.E., Obokata M., Redfield M.M., Borlaug B.A. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138:861&#x2013;870. doi: 10.1161/circulationaha.118.034646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.118.034646</ArticleId><ArticleId IdType="pmc">PMC6202181</ArticleId><ArticleId IdType="pubmed">29792299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieske B., Tsch&#xf6;pe C., Boer R.A., et al. How to diagnose heart failure with preserved ejection fraction: the HFA&#x2013;PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Eur J Heart Fail. 2020;22:391&#x2013;412. doi: 10.1002/ejhf.1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1741</ArticleId><ArticleId IdType="pubmed">32133741</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Toquica A., Echeverr&#xed;a L.E., Arias-Barrera C.A., et al. Adherence to treatment guidelines in ambulatory heart failure patients with reduced ejection fraction in a Latin-American country: observational study of the Colombian Heart Failure Registry (RECOLFACA) Cardiology. 2024;149:1&#x2013;9. doi: 10.1159/000535916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000535916</ArticleId><ArticleId IdType="pmc">PMC11152016</ArticleId><ArticleId IdType="pubmed">38359813</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnicelli A.P., Li Z., Greiner M.A., et al. Sacubitril/valsartan adherence and postdischarge outcomes among patients hospitalized for heart failure with reduced ejection fraction. JACC Heart Fail. 2021;9:876&#x2013;886. doi: 10.1016/j.jchf.2021.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.06.018</ArticleId><ArticleId IdType="pubmed">34509408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40540063</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>The Impact of Artificial Intelligence on Women's Cardiovascular Disease Care.</ArticleTitle><Pagination><StartPage>98</StartPage><MedlinePgn>98</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-025-02250-7</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">To review current artificial intelligence (AI) applications impacting cardiovascular disease care in women.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Women differ from men in cardiovascular anatomy, physiology, presentation, and treatment response, yet face disparities due to underrepresentation in trials and referral bias. AI applications offer promising tools to close these gaps by enhancing screening, diagnosis, monitoring, and treatment. This review explores female representation, outcomes, and future directions in AI-driven advancements in coronary artery disease, heart failure with preserved ejection fraction, valvular heart disease, ischemic and nonischemic cardiomyopathies, including peripartum cardiovascular disease. AI holds the potential to transform cardiovascular disease care in women by leveraging multidimensional datasets for sex-specific screening, risk prediction, prognostic phenomapping and therapeutic decision support. Expanding female representation and integrating sex-specific factors in AI research are essential to minimize bias, ensure robust external validation and enable equitable, scalable implementation.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Jina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Harbor UCLA Medical Center, Torrance, CA, USA. jinachung@lundquist.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Geffen School of Medicine at UCLA, Los Angeles, CA, 90095, USA. jinachung@lundquist.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangathurai</LastName><ForeName>Jenica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Los Angeles General Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade-Bucknor</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Miami, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parashar</LastName><ForeName>Susmita</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Emory University, Decatur, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Karina Gonzalez</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Medicine of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epp</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Palos Verdes Peninsula High School, Palos Verdes Estates, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AdventHealth Medical Group Cardiology, Orlando, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016387" MajorTopicYN="Y">Women's Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial Intelligence</Keyword><Keyword MajorTopicYN="N">Deep Learning</Keyword><Keyword MajorTopicYN="N">Health Equity</Keyword><Keyword MajorTopicYN="N">Machine Learning</Keyword><Keyword MajorTopicYN="N">Sex-specific Differences</Keyword><Keyword MajorTopicYN="N">Women&#x2019;s Cardiovascular Disease</Keyword></KeywordList><CoiStatement>Declarations. Human and Animal Rights and Informed Consent: No animal or human subjects by the authors were used in this study. Competing Interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>12</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>20</Day><Hour>11</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40540063</ArticleId><ArticleId IdType="doi">10.1007/s11886-025-02250-7</ArticleId><ArticleId IdType="pii">10.1007/s11886-025-02250-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, et al. The lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385&#x2013;438. https://doi.org/10.1016/S0140-6736(21)00684-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00684-X</ArticleId><ArticleId IdType="pubmed">34010613</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women&#x2019;s participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141(7):540&#x2013;8. https://doi.org/10.1161/CIRCULATIONAHA.119.043594 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043594</ArticleId><ArticleId IdType="pubmed">32065763</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervoort D, Wang R, Li G, Filbey L, Maduka O, Brewer LC, et al. Addressing the global burden of cardiovascular disease in women: JACC State-of-the-Art review. J Am Coll Cardiol. 2024;83(25):2690&#x2013;707. https://doi.org/10.1016/j.jacc.2024.04.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.04.028</ArticleId><ArticleId IdType="pubmed">38897679</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarraju A, Ouyang D. Navigating the Gray Zone: AI Decision Support to Identify Aortic Stenosis Severity. JACC Adv. vol 9. United States2024. p. 101178.</Citation></Reference><Reference><Citation>Mihan A, Pandey A, Van Spall HG. Mitigating the risk of artificial intelligence bias in cardiovascular care. Lancet Digit Health. 2024;6(10):e749&#x2013;54. https://doi.org/10.1016/S2589-7500(24)00155-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(24)00155-9</ArticleId><ArticleId IdType="pubmed">39214762</ArticleId></ArticleIdList></Reference><Reference><Citation>Thamman R, Yong CM, Tran AH, Tobb K, Brandt EJ. Role of artificial intelligence in cardiovascular health disparities: the risk of greasing the slippery slope. JACC Adv. 2023;2(7):100578. https://doi.org/10.1016/j.jacadv.2023.100578 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2023.100578</ArticleId><ArticleId IdType="pubmed">38939488</ArticleId><ArticleId IdType="pmc">11198264</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990&#x2013;2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982&#x2013;3021. https://doi.org/10.1016/j.jacc.2020.11.010 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId><ArticleId IdType="pmc">7755038</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke Statistics-2021 update: A report from the American heart association. Circulation. 2021;143(8):e254&#x2013;743. https://doi.org/10.1161/CIR.0000000000000950 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000950</ArticleId><ArticleId IdType="pubmed">33501848</ArticleId></ArticleIdList></Reference><Reference><Citation>Mieres JH, Gulati M, Bairey Merz N, Berman DS, Gerber TC, Hayes SN, et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American heart association. Circulation. 2014;130(4):350&#x2013;79. https://doi.org/10.1161/CIR.0000000000000061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000061</ArticleId><ArticleId IdType="pubmed">25047587</ArticleId></ArticleIdList></Reference><Reference><Citation>Crea F, Battipaglia I, Andreotti F. Sex differences in mechanisms, presentation and management of ischaemic heart disease. Atherosclerosis. 2015;241(1):157&#x2013;68. https://doi.org/10.1016/j.atherosclerosis.2015.04.802 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2015.04.802</ArticleId><ArticleId IdType="pubmed">25988360</ArticleId></ArticleIdList></Reference><Reference><Citation>Solola Nussbaum S, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex-Specific considerations in the presentation, diagnosis, and management of ischemic heart disease: JACC focus seminar 2/7. J Am Coll Cardiol. 2022;79(14):1398&#x2013;406. https://doi.org/10.1016/j.jacc.2021.11.065 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.11.065</ArticleId><ArticleId IdType="pubmed">35393022</ArticleId><ArticleId IdType="pmc">9009217</ArticleId></ArticleIdList></Reference><Reference><Citation>Iribarren C, Chandra M, Lee C, Sanchez G, Sam DL, Azamian FF, et al. Breast arterial calcification: a novel cardiovascular risk enhancer among postmenopausal women. Circ Cardiovasc Imaging. 2022;15(3):e013526. https://doi.org/10.1161/CIRCIMAGING.121.013526 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.121.013526</ArticleId><ArticleId IdType="pubmed">35290077</ArticleId><ArticleId IdType="pmc">8931858</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccenti L, Ben Jedida B, Minssen L, Nouri R, Bejjani LE, Remili H, et al. Evaluation of a deep learning-based software to automatically detect and quantify breast arterial calcifications on digital mammogram. Diagn Interv Imaging. 2024. https://doi.org/10.1016/j.diii.2024.10.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diii.2024.10.001</ArticleId><ArticleId IdType="pubmed">39490357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Min JK, Nasir K, Xie JX, Berman DS, Miedema MD, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC consortium. Eur Heart J. 2018;39(41):3727&#x2013;35. https://doi.org/10.1093/eurheartj/ehy534 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy534</ArticleId><ArticleId IdType="pubmed">30212857</ArticleId><ArticleId IdType="pmc">6209852</ArticleId></ArticleIdList></Reference><Reference><Citation>Commandeur F, Slomka PJ, Goeller M, Chen X, Cadet S, Razipour A, et al. Machine learning to predict the long-term risk of myocardial infarction and cardiac death based on clinical risk, coronary calcium, and epicardial adipose tissue: a prospective study. Cardiovasc Res. 2020;116(14):2216&#x2013;25. https://doi.org/10.1093/cvr/cvz321 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz321</ArticleId><ArticleId IdType="pubmed">31853543</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann S, Renker M, Schoepf UJ, De Cecco CN, Coenen A, De Geer J, et al. Gender differences in the diagnostic performance of machine learning coronary CT angiography-derived fractional flow reserve -results from the MACHINE registry. Eur J Radiol. 2019;119:108657. https://doi.org/10.1016/j.ejrad.2019.108657 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2019.108657</ArticleId><ArticleId IdType="pubmed">31521876</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Rifai M, Ahmed AI, Han Y, Saad JM, Alnabelsi T, Nabi F, et al. Sex differences in machine learning computed tomography-derived fractional flow reserve. Sci Rep. 2022;12(1):13861. https://doi.org/10.1038/s41598-022-17875-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17875-9</ArticleId><ArticleId IdType="pubmed">35974055</ArticleId><ArticleId IdType="pmc">9381799</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnib S, Chinnaiyan KM. Coronary computed tomography angiography: enhancing risk stratification and diagnosis of cardiovascular disease in women. Curr Treat Options Cardiovasc Med. 2019;21(10):62. https://doi.org/10.1007/s11936-019-0760-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11936-019-0760-1</ArticleId><ArticleId IdType="pubmed">31584125</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansoor H, Elgendy IY, Segal R, Bavry AA, Bian J. Risk prediction model for in-hospital mortality in women with ST-elevation myocardial infarction: A machine learning approach. Heart Lung. 2017;46(6):405&#x2013;11. https://doi.org/10.1016/j.hrtlng.2017.09.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2017.09.003</ArticleId><ArticleId IdType="pubmed">28992993</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasim S, Amir Rudin PNF, Malek S, Ibrahim KS, Wan Ahmad WA, Fong AYY, et al. Ensemble machine learning for predicting in-hospital mortality in Asian women with ST-elevation myocardial infarction (STEMI). Sci Rep. 2024;14(1):12378. https://doi.org/10.1038/s41598-024-61151-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-61151-x</ArticleId><ArticleId IdType="pubmed">38811643</ArticleId><ArticleId IdType="pmc">11137033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Di Franco A, Cao D, Giustino G, Bairey Merz CN, Fremes SE, et al. Sex-Related outcomes of medical, percutaneous, and surgical interventions for coronary artery disease: JACC focus seminar 3/7. J Am Coll Cardiol. 2022;79(14):1407&#x2013;25. https://doi.org/10.1016/j.jacc.2021.07.066 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.07.066</ArticleId><ArticleId IdType="pubmed">35393023</ArticleId><ArticleId IdType="pmc">12096526</ArticleId></ArticleIdList></Reference><Reference><Citation>Min HS, Ryu D, Kang SJ, Lee JG, Yoo JH, Cho H, et al. Prediction of coronary stent underexpansion by Pre-Procedural intravascular Ultrasound-Based deep learning. JACC Cardiovasc Interv. 2021;14(9):1021&#x2013;9. https://doi.org/10.1016/j.jcin.2021.01.033 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2021.01.033</ArticleId><ArticleId IdType="pubmed">33865741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tweet MS, Gulati R, Williamson EE, Vrtiska TJ, Hayes SN. Multimodality imaging for spontaneous coronary artery dissection in women. JACC Cardiovasc Imaging. 2016;9(4):436&#x2013;50. https://doi.org/10.1016/j.jcmg.2016.01.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2016.01.009</ArticleId><ArticleId IdType="pubmed">27056163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, et al. Spontaneous coronary artery dissection: current state of the science: A scientific statement from the American heart association. Circulation. 2018;137(19):e523&#x2013;57. https://doi.org/10.1161/CIR.0000000000000564 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000564</ArticleId><ArticleId IdType="pubmed">29472380</ArticleId><ArticleId IdType="pmc">5957087</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Pollak AW, Phillips SD, Smith TL, Svatikova A, Hayes SN, et al. Cardiovascular disease screening in women: leveraging artificial intelligence and digital tools. Circ Res. 2022;130(4):673&#x2013;90. https://doi.org/10.1161/CIRCRESAHA.121.319876 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319876</ArticleId><ArticleId IdType="pubmed">35175849</ArticleId><ArticleId IdType="pmc">8889564</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolub G, Khurshid S, Theriault-Lauzier P, Nolin Lapalme A, Tastet O, So D, et al. Revolutionising acute cardiac care with artificial intelligence: opportunities and challenges. Can J Cardiol. 2024;40(10):1813&#x2013;27. https://doi.org/10.1016/j.cjca.2024.06.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2024.06.011</ArticleId><ArticleId IdType="pubmed">38901544</ArticleId></ArticleIdList></Reference><Reference><Citation>Adlam D, Alfonso F, Maas A, Vrints C. European society of cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. Eur Heart J. 2018;39(36):3353&#x2013;68. https://doi.org/10.1093/eurheartj/ehy080 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy080</ArticleId><ArticleId IdType="pubmed">29481627</ArticleId><ArticleId IdType="pmc">6148526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffer FA, Tocchi M. C-73| advancing coronary imaging: augmented hybrid NIRF-IVUS technology for improved detection of coronary. J Soc Cardiovasc Angiography Interventions. 2024;3(5). https://doi.org/10.1016/j.jscai.2024.101894 .</Citation></Reference><Reference><Citation>Bednarek A, Gumi&#x119;&#x17c;na K, Baru&#x15b; P, Kochman J, Tomaniak M. Artificial intelligence in imaging for personalized management of coronary artery disease. J Clin Med. 2025;14(2). https://doi.org/10.3390/jcm14020462 .</Citation></Reference><Reference><Citation>Shafi I, Maruthi R, Khalid MU, Juarez JJ, Zhao H, Lakhter V, et al. Derivation and validation of spontaneous coronary artery dissection prediction score in patients with myocardial infarction. Am J Cardiol. 2023;201:170&#x2013;6. https://doi.org/10.1016/j.amjcard.2023.05.051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2023.05.051</ArticleId><ArticleId IdType="pubmed">37385171</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Arockiam AD, bhagat u, Haroun E, Majid M, Wang TKM. Abstract 4138217: A machine Learning-Based novel risk score model for spontaneous coronary artery dissection. Circulation. 2024;150(Suppl1):A4138217&#x2013;A. https://doi.org/10.1161/circ.150.suppl_1.4138217 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.150.suppl_1.4138217</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittanawong C, Virk HUH, Kumar A, Aydar M, Wang Z, Stewart MP, et al. Machine learning and deep learning to predict mortality in patients with spontaneous coronary artery dissection. Sci Rep. 2021;11(1):8992. https://doi.org/10.1038/s41598-021-88172-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88172-0</ArticleId><ArticleId IdType="pubmed">33903608</ArticleId><ArticleId IdType="pmc">8076284</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke Statistics-2017 update: A report from the American heart association. Circulation. 2017;135(10):e146&#x2013;603. https://doi.org/10.1161/CIR.0000000000000485 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000485</ArticleId><ArticleId IdType="pubmed">28122885</ArticleId><ArticleId IdType="pmc">5408160</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer S, van der Meer P, Massie BM, O&#x2019;Connor CM, Metra M, Ponikowski P, et al. Sex-specific acute heart failure phenotypes and outcomes from PROTECT. Eur J Heart Fail. 2013;15(12):1374&#x2013;81. https://doi.org/10.1093/eurjhf/hft115 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjhf/hft115</ArticleId><ArticleId IdType="pubmed">24259042</ArticleId></ArticleIdList></Reference><Reference><Citation>Parashar S, Katz R, Smith NL, Arnold AM, Vaccarino V, Wenger NK, et al. Race, gender, and mortality in adults&#x2009;&gt;&#x2009;or =&#x2009;65 years of age with incident heart failure (from the cardiovascular health Study). Am J Cardiol. 2009;103(8):1120&#x2013;7. https://doi.org/10.1016/j.amjcard.2008.12.043 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.12.043</ArticleId><ArticleId IdType="pubmed">19361600</ArticleId><ArticleId IdType="pmc">4122325</ArticleId></ArticleIdList></Reference><Reference><Citation>Armoundas AA, Narayan SM, Arnett DK, Spector-Bagdady K, Bennett DA, Celi LA, et al. Use of artificial intelligence in improving outcomes in heart disease: A scientific statement from the American heart association. Circulation. 2024;149(14):e1028&#x2013;50. https://doi.org/10.1161/CIR.0000000000001201 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001201</ArticleId><ArticleId IdType="pubmed">38415358</ArticleId><ArticleId IdType="pmc">11042786</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi DJ, Park JJ, Ali T, Lee S. Artificial intelligence for the diagnosis of heart failure. NPJ Digit Med. 2020;3:54. https://doi.org/10.1038/s41746-020-0261-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0261-3</ArticleId><ArticleId IdType="pubmed">32285014</ArticleId><ArticleId IdType="pmc">7142093</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R, Pisu F, Suri JS, Montisci R, Gatti M, Mannelli L, et al. Artificial intelligence in the differential diagnosis of cardiomyopathy phenotypes. Diagnostics (Basel). 2024;14(2). https://doi.org/10.3390/diagnostics14020156 .</Citation></Reference><Reference><Citation>Zhao J, Feng Q, Wu P, Lupu RA, Wilke RA, Wells QS, et al. Sci Rep. 2019;9(1):717. https://doi.org/10.1038/s41598-018-36745-x . Learning from Longitudinal Data in Electronic Health Record and Genetic Data to Improve Cardiovascular Event Prediction.</Citation></Reference><Reference><Citation>Gottlieb M, Schraft E, O&#x2019;Brien J, Patel D. Diagnostic accuracy of artificial intelligence for identifying systolic and diastolic cardiac dysfunction in the emergency department. Am J Emerg Med. 2024;86:115&#x2013;9. https://doi.org/10.1016/j.ajem.2024.10.019 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2024.10.019</ArticleId><ArticleId IdType="pubmed">39426020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Deng Y, Liu Y, Su X, Zeng X. Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy. BMC Cardiovasc Disord. 2023;23(1):476. https://doi.org/10.1186/s12872-023-03520-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03520-4</ArticleId><ArticleId IdType="pubmed">37752424</ArticleId><ArticleId IdType="pmc">10521456</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti SS, Martin-Gill C, Z&#xe8;gre-Hemsey JK, Bouzid Z, Faramand Z, Alrawashdeh MO, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023;29(7):1804&#x2013;13. https://doi.org/10.1038/s41591-023-02396-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02396-3</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId><ArticleId IdType="pmc">10353937</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz R, &#xd6;z E. Comparison of electrocardiographic parameters by gender in heart failure patients with preserved ejection fraction via artificial intelligence. Diagnostics (Basel). 2023;13(20). https://doi.org/10.3390/diagnostics13203221 .</Citation></Reference><Reference><Citation>Krittanawong C, Rogers AJ, Aydar M, Choi E, Johnson KW, Wang Z, et al. Integrating blockchain technology with artificial intelligence for cardiovascular medicine. Nat Rev Cardiol. 2020;17(1):1&#x2013;3. https://doi.org/10.1038/s41569-019-0294-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0294-y</ArticleId><ArticleId IdType="pubmed">31605093</ArticleId><ArticleId IdType="pmc">8186804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaji DA, Zech JR, Kim JS, Cho SK, Dangayach NS, Costa AB, et al. An attention based deep learning model of clinical events in the intensive care unit. PLoS ONE. 2019;14(2):e0211057. https://doi.org/10.1371/journal.pone.0211057 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0211057</ArticleId><ArticleId IdType="pubmed">30759094</ArticleId><ArticleId IdType="pmc">6373907</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzokov J, Alyavi A, Alyavi B, Abdullaev A. How artificial intelligence can assist with ischaemic heart disease. Eur Heart J. 2024;45(21):1866&#x2013;8. https://doi.org/10.1093/eurheartj/ehae030 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae030</ArticleId><ArticleId IdType="pubmed">38339876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibrewala A, Yancy CW. Heart failure with preserved ejection fraction in women. Heart Fail Clin. 2019;15(1):9&#x2013;18. https://doi.org/10.1016/j.hfc.2018.08.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hfc.2018.08.002</ArticleId><ArticleId IdType="pubmed">30449384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotomi Y, Hikoso S, Nakatani D, Mizuno H, Okada K, Dohi T, et al. Sex differences in heart failure with preserved ejection fraction. J Am Heart Association. 2021;10(5):e018574. https://doi.org/10.1161/JAHA.120.018574 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.018574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabassian M, Sunderji I, Erdei T, Sanchez-Martinez S, Degiovanni A, Marino P, et al. Diagnosis of heart failure with preserved ejection fraction: machine learning of Spatiotemporal variations in left ventricular deformation. J Am Soc Echocardiogr. 2018;31(12):1272&#x2013;e849. https://doi.org/10.1016/j.echo.2018.07.013 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2018.07.013</ArticleId><ArticleId IdType="pubmed">30146187</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerman AP, Porumb M, Scott CG, Beqiri A, Chartsias A, Ryu AJ, et al. Automated echocardiographic detection of heart failure with preserved ejection fraction using artificial intelligence. JACC Adv. 2023;2(6):100452. https://doi.org/10.1016/j.jacadv.2023.100452 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2023.100452</ArticleId><ArticleId IdType="pubmed">38939447</ArticleId><ArticleId IdType="pmc">11198161</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters AE, Tromp J, Shah SJ, Lam CSP, Lewis GD, Borlaug BA, et al. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions. Cardiovasc Res. 2023;118(18):3403&#x2013;15. https://doi.org/10.1093/cvr/cvac179 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvac179</ArticleId><ArticleId IdType="pubmed">36448685</ArticleId></ArticleIdList></Reference><Reference><Citation>Segar MW, Patel KV, Ayers C, Basit M, Tang WHW, Willett D, et al. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. Eur J Heart Fail. 2020;22(1):148&#x2013;58. https://doi.org/10.1002/ejhf.1621 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1621</ArticleId><ArticleId IdType="pubmed">31637815</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia F, Limongelli G, Autore C, Gimeno-Blanes JR, Basso C, Elliott P. Sex-related differences in cardiomyopathies. Int J Cardiol. 2019;286:239&#x2013;43. https://doi.org/10.1016/j.ijcard.2018.10.091 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.10.091</ArticleId><ArticleId IdType="pubmed">30409740</ArticleId></ArticleIdList></Reference><Reference><Citation>Butters A, Lakdawala NK, Ingles J. Sex differences in hypertrophic cardiomyopathy: interaction with genetics and environment. Curr Heart Fail Rep. 2021;18(5):264&#x2013;73. https://doi.org/10.1007/s11897-021-00526-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-021-00526-x</ArticleId><ArticleId IdType="pubmed">34478112</ArticleId><ArticleId IdType="pmc">8484093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2020;142(25):e558&#x2013;631. https://doi.org/10.1161/cir.0000000000000937 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/cir.0000000000000937</ArticleId><ArticleId IdType="pubmed">33215931</ArticleId></ArticleIdList></Reference><Reference><Citation>van Driel B, Nijenkamp L, Huurman R, Michels M, van der Velden J. Sex differences in hypertrophic cardiomyopathy: new insights. Curr Opin Cardiol. 2019;34(3):254&#x2013;9. https://doi.org/10.1097/HCO.0000000000000612 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000612</ArticleId><ArticleId IdType="pubmed">30747730</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (Young) adults. Circulation. 1995;92(4):785&#x2013;9. https://doi.org/10.1161/01.cir.92.4.785 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.92.4.785</ArticleId><ArticleId IdType="pubmed">7641357</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes LR, Aung N, van Duijvenboden S, Munroe PB, Elliott PM, Petersen SE. Prevalence of hypertrophic cardiomyopathy in the UK biobank population. JAMA Cardiol. 2021;6(7):852&#x2013;4. https://doi.org/10.1001/jamacardio.2021.0689 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0689</ArticleId><ArticleId IdType="pubmed">33851951</ArticleId><ArticleId IdType="pmc">8047757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko WY, Siontis KC, Attia ZI, Carter RE, Kapa S, Ommen SR, et al. Detection of hypertrophic cardiomyopathy using a convolutional neural Network-Enabled electrocardiogram. J Am Coll Cardiol. 2020;75(7):722&#x2013;33. https://doi.org/10.1016/j.jacc.2019.12.030 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.12.030</ArticleId><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordine L, Canciello G, Borrelli F, Lombardi R, Di Napoli S, Polizzi R, et al. Artificial intelligence-driven electrocardiography: innovations in hypertrophic cardiomyopathy management. Trends Cardiovasc Med. 2025;35(2):126&#x2013;34. https://doi.org/10.1016/j.tcm.2024.08.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2024.08.002</ArticleId><ArticleId IdType="pubmed">39147002</ArticleId></ArticleIdList></Reference><Reference><Citation>Narula S, Shameer K, Salem Omar AM, Dudley JT, Sengupta PP. Machine-Learning algorithms to Automate morphological and functional assessments in 2D echocardiography. J Am Coll Cardiol. 2016;68(21):2287&#x2013;95. https://doi.org/10.1016/j.jacc.2016.08.062 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.08.062</ArticleId><ArticleId IdType="pubmed">27884247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang ZC, Fan ZZ, Liu XY, Zhu MJ, Jiang SS, Tian S, et al. Deep learning for discrimination of hypertrophic cardiomyopathy and hypertensive heart disease on MRI native T1 maps. J Magn Reson Imaging. 2024;59(3):837&#x2013;48. https://doi.org/10.1002/jmri.28904 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.28904</ArticleId><ArticleId IdType="pubmed">37431848</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel S, Vashisht K, John S, Abraham D, Bansal V, Nawaz F, ARTIFICIAL INTELLIGENCE MODELS FOR DIAGNOSIS AND PROGNOSIS IN HYPERTROPHIC CARDIOMYOPATHY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS, et al. J Am Coll Cardiol. 2024;83(13Supplement):438. https://doi.org/10.1016/S0735-1097(24)02428-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(24)02428-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrick RT, Ahamed H, Sung E, Maron MS, Madias C, Avula V, et al. Identification of high-risk imaging features in hypertrophic cardiomyopathy using electrocardiography: A deep-learning approach. Heart Rhythm. 2024;21(8):1390&#x2013;7. https://doi.org/10.1016/j.hrthm.2024.01.031 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2024.01.031</ArticleId><ArticleId IdType="pubmed">38280624</ArticleId></ArticleIdList></Reference><Reference><Citation>Togo S, Sugiura Y, Suzuki S, Ohno K, Akita K, Suwa K, et al. Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram. Open Heart. 2023;10(2). https://doi.org/10.1136/openhrt-2023-002414 .</Citation></Reference><Reference><Citation>Kroi F, Fischer N, Gezin A, Hashim M, Rozenbaum MH. Estimating the gender distribution of patients with Wild-Type transthyretin amyloid cardiomyopathy: A systematic review and Meta-Analysis. Cardiol Ther. 2021;10(1):41&#x2013;55. https://doi.org/10.1007/s40119-020-00205-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40119-020-00205-3</ArticleId><ArticleId IdType="pubmed">33315233</ArticleId></ArticleIdList></Reference><Reference><Citation>Grogan M, Lopez-Jimenez F, Cohen-Shelly M, Dispenzieri A, Attia ZI, Abou Ezzedine OF et al. Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin Proc. 2021;96(11):2768-78. https://doi.org/10.1016/j.mayocp.2021.04.023</Citation></Reference><Reference><Citation>Harmon DM, Mangold K, Suarez AB, Scott CG, Murphree DH, Malik A, et al. Postdevelopment performance and validation of the artificial Intelligence-Enhanced electrocardiogram for detection of cardiac amyloidosis. JACC Adv. 2023;2(8). https://doi.org/10.1016/j.jacadv.2023.100612 .</Citation></Reference><Reference><Citation>Adams DH, Tang GHL, Whisenant BK, Kodali SK, Singh GD, Fam NP, et al. Transcatheter Edge-to-Edge repair in patients with complex tricuspid valve anatomy. JACC Cardiovasc Interv. 2024;17(23):2749&#x2013;60. https://doi.org/10.1016/j.jcin.2024.08.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2024.08.035</ArticleId><ArticleId IdType="pubmed">39663056</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams C, Gorrie N, Raftopulos N, Olsen N, Bart N, AI FOR THE DETECTION OF CARDIAC, AMYLOIDOSIS: INSIGHTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS. J Am Coll Cardiol. 2024;83(13Supplement):400. https://doi.org/10.1016/S0735-1097(24)02390-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(24)02390-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub-Weidinger T, et al. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study. Lancet Digit Health. 2024;6(4):e251&#x2013;60. https://doi.org/10.1016/s2589-7500(23)00265-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(23)00265-0</ArticleId><ArticleId IdType="pubmed">38519153</ArticleId></ArticleIdList></Reference><Reference><Citation>Manhil D, Crawford Thomas C, Bogun Frank M, Gu X, Chicos Alexandru B, Roukoz H, SEX DIFFERENCES IN CARDIAC SARCOIDOSIS TREATMENT AND OUTCOMES: FINDINGS FROM THE CARDIAC SARCOIDOSIS CONSORTIUM, et al. JACC. 2024;83(13Supplement):397. https://doi.org/10.1016/S0735-1097(24)02387-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(24)02387-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsushika S, Kodera S, Nakamoto M, Ninomiya K, Kakuda N, Shinohara H, et al. Deep learning algorithm to detect cardiac sarcoidosis from echocardiographic movies. Circ J. 2021;86(1):87&#x2013;95. https://doi.org/10.1253/circj.CJ-21-0265 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-21-0265</ArticleId><ArticleId IdType="pubmed">34176867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HY, Doh JH, Jang SY, Kim EK, Hahn JY, Kim DK. Gender differences in clinical profiles of Stress-Induced cardiomyopathy. J Cardiovasc Ultrasound. 2017;25(4):111&#x2013;7. https://doi.org/10.4250/jcu.2017.25.4.111 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4250/jcu.2017.25.4.111</ArticleId><ArticleId IdType="pubmed">29333217</ArticleId><ArticleId IdType="pmc">5762693</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Perone F, Leung KSK, Ullah I, Lee Q, Chew N, et al. The utility of artificial intelligence and machine learning in the diagnosis of Takotsubo cardiomyopathy: A systematic review. Heart Mind. 2024;8(3):165&#x2013;76. https://doi.org/10.4103/hm.HM-D-23-00061 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/hm.HM-D-23-00061</ArticleId></ArticleIdList></Reference><Reference><Citation>Laumer F, Di Vece D, Cammann VL, W&#xfc;rdinger M, Petkova V, Sch&#xf6;nberger M, et al. Assessment of artificial intelligence in echocardiography diagnostics in differentiating Takotsubo syndrome from myocardial infarction. JAMA Cardiol. 2022;7(5):494&#x2013;503. https://doi.org/10.1001/jamacardio.2022.0183 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2022.0183</ArticleId><ArticleId IdType="pubmed">35353118</ArticleId><ArticleId IdType="pmc">8968683</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanaji Y, Ozcan I, Tryon DN, Ahmad A, Sara JDS, Lewis B, et al. Predictive value of artificial Intelligence-Enabled electrocardiography in patients with Takotsubo cardiomyopathy. J Am Heart Assoc. 2024;13(5):e031859. https://doi.org/10.1161/jaha.123.031859 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.123.031859</ArticleId><ArticleId IdType="pubmed">38390798</ArticleId><ArticleId IdType="pmc">10944041</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink DA, Kilday D, Cao Z, Larson K, Smith A, Lipkin C, et al. Trends in maternal mortality and severe maternal morbidity during Delivery-Related hospitalizations in the united states, 2008 to 2021. JAMA Netw Open. 2023;6(6):e2317641. https://doi.org/10.1001/jamanetworkopen.2023.17641 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.17641</ArticleId><ArticleId IdType="pubmed">37347486</ArticleId><ArticleId IdType="pmc">10288331</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahid S, Jha S, Kaur G, Jung YH, Minhas AS, Hays AG, et al. PARCCS: A machine learning Risk-Prediction model for acute peripartum cardiovascular complications during delivery admissions. JACC Adv. 2024;3(8):101095. https://doi.org/10.1016/j.jacadv.2024.101095 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101095</ArticleId><ArticleId IdType="pubmed">39135918</ArticleId><ArticleId IdType="pmc">11318475</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman MK, Ma N, Roberts A. A machine learning algorithm for predicting maternal readmission for hypertensive disorders of pregnancy. Am J Obstet Gynecol MFM. 2021;3(1):100250. https://doi.org/10.1016/j.ajogmf.2020.100250 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajogmf.2020.100250</ArticleId><ArticleId IdType="pubmed">33451620</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Choi B, Lee MS, Jin U, Yoon S, Jo YY, et al. An artificial intelligence electrocardiogram analysis for detecting cardiomyopathy in the peripartum period. Int J Cardiol. 2022;352:72&#x2013;7. https://doi.org/10.1016/j.ijcard.2022.01.064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.01.064</ArticleId><ArticleId IdType="pubmed">35122911</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Johnson PW, Douglass EJ, Attia IZ, Phillips SD, Goswami RM, et al. Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model. Eur Heart J Digit Health. 2021;2(4):586&#x2013;96. https://doi.org/10.1093/ehjdh/ztab078 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztab078</ArticleId><ArticleId IdType="pubmed">34993486</ArticleId><ArticleId IdType="pmc">8715757</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Morales-Lara AC, Afolabi BB, Kushimo OA, Mbakwem AC, Ibiyemi KF, et al. Artificial intelligence guided screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical trial. Nat Med. 2024;30(10):2897&#x2013;906. https://doi.org/10.1038/s41591-024-03243-9 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-03243-9</ArticleId><ArticleId IdType="pubmed">39223284</ArticleId><ArticleId IdType="pmc">11485252</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Li W, Xiang M. Burden of valvular heart disease, 1990&#x2013;2017: results from the global burden of disease study 2017. J Glob Health. 2020;10(2):020404. https://doi.org/10.7189/jogh.10.020404 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.10.020404</ArticleId><ArticleId IdType="pubmed">33110570</ArticleId><ArticleId IdType="pmc">7568921</ArticleId></ArticleIdList></Reference><Reference><Citation>Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e35&#x2013;71. https://doi.org/10.1161/CIR.0000000000000932 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000932</ArticleId><ArticleId IdType="pubmed">33332149</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers A, Lavoie N, Le Nezet E, Clavel MA. Unique aspects of women&#x2019;s valvular heart diseases: impact for diagnosis and treatment. CJC Open. 2024;6(2Part B):503&#x2013;16. https://doi.org/10.1016/j.cjco.2023.10.017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2023.10.017</ArticleId><ArticleId IdType="pubmed">38487043</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner N, Puls M, Baldus S, Lubos E, Bekeredjian R, Sievert H, et al. Gender-related differences in patients undergoing transcatheter mitral valve interventions in clinical practice: 1-year results from the German TRAMI registry. Catheter Cardiovasc Interv. 2020;95(4):819&#x2013;29. https://doi.org/10.1002/ccd.28372 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.28372</ArticleId><ArticleId IdType="pubmed">31233278</ArticleId></ArticleIdList></Reference><Reference><Citation>Bach DS, Radeva JI, Birnbaum HG, Fournier AA, Tuttle EG. Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind? J Heart Valve Dis. 2007;16(4):362&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17702360</ArticleId></ArticleIdList></Reference><Reference><Citation>Bienjonetti-Boudreau D, Fleury MA, Voisine M, Paquin A, Chouinard I, Tailleur M, et al. Impact of sex on the management and outcome of aortic stenosis patients. Eur Heart J. 2021;42(27):2683&#x2013;91. https://doi.org/10.1093/eurheartj/ehab242 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab242</ArticleId><ArticleId IdType="pubmed">34023890</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias P, Poterucha TJ, Rajaram V, Moller LM, Rodriguez V, Bhave S, et al. Deep learning electrocardiographic analysis for detection of Left-Sided valvular heart disease. J Am Coll Cardiol. 2022;80(6):613&#x2013;26. https://doi.org/10.1016/j.jacc.2022.05.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.05.029</ArticleId><ArticleId IdType="pubmed">35926935</ArticleId></ArticleIdList></Reference><Reference><Citation>Uretsky S, Aldaia L, Marcoff L, Koulogiannis K, Argulian E, Lasam G, et al. Concordance and discordance of echocardiographic parameters recommended for assessing the severity of mitral regurgitation. Circ Cardiovasc Imaging. 2020;13(5):e010278. https://doi.org/10.1161/CIRCIMAGING.119.010278 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.119.010278</ArticleId><ArticleId IdType="pubmed">32408828</ArticleId></ArticleIdList></Reference><Reference><Citation>Biner S, Rafique A, Rafii F, Tolstrup K, Noorani O, Shiota T, et al. Reproducibility of proximal isovelocity surface area, Vena contracta, and regurgitant jet area for assessment of mitral regurgitation severity. JACC Cardiovasc Imaging. 2010;3(3):235&#x2013;43. https://doi.org/10.1016/j.jcmg.2009.09.029 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2009.09.029</ArticleId><ArticleId IdType="pubmed">20223419</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrudhula A, Duffy G, Vukadinovic M, Liang D, Cheng S, Ouyang D. High-Throughput deep learning detection of mitral regurgitation. Circulation. 2024;150(12):923&#x2013;33. https://doi.org/10.1161/CIRCULATIONAHA.124.069047 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.124.069047</ArticleId><ArticleId IdType="pubmed">39129623</ArticleId><ArticleId IdType="pmc">11404758</ArticleId></ArticleIdList></Reference><Reference><Citation>Namasivayam M, Myers PD, Guttag JV, Capoulade R, Pibarot P, Picard MH, et al. Predicting outcomes in patients with aortic stenosis using machine learning: the aortic stenosis risk (ASteRisk) score. Open Heart. 2022;9(1). https://doi.org/10.1136/openhrt-2022-001990 .</Citation></Reference><Reference><Citation>Bohbot Y, Raiti&#xe8;re O, Guignant P, Ariza M, Diouf M, Rusinaru D, et al. Unsupervised clustering of patients with severe aortic stenosis: A myocardial continuum. Arch Cardiovasc Dis. 2022;115(11):578&#x2013;87. https://doi.org/10.1016/j.acvd.2022.06.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2022.06.007</ArticleId><ArticleId IdType="pubmed">36241549</ArticleId></ArticleIdList></Reference><Reference><Citation>Strom JB, Playford D, Stewart S, Strange G. An artificial intelligence algorithm for detection of severe aortic stenosis: A clinical cohort study. JACC Adv. 2024;3(9):101176. https://doi.org/10.1016/j.jacadv.2024.101176 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101176</ArticleId><ArticleId IdType="pubmed">39372458</ArticleId><ArticleId IdType="pmc">11450902</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghpour A, Jiang Z, Hummel YM, Frost M, Lam CSP, Shah SJ, et al. An automated machine Learning-Based quantitative multiparametric approach for mitral regurgitation severity grading. JACC Cardiovasc Imaging. 2025;18(1):1&#x2013;12. https://doi.org/10.1016/j.jcmg.2024.06.011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2024.06.011</ArticleId><ArticleId IdType="pubmed">39152959</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich S, Gro&#xdf; S, K&#xf6;nig IR, Engelhardt S, Bahls M, Heinz J, et al. Applications of artificial intelligence/machine learning approaches in cardiovascular medicine: a systematic review with recommendations. Eur Heart J Digit Health. 2021;2(3):424&#x2013;36. https://doi.org/10.1093/ehjdh/ztab054 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztab054</ArticleId><ArticleId IdType="pubmed">36713608</ArticleId><ArticleId IdType="pmc">9707954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham JW, Abraham WT, Bhatt AS, Dunn J, Felker GM, Jain SS, et al. Artificial intelligence in cardiovascular clinical trials. J Am Coll Cardiol. 2024;84(20):2051&#x2013;62. https://doi.org/10.1016/j.jacc.2024.08.069 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.08.069</ArticleId><ArticleId IdType="pubmed">39505413</ArticleId><ArticleId IdType="pmc">12178241</ArticleId></ArticleIdList></Reference><Reference><Citation>Moosavi A, Huang S, Vahabi M, Motamedivafa B, Tian N, Mahmood R, et al. Prospective human validation of artificial intelligence interventions in cardiology: A scoping review. JACC Adv. 2024;3(9):101202. https://doi.org/10.1016/j.jacadv.2024.101202 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101202</ArticleId><ArticleId IdType="pubmed">39372457</ArticleId><ArticleId IdType="pmc">11450923</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40564486</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2306-5354</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>Bioengineering (Basel, Switzerland)</Title><ISOAbbreviation>Bioengineering (Basel)</ISOAbbreviation></Journal><ArticleTitle>An Innovative Artificial Intelligence Classification Model for Non-Ischemic Cardiomyopathy Utilizing Cardiac Biomechanics Derived from Magnetic Resonance Imaging.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">670</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/bioengineering12060670</ELocationID><Abstract><AbstractText>Significant challenges persist in diagnosing non-ischemic cardiomyopathies (NICMs) owing to early morphological overlap and subtle functional changes. While cardiac magnetic resonance (CMR) offers gold-standard structural assessment, current morphology-based AI models frequently overlook key biomechanical dysfunctions like diastolic/systolic abnormalities. To address this, we propose a dual-path hybrid deep learning framework based on CNN-LSTM and MLP, integrating anatomical features from cine CMR with biomechanical markers derived from intraventricular pressure gradients (IVPGs), significantly enhancing NICM subtype classification by capturing subtle biomechanical dysfunctions overlooked by traditional morphological models. Our dual-path architecture combines a CNN-LSTM encoder for cine CMR analysis and an MLP encoder for IVPG time-series data, followed by feature fusion and dense classification layers. Trained on a multicenter dataset of 1196 patients and externally validated on 137 patients from a distinct institution, the model achieved a superior performance (internal AUC: 0.974; external AUC: 0.962), outperforming ResNet50, VGG16, and radiomics-based SVM. Ablation studies confirmed IVPGs' significant contribution, while gradient saliency and gradient-weighted class activation mapping (Grad-CAM) visualizations proved the model pays attention to physiologically relevant cardiac regions and phases. The framework maintained robust generalizability across imaging protocols and institutions with minimal performance degradation. By synergizing biomechanical insights with deep learning, our approach offers an interpretable, data-efficient solution for early NICM detection and subtype differentiation, holding strong translational potential for clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Liqiang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Chinese PLA Medical School, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Peifang</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>BioMind Technology Inc., Beijing 101318, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Liuquan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100048, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhi</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Chinese PLA Medical School, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiayu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chinese PLA Medical School, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaolei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chinese PLA Medical School, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ziwen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Chinese PLA Medical School, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Kunlun</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3335-5700</Identifier><AffiliationInfo><Affiliation>Medical Innovation Research Department, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Research and Evaluation of Artificial Intelligence Medical Devices, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Engineering Laboratory, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Biomedical Engineering and Translational Medicine, Ministry of Industry and Information Technology, Chinese PLA General Hospital, Beijing 100853, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AHQ140010000X</GrantID><Agency>Construction Project</Agency><Country/></Grant><Grant><GrantID>2021ZD0140408</GrantID><Agency>National Science and Technology Major Project of the Ministry of Science and Technology of China</Agency><Country/></Grant><Grant><GrantID>2021ZD0140406</GrantID><Agency>National Key R and D Program of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Bioengineering (Basel)</MedlineTA><NlmUniqueID>101676056</NlmUniqueID><ISSNLinking>2306-5354</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomechanical analysis</Keyword><Keyword MajorTopicYN="N">cardiac MRI</Keyword><Keyword MajorTopicYN="N">convolutional neural network</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">generative adversarial network</Keyword><Keyword MajorTopicYN="N">intraventricular pressure gradient</Keyword><Keyword MajorTopicYN="N">non-ischemic cardiomyopathy</Keyword></KeywordList><CoiStatement>Author Peifang Zhang was employed by the company BioMind Technology Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40564486</ArticleId><ArticleId IdType="pmc">PMC12189867</ArticleId><ArticleId IdType="doi">10.3390/bioengineering12060670</ArticleId><ArticleId IdType="pii">bioengineering12060670</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Garcia-Pavia P., Rapezzi C., Adler Y., Arad M., Basso C., Brucato A., Burazor I., Caforio A.L.P., Damy T., Eriksson U., et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. J. Heart Fail. 2021;23:512&#x2013;526. doi: 10.1002/ejhf.2140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2140</ArticleId><ArticleId IdType="pubmed">33826207</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.E., Oh J., Hong Y.J., Kim D., Yu H.T., Lee C.J., Kim T.H., Uhm J.S., Joung B., Pak H.N., et al. Tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy. EP Eur. 2025;27:euaf043. doi: 10.1093/europace/euaf043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euaf043</ArticleId><ArticleId IdType="pmc">PMC11982015</ArticleId><ArticleId IdType="pubmed">40205768</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbero&#x11f;lu E., Stoeck C.T., Kozerke S., Genet M. Quantification of left ventricular strain and torsion by joint analysis of 3D tagging and cine MR images. Med. Image Anal. 2022;82:102598. doi: 10.1016/j.media.2022.102598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.media.2022.102598</ArticleId><ArticleId IdType="pubmed">36049451</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor R.J., Moody W.E., Umar F., Edwards N.C., Taylor T.J., Stegemann B., Townend J.N., Hor K.N., Steeds R.P., Mazur W., et al. Myocardial strain measurement with feature-tracking cardiovascular magnetic resonance: Normal values. Eur. Heart J. Cardiovasc. Imaging. 2015;16:871&#x2013;881. doi: 10.1093/ehjci/jev006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev006</ArticleId><ArticleId IdType="pubmed">25711353</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S., Falk V., Gonz&#xe1;lez-Juanatey J.R., Harjola V.P., Jankowska E.A., et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Rev. Esp. Cardiol. 2016;69:1167. doi: 10.1016/j.rec.2016.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2016.11.005</ArticleId><ArticleId IdType="pubmed">27894487</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo M., Gagno G., Baritussio A., Bauce B., Biagini E., Canepa M., Cipriani A., Castelletti S., Dellegrottaglie S., Guaricci A.I., et al. Clinical application of CMR in cardiomyopathies: Evolving concepts and techniques. Heart Fail. Rev. 2023;28:77&#x2013;95. doi: 10.1007/s10741-022-10235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-022-10235-9</ArticleId><ArticleId IdType="pmc">PMC9902331</ArticleId><ArticleId IdType="pubmed">35536402</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E., Ibrahim E.H., Parwani P., Bhave N., Stojanovska J. Practical Guide to Evaluating Myocardial Disease by Cardiac MRI. AJR Am. J. Roentgenol. 2020;214:546&#x2013;556. doi: 10.2214/AJR.19.22076.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.19.22076</ArticleId><ArticleId IdType="pubmed">31967503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaskaran A., De Silva K., Kumar S. Contemporary updates on ventricular arrhythmias: From mechanisms to management. Intern. Med. J. 2023;53:892&#x2013;906. doi: 10.1111/imj.15976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imj.15976</ArticleId><ArticleId IdType="pmc">PMC10947276</ArticleId><ArticleId IdType="pubmed">36369893</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J.A., Patel A.R. The role of multimodality imaging in cardiomyopathy. Curr. Cardiol. Rep. 2024;26:689&#x2013;703. doi: 10.1007/s11886-024-02068-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-024-02068-9</ArticleId><ArticleId IdType="pmc">PMC11236518</ArticleId><ArticleId IdType="pubmed">38753290</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima M., Chen D., Basnet R., Benovoy M., Hwang T.H., Geschke R., Grimm R.A., Kapadia S.R., Svensson L.G., Griffin B.P., et al. Comparison of deep learning and radiomic features to differentiate non-ischemic and ischemic cardiomyopathy using cardiac MRI cine imaging. Circulation. 2021;144:A12691. doi: 10.1161/circ.144.suppl_1.12691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.144.suppl_1.12691</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakashima M., Cockrum J., Salam D., Mazumder S., Sreedhara K., Kapadia S.R., Svensson L.G., Grimm R.A., Nguyen C., Tang W.H.W., et al. Segmentation improves deep learning accuracy for differentiating non-ischemic and ischemic cardiomyopathy using cardiac MRI cine imaging. Circulation. 2022;146:A15522. doi: 10.1161/circ.146.suppl_1.15522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.146.suppl_1.15522</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R., Pisu F., Pintus A., Palmisano V., Montisci R., Suri J.S., Salgado R., Saba L. Cine-cardiac magnetic resonance to distinguish between ischemic and non-ischemic cardiomyopathies: A machine learning approach. Eur. Radiol. 2024;34:5691&#x2013;5704. doi: 10.1007/s00330-024-10640-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-024-10640-8</ArticleId><ArticleId IdType="pmc">PMC11364683</ArticleId><ArticleId IdType="pubmed">38451322</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S., Zhang L., Wang J., Li X., Hu S., Fu Y., Wang X., Hao S., Hu C. Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics. Front. Cardiovasc. Med. 2022;9:1001269. doi: 10.3389/fcvm.2022.1001269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1001269</ArticleId><ArticleId IdType="pmc">PMC9643770</ArticleId><ArticleId IdType="pubmed">36386316</ArticleId></ArticleIdList></Reference><Reference><Citation>Avard E., Shiri I., Hajianfar G., Abdollahi H., Kalantari K.R., Houshmand G., Kasani K., Bitarafan-Rajabi A., Deevband M.R., Oveisi M., et al. Non-contrast cine cardiac magnetic resonance image radiomics features and machine learning algorithms for myocardial infarction detection. Comput. Biol. Med. 2022;141:105145. doi: 10.1016/j.compbiomed.2021.105145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105145</ArticleId><ArticleId IdType="pubmed">34929466</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R., Kerfoot E., Mauger C., Ismail T.F., Young A.A., Nordsletten D.A. An implementation of patient-specific biventricular mechanics simulations with a deep learning and computational pipeline. Front. Physiol. 2021;12:716597. doi: 10.3389/fphys.2021.716597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.716597</ArticleId><ArticleId IdType="pmc">PMC8481785</ArticleId><ArticleId IdType="pubmed">34603077</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulkareem M., Kenawy A.A., Rauseo E., Lee A.M., Sojoudi A., Amir-Khalili A., Lekadir K., Young A.A., Barnes M.R., Barckow P., et al. Predicting post-contrast information from contrast agent free cardiac MRI using machine learning: Challenges and methods. Front. Cardiovasc. Med. 2022;9:894503. doi: 10.3389/fcvm.2022.894503.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.894503</ArticleId><ArticleId IdType="pmc">PMC9426684</ArticleId><ArticleId IdType="pubmed">36051279</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand S., Janardhanan R. Role of cardiac MRI in nonischemic cardiomyopathies. Indian Heart J. 2016;68:405&#x2013;409. doi: 10.1016/j.ihj.2015.09.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ihj.2015.09.032</ArticleId><ArticleId IdType="pmc">PMC4912037</ArticleId><ArticleId IdType="pubmed">27316506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Jia H., Song J. Accurate classification of non-ischemic cardiomyopathy. Curr. Cardiol. Rep. 2023;25:1299&#x2013;1317. doi: 10.1007/s11886-023-01944-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01944-0</ArticleId><ArticleId IdType="pmc">PMC10651539</ArticleId><ArticleId IdType="pubmed">37721634</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Zhou L., Liao B., Cai Q., Luo G., Zhou H., Tang H. Challenges in clinical translation of cardiac magnetic resonance imaging radiomics in non-ischemic cardiomyopathy: A narrative review. Cardiovasc. Diagn. Ther. 2024;14:1210&#x2013;1227. doi: 10.21037/cdt-24-138.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/cdt-24-138</ArticleId><ArticleId IdType="pmc">PMC11707483</ArticleId><ArticleId IdType="pubmed">39790204</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Husseiny H.M., Mady E.A., Ma D., Hamabe L., Takahashi K., Tanaka R. Intraventricular pressure gradient: A novel tool to assess the post-infarction chronic congestive heart failure. Front. Cardiovasc. Med. 2022;9:944171. doi: 10.3389/fcvm.2022.944171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.944171</ArticleId><ArticleId IdType="pmc">PMC9425054</ArticleId><ArticleId IdType="pubmed">36051280</ArticleId></ArticleIdList></Reference><Reference><Citation>Konijnenberg L.S., Beijnink C.W., van Lieshout M., Vos J.L., Rodwell L., Bodi V., Ortiz-P&#xe9;rez J.T., van Royen N., Rodriguez Palomares J., Nijveldt R. Cardiovascular magnetic resonance imaging-derived intraventricular pressure gradients in ST-segment elevation myocardial infarction: A long-term follow-up study. Eur. Heart J. Imaging Methods Pract. 2024;2:qyae009. doi: 10.1093/ehjimp/qyae009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjimp/qyae009</ArticleId><ArticleId IdType="pmc">PMC11195698</ArticleId><ArticleId IdType="pubmed">39045208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirose M., Ma D., Shimada K., Yoshida T., Matsuura K., Kitpipatkun P., Hatanaka A., Zhao Y., Takahashi K., Tanaka R., et al. Effects of trans-mitral flow patterns and heart rate on intraventricular pressure gradients and E/E&#x2019; in the early stage of a rat model of hypertensive cardiomyopathy. Front. Vet. Sci. 2025;12:1507817. doi: 10.3389/fvets.2025.1507817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2025.1507817</ArticleId><ArticleId IdType="pmc">PMC11879942</ArticleId><ArticleId IdType="pubmed">40046410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Ma X., Dong Z., Chen X., Yang S., Chen X., Yang K., Zhao S. Cardiac magnetic resonance visualization of the myocardial microstructure in non-ischemic cardiomyopathies. Cardiovasc. Innov. Appl. 2024;9:e939. doi: 10.15212/CVIA.2024.0042.</Citation><ArticleIdList><ArticleId IdType="doi">10.15212/CVIA.2024.0042</ArticleId></ArticleIdList></Reference><Reference><Citation>Jumadilova D., Rakhmanov Y., Khissamutdinov N., Zhankorazova A., Toktarbay B., Khamitova Z., Zholshybek N., Bekbossynova M., Dautov T., Gaipov A., et al. Differences in cardiac mechanics assessed by left ventricular hemodynamic forces in athletes and patients with hypertension. Sci. Rep. 2024;14:27402. doi: 10.1038/s41598-024-78560-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-78560-7</ArticleId><ArticleId IdType="pmc">PMC11550801</ArticleId><ArticleId IdType="pubmed">39521868</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong H.S., Chan W.X., Mao W., Yap C.H. 3D velocity and pressure field reconstruction in the cardiac left ventricle via physics-informed neural network from echocardiography guided by 3D colour Doppler. Comput. Methods Programs Biomed. 2025;263:108671. doi: 10.1016/j.cmpb.2025.108671.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2025.108671</ArticleId><ArticleId IdType="pubmed">39993372</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers B.A. Ph.D. Dissertation. Purdue University; West Lafayette, IN, USA: 2021. Methods for Echocardiographic Biomechanical Measurements.</Citation></Reference><Reference><Citation>Fatehi Hassanabad A., Garcia J. Intra-cardiac kinetic energy and ventricular flow analysis in bicuspid aortic valve: Impact on left ventricular function, dilation severity, and surgical referral. Fluids. 2024;10:5. doi: 10.3390/fluids10010005.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/fluids10010005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura T., Nawaz S., Shahannaz D.C., Ferrell B.E., Yoshida T. From injury to repair: The therapeutic potential of induced pluripotent stem cells in heart failure. Regener. Med. Rep. 2025;2:22&#x2013;30. doi: 10.4103/REGENMED.REGENMED-D-25-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/REGENMED.REGENMED-D-25-00002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Zou Y., Qiao L., Lin L. Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples. Mol. Ther. 2024;32:3288&#x2013;3312. doi: 10.1016/j.ymthe.2024.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2024.08.030</ArticleId><ArticleId IdType="pmc">PMC11489546</ArticleId><ArticleId IdType="pubmed">39233439</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40593134</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Automated ejection fraction and risk stratification in cardiomyopathy patients with diverse LV geometry using 2D echocardiography.</ArticleTitle><Pagination><StartPage>22332</StartPage><MedlinePgn>22332</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22332</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-06738-8</ELocationID><Abstract><AbstractText>Cardiomyopathy often alters left ventricular geometry (LVG), impairing cardiac function. We developed a deep learning (DL) model to estimate left ventricular ejection fraction (LVEF) from echocardiographic images while accounting for LVG variability and assessed prognostic factors across LVG subtypes. For all patients with cardiomyopathy, we computed LV volume on apical two- and four-chamber views processed with novel DeepLabV3+ algorithm and calculate EF using Simpson's method. The model was pre-trained on public data, then validated in 120 patients classified into concentric hypertrophy (CH), eccentric hypertrophy (EH), concentric remodeling (CR), or normal geometry (NG). Outcomes included cardiac death and heart failure rehospitalization, analyzed via logistic and LASSO regression within each LVG subtype. The model achieved high LV segmentation accuracy, with an overall Dice similarity coefficient of 90.07% and IoU of 82.17%. Subgroup analysis on A4C images showed Dice/IoU values of 92.49%/86.34% (NG), 88.91%/80.11% (CR), 88.81%/80.23% (CH), and 89.75%/81.59% (EH). The mean absolute error in LVEF estimation was 4.70%, and Bland-Altman analysis showed a mean bias of&#xa0;0.95&#xa0;&#xb1;&#xa0;4.53% (95% limits, -&#xa0;7.92% to 9.82%; P&#x2009;=&#x2009;0.002) between AI-predicted and manual LVEF measurements. Subgroup analysis revealed r<sup>2</sup> values of 0.794 (CR), 0.526 (CH), and 0.968 (EH). During follow-up, 20 patients experienced adverse outcomes. LASSO regression identified predicted LVEF, E/e' ratio, and age as significant predictors, with AUC values of 0.833 (CR), 0.695 (CH), and 0.938 (EH) for adverse outcomes prediction. This DL model provides accurate LVEF estimates across diverse LVG subtypes, offering a geometry-specific tool for clinical assessment and risk stratification in cardiomyopathy.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Ziwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rare Disease Medical Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Science, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fan</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Computing Technology, Chinese Academy of Sciences, Rd Zhongguancun Kexueyuan No.6, Haidian District, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuyuan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rare Disease Medical Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Science, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jingyi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ze</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute of Computing Technology, Chinese Academy of Sciences, Rd Zhongguancun Kexueyuan No.6, Haidian District, Beijing, China. zhaoze@ict.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. jinye10564@pumch.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rare Disease Medical Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Science, Beijing, 100730, China. jinye10564@pumch.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Digital Medicine and Artificial Intelligence, National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Science, Beijing, 100730, China. jinye10564@pumch.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuyang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Peking Union Medical College Hospital (Dongdan Campus), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China. shuyangzhang103@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rare Disease Medical Center, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Science, Beijing, 100730, China. shuyangzhang103@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022ZD0116001</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-098</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-098</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-098</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant><Grant><GrantID>2022-PUMCH-B-098</GrantID><Agency>National High Level Hospital Clinical Research Funding</Agency><Country/></Grant><Grant><GrantID>No. 2021-I2M-1-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant><Grant><GrantID>No. 2021-I2M-1-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant><Grant><GrantID>No. 2021-I2M-1-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant><Grant><GrantID>No. 2021-I2M-1-003</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant><Grant><GrantID>No.2022YFC2703100</GrantID><Agency>the 14th Five-Year Key Research and Development Plan, Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>No.2022YFC2703100</GrantID><Agency>the 14th Five-Year Key Research and Development Plan, Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>No.2022YFC2703100</GrantID><Agency>the 14th Five-Year Key Research and Development Plan, Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>No.2022YFC2703100</GrantID><Agency>the 14th Five-Year Key Research and Development Plan, Ministry of Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006352" MajorTopicYN="Y">Heart Ventricles</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Left ventricular ejection fraction (LVEF)</Keyword><Keyword MajorTopicYN="N">Left ventricular geometry (LVG)</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>2</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40593134</ArticleId><ArticleId IdType="pmc">PMC12217971</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-06738-8</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-06738-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Draper, T. S. Jr. et al. Adverse structural remodeling of the left ventricle and ventricular arrhythmias in patients with depressed ejection fraction. <i>J. Card. Fail.</i><b>21</b>, 97&#x2013;102. 10.1016/j.cardfail.2014.10.018 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25463741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombelli, M. et al. Impact of the increase in left ventricular mass on the risk of long-term cardiovascular mortality: A prospective cohort study. <i>Hypertension</i><b>80</b>, 1321&#x2013;1330. 10.1161/hypertensionaha.122.19988 (2023).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37073730</ArticleId></ArticleIdList></Reference><Reference><Citation>Przewlocka-Kosmala, M., Kosmala, W. &amp; Mazurek, W. Left ventricular circumferential function in patients with essential hypertension. <i>J. Hum. Hypertens.</i><b>20</b>, 666&#x2013;671. 10.1038/sj.jhh.1002054 (2006).
</Citation><ArticleIdList><ArticleId IdType="pubmed">16738687</ArticleId></ArticleIdList></Reference><Reference><Citation>Soullier, C. et al. Exercise response in hypertrophic cardiomyopathy: Blunted left ventricular deformational and twisting reserve with altered systolic-diastolic coupling. <i>Circ Cardiovasc Imaging</i><b>5</b>, 324&#x2013;332. 10.1161/circimaging.111.968859 (2012).
</Citation><ArticleIdList><ArticleId IdType="pubmed">22414888</ArticleId></ArticleIdList></Reference><Reference><Citation>Thavendiranathan, P. et al. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: Application to patients undergoing cancer chemotherapy. <i>J. Am. Coll. Cardiol.</i><b>61</b>, 77&#x2013;84. 10.1016/j.jacc.2012.09.035 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23199515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Jimenez, F. et al. Artificial intelligence in cardiology: Present and future. <i>Mayo Clin. Proc.</i><b>95</b>, 1015&#x2013;1039. 10.1016/j.mayocp.2020.01.038 (2020).
</Citation><ArticleIdList><ArticleId IdType="pubmed">32370835</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang, D. et al. Video-based AI for beat-to-beat assessment of cardiac function. <i>Nature</i><b>580</b>, 252&#x2013;256. 10.1038/s41586-020-2145-8 (2020).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8979576</ArticleId><ArticleId IdType="pubmed">32269341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Development of automated neural network prediction for echocardiographic left ventricular ejection fraction. <i>Front. Med. (Lausanne)</i><b>11</b>, 1354070. 10.3389/fmed.2024.1354070 (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11057494</ArticleId><ArticleId IdType="pubmed">38686369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H. et al. Semi-supervised segmentation of echocardiography videos via noise-resilient spatiotemporal semantic calibration and fusion. <i>Med. Image Anal.</i><b>78</b>, 102397. 10.1016/j.media.2022.102397 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">35259635</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp, J. et al. Automated interpretation of systolic and diastolic function on the echocardiogram: A multicohort study. <i>Lancet Digit Health</i><b>4</b>, e46&#x2013;e54. 10.1016/s2589-7500(21)00235-1 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34863649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. Fully automated echocardiogram interpretation in clinical practice. <i>Circulation</i><b>138</b>, 1623&#x2013;1635. 10.1161/circulationaha.118.034338 (2018).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6200386</ArticleId><ArticleId IdType="pubmed">30354459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. C. et al. Encoder-decoder with atrous separable convolution for semantic image segmentation. in <i>Computer Vision &#x2013; ECCV 2018</i>. Lecture Notes in Computer Science, Vol. 11211 (eds Ferrari, V. et al) 10.1007/978-3-030-01234-2_49 (Springer, Cham, 2018). </Citation></Reference><Reference><Citation>Leclerc, S. et al. Deep learning for segmentation using an open large-scale dataset in 2D echocardiography. <i>IEEE Trans Med Imaging</i><b>38</b>, 2198&#x2013;2210. 10.1109/tmi.2019.2900516 (2019).
</Citation><ArticleIdList><ArticleId IdType="pubmed">30802851</ArticleId></ArticleIdList></Reference><Reference><Citation>Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of, Cardiovascular Imaging. <i>Eur Heart J Cardiovasc Imaging</i><b>17</b>, 412, 10.1093/ehjci/jew041 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26983884</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>Eur. Heart J. Cardiovasc. Imaging</i><b>16</b>, 233&#x2013;270. 10.1093/ehjci/jev014 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25712077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronneberger, O. et al. U-Net: Convolutional networks for biomedical image segmentation. in <i>Medical Image Computing and Computer-Assisted Intervention &#x2013; MICCAI 2015</i>. Lecture Notes in Computer Science, Vol. 9351 (eds Navab, N. et al.). 10.1007/978-3-319-24574-4_28 (Springer, Cham, 2015).</Citation></Reference><Reference><Citation>Zeng, Y. et al. MAEF-Net: Multi-attention efficient feature fusion network for left ventricular segmentation and quantitative analysis in two-dimensional echocardiography. <i>Ultrasonics</i><b>127</b>, 106855. 10.1016/j.ultras.2022.106855 (2023).
</Citation><ArticleIdList><ArticleId IdType="pubmed">36206610</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehdi, R. R. et al. Comparison of three machine learning methods to estimate myocardial stiffness. In <i>Reduced Order Models for the Biomechanics of Living Organs</i> 363-382. 10.1016/B978-0-32-389967-3.00025-1 (Elsevier Science Ltd., 2023). </Citation></Reference><Reference><Citation>Feigenbaum, H. Role of M-mode technique in today&#x2019;s echocardiography. <i>J. Am. Soc. Echocardiogr.</i><b>23</b>(240&#x2013;257), 335&#x2013;247. 10.1016/j.echo.2010.01.015 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20206828</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, W. C. et al. Beyond Simpson&#x2019;s Rule: Accounting for orientation and ellipticity assumptions. <i>Ultrasound. Med. Biol.</i><b>48</b>, 2476&#x2013;2485. 10.1016/j.ultrasmedbio.2022.07.013 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9810537</ArticleId><ArticleId IdType="pubmed">36137846</ArticleId></ArticleIdList></Reference><Reference><Citation>He, B. et al. Blinded, randomized trial of sonographer versus AI cardiac function assessment. <i>Nature</i><b>616</b>, 520&#x2013;524. 10.1038/s41586-023-05947-3 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115627</ArticleId><ArticleId IdType="pubmed">37020027</ArticleId></ArticleIdList></Reference><Reference><Citation>Alv&#xe9;n, J. et al. A deep multi-stream model for robust prediction of left ventricular ejection fraction in 2D echocardiography. <i>Sci. Rep.</i><b>14</b>, 2104. 10.1038/s41598-024-52480-y (2024).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10808096</ArticleId><ArticleId IdType="pubmed">38267630</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, T. et al. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: A rural cohort population study. <i>BMC Cardiovasc. Disord.</i><b>21</b>, 238. 10.1186/s12872-021-02055-w (2021).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8114526</ArticleId><ArticleId IdType="pubmed">33980151</ArticleId></ArticleIdList></Reference><Reference><Citation>Aro, A. L. et al. Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction. <i>Europace</i><b>19</b>, 1146&#x2013;1152. 10.1093/europace/euw126 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075451</ArticleId><ArticleId IdType="pubmed">27256423</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukadinovic, M. et al. Deep learning-enabled analysis of medical images identifies cardiac sphericity as an early marker of cardiomyopathy and related outcomes. <i>Med</i><b>4</b>, 252-262.e253. 10.1016/j.medj.2023.02.009 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10106428</ArticleId><ArticleId IdType="pubmed">36996817</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, H. et al. Deep learning algorithm to improve hypertrophic cardiomyopathy mutation prediction using cardiac cine images. <i>Eur. Radiol.</i><b>31</b>, 3931&#x2013;3940. 10.1007/s00330-020-07454-9 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33241513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, R. M. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J. Am. Soc. Echocardiogr.</i><b>28</b>, 1-39.e14. 10.1016/j.echo.2014.10.003 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzik, B. M. et al. Echocardiography predictors of survival in hypertensive patients with left ventricular hypertrophy. <i>Am. J. Hypertens.</i><b>34</b>, 636&#x2013;644. 10.1093/ajh/hpaa194 (2021).
</Citation><ArticleIdList><ArticleId IdType="pubmed">33950188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40589502</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1016-7315</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Journal of the Saudi Heart Association</Title><ISOAbbreviation>J Saudi Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence-enhanced Electrocardiography for Hypertrophic Cardiomyopathy Diagnosis: A Systematic Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>8</StartPage><MedlinePgn>8</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.37616/2212-5043.1431</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Diagnosing hypertrophic cardiomyopathy (HCM) can be challenging due to its nonspecific clinical manifestations, variability in electrocardiographic (ECG) patterns, and limited access to echocardiography, the gold standard for diagnosis, often leading to delayed detection. Recent artificial intelligence (AI) advancements have enabled ECG-based algorithms to improve HCM detection. This systematic review and meta-analysis aim to assess the overall diagnostic performance of AI-enhanced ECG in identifying HCM.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Articles were retrieved from PubMed, EBSCO, and Proquest. Inclusion criteria encompassed all studies evaluating AI algorithms for the detection of HCM from 12-lead ECGs. Meta-analysis was performed using R v4.4.1. Bivariate random-effects models were employed to derive pooled estimates of sensitivity, specificity, and the area under the curve (AUC) of the summary receiver operating characteristic (SROC).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of five retrospective cohort studies involving 69,343 participants, were included. The pooled sensitivity of AI-enhanced ECG for detecting HCM was 0.84, and the specificity was 0.86. The AI-enhanced ECG demonstrated excellent diagnostic accuracy, with an SROC-AUC of 0.927 in detecting HCM.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">AI-enhanced ECG shows promise as a novel screening tool for detecting hypertrophic cardiomyopathy. However, the considerable heterogeneity and the limited number of studies necessitate careful interpretation and highlight the need for additional research in the future.</AbstractText><CopyrightInformation>&#xa9; 2025 Saudi Heart Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theja</LastName><ForeName>Fernando A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jusni</LastName><ForeName>Louis F J</ForeName><Initials>LFJ</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soetedjo</LastName><ForeName>Robby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theja</LastName><ForeName>Dimetrio A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>J Saudi Heart Assoc</MedlineTA><NlmUniqueID>9887261</NlmUniqueID><ISSNLinking>1016-7315</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI-enhanced ECG</Keyword><Keyword MajorTopicYN="N">Diagnostic</Keyword><Keyword MajorTopicYN="N">Hypertrophic cardiomyopathy</Keyword></KeywordList><CoiStatement>Conflict of interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>9</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>9</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40589502</ArticleId><ArticleId IdType="pmc">PMC12207979</ArticleId><ArticleId IdType="doi">10.37616/2212-5043.1431</ArticleId><ArticleId IdType="pii">sha19</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017 Sep 15;121(7):749&#x2013;70. doi: 10.1161/circresaha.117.311059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circresaha.117.311059</ArticleId><ArticleId IdType="pmc">PMC5654557</ArticleId><ArticleId IdType="pubmed">28912181</ArticleId></ArticleIdList></Reference><Reference><Citation>Butzner M, Leslie DL, Cuffee Y, Hollenbeak CS, Sciamanna C, Abraham T. Stable rates of obstructive hypertrophic cardiomyopathy in a contemporary era. Front Cardiovasc Med. 2022 Jan 6;8:765876. doi: 10.3389/fcvm.2021.765876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.765876</ArticleId><ArticleId IdType="pmc">PMC8770922</ArticleId><ArticleId IdType="pubmed">35071348</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze M, Zema C, Carroll R, Hurst M, Borchert J, Zhong Y, et al. Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany. Eur Heart J. 2022 Oct 1;43(Supplement_2):ehac544&#x2013;1747. doi: 10.1093/eurheartj/ehac544.1747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac544.1747</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. AmJ Cardiol. 2016 May 15;117(10):1651&#x2013;4. doi: 10.1016/j.amjcard.2016.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.02.044</ArticleId><ArticleId IdType="pubmed">27006153</ArticleId></ArticleIdList></Reference><Reference><Citation>Task A, Elliott PM, Uk C, Anastasakis A, Germany MA, Germany MB, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35(39):2733&#x2013;79. doi: 10.1093/eurheartj/ehu284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu284</ArticleId><ArticleId IdType="pubmed">25173338</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard J, Barry J, Joseph A. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. JACC (J Am Coll Cardiol) 2011;58(23):735&#x2013;1097. doi: 10.1016/j.jacc.2011.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.06.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardini A, Crotti L, Olivotto I, Cecchi F. Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy. Eur Heart J Suppl. 2023 doi: 10.1093/eurheartjsupp/suad074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartjsupp/suad074</ArticleId><ArticleId IdType="pmc">PMC10132576</ArticleId><ArticleId IdType="pubmed">37125268</ArticleId></ArticleIdList></Reference><Reference><Citation>Palermi S, Cavarretta E, D&#x2019;Ascenzi F, Castelletti S, Ricci F, Vecchiato M, et al. Athlete&#x2019;s Heart: a cardiovascular step-by-step multimodality approach. Rev Cardiovasc Med. 2023 May 19;24(5):151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11273059</ArticleId><ArticleId IdType="pubmed">39076743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi A, Brunetti G, Corrado D. Differential diagnosis between athlete&#x2019;s heart and hypertrophic cardiomyopathy: new pieces of the puzzle. Int J Cardiol. 2022 Apr 15;353:77&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">35134446</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzammil MA, Javid S, Afridi AK, Siddineni R, Shahabi M, Haseeb M, et al. Artificial intelligence-enhanced electrocardiography for accurate diagnosis and management of cardiovascular diseases. J Electrocardiol. 2024. Jan 28,</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2024.01006</ArticleId><ArticleId IdType="pubmed">38301492</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis KC, Wieczorek MA, Maanja M, Hodge DO, Kim HK, Lee HJ, et al. Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study. European Heart Journal-Digital Health. 2024. Apr 15, p. ztae029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztae029</ArticleId><ArticleId IdType="pmc">PMC11284003</ArticleId><ArticleId IdType="pubmed">39081936</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis KC, Su&#xe1;rez AB, Sehrawat O, Ackerman MJ, Attia ZI, Friedman PA, et al. Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy. J Electrocardiol. 2023 Nov 1;81:286&#x2013;91. doi: 10.1016/j.jelectrocard.2023.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2023.07.002</ArticleId><ArticleId IdType="pubmed">37599145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko WY, Siontis KC, Attia ZI, Carter RE, Kapa S, Ommen SR, et al. Detection of hypertrophic cardiomyopathy using a convolutional neural network-enabled electrocardiogram. J Am Coll Cardiol. 2020 Feb 25;75(7):722&#x2013;33. doi: 10.1016/j.jacc.2019.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.12.030</ArticleId><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis KC, Liu K, Bos JM, Attia ZI, Cohen-Shelly M, Arruda-Olson AM, et al. Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents. Int J Cardiol. 2021 Oct 1;340:42&#x2013;7. doi: 10.1016/j.ijcard.2021.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.08.026</ArticleId><ArticleId IdType="pubmed">34419527</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota N, Suzuki S, Motogi J, Umemoto T, Nakai H, Matsuzawa W, et al. Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting. Heart Vessel. 2024 Jun;39(6):524&#x2013;38. doi: 10.1007/s00380-024-02367-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-024-02367-9</ArticleId><ArticleId IdType="pubmed">38553520</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 2021 Mar;29:372. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011 Oct 18;155(8):529&#x2013;36. doi: 10.7326/0003-4819-155-8-201110180-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-155-8-201110180-00009</ArticleId><ArticleId IdType="pubmed">22007046</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a metaanalysis with R: a practical tutorial. BMJ Ment Health. 2019 Nov 1;22(4):153&#x2013;60. doi: 10.1136/ebmental-2019-300117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Choi B, Lee MS, Jin U, Yoon S, Jo YY, et al. An artificial intelligence electrocardiogram analysis for detecting cardiomyopathy in the peripartum period. Int J Cardiol. 2022 doi: 10.1016/j.ijcard.2022.01.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.01.064</ArticleId><ArticleId IdType="pubmed">35122911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y, Su WW, Li X. Risk factors of sudden cardiac death in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2022 doi: 10.1097/HCO.0000000000000939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000939</ArticleId><ArticleId IdType="pmc">PMC8654272</ArticleId><ArticleId IdType="pubmed">34636345</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki Varnosfaderani S, Forouzanfar M. The role of AI in hospitals and clinics: transforming healthcare in the 21st century. Bioengineering. 2024 Mar 29;11(4):337. doi: 10.3390/bioengineering11040337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bioengineering11040337</ArticleId><ArticleId IdType="pmc">PMC11047988</ArticleId><ArticleId IdType="pubmed">38671759</ArticleId></ArticleIdList></Reference><Reference><Citation>Armoundas AA, Narayan SM, Arnett DK, Spector-Bagdady K, Bennett DA, Celi LA, et al. Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association. Circulation. 2024 doi: 10.1161/CIR0000000000001201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR0000000000001201</ArticleId><ArticleId IdType="pmc">PMC11042786</ArticleId><ArticleId IdType="pubmed">38415358</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigolli M, Anandabaskaran S, Christiansen JP, Whalley GA.Bias associated with left ventricular quantification by multi-modality imaging: a systematic review and meta-analysis Open Heart 2016 10.1136/openhrt-2015-000388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2015-000388</ArticleId><ArticleId IdType="pmc">PMC4854151</ArticleId><ArticleId IdType="pubmed">27158524</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner de Vargas V, Schneider Aranda JA, dos Santos Costa R, da Silva Pereira PR, Vict&#xf3;ria Barbosa JL. Imbalanced data preprocessing techniques for machine learning: a systematic mapping study. Knowl Inf Syst. 2023 doi: 10.1007/s10115-022-01772-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10115-022-01772-8</ArticleId><ArticleId IdType="pmc">PMC9645765</ArticleId><ArticleId IdType="pubmed">36405957</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40507801</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>11</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Induced Pluripotent Stem Cells in Cardiomyopathy: Advancing Disease Modeling, Therapeutic Development, and Regenerative Therapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4984</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms26114984</ELocationID><Abstract><AbstractText>Cardiomyopathies are a heterogeneous group of heart muscle diseases that can lead to heart failure, arrhythmias, and sudden cardiac death. Traditional animal models and in vitro systems have limitations in replicating the complex pathology of human cardiomyopathies. Induced pluripotent stem cells (iPSCs) offer a transformative platform by enabling the generation of patient-specific cardiomyocytes, thus opening new avenues for disease modeling, drug discovery, and regenerative therapy. This process involves reprogramming somatic cells into iPSCs and subsequently differentiating them into functional cardiomyocytes, which can be characterized using techniques such as electrophysiology, contractility assays, and gene expression profiling. iPSC-derived cardiomyocyte (iPSC-CM) platforms are also being explored for drug screening and personalized medicine, including high-throughput testing for cardiotoxicity and the identification of patient-tailored therapies. While iPSC-CMs already serve as valuable models for understanding disease mechanisms and screening drugs, ongoing advances in maturation and bioengineering are bringing iPSC-based therapies closer to clinical application. Furthermore, the integration of multi-omics approaches and artificial intelligence (AI) is enhancing the predictive power of iPSC models. iPSC-based technologies are paving the way for a new era of personalized cardiology, with the potential to revolutionize the management of cardiomyopathies through patient-specific insights and regenerative strategies.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vo</LastName><ForeName>Quan Duy</ForeName><Initials>QD</Initials><Identifier Source="ORCID">0000-0001-6100-5452</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Kazufumi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-8845-3626</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Advanced Heart Failure, Okayama University Hospital, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Yukihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Hospital, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akagi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9392-7117</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyoshi</LastName><ForeName>Toru</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9039-3439</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuasa</LastName><ForeName>Shinsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2024</GrantID><Agency>Miyata Foundation Bounty for Pediatric Cardiovascular Research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044968" MajorTopicYN="Y">Regenerative Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">disease modeling</Keyword><Keyword MajorTopicYN="N">drug screening</Keyword><Keyword MajorTopicYN="N">induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">regenerative therapy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>13</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40507801</ArticleId><ArticleId IdType="pmc">PMC12155407</ArticleId><ArticleId IdType="doi">10.3390/ijms26114984</ArticleId><ArticleId IdType="pii">ijms26114984</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Polovina M., Tsch&#xf6;pe C., Rosano G., Metra M., Crea F., Mullens W., Bauersachs J., Sliwa K., de Boer R.A., Farmakis D., et al. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies. Eur. J. Heart Fail. 2023;25:2144&#x2013;2163. doi: 10.1002/ejhf.3076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3076</ArticleId><ArticleId IdType="pubmed">37905371</ArticleId></ArticleIdList></Reference><Reference><Citation>Seferovi&#x107; P.M., Polovina M., Bauersachs J., Arad M., Ben Gal T., Lund L.H., Felix S.B., Arbustini E., Caforio A.L.P., Farmakis D., et al. Heart failure in cardiomyopathies: A position paper from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2019;21:553&#x2013;576. doi: 10.1002/ejhf.1461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1461</ArticleId><ArticleId IdType="pubmed">30989768</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin J.F., Oakley C.M. The cardiomyopathies. Br. Heart J. 1972;34:545&#x2013;552. doi: 10.1136/hrt.34.6.545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.34.6.545</ArticleId><ArticleId IdType="pmc">PMC458499</ArticleId><ArticleId IdType="pubmed">4402697</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D., Graziano F., Bauce B., Bueno Marinas M., Calore C., Celeghin R., Cipriani A., De Gaspari M., De Lazzari M., Migliore F., et al. The &#x2018;Padua classification&#x2019; of cardiomyopathies into three groups: Hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic. Eur. Heart J. Suppl. 2025;27:i73&#x2013;i82. doi: 10.1093/eurheartjsupp/suae108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartjsupp/suae108</ArticleId><ArticleId IdType="pmc">PMC11836707</ArticleId><ArticleId IdType="pubmed">39980775</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.J., Spirito P., Roman M.J., Paranicas M., Okin P.M., Best L.G., Lee E.T., Devereux R.B. Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study) Am. J. Cardiol. 2004;93:1510&#x2013;1514. doi: 10.1016/j.amjcard.2004.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2004.03.007</ArticleId><ArticleId IdType="pubmed">15194022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tudurachi B.S., Z&#x103;voi A., Leonte A., &#x21a;&#x103;poi L., Ureche C., B&#xee;rgoan S.G., Chiuariu T., Anghel L., Radu R., Sasc&#x103;u R.A., et al. An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy. Int. J. Mol. Sci. 2023;24:10510. doi: 10.3390/ijms241310510.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241310510</ArticleId><ArticleId IdType="pmc">PMC10341819</ArticleId><ArticleId IdType="pubmed">37445689</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke M., Ksi&#x105;&#x17c;czyk T.M., Dux M., Chmielewski P., Truszkowska G., Czapczak D., Pietrzak R., Bilinska Z.T., Demkow U., Werner B. A MYH7 variant in a five-generation-family with hypertrophic cardiomyopathy. Front. Genet. 2024;15:1306333. doi: 10.3389/fgene.2024.1306333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2024.1306333</ArticleId><ArticleId IdType="pmc">PMC10883303</ArticleId><ArticleId IdType="pubmed">38389574</ArticleId></ArticleIdList></Reference><Reference><Citation>Anfinson M., Fitts R.H., Lough J.W., James J.M., Simpson P.M., Handler S.S., Mitchell M.E., Tomita-Mitchell A. Significance of &#x3b1;-Myosin Heavy Chain (MYH6) Variants in Hypoplastic Left Heart Syndrome and Related Cardiovascular Diseases. J. Cardiovasc. Dev. Dis. 2022;9:144. doi: 10.3390/jcdd9050144.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd9050144</ArticleId><ArticleId IdType="pmc">PMC9147009</ArticleId><ArticleId IdType="pubmed">35621855</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichart D., Magnussen C., Zeller T., Blankenberg S. Dilated cardiomyopathy: From epidemiologic to genetic phenotypes: A translational review of current literature. J. Intern. Med. 2019;286:362&#x2013;372. doi: 10.1111/joim.12944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12944</ArticleId><ArticleId IdType="pubmed">31132311</ArticleId></ArticleIdList></Reference><Reference><Citation>Chmielewski P., Truszkowska G., Kowalik I., Rydzanicz M., Michalak E., Sobieszcza&#x144;ska-Ma&#x142;ek M., Franaszczyk M., Stawi&#x144;ski P., St&#x119;pie&#x144;-Wojno M., Or&#x119;ziak A., et al. Titin-Related Dilated Cardiomyopathy: The Clinical Trajectory and the Role of Circulating Biomarkers in the Clinical Assessment. Diagnostics. 2021;12:13. doi: 10.3390/diagnostics12010013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12010013</ArticleId><ArticleId IdType="pmc">PMC8775078</ArticleId><ArticleId IdType="pubmed">35054181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaragoza M.V., Bui T.A., Widyastuti H.P., Mehrabi M., Cang Z., Sha Y., Grosberg A., Nie Q. LMNA-Related Dilated Cardiomyopathy: Single-Cell Transcriptomics during Patient-Derived iPSC Differentiation Support Cell Type and Lineage-Specific Dysregulation of Gene Expression and Development for Cardiomyocytes and Epicardium-Derived Cells with Lamin A/C Haploinsufficiency. Cells. 2024;13:1479. doi: 10.3390/cells13171479.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells13171479</ArticleId><ArticleId IdType="pmc">PMC11394257</ArticleId><ArticleId IdType="pubmed">39273049</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Gerull B. Genetic Insights into Primary Restrictive Cardiomyopathy. J. Clin. Med. 2022;11:2094. doi: 10.3390/jcm11082094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11082094</ArticleId><ArticleId IdType="pmc">PMC9027761</ArticleId><ArticleId IdType="pubmed">35456187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen J., Kubo T., Duque M., Uribe W., Shaw A., Murphy R., Gimeno J.R., Elliott P., McKenna W.J. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J. Clin. Investig. 2003;111:209&#x2013;216. doi: 10.1172/JCI200316336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200316336</ArticleId><ArticleId IdType="pmc">PMC151864</ArticleId><ArticleId IdType="pubmed">12531876</ArticleId></ArticleIdList></Reference><Reference><Citation>Peddy S.B., Vricella L.A., Crosson J.E., Oswald G.L., Cohn R.D., Cameron D.E., Valle D., Loeys B.L. Infantile restrictive cardiomyopathy resulting from a mutation in the cardiac troponin T gene. Pediatrics. 2006;117:1830&#x2013;1833. doi: 10.1542/peds.2005-2301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2005-2301</ArticleId><ArticleId IdType="pubmed">16651346</ArticleId></ArticleIdList></Reference><Reference><Citation>Ploski R., Rydzanicz M., Ksiazczyk T.M., Franaszczyk M., Pollak A., Kosinska J., Michalak E., Stawinski P., Ziolkowska L., Bilinska Z.T., et al. Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy. Am. J. Med. Genet. A. 2016;170:3241&#x2013;3248. doi: 10.1002/ajmg.a.37860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.37860</ArticleId><ArticleId IdType="pubmed">27604170</ArticleId></ArticleIdList></Reference><Reference><Citation>Caleshu C., Sakhuja R., Nussbaum R.L., Schiller N.B., Ursell P.C., Eng C., De Marco T., McGlothlin D., Burchard E.G., Rame J.E. Furthering the link between the sarcomere and primary cardiomyopathies: Restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy. Am. J. Med. Genet. A. 2011;155:2229&#x2013;2235. doi: 10.1002/ajmg.a.34097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.34097</ArticleId><ArticleId IdType="pmc">PMC3158811</ArticleId><ArticleId IdType="pubmed">21823217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaski J.P., Syrris P., Burch M., Tom&#xe9;-Esteban M.T., Fenton M., Christiansen M., Andersen P.S., Sebire N., Ashworth M., Deanfield J.E., et al. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes. Heart. 2008;94:1478&#x2013;1484. doi: 10.1136/hrt.2007.134684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2007.134684</ArticleId><ArticleId IdType="pubmed">18467357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W., Lu C.X., Wang Y.N., Liu F., Chen W., Liu Y.T., Han Y.C., Cao J., Zhang S.Y., Zhang X. Novel Phenotype-Genotype Correlations of Restrictive Cardiomyopathy With Myosin-Binding Protein C (MYBPC3) Gene Mutations Tested by Next-Generation Sequencing. J. Am. Heart Assoc. 2015;4:e001879. doi: 10.1161/JAHA.115.001879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.001879</ArticleId><ArticleId IdType="pmc">PMC4608072</ArticleId><ArticleId IdType="pubmed">26163040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hager S., Mahrholdt H., Goldfarb L.G., Goebel H.H., Sechtem U. Images in cardiovascular medicine. Giant right atrium in the setting of desmin-related restrictive cardiomyopathy. Circulation. 2006;113:e53&#x2013;e55. doi: 10.1161/CIRCULATIONAHA.105.502575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.502575</ArticleId><ArticleId IdType="pubmed">16449718</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Ferrier R.A., Hamilton S.J., Greenway S.C., Brundler M.A., Yu W., Gibson W.T., McKinnon M.L., McGillivray B., Alvarez N., et al. Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy. Hum. Mutat. 2016;37:269&#x2013;279. doi: 10.1002/humu.22942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22942</ArticleId><ArticleId IdType="pubmed">26666891</ArticleId></ArticleIdList></Reference><Reference><Citation>Paller M.S., Martin C.M., Pierpont M.E. Restrictive cardiomyopathy: An unusual phenotype of a lamin A variant. ESC Heart Fail. 2018;5:724&#x2013;726. doi: 10.1002/ehf2.12294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12294</ArticleId><ArticleId IdType="pmc">PMC6073024</ArticleId><ArticleId IdType="pubmed">29741282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H.C., Coughlin C.R., Geiger E.A., Salvador B.J., Elias E.R., Cavanaugh J.L., Chatfield K.C., Miyamoto S.D., Shaikh T.H. Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy. Cold Spring Harb. Mol. Case Stud. 2016;2:a000844. doi: 10.1101/mcs.a000844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/mcs.a000844</ArticleId><ArticleId IdType="pmc">PMC4853521</ArticleId><ArticleId IdType="pubmed">27148590</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhamoudi K.M., Barhoumi T., Al-Eidi H., Asiri A., Nashabat M., Alaamery M., Alharbi M., Alhaidan Y., Tabarki B., Umair M., et al. A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy. Sci. Rep. 2021;11:12861. doi: 10.1038/s41598-021-92026-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92026-0</ArticleId><ArticleId IdType="pmc">PMC8213761</ArticleId><ArticleId IdType="pubmed">34145321</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Gaertner-Rommel A., Klauke B., Grewe S.A., Schirmer I., Peterschr&#xf6;der A., Faber L., Vorgerd M., Gummert J., Anselmetti D., et al. The novel &#x3b1;B-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. Hum. Mutat. 2017;38:947&#x2013;952. doi: 10.1002/humu.23248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.23248</ArticleId><ArticleId IdType="pubmed">28493373</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D., Basso C., Judge D.P. Arrhythmogenic Cardiomyopathy. Circ. Res. 2017;121:784&#x2013;802. doi: 10.1161/CIRCRESAHA.117.309345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.309345</ArticleId><ArticleId IdType="pubmed">28912183</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman M., Simpson M., Mogensen J., Shaw A., Hughes S., Syrris P., Sen-Chowdhry S., Rowland E., Crosby A., McKenna W.J. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation. 2005;112:636&#x2013;642. doi: 10.1161/CIRCULATIONAHA.104.532234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.532234</ArticleId><ArticleId IdType="pubmed">16061754</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus F.I., McKenna W.J., Sherrill D., Basso C., Bauce B., Bluemke D.A., Calkins H., Corrado D., Cox M.G., Daubert J.P., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed modification of the task force criteria. Circulation. 2010;121:1533&#x2013;1541. doi: 10.1161/CIRCULATIONAHA.108.840827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.108.840827</ArticleId><ArticleId IdType="pmc">PMC2860804</ArticleId><ArticleId IdType="pubmed">20172911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerull B., Brodehl A. Insights Into Genetics and Pathophysiology of Arrhythmogenic Cardiomyopathy. Curr. Heart Fail. Rep. 2021;18:378&#x2013;390. doi: 10.1007/s11897-021-00532-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11897-021-00532-z</ArticleId><ArticleId IdType="pmc">PMC8616880</ArticleId><ArticleId IdType="pubmed">34478111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerull B., Heuser A., Wichter T., Paul M., Basson C.T., McDermott D.A., Lerman B.B., Markowitz S.M., Ellinor P.T., MacRae C.A., et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 2004;36:1162&#x2013;1164. doi: 10.1038/ng1461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1461</ArticleId><ArticleId IdType="pubmed">15489853</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Meshkov A., Myasnikov R., Kiseleva A., Kulikova O., Klauke B., Sotnikova E., Stanasiuk C., Divashuk M., Pohl G.M., et al. Hemi- and Homozygous Loss-of-Function Mutations in DSG2 (Desmoglein-2) Cause Recessive Arrhythmogenic Cardiomyopathy with an Early Onset. Int. J. Mol. Sci. 2021;22:3786. doi: 10.3390/ijms22073786.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22073786</ArticleId><ArticleId IdType="pmc">PMC8038858</ArticleId><ArticleId IdType="pubmed">33917638</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodehl A., Weiss J., Debus J.D., Stanasiuk C., Klauke B., Deutsch M.A., Fox H., Bax J., Ebbinghaus H., G&#xe4;rtner A., et al. A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy. J. Mol. Cell. Cardiol. 2020;141:17&#x2013;29. doi: 10.1016/j.yjmcc.2020.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.03.006</ArticleId><ArticleId IdType="pubmed">32201174</ArticleId></ArticleIdList></Reference><Reference><Citation>Heuser A., Plovie E.R., Ellinor P.T., Grossmann K.S., Shin J.T., Wichter T., Basson C.T., Lerman B.B., Sasse-Klaassen S., Thierfelder L., et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 2006;79:1081&#x2013;1088. doi: 10.1086/509044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/509044</ArticleId><ArticleId IdType="pmc">PMC1698714</ArticleId><ArticleId IdType="pubmed">17186466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Genga M.F., Cuenca S., Dal Ferro M., Zorio E., Salgado-Aranda R., Climent V., Padr&#xf3;n-Barthe L., Duro-Aguado I., Jim&#xe9;nez-J&#xe1;imez J., Hidalgo-Olivares V.M., et al. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J. Am. Coll. Cardiol. 2016;68:2440&#x2013;2451. doi: 10.1016/j.jacc.2016.09.927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.09.927</ArticleId><ArticleId IdType="pubmed">27908349</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hengel J., Calore M., Bauce B., Dazzo E., Mazzotti E., De Bortoli M., Lorenzon A., Li Mura I.E., Beffagna G., Rigato I., et al. Mutations in the area composita protein &#x3b1;T-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2013;34:201&#x2013;210. doi: 10.1093/eurheartj/ehs373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs373</ArticleId><ArticleId IdType="pubmed">23136403</ArticleId></ArticleIdList></Reference><Reference><Citation>Merner N.D., Hodgkinson K.A., Haywood A.F., Connors S., French V.M., Drenckhahn J.D., Kupprion C., Ramadanova K., Thierfelder L., McKenna W., et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am. J. Hum. Genet. 2008;82:809&#x2013;821. doi: 10.1016/j.ajhg.2008.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.01.010</ArticleId><ArticleId IdType="pmc">PMC2427209</ArticleId><ArticleId IdType="pubmed">18313022</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C., Corrado D., Marcus F.I., Nava A., Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373:1289&#x2013;1300. doi: 10.1016/S0140-6736(09)60256-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)60256-7</ArticleId><ArticleId IdType="pubmed">19362677</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiene G., Nava A., Corrado D., Rossi L., Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med. 1988;318:129&#x2013;133. doi: 10.1056/NEJM198801213180301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198801213180301</ArticleId><ArticleId IdType="pubmed">3336399</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman R.L. Mouse models of human disease: An evolutionary perspective. Evol. Med. Public Health. 2016;2016:170&#x2013;176. doi: 10.1093/emph/eow014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emph/eow014</ArticleId><ArticleId IdType="pmc">PMC4875775</ArticleId><ArticleId IdType="pubmed">27121451</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A., Norton N., Bruno K.A., Cooper L.T., Jr., Atwal P.S., Fairweather D. Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy. J. Clin. Med. 2021;10:2289. doi: 10.3390/jcm10112289.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112289</ArticleId><ArticleId IdType="pmc">PMC8197492</ArticleId><ArticleId IdType="pubmed">34070351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartiala J.A., Hilser J.R., Biswas S., Lusis A.J., Allayee H. Gene-Environment Interactions for Cardiovascular Disease. Curr. Atheroscler. Rep. 2021;23:75. doi: 10.1007/s11883-021-00974-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-021-00974-9</ArticleId><ArticleId IdType="pmc">PMC8903169</ArticleId><ArticleId IdType="pubmed">34648097</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;676. doi: 10.1016/j.cell.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.07.024</ArticleId><ArticleId IdType="pubmed">16904174</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedada F.B., Wheelwright M., Metzger J.M. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. Biochim. Biophys. Acta. 2016;1863:1829&#x2013;1838. doi: 10.1016/j.bbamcr.2015.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2015.11.005</ArticleId><ArticleId IdType="pmc">PMC4864165</ArticleId><ArticleId IdType="pubmed">26578113</ArticleId></ArticleIdList></Reference><Reference><Citation>Clancy C.E., Santana L.F. Advances in induced pluripotent stem cell-derived cardiac myocytes: Technological breakthroughs, key discoveries and new applications. J. Physiol. 2024;602:3871&#x2013;3892. doi: 10.1113/JP282562.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP282562</ArticleId><ArticleId IdType="pmc">PMC11326976</ArticleId><ArticleId IdType="pubmed">39032073</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L., Li Y., Tchao J., Kaplan A.D., Lin B., Li Y., Mich-Basso J., Lis A., Hassan N., London B., et al. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc. Res. 2014;104:258&#x2013;269. doi: 10.1093/cvr/cvu205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvu205</ArticleId><ArticleId IdType="pmc">PMC4217687</ArticleId><ArticleId IdType="pubmed">25209314</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Kim K., Parikh S., Cadar A.G., Bersell K.R., He H., Pinto J.R., Kryshtal D.O., Knollmann B.C. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes. J. Mol. Cell. Cardiol. 2018;114:320&#x2013;327. doi: 10.1016/j.yjmcc.2017.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2017.12.002</ArticleId><ArticleId IdType="pmc">PMC5800960</ArticleId><ArticleId IdType="pubmed">29217433</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R., Clark A.T., Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA. 2008;105:2883&#x2013;2888. doi: 10.1073/pnas.0711983105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0711983105</ArticleId><ArticleId IdType="pmc">PMC2268554</ArticleId><ArticleId IdType="pubmed">18287077</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki T., Yuasa S., Oda M., Egashira T., Yae K., Kusumoto D., Nakata H., Tohyama S., Hashimoto H., Kodaira M., et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell. 2010;7:11&#x2013;14. doi: 10.1016/j.stem.2010.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.06.003</ArticleId><ArticleId IdType="pubmed">20621043</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki T., Yuasa S., Fukuda K. Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus. Nat. Protoc. 2012;7:718&#x2013;728. doi: 10.1038/nprot.2012.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.015</ArticleId><ArticleId IdType="pubmed">22422317</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlahos K., Sourris K., Mayberry R., McDonald P., Bruveris F.F., Schiesser J.V., Bozaoglu K., Lockhart P.J., Stanley E.G., Elefanty A.G. Generation of iPSC lines from peripheral blood mononuclear cells from 5 healthy adults. Stem Cell Res. 2019;34:101380. doi: 10.1016/j.scr.2018.101380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2018.101380</ArticleId><ArticleId IdType="pubmed">30605840</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T., Benda C., Dunzinger S., Huang Y., Ho J.C., Yang J., Wang Y., Zhang Y., Zhuang Q., Li Y., et al. Generation of human induced pluripotent stem cells from urine samples. Nat. Protoc. 2012;7:2080&#x2013;2089. doi: 10.1038/nprot.2012.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.115</ArticleId><ArticleId IdType="pubmed">23138349</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal M.Z., Gartz M., Klyachko E.A., Khan S.S., Shah S.J., Gupta S., Shapiro A.D., Vaughan D.E., Strande J.L. Generation of human iPSCs from urine derived cells of a non-affected control subject. Stem Cell Res. 2017;18:33&#x2013;36. doi: 10.1016/j.scr.2016.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2016.12.008</ArticleId><ArticleId IdType="pmc">PMC5389122</ArticleId><ArticleId IdType="pubmed">28395799</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao L., Wu W.S. Gene-delivery systems for iPS cell generation. Expert Opin. Biol. Ther. 2010;10:231&#x2013;242. doi: 10.1517/14712590903455989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14712590903455989</ArticleId><ArticleId IdType="pmc">PMC2811526</ArticleId><ArticleId IdType="pubmed">20088717</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlaeger T.M., Daheron L., Brickler T.R., Entwisle S., Chan K., Cianci A., DeVine A., Ettenger A., Fitzgerald K., Godfrey M., et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 2015;33:58&#x2013;63. doi: 10.1038/nbt.3070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3070</ArticleId><ArticleId IdType="pmc">PMC4329913</ArticleId><ArticleId IdType="pubmed">25437882</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozner T., Grandizio C., Mitchell M.W., Turan N., Scheinfeldt L. Human iPSC Reprogramming Success: The Impact of Approaches and Source Materials. Stem Cells Int. 2025;2025:2223645. doi: 10.1155/sci/2223645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/sci/2223645</ArticleId><ArticleId IdType="pmc">PMC11756937</ArticleId><ArticleId IdType="pubmed">39850337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan S., Stacey G.N., Akazawa C., Aoyama N., Baptista R., Bedford P., Bennaceur Griscelli A., Chandra A., Elwood N., Girard M., et al. Quality control guidelines for clinical-grade human induced pluripotent stem cell lines. Regen. Med. 2018;13:859&#x2013;866. doi: 10.2217/rme-2018-0095.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/rme-2018-0095</ArticleId><ArticleId IdType="pubmed">30205750</ArticleId></ArticleIdList></Reference><Reference><Citation>Novoa J., Westra I., Steeneveld E., Neves N.F., Daleman L., Asensio A.B., Davis R.P., Carlotti F., Freund C., Rabelink T., et al. Validating human induced pluripotent stem cell-specific quality control tests for the release of an intermediate drug product in a Good Manufacturing Practice quality system. Cytotherapy. 2024;26:1105&#x2013;1117. doi: 10.1016/j.jcyt.2024.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcyt.2024.04.004</ArticleId><ArticleId IdType="pubmed">38703154</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo A.K., Ali Y., Wong K.Y., Chipperfield H., Sadasivam A., Poobalan Y., Tan E.K., Wang S.T., Abraham S., Tsuneyoshi N., et al. Activin and BMP4 synergistically promote formation of definitive endoderm in human embryonic stem cells. Stem Cells. 2012;30:631&#x2013;642. doi: 10.1002/stem.1022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1022</ArticleId><ArticleId IdType="pubmed">22893457</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattman S.J., Witty A.D., Gagliardi M., Dubois N.C., Niapour M., Hotta A., Ellis J., Keller G. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell. 2011;8:228&#x2013;240. doi: 10.1016/j.stem.2010.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2010.12.008</ArticleId><ArticleId IdType="pubmed">21295278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadari A., Mekala S., Wagner N., Malan D., K&#xf6;th J., Doll K., Stappert L., Eckert D., Peitz M., Matthes J., et al. Robust Generation of Cardiomyocytes from Human iPS Cells Requires Precise Modulation of BMP and WNT Signaling. Stem Cell Rev. Rep. 2015;11:560&#x2013;569. doi: 10.1007/s12015-014-9564-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-014-9564-6</ArticleId><ArticleId IdType="pmc">PMC4493626</ArticleId><ArticleId IdType="pubmed">25392050</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian X., Zhang J., Azarin S.M., Zhu K., Hazeltine L.B., Bao X., Hsiao C., Kamp T.J., Palecek S.P. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/&#x3b2;-catenin signaling under fully defined conditions. Nat. Protoc. 2013;8:162&#x2013;175. doi: 10.1038/nprot.2012.150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.150</ArticleId><ArticleId IdType="pmc">PMC3612968</ArticleId><ArticleId IdType="pubmed">23257984</ArticleId></ArticleIdList></Reference><Reference><Citation>Buikema J.W., Lee S., Goodyer W.R., Maas R.G., Chirikian O., Li G., Miao Y., Paige S.L., Lee D., Wu H., et al. Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes. Cell Stem Cell. 2020;27:50&#x2013;63.e55. doi: 10.1016/j.stem.2020.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7334437</ArticleId><ArticleId IdType="pubmed">32619518</ArticleId></ArticleIdList></Reference><Reference><Citation>Burridge P.W., Holmstr&#xf6;m A., Wu J.C. Chemically Defined Culture and Cardiomyocyte Differentiation of Human Pluripotent Stem Cells. Curr. Protoc. Hum. Genet. 2015;87:21.3.1&#x2013;21.3.15. doi: 10.1002/0471142905.hg2103s87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142905.hg2103s87</ArticleId><ArticleId IdType="pmc">PMC4597313</ArticleId><ArticleId IdType="pubmed">26439715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Zou J. Differentiation of Cardiomyocytes from Human Pluripotent Stem Cells in Fully Chemically Defined Conditions. STAR Protoc. 2020;1:100015. doi: 10.1016/j.xpro.2020.100015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2020.100015</ArticleId><ArticleId IdType="pmc">PMC7392178</ArticleId><ArticleId IdType="pubmed">32734277</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshanravan N., Ghaffari S., Bastani S., Pahlavan S., Asghari S., Doustvandi M.A., Jalilzadeh-Razin S., Dastouri M. Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine. J. Cardiovasc. Thorac. Res. 2023;15:68&#x2013;72. doi: 10.34172/jcvtr.2023.31830.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jcvtr.2023.31830</ArticleId><ArticleId IdType="pmc">PMC10466470</ArticleId><ArticleId IdType="pubmed">37654821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurokawa Y.K., George S.C. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening. Adv. Drug Deliv. Rev. 2016;96:225&#x2013;233. doi: 10.1016/j.addr.2015.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2015.07.004</ArticleId><ArticleId IdType="pmc">PMC4869857</ArticleId><ArticleId IdType="pubmed">26212156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopaschuk G.D., Jaswal J.S. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. J. Cardiovasc. Pharmacol. 2010;56:130&#x2013;140. doi: 10.1097/FJC.0b013e3181e74a14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0b013e3181e74a14</ArticleId><ArticleId IdType="pubmed">20505524</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohyama S., Hattori F., Sano M., Hishiki T., Nagahata Y., Matsuura T., Hashimoto H., Suzuki T., Yamashita H., Satoh Y., et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 2013;12:127&#x2013;137. doi: 10.1016/j.stem.2012.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2012.09.013</ArticleId><ArticleId IdType="pubmed">23168164</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharya S., Burridge P.W., Kropp E.M., Chuppa S.L., Kwok W.M., Wu J.C., Boheler K.R., Gundry R.L. High efficiency differentiation of human pluripotent stem cells to cardiomyocytes and characterization by flow cytometry. J. Vis. Exp. 2014;91:52010. doi: 10.3791/52010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/52010</ArticleId><ArticleId IdType="pmc">PMC4448667</ArticleId><ArticleId IdType="pubmed">25286293</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolnik J., Adamska P., Oleksy A., Dulak J., Biniecka M. Enriching Cardiomyocytes Derived from hiPSCs by Magnetic-Activated Cell Sorting (MACS) Methods Mol. Biol. 2024;2835:83&#x2013;98. doi: 10.1007/978-1-0716-3995-5_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-3995-5_8</ArticleId><ArticleId IdType="pubmed">39105908</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou R., Huang W., Wang J., Jiang C., Li A., Huang C.L.H., Zhang Y. Gene Expression, Morphology, and Electrophysiology During the Dynamic Development of Human Induced Pluripotent Stem Cell-Derived Atrial- and Ventricular-Like Cardiomyocytes. Biologics. 2024;18:115&#x2013;127. doi: 10.2147/btt.S448054.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/btt.S448054</ArticleId><ArticleId IdType="pmc">PMC11093124</ArticleId><ArticleId IdType="pubmed">38746773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev. 2013;22:1991&#x2013;2002. doi: 10.1089/scd.2012.0490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2012.0490</ArticleId><ArticleId IdType="pmc">PMC3699903</ArticleId><ArticleId IdType="pubmed">23461462</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherghiceanu M., Barad L., Novak A., Reiter I., Itskovitz-Eldor J., Binah O., Popescu L.M. Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: Comparative ultrastructure. J. Cell. Mol. Med. 2011;15:2539&#x2013;2551. doi: 10.1111/j.1582-4934.2011.01417.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2011.01417.x</ArticleId><ArticleId IdType="pmc">PMC3822963</ArticleId><ArticleId IdType="pubmed">21883888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatani T., Funakoshi S., Deerinck T.J., Bushong E.A., Kimura T., Takeshima H., Ellisman M.H., Hoshijima M., Yoshida Y. Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2. Biochem. Biophys. Res. Commun. 2018;505:1251&#x2013;1256. doi: 10.1016/j.bbrc.2018.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.10.020</ArticleId><ArticleId IdType="pmc">PMC7478876</ArticleId><ArticleId IdType="pubmed">30333092</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinaga D., Wuriyanghai Y., Makiyama T. Multielectrode Array Assays Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Methods Mol. Biol. 2021;2320:111&#x2013;119. doi: 10.1007/978-1-0716-1484-6_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1484-6_12</ArticleId><ArticleId IdType="pubmed">34302653</ArticleId></ArticleIdList></Reference><Reference><Citation>Astro V., Ramirez-Calderon G., Adamo A. Protocol to measure calcium spikes in cardiomyocytes obtained from human pluripotent stem cells using a ready-to-use media. STAR Protoc. 2023;4:102252. doi: 10.1016/j.xpro.2023.102252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2023.102252</ArticleId><ArticleId IdType="pmc">PMC10140149</ArticleId><ArticleId IdType="pubmed">37060558</ArticleId></ArticleIdList></Reference><Reference><Citation>Koivum&#xe4;ki J.T., Naumenko N., Tuomainen T., Takalo J., Oksanen M., Puttonen K.A., Lehtonen &#x160;., Kuusisto J., Laakso M., Koistinaho J., et al. Structural Immaturity of Human iPSC-Derived Cardiomyocytes: In Silico Investigation of Effects on Function and Disease Modeling. Front. Physiol. 2018;9:80. doi: 10.3389/fphys.2018.00080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00080</ArticleId><ArticleId IdType="pmc">PMC5808345</ArticleId><ArticleId IdType="pubmed">29467678</ArticleId></ArticleIdList></Reference><Reference><Citation>Goversen B., van der Heyden M.A.G., van Veen T.A.B., de Boer T.P. The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: Special focus on IK1. Pharmacol. Ther. 2018;183:127&#x2013;136. doi: 10.1016/j.pharmthera.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2017.10.001</ArticleId><ArticleId IdType="pubmed">28986101</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Fl&#xfc;gel L., Dorn T., Goedel A., H&#xf6;hnke C., Hofmann F., et al. Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome. N. Engl. J. Med. 2010;363:1397&#x2013;1409. doi: 10.1056/NEJMoa0908679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0908679</ArticleId><ArticleId IdType="pubmed">20660394</ArticleId></ArticleIdList></Reference><Reference><Citation>Garfinkel A.C., Seidman J.G., Seidman C.E. Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy. Heart Fail. Clin. 2018;14:139&#x2013;146. doi: 10.1016/j.hfc.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hfc.2017.12.004</ArticleId><ArticleId IdType="pmc">PMC5851453</ArticleId><ArticleId IdType="pubmed">29525643</ArticleId></ArticleIdList></Reference><Reference><Citation>Marian A.J., Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ. Res. 2017;121:749&#x2013;770. doi: 10.1161/CIRCRESAHA.117.311059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311059</ArticleId><ArticleId IdType="pmc">PMC5654557</ArticleId><ArticleId IdType="pubmed">28912181</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncker D.J., Bakkers J., Brundel B.J., Robbins J., Tardiff J.C., Carrier L. Animal and in silico models for the study of sarcomeric cardiomyopathies. Cardiovasc. Res. 2015;105:439&#x2013;448. doi: 10.1093/cvr/cvv006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvv006</ArticleId><ArticleId IdType="pmc">PMC4375391</ArticleId><ArticleId IdType="pubmed">25600962</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan F., Lee A.S., Liang P., Sanchez-Freire V., Nguyen P.K., Wang L., Han L., Yen M., Wang Y., Sun N., et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell. 2013;12:101&#x2013;113. doi: 10.1016/j.stem.2012.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2012.10.010</ArticleId><ArticleId IdType="pmc">PMC3638033</ArticleId><ArticleId IdType="pubmed">23290139</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwan J.R., Mosqueira D., Chairez-Cantu K., Mannhardt I., Bodbin S.E., Bakar M., Smith J.G.W., Denning C. Isogenic models of hypertrophic cardiomyopathy unveil differential phenotypes and mechanism-driven therapeutics. J. Mol. Cell. Cardiol. 2020;145:43&#x2013;53. doi: 10.1016/j.yjmcc.2020.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.06.003</ArticleId><ArticleId IdType="pmc">PMC7487780</ArticleId><ArticleId IdType="pubmed">32531470</ArticleId></ArticleIdList></Reference><Reference><Citation>Dainis A., Zaleta-Rivera K., Ribeiro A., Chang A.C.H., Shang C., Lan F., Burridge P.W., Liu W.R., Wu J.C., Chang A.C.Y., et al. Silencing of MYH7 ameliorates disease phenotypes in human iPSC-cardiomyocytes. Physiol. Genom. 2020;52:293&#x2013;303. doi: 10.1152/physiolgenomics.00021.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00021.2020</ArticleId><ArticleId IdType="pmc">PMC7468691</ArticleId><ArticleId IdType="pubmed">32567507</ArticleId></ArticleIdList></Reference><Reference><Citation>Shemer Y., Mekies L.N., Ben Jehuda R., Baskin P., Shulman R., Eisen B., Regev D., Arbustini E., Gerull B., Gherghiceanu M., et al. Investigating LMNA-Related Dilated Cardiomyopathy Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Int. J. Mol. Sci. 2021;22:7874. doi: 10.3390/ijms22157874.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157874</ArticleId><ArticleId IdType="pmc">PMC8346174</ArticleId><ArticleId IdType="pubmed">34360639</ArticleId></ArticleIdList></Reference><Reference><Citation>Korover N., Etzion S., Cherniak A., Rabinski T., Levitas A., Etzion Y., Ofir R., Parvari R., Cohen S. Functional defects in hiPSCs-derived cardiomyocytes from patients with a PLEKHM2-mutation associated with dilated cardiomyopathy and left ventricular non-compaction. Biol. Res. 2023;56:34. doi: 10.1186/s40659-023-00442-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-023-00442-5</ArticleId><ArticleId IdType="pmc">PMC10288792</ArticleId><ArticleId IdType="pubmed">37349842</ArticleId></ArticleIdList></Reference><Reference><Citation>Schick R., Mekies L.N., Shemer Y., Eisen B., Hallas T., Ben Jehuda R., Ben-Ari M., Szantai A., Willi L., Shulman R., et al. Functional abnormalities in induced Pluripotent Stem Cell-derived cardiomyocytes generated from titin-mutated patients with dilated cardiomyopathy. PLoS ONE. 2018;13:e0205719. doi: 10.1371/journal.pone.0205719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0205719</ArticleId><ArticleId IdType="pmc">PMC6192629</ArticleId><ArticleId IdType="pubmed">30332462</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosqueira D., Mannhardt I., Bhagwan J.R., Lis-Slimak K., Katili P., Scott E., Hassan M., Prondzynski M., Harmer S.C., Tinker A., et al. CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Eur. Heart J. 2018;39:3879&#x2013;3892. doi: 10.1093/eurheartj/ehy249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy249</ArticleId><ArticleId IdType="pmc">PMC6234851</ArticleId><ArticleId IdType="pubmed">29741611</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeger T., Shrestha R., Lam C.K., Chen C., McKeithan W.L., Lau E., Wnorowski A., McMullen G., Greenhaw M., Lee J., et al. A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation. 2019;139:799&#x2013;811. doi: 10.1161/CIRCULATIONAHA.118.034624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.034624</ArticleId><ArticleId IdType="pmc">PMC6443405</ArticleId><ArticleId IdType="pubmed">30586709</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer C.N., Garfinkel A.C., Venturini G., Wakimoto H., Repetti G., Alamo L., Sharma A., Agarwal R., Ewoldt J.K., Cloonan P., et al. Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy. Circulation. 2020;141:828&#x2013;842. doi: 10.1161/CIRCULATIONAHA.119.042339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.042339</ArticleId><ArticleId IdType="pmc">PMC7077965</ArticleId><ArticleId IdType="pubmed">31983222</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka A., Yuasa S., Mearini G., Egashira T., Seki T., Kodaira M., Kusumoto D., Kuroda Y., Okata S., Suzuki T., et al. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes. J. Am. Heart Assoc. 2014;3:e001263. doi: 10.1161/JAHA.114.001263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.001263</ArticleId><ArticleId IdType="pmc">PMC4338713</ArticleId><ArticleId IdType="pubmed">25389285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., Navarrete E.G., Hu S., Wang L., Lee A., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci. Transl. Med. 2012;4:130ra47. doi: 10.1126/scitranslmed.3003552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3003552</ArticleId><ArticleId IdType="pmc">PMC3657516</ArticleId><ArticleId IdType="pubmed">22517884</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse H.F., Ho J.C., Choi S.W., Lee Y.K., Butler A.W., Ng K.M., Siu C.W., Simpson M.A., Lai W.H., Chan Y.C., et al. Patient-specific induced-pluripotent stem cells-derived cardiomyocytes recapitulate the pathogenic phenotypes of dilated cardiomyopathy due to a novel DES mutation identified by whole exome sequencing. Hum. Mol. Genet. 2013;22:1395&#x2013;1403. doi: 10.1093/hmg/dds556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds556</ArticleId><ArticleId IdType="pubmed">23300193</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y., Amenov A., Ignatyeva N., Koschinski A., Xu H., Soong P.L., Tiburcy M., Linke W.A., Zaccolo M., Hasenfuss G., et al. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients. Sci. Rep. 2020;10:209. doi: 10.1038/s41598-019-56597-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56597-3</ArticleId><ArticleId IdType="pmc">PMC6959358</ArticleId><ArticleId IdType="pubmed">31937807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.K., Lau Y.M., Cai Z.J., Lai W.H., Wong L.Y., Tse H.F., Ng K.M., Siu C.W. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells. J. Am. Heart Assoc. 2017;6:e005677. doi: 10.1161/JAHA.117.005677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.005677</ArticleId><ArticleId IdType="pmc">PMC5586427</ArticleId><ArticleId IdType="pubmed">28754655</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Termglinchan V., Diecke S., Itzhaki I., Lam C.K., Garg P., Lau E., Greenhaw M., Seeger T., Wu H., et al. Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy. Nature. 2019;572:335&#x2013;340. doi: 10.1038/s41586-019-1406-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1406-x</ArticleId><ArticleId IdType="pmc">PMC6779479</ArticleId><ArticleId IdType="pubmed">31316208</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasaki A., Hirono K., Hata Y., Wang C., Takeda M., Yamashita J.K., Chang B., Nakaoka H., Okabe M., Miyao N., et al. Sarcomere gene variants act as a genetic trigger underlying the development of left ventricular noncompaction. Pediatr. Res. 2018;84:733&#x2013;742. doi: 10.1038/s41390-018-0162-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41390-018-0162-1</ArticleId><ArticleId IdType="pubmed">30188508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodo K., Ong S.G., Jahanbani F., Termglinchan V., Hirono K., InanlooRahatloo K., Ebert A.D., Shukla P., Abilez O.J., Churko J.M., et al. iPSC-derived cardiomyocytes reveal abnormal TGF-&#x3b2; signalling in left ventricular non-compaction cardiomyopathy. Nat. Cell Biol. 2016;18:1031&#x2013;1042. doi: 10.1038/ncb3411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb3411</ArticleId><ArticleId IdType="pmc">PMC5042877</ArticleId><ArticleId IdType="pubmed">27642787</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahim M.A., Ali N.M., Albash B.Y., Al Sayegh A.H., Ahmad N.B., Vo&#xdf; S., Klag F., Gro&#xdf; J., Holler S., Walhorn V., et al. Phenotypic Diversity Caused by the DES Missense Mutation p.R127P (c.380G&gt;C) Contributing to Significant Cardiac Mortality and Morbidity Associated With a Desmin Filament Assembly Defect. Circ. Genom. Precis. Med. 2025:e004896. doi: 10.1161/CIRCGEN.124.004896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.124.004896</ArticleId><ArticleId IdType="pubmed">40265264</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovhannisyan Y., Li Z., Callon D., Susp&#xe8;ne R., Batoumeni V., Canette A., Blanc J., Hocini H., Lefebvre C., El-Jahrani N., et al. Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation. Stem Cell Res. Ther. 2024;15:10. doi: 10.1186/s13287-023-03619-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-023-03619-7</ArticleId><ArticleId IdType="pmc">PMC10763022</ArticleId><ArticleId IdType="pubmed">38167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulikova O., Brodehl A., Kiseleva A., Myasnikov R., Meshkov A., Stanasiuk C., G&#xe4;rtner A., Divashuk M., Sotnikova E., Koretskiy S., et al. The Desmin (DES) Mutation p.A337P Is Associated with Left-Ventricular Non-Compaction Cardiomyopathy. Genes. 2021;12:121. doi: 10.3390/genes12010121.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes12010121</ArticleId><ArticleId IdType="pmc">PMC7835827</ArticleId><ArticleId IdType="pubmed">33478057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D., Wei H., Lu J., Ho S., Zhang G., Sun X., Oh Y., Tan S.H., Ng M.L., Shim W., et al. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. Eur. Heart J. 2013;34:1122&#x2013;1133. doi: 10.1093/eurheartj/ehs226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs226</ArticleId><ArticleId IdType="pubmed">22798562</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspi O., Huber I., Gepstein A., Arbel G., Maizels L., Boulos M., Gepstein L. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells. Circ. Cardiovasc. Genet. 2013;6:557&#x2013;568. doi: 10.1161/CIRCGENETICS.113.000188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.113.000188</ArticleId><ArticleId IdType="pubmed">24200905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J.Y., Wei C.Y., Shah K., Wong J., Wang C., Chen H.S. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells. Circ. J. 2015;79:1402&#x2013;1408. doi: 10.1253/circj.CJ-15-0363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-15-0363</ArticleId><ArticleId IdType="pubmed">25971409</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn T., Kornherr J., Parrotta E.I., Zawada D., Ayetey H., Santamaria G., Iop L., Mastantuono E., Sinnecker D., Goedel A., et al. Interplay of cell-cell contacts and RhoA/MRTF-A signaling regulates cardiomyocyte identity. EMBO J. 2018;37:e98133. doi: 10.15252/embj.201798133.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798133</ArticleId><ArticleId IdType="pmc">PMC6003642</ArticleId><ArticleId IdType="pubmed">29764980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Xiao Y., Wang Y., Zheng Z., Chen L., Yang X., Li J., Wu W., Zhang S. Intracellular calcium current disorder and disease phenotype in OBSCN mutant iPSC-based cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy. Theranostics. 2020;10:11215&#x2013;11229. doi: 10.7150/thno.45172.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.45172</ArticleId><ArticleId IdType="pmc">PMC7532677</ArticleId><ArticleId IdType="pubmed">33042279</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Battrawy I., Zhao Z., Lan H., Cyganek L., Tombers C., Li X., Buljubasic F., Lang S., Tiburcy M., Zimmermann W.H., et al. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy. Europace. 2018;20:f46&#x2013;f56. doi: 10.1093/europace/euy042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euy042</ArticleId><ArticleId IdType="pubmed">29566126</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng R., Manring H., Papoutsidakis N., Albertelli T., Tsai N., See C.J., Li X., Park J., Stevens T.L., Bobbili P.J., et al. Patient mutations linked to arrhythmogenic cardiomyopathy enhance calpain-mediated desmoplakin degradation. JCI Insight. 2019;5:e128643. doi: 10.1172/jci.insight.128643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.128643</ArticleId><ArticleId IdType="pmc">PMC6675562</ArticleId><ArticleId IdType="pubmed">31194698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.M., Mok P.Y., Butler A.W., Ho J.C., Choi S.W., Lee Y.K., Lai W.H., Au K.W., Lau Y.M., Wong L.Y., et al. Amelioration of X-Linked Related Autophagy Failure in Danon Disease With DNA Methylation Inhibitor. Circulation. 2016;134:1373&#x2013;1389. doi: 10.1161/CIRCULATIONAHA.115.019847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.019847</ArticleId><ArticleId IdType="pubmed">27678261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L., Lu Z., Zhang Y., Liu L., Sun J., Fu H., Mao J., Hu L. Clinical characteristics and induced pluripotent stem cells (iPSCs) disease model of Fabry disease caused by a novel GLA mutation. QJM Int. J. Med. 2024;117:566&#x2013;573. doi: 10.1093/qjmed/hcae038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcae038</ArticleId><ArticleId IdType="pmc">PMC11389907</ArticleId><ArticleId IdType="pubmed">38429952</ArticleId></ArticleIdList></Reference><Reference><Citation>Raval K.K., Tao R., White B.E., De Lange W.J., Koonce C.H., Yu J., Kishnani P.S., Thomson J.A., Mosher D.F., Ralphe J.C., et al. Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes. J. Biol. Chem. 2015;290:3121&#x2013;3136. doi: 10.1074/jbc.M114.628628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.628628</ArticleId><ArticleId IdType="pmc">PMC4317045</ArticleId><ArticleId IdType="pubmed">25488666</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilauri B., Shin H.S., Htet M., Yan C.D., Witteles R.M., Sallam K., Wu J.C. Generation of two induced pluripotent stem cell lines from patients with cardiac amyloidosis carrying heterozygous transthyretin (TTR) mutation. Stem Cell Res. 2023;72:103215. doi: 10.1016/j.scr.2023.103215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2023.103215</ArticleId><ArticleId IdType="pmc">PMC10821799</ArticleId><ArticleId IdType="pubmed">37788558</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero-Calle P., Flandes-Iparraguirre M., Kuebler B., Ar&#xe1;n B., Larequi E., Anaut I., Coppiello G., Aranguren X.L., Veiga A., Elorz M.T.B., et al. Generation of an induced pluripotent stem cell line (ESi107-A) from a transthyretin amyloid cardiomyopathy (ATTR-CM) patient carrying a p.Ser43Asn mutation in the TTR gene. Stem Cell Res. 2023;71:103189. doi: 10.1016/j.scr.2023.103189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2023.103189</ArticleId><ArticleId IdType="pubmed">37660554</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt L.P., Rebs S., Maurer W., H&#xfc;bscher D., Tiburcy M., Pabel S., Maus A., K&#xf6;hne S., Tappu R., Haas J., et al. Doxorubicin induces cardiotoxicity in a pluripotent stem cell model of aggressive B cell lymphoma cancer patients. Basic. Res. Cardiol. 2022;117:13. doi: 10.1007/s00395-022-00918-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-022-00918-7</ArticleId><ArticleId IdType="pmc">PMC8904375</ArticleId><ArticleId IdType="pubmed">35260914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampoldi A., Singh M., Wu Q., Duan M., Jha R., Maxwell J.T., Bradner J.M., Zhang X., Saraf A., Miller G.W., et al. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol. Sci. 2019;169:280&#x2013;292. doi: 10.1093/toxsci/kfz038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfz038</ArticleId><ArticleId IdType="pmc">PMC6484889</ArticleId><ArticleId IdType="pubmed">31059573</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R., Sun F., Armand L.C., Wu R., Xu C. Chronic Ethanol Exposure Induces Deleterious Changes in Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells. Stem Cell Rev. Rep. 2021;17:2314&#x2013;2331. doi: 10.1007/s12015-021-10267-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-021-10267-y</ArticleId><ArticleId IdType="pmc">PMC9244775</ArticleId><ArticleId IdType="pubmed">34564802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gintant G., Burridge P., Gepstein L., Harding S., Herron T., Hong C., Jalife J., Wu J.C. Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association. Circ. Res. 2019;125:e75&#x2013;e92. doi: 10.1161/RES.0000000000000291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/RES.0000000000000291</ArticleId><ArticleId IdType="pmc">PMC7398423</ArticleId><ArticleId IdType="pubmed">31533542</ArticleId></ArticleIdList></Reference><Reference><Citation>van Doorn E.C.H., Amesz J.H., Sadeghi A.H., de Groot N.M.S., Manintveld O.C., Taverne Y.J.H.J. Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists. Cardiovasc. Eng. Technol. 2024;15:232&#x2013;249. doi: 10.1007/s13239-023-00707-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13239-023-00707-w</ArticleId><ArticleId IdType="pmc">PMC11116217</ArticleId><ArticleId IdType="pubmed">38228811</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnett S.D., Blanchette A.D., Chiu W.A., Rusyn I. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: Strengths and weaknesses for hazard identification and risk characterization. Expert Opin. Drug Metab. Toxicol. 2021;17:887&#x2013;902. doi: 10.1080/17425255.2021.1894122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17425255.2021.1894122</ArticleId><ArticleId IdType="pmc">PMC8363519</ArticleId><ArticleId IdType="pubmed">33612039</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration (FDA)  [(accessed on 18 May 2025)]; Available online:  https://www.fda.gov/drugs/regulatory-science-action/impact-story-improved-assessment-cardiotoxic-risk-drug-candidates-comprehensive-in-vitro-proarrhythmia.</Citation></Reference><Reference><Citation>Pan D., Li B., Wang S. Establishment and validation of a torsade de pointes prediction model based on human iPSC&#x2014;Derived cardiomyocytes. Exp. Ther. Med. 2023;25:61. doi: 10.3892/etm.2022.11760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11760</ArticleId><ArticleId IdType="pmc">PMC9780517</ArticleId><ArticleId IdType="pubmed">36588805</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshinaga D., Baba S., Makiyama T., Shibata H., Hirata T., Akagi K., Matsuda K., Kohjitani H., Wuriyanghai Y., Umeda K., et al. Phenotype-Based High-Throughput Classification of Long QT Syndrome Subtypes Using Human Induced Pluripotent Stem Cells. Stem Cell Rep. 2019;13:394&#x2013;404. doi: 10.1016/j.stemcr.2019.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.06.007</ArticleId><ArticleId IdType="pmc">PMC6700479</ArticleId><ArticleId IdType="pubmed">31378668</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz L.H., Schork N.J. Personalized medicine: Motivation, challenges, and progress. Fertil. Steril. 2018;109:952&#x2013;963. doi: 10.1016/j.fertnstert.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2018.05.006</ArticleId><ArticleId IdType="pmc">PMC6366451</ArticleId><ArticleId IdType="pubmed">29935653</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh J., Kwon O.B., Park S.W., Kim J.W., Lee H., Kim Y.K., Choi E.J., Jung H., Choi D.K., Oh B.J., et al. Advancing Cardiovascular Drug Screening Using Human Pluripotent Stem Cell-Derived Cardiomyocytes. Int. J. Mol. Sci. 2024;25:7971. doi: 10.3390/ijms25147971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms25147971</ArticleId><ArticleId IdType="pmc">PMC11277421</ArticleId><ArticleId IdType="pubmed">39063213</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Swanson K., Yildirim Z., Liu W., Liao R., Wu J.C. Clinical trials in-a-dish for cardiovascular medicine. Eur. Heart J. 2024;45:4275&#x2013;4290. doi: 10.1093/eurheartj/ehae519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae519</ArticleId><ArticleId IdType="pmc">PMC11491156</ArticleId><ArticleId IdType="pubmed">39270727</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferdinandy P., Baczk&#xf3; I., Bencsik P., Giricz Z., G&#xf6;rbe A., Pacher P., Varga Z.V., Varr&#xf3; A., Schulz R. Definition of hidden drug cardiotoxicity: Paradigm change in cardiac safety testing and its clinical implications. Eur. Heart J. 2019;40:1771&#x2013;1777. doi: 10.1093/eurheartj/ehy365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy365</ArticleId><ArticleId IdType="pmc">PMC6554653</ArticleId><ArticleId IdType="pubmed">29982507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee T.Y.T., Coles J.G., Maynes J.T. iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity. Front. Pharmacol. 2024;15:1308217. doi: 10.3389/fphar.2024.1308217.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1308217</ArticleId><ArticleId IdType="pmc">PMC10933010</ArticleId><ArticleId IdType="pubmed">38482053</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Burridge P.W., McKeithan W.L., Serrano R., Shukla P., Sayed N., Churko J.M., Kitani T., Wu H., Holmstr&#xf6;m A., et al. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells. Sci. Transl. Med. 2017;9:eaaf2584. doi: 10.1126/scitranslmed.aaf2584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf2584</ArticleId><ArticleId IdType="pmc">PMC5409837</ArticleId><ArticleId IdType="pubmed">28202772</ArticleId></ArticleIdList></Reference><Reference><Citation>Grafton F., Ho J., Ranjbarvaziri S., Farshidfar F., Budan A., Steltzer S., Maddah M., Loewke K.E., Green K., Patel S., et al. Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes. eLife. 2021;10:e68714. doi: 10.7554/eLife.68714.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.68714</ArticleId><ArticleId IdType="pmc">PMC8367386</ArticleId><ArticleId IdType="pubmed">34338636</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf6;l&#xf6;nen R.P., Swan H., Aalto-Set&#xe4;l&#xe4; K. Mutation-specific differences in arrhythmias and drug responses in CPVT patients: Simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes. Mol. Biol. Rep. 2020;47:1067&#x2013;1077. doi: 10.1007/s11033-019-05201-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-019-05201-y</ArticleId><ArticleId IdType="pubmed">31786768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnear C., Said A., Meng G., Zhao Y., Wang E.Y., Rafatian N., Parmar N., Wei W., Billia F., Simmons C.A., et al. Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction. Cell Rep. Med. 2024;5:101520. doi: 10.1016/j.xcrm.2024.101520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2024.101520</ArticleId><ArticleId IdType="pmc">PMC11148569</ArticleId><ArticleId IdType="pubmed">38642550</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Deschenes I., Zhao M.T. Precision medicine for long QT syndrome: Patient-specific iPSCs take the lead. Expert Rev. Mol. Med. 2023;25:e5. doi: 10.1017/erm.2022.43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2022.43</ArticleId><ArticleId IdType="pmc">PMC10302164</ArticleId><ArticleId IdType="pubmed">36597672</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomopoulos A., Kitani T., Wu J.C. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation. Mol. Ther. 2018;26:1624&#x2013;1634. doi: 10.1016/j.ymthe.2018.02.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2018.02.026</ArticleId><ArticleId IdType="pmc">PMC6035734</ArticleId><ArticleId IdType="pubmed">29699941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson J.T., Chopra A., Nafissi N., Polacheck W.J., Benson C.C., Swist S., Gorham J., Yang L., Schafer S., Sheng C.C., et al. HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science. 2015;349:982&#x2013;986. doi: 10.1126/science.aaa5458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa5458</ArticleId><ArticleId IdType="pmc">PMC4618316</ArticleId><ArticleId IdType="pubmed">26315439</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott-Roe C., Lv W., Maximova T., Wada S., Bukowy J., Marquez M., Lai S., Shehu A., Benjamin I., Geurts A., et al. Investigation of a dilated cardiomyopathy-associated variant in BAG3 using genome-edited iPSC-derived cardiomyocytes. JCI Insight. 2019;4:e128799. doi: 10.1172/jci.insight.128799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.128799</ArticleId><ArticleId IdType="pmc">PMC6948852</ArticleId><ArticleId IdType="pubmed">31723063</ArticleId></ArticleIdList></Reference><Reference><Citation>Te Riele A.S., Agullo-Pascual E., James C.A., Leo-Macias A., Cerrone M., Zhang M., Lin X., Lin B., Sobreira N.L., Amat-Alarcon N., et al. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis. Cardiovasc. Res. 2017;113:102&#x2013;111. doi: 10.1093/cvr/cvw234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvw234</ArticleId><ArticleId IdType="pmc">PMC5220677</ArticleId><ArticleId IdType="pubmed">28069705</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaffr&#xe9; F., Miller C.L., Sch&#xe4;nzer A., Evans T., Roberts A.E., Hahn A., Kontaridis M.I. Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. Circulation. 2019;140:207&#x2013;224. doi: 10.1161/CIRCULATIONAHA.118.037227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.037227</ArticleId><ArticleId IdType="pmc">PMC6709678</ArticleId><ArticleId IdType="pubmed">31163979</ArticleId></ArticleIdList></Reference><Reference><Citation>Chai A.C., Cui M., Chemello F., Li H., Chen K., Tan W., Atmanli A., McAnally J.R., Zhang Y., Xu L., et al. Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nat. Med. 2023;29:401&#x2013;411. doi: 10.1038/s41591-022-02176-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02176-5</ArticleId><ArticleId IdType="pmc">PMC10053064</ArticleId><ArticleId IdType="pubmed">36797478</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama T., Zhang Y., Cui M., Li H., Sanchez-Ortiz E., McAnally J.R., Tan W., Kim J., Chen K., Xu L., et al. Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Sci. Transl. Med. 2022;14:eade1633. doi: 10.1126/scitranslmed.ade1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.ade1633</ArticleId><ArticleId IdType="pmc">PMC10088465</ArticleId><ArticleId IdType="pubmed">36417486</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Liu Z., Sun J., Chen Z., Gao F., Guo Y. Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C&#x2009;&gt;&#x2009;T mutation in murine hearts. J. Cell. Mol. Med. 2024;28:e18145. doi: 10.1111/jcmm.18145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.18145</ArticleId><ArticleId IdType="pmc">PMC10853587</ArticleId><ArticleId IdType="pubmed">38332517</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Jiang W., Liu X., Lu W.J., Qi T., Wei J., Wu F., Chang Y., Zhang S., Song Y., et al. Efficient Correction of a Hypertrophic Cardiomyopathy Mutation by ABEmax-NG. Circ. Res. 2021;129:895&#x2013;908. doi: 10.1161/CIRCRESAHA.120.318674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.318674</ArticleId><ArticleId IdType="pubmed">34525843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan X., Philippen L., Lahiri S.K., Lee C., Park S.H., Word T.A., Li N., Jarrett K.E., Gupta R., Reynolds J.O., et al. In Vivo Ryr2 Editing Corrects Catecholaminergic Polymorphic Ventricular Tachycardia. Circ. Res. 2018;123:953&#x2013;963. doi: 10.1161/CIRCRESAHA.118.313369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313369</ArticleId><ArticleId IdType="pmc">PMC6206886</ArticleId><ArticleId IdType="pubmed">30355031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleppe H., Budan A., Zhang L., Majetic M., Shenwai R., Levinson A., Cisne-Thompson O., Farshidfar F., Tsui J., Figarska S., et al.  Reduced Expression of MTSS1 Increases Sarcomere Number and Improves Contractility in Select Forms of Monogenic DCM.  [(accessed on 18 May 2025)];medRxiv. 2024 :24311020. Available online:  https://www.medrxiv.org/content/10.1101/2024.08.14.24311020v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.08.14.24311020v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer-Short A., Greenwood A., Leon E.C., Qureshi T.N., von Kraut K., Wong J., Tsui J.H., Reid C.A., Cheng Z., Easter E., et al. AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models. Nat. Commun. 2025;16:2196. doi: 10.1038/s41467-025-57481-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-025-57481-7</ArticleId><ArticleId IdType="pmc">PMC11880196</ArticleId><ArticleId IdType="pubmed">40038304</ArticleId></ArticleIdList></Reference><Reference><Citation>Min Y.-L., Li H., Rodriguez-Caycedo C., Mireault A.A., Huang J., Shelton J.M., McAnally J.R., Amoasii L., Mammen P.P.A., Bassel-Duby R., et al. CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells. Sci. Adv. 2019;5:eaav4324. doi: 10.1126/sciadv.aav4324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aav4324</ArticleId><ArticleId IdType="pmc">PMC6402849</ArticleId><ArticleId IdType="pubmed">30854433</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Li H., Zhu M., Han R.Y., Guo S., Han R. Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping. Mol. Ther. Methods Clin. Dev. 2023;28:40&#x2013;50. doi: 10.1016/j.omtm.2022.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtm.2022.11.010</ArticleId><ArticleId IdType="pmc">PMC9792405</ArticleId><ArticleId IdType="pubmed">36588820</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks I.R., Garrone C.M., Kerins C., Kiar C.S., Syntaka S., Xu J.Z., Spagnoli F.M., Watt F.M. Functional genomics and the future of iPSCs in disease modeling. Stem Cell Rep. 2022;17:1033&#x2013;1047. doi: 10.1016/j.stemcr.2022.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.03.019</ArticleId><ArticleId IdType="pmc">PMC9133703</ArticleId><ArticleId IdType="pubmed">35487213</ArticleId></ArticleIdList></Reference><Reference><Citation>Su J., Song Y., Zhu Z., Huang X., Fan J., Qiao J., Mao F. Cell&#x2013;cell communication: New insights and clinical implications. Signal Transduct. Target. Ther. 2024;9:196. doi: 10.1038/s41392-024-01888-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-024-01888-z</ArticleId><ArticleId IdType="pmc">PMC11382761</ArticleId><ArticleId IdType="pubmed">39107318</ArticleId></ArticleIdList></Reference><Reference><Citation>Denning C., Borgdorff V., Crutchley J., Firth K.S., George V., Kalra S., Kondrashov A., Hoang M.D., Mosqueira D., Patel A., et al. Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochim. Biophys. Acta. 2016;1863:1728&#x2013;1748. doi: 10.1016/j.bbamcr.2015.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2015.10.014</ArticleId><ArticleId IdType="pmc">PMC5221745</ArticleId><ArticleId IdType="pubmed">26524115</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashchenko C.Y., Pipes G.C., Lozinskaya I.M., Lin Z., Xiaoping X., Needle S., Grygielko E.T., Hu E., Toomey J.R., Lepore J.J., et al. Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. Am. J. Physiol. Heart Circ. Physiol. 2013;305:H913&#x2013;H922. doi: 10.1152/ajpheart.00819.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00819.2012</ArticleId><ArticleId IdType="pubmed">23832699</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesl M., Pribyl J., Caluori G., Cmiel V., Acimovic I., Jelinkova S., Dvorak P., Starek Z., Skladal P., Rotrekl V. Phenotypic assays for analyses of pluripotent stem cell-derived cardiomyocytes. J. Mol. Recognit. 2017;30:e2602. doi: 10.1002/jmr.2602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.2602</ArticleId><ArticleId IdType="pubmed">27995655</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.S., Kim C., Mercola M. Electrophysiological challenges of cell-based myocardial repair. Circulation. 2009;120:2496&#x2013;2508. doi: 10.1161/CIRCULATIONAHA.107.751412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.751412</ArticleId><ArticleId IdType="pmc">PMC3293934</ArticleId><ArticleId IdType="pubmed">20008740</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitale A.M., Matigian N.A., Ravishankar S., Bellette B., Wood S.A., Wolvetang E.J., Mackay-Sim A. Variability in the generation of induced pluripotent stem cells: Importance for disease modeling. Stem Cells Transl. Med. 2012;1:641&#x2013;650. doi: 10.5966/sctm.2012-0043.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2012-0043</ArticleId><ArticleId IdType="pmc">PMC3659735</ArticleId><ArticleId IdType="pubmed">23197870</ArticleId></ArticleIdList></Reference><Reference><Citation>Scesa G., Adami R., Bottai D. iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter? Cells. 2021;10:1470. doi: 10.3390/cells10061470.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061470</ArticleId><ArticleId IdType="pmc">PMC8230744</ArticleId><ArticleId IdType="pubmed">34208270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara M., Hayashizaki Y., Murakawa Y. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Rev. Rep. 2017;13:7&#x2013;16. doi: 10.1007/s12015-016-9680-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-016-9680-6</ArticleId><ArticleId IdType="pmc">PMC5346115</ArticleId><ArticleId IdType="pubmed">27592701</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Feng X., Li G., Gokulnath P., Xiao J. Generating 3D human cardiac constructs from pluripotent stem cells. eBioMedicine. 2022;76:103813. doi: 10.1016/j.ebiom.2022.103813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103813</ArticleId><ArticleId IdType="pmc">PMC8804169</ArticleId><ArticleId IdType="pubmed">35093634</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Hwang B., Rezapourdamanab S., Sridhar V., Nandwani R., Amoli M.S., Serpooshan V. Bioengineering Approaches to In Vitro Modeling of Genetic and Acquired Cardiac Diseases. Curr. Cardiol. Rep. 2025;27:72. doi: 10.1007/s11886-025-02218-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-025-02218-7</ArticleId><ArticleId IdType="pmc">PMC11926001</ArticleId><ArticleId IdType="pubmed">40111543</ArticleId></ArticleIdList></Reference><Reference><Citation>Omole A.E., Fakoya A.O.J. Ten years of progress and promise of induced pluripotent stem cells: Historical origins, characteristics, mechanisms, limitations, and potential applications. PeerJ. 2018;6:e4370. doi: 10.7717/peerj.4370.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.4370</ArticleId><ArticleId IdType="pmc">PMC5951134</ArticleId><ArticleId IdType="pubmed">29770269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.L. Some Ethical Concerns About Human Induced Pluripotent Stem Cells. Sci. Eng. Ethics. 2016;22:1277&#x2013;1284. doi: 10.1007/s11948-015-9693-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11948-015-9693-6</ArticleId><ArticleId IdType="pubmed">26276162</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornetta K., Patel K., Wanjiku C.M., Busakhala N. Equitable Access to Gene Therapy: A Call to Action for the American Society of Gene and Cell Therapy. Mol. Ther. 2018;26:2715&#x2013;2716. doi: 10.1016/j.ymthe.2018.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2018.11.002</ArticleId><ArticleId IdType="pmc">PMC6277505</ArticleId><ArticleId IdType="pubmed">30454956</ArticleId></ArticleIdList></Reference><Reference><Citation>Steeg R., Mueller S.C., Mah N., Holst B., Cabrera-Socorro A., Stacey G.N., De Sousa P.A., Courtney A., Zimmermann H. EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines. Stem Cell Rep. 2021;16:1853&#x2013;1867. doi: 10.1016/j.stemcr.2021.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.07.009</ArticleId><ArticleId IdType="pmc">PMC8365092</ArticleId><ArticleId IdType="pubmed">34380020</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira T., Kweder S.L., Saint-Raymond A. Are the European Medicines Agency, US Food and Drug Administration, and Other International Regulators Talking to Each Other? Clin. Pharmacol. Ther. 2020;107:507&#x2013;513. doi: 10.1002/cpt.1617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.1617</ArticleId><ArticleId IdType="pmc">PMC7028217</ArticleId><ArticleId IdType="pubmed">31449664</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan J.L., Tulloch N.L., Razumova M.V., Saiget M., Muskheli V., Pabon L., Reinecke H., Regnier M., Murry C.E. Mechanical Stress Conditioning and Electrical Stimulation Promote Contractility and Force Maturation of Induced Pluripotent Stem Cell-Derived Human Cardiac Tissue. Circulation. 2016;134:1557&#x2013;1567. doi: 10.1161/CIRCULATIONAHA.114.014998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.114.014998</ArticleId><ArticleId IdType="pmc">PMC5123912</ArticleId><ArticleId IdType="pubmed">27737958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronaldson-Bouchard K., Ma S.P., Yeager K., Chen T., Song L., Sirabella D., Morikawa K., Teles D., Yazawa M., Vunjak-Novakovic G. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature. 2018;556:239&#x2013;243. doi: 10.1038/s41586-018-0016-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0016-3</ArticleId><ArticleId IdType="pmc">PMC5895513</ArticleId><ArticleId IdType="pubmed">29618819</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyra-Leite D.M., Guti&#xe9;rrez-Guti&#xe9;rrez &#xd3;., Wang M., Zhou Y., Cyganek L., Burridge P.W. A review of protocols for human iPSC culture, cardiac differentiation, subtype-specification, maturation, and direct reprogramming. STAR Protoc. 2022;3:101560. doi: 10.1016/j.xpro.2022.101560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xpro.2022.101560</ArticleId><ArticleId IdType="pmc">PMC9405110</ArticleId><ArticleId IdType="pubmed">36035804</ArticleId></ArticleIdList></Reference><Reference><Citation>Kistam&#xe1;s K., M&#xfc;ller A., Muenthaisong S., Lamberto F., Zana M., Dulac M., Leal F., Maziz A., Costa P., Bernotiene E., et al. Multifactorial approaches to enhance maturation of human iPSC-derived cardiomyocytes. J. Mol. Liq. 2023;387:122668. doi: 10.1016/j.molliq.2023.122668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molliq.2023.122668</ArticleId></ArticleIdList></Reference><Reference><Citation>Besser R.R., Ishahak M., Mayo V., Carbonero D., Claure I., Agarwal A. Engineered Microenvironments for Maturation of Stem Cell Derived Cardiac Myocytes. Theranostics. 2018;8:124&#x2013;140. doi: 10.7150/thno.19441.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.19441</ArticleId><ArticleId IdType="pmc">PMC5743464</ArticleId><ArticleId IdType="pubmed">29290797</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Li D., Wang J., Dai Y. Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes. Sci. Rep. 2024;14:29268. doi: 10.1038/s41598-024-79488-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-79488-8</ArticleId><ArticleId IdType="pmc">PMC11589621</ArticleId><ArticleId IdType="pubmed">39587160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Morgan W., Saini A., Liu T., Lough J., Han L. Single-cell transcriptomic profiling reveals specific maturation signatures in human cardiomyocytes derived from LMNB2-inactivated induced pluripotent stem cells. Front. Cell Dev. Biol. 2022;10:895162. doi: 10.3389/fcell.2022.895162.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.895162</ArticleId><ArticleId IdType="pmc">PMC9742441</ArticleId><ArticleId IdType="pubmed">36518540</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh S., Baljinnyam E., Tong M., Kashihara T., Yan L., Liu T., Li H., Xie L.H., Nakamura M., Oka S.I., et al. Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2021;320:R547&#x2013;R562. doi: 10.1152/ajpregu.00207.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00207.2020</ArticleId><ArticleId IdType="pmc">PMC8238141</ArticleId><ArticleId IdType="pubmed">33112656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter B., Li M., Parker B.L., Koay Y.C., Harney D.J., Pearson E., Cao J., Chen G.T., Guneratne O., Smyth G.K., et al. Proteomic and metabolomic analyses of the human adult myocardium reveal ventricle-specific regulation in end-stage cardiomyopathies. Commun. Biol. 2024;7:1666. doi: 10.1038/s42003-024-07306-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-024-07306-y</ArticleId><ArticleId IdType="pmc">PMC11659555</ArticleId><ArticleId IdType="pubmed">39702518</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrino C., Barab&#xe1;si A.L., Condorelli G., Davidson S.M., De Windt L., Dimmeler S., Engel F.B., Hausenloy D.J., Hill J.A., Van Laake L.W., et al. Epigenomic and transcriptomic approaches in the post-genomic era: Path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc. Res. 2017;113:725&#x2013;736. doi: 10.1093/cvr/cvx070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvx070</ArticleId><ArticleId IdType="pmc">PMC5437366</ArticleId><ArticleId IdType="pubmed">28460026</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M., Ulfenborg B., Andersson C.X., Heydarkhan-Hagvall S., Jeppsson A., Sartipy P., Synnergren J. Multi-Omics Characterization of a Human Stem Cell-Based Model of Cardiac Hypertrophy. Life. 2022;12:293. doi: 10.3390/life12020293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12020293</ArticleId><ArticleId IdType="pmc">PMC8875317</ArticleId><ArticleId IdType="pubmed">35207580</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan W.L.W., Seow W.Q., Zhang A., Rhee S., Wong W.H., Greenleaf W.J., Wu J.C. Current and future perspectives of single-cell multi-omics technologies in cardiovascular research. Nat. Cardiovasc. Res. 2023;2:20&#x2013;34. doi: 10.1038/s44161-022-00205-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00205-7</ArticleId><ArticleId IdType="pmc">PMC11974510</ArticleId><ArticleId IdType="pubmed">39196210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernik D.C., Morotti S., Wu H., Garg P., Duff H.J., Kurokawa J., Jalife J., Wu J.C., Grandi E., Clancy C.E. A computational model of induced pluripotent stem-cell derived cardiomyocytes incorporating experimental variability from multiple data sources. J. Physiol. 2019;597:4533&#x2013;4564. doi: 10.1113/JP277724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP277724</ArticleId><ArticleId IdType="pmc">PMC6767694</ArticleId><ArticleId IdType="pubmed">31278749</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusumoto D., Lachmann M., Kunihiro T., Yuasa S., Kishino Y., Kimura M., Katsuki T., Itoh S., Seki T., Fukuda K. Automated Deep Learning-Based System to Identify Endothelial Cells Derived from Induced Pluripotent Stem Cells. Stem Cell Rep. 2018;10:1687&#x2013;1695. doi: 10.1016/j.stemcr.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.04.007</ArticleId><ArticleId IdType="pmc">PMC5989816</ArticleId><ArticleId IdType="pubmed">29754958</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouard G., Mykk&#xe4;nen J., Heiskanen J., Pohjonen J., Ruohonen S., Pahkala K., Lehtim&#xe4;ki T., Wang X., Ollikainen M., Ripatti S., et al. Exploring machine learning strategies for predicting cardiovascular disease risk factors from multi-omic data. BMC Med. Inform. Decis. Mak. 2024;24:116. doi: 10.1186/s12911-024-02521-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-024-02521-3</ArticleId><ArticleId IdType="pmc">PMC11064347</ArticleId><ArticleId IdType="pubmed">38698395</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S.M., Lan J., Kaeli D., Dy J., Alshawabkeh A., Gu A.Z. Machine learning-based biomarkers identification from toxicogenomics&#x2014;Bridging to regulatory relevant phenotypic endpoints. J. Hazard. Mater. 2022;423:127141. doi: 10.1016/j.jhazmat.2021.127141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhazmat.2021.127141</ArticleId><ArticleId IdType="pmc">PMC9628282</ArticleId><ArticleId IdType="pubmed">34560480</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B., Halloin C., L&#xf6;bel W., Finklea F., Lipke E., Zweigerdt R., Cremaschi S. Data-Driven Model Development for Cardiomyocyte Production Experimental Failure Prediction. In: Pierucci S., Manenti F., Bozzano G.L., Manca D., editors. Computer Aided Chemical Engineering. Volume 48. Elsevier; Amsterdam, The Netherlands: 2020. pp. 1639&#x2013;1644.</Citation></Reference><Reference><Citation>Schork N.J. Artificial Intelligence and Personalized Medicine. Cancer Treat Res. 2019;178:265&#x2013;283. doi: 10.1007/978-3-030-16391-4_11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-16391-4_11</ArticleId><ArticleId IdType="pmc">PMC7580505</ArticleId><ArticleId IdType="pubmed">31209850</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo Q.D., Saito Y., Ida T., Nakamura K., Yuasa S. The use of artificial intelligence in induced pluripotent stem cell-based technology over 10-year period: A systematic scoping review. PLoS ONE. 2024;19:e0302537. doi: 10.1371/journal.pone.0302537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0302537</ArticleId><ArticleId IdType="pmc">PMC11108174</ArticleId><ArticleId IdType="pubmed">38771829</ArticleId></ArticleIdList></Reference><Reference><Citation>Bettini A., Camelliti P., Stuckey D.J., Day R.M. Injectable biodegradable microcarriers for iPSC expansion and cardiomyocyte differentiation. Adv. Sci. 2024;11:2404355. doi: 10.1002/advs.202404355.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.202404355</ArticleId><ArticleId IdType="pmc">PMC11348074</ArticleId><ArticleId IdType="pubmed">38900068</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N., Ye X., Yao B., Zhao M., Wu P., Liu G., Zhuang D., Jiang H., Chen X., He Y., et al. Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration. Bioact. Mater. 2021;6:1388&#x2013;1401. doi: 10.1016/j.bioactmat.2020.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bioactmat.2020.10.021</ArticleId><ArticleId IdType="pmc">PMC7658327</ArticleId><ArticleId IdType="pubmed">33210031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura T., Ito Y., Ito E., Takeda M., Mikami T., Taguchi T., Mochizuki-Oda N., Sasai M., Shimamoto T., Nitta Y., et al. Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: First three case reports. Front. Cardiovasc. Med. 2023;10:1182209. doi: 10.3389/fcvm.2023.1182209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1182209</ArticleId><ArticleId IdType="pmc">PMC10540447</ArticleId><ArticleId IdType="pubmed">37781295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkeby A., Main H., Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update. Cell Stem Cell. 2025;32:10&#x2013;37. doi: 10.1016/j.stem.2024.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2024.12.005</ArticleId><ArticleId IdType="pubmed">39753110</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar D., Reyes L., Chong J.J.H. Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do? Curr. Cardiol. Rep. 2022;24:445&#x2013;461. doi: 10.1007/s11886-022-01666-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01666-9</ArticleId><ArticleId IdType="pmc">PMC9068652</ArticleId><ArticleId IdType="pubmed">35275365</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40528388</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8344</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Expert review of cardiovascular therapy</Title><ISOAbbreviation>Expert Rev Cardiovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Bleeding risk assessment tools for patients with myocardial infarction: a comparative review and clinical implications.</ArticleTitle><Pagination><StartPage>287</StartPage><EndPage>301</EndPage><MedlinePgn>287-301</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14779072.2025.2520827</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Bleeding risk stratification tools are essential for optimizing ischemic protection while minimizing bleeding complications in patients with myocardial infarction, particularly for those undergoing percutaneous coronary intervention (PCI) or dual antiplatelet therapy.</AbstractText><AbstractText Label="AREAS COVERED" NlmCategory="UNASSIGNED">A structured search of PubMed, Scopus, and Web of Science was conducted for studies published from January 2005 to December 2024. This review evaluates traditional and novel bleeding risk models in MI management. Established tools like CRUSADE, ACUITY-HORIZONS, ACTION, and PRECISE-DAPT aid in predicting in-hospital and early post-discharge bleeding but have limitations in long-term risk assessment and adapting to modern PCI techniques. Emerging models - SWEDEHEART, ARC-HBR, CREDO-KYOTO, and BleeMACS - offer enhanced risk stratification by incorporating broader clinical variables and long-term bleeding predictors, improving their applicability to contemporary MI management.</AbstractText><AbstractText Label="EXPERT OPINION" NlmCategory="UNASSIGNED">Despite advancements, current models exhibit moderate predictive accuracy (c-statistics 0.70-0.80) and rely on static baseline factors, limiting real-time applicability. They also fail to integrate ischemic risk assessment, creating challenges in balancing thrombotic and bleeding risks. Future research should focus on AI-driven dynamic risk models, broader validation across diverse populations, and integrating bleeding and ischemic risk stratification into a unified framework. Embedding these tools into electronic health records will enhance clinical decision-making and improve patient outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thiruchelvam</LastName><ForeName>Kaeshaelya</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3754-1690</Identifier><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun Xin</LastName><ForeName>Jonathan Than</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Law</LastName><ForeName>Win Kit</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Lyn Feng</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Xuen Bei</ForeName><Initials>XB</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Lim</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hui Min</LastName><ForeName>Olivia Sim</ForeName><Initials>OS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Zhi Qi</ForeName><Initials>ZQ</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kow</LastName><ForeName>Chia Siang</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>School of Pharmacy, IMU University, Bukit Jalil, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Applied Sciences, University of Huddersfield, Huddersfield, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Cardiovasc Ther</MedlineTA><NlmUniqueID>101182328</NlmUniqueID><ISSNLinking>1477-9072</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010975">Platelet Aggregation Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="Y">Hemorrhage</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010975" MajorTopicYN="Y">Platelet Aggregation Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000080903" MajorTopicYN="N">Dual Anti-Platelet Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clopidogrel</Keyword><Keyword MajorTopicYN="N">enoxaparin</Keyword><Keyword MajorTopicYN="N">fondaparinux</Keyword><Keyword MajorTopicYN="N">prasugrel</Keyword><Keyword MajorTopicYN="N">ticagrelor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>2</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40528388</ArticleId><ArticleId IdType="doi">10.1080/14779072.2025.2520827</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40529550</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Editorial: Contemporary applications of machine learning and artificial intelligence for the management of heart failure.</ArticleTitle><Pagination><StartPage>1611859</StartPage><MedlinePgn>1611859</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1611859</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2025.1611859</ELocationID><Abstract><AbstractText>Heart failure (HF) is a complex syndrome with substantial clinical and economic impact. This editorial highlights four original articles published in <i>Frontiers in Cardiovascular Medicine</i> that showcase contemporary applications of machine learning and artificial intelligence (AI) in HF management. These studies address early diagnosis through novel biomarkers, disease stratification based on transcriptomics, mechanistic insight into apoptotic pathways, and predictive telemonitoring using real-time AI models. Collectively, these contributions exemplify the transformative potential of data-driven technologies in personalizing care and preventing decompensation in HF. We discuss both the promise and challenges of integrating these tools into routine.</AbstractText><CopyrightInformation>&#xa9; 2025 Duraes, Gomes-Neto and Bocchi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duraes</LastName><ForeName>Andre Rodrigues</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Federal University of Bahia (UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes-Neto</LastName><ForeName>Mansueto</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Federal University of Bahia (UFBA), Salvador, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocchi</LastName><ForeName>Edimar Alcides</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Heart Institute (InCor), S&#xe3;o Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Editorial on the Research Topic Contemporary applications of machine learning and artificial intelligence for the management of heart failure</RefSource></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">healthcare technology</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">precision medicine</Keyword><Keyword MajorTopicYN="N">telemonitoring</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>18</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40529550</ArticleId><ArticleId IdType="pmc">PMC12170515</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2025.1611859</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40484621</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8232</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Critical care clinics</Title><ISOAbbreviation>Crit Care Clin</ISOAbbreviation></Journal><ArticleTitle>Mechanical Circulatory Support Devices.</ArticleTitle><Pagination><StartPage>555</StartPage><EndPage>572</EndPage><MedlinePgn>555-572</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ccc.2025.02.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0749-0704(25)00016-8</ELocationID><Abstract><AbstractText>Ultrasonography is essential in intensive care units for rapid, real-time assessment and management of various organ systems, particularly for patients with mechanical circulatory support (MCS) devices. It aids in the diagnosis, safe placement, and monitoring of MCS devices such as extracorporeal membrane oxygenation, Impella, and implantable left ventricular assist devices, used for conditions like cardiogenic shock and severe respiratory failure. Ultrasonography ensures precise device positioning, identifies complications, and facilitates weaning. Future advancements in AI, portable devices, and advanced imaging techniques will enhance diagnostic accuracy and patient care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Bhoumesh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jersey Shore Medical Center, Hackensack Meridian Health, 1945 NJ-33, Neptune City, NJ 07753, USA; Deparmtent of Anesthesiology, Yale School of Medicine, 333 Cedar Street, P.O BOX 208051, New Haven, CT 06520-8051, USA. Electronic address: bhoumesh.patel@yale.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Griffee</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, University of Utah, 30 North MArio Capecchi Drive, Salt Lake City, UT 84112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munoz-Acuna</LastName><ForeName>Ronny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Deparmtent of Anesthesiology, Yale School of Medicine, 333 Cedar Street, P.O BOX 208051, New Haven, CT 06520-8051, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Clin</MedlineTA><NlmUniqueID>8507720</NlmUniqueID><ISSNLinking>0749-0704</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006353" MajorTopicYN="Y">Heart-Assist Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="Y">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Heart-assist devices</Keyword><Keyword MajorTopicYN="N">Mechanical circulatory support</Keyword><Keyword MajorTopicYN="N">Shock</Keyword><Keyword MajorTopicYN="N">Ultrasonography</Keyword></KeywordList><CoiStatement>Disclosure Support was provided solely from institutional and departmental sources. There were no external sources of funding. The authors declare no relevant financial disclosures and no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>9</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>9</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>8</Day><Hour>20</Hour><Minute>59</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40484621</ArticleId><ArticleId IdType="doi">10.1016/j.ccc.2025.02.006</ArticleId><ArticleId IdType="pii">S0749-0704(25)00016-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40672503</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET): Rationale and Design.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2025.07.10.25330435</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2025.07.10.25330435</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="UNASSIGNED">The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET) was established to aggregate PET and associated computed tomography (CT) images with clinical data from hospitals around the world into one comprehensive research resource.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">REFINE PET is a multicenter, international registry that contains both clinical and imaging data. The PET scans were processed using QPET software (Cedars-Sinai Medical Center, Los Angeles, CA), while the CT scans were processed using deep learning (DL) to detect coronary artery calcium (CAC). Patients were followed up for the occurrence of major adverse cardiovascular events (MACE), which include death, myocardial infarction, unstable angina, and late revascularization (&gt;90 days from PET).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The REFINE PET registry currently contains data for 35,588 patients from 14 sites, with additional patient data and sites anticipated. Comprehensive clinical data (including demographics, medical history, and stress test results) were integrated with more than 2200 imaging variables across 42 categories. The registry is poised to address a broad range of clinical questions, supported by correlating invasive angiography (within 6 months of MPI) in 5972 patients and a total of 9252 major adverse cardiovascular events during a median follow-up of 4.2 years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The REFINE PET registry leverages the integration of clinical, multimodality imaging, and novel quantitative and AI tools to advance the role of PET/CT MPI in diagnosis and risk stratification.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramirez</LastName><ForeName>Giselle</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemley</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanbhag</LastName><ForeName>Aakash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Signal and Image Processing Institute, Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwiecinski</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Robert J H</ForeName><Initials>RJH</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavanagh</LastName><ForeName>Paul B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Joanna X</ForeName><Initials>JX</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Damini</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slipczuk</LastName><ForeName>Leandro</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3091-3735</Identifier><AffiliationInfo><Affiliation>Cardiology Division, Montefiore Health System/Albert Einstein College of Medicine, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Travin</LastName><ForeName>Mark I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Department of Radiology (Nuclear Medicine), Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexanderson</LastName><ForeName>Erick</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Nuclear Cardiology, Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvajal-Juarez</LastName><ForeName>Isabel</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nuclear Cardiology, Ignacio Chavez National Institute of Cardiology, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Packard</LastName><ForeName>Ren&#xe9; R S</ForeName><Initials>RRS</Initials><Identifier Source="ORCID">0000-0002-8520-5843</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West Los Angeles Veterans Affairs Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mallah</LastName><ForeName>Mouaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart &amp; Vascular Center, Houston Methodist Academic Institute, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einstein</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, and Department of Radiology, Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feher</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acampa</LastName><ForeName>Wanda</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Stacey</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Utah, Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Viet T</ForeName><Initials>VT</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mason</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center Heart Institute, Intermountain Healthcare, Murray, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanghani</LastName><ForeName>Rupa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Section of Cardiology, Department of Medicine, Rush University Medical Center, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wopperer</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chareonthaitawee</LastName><ForeName>Panithaya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buechel</LastName><ForeName>Ronny R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosamond</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The University of Kansas Medical Center, Kansas City, KS, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>deKemp</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Carli</LastName><ForeName>Marcelo F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Cardiovascular Imaging Program, Departments of Radiology and Medicine; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slomka</LastName><ForeName>Piotr J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-6110-938X</Identifier><AffiliationInfo><Affiliation>Departments of Medicine (Division of Artificial Intelligence in Medicine), Imaging, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 EB034586</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 HL161195</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>J Nucl Cardiol. 2025 Aug 5:102449. doi: 10.1016/j.nuclcard.2025.102449.</RefSource><PMID Version="1">40774620</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PET</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">myocardial perfusion imaging</Keyword><Keyword MajorTopicYN="N">quantitative analysis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40672503</ArticleId><ArticleId IdType="pmc">PMC12265749</ArticleId><ArticleId IdType="doi">10.1101/2025.07.10.25330435</ArticleId><ArticleId IdType="pii">2025.07.10.25330435</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Association A.H., Cardiovascular Disease: A Costly Burden for America Projections Through 2035. 2017.</Citation></Reference><Reference><Citation>Roth G.A., et al. , Global Burden of Cardiovascular Diseases and Risk Factors, 1990&#x2013;2019: Update From the GBD 2019 Study. J Am Coll Cardiol, 2020. 76(25): p. 2982&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj N.S., et al. , Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients. J Am Coll Cardiol, 2018. 72(7): p. 707&#x2013;717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592712</ArticleId><ArticleId IdType="pubmed">30092946</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy V.L., et al. , Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation, 2012. 126(15): p. 1858&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3495105</ArticleId><ArticleId IdType="pubmed">22919001</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborne M.T., et al. , Coronary Microvascular Dysfunction Identifies Patients at High Risk of Adverse Events Across Cardiometabolic Diseases. J Am Coll Cardiol, 2017. 70(22): p. 2835&#x2013;2837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5728431</ArticleId><ArticleId IdType="pubmed">29191335</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W., et al. , Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failure. Eur Heart J, 2020. 41(25): p. 2366&#x2013;2375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7327534</ArticleId><ArticleId IdType="pubmed">32221588</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani S.S., et al. , 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 2023. 148(9): p. e9&#x2013;e119.</Citation><ArticleIdList><ArticleId IdType="pubmed">37471501</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrints C., et al. , 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J, 2024. 45(36): p. 3415&#x2013;3537.</Citation><ArticleIdList><ArticleId IdType="pubmed">39210710</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Mallah M., et al. , Cardiac positron emission tomography and other modalities for coronary artery disease assessment: A snapshot from the medicare data. J Nucl Cardiol, 2024. 41: p. 102030.</Citation><ArticleIdList><ArticleId IdType="pubmed">39233112</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.J.H., et al. , The Updated Registry of Fast Myocardial Perfusion Imaging with Next-Generation SPECT (REFINE SPECT 2.0). J Nucl Med, 2024. 65(11): p. 1795&#x2013;1801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11533915</ArticleId><ArticleId IdType="pubmed">39362762</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., et al. , Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol, 2018. 72(18): p. 2231&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray J.J.V., et al. , Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med, 2019. 381(21): p. 1995&#x2013;2008.</Citation><ArticleIdList><ArticleId IdType="pubmed">31535829</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.J.H., et al. , Percutaneous or surgical revascularization is associated with survival benefit in stable coronary artery disease. Eur Heart J Cardiovasc Imaging, 2020. 21(9): p. 961&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pubmed">32417892</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., et al. , Third universal definition of myocardial infarction. Circulation, 2012. 126(16): p. 2020&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">22923432</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicks K.A., et al. , 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation, 2018. 137(9): p. 961&#x2013;972.</Citation><ArticleIdList><ArticleId IdType="pubmed">29483172</ArticleId></ArticleIdList></Reference><Reference><Citation>Amsterdam E.A., et al. , 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014. 64(24): p. e139&#x2013;e228.</Citation><ArticleIdList><ArticleId IdType="pubmed">25260718</ArticleId></ArticleIdList></Reference><Reference><Citation>Slomka P.J., et al. , Rationale and design of the REgistry of Fast Myocardial Perfusion Imaging with NExt generation SPECT (REFINE SPECT). J Nucl Cardiol, 2020. 27(3): p. 1010&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6301135</ArticleId><ArticleId IdType="pubmed">29923104</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerqueira M.D., et al. , Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation, 2002. 105(4): p. 539&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">11815441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieszko K., et al. , Deep Learning of Coronary Calcium Scores From PET/CT Attenuation Maps Accurately Predicts Adverse Cardiovascular Events. JACC Cardiovasc Imaging, 2023. 16(5): p. 675&#x2013;687.</Citation><ArticleIdList><ArticleId IdType="pubmed">36284402</ArticleId></ArticleIdList></Reference><Reference><Citation>Agatston A.S., et al. , Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol, 1990. 15(4): p. 827&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">2407762</ArticleId></ArticleIdList></Reference><Reference><Citation>Charytan D.M., et al. , Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. Kidney Int, 2018. 93(2): p. 501&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6381827</ArticleId><ArticleId IdType="pubmed">29032954</ArticleId></ArticleIdList></Reference><Reference><Citation>Murthy V.L., et al. , Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation, 2011. 124(20): p. 2215&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3495106</ArticleId><ArticleId IdType="pubmed">22007073</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel K.K., et al. , Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization. Eur Heart J, 2020. 41(6): p. 759&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7828468</ArticleId><ArticleId IdType="pubmed">31228200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziadi M.C., et al. , Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? J Nucl Cardiol, 2012. 19(4): p. 670&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">22415819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hijazi W., et al. , Deep Learning-Derived Cardiac Chamber Volumes and Mass From PET/CT Attenuation Scans: Associations With Myocardial Flow Reserve and Heart Failure. Circ Cardiovasc Imaging, 2025: p. e018188.</Citation><ArticleIdList><ArticleId IdType="pubmed">40357553</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.J.H., et al. , AI-Defined Cardiac Anatomy Improves Risk Stratification of Hybrid Perfusion Imaging. JACC Cardiovasc Imaging, 2024. 17(7): p. 780&#x2013;791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11222053</ArticleId><ArticleId IdType="pubmed">38456877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dharmavaram N.L., et al. , AI-Derived Splenic Response in Cardiac PET Predicts Mortality: A Multi-Site Study. medRxiv, 2025: p. 2025.06.27.25330278.</Citation></Reference><Reference><Citation>Marcinkiewicz A.M., et al. , Holistic AI analysis of hybrid cardiac perfusion images for mortality prediction. NPJ Digit Med, 2025. 8(1): p. 158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11906890</ArticleId><ArticleId IdType="pubmed">40082599</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.J.H., et al. , Deep learning-quantified body composition from positron emission tomography/computed tomography and cardiovascular outcomes: a multicentre study. Eur Heart J, 2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12190801</ArticleId><ArticleId IdType="pubmed">40159388</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., et al. , AI-based volumetric six-tissue body composition quantification from CT cardiac attenuation scans for mortality prediction: a multicentre study. The Lancet Digital Health, 2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12126277</ArticleId><ArticleId IdType="pubmed">40382274</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi J., et al. , AI-based Hepatic Steatosis Detection and Integrated Hepatic Assessment from Cardiac CT Attenuation Scans Enhances All-cause Mortality Risk Stratification: A Multi-center Study. medRxiv, 2025: p. 2025.06.09.25329157.</Citation></Reference><Reference><Citation>Tonino P.A., et al. , Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol, 2010. 55(25): p. 2816&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">20579537</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40666192</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1661-3791</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2025</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Breast care (Basel, Switzerland)</Title><ISOAbbreviation>Breast Care (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Risk of Cardiovascular Disease following Aromatase Inhibitor Therapy for Breast Cancer in Postmenopausal Women: A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1159/000546089</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">More women are recovering and living longer lives due to advancement in breast cancer therapies. Aromatase inhibitors (AIs) are one form of endocrine therapy for breast cancer that may have an impact on the risk of developing cardiovascular diseases later in life. This study investigated whether AI therapy for breast cancer in postmenopausal women increases the risk of developing cardiovascular disease in comparison with tamoxifen therapy or no hormonal therapy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Comparisons were made between tamoxifen and no hormonal therapy using PRISMA guidelines. We searched publicly available databases for studies including postmenopausal women who underwent AI therapy for breast cancer investigating the risk ratio of specific cardiovascular outcomes and cardiovascular death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">There was a significant increase in the risk of ischaemic heart disease (RR 1.59, 95% CI: 1.25-2.02, <i>p</i> &lt; 0.05), myocardial infarction (RR 1.50, 95% CI: 1.13-1.99, <i>p</i> &lt; 0.05), heart failure (RR 1.63, 95% CI: 1.14-2.32, <i>p</i> &lt; 0.05), and other cardiovascular events (RR 1.26, 95% CI: 1.12-1.40, <i>p</i> &lt; 0.05) in the AI group when compared to tamoxifen. However, there was a significant decrease in the risk of myocardial infarction (RR 0.77, 95% CI: 0.65-0.90, <i>p</i> &lt; 0.05) in the AI group when compared to no hormonal treatment.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">There is an increased risk of cardiovascular disease for AI therapy in comparison to tamoxifen therapy. However, further research is needed to establish the cardiovascular risk of AIs when compared to no hormonal therapy. Prognosis and survival of patients should be an important consideration in choosing between tamoxifen and AI therapy among patients receiving treatment for breast cancer. Regular monitoring is essential to facilitate personalized approaches aimed at mitigating the risk of cardiovascular toxicity.</AbstractText><CopyrightInformation>&#xa9; 2025 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Berbari</LastName><ForeName>Elijah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anees</LastName><ForeName>Arsalan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Nepean Clinical School, The University of Sydney, Kingswood, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaur</LastName><ForeName>Rajneesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayeni</LastName><ForeName>Femi E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Nepean Clinical School, The University of Sydney, Kingswood, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nepean Institute of Academic Surgery, Nepean Clinical School, The University of Sydney, Kingswood, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edirimanne</LastName><ForeName>Senarath</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Nepean Clinical School, The University of Sydney, Kingswood, NSW, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Breast Care (Basel)</MedlineTA><NlmUniqueID>101254060</NlmUniqueID><ISSNLinking>1661-3791</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aromatase inhibitors</Keyword><Keyword MajorTopicYN="N">Breast cancer</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Hormonal therapy</Keyword><Keyword MajorTopicYN="N">Tamoxifen</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest regarding the publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40666192</ArticleId><ArticleId IdType="pmc">PMC12259065</ArticleId><ArticleId IdType="doi">10.1159/000546089</ArticleId><ArticleId IdType="pii">546089</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Coutinho Cruz M, Moura Branco L, Portugal G, Galrinho A, Tim&#xf3;teo AT, Rio P, et al. Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. Clin Res Cardiol. 2020;109(6):673&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">31559482</ArticleId></ArticleIdList></Reference><Reference><Citation>Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">16054566</ArticleId></ArticleIdList></Reference><Reference><Citation>Leemasawat K, Phrommintikul A, Chattipakorn SC, Chattipakorn N. Mechanisms and potential interventions associated with the cardiotoxicity of ErbB2-targeted drugs: insights from in vitro, in vivo, and clinical studies in breast cancer patients. Cell Mol Life Sci. 2020;77(8):1571&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11104997</ArticleId><ArticleId IdType="pubmed">31650186</ArticleId></ArticleIdList></Reference><Reference><Citation>Roychoudhuri R, Robinson D, Putcha V, Cuzick J, Darby S, M&#xf8;ller H. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: a population-based study. BMC Cancer. 2007;7:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1784099</ArticleId><ArticleId IdType="pubmed">17224064</ArticleId></ArticleIdList></Reference><Reference><Citation>Australian Institute of Health and Welfare (AIHW) . Australian cancer incidence and mortality (ACIM) books: breast cancer. Canberra: AIHW; 2017.</Citation></Reference><Reference><Citation>Australian Institute of Health and Welfare (AIHW) . Cancer in Australia 2019. Cancer series no.119. Cat. no. CAN 123. Canberra: AIHW; 2019.</Citation></Reference><Reference><Citation>Ryd&#xe9;n L, Heibert Arnlind M, Vitols S, H&#xf6;istad M, Ahlgren J. Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo: meta-analyses on efficacy and adverse events based on randomized clinical trials. Breast. 2016;26:106&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">27017249</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA, et al. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol. 2019;37(5):423&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">30452337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabian CJ. The what, why and how of aromatase inhibitors: hormonal agents for treatment and prevention of breast cancer. Int J Clin Pract. 2007;61(12):2051&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2228389</ArticleId><ArticleId IdType="pubmed">17892469</ArticleId></ArticleIdList></Reference><Reference><Citation>Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res. 2004;64(4):1522&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14973112</ArticleId></ArticleIdList></Reference><Reference><Citation>Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5655818</ArticleId><ArticleId IdType="pubmed">29065927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol. 2002;89(12A):12E&#x2013;18E.</Citation><ArticleIdList><ArticleId IdType="pubmed">12084397</ArticleId></ArticleIdList></Reference><Reference><Citation>Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973;36(2):207&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">4688315</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosano GM, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric. 2007;10(Suppl 1):19&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">17364594</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir E, Seruga B, Niraula S, Carlsson L, Oca&#xf1;a A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">21743022</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrow-Khavar F, Filion KB, Al-Qurashi S, Torabi N, Bouganim N, Suissa S, et al. Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol. 2017;28(3):487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834146</ArticleId><ArticleId IdType="pubmed">27998966</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydiner A. Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women. Breast. 2013;22(2):121&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23462682</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuppone F, Bria E, Verma S, Pritchard KI, Gandhi S, Carlini P, et al. Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials. Cancer. 2008;112(2):260&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18041059</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, et al. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 2018;363:k3845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174332</ArticleId><ArticleId IdType="pubmed">30297439</ArticleId></ArticleIdList></Reference><Reference><Citation>Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC. Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy. Clin Chim Acta. 1993;223(1&#x2013;2):43&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">8143369</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewar JA, Horobin JM, Preece PE, Tavendale R, Tunstall-Pedoe H, Wood RA. Long term effects of tamoxifen on blood lipid values in breast cancer. BMJ. 1992;305(6847):225&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1882673</ArticleId><ArticleId IdType="pubmed">1392827</ArticleId></ArticleIdList></Reference><Reference><Citation>Guetta V, Lush RM, Figg WD, Waclawiw MA, Cannon RO 3rd. Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women. Am J Cardiol. 1995;76(14):1072&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">7484866</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerging Risk, Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714101</ArticleId><ArticleId IdType="pubmed">23034020</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med. 2016;375(3):209&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5024713</ArticleId><ArticleId IdType="pubmed">27264120</ArticleId></ArticleIdList></Reference><Reference><Citation>Early Breast Cancer Trialists&#x2019; Collaborative Group EBCTCG . Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">26211827</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007028</ArticleId><ArticleId IdType="pubmed">33780438</ArticleId></ArticleIdList></Reference><Reference><Citation>Colleoni M, Giobbie-Hurder A, Regan MM, Th&#xfc;rlimann B, Mouridsen H, Mauriac L, et al. Analyses adjusting for selective crossover show improved overall survival with adjuvant letrozole compared with tamoxifen in the BIG 1-98 study. J Clin Oncol. 2011;29(9):1117&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3083867</ArticleId><ArticleId IdType="pubmed">21321298</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouridsen H, Keshaviah A, Coates AS, Rabaglio M, Castiglione-Gertsch M, Sun Z, et al. Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial. J Clin Oncol. 2007;25(36):5715&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17998546</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaglio M, Sun Z, Maibach R, Giobbie-Hurder A, Ejlertsen B, Harvey VJ, et al. Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial. Breast Cancer Res Treat. 2021;185(3):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">33159633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliss JM, Kilburn LS, Coleman RE, Forbes JF, Coates AS, Jones SE, et al. Disease-related outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study. J Clin Oncol. 2012;30(7):709&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">22042946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, et al. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years&#x2019; adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet. 2005;366(9484):455&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">16084253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufmann M, Jonat W, Hilfrich J, Eidtmann H, Gademann G, Zuna I, et al. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study. J Clin Oncol. 2007;25(19):2664&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">17563395</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum M, Budzar AU, Cuzick J, Forbes J, Houghton J, Klijn JGM, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. Lancet. 2002;359(9324):2131&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12090977</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum M, Buzdar A, Cuzick J, Forbes J, Houghton J, Howell A, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98(9):1802&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">14584060</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, ATAC/LATTE investigators, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol. 2010;11(12):1135&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">21087898</ArticleId></ArticleIdList></Reference><Reference><Citation>Boccardo F, Rubagotti A, Guglielmini P, Fini A, Paladini G, Mesiti M, et al. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol. 2006;17(Suppl 7):vii10&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">16760270</ArticleId></ArticleIdList></Reference><Reference><Citation>Aihara T, Takatsuka Y, Ohsumi S, Aogi K, Hozumi Y, Imoto S, et al. Phase III randomized adjuvant study of tamoxifen alone versus sequential tamoxifen and anastrozole in Japanese postmenopausal women with hormone-responsive breast cancer: N-SAS BC03 study. Breast Cancer Res Treat. 2010;121(2):379&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">20390343</ArticleId></ArticleIdList></Reference><Reference><Citation>Paridaens RJ, Dirix LY, Beex LV, Nooij M, Cameron DA, Cufer T, et al. Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group. J Clin Oncol. 2008;26(30):4883&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2652082</ArticleId><ArticleId IdType="pubmed">18794551</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo-Touk NA, Sakr HA, Abd El-Lattef A. Switching to letrozole versus continued tamoxifen therapy in treatment of postmenopausal women with early breast cancer. J Egypt Natl Canc Inst. 2010;22(1):79&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">21503010</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, et al. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a. J Natl Cancer Inst. 2007;99(24):1845&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">18073378</ArticleId></ArticleIdList></Reference><Reference><Citation>Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, et al. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. J Natl Cancer Inst. 2005;97(17):1262&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">16145047</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamounas EP, Bandos H, Lembersky BC, Jeong JH, Geyer CEJ, Rastogi P, et al. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019;20(1):88&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6691732</ArticleId><ArticleId IdType="pubmed">30509771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuzick J, Sestak I, Forbes JF, Dowsett M, Cawthorn S, Mansel RE, et al. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial. Lancet. 2020;395(10218):117&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961114</ArticleId><ArticleId IdType="pubmed">31839281</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Qadir H, Amir E, Fischer HD, Fu L, Austin PC, Harvey PJ, et al. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer. Eur J Cancer. 2016;68:11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">27693889</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque R, Shi J, Schottinger JE, Chung J, Avila C, Amundsen B, et al. Cardiovascular disease after aromatase inhibitor use. JAMA Oncol. 2016;2(12):1590&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27100398</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L. Aromatase inhibitors and the risk of cardiovascular outcomes in women with breast cancer: a population-based cohort study. Circulation. 2020;141(7):549&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">32065766</ArticleId></ArticleIdList></Reference><Reference><Citation>Ligibel JA, James O&#x2019;Malley A, Fisher M, Daniel GW, Winer EP, Keating NL, et al. Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients. Breast Cancer Res Treat. 2012;131(2):589&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">21881937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pineda-Moncus&#xed; M, Garcia-Giralt N, Diez-Perez A, Tusquets I, Servitja S, Albanell J, et al. Thromboembolic, cardiovascular and overall mortality risks of aromatase inhibitors, compared with tamoxifen treatment: an outpatient-register-based retrospective cohort study. Ther Adv Med Oncol. 2020;12:1758835920909660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097872</ArticleId><ArticleId IdType="pubmed">32231712</ArticleId></ArticleIdList></Reference><Reference><Citation>Matthews AA, Peacock Hinton S, Stanway S, Lyon AR, Smeeth L, Lund JL, et al. Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors. Heart. 2021;107(16):1327&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327412</ArticleId><ArticleId IdType="pubmed">33177117</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamaraju S, Shi Y, Smith E, Nattinger AB, Laud P, Neuner J. Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population-based study. Clin Cardiol. 2019;42(1):93&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6344290</ArticleId><ArticleId IdType="pubmed">30443921</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi M, Tritto R, Tarantini L, Navazio A, Corrao G. Adjuvant hormonotherapy and cardiovascular risk in post-menopausal women with breast cancer: a large population-based cohort study. Cancers. 2021;13(9):2254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8125834</ArticleId><ArticleId IdType="pubmed">34066685</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SH, Kim KE, Park Y, Ju YW, Jung JG, Lee ES, et al. Effects of tamoxifen and aromatase inhibitors on the risk of acute coronary syndrome in elderly breast cancer patients: an analysis of nationwide data. Breast. 2020;54:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481564</ArticleId><ArticleId IdType="pubmed">32890789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Choi J, Park J, Han W, Kang D, Choi JY. Effects of endocrine therapy on cardiovascular diseases and type 2 diabetes among breast cancer survivors: the national health insurance service database of korea. J Am Heart Assoc. 2022;11(20):e026743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9673673</ArticleId><ArticleId IdType="pubmed">36250658</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Bhoo-Pathy N, Brand JS, Hedayati E, Grassmann F, Zeng E, et al. Risk of heart disease following treatment for breast cancer - results from a population-based cohort study. Elife. 2022;11:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8940173</ArticleId><ArticleId IdType="pubmed">35293856</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobse JN, Schaapveld M, Boekel NB, Hooning MJ, Jager A, Baaijens MHA, et al. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study. Breast Cancer Res Treat. 2021;185(1):205&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32964358</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5. Cochrane Collaboration; 2011;1.</Citation></Reference><Reference><Citation>Wells GA. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015.</Citation></Reference><Reference><Citation>Sporn MB, Lippman SM. Agents for chemoprevention and their mechanism of action. In: Kufe DW, Pollock RE, Weichselbaum RR, et al., editors. Holland-frei cancer medicine. 6th ed. Hamilton (ON): BC Decker; 2003.</Citation></Reference><Reference><Citation>Foglietta J, Inno A, de Iuliis F, Sini V, Duranti S, Turazza M, et al. Cardiotoxicity of aromatase inhibitors in breast cancer patients. Clin Breast Cancer. 2017;17(1):11&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27561703</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell LN, Nguyen AT, Li L, Desta Z, Henry NL, Hayes DF, et al. Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole. J Clin Pharmacol. 2012;52(12):1852&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3616612</ArticleId><ArticleId IdType="pubmed">22174434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasan KM, Goss PE, Pritchard PH, Shepherd L, Palmer MJ, Liu S, et al. The influence of letrozole on serum lipid concentrations in postmenopausal women with primary breast cancer who have completed 5 years of adjuvant tamoxifen (NCIC CTG MA.17L). Ann Oncol. 2005;16(5):707&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817595</ArticleId></ArticleIdList></Reference><Reference><Citation>Markopoulos C, Dafni U, Misitzis J, Zobolas V, Tzoracoleftherakis E, Koukouras D, et al. Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy. Breast Cancer Res. 2009;11(3):R35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2716503</ArticleId><ArticleId IdType="pubmed">19531217</ArticleId></ArticleIdList></Reference><Reference><Citation>Besseling J, Kindt I, Hof M, Kastelein JJ, Hutten BA, Hovingh GK. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Atherosclerosis. 2014;233(1):219&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24529147</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol. 2001;28(9):865&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11493357</ArticleId></ArticleIdList></Reference><Reference><Citation>Alloubani A, Nimer R, Samara R. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review. Curr Cardiol Rev. 2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8950504</ArticleId><ArticleId IdType="pubmed">33305711</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American heart association. Circulation. 2018;137(8):e30&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6722327</ArticleId><ArticleId IdType="pubmed">29437116</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis JR, Larson JC, Delzell E, Brookhart MA, Cadarette SM, Chlebowski R, et al. Placebo adherence, clinical outcomes, and mortality in the women&#x2019;s health initiative randomized hormone therapy trials. Med Care. 2011;49(5):427&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4217207</ArticleId><ArticleId IdType="pubmed">21422960</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosrow-Khavar F, Azoulay L. Hormonal therapy and Cardiovascular Health: examining the risk among premenopausal women Diagnosed With breast cancer. JACC CardioOncol. 2024;6(6):919&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11712015</ArticleId><ArticleId IdType="pubmed">39801651</ArticleId></ArticleIdList></Reference><Reference><Citation>Polter EJ, E Prizment A, Walker RF, Ryan Z, Wang W, Blaes AH, et al. Cardiovascular disease with hormone therapy and ovarian suppression in premenopausal breast cancer survivors. JACC CardioOncol. 2024;6(6):907&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11711817</ArticleId><ArticleId IdType="pubmed">39801644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon A, L&#xf3;pez-Fern&#xe1;ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS). Eur Heart J. 2022;43(41):4229&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017568</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Fern&#xe1;ndez T, Marco I, Aznar MC, Aznar MC, Barac A, Meattini I, et al. Breast cancer and cardiovascular health. Eur Heart J. 2024;45(41):4366&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">39320463</ArticleId></ArticleIdList></Reference><Reference><Citation>Okwuosa TM, Morgans A, Rhee JW, Reding KW, Maliski S, Plana JC, et al. Impact of hormonal therapies for treatment of hormone-dependent cancers (breast and prostate) on the cardiovascular system: effects and modifications: a scientific statement from the American heart association. Circ Genom Precis Med. 2021;14(3):e000082.</Citation><ArticleIdList><ArticleId IdType="pubmed">33896190</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40679604</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ehaf450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehaf450</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">The diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) requires advanced imaging, precluding large-scale preclinical testing. Artificial intelligence (AI)-enabled transthoracic echocardiography (TTE) and electrocardiography (ECG) may provide a scalable strategy for preclinical monitoring.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective analysis of individuals referred for nuclear cardiac amyloid testing at the Yale-New Haven Health System (YNHHS, internal cohort) and Houston Methodist Hospitals (HMH, external cohort). Deep learning models trained to discriminate ATTR-CM from age/sex-matched controls on TTE videos (AI-Echo) and ECG images (AI-ECG) were deployed to generate study-level ATTR-CM probabilities (0%-100%). Longitudinal trends in AI-derived probabilities were examined using age/sex-adjusted linear mixed models, and their discrimination of future disease was evaluated across preclinical stages.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 984 participants at YNHHS (median age 74 years, 44.3% female) and 806 at HMH (median age 69 years, 34.5% female), 112 (11.4%) and 174 (21.6%) tested positive for ATTR-CM, respectively. Across cohorts and modalities, AI-derived ATTR-CM probabilities from 7352 TTEs and 32 205 ECGs diverged as early as 3 years before diagnosis in cases vs controls (ptime(x)group interaction &#xa0;&#x2264; .004). Among those with both AI-Echo and AI-ECG probabilities available 1 to 3 years before nuclear testing [n = 433 (YNHHS) sand 174 (HMH)], a double-negative screen at a 0.05 threshold [164 (37.9%) and 66 (37.9%), vs all else] had 90.9% and 85.7% sensitivity (specificity of 40.3% and 41.2%), whereas a double-positive screen [78 (18.0%) and 26 (14.9%), vs all else] had 85.5% and 88.9% specificity (sensitivity of 60.6% and 42.9%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Artificial intelligence-enabled echocardiography and electrocardiography may enable scalable risk stratification of ATTR-CM during its preclinical course.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Evangelos K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-4362-0720</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangha</LastName><ForeName>Veer</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8524-1203</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasisht Shankar</LastName><ForeName>Sumukh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0005-3034-0641</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppi</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-2046-127X</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasir</LastName><ForeName>Khurram</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist-Rice Digital Health Institute, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cardiovascular Computational and Precision Health, Houston Methodist DeBakey Heart &amp; Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallegos Kattan</LastName><ForeName>Cesia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mallah</LastName><ForeName>Mouaz H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Kindi</LastName><ForeName>Sadeer</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1122-7695</Identifier><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cardiovascular Computational and Precision Health, Houston Methodist DeBakey Heart &amp; Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9467-6199</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, 195 Church St, 6th Floor, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL167858</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23HL153775</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1F32HL170592</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>BridgeBio</Agency><Country/></Grant><Grant><Agency>Yale University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2025 Feb 24:2024.08.25.24312556. doi: 10.1101/2024.08.25.24312556.</RefSource><PMID Version="1">39252891</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">Screening</Keyword><Keyword MajorTopicYN="N">Transthyretin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40679604</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaf450</ArticleId><ArticleId IdType="pii">8206181</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40677492</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Understanding 30-Day Mortality After First STEMI Through DAGs: Unravelling Epidemiological Cause-Effect Links.</ArticleTitle><Pagination><StartPage>e86178</StartPage><MedlinePgn>e86178</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86178</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86178</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM" NlmCategory="OBJECTIVE">Traditional statistical tests have limitations in analyzing cause-and-effect relationships. Directed acyclic graphs (DAGs) offer a structured representation of causality. This study aimed to utilize DAGs to explore the causal impact of epidemiological factors on 30-day mortality among patients following their first acute ST-elevation myocardial infarction (STEMI).</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The study employs data from the North India (NORIN)-STEMI study registry, comprising 3,192 first-time STEMI patients collected prospectively from two tertiary care hospitals in Delhi, India. Continuous optimization structure learning using the Non-combinatorial Optimization via Trace Exponential and Augmented Lagrangian for Structure Learning (NOTEARS) method is applied to learn the DAG. Additionally, a permutation testing framework is proposed for the statistical validation of the links of the DAG.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 2,946 first-time STEMI patients, 246 (7.7%) experienced mortality during the study period. A t-test revealed that age was significantly different between the survival and mortality groups within 30 days post-STEMI (p&lt;0.0001). Patients who died within 30 days had a higher mean age (59.90&#xb1;13.89 years). Furthermore, the study identified a statistically significant association between mortality and HbA1c, triglycerides, smoking, sex, education, occupation, socioeconomic status, physical activity, overall stress, and hypertension.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our DAG reveals causal relationships and identifies confounding variables affecting mortality after STEMI. Sex is identified as a significant factor influencing mortality both directly and indirectly. This influence occurs through its effects on age, alcohol consumption, stress, hypertension, and socioeconomic status. Additionally, sex is recognized as a confounding factor whose impact on mortality is modified by other factors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Gupta et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Anubha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Excellence in Healthcare, Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arora</LastName><ForeName>Srijan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center of Excellence in Healthcare, Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shetty</LastName><ForeName>Manu K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Pharmacology and Therapeutics, Maulana Azad Medical College, New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Amulya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Excellence in Healthcare, Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chauhan</LastName><ForeName>Aniket</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Excellence in Healthcare, Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunal</LastName><ForeName>Shekhar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology, Employees' State Insurance Corporation Medical College and Hospital, Faridabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palleda</LastName><ForeName>Girish M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Cardiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Lalit</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesiology, Maulana Azad Medical College, New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goyal</LastName><ForeName>Dixit</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Mohit D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Cardiology, Govind Ballabh Pant Institute of Postgraduate Medical Education and Research, New Delhi, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ai in cvd</Keyword><Keyword MajorTopicYN="N">ai in epidemiology</Keyword><Keyword MajorTopicYN="N">directed acyclic graph (dag)</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">notears</Keyword><Keyword MajorTopicYN="N">stemi</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee of Maulana Azad Medical College issued approval #F.1/IEC/MAMC/85/04/2021/No.486. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: The author, Anubha Gupta, would like to acknowledge the financial support from the Centre of Excellence in Healthcare, IIIT-Delhi. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>5</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40677492</ArticleId><ArticleId IdType="pmc">PMC12268226</ArticleId><ArticleId IdType="doi">10.7759/cureus.86178</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403:2133&#x2013;2161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11122111</ArticleId><ArticleId IdType="pubmed">38642570</ArticleId></ArticleIdList></Reference><Reference><Citation>The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions. Kalra A, Jose AP, Prabhakaran P, et al. Lancet Reg Health Southeast Asia. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10305862</ArticleId><ArticleId IdType="pubmed">37384064</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. Roth GA, Mensah GA, Johnson CO, et al. J Am Coll Cardiol. 2020;76:2982&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Understanding and misunderstanding randomized controlled trials. Deaton A, Cartwright N. Soc Sci Med. 2018;210:2&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019115</ArticleId><ArticleId IdType="pubmed">29331519</ArticleId></ArticleIdList></Reference><Reference><Citation>Frailty for predicting all-cause mortality in elderly acute coronary syndrome patients: a meta-analysis. Man C, Xiang S, Fan Y. Ageing Res Rev. 2019;52:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30930229</ArticleId></ArticleIdList></Reference><Reference><Citation>Confounding in statistical mediation analysis: what it is and how to address it. Valente MJ, Pelham WE, Smyth H, MacKinnon DP. J Couns Psychol. 2017;64:659&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5726285</ArticleId><ArticleId IdType="pubmed">29154577</ArticleId></ArticleIdList></Reference><Reference><Citation>On the definition of a confounder. VanderWeele TJ, Shpitser I. Ann Stat. 2013;41:196&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4276366</ArticleId><ArticleId IdType="pubmed">25544784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;rulff UB, Madsen AL. Bayesian Networks and Influence Diagrams. New York City, NY: Springer; 2013. Bayesian Networks and Influence Diagrams: A Guide to Construction and Analysis.</Citation></Reference><Reference><Citation>Generating a robust statistical causal structure over 13 cardiovascular disease risk factors using genomics data. Yazdani A, Yazdani A, Samiei A, Boerwinkle E. J Biomed Inform. 2016;60:114&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4886234</ArticleId><ArticleId IdType="pubmed">26827624</ArticleId></ArticleIdList></Reference><Reference><Citation>Using directed acyclic graphs for investigating causal paths for cardiovascular disease. Thornley S, Marshall RJ, Wells S, Jackson R. J Biom Biostat. 2013;4</Citation></Reference><Reference><Citation>Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of mendelian randomization studies. Riaz H, Khan MS, Siddiqi TJ, et al. JAMA Netw Open. 2018;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324374</ArticleId><ArticleId IdType="pubmed">30646365</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Kannel WB, Castelli WP, Gordon T, McNamara PM. Ann Intern Med. 1971;74:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">5539274</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher-Pitman permutation tests based on nonparametric poisson mixtures with application to single cell genomics. Miao Z, Kong W, Vinayak RK, Sun W, Han F. J Am Stat Assoc. 2024;119:394&#x2013;406.</Citation></Reference><Reference><Citation>Functional brain connectivity analysis in intellectual developmental disorder during music perception. Sareen E, Singh L, Gupta A, Verma R, Achary GK, Varkey B. IEEE Trans Neural Syst Rehabil Eng. 2020;28:2420&#x2013;2430.</Citation><ArticleIdList><ArticleId IdType="pubmed">32956062</ArticleId></ArticleIdList></Reference><Reference><Citation>Permutation tests are robust and powerful at 0.5% and 5% significance levels. Noguchi K, Konietschke F, Marmolejo-Ramos F, Pauly M. Behav Res Methods. 2021;53:2712&#x2013;2724.</Citation><ArticleIdList><ArticleId IdType="pubmed">34050436</ArticleId></ArticleIdList></Reference><Reference><Citation>Design and rationale of the North India ST-segment elevation myocardial infarction registry: a prospective cohort study. Arora S, Qamar A, Gupta P, et al. Clin Cardiol. 2019;42:1140&#x2013;1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906983</ArticleId><ArticleId IdType="pubmed">31593344</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning to identify high-risk patients after STEMI in low/middle income countries. Gupta MD, Shetty MK, Mp G, et al. J Am Coll Cardiol. 2021;77</Citation></Reference><Reference><Citation>Machine learning based model for risk prediction after ST-Elevation myocardial infarction: insights from the North India ST elevation myocardial infarction (NORIN-STEMI) registry. Shetty MK, Kunal S, Girish MP, et al. Int J Cardiol. 2022;362:6&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">35577162</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Aragam B, Ravikumar P, Xing EP. Proceedings of the 32nd International Conference on Neural Information Processing Systems. Red Hook, NY: Curran Associates Inc.; 2018. DAGs with NO TEARS: continuous optimization for structure learning; pp. 9492&#x2013;9503.</Citation></Reference><Reference><Citation>Developing a novel causal inference algorithm for personalized biomedical causal graph learning using meta machine learning. Wu H, Shi W, Wang MD. BMC Med Inform Decis Mak. 2024;24</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11129385</ArticleId><ArticleId IdType="pubmed">38802809</ArticleId></ArticleIdList></Reference><Reference><Citation>Empirical evaluation of scoring functions for Bayesian network model selection. Liu Z, Malone B, Yuan C. BMC Bioinformatics. 2012;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439716</ArticleId><ArticleId IdType="pubmed">23046392</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimating the dimension of a model. Schwarz G. Ann Statist. 1978;6:461&#x2013;464.</Citation></Reference><Reference><Citation>Effect size measures for mediation models: quantitative strategies for communicating indirect effects. Preacher KJ, Kelley K. Psychol Methods. 2011;16:93&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pubmed">21500915</ArticleId></ArticleIdList></Reference><Reference><Citation>Confounding in observational studies evaluating the safety and effectiveness of medical treatments. Assimon MM. Kidney360. 2021;2:1156&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786092</ArticleId><ArticleId IdType="pubmed">35368357</ArticleId></ArticleIdList></Reference><Reference><Citation>Gender differences in the regulation of blood pressure. Reckelhoff JF. Hypertension. 2001;37:1199&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">11358929</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality differences between men and women after percutaneous coronary interventions: a 25-year, single-center experience. Singh M, Rihal CS, Gersh BJ, et al. J Am Coll Cardiol. 2008;51:2313&#x2013;2320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2733245</ArticleId><ArticleId IdType="pubmed">18549915</ArticleId></ArticleIdList></Reference><Reference><Citation>Gender differences in short- and long-term mortality in the Vienna STEMI registry. Piackova E, J&#xe4;ger B, Farhan S, et al. Int J Cardiol. 2017;244:303&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">28784448</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality of myocardial infarction by sex, age, and obstructive coronary artery disease status in the ACTION Registry - GWTG (acute coronary treatment and Intervention Outcomes Network Registry - get with the guidelines) Smilowitz NR, Mahajan AM, Roe MT, Hellkamp AS, Chiswell K, Gulati M, Reynolds HR. Circ Cardiovasc Qual Outcomes. 2017;10</Citation><ArticleIdList><ArticleId IdType="pubmed">29246884</ArticleId></ArticleIdList></Reference><Reference><Citation>Effects of uncontrolled diabetes on LDL levels of patients undergoing carotid endarterectomy on and off statin therapy: preliminary study. Oc M, Duman I, Oc B, Simsek M, Vatansev H, Arun O, Duman A. Clin Ther. 2015;37</Citation></Reference><Reference><Citation>Long-term association of low-density lipoprotein cholesterol with cardiovascular mortality in individuals at low 10-year risk of atherosclerotic cardiovascular disease. Abdullah SM, Defina LF, Leonard D, et al. Circulation. 2018;138:2315&#x2013;2325.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571575</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40650815</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1880-344X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Journal of echocardiography</Title><ISOAbbreviation>J Echocardiogr</ISOAbbreviation></Journal><ArticleTitle>Novel deep learning framework for simultaneous assessment of left ventricular mass and longitudinal strain: clinical feasibility and validation in patients with hypertrophic cardiomyopathy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12574-025-00694-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study aims to present the Segmentation-based Myocardial Advanced Refinement Tracking (SMART) system, a novel artificial intelligence (AI)-based framework for transthoracic echocardiography (TTE) that incorporates motion tracking and left ventricular (LV) myocardial segmentation for automated LV mass (LVM) and global longitudinal strain (LVGLS) assessment.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The SMART system demonstrates LV speckle tracking based on motion vector estimation, refined by structural information using endocardial and epicardial segmentation throughout the cardiac cycle. This approach enables automated measurement of LVM<sub>SMART</sub> and LVGLS<sub>SMART</sub>. The feasibility of SMART is validated in 111 hypertrophic cardiomyopathy (HCM) patients (median age: 58&#xa0;years, 69% male) who underwent TTE and cardiac magnetic resonance imaging (CMR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">LVGLS<sub>SMART</sub> showed a strong correlation with conventional manual LVGLS measurements (Pearson's correlation coefficient [PCC] 0.851; mean difference 0 [-2-0]). When compared to CMR as the reference standard for LVM, the conventional dimension-based TTE method overestimated LVM (PCC 0.652; mean difference: 106 [90-123]), whereas LVM<sub>SMART</sub> demonstrated excellent agreement with CMR (PCC 0.843; mean difference: 1 [-11-13]). For predicting extensive myocardial fibrosis, LVGLS<sub>SMART</sub> and LVM<sub>SMART</sub> exhibited performance comparable to conventional LVGLS and CMR (AUC: 0.72 and 0.66, respectively). Patients identified as high risk for extensive fibrosis by LVGLS<sub>SMART</sub> and LVM<sub>SMART</sub> had significantly higher rates of adverse outcomes, including heart failure hospitalization, new-onset atrial fibrillation, and defibrillator implantation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The SMART technique provides a comparable LVGLS evaluation and a more accurate LVM assessment than conventional TTE, with predictive values for myocardial fibrosis and adverse outcomes. These findings support its utility in HCM management.</AbstractText><CopyrightInformation>&#xa9; 2025. Japanese Society of Echocardiography.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jiesuck</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, 173 Beon-Gil, Gumi-Ro, Bundang-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoon</LastName><ForeName>Yeonyee E</ForeName><Initials>YE</Initials><Identifier Source="ORCID">0000-0002-8479-9889</Identifier><AffiliationInfo><Affiliation>Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, 173 Beon-Gil, Gumi-Ro, Bundang-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea. yeonyeeyoon@snubh.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. yeonyeeyoon@snubh.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea. yeonyeeyoon@snubh.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Yeonggul</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea. ygjang1722@yonsei.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Taekgeun</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Jaeik</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung-Ah</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CONNECT-AI Research Center, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Hong-Mi</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, 173 Beon-Gil, Gumi-Ro, Bundang-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>In-Chang</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, 173 Beon-Gil, Gumi-Ro, Bundang-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Eun Ju</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Radiology, Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Goo-Yeong</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, Seoul National University Bundang Hospital, 82, 173 Beon-Gil, Gumi-Ro, Bundang-Gu, Seongnam-Si, Gyeonggi-Do, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hyuk-Jae</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Ontact Health Inc., Seoul, Republic of Korea, 50-5, Ewhayeodae-Gil, Seodaemun-Gu, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CONNECT-AI Research Center, Yonsei University College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Yonsei University Health System, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No.2022000972</GrantID><Agency>Institute of Information &amp; communications Technology Planning &amp; Evaluation (IITP)</Agency><Country/></Grant><Grant><GrantID>No.: H0904-24-1002</GrantID><Agency>Medical AI Clinic Program through the NIPA</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Echocardiogr</MedlineTA><NlmUniqueID>101263153</NlmUniqueID><ISSNLinking>1349-0222</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Global longitudinal strain</Keyword><Keyword MajorTopicYN="N">Hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Left ventricle</Keyword><Keyword MajorTopicYN="N">Mass</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: Y.E.Y., Y.J., T.J., J.J., and S.A.L. are currently affiliated with Ontact Health, Inc. Y.J., and S.A.L are co-inventors on a patent related to this work filed by Ontact Health (Method For Providing Information On Strain Quantification And Device For Providing Information On Strain Quantification Using The Same). Y.E.Y., and H.J.C. holds stock in Ontact Health, Inc. The other authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40650815</ArticleId><ArticleId IdType="doi">10.1007/s12574-025-00694-y</ArticleId><ArticleId IdType="pii">10.1007/s12574-025-00694-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ommen SR, Ho CY, Asif IM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">38718139</ArticleId></ArticleIdList></Reference><Reference><Citation>Mande&#x15f; L, Ro&#x15f;ca M, Ciuperc&#x103; D, et al. The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy. J Echocardiogr. 2020;18(3):137&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">32301048</ArticleId><ArticleId IdType="pmc">7473965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;3914.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2936235</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen CB, Myhr KA, Grund FF, et al. A new method to quantify left ventricular mass by 2D echocardiography. Sci Rep. 2022;12(1):9980.</Citation><ArticleIdList><ArticleId IdType="pubmed">35705586</ArticleId><ArticleId IdType="pmc">9200734</ArticleId></ArticleIdList></Reference><Reference><Citation>Dohy Z, Szabo L, Toth A, et al. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging. 2021;37(6):2027&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555536</ArticleId><ArticleId IdType="pmc">8255255</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52(7):559&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">18687251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Gajjala S, Agrawal P, et al. Fully automated echocardiogram interpretation in clinical practice. Circulation. 2018;138(16):1623&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354459</ArticleId><ArticleId IdType="pmc">6200386</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon YE, Kim S, Chang HJ. Artificial Intelligence and Echocardiography. J Cardiovasc Imaging. 2021;29(3):193&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">34080347</ArticleId><ArticleId IdType="pmc">8318807</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Du M, Chang S, et al. Artificial intelligence in echocardiography: detection, functional evaluation, and disease diagnosis. Cardiovasc Ultrasound. 2021;19(1):29.</Citation><ArticleIdList><ArticleId IdType="pubmed">34416899</ArticleId><ArticleId IdType="pmc">8379752</ArticleId></ArticleIdList></Reference><Reference><Citation>Salte IM, Ostvik A, Smistad E, et al. Artificial intelligence for automatic measurement of left ventricular strain in echocardiography. JACC Cardiovasc Imaging. 2021;14(10):1918&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">34147442</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan AC, Chang EW, Jain I, et al. Deep Learning-Derived Myocardial Strain. JACC Cardiovasc Imaging. 2024;17(7):715&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">38551533</ArticleId></ArticleIdList></Reference><Reference><Citation>MA Azad, A Chernyshov, J Nyberg, et al. EchoTracker: Advancing Myocardial Point Tracking in Echocardiography. arXiv [cs.CV; 2024]. https://arxiv.org/abs/2405.08587 .</Citation></Reference><Reference><Citation>A Chernyshov, J Nyberg, V Holmstr&#xf8;m, et al. Low Complexity Point Tracking of the Myocardium in 2D Echocardiography. arXiv [eess.IV; 2025]. https://arxiv.org/abs/2503.10431</Citation></Reference><Reference><Citation>Jeon J, Ha S, Yoon YE, et al. Echocardiographic view classification with integrated out-of-distribution detection for enhanced automatic echocardiographic analysis. arXiv [eess.SP; 2023]. https://arxiv.org/abs/2308.16483 .</Citation></Reference><Reference><Citation>Jeon J, Kim J, Jang Y, et al. A Unified Approach for Comprehensive Analysis of Various Spectral and Tissue Doppler Echocardiography. arXiv [eess.IV; 2023]. https://arxiv.org/abs/2311.08439 .</Citation></Reference><Reference><Citation>Jeong D, Jung S, Yoon YE, et al. Artificial intelligence-enhanced automation for M-mode echocardiographic analysis: ensuring fully automated, reliable, and reproducible measurements. Int J Cardiovasc Imaging. 2024;40(6):1245&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">38652399</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Jeon J, Yoon YE, et al. Artificial intelligence-enhanced automation of left ventricular diastolic assessment: a pilot study for feasibility, diagnostic validation, and outcome prediction. Cardiovasc Diagnos Therapy. 2024;14(3):352&#x2013;66.</Citation></Reference><Reference><Citation>Jang Y, Choi H, Yoon YE, et al. An artificial intelligence-based automated echocardiographic analysis: enhancing efficiency and prognostic evaluation in patients with revascularized STEMI. Korean Circ J. 2024;54(11):743&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">39434367</ArticleId><ArticleId IdType="pmc">11569939</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Kim J, Jeon J, et al. Artificial Intelligence-Enhanced Comprehensive Assessment of the Aortic Valve Stenosis Continuum in Echocardiography. medRxiv 2024. https://doi.org/10.1101/2024.07.08.24310123 .</Citation></Reference><Reference><Citation>Agency NIS. Open AI Dataset Project (AI-Hub) [Available from: https://aihub.or.kr/ ].</Citation></Reference><Reference><Citation>Park J, Yoon YE, Chun EJ, et al. Endocardial versus whole-myocardial tracking global longitudinal strain analysis in patients with hypertrophic cardiomyopathy: A preliminary comparative study. PLoS ONE. 2023;18(7): e0288421.</Citation><ArticleIdList><ArticleId IdType="pubmed">37432934</ArticleId><ArticleId IdType="pmc">10335699</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon YE, Kang SH, Choi HM, et al. Prediction of infarct size and adverse cardiac outcomes by tissue tracking-cardiac magnetic resonance imaging in ST-segment elevation myocardial infarction. Eur Radiol. 2018;28(8):3454&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">29450717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RH, Maron BJ, Olivotto I, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">25092278</ArticleId></ArticleIdList></Reference><Reference><Citation>Salte IM, Ostvik A, Olaisen SH, et al. Deep learning for improved precision and reproducibility of left ventricular strain in echocardiography: a test-retest study. J Am Soc Echocardiogr. 2023;36(7):788&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">36933849</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch FM, Descamps T, Sarwar R, et al. Human versus artificial intelligence-based echocardiographic analysis as a predictor of outcomes: an analysis from the world alliance societies of echocardiography COVID study. J Am Soc Echocardiogr. 2022;35(12):1226-37.e7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35863542</ArticleId><ArticleId IdType="pmc">9293371</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbano-Moral JA, Gonzalez-Gonzalez AM, Maldonado G, et al. Contrast-enhanced echocardiographic measurement of left ventricular wall thickness in hypertrophic cardiomyopathy: comparison with standard echocardiography and cardiac magnetic resonance. J Am Soc Echocardiogr. 2020;33(9):1106&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">32564979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hindieh W, Weissler-Snir A, Hammer H, et al. Discrepant measurements of maximal left ventricular wall thickness between cardiac magnetic resonance imaging and echocardiography in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2017;10(8): e006309.</Citation><ArticleIdList><ArticleId IdType="pubmed">28794137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40660443</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-6557</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Current cardiology reviews</Title><ISOAbbreviation>Curr Cardiol Rev</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence Tools in Myocardial Infarction Prognosis: Evaluating the Performance of Machine Learning and Deep Learning Models.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.2174/011573403X380162250706094642</ELocationID><Abstract><AbstractText>In clinical practice, mortality risk assessment in patients with myocardial infarction often relies on scales such as GRACE and TIMI. However, these scales were developed based on cohorts assembled many years ago. Since then, numerous changes have occurred, ranging from shifts in MI patient profiles to the introduction of new antiplatelet medications and the adoption of more restrictive lipid therapy targets. To address this issue, researchers are working to develop new stratification tools. Artificial intelligence (AI), which finds applications in nearly every area of medicine, also presents solutions to this problem. This review includes sixteen papers that contain machine learning and deep learning models used to prognosticate mortality risk at different points. Machine learning (ML) models, such as random forest, gradient boosting, and support vector machines, have demonstrated good to excellent performance. However, no single algorithm appears to be top-performing. Although artificial neural networks are considered one of the most promising algorithms, they do not invariably outperform other ML methods. The adaptability of AI models to various scenarios and their ability to handle complex datasets reassures us of their potential in cardiology. Concerning variables that influence the risk of mortality, most are well-established factors, such as age, left-ventricular ejection fraction, lipid parameters, and B-type natriuretic peptide. Additionally, less apparent indicators include platelet parameters, neutrophil count, and blood urea nitrogen. In conclusion, utilizing AI-based models in myocardial infarction risk stratification presents a significant opportunity to develop effective and tailored tools.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szyma&#x144;ska</LastName><ForeName>Cyntia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0005-7889-7449</Identifier><AffiliationInfo><Affiliation>2nd Department of Cardiology, Poznan University of Medical Sciences, Pozna&#x144;, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baszko</LastName><ForeName>Artur</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>2nd Department of Cardiology, Poznan University of Medical Sciences, Pozna&#x144;, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Cardiol Rev</MedlineTA><NlmUniqueID>101261935</NlmUniqueID><ISSNLinking>1573-403X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">endpoints.</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prognostic tools</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40660443</ArticleId><ArticleId IdType="doi">10.2174/011573403X380162250706094642</ArticleId><ArticleId IdType="pii">CCR-EPUB-149342</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40777718</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Harnessing Artificial Intelligence in Interventional Cardiology: A Systematic Review of Current Applications.</ArticleTitle><Pagination><StartPage>e87494</StartPage><MedlinePgn>e87494</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87494</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87494</ELocationID><Abstract><AbstractText>Interventional cardiology has recently advanced with innovations such as percutaneous transluminal coronary angioplasty (PTCA), transcatheter aortic valve replacement (TAVR), and the emergence of artificial intelligence (AI) as a transformative tool. This systematic review explored the current landscape, methodologies, and applications of AI in interventional cardiology. A comprehensive literature search was conducted following preferred reporting guidelines, identifying 20 studies after data extraction and quality assessment. AI-particularly machine learning (ML) and deep learning (DL)-enhances diagnostic accuracy and procedural efficiency. ML aids in arrhythmia detection and coronary plaque characterization, while DL supports imaging interpretation, robotic navigation, and catheter tracking. Clinical applications show AI's potential in predicting myocardial infarction, guiding personalized treatment, and improving resource management. Despite these benefits, challenges such as data privacy, algorithm transparency, and generalizability remain. Addressing these requires collaborative efforts and robust data sharing. Future priorities include integrating AI into routine clinical workflows, resolving regulatory barriers, and ensuring interpretability. Multidisciplinary collaboration is essential to address ethical considerations and uphold patient safety. The integration of AI in interventional cardiology offers significant potential to enhance patient care, procedural precision, and resource utilization. However, its adoption must be guided by careful attention to ethical, technical, and regulatory constraints. Overcoming these barriers through coordinated efforts may allow AI to redefine standards in cardiovascular care and enable a more precise, efficient, and patient-centered approach to interventional cardiology.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Patel et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Priyansh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, University of Miami Miller School of Medicine, Miami, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Medical College, Baroda, Vadodara, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davitashvili</LastName><ForeName>Besiki</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tbilisi State Medical University, Tblisi, GEO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chitturi</LastName><ForeName>Sai Sujana</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dr. D. Y. Patel Medical College, Navi Mumbai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadaevi</LastName><ForeName>Mari</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Tbilisi State Medical University, Tblisi, GEO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Diya</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>General Medicine, Gujarat Medical Education and Research Society (GMERS) Sola, Ahmedabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tallapalli</LastName><ForeName>Jayanth Reddy</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, University of South Florida, Tampa, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butchireddy</LastName><ForeName>Jyothsna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Government Medical College Omandurar, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suresh</LastName><ForeName>Ria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, Government Kilpauk Medical College, Chennai, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nannegari</LastName><ForeName>Jayanth Jhishnu</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Bhaskar Medical College, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slathia</LastName><ForeName>Shivam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Acharya Shri Chander College of Medical Sciences, Jammu, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ai &amp; robotics healthcare</Keyword><Keyword MajorTopicYN="N">ai and machine learning</Keyword><Keyword MajorTopicYN="N">artificial intelligence (ai)</Keyword><Keyword MajorTopicYN="N">cognitive computing</Keyword><Keyword MajorTopicYN="N">convolutional neural networks (cnn)</Keyword><Keyword MajorTopicYN="N">deep learning (dl)</Keyword><Keyword MajorTopicYN="N">interventional cardiology</Keyword><Keyword MajorTopicYN="N">natural language processing (nlp)</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>8</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40777718</ArticleId><ArticleId IdType="pmc">PMC12329261</ArticleId><ArticleId IdType="doi">10.7759/cureus.87494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Precision medicine in interventional cardiology. Hokken TW, Ribeiro JM, De Jaegere PP, Van Mieghem NM. Interv Cardiol. 2020;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203877</ArticleId><ArticleId IdType="pubmed">32382319</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiovascular imaging for risk stratification in coronary artery disease. Lin A, Kolossv&#xe1;ry M, Motwani M, I&#x161;gum I, Maurovich-Horvat P, Slomka PJ, Dey D. Radiol Cardiothorac Imaging. 2021;3:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7978004</ArticleId><ArticleId IdType="pubmed">33778661</ArticleId></ArticleIdList></Reference><Reference><Citation>Opening the black box: The promise and limitations of explainable machine learning in cardiology. Petch J, Di S, Nelson W. Can J Cardiol. 2022;38:204&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">34534619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ethical implications of AI in robotic surgical training: A Delphi consensus statement. Collins JW, Marcus HJ, Ghazi A, et al. Eur Urol Focus. 2022;8:613&#x2013;622.</Citation><ArticleIdList><ArticleId IdType="pubmed">33941503</ArticleId></ArticleIdList></Reference><Reference><Citation>Estimating treatment effects with machine learning. McConnell KJ, Lindner S. Health Serv Res. 2019;54:1273&#x2013;1282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6863230</ArticleId><ArticleId IdType="pubmed">31602641</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in precision cardiovascular medicine. Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. J Am Coll Cardiol. 2017;69:2657&#x2013;2664.</Citation><ArticleIdList><ArticleId IdType="pubmed">28545640</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Page MJ, McKenzie JE, Bossuyt PM, et al. BMJ. 2021;372:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8008539</ArticleId><ArticleId IdType="pubmed">33781348</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of coronary stent underexpansion by pre-procedural intravascular ultrasound-based deep learning. Min HS, Ryu D, Kang SJ, et al. JACC Cardiovasc Interv. 2021;14:1021&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">33865741</ArticleId></ArticleIdList></Reference><Reference><Citation>Is neural network better than logistic regression in death prediction in patients after ST-segment elevation myocardial infarction? Niedziela JT, Cie&#x15b;la D, Wojakowski W, et al. Kardiol Pol. 2021;79:1353&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">34704605</ArticleId></ArticleIdList></Reference><Reference><Citation>Longitudinal geographic miss (LGM) in robotic assisted versus manual percutaneous coronary interventions. Bezerra HG, Mehanna E, W Vetrovec G, A Costa M, Weisz G. J Interv Cardiol. 2015;28:449&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">26489972</ArticleId></ArticleIdList></Reference><Reference><Citation>Transapical TAVI: Survival, hemodynamics, devices and machine learning. Lessons learned after 10-year experience. D'Onofrio A, Tessari C, Tarantini G, et al. Curr Probl Cardiol. 2023;48:101734.</Citation><ArticleIdList><ArticleId IdType="pubmed">37044271</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in the diagnosis and management of arrhythmias. Nagarajan VD, Lee SL, Robertus JL, Nienaber CA, Trayanova NA, Ernst S. Eur Heart J. 2021;42:3904&#x2013;3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8497074</ArticleId><ArticleId IdType="pubmed">34392353</ArticleId></ArticleIdList></Reference><Reference><Citation>Imaging for native mitral valve surgical and transcatheter interventions. Gheorghe LL, Mobasseri S, Agricola E, et al. JACC Cardiovasc Imaging. 2021;14:112&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">33413881</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of artificial intelligence on interventional cardiology: From decision-making aid to advanced interventional procedure assistance. Sardar P, Abbott JD, Kundu A, Aronow HD, Granada JF, Giri J. JACC Cardiovasc Interv. 2019;12:1293&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">31320024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular imaging and intervention through the lens of artificial intelligence. Seetharam K, Shrestha S, Sengupta PP. Interv Cardiol. 2021;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559149</ArticleId><ArticleId IdType="pubmed">34754333</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence, computational simulations, and extended reality in cardiovascular interventions. Samant S, Bakhos JJ, Wu W, et al. JACC Cardiovasc Interv. 2023;16:2479&#x2013;2497.</Citation><ArticleIdList><ArticleId IdType="pubmed">37879802</ArticleId></ArticleIdList></Reference><Reference><Citation>Current state and future perspectives of artificial intelligence for automated coronary angiography imaging analysis in patients with ischemic heart disease. Molenaar MA, Selder JL, Nicolas J, et al. Curr Cardiol Rep. 2022;24:365&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8979928</ArticleId><ArticleId IdType="pubmed">35347566</ArticleId></ArticleIdList></Reference><Reference><Citation>Applications of machine learning in cardiology. Seetharam K, Balla S, Bianco C, et al. Cardiol Ther. 2022;11:355&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9381660</ArticleId><ArticleId IdType="pubmed">35829916</ArticleId></ArticleIdList></Reference><Reference><Citation>Implementing machine learning in interventional cardiology: The benefits are worth the trouble. Ben Ali W, Pesaranghader A, Avram R, et al. Front Cardiovasc Med. 2021;8:711401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8692711</ArticleId><ArticleId IdType="pubmed">34957230</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of intracoronary imaging for the management of calcified lesions . Petousis S, Skalidis E, Zacharis E, Kochiadakis G, Hamilos M. J Clin Med. 2023;12:4622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10380390</ArticleId><ArticleId IdType="pubmed">37510737</ArticleId></ArticleIdList></Reference><Reference><Citation>Physiological assessment of coronary lesions in 2020. Chowdhury M, Osborn EA. Curr Treat Options Cardiovasc Med. 2020;22:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012056</ArticleId><ArticleId IdType="pubmed">31938934</ArticleId></ArticleIdList></Reference><Reference><Citation>Advances in diagnosis, therapy, and prognosis of coronary artery disease powered by deep learning algorithms. Chu M, Wu P, Li G, Yang W, Guti&#xe9;rrez-Chico JL, Tu S. JACC Asia. 2023;3:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9982227</ArticleId><ArticleId IdType="pubmed">36873752</ArticleId></ArticleIdList></Reference><Reference><Citation>A survey of catheter tracking concepts and methodologies. Ramadani A, Bui M, Wendler T, Schunkert H, Ewert P, Navab N. Med Image Anal. 2022;82:102584.</Citation><ArticleIdList><ArticleId IdType="pubmed">36063746</ArticleId></ArticleIdList></Reference><Reference><Citation>On medical application of neural networks trained with various types of data. Karako K, Chen Y, Tang W. Biosci Trends. 2019;12:553&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">30555113</ArticleId></ArticleIdList></Reference><Reference><Citation>Current surgical management of mitral regurgitation. Calvinho P, Antunes M. Expert Rev Cardiovasc Ther. 2008;6:481&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">18402538</ArticleId></ArticleIdList></Reference><Reference><Citation>Advances in imaging for tricuspid transcatheter edge-to-edge repair: Lessons learned and future perspectives. Prandi FR, Lerakis S, Belli M, et al. J Clin Med. 2023;12:3384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219492</ArticleId><ArticleId IdType="pubmed">37240489</ArticleId></ArticleIdList></Reference><Reference><Citation>Advances in the assessment of coronary artery disease activity with PET/CT and CTA. Kwiecinski J, Wolny R, Chwala A, Slomka P. Tomography. 2023;9:328&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9962109</ArticleId><ArticleId IdType="pubmed">36828378</ArticleId></ArticleIdList></Reference><Reference><Citation>PRISMA2020 : An R package and shiny app for producing PRISMA 2020&#x2010;compliant flow diagrams, with interactivity for optimized digital transparency and open synthesis. Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. Campbell Syst Rev. 2022;18:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8958186</ArticleId><ArticleId IdType="pubmed">36911350</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning and deep learning. Janiesch C, Zschech P, Heinrich K. Electron Markets. 2021;31:685&#x2013;695.</Citation></Reference><Reference><Citation>Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media. Azzalini L, Vilca LM, Lombardo F, et al. Int J Cardiol. 2018;273:69&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30196995</ArticleId></ArticleIdList></Reference><Reference><Citation>Usefulness of semisupervised machine-learning-based phenogrouping to improve risk assessment for patients undergoing transcatheter aortic valve implantation. Ghffar YA, Osman M, Shrestha S, et al. Am J Cardiol. 2020;136:122&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941814</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning prediction models for in-hospital mortality after transcatheter aortic valve replacement. Hernandez-Suarez DF, Kim Y, Villablanca P, et al. JACC Cardiovasc Interv. 2019;12:1328&#x2013;1338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6650265</ArticleId><ArticleId IdType="pubmed">31320027</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning to classify intracardiac electrical patterns during atrial fibrillation. Alhusseini MI, Abuzaid F, Rogers AJ, et al. Circ Arrhythm Electrophysiol. 2020;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438307</ArticleId><ArticleId IdType="pubmed">32631100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuzzy decision tree to classify complex fractionated atrial electrograms. Schilling C, Keller M, Scherr D, et al. Biomed Tech (Berl) 2015;60:245&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">25781659</ArticleId></ArticleIdList></Reference><Reference><Citation>Intravascular ultrasound-based deep learning for plaque characterization in coronary artery disease. Cho H, Kang SJ, Min HS, et al. Atherosclerosis. 2021;324:69&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">33831671</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease. Nishi T, Yamashita R, Imura S, et al. Int J Cardiol. 2021;333:55&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pubmed">33741429</ArticleId></ArticleIdList></Reference><Reference><Citation>TCT-235 Intelligent recognition of coronary angiography by deep learning technology: A novel computer-aided diagnostic system. Du T, Xie L, Liu X, Guan C, Zhang H, Xu B. JACC. 2018;72:0.</Citation></Reference><Reference><Citation>TCT-231 An artificial intelligence based solution for fully automated cardiac phase and end-diastolic frame detection on coronary angiographies. Ciusdel C, Turcea A, Puiu A, et al. JACC. 2018;72:96&#x2013;97.</Citation></Reference><Reference><Citation>A machine-learning approach for computation of fractional flow reserve from coronary computed tomography. Itu L, Rapaka S, Passerini T, et al. J Appl Physiol. 2016;121:42&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">27079692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40782772</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7487</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Journal of forensic and legal medicine</Title><ISOAbbreviation>J Forensic Leg Med</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence in forensic neuropathology: A systematic review.</ArticleTitle><Pagination><StartPage>102944</StartPage><MedlinePgn>102944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jflm.2025.102944</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1752-928X(25)00145-3</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES" NlmCategory="OBJECTIVE">In recent years, Artificial Intelligence (AI) has gained prominence as a robust tool for clinical decision-making and diagnostics, owing to its capacity to process and analyze large datasets with high accuracy. More specifically, Deep Learning, and its subclasses, have shown significant potential in image processing, including medical imaging and histological analysis. In forensic pathology, AI has been employed for the interpretation of histopathological data, identifying conditions such as myocardial infarction, traumatic injuries, and heart rhythm abnormalities. This review aims to highlight key advances in AI's role, particularly machine learning (ML) and deep learning (DL) techniques, in forensic neuropathology, with a focus on its ability to interpret instrumental and histopathological data to support professional diagnostics.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">A systematic review of the literature regarding applications of Artificial Intelligence in forensic neuropathology was carried out according to the Preferred Reporting Item for Systematic Review (PRISMA) standards. We selected 34 articles regarding the main applications of AI in this field, dividing them into two categories: those addressing traumatic brain injury (TBI), including intracranial hemorrhage or cerebral microbleeds, and those focusing on epilepsy and SUDEP, including brain disorders and central nervous system neoplasms capable of inducing seizure activity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In both cases, the application of AI techniques demonstrated promising results in the forensic investigation of cerebral pathology, providing a valuable computer-assisted diagnostic tool to aid in post-mortem computed tomography (PMCT) assessments of cause of death and histopathological analyses.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In conclusion, this paper presents a comprehensive overview of the key neuropathology areas where the application of artificial intelligence can be valuable in investigating causes of death.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Treglia</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Rome, Italy. Electronic address: michele.treglia@uniroma2.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Russa</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Public Health, Life Sciences, and Environmental Sciences, University of L'Aquila, 67100, L'Aquila, Italy. Electronic address: raffaele.larussa@univaq.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Napoletano</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: gabriele.napoletano@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghamlouch</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: alessandro.ghamlouch@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Duca</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: fabio.delduca@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treves</LastName><ForeName>Biancamaria</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: biancamaria.treves@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frati</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: paola.frati@uniroma1.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiese</LastName><ForeName>Aniello</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University of Rome, Viale Regina Elena 336, 00161, Rome, Italy. Electronic address: aniello.maiese@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Forensic Leg Med</MedlineTA><NlmUniqueID>101300022</NlmUniqueID><ISSNLinking>1752-928X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Convolutional neuronal network</Keyword><Keyword MajorTopicYN="N">Deep learning</Keyword><Keyword MajorTopicYN="N">Forensic</Keyword><Keyword MajorTopicYN="N">Forensic neuropathology</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Neuropathology</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>9</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40782772</ArticleId><ArticleId IdType="doi">10.1016/j.jflm.2025.102944</ArticleId><ArticleId IdType="pii">S1752-928X(25)00145-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40760711</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1793-6462</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>International journal of neural systems</Title><ISOAbbreviation>Int J Neural Syst</ISOAbbreviation></Journal><ArticleTitle>Expanding Domain-Specific Datasets with Stable Diffusion Generative Models for Simulating Myocardial Infarction.</ArticleTitle><Pagination><StartPage>2550052</StartPage><MedlinePgn>2550052</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1142/S0129065725500522</ELocationID><Abstract><AbstractText>Areas, such as the identification of human activity, have accelerated thanks to the immense development of artificial intelligence (AI). However, the lack of data is a major obstacle to even faster progress. This is particularly true in computer vision, where training a model typically requires at least tens of thousands of images. Moreover, when the activity a researcher is interested in is far from the usual, such as falls, it is difficult to have a sufficiently large dataset. An example of this could be the identification of people suffering from a heart attack. In this sense, this work proposes a novel approach that relies on generative models to extend image datasets, adapting them to generate more domain-relevant images. To this end, a refinement to stable diffusion models was performed using low-rank adaptation. A dataset of 100 images of individuals simulating infarct situations and neutral poses was created, annotated, and used. The images generated with the adapted models were evaluated using learned perceptual image patch similarity to test their closeness to the target scenario. The results obtained demonstrate the potential of synthetic datasets, and in particular the strategy proposed here, to overcome data sparsity in AI-based applications. This approach can not only be more cost-effective than building a dataset in the traditional way, but also reduces the ethical concerns of its applicability in smart environments, health monitoring, and anomaly detection. In fact, all data are owned by the researcher and can be added and modified at any time without requiring additional permissions, streamlining their research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rojas-Albarrac&#xed;n</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-7597-9274</Identifier><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Universidad de Cundinamarca, Sector El Cuarenta, Ch&#xed;a, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereira</LastName><ForeName>Ant&#xf3;nio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5062-1241</Identifier><AffiliationInfo><Affiliation>Computer Science and Communications Research Centre, School of Technology and Management, Polytechnic Institute of Leiria, Leiria, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fern&#xe1;ndez-Caballero</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8211-0398</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Inform&#xe1;tica de Albacete, Calle de la Investigaci&#xf3;n 2, Albacete, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Sistemas Inform&#xe1;ticos, Universidad de Castilla-La Mancha, Avda. de Espa&#xf1;a, s/n, Albacete, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Mar&#xed;a T</ForeName><Initials>MT</Initials><Identifier Source="ORCID">0000-0002-2846-3483</Identifier><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n en Inform&#xe1;tica de Albacete, Calle de la Investigaci&#xf3;n 2, Albacete, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Sistemas Inform&#xe1;ticos, Universidad de Castilla-La Mancha, Avda. de Espa&#xf1;a, s/n, Albacete, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Int J Neural Syst</MedlineTA><NlmUniqueID>9100527</NlmUniqueID><ISSNLinking>0129-0657</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Synthetic data generation</Keyword><Keyword MajorTopicYN="N">fine-tuning</Keyword><Keyword MajorTopicYN="N">human activity recognition</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">stable diffusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40760711</ArticleId><ArticleId IdType="doi">10.1142/S0129065725500522</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40727351</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2223-4292</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Quantitative imaging in medicine and surgery</Title><ISOAbbreviation>Quant Imaging Med Surg</ISOAbbreviation></Journal><ArticleTitle>Application of non-invasive imaging in myocardial infarction: a bibliometric analysis from January 2003 to December 2022.</ArticleTitle><Pagination><StartPage>6340</StartPage><EndPage>6359</EndPage><MedlinePgn>6340-6359</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/qims-24-878</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Myocardial infarction (MI) is a leading cause of death and disability worldwide. Non-invasive cardiac imaging has garnered significant attention in both MI diagnostic and prognostic research. Despite the growing body of published articles, no comprehensive, quantitative analysis has been conducted to delineate key trends and emerging areas in the field of non-invasive imaging for MI. This bibliometric analysis aimed to systematically evaluate the landscape of non-invasive cardiac imaging-focused research on MI in terms of the research status, publication patterns, influential contributors, hotspots, and focal development trends.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We systematically searched the Web of Science Core Collection (WoSCC) to retrieve publications related to MI imaging between 2003 and 2022. Only "articles" and "reviews" written in English were included in the final analysis. Subsequently, a manual screening process was employed to eliminate articles not relevant to the topic. The search results were exported as a plain text file in "Full Record and Cited References" format, and stored as "download_*.txt". CiteSpace and VOSviewer software were used to conduct the bibliometric and visualization analyses. These tools allowed us to analyze countries/regions and institutions' contributions, the top journals, prolific authors, influential references, and keywords.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our bibliometric analysis included 33,480 publications from 138 countries, involving contributions from 19,554 institutions and 146,043 authors. Annual publications in this field have shown a rapid increase since approximately 2004. The United States of America (USA) leads in MI imaging research, boasting the highest number of publications (n=11,431), prolific research institutions, and numerous core authors. Notably, Harvard University and the University of California System emerged as the primary research institutions. Among the authors, Budoff was the most prolific contributor (n=209). The co-citation analysis, which measures how frequently an author's work is cited together with other key studies in the field, showed that Kim (n=2,794) was the most influential author based on co-citations, highlighting his significant influence in the area. Most articles appeared in the journal of the <i>American College of Cardiology</i>, while <i>Circulation</i> was the most frequently co-cited journal. Key topics included MI, risk-factor, magnetic resonance imaging (MRI), and atherosclerosis. Recent popular keywords such as ST-elevation myocardial infarction (STEMI), coronary computed tomography angiography (CTA), guidelines, and recommendations indicated future research directions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our bibliometric analysis revealed that MI non-invasive imaging is a rapidly developing field, with emerging trends in multimodal imaging and artificial intelligence (AI). These findings suggest that the integration of various imaging techniques and the use of AI could enhance the clinical application of MI non-invasive imaging, particularly in terms of early diagnosis, risk stratification, and personalized treatment strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 AME Publishing Company. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xinwen</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yaya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Qingyou</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Mengyao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leng</LastName><ForeName>Yinping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ren</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gong</LastName><ForeName>Lianggeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jiangxi Provincial Key Laboratory of Intelligent Medical Imaging, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Quant Imaging Med Surg</MedlineTA><NlmUniqueID>101577942</NlmUniqueID><ISSNLinking>2223-4306</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CiteSpace</Keyword><Keyword MajorTopicYN="N">Myocardial infarction (MI)</Keyword><Keyword MajorTopicYN="N">bibliometric</Keyword><Keyword MajorTopicYN="N">non-invasive cardiac imaging</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-24-878/coif). The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40727351</ArticleId><ArticleId IdType="pmc">PMC12290736</ArticleId><ArticleId IdType="doi">10.21037/qims-24-878</ArticleId><ArticleId IdType="pii">qims-15-07-6340</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol 2020;76:2982-3021. 10.1016/j.jacc.2020.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Y, Guo J, Wang X, Wang G, Fan Z, Yin D, Wang Z, Zhang F, Tian C, Gong W, Liu J, Lu J, Li Y, Ma C, Vicaut E, Montalescot G, Nie S; RIGHT Investigators. Postprocedural Anticoagulation After Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: A Multicenter, Randomized, Double-Blind Trial. Circulation 2024;149:1258-67. 10.1161/CIRCULATIONAHA.123.067079</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.067079</ArticleId><ArticleId IdType="pubmed">38406848</ArticleId></ArticleIdList></Reference><Reference><Citation>Beijnink CWH, van der Hoeven NW, Konijnenberg LSF, Kim RJ, Bekkers SCAM, Kloner RA, Everaars H, El Messaoudi S, van Rossum AC, van Royen N, Nijveldt R. Cardiac MRI to Visualize Myocardial Damage after ST-Segment Elevation Myocardial Infarction: A Review of Its Histologic Validation. Radiology 2021;301:4-18. 10.1148/radiol.2021204265</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204265</ArticleId><ArticleId IdType="pubmed">34427461</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy CP, Murphy SP, Amponsah DK, Rambarat PK, Lin C, Liu Y, Mohebi R, Levin A, Raghavan A, Miksenas H, Rogers C, Wasfy JH, Blankstein R, Ghoshhajra B, Hedgire S, Januzzi JL, Jr. Coronary Computed Tomographic Angiography With Fractional Flow Reserve in Patients With Type 2 Myocardial Infarction. J Am Coll Cardiol 2023;82:1676-87. 10.1016/j.jacc.2023.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.08.020</ArticleId><ArticleId IdType="pubmed">37777947</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirajuddin A, Mirmomen SM, Kligerman SJ, Groves DW, Burke AP, Kureshi F, White CS, Arai AE. Ischemic Heart Disease: Non-invasive Imaging Techniques and Findings. Radiographics 2021;41:990-1021. 10.1148/rg.2021200125</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/rg.2021200125</ArticleId><ArticleId IdType="pmc">PMC8262179</ArticleId><ArticleId IdType="pubmed">34019437</ArticleId></ArticleIdList></Reference><Reference><Citation>Ties D, van Dorp P, Pundziute G, Lipsic E, van der Aalst CM, Oudkerk M, de Koning HJ, Vliegenthart R, van der Harst P. Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time? J Clin Med 2022;11:2965. 10.3390/jcm11112965</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11112965</ArticleId><ArticleId IdType="pmc">PMC9181560</ArticleId><ArticleId IdType="pubmed">35683356</ArticleId></ArticleIdList></Reference><Reference><Citation>Willemink MJ, Varga-Szemes A, Schoepf UJ, Codari M, Nieman K, Fleischmann D, Mastrodicasa D. Emerging methods for the characterization of ischemic heart disease: ultrafast Doppler angiography, micro-CT, photon-counting CT, novel MRI and PET techniques, and artificial intelligence. Eur Radiol Exp 2021;5:12. 10.1186/s41747-021-00207-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41747-021-00207-3</ArticleId><ArticleId IdType="pmc">PMC7991013</ArticleId><ArticleId IdType="pubmed">33763754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: How great is the impact? Scientometrics 2015;105:1809-31. 10.1007/s11192-015-1645-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-015-1645-z</ArticleId><ArticleId IdType="pmc">PMC4643120</ArticleId><ArticleId IdType="pubmed">26594073</ArticleId></ArticleIdList></Reference><Reference><Citation>Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: An overview and guidelines. Journal of Business Research 2021;133:285-96.</Citation></Reference><Reference><Citation>Edlinger C, Schreiber C, Wernly B, Anker A, Ruzicka K, Jung C, Hoppe UC, Lichtenauer M. Stem Cell Therapy for Myocardial Infarction 2001-2013 Revisited. Stem Cell Rev Rep 2015;11:743-51. 10.1007/s12015-015-9602-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-015-9602-z</ArticleId><ArticleId IdType="pubmed">26105665</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Yang F, Shen B, Wang J, Niu W, Chen H, Li N, Chen W, Wang Q, He Z, Ding R. A bibliometric analysis of acute myocardial infarction in women from 2000 to 2022. Front Cardiovasc Med 2023;10:1090220. 10.3389/fcvm.2023.1090220</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1090220</ArticleId><ArticleId IdType="pmc">PMC10416645</ArticleId><ArticleId IdType="pubmed">37576112</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab SI, Taha MME, Farasani A, Jerah AA, Abdullah SM, Oraibi B, Babiker Y, Alfaifi HA, Alzahrani AH, Alamer AS, Altherwi T, Aziz Ibrahim IA, Hassan W. Bibliometric analysis of ST elevation myocardial infarction research from 1933 to 2023: Focus on top 100 most-cited articles. Curr Probl Cardiol 2025;50:102923. 10.1016/j.cpcardiol.2024.102923</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2024.102923</ArticleId><ArticleId IdType="pubmed">39510401</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo M, Lin SC. An analysis of reporting practices in the top 100 cited health and medicine-related bibliometric studies from 2019 to 2021 based on a proposed guidelines. Heliyon 2023;9:e16780. 10.1016/j.heliyon.2023.e16780</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e16780</ArticleId><ArticleId IdType="pmc">PMC10245063</ArticleId><ArticleId IdType="pubmed">37292336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk&#xfd; P. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Kardiol Pol 2018;76:229-313. 10.5603/KP.2018.0041</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/KP.2018.0041</ArticleId><ArticleId IdType="pubmed">29457615</ArticleId></ArticleIdList></Reference><Reference><Citation>Flachskampf FA, Schmid M, Rost C, Achenbach S, DeMaria AN, Daniel WG. Cardiac imaging after myocardial infarction. Eur Heart J 2011;32:272-83. 10.1093/eurheartj/ehq446</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq446</ArticleId><ArticleId IdType="pubmed">21163851</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu SD, Frangogiannis NG. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res 2016;119:91-112. 10.1161/CIRCRESAHA.116.303577</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.303577</ArticleId><ArticleId IdType="pmc">PMC4922528</ArticleId><ArticleId IdType="pubmed">27340270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol 2016;13:193-209. 10.1038/nrcardio.2016.5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2016.5</ArticleId><ArticleId IdType="pubmed">26843289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner I, Reindl M, Tiller C, Holzknecht M, Troger F, Fink P, Mayr A, Klug G, Bauer A, Metzler B, Reinstadler SJ. Impact of COVID-19 pandemic restrictions on ST-elevation myocardial infarction: a cardiac magnetic resonance imaging study. Eur Heart J 2022;43:1141-53. 10.1093/eurheartj/ehab621</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab621</ArticleId><ArticleId IdType="pmc">PMC8524546</ArticleId><ArticleId IdType="pubmed">34632491</ArticleId></ArticleIdList></Reference><Reference><Citation>Naghavi M, Reeves AP, Atlas K, Zhang C, Atlas T, Henschke CI, et al. Artificial intelligence applied to coronary artery calcium scans (AI-CAC) significantly improves cardiovascular events prediction. NPJ Digit Med 2024;7:309. 10.1038/s41746-024-01308-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-024-01308-0</ArticleId><ArticleId IdType="pmc">PMC11538462</ArticleId><ArticleId IdType="pubmed">39501071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordlund D, Klug G, Heiberg E, Koul S, Larsen TH, Hoffmann P, Metzler B, Erlinge D, Atar D, Aletras AH, Carlsson M, Engblom H, Arheden H. Multi-vendor, multicentre comparison of contrast-enhanced SSFP and T2-STIR CMR for determining myocardium at risk in ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 2016;17:744-53. 10.1093/ehjci/jew027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jew027</ArticleId><ArticleId IdType="pmc">PMC4907382</ArticleId><ArticleId IdType="pubmed">27002140</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanbari F, Joyce T, Lorenzoni V, Guaricci AI, Pavon AG, Fusini L, et al. AI Cardiac MRI Scar Analysis Aids Prediction of Major Arrhythmic Events in the Multicenter DERIVATE Registry. Radiology 2023;307:e222239. 10.1148/radiol.222239</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.222239</ArticleId><ArticleId IdType="pubmed">36943075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzimas G, Gulsin GS, Everett RJ, Akodad M, Meier D, Sewnarain K, Ally Z, Alnamasy R, Ng N, Mullen S, Rotzinger D, Sathananthan J, Sellers SL, Blanke P, Leipsic JA. Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort. JACC Cardiovasc Imaging 2024;17:165-75. 10.1016/j.jcmg.2023.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.05.011</ArticleId><ArticleId IdType="pubmed">37410009</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, Seeman TE, Horwich T, Budoff MJ, Watson KE. Heterogeneity in the Association Between the Presence of Coronary Artery Calcium and Cardiovascular Events: A Machine-Learning Approach in the MESA Study. Circulation 2023;147:132-41. 10.1161/CIRCULATIONAHA.122.062626</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062626</ArticleId><ArticleId IdType="pmc">PMC9812415</ArticleId><ArticleId IdType="pubmed">36314118</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi R, Slomka PJ, Rios R, Betancur J, Blaha MJ, Nasir K, Miedema MD, Rumberger JA, Gransar H, Shaw LJ, Rozanski A, Budoff MJ, Berman DS. Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths. JACC Cardiovasc Imaging 2021;14:615-25. 10.1016/j.jcmg.2020.08.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.08.024</ArticleId><ArticleId IdType="pmc">PMC7987201</ArticleId><ArticleId IdType="pubmed">33129741</ArticleId></ArticleIdList></Reference><Reference><Citation>Golub IS, Termeie OG, Kristo S, Schroeder LP, Lakshmanan S, Shafter AM, Hussein L, Verghese D, Aldana-Bitar J, Manubolu VS, Budoff MJ. Major Global Coronary Artery Calcium Guidelines. JACC Cardiovasc Imaging 2023;16:98-117. 10.1016/j.jcmg.2022.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.06.018</ArticleId><ArticleId IdType="pubmed">36599573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendell D, Jenista E, Kim HW, Chen EL, Azevedo CF, Kaolawanich Y, Alenezi F, Rehwald W, Darty S, Parker M, Kim RJ. Assessment of Papillary Muscle Infarction with Dark-Blood Delayed Enhancement Cardiac MRI in Canines and Humans. Radiology 2022;305:329-38. 10.1148/radiol.220251</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220251</ArticleId><ArticleId IdType="pmc">PMC9619201</ArticleId><ArticleId IdType="pubmed">35880980</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulders MW, Kietselaer BLJH, Wildberger JE, Dagnelie PC, Brunner-La Rocca HP, Mingels AMA, van Cauteren YJM, Theunissen RALJ, Post MJ, Schalla S, van Kuijk SMJ, Das M, Kim RJ, Crijns HJGM, Bekkers SCAM. Initial Imaging-Guided Strategy Versus Routine Care in Patients With Non-ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol 2019;74:2466-77. 10.1016/j.jacc.2019.09.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.09.027</ArticleId><ArticleId IdType="pubmed">31727284</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezel T, Toupin S, Bousson V, Hamzi K, Hovasse T, Lefevre T, et al. A Machine Learning Model Using Cardiac CT and MRI Data Predicts Cardiovascular Events in Obstructive Coronary Artery Disease. Radiology 2025;314:e233030. 10.1148/radiol.233030</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.233030</ArticleId><ArticleId IdType="pubmed">39807980</ArticleId></ArticleIdList></Reference><Reference><Citation>Newby DE, Adamson PD, Berry C, Boon NA, Dweck MR, Flather M, Forbes J, Hunter A, Lewis S, MacLean S, Mills NL, Norrie J, Roditi G, Shah ASV, Timmis AD, van Beek EJR, Williams MC, Coronary CT. Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med 2018;379:924-33. 10.1056/NEJMoa1805971</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805971</ArticleId><ArticleId IdType="pubmed">30145934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9. 10.1016/S0140-6736(03)12389-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12389-6</ArticleId><ArticleId IdType="pubmed">12573373</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J 2022;43:2549-61. 10.1093/eurheartj/ehac223</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac223</ArticleId><ArticleId IdType="pmc">PMC9336586</ArticleId><ArticleId IdType="pubmed">35511857</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-23. 10.1148/radiology.218.1.r01ja50215</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.218.1.r01ja50215</ArticleId><ArticleId IdType="pubmed">11152805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wereski R, Kimenai DM, Bularga A, Taggart C, Lowe DJ, Mills NL, Chapman AR. Risk factors for type 1 and type 2 myocardial infarction. Eur Heart J 2022;43:127-35. 10.1093/eurheartj/ehab581</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab581</ArticleId><ArticleId IdType="pmc">PMC8757580</ArticleId><ArticleId IdType="pubmed">34431993</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Cui J, Zhang X, Li J, Yang J, Li T. Right ventricular function and determining factors of dysfunction in ST-segment-elevation myocardial infarction: a cross-sectional study with cardiac magnetic resonance imaging (MRI). Quant Imaging Med Surg 2024;14:6895-907. 10.21037/qims-23-1804</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-23-1804</ArticleId><ArticleId IdType="pmc">PMC11400663</ArticleId><ArticleId IdType="pubmed">39281121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J, Qiao J, Tang Y, Zhao Y, Yang Z, Wang L, Tao X, Zhou X, Xia L, Tang D, Huang L. Cardiac magnetic resonance imaging detection of intramyocardial hemorrhage in patients with ST-elevated myocardial infarction: comparison between susceptibility-weighted imaging and T1/T2 mapping techniques. Quant Imaging Med Surg 2024;14:476-88. 10.21037/qims-23-591</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-23-591</ArticleId><ArticleId IdType="pmc">PMC10784041</ArticleId><ArticleId IdType="pubmed">38223054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Pu J. Recent Advances in Cardiac Magnetic Resonance for Imaging of Acute Myocardial Infarction. Small Methods 2024;8:e2301170. 10.1002/smtd.202301170</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/smtd.202301170</ArticleId><ArticleId IdType="pubmed">37992241</ArticleId></ArticleIdList></Reference><Reference><Citation>Giga V, Tesic M, Beleslin B, Boskovic N, Sobic-Saranovic D, Jovanovic I, Nedeljkovic I, Paunovic I, Dedic S, Djordjevic-Dikic A. Predictors of diastolic deceleration time of coronary flow velocity of infarct related and reference coronary artery assessed by transthoracic Doppler echocardiography in the chronic phase of successfully reperfused anterior myocardial infarction: relation to infarct size. Front Cardiovasc Med 2023;10:1196206. 10.3389/fcvm.2023.1196206</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1196206</ArticleId><ArticleId IdType="pmc">PMC10523777</ArticleId><ArticleId IdType="pubmed">37771666</ArticleId></ArticleIdList></Reference><Reference><Citation>Prastaro M, Pirozzi E, Gaibazzi N, Paolillo S, Santoro C, Savarese G, Losi MA, Esposito G, Perrone Filardi P, Trimarco B, Galderisi M. Expert Review on the Prognostic Role of Echocardiography after Acute Myocardial Infarction. J Am Soc Echocardiogr 2017;30:431-443.e2. 10.1016/j.echo.2017.01.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2017.01.020</ArticleId><ArticleId IdType="pubmed">28477781</ArticleId></ArticleIdList></Reference><Reference><Citation>Caunite L, Myagmardorj R, Galloo X, Laenens D, Stassen J, Nabeta T, Yedidya I, Meucci MC, Kuneman JH, van den Hoogen IJ, van Rosendael SE, Wu HW, van den Brand VM, Giuca A, Trusinskis K, van der Bijl P, Bax JJ, Ajmone Marsan N. Prognostic Value of Follow-up Measures of Left Ventricular Global Longitudinal Strain in Patients With ST-Segment Elevation Myocardial Infarction. J Am Soc Echocardiogr 2024;37:666-73. 10.1016/j.echo.2024.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2024.03.007</ArticleId><ArticleId IdType="pubmed">38513963</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghezzaf S, Coisne A, Bauters C, Favata F, Delsart P, Coppin A, Seunes C, Schurtz G, Verdier B, Lamblin N, Tazibet A, Le Taillandier de Gabory J, Ninni S, Donal E, Lemesle G, Montaigne D. Feasibility and prognostic significance of ventricular-arterial coupling after myocardial infarction: the RIGID-MI cohort. Eur Heart J Cardiovasc Imaging 2024;25:668-77. 10.1093/ehjci/jead342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jead342</ArticleId><ArticleId IdType="pubmed">38133627</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong JH, Abdulkareem M, Petersen SE, Khanji MY. Artificial Intelligence and Cardiovascular Magnetic Resonance Imaging in Myocardial Infarction Patients. Curr Probl Cardiol 2022;47:101330. 10.1016/j.cpcardiol.2022.101330</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101330</ArticleId><ArticleId IdType="pubmed">35870544</ArticleId></ArticleIdList></Reference><Reference><Citation>Alalawi L, Budoff MJ. Recent Advances in Coronary Computed Tomography Angiogram: The Ultimate Tool for Coronary Artery Disease. Curr Atheroscler Rep 2022;24:557-62. 10.1007/s11883-022-01029-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-022-01029-3</ArticleId><ArticleId IdType="pubmed">35507277</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K, Zhou Y, Ni W, Guo K, Li Y, Ke J, Cheng L, Ni Q, Shi S, Lu Y, Sun L, Zhou H. Assessment of perioperative cardiac risk using preoperative quantitative flow ratio in patients with coronary artery disease undergoing noncardiac surgery: a retrospective cohort study. Quant Imaging Med Surg 2024;14:5682-700. 10.21037/qims-24-63</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-24-63</ArticleId><ArticleId IdType="pmc">PMC11320557</ArticleId><ArticleId IdType="pubmed">39143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Driessen RS, Danad I, Stuijfzand WJ, Raijmakers PG, Schumacher SP, van Diemen PA, Leipsic JA, Knuuti J, Underwood SR, van de Ven PM, van Rossum AC, Taylor CA, Knaapen P. Comparison of Coronary Computed Tomography Angiography, Fractional Flow Reserve, and Perfusion Imaging for Ischemia Diagnosis. J Am Coll Cardiol 2019;73:161-73. 10.1016/j.jacc.2018.10.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.10.056</ArticleId><ArticleId IdType="pubmed">30654888</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquino-Bruno H, Andrade-Cuellar EN, Mel&#xe9;ndez-Ram&#xed;rez G, Roque-Palacios CJ, Morales-Portano JD, Flores-Puente F. Myocardial Infarction Due to Nonvalvular Papillary Fibroelastoma of the Left Coronary Sinus: The Importance of Multimodal Imaging. CJC Open 2023;5:158-60. 10.1016/j.cjco.2022.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC9984878</ArticleId><ArticleId IdType="pubmed">36880071</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet JP, Thiele H, Barbato E, Barth&#xe9;l&#xe9;my O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2021;42:1289-367. 10.1093/eurheartj/ehaa575</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa575</ArticleId><ArticleId IdType="pubmed">32860058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Ayala P, Boeddinghaus J, Nestelberger T, Koechlin L, Zimmermann T, Bima P, Glaeser J, Spagnuolo CC, Champetier A, Miro O, Martin-Sanchez FJ, Keller DI, Christ M, Wildi K, Breidthardt T, Strebel I, Mueller C; . External validation of the myocardial-ischaemic-injury-index machine learning algorithm for the early diagnosis of myocardial infarction: a multicentre cohort study. Lancet Digit Health 2024;6:e480-8. 10.1016/S2589-7500(24)00088-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(24)00088-8</ArticleId><ArticleId IdType="pubmed">38906613</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RJH, Manral N, Lin A, Shanbhag A, Park C, Kwiecinski J, et al. Patient-Specific Myocardial Infarction Risk Thresholds From AI-Enabled Coronary Plaque Analysis. Circ Cardiovasc Imaging 2024;17:e016958. 10.1161/CIRCIMAGING.124.016958</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.124.016958</ArticleId><ArticleId IdType="pmc">PMC11834154</ArticleId><ArticleId IdType="pubmed">39405390</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40786090</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Machine learning based insights into cardiomyopathy and heart failure research: a bibliometric analysis from 2005 to 2024.</ArticleTitle><Pagination><StartPage>1602077</StartPage><MedlinePgn>1602077</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1602077</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2025.1602077</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Cardiomyopathy and heart failure are among the most critical challenges in modern cardiology, with increasing attention to the integration of machine learning (ML) and artificial intelligence (AI) for diagnostics, risk prediction, and therapeutic strategies. This study was aimed at evaluating global research trends, influential contributions, and emerging themes in the domain of cardiomyopathy and heart failure from 2005 to 2024.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="UNASSIGNED">A comprehensive bibliometric analysis was conducted using the Web of Science Core Collection (WoSCC) database. The study utilized the R- package bibliometrix-biblioshiny, VOSviewer, Scimago Graphica and CiteSpace to analyze the publications on cardiomyopathy, heart failure, machine learning, and artificial intelligence. Key metrics examined included top institutions, countries, journals, keywords, co-authorship networks, and keyword co-occurrence patterns. Additionally, the analysis evaluated publication counts, citation trends, H-index, and collaboration metrics to identify research trends and emerging themes in the field.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 2,110 publications retrieved from the last 20 years were included in the analysis. The United States of America (USA), China, and the United Kingdom (UK), emerged as leading contributors, with institutions such as Mayo Clinic and Harvard University producing high-impact research. Dominant keywords included "heart failure," "risk," "diagnosis," and "artificial intelligence," reflecting the increasing reliance on ML for predictive analytics. Thematic evolution revealed a transition from traditional classification methods to advanced techniques, including feature selection and proteomics. Influential studies, including those by Friedman PA, Noseworthy PA, and Attia ZI, showcased the transformative potential of AI in cardiology. Global collaboration networks underscored strong partnerships but highlighted disparities in contributions from low-income regions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This analysis highlights the dynamic evolution of cardiomyopathy research, emphasizing the critical role of ML and AI in advancing diagnostics and therapeutic strategies. Future research should address challenges in scalability, data standardization, and ethical considerations to ensure equitable access and implementation of these technologies, particularly in underrepresented regions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Akram, Nawaz, Yuxing, Zhang, Haixin, Liu, Qian and Tian.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akram</LastName><ForeName>Muhammad Junaid</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nawaz</LastName><ForeName>Asad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuxing</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jinpeng</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haixin</LastName><ForeName>Huang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Lingjuan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qian</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Library, Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ministry of Education Key Laboratory of Child Development and Disorders, Department of Pediatric Cardiology, National Clinical Key Cardiovascular Specialty, National Clinical Research Center for Child Health and Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Children's Important Organ Development and Diseases, Children's Hospital of Chongqing Medical University, Chongqing Municipal Health Commission, Chongqing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CiteSpace</Keyword><Keyword MajorTopicYN="N">VOSviewer</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">bibliometric</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40786090</ArticleId><ArticleId IdType="pmc">PMC12331722</ArticleId><ArticleId IdType="doi">10.3389/fmed.2025.1602077</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L, et al. 
Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.
<i>J Am Coll Cardiol.</i> (2020) 76:2982&#x2013;3021. 10.1016/j.jacc.2020.11.010

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P, Leong D, McKee M, Anand S, Schwalm J, Teo K, et al. 
Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors.
<i>Circ Res.</i> (2017) 121:677&#x2013;94. 10.1161/CIRCRESAHA.117.308903

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.308903</ArticleId><ArticleId IdType="pubmed">28860318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez F, K&#xfc;hl U, Pieske B, Garcia-Pavia P, Tsch&#xf6;pe C. Update on myocarditis and inflammatory cardiomyopathy: re-emergence of endomyocardial biopsy.
<i>Rev Esp Cardiol (Engl Ed).</i> (2016) 69:178&#x2013;87. 10.1016/j.rec.2015.10.015

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2015.10.015</ArticleId><ArticleId IdType="pubmed">26795929</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsch&#xf6;pe C, Ammirati E, Bozkurt B, Caforio A, Cooper L, Felix S, et al. 
Myocarditis and inflammatory cardiomyopathy: current evidence and future directions.
<i>Nat Rev Cardiol.</i> (2021) 18:169&#x2013;93. 10.1038/s41569-020-00435-x

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00435-x</ArticleId><ArticleId IdType="pmc">PMC7548534</ArticleId><ArticleId IdType="pubmed">33046850</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso R, Nasir K. Primary prevention of cardiovascular disease: 2019 and beyond.
<i>Nat Rev Cardiol.</i> (2019) 16:387&#x2013;8. 10.1038/s41569-019-0213-2

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0213-2</ArticleId><ArticleId IdType="pubmed">31110263</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng S, Han Y, Jiang L, Lan Z, Guo J. National, regional, and global cardiomyopathy burden from 1990 to 2019.
<i>Front Cardiovasc Med.</i> (2022) 9:1042448. 10.3389/fcvm.2022.1042448

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.1042448</ArticleId><ArticleId IdType="pmc">PMC9748073</ArticleId><ArticleId IdType="pubmed">36531740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipshultz S, Sleeper L, Towbin J, Lowe A, Orav E, Cox G, et al. 
The incidence of pediatric cardiomyopathy in two regions of the United States.
<i>N Engl J Med.</i> (2003) 348:1647&#x2013;55. 10.1056/NEJMoa021715

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021715</ArticleId><ArticleId IdType="pubmed">12711739</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent A, Daubeney P, Chondros P, Carlin J, Cheung M, Wilkinson L, et al. 
The epidemiology of childhood cardiomyopathy in Australia.
<i>N Engl J Med.</i> (2003) 348:1639&#x2013;46. 10.1056/NEJMoa021737

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021737</ArticleId><ArticleId IdType="pubmed">12711738</ArticleId></ArticleIdList></Reference><Reference><Citation>Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela A, et al. 
Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland.
<i>Am J Epidemiol.</i> (1997) 146:385&#x2013;93. 10.1093/oxfordjournals.aje.a009291

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009291</ArticleId><ArticleId IdType="pubmed">9290498</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Cheng X, Qu N, Song H, Luo Y, Ye T, et al. 
Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.
<i>Front Public Health.</i> (2022) 10:1018385. 10.3389/fpubh.2022.1018385

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1018385</ArticleId><ArticleId IdType="pmc">PMC9545016</ArticleId><ArticleId IdType="pubmed">36211688</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiler T, Paul M. [Heart failure with reduced left ventricular ejection fraction (HFrEF, HFmrEF)].
<i>Ther Umsch.</i> (2024) 81:41&#x2013;6.
</Citation><ArticleIdList><ArticleId IdType="pubmed">38780209</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedacko J, Tuppo E, Singh R, Elkilany G, Hristova K. Epidemiology and mortality due to heart failure. In: Singh RB, Fedacko J, Hristova K, Elkilany GEN.
editors. <i>Pathophysiology, Risk Factors, and Management of Chronic Heart Failure.</i>
Amsterdam: Elsevier;  (2024). p. 23&#x2013;40.</Citation></Reference><Reference><Citation>Ziaeian B, Fonarow G. Epidemiology and aetiology of heart failure.
<i>Nat Rev Cardiol.</i> (2016) 13:368&#x2013;78. 10.1038/nrcardio.2016.25

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2016.25</ArticleId><ArticleId IdType="pmc">PMC4868779</ArticleId><ArticleId IdType="pubmed">26935038</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. Artificial Intelligence in Precision Cardiovascular Medicine.
<i>J Am Coll Cardiol.</i> (2017) 69:2657&#x2013;64. 10.1016/j.jacc.2017.03.571

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.03.571</ArticleId><ArticleId IdType="pubmed">28545640</ArticleId></ArticleIdList></Reference><Reference><Citation>Segar M, Patel K, Ayers C, Basit M, Tang W, Willett D, et al. 
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
<i>Eur J Heart Fail.</i> (2020) 22:148&#x2013;58. 10.1002/ejhf.1621

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1621</ArticleId><ArticleId IdType="pubmed">31637815</ArticleId></ArticleIdList></Reference><Reference><Citation>Segar M, Patel K, Vaduganathan M, Caughey M, Jaeger B, Basit M, et al. 
Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
<i>Diabetologia.</i> (2021) 64:1583&#x2013;94. 10.1007/s00125-021-05426-2

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-021-05426-2</ArticleId><ArticleId IdType="pmc">PMC10535363</ArticleId><ArticleId IdType="pubmed">33715025</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee T, Ko Y, Kim H, Lee S, Kim B, Choi H, et al. 
Machine learning-based discrimination of cardiovascular outcomes in patients with hypertrophic cardiomyopathy.
<i>JACC Asia.</i> (2024) 4:375&#x2013;86. 10.1016/j.jacasi.2023.12.001

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacasi.2023.12.001</ArticleId><ArticleId IdType="pmc">PMC11099823</ArticleId><ArticleId IdType="pubmed">38765660</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto J, Davies R, Bhuva A, Knott K, Seraphim A, Alfarih M, et al. 
Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance.
<i>Lancet Digit Health.</i> (2021) 3:e20&#x2013;8. 10.1016/S2589-750030267-3
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-750030267-3</ArticleId><ArticleId IdType="pubmed">33735065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidik A, Komarov R, Gawusu S, Moomin A, Al-Ariki M, Elias M, et al. 
Application of artificial intelligence in cardiology: a bibliometric analysis.
<i>Cureus.</i> (2024) 16:e66925. 10.7759/cureus.66925

</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.66925</ArticleId><ArticleId IdType="pmc">PMC11401640</ArticleId><ArticleId IdType="pubmed">39280440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuang X, Zhong Z, Liang W, Huang S, Luo R, Luo H, et al. 
Bibliometric analysis of 100 top cited articles of heart failure-associated diseases in combination with machine learning.
<i>Front Cardiovasc Med.</i> (2023) 10:1158509. 10.3389/fcvm.2023.1158509

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1158509</ArticleId><ArticleId IdType="pmc">PMC10248156</ArticleId><ArticleId IdType="pubmed">37304963</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Arshad M, Greene S, Van Spall H, Pandey A, Vemulapalli S, et al. 
Artificial intelligence and heart failure: a state-of-the-art review.
<i>Eur J Heart Fail.</i> (2023) 25:1507&#x2013;25. 10.1002/ejhf.2994

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2994</ArticleId><ArticleId IdType="pubmed">37560778</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter J, Zadpoor A, Dodou D. The expansion of google scholar versus web of science: a longitudinal study.
<i>Scientometrics.</i> (2014) 98:1547&#x2013;65. 10.1007/s11192-013-1089-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-013-1089-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilkington A.
<i>Bibexcel-Quick Start Guide to Bibliometrics and Citation Analysis.</i>
World Scientific Publishing: London:  (2018).</Citation></Reference><Reference><Citation>van Eck N, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping.
<i>Scientometrics.</i> (2010) 84:523&#x2013;38. 10.1007/s11192-009-0146-3

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-009-0146-3</ArticleId><ArticleId IdType="pmc">PMC2883932</ArticleId><ArticleId IdType="pubmed">20585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin D, Li M, Xiang P. Mapping research performance and hotspots on nanoparticles in cardiovascular diseases.
<i>Medicine (Baltimore).</i> (2023) 102:e33520. 10.1097/MD.0000000000033520

</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000033520</ArticleId><ArticleId IdType="pmc">PMC10101270</ArticleId><ArticleId IdType="pubmed">37058013</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eck N, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer.
<i>Scientometrics.</i> (2017) 111:1053&#x2013;70. 10.1007/s11192-017-2300-7

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11192-017-2300-7</ArticleId><ArticleId IdType="pmc">PMC5400793</ArticleId><ArticleId IdType="pubmed">28490825</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Searching for intellectual turning points: progressive knowledge domain visualization.
<i>Proc Natl Acad Sci USA.</i> (2004) 101:5303&#x2013;10. 10.1073/pnas.0307513100

</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307513100</ArticleId><ArticleId IdType="pmc">PMC387312</ArticleId><ArticleId IdType="pubmed">14724295</ArticleId></ArticleIdList></Reference><Reference><Citation>Synnestvedt M, Chen C, Holmes J. CiteSpace II: visualization and knowledge discovery in bibliographic databases.
<i>AMIA Annu Symp Proc.</i> (2005) 2005:724&#x2013;8.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1560567</ArticleId><ArticleId IdType="pubmed">16779135</ArticleId></ArticleIdList></Reference><Reference><Citation>Posit Team.
<i>Rstudio: Integrated Development Environment for R. Posit Software.</i>
Boston, MA: PBC;  (2024).</Citation></Reference><Reference><Citation>Aria M, Cuccurullo C. Bibliometrix: an R-tool for comprehensive science mapping analysis.
<i>J Informetr.</i> (2017) 11:959&#x2013;75. 10.1016/j.joi.2017.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joi.2017.08.007</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team.
<i>RA Language and Environment for Statistical Computing.</i>
Vienna: R Foundation for Statistical Computing;  (2020).</Citation></Reference><Reference><Citation>Mondal H, Deepak K, Gupta M, Kumar R. The h-Index: understanding its predictors, significance, and criticism.
<i>J Fam Med Prim Care.</i> (2023) 12:2531&#x2013;7. 10.4103/jfmpc.jfmpc_1613_23

</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1613_23</ArticleId><ArticleId IdType="pmc">PMC10771139</ArticleId><ArticleId IdType="pubmed">38186773</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah F, Jawaid S. The h-index: an indicator of research and publication output.
<i>Pak J Med Sci.</i> (2023) 39:315&#x2013;6. 10.12669/pjms.39.2.7398

</Citation><ArticleIdList><ArticleId IdType="doi">10.12669/pjms.39.2.7398</ArticleId><ArticleId IdType="pmc">PMC10025721</ArticleId><ArticleId IdType="pubmed">36950422</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjareeka M. Evaluation of researchers: H-Index or G-Index which is better?
<i>J Integr Med Res.</i> (2023) 1:34&#x2013;6. 10.4103/jimr.jimr_11_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jimr.jimr_11_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Ndwandwe M, Bishop D, Wise R, Rodseth R. Bibliometrics to assess the productivity and impact of medical research.
<i>South Afr J High Educ.</i> (2021) 35:224&#x2013;36. 10.20853/35-4-4341

</Citation><ArticleIdList><ArticleId IdType="doi">10.20853/35-4-4341</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocumbi A. Cardiovascular health care in low- and middle-income countries.
<i>Circulation.</i> (2024) 149:557&#x2013;9. 10.1161/CIRCULATIONAHA.123.065717

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.123.065717</ArticleId><ArticleId IdType="pubmed">38377254</ArticleId></ArticleIdList></Reference><Reference><Citation>Fundikira L, Chillo P, Mutagaywa R, Kamuhabwa A, Kwesigabo G, Asselbergs F, et al. 
Risk factors and prevalence of dilated cardiomyopathy in sub-saharan africa: a systematic review.
<i>Glob Heart.</i> (2022) 17:76. 10.5334/gh.1166

</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.1166</ArticleId><ArticleId IdType="pmc">PMC9585983</ArticleId><ArticleId IdType="pubmed">36382153</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M, Padhiyar P, Parmar K, Patel J, Panesar S, Raja K. Recent challenges in medical science using machine learning techniques: a review.
<i>Proceedings of the 2023 7th International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC).</i>
Kirtipur: (2023). p. 516&#x2013;23.</Citation></Reference><Reference><Citation>Elias P, Jain S, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, et al. 
Artificial intelligence for cardiovascular care-part 1: advances: JACC review topic of the week.
<i>J Am Coll Cardiol.</i> (2024) 83:2472&#x2013;86. 10.1016/j.jacc.2024.03.400

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.03.400</ArticleId><ArticleId IdType="pubmed">38593946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Elias P, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, et al. 
Artificial intelligence in cardiovascular care-part 2: applications: JACC review topic of the week.
<i>J Am Coll Cardiol.</i> (2024) 83:2487&#x2013;96. 10.1016/j.jacc.2024.03.401

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.03.401</ArticleId><ArticleId IdType="pmc">PMC12215878</ArticleId><ArticleId IdType="pubmed">38593945</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Oikonomou E, Nadkarni G, Morley J, Wiens J, Butte A, et al. 
Transforming cardiovascular care with artificial intelligence: from discovery to practice: JACC state-of-the-art review.
<i>J Am Coll Cardiol.</i> (2024) 84:97&#x2013;114. 10.1016/j.jacc.2024.05.003

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.05.003</ArticleId><ArticleId IdType="pmc">PMC12204085</ArticleId><ArticleId IdType="pubmed">38925729</ArticleId></ArticleIdList></Reference><Reference><Citation>Strianese O, Rizzo F, Ciccarelli M, Galasso G, D&#x2019;Agostino Y, Salvati A, et al. 
Precision and personalized medicine: how genomic approach improves the management of cardiovascular and neurodegenerative disease.
<i>Genes (Basel).</i> (2020) 11:747. 10.3390/genes11070747

</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11070747</ArticleId><ArticleId IdType="pmc">PMC7397223</ArticleId><ArticleId IdType="pubmed">32640513</ArticleId></ArticleIdList></Reference><Reference><Citation>Peirlinck M, Costabal F, Yao J, Guccione J, Tripathy S, Wang Y, et al. 
Precision medicine in human heart modeling: perspectives, challenges, and opportunities.
<i>Biomech Model Mechanobiol.</i> (2021) 20:803&#x2013;31. 10.1007/s10237-021-01421-z

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10237-021-01421-z</ArticleId><ArticleId IdType="pmc">PMC8154814</ArticleId><ArticleId IdType="pubmed">33580313</ArticleId></ArticleIdList></Reference><Reference><Citation>Olawade D, Aderinto N, Olatunji G, Kokori E, David-Olawade A, Hadi M. Advancements and applications of artificial intelligence in cardiology: current trends and future prospects.
<i>J Med Surg Public Health.</i> (2024) 3:100109. 10.1016/j.glmedi.2024.100109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.glmedi.2024.100109</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza-Soltani S, Fakhare Alam L, Debellotte O, Monga T, Coyalkar V, Tarnate V, et al. 
The role of artificial intelligence and machine learning in cardiovascular imaging and diagnosis.
<i>Cureus.</i> (2024) 16:e68472. 10.7759/cureus.68472

</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.68472</ArticleId><ArticleId IdType="pmc">PMC11446464</ArticleId><ArticleId IdType="pubmed">39360044</ArticleId></ArticleIdList></Reference><Reference><Citation>Chidzwondo F, Mutapi F. Challenge of diagnosing acute infections in poor resource settings in Africa.
<i>AAS Open Res.</i> (2024) 4:28. 10.12688/aasopenres.13234.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/aasopenres.13234.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduoye M, Fatima E, Muzammil M, Dave T, Irfan H, Fariha F, et al. 
Impacts of the advancement in artificial intelligence on laboratory medicine in low- and middle-income countries: challenges and recommendations-A literature review.
<i>Health Sci Rep.</i> (2024) 7:e1794. 10.1002/hsr2.1794

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1794</ArticleId><ArticleId IdType="pmc">PMC10766873</ArticleId><ArticleId IdType="pubmed">38186931</ArticleId></ArticleIdList></Reference><Reference><Citation>Francisco K, Apuhin A, Tan M, Byers M, Maravilla N, Karim H, et al. 
Can personalized medicine coexist with health equity? Examining the cost barrier and ethical implications.
<i>arXiv</i> [Preprint]. (2024): 10.48550/arXiv.2411.02307
arXiv:241102307.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2411.02307</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav N, Pandey S, Gupta A, Dudani P, Gupta S, Rangarajan K. Data privacy in healthcare: in the era of artificial intelligence.
<i>Indian Dermatol Online J.</i> (2023) 14:788&#x2013;92. 10.4103/idoj.idoj_543_23

</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/idoj.idoj_543_23</ArticleId><ArticleId IdType="pmc">PMC10718098</ArticleId><ArticleId IdType="pubmed">38099022</ArticleId></ArticleIdList></Reference><Reference><Citation>Dychiao R, Nazer L, Mlombwa D, Celi L. Artificial intelligence and global health equity.
<i>BMJ.</i> (2024) 387:q2194. 10.1136/bmj.q2194

</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.q2194</ArticleId><ArticleId IdType="pubmed">39393825</ArticleId></ArticleIdList></Reference><Reference><Citation>Boppiniti S. Data ethics in AI: addressing challenges in machine learning and data governance for responsible data science.
<i>Int Sci J Res.</i> (2023) 5:1&#x2013;29.</Citation></Reference><Reference><Citation>Morita H, Noor K.
<i>Overcoming Challenges: Integrating AI/ML with Legacy Systems and Addressing Data Privacy Concerns.</i>
Stockport: EasyChair;  (2024).</Citation></Reference><Reference><Citation>Igwama G, Olaboye J, Cosmos C, Maha M, Abdul S. AI-powered predictive analytics in chronic disease management: regulatory and ethical considerations.
<i>Int J Eng Res Dev.</i> (2024) 20:152&#x2013;7.</Citation></Reference><Reference><Citation>Wang W, Jia H, Hua X, Song J. New insights gained from cellular landscape changes in myocarditis and inflammatory cardiomyopathy.
<i>Heart Fail Rev.</i> (2024) 29:883&#x2013;907. 10.1007/s10741-024-10406-w

</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-024-10406-w</ArticleId><ArticleId IdType="pubmed">38896377</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira G.
<i>Defining The Molecular Landscape of Reparative Cardiac Progenitor Cells by MS-Imaging and Advanced MS-Proteomics Approaches.</i>
Guildford: University of Surrey;  (2024).</Citation></Reference><Reference><Citation>Sapna F, Raveena F, Chandio M, Bai K, Sayyar M, Varrassi G, et al. 
Advancements in heart failure management: a comprehensive narrative review of emerging therapies.
<i>Cureus.</i> (2023) 15:e46486. 10.7759/cureus.46486

</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.46486</ArticleId><ArticleId IdType="pmc">PMC10623504</ArticleId><ArticleId IdType="pubmed">37927716</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhussein M. Use of real-time remote tele-mentored ultrasound echocardiography for cardiovascular disease diagnosis in adults: a systematic review.
<i>Ultrasound Med Biol.</i> (2024) 50:779&#x2013;87. 10.1016/j.ultrasmedbio.2024.01.073

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ultrasmedbio.2024.01.073</ArticleId><ArticleId IdType="pubmed">38448316</ArticleId></ArticleIdList></Reference><Reference><Citation>Camm N, Redzeppagc S, Raufi A, Banach M, Oterino A. Revolutionizing cardiac diagnosis: an AI algorithm for heart abnormality detection in medical imaging-a review of current and emerging techniques.
<i>J Clin Cardiol Cardiovasc Interv.</i> (2023) 6:2641. 10.31579/2641-0419/304</Citation><ArticleIdList><ArticleId IdType="doi">10.31579/2641-0419/304</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Worafi Y. Radiology and medical imaging research in developing countries. In: Al-Worafi YM.
editor.
<i>Handbook of Medical and Health Sciences in Developing Countries: Education, Practice, and Research.</i>
Cham: Springer;  (2024). p. 1&#x2013;29.</Citation></Reference><Reference><Citation>Deo R. Machine learning in medicine.
<i>Circulation.</i> (2015) 132:1920&#x2013;30. 10.1161/CIRCULATIONAHA.115.001593

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.001593</ArticleId><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Z, Noseworthy P, Lopez-Jimenez F, Asirvatham S, Deshmukh A, Gersh B, et al. 
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction.
<i>Lancet.</i> (2019) 394:861&#x2013;7. 10.1016/S0140-673631721-0
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-673631721-0</ArticleId><ArticleId IdType="pubmed">31378392</ArticleId></ArticleIdList></Reference><Reference><Citation>Doolub G, Mamalakis M, Alabed S, Van der Geest R, Swift A, Rodrigues J, et al. 
Artificial intelligence as a diagnostic tool in non-invasive imaging in the assessment of coronary artery disease.
<i>Med Sci (Basel).</i> (2023) 11:20. 10.3390/medsci11010020

</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci11010020</ArticleId><ArticleId IdType="pmc">PMC10053913</ArticleId><ArticleId IdType="pubmed">36976528</ArticleId></ArticleIdList></Reference><Reference><Citation>Gala D, Behl H, Shah M, Makaryus A. The role of artificial intelligence in improving patient outcomes and future of healthcare delivery in cardiology: a narrative review of the literature.
<i>Healthcare (Basel).</i> (2024) 12:481. 10.3390/healthcare12040481

</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare12040481</ArticleId><ArticleId IdType="pmc">PMC10887513</ArticleId><ArticleId IdType="pubmed">38391856</ArticleId></ArticleIdList></Reference><Reference><Citation>Cau R, Pisu F, Porcu M, Cademartiri F, Montisci R, Bassareo P, et al. 
Machine learning approach in diagnosing Takotsubo cardiomyopathy: the role of the combined evaluation of atrial and ventricular strain, and parametric mapping.
<i>Int J Cardiol.</i> (2023) 373:124&#x2013;33. 10.1016/j.ijcard.2022.11.021

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2022.11.021</ArticleId><ArticleId IdType="pubmed">36410545</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma T. Building successful international cardiovascular nursing research in heart failure care.
<i>Am Heart Assoc.</i> (2013) 128:A608. 10.1161/circ.128.suppl_22.A608</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circ.128.suppl_22.A608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismail T. Understanding heart failure and cardiomyopathy in Africa: insights from cardiovascular magnetic resonance.
<i>Int J Cardiol.</i> (2024) 402:131847. 10.1016/j.ijcard.2024.131847

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2024.131847</ArticleId><ArticleId IdType="pubmed">38354982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, Anker S, AlHabib K, Cowie M, Force T, Hu S, et al. 
Heart failure: preventing disease and death worldwide.
<i>ESC Heart Fail.</i> (2014) 1:4&#x2013;25. 10.1002/ehf2.12005

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12005</ArticleId><ArticleId IdType="pubmed">28834669</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasiruddin M, Dutta S, Sikder R, Islam M, Mukaddim A, Hider M. Predicting heart failure survival with machine learning: assessing my risk.
<i>J Comput Sci Technol Stud.</i> (2024) 6:32996. 10.32996/jcsts.2024.6.3.5</Citation><ArticleIdList><ArticleId IdType="doi">10.32996/jcsts.2024.6.3.5</ArticleId></ArticleIdList></Reference><Reference><Citation>Abd-Elkawy E, Ahmed R. Clinical applications of machine learning in the diagnosis, classification and prediction of heart failure.
<i>J Electr Syst.</i> (2024) 20:2160&#x2013;70. 10.52783/jes.1815</Citation><ArticleIdList><ArticleId IdType="doi">10.52783/jes.1815</ArticleId></ArticleIdList></Reference><Reference><Citation>Smole T, &#x17d;unkovi&#x10d; B, Pi&#x10d;ulin M, Kokalj E, Robnik-&#x160;ikonja M, Kukar M, et al. 
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy.
<i>Comput Biol Med.</i> (2021) 135:104648. 10.1016/j.compbiomed.2021.104648

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.104648</ArticleId><ArticleId IdType="pubmed">34280775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan Y, Nazar S, Krishnan R, Dinakarkumar Y, Varadarajan V, Sebastian L, et al. 
Understanding integrative approach of translational bioinformatics on cardiovascular disease: myocardial ischemia.
<i>Egypt J Med Hum Genet.</i> (2024) 25:153. 10.1186/s43042-024-00622-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43042-024-00622-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunjobi T, Ohaeri P, Akintola O, Atanda D, Orji F, Adebayo J, et al. 
Bioinformatics applications in chronic diseases: a comprehensive review of genomic, transcriptomics, proteomic, metabolomics, and machine learning approaches.
<i>Medinformatics.</i> (2024) 1:1&#x2013;18. 10.47852/bonviewmedin42022335</Citation><ArticleIdList><ArticleId IdType="doi">10.47852/bonviewmedin42022335</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong H, Zheng Z, Zhao C, Zhao M, Wang Q, Zhang P, et al. 
Insight into the underlying molecular mechanism of dilated cardiomyopathy through integrative analysis of data mining, iTRAQ-PRM proteomics and bioinformatics.
<i>Proteome Sci.</i> (2023) 21:13. 10.1186/s12953-023-00214-9

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12953-023-00214-9</ArticleId><ArticleId IdType="pmc">PMC10517512</ArticleId><ArticleId IdType="pubmed">37740197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Xiang T, Wang Y, Shu T, Yin C, Li H, et al. 
Explainable machine learning for predicting 30-day readmission in acute heart failure patients.
<i>iScience.</i> (2024) 27:110281. 10.1016/j.isci.2024.110281

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2024.110281</ArticleId><ArticleId IdType="pmc">PMC11261142</ArticleId><ArticleId IdType="pubmed">39040074</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi E, Schuetz A, Stewart W, Sun J. Using recurrent neural network models for early detection of heart failure onset.
<i>J Am Med Inform Assoc.</i> (2016) 24:361&#x2013;70. 10.1093/jamia/ocw112

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocw112</ArticleId><ArticleId IdType="pmc">PMC5391725</ArticleId><ArticleId IdType="pubmed">27521897</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun A, Rajpurkar P, Haghpanahi M, Tison G, Bourn C, Turakhia M, et al. 
Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network.
<i>Nat Med.</i> (2019) 25:65&#x2013;9. 10.1038/s41591-018-0268-3

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0268-3</ArticleId><ArticleId IdType="pmc">PMC6784839</ArticleId><ArticleId IdType="pubmed">30617320</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin F, Shah S, Naeem A, Shujauddin S, Jabeen A, Kazmi S, et al. 
Artificial intelligence in the diagnosis and detection of heart failure: the past, present, and future.
<i>Rev Cardiovasc Med.</i> (2021) 22:1095&#x2013;113. 10.31083/j.rcm2204121

</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2204121</ArticleId><ArticleId IdType="pubmed">34957756</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia I, Tseng A, Benavente, Medina-Inojosa J, Clark T, Malyutina S, et al. 
External validation of a deep learning electrocardiogram algorithm to detect ventricular dysfunction.
<i>Int J Cardiol.</i> (2021) 329:130&#x2013;5. 10.1016/j.ijcard.2020.12.065

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.12.065</ArticleId><ArticleId IdType="pmc">PMC7955278</ArticleId><ArticleId IdType="pubmed">33400971</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Son Y. Machine learning-based 30-day readmission prediction models for patients with heart failure: a systematic review.
<i>Eur J Cardiovasc Nurs.</i> (2024) 23:711&#x2013;9. 10.1093/eurjcn/zvae031

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjcn/zvae031</ArticleId><ArticleId IdType="pubmed">38421187</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu J, Yao Y, Wang X. Development and validation of a machine learning model for online predicting the risk of in heart failure: based on the routine blood test and their derived parameters.
<i>Front Cardiovasc Med.</i> (2025) 12:1539966. 10.3389/fcvm.2025.1539966

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2025.1539966</ArticleId><ArticleId IdType="pmc">PMC11955618</ArticleId><ArticleId IdType="pubmed">40166596</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo D, Carter R, Attia Z, Johnson P, Kashou A, Dugan J, et al. 
Artificial intelligence-enabled ECG algorithm to identify patients with left ventricular systolic dysfunction presenting to the emergency department with dyspnea.
<i>Circ Arrhythm Electrophysiol.</i> (2020) 13:e008437. 10.1161/CIRCEP.120.008437

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.120.008437</ArticleId><ArticleId IdType="pubmed">32986471</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmstrom L, Bednarski B, Chugh H, Aziz H, Pham H, Sargsyan A, et al. 
Artificial intelligence model predicts sudden cardiac arrest manifesting with pulseless electric activity versus ventricular fibrillation.
<i>Circ Arrhythm Electrophysiol.</i> (2024) 17:e012338. 10.1161/CIRCEP.123.012338

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.123.012338</ArticleId><ArticleId IdType="pmc">PMC10876166</ArticleId><ArticleId IdType="pubmed">38284289</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Huang G, Wu L, Wang M, He X, Wang J, et al. 
Deep learning assessment of left ventricular hypertrophy based on electrocardiogram.
<i>Front Cardiovasc Med.</i> (2022) 9:952089. 10.3389/fcvm.2022.952089

</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.952089</ArticleId><ArticleId IdType="pmc">PMC9406285</ArticleId><ArticleId IdType="pubmed">36035939</ArticleId></ArticleIdList></Reference><Reference><Citation>Akerman A, Al-Roub N, Angell-James C, Cassidy M, Thompson R, Bosque L, et al. 
External validation of artificial intelligence for detection of heart failure with preserved ejection fraction.
<i>Nat Commun.</i> (2025) 16:3662. 10.1038/s41467-025-59097-3

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-025-59097-3</ArticleId><ArticleId IdType="pmc">PMC12006409</ArticleId><ArticleId IdType="pubmed">40246975</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40809637</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence in Hypertrophic Cardiomyopathy: Advances, Challenges, and Future Directions for Personalized Risk Prediction and Management.</ArticleTitle><Pagination><StartPage>e87907</StartPage><MedlinePgn>e87907</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87907</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87907</ELocationID><Abstract><AbstractText>Hypertrophic cardiomyopathy (HCM) is a complex genetic cardiovascular disease,&#xa0;with current risk stratification strategies showing limited accuracy in predicting sudden cardiac death and clinical outcomes. This review examines how artificial intelligence (AI) is transforming personalized risk prediction and management in HCM, with particular focus on validated clinical applications. We conducted a comprehensive literature search across PubMed, IEEE Xplore, Web of Science, and Scopus databases from January 2015 to January 2025. Search terms included "artificial intelligence", "machine learning", "deep learning", "hypertrophic cardiomyopathy", and "risk prediction". Inclusion criteria comprised peer-reviewed studies reporting AI applications in HCM with validated performance metrics. We excluded case reports, editorials, and studies without clinical validation. Of 487 identified articles, 84 met inclusion criteria and were analyzed for AI techniques, clinical applications, performance metrics, and implementation challenges. Machine learning algorithms have achieved significant breakthroughs in HCM care. Random forest models identifying ventricular arrhythmias demonstrated 83% accuracy (area under the curve (AUC): 0.83), discovering 12 novel predictors, including left atrial volume index. Deep learning ECG analysis using convolutional neural networks achieved 85-87% accuracy in sudden cardiac death prediction, substantially outperforming traditional risk scores (AUC: 0.87 vs. 0.62). AI-enhanced genetic testing has shown 96% accuracy in reclassifying variants of uncertain significance, while automated cardiac MRI analysis provides objective disease progression monitoring with reduced inter-observer variability. Real-time applications include automated ECG screening tools currently in pilot programs at major cardiac centers, and decision support systems for therapy selection showing &gt;90% accuracy in predicting response to cardiac resynchronization therapy. Multi-center collaborations such as the SHaRe Registry are developing standardized AI models across institutions. Implementation faces specific barriers, including data bias from underrepresented populations, lack of standardized electronic health record formats across centers, regulatory approval pathways for AI-based clinical tools, and "black box" interpretability issues requiring explainable AI solutions. Integration requires addressing these challenges through prospective validation studies, development of regulatory frameworks, and clinician training programs. AI demonstrates transformative potential in HCM management, but realizing clinical benefits requires addressing technical, ethical, and implementation challenges through coordinated multidisciplinary efforts.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Mohyeldin et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohyeldin</LastName><ForeName>Moiud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiology, University of Medical Sciences and Technology (UMST), Khartoum, SDN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Feras O</ForeName><Initials>FO</Initials><AffiliationInfo><Affiliation>Diagnostic and Interventional Radiology, Texas Medical Center Memorial Hermann Hospital, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Towfig</LastName><ForeName>Muhanned Faisal</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Geriatrics, Montefiore Medical Center, Wakefield Campus, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Ahmed M G</ForeName><Initials>AMG</Initials><AffiliationInfo><Affiliation>Cardiology, Salaam Clinic, Cleveland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology, Mercy University Hospital, Cork, IRL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhussein</LastName><ForeName>Ahmed H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Internal Medicine, The National Ribat University, Khartoum, SDN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamin</LastName><ForeName>Faris</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Medical Sciences and Technology (UMST), Khartoum, SDN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaja</LastName><ForeName>Misbahuddin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadhav</LastName><ForeName>Preeti</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ai and machine learning</Keyword><Keyword MajorTopicYN="N">artificial intelligence (ai)</Keyword><Keyword MajorTopicYN="N">convolutional neural networks</Keyword><Keyword MajorTopicYN="N">deep learning artificial intelligence</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">hypertrophic obstructive cardiomyopathy (hocm)</Keyword><Keyword MajorTopicYN="N">natural language processing models</Keyword><Keyword MajorTopicYN="N">personalized management</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40809637</ArticleId><ArticleId IdType="pmc">PMC12348218</ArticleId><ArticleId IdType="doi">10.7759/cureus.87907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hypertrophic cardiomyopathy. Maron BJ, Maron MS. Lancet. 2013;381:242&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874472</ArticleId></ArticleIdList></Reference><Reference><Citation>New perspectives on the prevalence of hypertrophic cardiomyopathy. Semsarian C, Ingles J, Maron MS, Maron BJ. J Am Coll Cardiol. 2015;65:1249&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. Maron BJ, Rowin EJ, Casey SA, et al. J Am Coll Cardiol. 2015;65:1915&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pubmed">25953744</ArticleId></ArticleIdList></Reference><Reference><Citation>How to image hypertrophic cardiomyopathy. Maron MS, Rowin EJ, Maron BJ. Circ Cardiovasc Imaging. 2017;10</Citation><ArticleIdList><ArticleId IdType="pubmed">28701526</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Circ Heart Fail. 2012;5:535&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">22811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) Ho CY, Day SM, Ashley EA, et al. Circulation. 2018;138:1387&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170149</ArticleId><ArticleId IdType="pubmed">30297972</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) O'Mahony C, Jichi F, Pavlou M, et al. Eur Heart J. 2014;35:2010&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126876</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in precision&#xa0;cardiovascular medicine. Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. J Am Coll Cardiol. 2017;69:2657&#x2013;2664.</Citation><ArticleIdList><ArticleId IdType="pubmed">28545640</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifying ventricular arrhythmias and their predictors by applying machine learning methods to electronic health records in patients with hypertrophic cardiomyopathy (HCM-VAR-risk model) Bhattacharya M, Lu DY, Kudchadkar SM, et al. Am J Cardiol. 2019;123:1681&#x2013;1689.</Citation><ArticleIdList><ArticleId IdType="pubmed">30952382</ArticleId></ArticleIdList></Reference><Reference><Citation>Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers. Lyon A, Ariga R, Minchol&#xe9; A, et al. Front Physiol. 2018;9:213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859357</ArticleId><ArticleId IdType="pubmed">29593570</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiology. Johnson KW, Torres Soto J, Glicksberg BS, et al. J Am Coll Cardiol. 2018;71:2668&#x2013;2679.</Citation><ArticleIdList><ArticleId IdType="pubmed">29880128</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in cardiovascular medicine: are we there yet? Shameer K, Johnson KW, Glicksberg BS, Dudley JT, Sengupta PP. Heart. 2018;104:1156&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType="pubmed">29352006</ArticleId></ArticleIdList></Reference><Reference><Citation>A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy. Smole T, &#x17d;unkovi&#x10d; B, Pi&#x10d;ulin M, et al. Comput Biol Med. 2021;135:104648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34280775</ArticleId></ArticleIdList></Reference><Reference><Citation>Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction. Aro AL, Reinier K, Phan D, et al. Europace. 2017;19:1146&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075451</ArticleId><ArticleId IdType="pubmed">27256423</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center. Mazzarotto F, Girolami F, Boschi B, et al. Genet Med. 2019;21:284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752309</ArticleId><ArticleId IdType="pubmed">29875424</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Cikes M, Sanchez-Martinez S, Claggett B, et al. Eur J Heart Fail. 2019;21:74&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">30328654</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of hypertrophic&#xa0;cardiomyopathy. Maron BJ, Rowin EJ, Maron MS. JACC Heart Fail. 2018;6:376&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">29724362</ArticleId></ArticleIdList></Reference><Reference><Citation>Implementing machine learning in health care - addressing ethical challenges. Char DS, Shah NH, Magnus D. N Engl J Med. 2018;378:981&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962261</ArticleId><ArticleId IdType="pubmed">29539284</ArticleId></ArticleIdList></Reference><Reference><Citation>High-performance medicine: the convergence of human and artificial intelligence. Topol EJ. Nat Med. 2019;25:44&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617339</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in medicine. Deo RC. Circulation. 2015;132:1920&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel approach to predict sudden cardiac death (SCD) using nonlinear and time-frequency analyses from HRV signals. Ebrahimzadeh E, Pooyan M, Bijar A. PLoS One. 2014;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913584</ArticleId><ArticleId IdType="pubmed">24504331</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. Kochav SM, Raita Y, Fifer MA, et al. Int J Cardiol. 2021;327:117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">33181159</ArticleId></ArticleIdList></Reference><Reference><Citation>Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. Neubauer S, Kolm P, Ho CY, et al. J Am Coll Cardiol. 2019;74:2333&#x2013;2345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6905038</ArticleId><ArticleId IdType="pubmed">31699273</ArticleId></ArticleIdList></Reference><Reference><Citation>Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Mayo Clin Proc. 2014;89:727&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234122</ArticleId><ArticleId IdType="pubmed">24793961</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning. LeCun Y, Bengio Y, Hinton G. Nature. 2015;521:436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting survival from large echocardiography and electronic health record datasets: optimization with machine learning. Samad MD, Ulloa A, Wehner GJ, et al. JACC Cardiovasc Imaging. 2019;12:681&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286869</ArticleId><ArticleId IdType="pubmed">29909114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy. Zhang J, Gajjala S, Agrawal P, et al. Circulation. 2018;138:1623&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6200386</ArticleId><ArticleId IdType="pubmed">30354459</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning techniques for automatic MRI cardiac multi-structures segmentation and diagnosis: is the problem solved? Bernard O, Lalande A, Zotti C, et al. IEEE Trans Med Imaging. 2018;37:2514&#x2013;2525.</Citation><ArticleIdList><ArticleId IdType="pubmed">29994302</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in cardiovascular magnetic resonance: basic concepts and applications. Leiner T, Rueckert D, Suinesiaputra A, Bae&#xdf;ler B, Nezafat R, I&#x161;gum I, Young AA. J Cardiovasc Magn Reson. 2019;21:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778980</ArticleId><ArticleId IdType="pubmed">31590664</ArticleId></ArticleIdList></Reference><Reference><Citation>Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances. Lyon A, Minchol&#xe9; A, Mart&#xed;nez JP, Laguna P, Rodriguez B. J R Soc Interface. 2018;15:20170821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805987</ArticleId><ArticleId IdType="pubmed">29321268</ArticleId></ArticleIdList></Reference><Reference><Citation>Utilizing ECG-based heartbeat classification for hypertrophic cardiomyopathy identification. Rahman QA, Tereshchenko LG, Kongkatong M, Abraham T, Abraham MR, Shatkay H. IEEE Trans Nanobioscience. 2015;14:505&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658666</ArticleId><ArticleId IdType="pubmed">25915962</ArticleId></ArticleIdList></Reference><Reference><Citation>Natural language processing: an introduction. Nadkarni PM, Ohno-Machado L, Chapman WW. J Am Med Inform Assoc. 2011;18:544&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168328</ArticleId><ArticleId IdType="pubmed">21846786</ArticleId></ArticleIdList></Reference><Reference><Citation>Natural language processing of clinical notes on chronic diseases: systematic review. Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. JMIR Med Inform. 2019;7:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6528438</ArticleId><ArticleId IdType="pubmed">31066697</ArticleId></ArticleIdList></Reference><Reference><Citation>Questions for artificial intelligence in health care. Maddox TM, Rumsfeld JS, Payne PR. JAMA. 2019;321:31&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30535130</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximising the impact of patient reported outcome assessment for patients and society. Calvert M, Kyte D, Price G, Valderas JM, Hjollund NH. BMJ. 2019;364:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">30679170</ArticleId></ArticleIdList></Reference><Reference><Citation>Social media use in healthcare: a systematic review of effects on patients and on their relationship with healthcare professionals. Smailhodzic E, Hooijsma W, Boonstra A, Langley DJ. BMC Health Serv Res. 2016;16:442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5000484</ArticleId><ArticleId IdType="pubmed">27562728</ArticleId></ArticleIdList></Reference><Reference><Citation>Correlation between liver volume and liver weight in a cohort with chronic liver disease: a semiautomated CT-volumetry study. Hagen F, Mair A, B&#xf6;sm&#xfc;ller H, Horger M. Quant Imaging Med Surg. 2022;12:376&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666767</ArticleId><ArticleId IdType="pubmed">34993086</ArticleId></ArticleIdList></Reference><Reference><Citation>A multicenter, scan-rescan, human and machine learning CMR study to test generalizability and precision in imaging biomarker analysis. Bhuva AN, Bai W, Lau C, et al. Circ Cardiovasc Imaging. 2019;12:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31547689</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning for prediction of obstructive disease from fast myocardial perfusion SPECT: a multicenter study. Betancur J, Commandeur F, Motlagh M, et al. JACC Cardiovasc Imaging. 2018;11:1654&#x2013;1663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6135711</ArticleId><ArticleId IdType="pubmed">29550305</ArticleId></ArticleIdList></Reference><Reference><Citation>A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&amp;E tissue. Nirschl JJ, Janowczyk A, Peyster EG, Frank R, Margulies KB, Feldman MD, Madabhushi A. PLoS One. 2018;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882098</ArticleId><ArticleId IdType="pubmed">29614076</ArticleId></ArticleIdList></Reference><Reference><Citation>cMRI-BED: a novel informatics framework for cardiac MRI biomarker extraction and discovery applied to pediatric cardiomyopathy classification. Gopalakrishnan V, Menon PG, Madan S. Biomed Eng Online. 2015;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547147</ArticleId><ArticleId IdType="pubmed">26329721</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifying facial phenotypes of genetic disorders using deep learning. Gurovich Y, Hanani Y, Bar O, et al. Nat Med. 2019;25:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Poplin R, Varadarajan AV, Blumer K, et al. Nat Biomed Eng. 2018;2:158&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">31015713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study. Siontis KC, Wieczorek MA, Maanja M, et al. Eur Heart J Digit Health. 2024;5:416&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11284003</ArticleId><ArticleId IdType="pubmed">39081936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. https://pubmed.ncbi.nlm.nih.gov/24998133/ J Am Coll Cardiol. 2014;64:83&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">24998133</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. Heart Rhythm. Vol. 15. Heart Rhythm: 2018. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society; pp. 0&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097320</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence-enabled ECG algorithm to identify patients with left ventricular systolic dysfunction presenting to the emergency department with dyspnea. Adedinsewo D, Carter RE, Attia Z, et al. Circ Arrhythm Electrophysiol. 2020;13:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32986471</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in ventricular arrhythmias and sudden death. Holmstr&#xf6;m L, Zhang FZ, Ouyang D, Dey D, Slomka PJ, Chugh SS. Arrhythm Electrophysiol Rev. 2023;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10345967</ArticleId><ArticleId IdType="pubmed">37457439</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Norrish G, Topriceanu C, Qu C, et al. Eur J Prev Cardiol. 2022;29:645&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967480</ArticleId><ArticleId IdType="pubmed">33772274</ArticleId></ArticleIdList></Reference><Reference><Citation>Current and future use of artificial intelligence in electrocardiography. Mart&#xed;nez-Sell&#xe9;s M, Marina-Breysse M. J Cardiovasc Dev Dis. 2023;10:175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145690</ArticleId><ArticleId IdType="pubmed">37103054</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetic advances in sarcomeric cardiomyopathies: state of the art. Ho CY, Charron P, Richard P, Girolami F, Van Spaendonck-Zwarts KY, Pinto Y. Cardiovasc Res. 2015;105:397&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349164</ArticleId><ArticleId IdType="pubmed">25634555</ArticleId></ArticleIdList></Reference><Reference><Citation>The outcomes of coronary artery bypass surgery after 18 months&#x2014;is there an influence of the initial right ventricle diastolic dysfunction? Sumin AN, Shcheglova AV, Korok EV, Sergeeva TJ. J Cardiovasc Dev Dis. 2023;10:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9866549</ArticleId><ArticleId IdType="pubmed">36661913</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecular diagnosis of hypertrophic cardiomyopathy (HCM): in the heart of cardiac disease. Melas M, Beltsios ET, Adamou A, Koumarelas K, McBride KL. J Clin Med. 2023;12:225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9821215</ArticleId><ArticleId IdType="pubmed">36615026</ArticleId></ArticleIdList></Reference><Reference><Citation>2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC) Elliott PM, Anastasakis A, Borger MA, et al. Eur Heart J. 2014;35:2733&#x2013;2779.</Citation><ArticleIdList><ArticleId IdType="pubmed">25173338</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning for predicting heart failure progression in hypertrophic cardiomyopathy. Fahmy AS, Rowin EJ, Manning WJ, Maron MS, Nezafat R. Front Cardiovasc Med. 2021;8:647857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155292</ArticleId><ArticleId IdType="pubmed">34055932</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical trials in hypertrophic cardiomyopathy therapy: a comprehensive analysis of trials registered in global clinical databases. Zhang H, Yu C, Cheng Y, et al. Drug Des Devel Ther. 2023;17:1863&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10291003</ArticleId><ArticleId IdType="pubmed">37377648</ArticleId></ArticleIdList></Reference><Reference><Citation>Advances in multi-modality imaging in hypertrophic cardiomyopathy. Goldie FC, Lee MM, Coats CJ, Nordin S. J Clin Med. 2024;13:842&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10856479</ArticleId><ArticleId IdType="pubmed">38337535</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiac MRI: is clinical adoption forthcoming? Fotaki A, Puyol-Ant&#xf3;n E, Chiribiri A, Botnar R, Pushparajah K, Prieto C. Front Cardiovasc Med. 2021;8:818765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785419</ArticleId><ArticleId IdType="pubmed">35083303</ArticleId></ArticleIdList></Reference><Reference><Citation>Disease progression of hypertrophic cardiomyopathy: modeling using machine learning. Pi&#x10d;ulin M, Smole T, &#x17d;unkovi&#x10d; B, et al. JMIR Med Inform. 2022;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8851344</ArticleId><ArticleId IdType="pubmed">35107432</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiovascular medicine: an updated review of the literature. Zargarzadeh A, Javanshir E, Ghaffari A, Mosharkesh E, Anari B. J Cardiovasc Thorac Res. 2023;15:204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10862032</ArticleId><ArticleId IdType="pubmed">38357567</ArticleId></ArticleIdList></Reference><Reference><Citation>Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy. Hiemstra YL, Debonnaire P, Bootsma M, et al. Circ Cardiovasc Imaging. 2017;10</Citation><ArticleIdList><ArticleId IdType="pubmed">28679523</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of outcomes in patients with nonobstructive, labile-obstructive, and chronically obstructive hypertrophic cardiomyopathy. Pozios I, Corona-Villalobos C, Sorensen LL, et al. Am J Cardiol. 2015;116:938&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554842</ArticleId><ArticleId IdType="pubmed">26239580</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring. Bleszynski PA, Goldenberg I, Fernandez G, et al. Heart Rhythm. 2021;18:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">32853778</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced American College of Cardiology/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. Maron MS, Rowin EJ, Wessler BS, et al. JAMA Cardiol. 2019;4:644&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537832</ArticleId><ArticleId IdType="pubmed">31116360</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) Hershberger RE, Givertz MM, Ho CY, et al.  https://pubmed.ncbi.nlm.nih.gov/29904160/ Genet Med. 2018;20:899&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">29904160</ArticleId></ArticleIdList></Reference><Reference><Citation>Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Rudin C. Nat Mach Intell. 2019;1:206&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9122117</ArticleId><ArticleId IdType="pubmed">35603010</ArticleId></ArticleIdList></Reference><Reference><Citation>A survey on explainable artificial intelligence (XAI): toward medical XAI. Tjoa E, Guan C. IEEE Trans Neural Netw Learn Syst. 2021;32:4793&#x2013;4813.</Citation><ArticleIdList><ArticleId IdType="pubmed">33079674</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in medicine: addressing ethical challenges. Vayena E, Blasimme A, Cohen IG. PLoS Med. 2018;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6219763</ArticleId><ArticleId IdType="pubmed">30399149</ArticleId></ArticleIdList></Reference><Reference><Citation>The legal and ethical concerns that arise from using complex predictive analytics in health care. Cohen IG, Amarasingham R, Shah A, Xie B, Lo B. Health Aff (Millwood) 2014;33:1139&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensuring fairness in machine learning to advance health equity. Rajkomar A, Hardt M, Howell MD, Corrado G, Chin MH. Ann Intern Med. 2018;169:866&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6594166</ArticleId><ArticleId IdType="pubmed">30508424</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical decision support in the era of artificial intelligence. Shortliffe EH, Sep&#xfa;lveda MJ. JAMA. 2018;320:2199&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398550</ArticleId></ArticleIdList></Reference><Reference><Citation>Phenomapping for novel classification of heart failure with preserved ejection fraction. Shah SJ, Katz DH, Selvaraj S, et al. Circulation. 2015;131:269&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302027</ArticleId><ArticleId IdType="pubmed">25398313</ArticleId></ArticleIdList></Reference><Reference><Citation>Key challenges for delivering clinical impact with artificial intelligence. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. BMC Med. 2019;17:195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821018</ArticleId><ArticleId IdType="pubmed">31665002</ArticleId></ArticleIdList></Reference><Reference><Citation>2017 roadmap for innovation&#x2014;ACC health policy statement on healthcare transformation in the era of digital health, big data, and precision health: a report of the American College of Cardiology task force on health policy statements and systems of care. Bhavnani SP, Parakh K, Atreja A, et al. J Am Coll Cardiol. 2017;70:2696&#x2013;2718.</Citation><ArticleIdList><ArticleId IdType="pubmed">29169478</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Hripcsak G, Duke JD, Shah NH, et al. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Hemingway H, Asselbergs FW, Danesh J, et al. Eur Heart J. 2018;39:1481&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019015</ArticleId><ArticleId IdType="pubmed">29370377</ArticleId></ArticleIdList></Reference><Reference><Citation>UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. Denaxas S, Gonzalez-Izquierdo A, Direk K, et al. J Am Med Inform Assoc. 2019;26:1545&#x2013;1559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857510</ArticleId><ArticleId IdType="pubmed">31329239</ArticleId></ArticleIdList></Reference><Reference><Citation>Integrative omics for health and disease. Karczewski KJ, Snyder MP. Nat Rev Genet. 2018;19:299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990367</ArticleId><ArticleId IdType="pubmed">29479082</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-omics approaches to disease. Hasin Y, Seldin M, Lusis A. Genome Biol. 2017;18:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418815</ArticleId><ArticleId IdType="pubmed">28476144</ArticleId></ArticleIdList></Reference><Reference><Citation>More is better: recent progress in multi-omics data integration methods. Huang S, Chaudhary K, Garmire LX. Front Genet. 2017;8:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472696</ArticleId><ArticleId IdType="pubmed">28670325</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning and integrative analysis of biomedical big data. Mirza B, Wang W, Wang J, Choi H, Chung NC, Ping P. Genes (Basel) 2019;10:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410075</ArticleId><ArticleId IdType="pubmed">30696086</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in healthcare: past, present and future. Jiang F, Jiang Y, Zhi H, et al. Stroke Vasc Neurol. 2017;2:230&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829945</ArticleId><ArticleId IdType="pubmed">29507784</ArticleId></ArticleIdList></Reference><Reference><Citation>An overview of clinical decision support systems: benefits, risks, and strategies for success. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. NPJ Digit Med. 2020;3:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Health care robotics: qualitative exploration of key challenges and future directions. Cresswell K, Cunningham-Burley S, Sheikh A. J Med Internet Res. 2018;20:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053611</ArticleId><ArticleId IdType="pubmed">29973336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40418621</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-2412</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular Imaging</Title><ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Vendor differences in 2D-speckle tracking global longitudinal strain: an update on a 10-year standardization effort.</ArticleTitle><Pagination><StartPage>1360</StartPage><EndPage>1373</EndPage><MedlinePgn>1360-1373</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jeaf155</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To assess the inter-vendor differences in global longitudinal strain measurements and determine a potential improvement compared with the situation 10 years ago.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">372 echocardiographic exams were performed in 62 subjects (50 male, age 56 &#xb1; 17) with LV ejection fraction ranging from 30% to 68%, using ultrasound systems from six manufacturers: GE, Philips, Canon, Siemens, Fujifilm and Esaote. Each subject was scanned consecutively on all machines by the same assigned sonographer, with two image sets per subject to assess test-retest setting reproducibility. Average peak systolic global strain from the three apical views (GLSAV) was measured on three vendor-specific (Canon, Siemens, and Fujifilm) and six vendor-agnostic (GE, Philips, US2.AI, Caas Qardia, Medis, and Epsilon) software solutions (SWS). Endocardial and mid-/full-wall GLS were measured and compared with the mean GLS of contemporary semi-automated clinical software: GE, Philips, Canon, Fujifilm, and Caas Qardia. Endocardial and mid-/full-wall GLS measurements from contemporary semi-automated clinical software showed minimal inter-vendor differences, with an average maximum bias of 0.6% strain units. There was a remaining inter-vendor bias with and among some other vendors. The average minimal detectable change with contemporary semi-automated clinical software was 2.5 and 2.4 strain% for endocardial and mid-/full-wall GLS, resp. These values were higher for and among some other vendors. Test-retest variability of GLS measurements was good and similar to that of LV ejection fraction (6.6% vs. 6.5%, P &gt; 0.05), indicating consistent results across repeated scans.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this controlled study setting, GLS measurements from companies that provide contemporary semi-automated clinical software have become more consistent, compared with 10 years ago. Mid-/full-wall strain was now available in all but one software.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balinisteanu</LastName><ForeName>Anca</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0003-8502-6903</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duchenne</LastName><ForeName>J&#xfc;rgen</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0221-5753</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group Cardio and Organ Systems, UHasselt, Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Jessa Hospital, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puvrez</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wouters</LastName><ForeName>Laurine</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe9;zy</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Youssef</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minten</LastName><ForeName>Lennert</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekhuis</LastName><ForeName>Youri</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Life Sciences, UHasselt, Hasselt, Diepenbeek, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Langenhoven</LastName><ForeName>Leen</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papangelopoulou</LastName><ForeName>Konstantina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cieplucha</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattapan</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tostes</LastName><ForeName>Paulo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogaert</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7495-9183</Identifier><AffiliationInfo><Affiliation>Department of Radiology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinereanu</LastName><ForeName>Dragos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Surgery, University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>James D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badano</LastName><ForeName>Luigi P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Voigt</LastName><ForeName>Jens-Uwe</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T004420N</GrantID><Agency>Research Foundation Flanders</Agency><Country/></Grant><Grant><GrantID>12ZZN22N</GrantID><Agency>Research Foundation Flanders</Agency><Country/></Grant><Grant><GrantID>11PP524N</GrantID><Agency>Research Foundation Flanders</Agency><Country/></Grant><Grant><GrantID>1832922N</GrantID><Agency>Research Foundation Flanders</Agency><Country/></Grant><Grant><Agency>Egyptian Ministry of Research and Higher Education</Agency><Country/></Grant><Grant><GrantID>489708</GrantID><Agency>Belgian Fund for Cardiac Surgery</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA><NlmUniqueID>101573788</NlmUniqueID><ISSNLinking>2047-2404</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Heart J Cardiovasc Imaging. 2025 Jul 31;26(8):1374-1375. doi: 10.1093/ehjci/jeaf171.</RefSource><PMID Version="1">40581067</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094582" MajorTopicYN="N">Global Longitudinal Strain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inter-vendor</Keyword><Keyword MajorTopicYN="N">left ventricle</Keyword><Keyword MajorTopicYN="N">speckle-tracking echocardiography</Keyword><Keyword MajorTopicYN="N">standardization</Keyword><Keyword MajorTopicYN="N">strain</Keyword></KeywordList><CoiStatement>Conflict of interest: A report of the EACVI Task Force on Strain Standardization (chair: J.-U.V.), a collaboration of health professionals and Industry Partners: Nina Ajmone (University Leiden, NL); Gerard Aurigemma (University of Massachusetts, Worcester, USA); Luigi P. Badano (University Milano-Bicocca, IT); Anca Balinisteanu (KU Leuven, BE and University of Medicine and Pharmacy Carol Davila, Bucharest, RO); Victoria Delgado (Germans Trias i Pujol Hospital, Barcelona, ES); Erwan Donal (University Rennes, FR); J&#xfc;rgen Duchenne (KU Leuven, BE); Thor Edvardsen (University Oslo, NO); Alan Fraser (University Cardiff, UK); Marc Friedberg (University of Toronto, CA); Ruxandra Jurcut (Institute of Cardiovascular Diseases Prof. C.C. Iliescu, Bucharest, RO); Jaroslaw D. Kasprzak (Medical University of Lodz, PL); Theodore Kolias (University of Michigan, Ann Arbor, USA); Shelby Kutty (Johns Hopkins School of Medicine, Baltimore, USA); Tom Marwick (Baker Institute, Melbourne, AU); Luc Mertens (University of Toronto, CA); Denisa Muraru (University Milano-Bicocca, IT); James D. Thomas (Northwestern University, Chicago, US); Jens-Uwe Voigt (KU Leuven, BE); Wim Gorissen (Canon); Carla Witkam (Canon); Megan McAuliffe (Epsilon Imaging); James Graham (Epsilon Imaging); Marco Maglione (Esaote); Stefano Pedri (Esaote); Tomoaki Chono (FUJIFILM); Saki Ochiai (FUJIFILM); Gunnar Hanssen (GE Vingmed Ultrasound); Hani Nozari Mirar (GE Vingmed Ultrasound); Sten Roar Snare (GE Vingmed Ultrasound); Marieke Vermeulen (Medis Imaging); Verena Roediger (Philips); Marcus Schreckenberg (Philips); Jane Vogel (Philips); Jean-Paul Aben (Pie Medical Imaging); Maarten Heusinkveld (Pie Medical Imaging); Myra Cocker (Siemens Healthineers); Gunilla Fritzon (Siemens Healthineers); Marti McCulloch (Siemens Healthineers); Michael Snyder (Siemens Healthineers); Jose Rivero (US2.AI); Yoran Hummel (US2.AI). Aleksandra Cieplucha is currently affiliated with the University of Medicine and Pharmacy, Poznan, Poland. Irene Catapan is currently affiliated with the University of Medicine and Pharmacy, Padua, Italy.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40418621</ArticleId><ArticleId IdType="doi">10.1093/ehjci/jeaf155</ArticleId><ArticleId IdType="pii">8149265</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40426849</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>Hearts, Data, and Artificial Intelligence Wizardry: From Imitation to Innovation in Cardiovascular Care.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1019</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines13051019</ELocationID><Abstract><AbstractText>Artificial intelligence (AI) is transforming cardiovascular medicine by enabling the analysis of high-dimensional biomedical data with unprecedented precision. Initially employed to automate human tasks such as electrocardiogram (ECG) interpretation and imaging segmentation, AI's true potential lies in uncovering hidden disease data patterns, predicting long-term cardiovascular risk, and personalizing treatments. Unlike human cognition, which excels in certain tasks but is limited by memory and processing constraints, AI integrates multimodal data sources-including ECG, echocardiography, cardiac magnetic resonance (CMR) imaging, genomics, and wearable sensor data-to generate novel clinical insights. AI models have demonstrated remarkable success in early dis-ease detection, such as predicting heart failure from standard ECGs before symptom on-set, distinguishing genetic cardiomyopathies, and forecasting arrhythmic events. However, several challenges persist, including AI's lack of contextual understanding in most of these tasks, its "black-box" nature, and biases in training datasets that may contribute to disparities in healthcare delivery. Ethical considerations and regulatory frameworks are evolving, with governing bodies establishing guidelines for AI-driven medical applications. To fully harness the potential of AI, interdisciplinary collaboration among clinicians, data scientists, and engineers is essential, alongside open science initiatives to promote data accessibility and reproducibility. Future AI models must go beyond task automation, focusing instead on augmenting human expertise to enable proactive, precision-driven cardiovascular care. By embracing AI's computational strengths while addressing its limitations, cardiology is poised to enter an era of transformative innovation beyond traditional diagnostic and therapeutic paradigms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pantelidis</LastName><ForeName>Panteleimon</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-5394-832X</Identifier><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer and Systems Sciences, Stockholm University, 16455 Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dilaveris</LastName><ForeName>Polychronis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0399-4111</Identifier><AffiliationInfo><Affiliation>1st Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruip&#xe9;rez-Campillo</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5425-4175</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, ETH Zurich, 8092 Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA 94305, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goliopoulou</LastName><ForeName>Athina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giannakodimos</LastName><ForeName>Alexios</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0570-8510</Identifier><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theofilis</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9260-6306</Identifier><AffiliationInfo><Affiliation>1st Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Lucia</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-8222-3977</Identifier><AffiliationInfo><Affiliation>2nd Division of Cardiology, Cardiac Thoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, 56124 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsarou</LastName><ForeName>Ourania</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zisimos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalogeras</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2036-6192</Identifier><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siasos</LastName><ForeName>Gerasimos</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>3rd Department of Cardiology, National and Kapodistrian University of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiology</Keyword><Keyword MajorTopicYN="N">cardiovascular imaging</Keyword><Keyword MajorTopicYN="N">cardiovascular medicine</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">multi-modal data</Keyword><Keyword MajorTopicYN="N">omics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40426849</ArticleId><ArticleId IdType="pmc">PMC12109432</ArticleId><ArticleId IdType="doi">10.3390/biomedicines13051019</ArticleId><ArticleId IdType="pii">biomedicines13051019</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sun X., Yin Y., Yang Q., Huo T. Artificial Intelligence in Cardiovascular Diseases: Diagnostic and Therapeutic Perspectives. Eur. J. Med. Res. 2023;28:242. doi: 10.1186/s40001-023-01065-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-023-01065-y</ArticleId><ArticleId IdType="pmc">PMC10360247</ArticleId><ArticleId IdType="pubmed">37475050</ArticleId></ArticleIdList></Reference><Reference><Citation>Faust O., Salvi M., Barua P.D., Chakraborty S., Molinari F., Acharya U.R. Issues and Limitations on the Road to Fair and Inclusive AI Solutions for Biomedical Challenges. Sensors. 2025;25:205. doi: 10.3390/s25010205.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s25010205</ArticleId><ArticleId IdType="pmc">PMC11723364</ArticleId><ArticleId IdType="pubmed">39796996</ArticleId></ArticleIdList></Reference><Reference><Citation>Takita H., Kabata D., Walston S.L., Tatekawa H., Saito K., Tsujimoto Y., Miki Y., Ueda D. Diagnostic Performance Comparison between Generative AI and Physicians: A Systematic Review and Meta-Analysis. medRxiv. 2024 doi: 10.1038/s41746-025-01543-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-025-01543-z</ArticleId><ArticleId IdType="pmc">PMC11929846</ArticleId><ArticleId IdType="pubmed">40121370</ArticleId></ArticleIdList></Reference><Reference><Citation>Korteling J.E.H., Van De Boer-Visschedijk G.C., Blankendaal R.A.M., Boonekamp R.C., Eikelboom A.R. Human-versus Artificial Intelligence. Front. Artif. Intell. 2021;4:622364. doi: 10.3389/frai.2021.622364.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/frai.2021.622364</ArticleId><ArticleId IdType="pmc">PMC8108480</ArticleId><ArticleId IdType="pubmed">33981990</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittanawong C., Zhang H., Wang Z., Aydar M., Kitai T. Artificial Intelligence in Precision Cardiovascular Medicine. J. Am. Coll. Cardiol. 2017;69:2657&#x2013;2664. doi: 10.1016/j.jacc.2017.03.571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.03.571</ArticleId><ArticleId IdType="pubmed">28545640</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohlin C. Guidelines for Snowballing in Systematic Literature Studies and a Replication in Software Engineering; Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering; London, UK. 13&#x2013;14 May 2014; pp. 1&#x2013;10.</Citation></Reference><Reference><Citation>Monteith S., Glenn T., Geddes J.R., Achtyes E.D., Whybrow P.C., Bauer M. Differences between Human and Artificial/Augmented Intelligence in Medicine. Comput. Hum. Behav. Artif. Hum. 2024;2:100084. doi: 10.1016/j.chbah.2024.100084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chbah.2024.100084</ArticleId></ArticleIdList></Reference><Reference><Citation>Lussier M.-T., Richard C. Handling Cues from Patients. Can. Fam. Physician Med. Fam. Can. 2009;55:1213&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2793229</ArticleId><ArticleId IdType="pubmed">20008602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly C.J., Karthikesalingam A., Suleyman M., Corrado G., King D. Key Challenges for Delivering Clinical Impact with Artificial Intelligence. BMC Med. 2019;17:195. doi: 10.1186/s12916-019-1426-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-019-1426-2</ArticleId><ArticleId IdType="pmc">PMC6821018</ArticleId><ArticleId IdType="pubmed">31665002</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelidis P., Bampa M., Oikonomou E., Papapetrou P. Machine Learning Models for Automated Interpretation of 12-Lead Electrocardiographic Signals: A Narrative Review of Techniques, Challenges, Achievements and Clinical Relevance. J. Med. Artif. Intell. 2023;6:6. doi: 10.21037/jmai-22-94.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jmai-22-94</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi A., Olanisa O.O., Nzeako T., Shahrokhi M., Esfahani E., Fakher N., Khazeei Tabari M.A. Revolutionizing Cardiac Imaging: A Scoping Review of Artificial Intelligence in Echocardiography, CTA, and Cardiac MRI. J. Imaging. 2024;10:193. doi: 10.3390/jimaging10080193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging10080193</ArticleId><ArticleId IdType="pmc">PMC11355719</ArticleId><ArticleId IdType="pubmed">39194982</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsky M.R., Bedoya A., Bihorac A., Celi L., Churpek M., Economou-Zavlanos N.J., Elbers P., Saria S., Liu V., Lyons P.G., et al. Use of Artificial Intelligence in Critical Care: Opportunities and Obstacles. Crit. Care. 2024;28:113. doi: 10.1186/s13054-024-04860-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-024-04860-z</ArticleId><ArticleId IdType="pmc">PMC11000355</ArticleId><ArticleId IdType="pubmed">38589940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton J.R., Hampton J. The ECG Made Easy. 9th ed. Elsevier; Edinburgh, UK: London, UK: New York, NY, USA: Oxford, UK: Philadelphia, PA, USA: St. Louis, MO, USA: Sydney, Australia: 2019.</Citation></Reference><Reference><Citation>Kaddoura S. Echo Made Easy. 3rd ed. Elsevier; Edinburgh, UK: London, UK: New York, NY, USA: Oxford, UK: Philadelphia, PA, USA: St. Louis, MO, USA: Sydney, Australia: Toronto, ON, Canada: 2016.</Citation></Reference><Reference><Citation>Pantelidis P., Oikonomou E., Gialamas I., Goliopoulou A., Sarantos S., Zakynthinos G.E., Anastasiou A., Gounaridi M.I., Kalogeras K., Siasos G. Decoding the Heart: How Artificial Intelligence Is Transforming Cardiology. J. Med. Artif. Intell. 2025;8:9. doi: 10.21037/jmai-24-139.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jmai-24-139</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Z.I., Kapa S., Lopez-Jimenez F., McKie P.M., Ladewig D.J., Satam G., Pellikka P.A., Enriquez-Sarano M., Noseworthy P.A., Munger T.M., et al. Screening for Cardiac Contractile Dysfunction Using an Artificial Intelligence&#x2013;Enabled Electrocardiogram. Nat. Med. 2019;25:70&#x2013;74. doi: 10.1038/s41591-018-0240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0240-2</ArticleId><ArticleId IdType="pubmed">30617318</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Chang H., Yang D., Yang F., Wang Q., Deng Y., Li L., Lv W., Zhang B., Yu L., et al. A Deep Learning Framework Assisted Echocardiography with Diagnosis, Lesion Localization, Phenogrouping Heterogeneous Disease, and Anomaly Detection. Sci. Rep. 2023;13:3. doi: 10.1038/s41598-022-27211-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-27211-w</ArticleId><ArticleId IdType="pmc">PMC9807607</ArticleId><ArticleId IdType="pubmed">36593284</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko W.-Y., Siontis K.C., Attia Z.I., Carter R.E., Kapa S., Ommen S.R., Demuth S.J., Ackerman M.J., Gersh B.J., Arruda-Olson A.M., et al. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram. J. Am. Coll. Cardiol. 2020;75:722&#x2013;733. doi: 10.1016/j.jacc.2019.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.12.030</ArticleId><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Z.I., Noseworthy P.A., Lopez-Jimenez F., Asirvatham S.J., Deshmukh A.J., Gersh B.J., Carter R.E., Yao X., Rabinstein A.A., Erickson B.J., et al. An Artificial Intelligence-Enabled ECG Algorithm for the Identification of Patients with Atrial Fibrillation during Sinus Rhythm: A Retrospective Analysis of Outcome Prediction. Lancet. 2019;394:861&#x2013;867. doi: 10.1016/S0140-6736(19)31721-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31721-0</ArticleId><ArticleId IdType="pubmed">31378392</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolk M.Z.H., Ruip&#xe9;rez-Campillo S., Alvarez-Florez L., Deb B., Bekkers E.J., Allaart C.P., Van Der Lingen A.-L.C.J., Clopton P., I&#x161;gum I., Wilde A.A.M., et al. Dynamic Prediction of Malignant Ventricular Arrhythmias Using Neural Networks in Patients with an Implantable Cardioverter-Defibrillator. eBioMedicine. 2024;99:104937. doi: 10.1016/j.ebiom.2023.104937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104937</ArticleId><ArticleId IdType="pmc">PMC10772563</ArticleId><ArticleId IdType="pubmed">38118401</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang R., Cheung C.C., Garcia-Montero M., Davies B., Cao J., Redfearn D., Laksman Z.M., Grondin S., Atallah J., Escudero C.A., et al. Deep Learning&#x2013;Augmented ECG Analysis for Screening and Genotype Prediction of Congenital Long QT Syndrome. JAMA Cardiol. 2024;9:377. doi: 10.1001/jamacardio.2024.0039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2024.0039</ArticleId><ArticleId IdType="pmc">PMC10918571</ArticleId><ArticleId IdType="pubmed">38446445</ArticleId></ArticleIdList></Reference><Reference><Citation>Economou Lundeberg J., M&#xe5;neheim A., Persson A., Dziubinski M., Sridhar A., Healey J.S., Slusarczyk M., Engstr&#xf6;m G., Johnson L.S. Ventricular Tachycardia Risk Prediction with an Abbreviated Duration Mobile Cardiac Telemetry. Heart Rhythm O2. 2023;4:500&#x2013;505. doi: 10.1016/j.hroo.2023.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hroo.2023.06.009</ArticleId><ArticleId IdType="pmc">PMC10461200</ArticleId><ArticleId IdType="pubmed">37645265</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolk M.Z.H., Frodi D.M., Langford J., Jacobsen P.K., Risum N., Andersen T.O., Tan H.L., Hastrup Svendsen J., Knops R.E., Diederichsen S.Z., et al. Artificial Intelligence-Enhanced Wearable Technology Enables Ventricular Arrhythmia Prediction. Eur. Heart J. Digit. Health. 2024:ztae069. doi: 10.1093/ehjdh/ztae069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztae069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavidia M., Zhu H., Montanari A.N., Fuentes J., Cheng C., Dubner S., Chames M., Maison-Blanche P., Rahman M.M., Sassi R., et al. Early Warning of Atrial Fibrillation Using Deep Learning. Patterns. 2024;5:100970. doi: 10.1016/j.patter.2024.100970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patter.2024.100970</ArticleId><ArticleId IdType="pmc">PMC11240177</ArticleId><ArticleId IdType="pubmed">39005489</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoire J.M., Gilon C., Bersini H., Groben L., Nguyen T., Godart P., Carlier S. Heart Rate Variability to Predict 1-Day Atrial Fibrillation Episode Onset Using Machine Learning. Eur. Heart J. 2024;45:ehae666.339. doi: 10.1093/eurheartj/ehae666.339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae666.339</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S., Mahara K., Beussink-Nelson L., Ikura H., Katsumata Y., Endo J., Gaggin H.K., Shah S.J., Itabashi Y., MacRae C.A., et al. Artificial Intelligence-Enabled Fully Automated Detection of Cardiac Amyloidosis Using Electrocardiograms and Echocardiograms. Nat. Commun. 2021;12:2726. doi: 10.1038/s41467-021-22877-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22877-8</ArticleId><ArticleId IdType="pmc">PMC8113484</ArticleId><ArticleId IdType="pubmed">33976142</ArticleId></ArticleIdList></Reference><Reference><Citation>Grogan M., Lopez-Jimenez F., Cohen-Shelly M., Dispenzieri A., Attia Z.I., Abou Ezzedine O.F., Lin G., Kapa S., Borgeson D.D., Friedman P.A., et al. Artificial Intelligence&#x2013;Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin. Proc. 2021;96:2768&#x2013;2778. doi: 10.1016/j.mayocp.2021.04.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.023</ArticleId><ArticleId IdType="pubmed">34218880</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng R., Deb B., Ganesan P., Tjong F.V.Y., Rogers A.J., Ruip&#xe9;rez-Campillo S., Somani S., Clopton P., Baykaner T., Rodrigo M., et al. Segmenting Computed Tomograms for Cardiac Ablation Using Machine Learning Leveraged by Domain Knowledge Encoding. Front. Cardiovasc. Med. 2023;10:1189293. doi: 10.3389/fcvm.2023.1189293.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1189293</ArticleId><ArticleId IdType="pmc">PMC10577270</ArticleId><ArticleId IdType="pubmed">37849936</ArticleId></ArticleIdList></Reference><Reference><Citation>Akita K., Kusunose K., Haga A., Shimomura T., Kosaka Y., Ishiyama K., Hasegawa K., Fifer M.A., Maurer M.S., Shimada Y.J. Deep Learning of Echocardiography Distinguishes between Presence and Absence of Late Gadolinium Enhancement on Cardiac Magnetic Resonance in Patients with Hypertrophic Cardiomyopathy. Echo Res. Pract. 2024;11:23. doi: 10.1186/s44156-024-00059-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s44156-024-00059-8</ArticleId><ArticleId IdType="pmc">PMC11472433</ArticleId><ArticleId IdType="pubmed">39396969</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M., Deng Y., Liu Y., Su X., Zeng X. Echocardiography-Based Machine Learning Algorithm for Distinguishing Ischemic Cardiomyopathy from Dilated Cardiomyopathy. BMC Cardiovasc. Disord. 2023;23:476. doi: 10.1186/s12872-023-03520-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03520-4</ArticleId><ArticleId IdType="pmc">PMC10521456</ArticleId><ArticleId IdType="pubmed">37752424</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita S.X., Kusunose K., Haga A., Sata M., Hasegawa K., Raita Y., Reilly M.P., Fifer M.A., Maurer M.S., Shimada Y.J. Deep Learning Analysis of Echocardiographic Images to Predict Positive Genotype in Patients with Hypertrophic Cardiomyopathy. Front. Cardiovasc. Med. 2021;8:669860. doi: 10.3389/fcvm.2021.669860.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.669860</ArticleId><ArticleId IdType="pmc">PMC8429777</ArticleId><ArticleId IdType="pubmed">34513940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolk M.Z.H., Ruip&#xe9;rez-Campillo S., Allaart C.P., Wilde A.A.M., Knops R.E., Narayan S.M., Tjong F.V.Y., DEEP RISK investigators Multimodal Explainable Artificial Intelligence Identifies Patients with Non-Ischaemic Cardiomyopathy at Risk of Lethal Ventricular Arrhythmias. Sci. Rep. 2024;14:14889. doi: 10.1038/s41598-024-65357-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-65357-x</ArticleId><ArticleId IdType="pmc">PMC11211323</ArticleId><ArticleId IdType="pubmed">38937555</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E.K., Aminorroaya A., Dhingra L.S., Partridge C., Velazquez E.J., Desai N.R., Krumholz H.M., Miller E.J., Khera R. Real-World Evaluation of an Algorithmic Machine-Learning-Guided Testing Approach in Stable Chest Pain: A Multinational, Multicohort Study. Eur. Heart J. Digit. Health. 2024;5:303&#x2013;313. doi: 10.1093/ehjdh/ztae023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztae023</ArticleId><ArticleId IdType="pmc">PMC11104476</ArticleId><ArticleId IdType="pubmed">38774380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolk M.Z.H., Ruip&#xe9;rez-Campillo S., Deb B., Bekkers E.J., Allaart C.P., Rogers A.J., Van Der Lingen A.-L.C.J., Alvarez Florez L., Isgum I., De Vos B.D., et al. Optimizing Patient Selection for Primary Prevention Implantable Cardioverter-Defibrillator Implantation: Utilizing Multimodal Machine Learning to Assess Risk of Implantable Cardioverter-Defibrillator Non-Benefit. EP Eur. 2023;25:euad271. doi: 10.1093/europace/euad271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euad271</ArticleId><ArticleId IdType="pmc">PMC10516624</ArticleId><ArticleId IdType="pubmed">37712675</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirruccello J.P., Di Achille P., Choi S.H., R&#xe4;m&#xf6; J.T., Khurshid S., Nekoui M., Jurgens S.J., Nauffal V., Kany S., FinnGen, et al. Deep Learning of Left Atrial Structure and Function Provides Link to Atrial Fibrillation Risk. Nat. Commun. 2024;15:4304. doi: 10.1038/s41467-024-48229-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-48229-w</ArticleId><ArticleId IdType="pmc">PMC11109224</ArticleId><ArticleId IdType="pubmed">38773065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D., Sami Z., Cannata M., Ciftcikal Y., Caron E., Thomas S.V., Porter C.R., Tsioulias A., Gujja M., Sakai K., et al. Artificial Intelligence in Intravascular Imaging for Percutaneous Coronary Interventions: A New Era of Precision. J. Soc. Cardiovasc. Angiogr. Interv. 2025;4:102506. doi: 10.1016/j.jscai.2024.102506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2024.102506</ArticleId><ArticleId IdType="pmc">PMC11993893</ArticleId><ArticleId IdType="pubmed">40230676</ArticleId></ArticleIdList></Reference><Reference><Citation>Samant S., Panagopoulos A.N., Wu W., Zhao S., Chatzizisis Y.S. Artificial Intelligence in Coronary Artery Interventions: Preprocedural Planning and Procedural Assistance. J. Soc. Cardiovasc. Angiogr. Interv. 2025;4:102519. doi: 10.1016/j.jscai.2024.102519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2024.102519</ArticleId><ArticleId IdType="pmc">PMC11993872</ArticleId><ArticleId IdType="pubmed">40230668</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz A.L., Chorin E., Mann T., Levi M.Y., Hochstadt A., Margolis G., Viskin S., Banai S., Rosso R. Reconstruction of the Left Atrium for Atrial Fibrillation Ablation Using the Machine Learning CARTO 3 M-FAM Software. J. Interv. Card. Electrophysiol. 2022;64:39&#x2013;47. doi: 10.1007/s10840-021-01045-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-021-01045-4</ArticleId><ArticleId IdType="pubmed">34382153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahlke F., Englert F., Popa M., Bourier F., Reents T., Lennerz C., Kraft H., Martinez A.T., Kottmaier M., Syv&#xe4;ri J., et al. First Clinical Data on Artificial Intelligence-guided Catheter Ablation in Long-standing Persistent Atrial Fibrillation. J. Cardiovasc. Electrophysiol. 2024;35:406&#x2013;414. doi: 10.1111/jce.16184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.16184</ArticleId><ArticleId IdType="pubmed">38197476</ArticleId></ArticleIdList></Reference><Reference><Citation>Martelli E., Capoccia L., Di Francesco M., Cavallo E., Pezzulla M.G., Giudice G., Bauleo A., Coppola G., Panagrosso M. Current Applications and Future Perspectives of Artificial and Biomimetic Intelligence in Vascular Surgery and Peripheral Artery Disease. Biomimetics. 2024;9:465. doi: 10.3390/biomimetics9080465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomimetics9080465</ArticleId><ArticleId IdType="pmc">PMC11351193</ArticleId><ArticleId IdType="pubmed">39194444</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGroat W., Abdelhalim H., Peker E., Sheth N., Narayanan R., Zeeshan S., Liang B.T., Ahmed Z. Multimodal AI/ML for Discovering Novel Biomarkers and Predicting Disease Using Multi-Omics Profiles of Patients with Cardiovascular Diseases. Sci. Rep. 2024;14:26503. doi: 10.1038/s41598-024-78553-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-78553-6</ArticleId><ArticleId IdType="pmc">PMC11532369</ArticleId><ArticleId IdType="pubmed">39489837</ArticleId></ArticleIdList></Reference><Reference><Citation>Drouard G., Mykk&#xe4;nen J., Heiskanen J., Pohjonen J., Ruohonen S., Pahkala K., Lehtim&#xe4;ki T., Wang X., Ollikainen M., Ripatti S., et al. Exploring Machine Learning Strategies for Predicting Cardiovascular Disease Risk Factors from Multi-Omic Data. BMC Med. Inform. Decis. Mak. 2024;24:116. doi: 10.1186/s12911-024-02521-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-024-02521-3</ArticleId><ArticleId IdType="pmc">PMC11064347</ArticleId><ArticleId IdType="pubmed">38698395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson P.W.F., D&#x2019;Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation. 1998;97:1837&#x2013;1847. doi: 10.1161/01.CIR.97.18.1837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.97.18.1837</ArticleId><ArticleId IdType="pubmed">9603539</ArticleId></ArticleIdList></Reference><Reference><Citation>Sytkowski P.A., Kannel W.B., D&#x2019;Agostino R.B. Changes in Risk Factors and the Decline in Mortality from Cardiovascular Disease: The Framingham Heart Study. N. Engl. J. Med. 1990;322:1635&#x2013;1641. doi: 10.1056/NEJM199006073222304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199006073222304</ArticleId><ArticleId IdType="pubmed">2288563</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng S.F., Reps J., Kai J., Garibaldi J.M., Qureshi N. Can Machine-Learning Improve Cardiovascular Risk Prediction Using Routine Clinical Data? PLoS ONE. 2017;12:e0174944. doi: 10.1371/journal.pone.0174944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174944</ArticleId><ArticleId IdType="pmc">PMC5380334</ArticleId><ArticleId IdType="pubmed">28376093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerculy R., Benedek I., Kov&#xe1;cs I., Rat N., Hala&#x21b;iu V.B., Rodean I., Bordi L., Bl&#xee;ndu E., Ro&#x219;ca A., M&#xe1;ty&#xe1;s B.-B., et al. CT-Assessment of Epicardial Fat Identifies Increased Inflammation at the Level of the Left Coronary Circulation in Patients with Atrial Fibrillation. J. Clin. Med. 2024;13:1307. doi: 10.3390/jcm13051307.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051307</ArticleId><ArticleId IdType="pmc">PMC10932380</ArticleId><ArticleId IdType="pubmed">38592141</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., Paolisso G., Marfella R. Inflammatory Related Cardiovascular Diseases: From Molecular Mechanisms to Therapeutic Targets. Curr. Pharm. Des. 2020;26:2565&#x2013;2573. doi: 10.2174/1381612826666200213123029.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612826666200213123029</ArticleId><ArticleId IdType="pubmed">32053065</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C., D&#x2019;Onofrio N., Torella M., Portoghese M., Mureddu S., Loreni F., Ferraraccio F., Panarese I., Trotta M.C., Gatta G., et al. Metformin Therapy Effects on the Expression of Sodium-Glucose Cotransporter 2, Leptin, and SIRT6 Levels in Pericoronary Fat Excised from Pre-Diabetic Patients with Acute Myocardial Infarction. Biomedicines. 2021;9:904. doi: 10.3390/biomedicines9080904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080904</ArticleId><ArticleId IdType="pmc">PMC8389537</ArticleId><ArticleId IdType="pubmed">34440108</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnicka Z., Proniewska K., Perkins M., Pregowska A. Cardiac Healthcare Digital Twins Supported by Artificial Intelligence-Based Algorithms and Extended Reality&#x2014;A Systematic Review. Electronics. 2024;13:866. doi: 10.3390/electronics13050866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/electronics13050866</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalakoti M., Wong S., Lee W., Lee J., Yang H., Loong S., Loh P.H., Tyebally S., Djohan A., Ong J., et al. Incorporating AI into Cardiovascular Diseases Prevention-Insights from Singapore. Lancet Reg. Health West. Pac. 2024;48:101102. doi: 10.1016/j.lanwpc.2024.101102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2024.101102</ArticleId><ArticleId IdType="pmc">PMC11154196</ArticleId><ArticleId IdType="pubmed">38855631</ArticleId></ArticleIdList></Reference><Reference><Citation>Agibetov A., Kammerlander A., Duca F., Nitsche C., Koschutnik M., Don&#xe0; C., Dachs T.-M., Rettl R., Stria A., Schrutka L., et al. Convolutional Neural Networks for Fully Automated Diagnosis of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging. J. Pers. Med. 2021;11:1268. doi: 10.3390/jpm11121268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11121268</ArticleId><ArticleId IdType="pmc">PMC8705947</ArticleId><ArticleId IdType="pubmed">34945740</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos J.M., Attia Z.I., Albert D.E., Noseworthy P.A., Friedman P.A., Ackerman M.J. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients with Electrocardiographically Concealed Long QT Syndrome from the Surface 12-Lead Electrocardiogram. JAMA Cardiol. 2021;6:532. doi: 10.1001/jamacardio.2020.7422.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.7422</ArticleId><ArticleId IdType="pmc">PMC7876623</ArticleId><ArticleId IdType="pubmed">33566059</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.-W., Kuo L., Lin Y.-X., Yu W.-C., Tseng C.-C., Lin Y.-J., Huang C.-C., Chang S.-L., Wu J.C.-H., Chen C.-K., et al. A Deep Learning Approach to Classify Fabry Cardiomyopathy from Hypertrophic Cardiomyopathy Using Cine Imaging on Cardiac Magnetic Resonance. Int. J. Biomed. Imaging. 2024;2024:6114826. doi: 10.1155/2024/6114826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2024/6114826</ArticleId><ArticleId IdType="pmc">PMC11068448</ArticleId><ArticleId IdType="pubmed">38706878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Shelly M., Attia Z.I., Friedman P.A., Ito S., Essayagh B.A., Ko W.-Y., Murphree D.H., Michelena H.I., Enriquez-Sarano M., Carter R.E., et al. Electrocardiogram Screening for Aortic Valve Stenosis Using Artificial Intelligence. Eur. Heart J. 2021;42:2885&#x2013;2896. doi: 10.1093/eurheartj/ehab153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab153</ArticleId><ArticleId IdType="pubmed">33748852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentzer J.C., Kashou A.H., Attia Z.I., Lopez-Jimenez F., Kapa S., Friedman P.A., Noseworthy P.A. Left Ventricular Systolic Dysfunction Identification Using Artificial Intelligence-Augmented Electrocardiogram in Cardiac Intensive Care Unit Patients. Int. J. Cardiol. 2021;326:114&#x2013;123. doi: 10.1016/j.ijcard.2020.10.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2020.10.074</ArticleId><ArticleId IdType="pubmed">33152415</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampert J., Vaid A., Whang W., Koruth J., Miller M.A., Langan M.-N., Musikantow D., Turagam M., Maan A., Kawamura I., et al. A Novel ECG-Based Deep Learning Algorithm to Predict Cardiomyopathy in Patients with Premature Ventricular Complexes. JACC Clin. Electrophysiol. 2023;9:1437&#x2013;1451. doi: 10.1016/j.jacep.2023.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacep.2023.05.025</ArticleId><ArticleId IdType="pubmed">37480862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Shin S.-Y., Seo M., Nam G.-B., Joo S. Prediction of Ventricular Tachycardia One Hour before Occurrence Using Artificial Neural Networks. Sci. Rep. 2016;6:32390. doi: 10.1038/srep32390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32390</ArticleId><ArticleId IdType="pmc">PMC4999952</ArticleId><ArticleId IdType="pubmed">27561321</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Kang B.G., Jo J., Park H.E., Yoon S., Choi S.-Y., Kim M.J. Deep Learning-Based Prediction for Significant Coronary Artery Stenosis on Coronary Computed Tomography Angiography in Asymptomatic Populations. Front. Cardiovasc. Med. 2023;10:1167468. doi: 10.3389/fcvm.2023.1167468.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1167468</ArticleId><ArticleId IdType="pmc">PMC10320158</ArticleId><ArticleId IdType="pubmed">37416918</ArticleId></ArticleIdList></Reference><Reference><Citation>Libiseller-Egger J., Phelan J.E., Attia Z.I., Benavente E.D., Campino S., Friedman P.A., Lopez-Jimenez F., Leon D.A., Clark T.G. Deep Learning-Derived Cardiovascular Age Shares a Genetic Basis with Other Cardiac Phenotypes. Sci. Rep. 2022;12:22625. doi: 10.1038/s41598-022-27254-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-27254-z</ArticleId><ArticleId IdType="pmc">PMC9805465</ArticleId><ArticleId IdType="pubmed">36587059</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo L., Ciconte G., Christy A., Vicedomini G., Anastasia L., Pappone C., Grant E. Deep Learning Unmasks the ECG Signature of Brugada Syndrome. PNAS Nexus. 2023;2:pgad327. doi: 10.1093/pnasnexus/pgad327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad327</ArticleId><ArticleId IdType="pmc">PMC10627411</ArticleId><ArticleId IdType="pubmed">37937270</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Driscoll J.M., Tuttolomondo D., Gaibazzi N. Artificial Intelligence Calculated Global Longitudinal Strain and Left Ventricular Ejection Fraction Predicts Cardiac Events and All-cause Mortality in Patients with Chest Pain. Echocardiography. 2023;40:1356&#x2013;1364. doi: 10.1111/echo.15714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15714</ArticleId><ArticleId IdType="pubmed">37964624</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou E.K., Holste G., Yuan N., Coppi A., McNamara R.L., Haynes N.A., Vora A.N., Velazquez E.J., Li F., Menon V., et al. A Multimodal Video-Based AI Biomarker for Aortic Stenosis Development and Progression. JAMA Cardiol. 2024;9:534. doi: 10.1001/jamacardio.2024.0595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2024.0595</ArticleId><ArticleId IdType="pmc">PMC10999005</ArticleId><ArticleId IdType="pubmed">38581644</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghunath S., Pfeifer J.M., Ulloa-Cerna A.E., Nemani A., Carbonati T., Jing L., vanMaanen D.P., Hartzel D.N., Ruhl J.A., Lagerman B.F., et al. Deep Neural Networks Can Predict New-Onset Atrial Fibrillation From the 12-Lead ECG and Help Identify Those at Risk of Atrial Fibrillation&#x2013;Related Stroke. Circulation. 2021;143:1287&#x2013;1298. doi: 10.1161/CIRCULATIONAHA.120.047829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047829</ArticleId><ArticleId IdType="pmc">PMC7996054</ArticleId><ArticleId IdType="pubmed">33588584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahashi Y., Ouyang D., Kwan A. Using Deep Learning to Predict Cardiovascular Magnetic Resonance Findings from Echocardiography Videos. Eur. Heart J. 2024;45:ehae666.3458. doi: 10.1093/eurheartj/ehae666.3458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae666.3458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun C., Liu C., Wang X., Liu Y., Zhao S. Coronary Artery Disease Detection Based on a Novel Multi-Modal Deep-Coding Method Using ECG and PCG Signals. Sensors. 2024;24:6939. doi: 10.3390/s24216939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s24216939</ArticleId><ArticleId IdType="pmc">PMC11548692</ArticleId><ArticleId IdType="pubmed">39517836</ArticleId></ArticleIdList></Reference><Reference><Citation>Surucu M., Isler Y., Perc M., Kara R. Convolutional Neural Networks Predict the Onset of Paroxysmal Atrial Fibrillation: Theory and Applications. Chaos Interdiscip. J. Nonlinear Sci. 2021;31:113119. doi: 10.1063/5.0069272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/5.0069272</ArticleId><ArticleId IdType="pubmed">34881615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokodi M., Magyar B., So&#xf3;s A., Takeuchi M., Tolvaj M., Lakatos B.K., Kitano T., Nabeshima Y., F&#xe1;bi&#xe1;n A., Szigeti M.B., et al. Deep Learning-Based Prediction of Right Ventricular Ejection Fraction Using 2D Echocardiograms. JACC Cardiovasc. Imaging. 2023;16:1005&#x2013;1018. doi: 10.1016/j.jcmg.2023.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.02.017</ArticleId><ArticleId IdType="pubmed">37178072</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto J.T., Weston Hughes J., Sanchez P.A., Perez M., Ouyang D., Ashley E.A. Multimodal Deep Learning Enhances Diagnostic Precision in Left Ventricular Hypertrophy. Eur. Heart J. Digit. Health. 2022;3:380&#x2013;389. doi: 10.1093/ehjdh/ztac033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztac033</ArticleId><ArticleId IdType="pmc">PMC9707995</ArticleId><ArticleId IdType="pubmed">36712167</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkat V., Abdelhalim H., DeGroat W., Zeeshan S., Ahmed Z. Investigating Genes Associated with Heart Failure, Atrial Fibrillation, and Other Cardiovascular Diseases, and Predicting Disease Using Machine Learning Techniques for Translational Research and Precision Medicine. Genomics. 2023;115:110584. doi: 10.1016/j.ygeno.2023.110584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2023.110584</ArticleId><ArticleId IdType="pubmed">36813091</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S., Koo B.-K., Hoshino M., Lee J.M., Murai T., Park J., Zhang J., Hwang D., Shin E.-S., Doh J.-H., et al. CT Angiographic and Plaque Predictors of Functionally Significant Coronary Disease and Outcome Using Machine Learning. JACC Cardiovasc. Imaging. 2021;14:629&#x2013;641. doi: 10.1016/j.jcmg.2020.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.08.025</ArticleId><ArticleId IdType="pubmed">33248965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Lin Y., He W., Yuan F., Zeng Y., Zhang S. GCN-GENE: A Novel Method for Prediction of Coronary Heart Disease-Related Genes. Comput. Biol. Med. 2022;150:105918. doi: 10.1016/j.compbiomed.2022.105918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105918</ArticleId><ArticleId IdType="pubmed">36215847</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Liang T., Su C., Qin S., Li J., Zeng D., Cai Y., Huang T., Wu J. Deep Learn-Based Computer-Assisted Transthoracic Echocardiography: Approach to the Diagnosis of Cardiac Amyloidosis. Int. J. Cardiovasc. Imaging. 2023;39:955&#x2013;965. doi: 10.1007/s10554-023-02806-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-023-02806-0</ArticleId><ArticleId IdType="pmc">PMC10159959</ArticleId><ArticleId IdType="pubmed">36763207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Sui Y., Ruan X., Wang X., He K., Dong W., Qu H., Fang X. A Deep Learning Model for Early Risk Prediction of Heart Failure with Preserved Ejection Fraction by DNA Methylation Profiles Combined with Clinical Features. Clin. Epigenet. 2022;14:11. doi: 10.1186/s13148-022-01232-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01232-8</ArticleId><ArticleId IdType="pmc">PMC8772140</ArticleId><ArticleId IdType="pubmed">35045866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg S.M., Lee S.-I. A Unified Approach to Interpreting Model Predictions; Proceedings of the 31st International Conference on Neural Information Processing Systems; Long Beach, CA, USA. 4&#x2013;9 December 2017; pp. 4768&#x2013;4777.</Citation></Reference><Reference><Citation>Selvaraju R.R., Cogswell M., Das A., Vedantam R., Parikh D., Batra D. Grad-CAM: Visual Explanations from Deep Networks via Gradient-Based Localization; Proceedings of the 2017 IEEE International Conference on Computer Vision (ICCV); Venice, Italy. 22&#x2013;29 October 2017; pp. 618&#x2013;626.</Citation></Reference><Reference><Citation>Arun N., Gaw N., Singh P., Chang K., Aggarwal M., Chen B., Hoebel K., Gupta S., Patel J., Gidwani M., et al. Assessing the (Un)Trustworthiness of Saliency Maps for Localizing Abnormalities in Medical Imaging. Radiol. Artif. Intell. 2020;3:e200267. doi: 10.1148/ryai.2021200267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryai.2021200267</ArticleId><ArticleId IdType="pmc">PMC8637231</ArticleId><ArticleId IdType="pubmed">34870212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Tourani R. Predictive and Causal Implications of Using Shapley Value for Model Interpretation; Proceedings of the 2020 KDD Workshop on Causal Discovery; San Diego, CA, USA. 24 August 2020.</Citation></Reference><Reference><Citation>Svennberg E., Han J.K., Caiani E.G., Engelhardt S., Ernst S., Friedman P., Garcia R., Ghanbari H., Hindricks G., Man S.H., et al. State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025. A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group in e-Cardiology. EP Eur. 2025:euaf071. doi: 10.1093/europace/euaf071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/euaf071</ArticleId><ArticleId IdType="pubmed">40163651</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Food and Drug Administration  Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices.  [(accessed on 1 March 2025)]; Available online:  https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices.</Citation></Reference><Reference><Citation>European Medicines Agency  Artificial Intelligence&#x2014;EMA.  [(accessed on 1 March 2025)]; Available online:  https://www.ema.europa.eu/en/about-us/how-we-work/big-data/artificial-intelligence.</Citation></Reference><Reference><Citation>Medicines and Healthcare Products Regulatory Agency  MHRA&#x2019;s AI Regulatory Strategy Ensures Patient Safety and Industry Innovation into 2030.  [(accessed on 1 March 2025)]; Available online:  https://www.gov.uk/government/news/mhras-ai-regulatory-strategy-ensures-patient-safety-and-industry-innovation-into-2030.</Citation></Reference><Reference><Citation>Nikoli&#x107; G.S., Dimitrijevi&#x107; B.R., Nikoli&#x107; T.R., Stojcev M.K. Survey of Three Types of Processing Units: CPU, GPU and TPU; Proceedings of the 2022 57th International Scientific Conference on Information, Communication and Energy Systems and Technologies (ICEST); Ohrid, North Macedonia. 16&#x2013;18 June 2022; pp. 1&#x2013;6.</Citation></Reference><Reference><Citation>Huang S.-C., Pareek A., Jensen M., Lungren M.P., Yeung S., Chaudhari A.S. Self-Supervised Learning for Medical Image Classification: A Systematic Review and Implementation Guidelines. npj Digit. Med. 2023;6:74. doi: 10.1038/s41746-023-00811-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-023-00811-0</ArticleId><ArticleId IdType="pmc">PMC10131505</ArticleId><ArticleId IdType="pubmed">37100953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mugambi L., Wa Maina C., Z&#xfc;hlke L. Self-Supervised Multi-Task Learning for the Detection and Classification of RHD-Induced Valvular Pathology. J. Imaging. 2025;11:97. doi: 10.3390/jimaging11040097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jimaging11040097</ArticleId><ArticleId IdType="pmc">PMC12028028</ArticleId><ArticleId IdType="pubmed">40278013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehari T., Strodthoff N. Self-Supervised Representation Learning from 12-Lead ECG Data. Comput. Biol. Med. 2022;141:105114. doi: 10.1016/j.compbiomed.2021.105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2021.105114</ArticleId><ArticleId IdType="pubmed">34973584</ArticleId></ArticleIdList></Reference><Reference><Citation>European Union Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of Such Data (General Data Protection Regulation) 2016.  [(accessed on 1 March 2025)].  Available online:  https://eur-lex.europa.eu/eli/reg/2016/679/oj/eng.</Citation></Reference><Reference><Citation>Manocha A., Sood S.K., Bhatia M. Federated Learning-Inspired Smart ECG Classification: An Explainable Artificial Intelligence Approach. Multimed. Tools Appl. 2024 doi: 10.1007/s11042-024-20084-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11042-024-20084-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Goto S., Solanki D., John J.E., Yagi R., Homilius M., Ichihara G., Katsumata Y., Gaggin H.K., Itabashi Y., MacRae C.A., et al. Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection. Circulation. 2022;146:755&#x2013;769. doi: 10.1161/CIRCULATIONAHA.121.058696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.058696</ArticleId><ArticleId IdType="pmc">PMC9439630</ArticleId><ArticleId IdType="pubmed">35916132</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvino G., Peconi C., Strafella C., Trastulli G., Megalizzi D., Andreucci S., Cascella R., Caltagirone C., Zampatti S., Giardina E. Federated Learning: Breaking Down Barriers in Global Genomic Research. Genes. 2024;15:1650. doi: 10.3390/genes15121650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes15121650</ArticleId><ArticleId IdType="pmc">PMC11728131</ArticleId><ArticleId IdType="pubmed">39766917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew G., Barbosa D., Prince J., Venkatraman S. Foundation Models for Cardiovascular Disease Detection via Biosignals from Digital Stethoscopes. npj Cardiovasc. Health. 2024;1:25. doi: 10.1038/s44325-024-00027-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44325-024-00027-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Quer G., Topol E.J. The Potential for Large Language Models to Transform Cardiovascular Medicine. Lancet Digit. Health. 2024;6:e767&#x2013;e771. doi: 10.1016/S2589-7500(24)00151-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(24)00151-1</ArticleId><ArticleId IdType="pubmed">39214760</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid A., Jiang J., Sawant A., Lerakis S., Argulian E., Ahuja Y., Lampert J., Charney A., Greenspan H., Narula J., et al. A Foundational Vision Transformer Improves Diagnostic Performance for Electrocardiograms. npj Digit. Med. 2023;6:108. doi: 10.1038/s41746-023-00840-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-023-00840-9</ArticleId><ArticleId IdType="pmc">PMC10242218</ArticleId><ArticleId IdType="pubmed">37280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Christensen M., Vukadinovic M., Yuan N., Ouyang D. Vision&#x2013;Language Foundation Model for Echocardiogram Interpretation. Nat. Med. 2024;30:1481&#x2013;1488. doi: 10.1038/s41591-024-02959-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02959-y</ArticleId><ArticleId IdType="pmc">PMC11108770</ArticleId><ArticleId IdType="pubmed">38689062</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng R., Brennan K.A., Azizi Z., Goyal J., Deb B., Chang H.J., Ganesan P., Clopton P., Pedron M., Ruip&#xe9;rez-Campillo S., et al. Engineering of Generative Artificial Intelligence and Natural Language Processing Models to Accurately Identify Arrhythmia Recurrence. Circ. Arrhythm. Electrophysiol. 2025;18:e013023. doi: 10.1161/CIRCEP.124.013023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.124.013023</ArticleId><ArticleId IdType="pmc">PMC11771986</ArticleId><ArticleId IdType="pubmed">39676642</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C., Gallacher J., Allen N., Beral V., Burton P., Danesh J., Downey P., Elliott P., Green J., Landray M., et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age. PLoS Med. 2015;12:e1001779. doi: 10.1371/journal.pmed.1001779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001779</ArticleId><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bild D.E. Multi-Ethnic Study of Atherosclerosis: Objectives and Design. Am. J. Epidemiol. 2002;156:871&#x2013;881. doi: 10.1093/aje/kwf113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwf113</ArticleId><ArticleId IdType="pubmed">12397006</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger A.L., Amaral L.A.N., Glass L., Hausdorff J.M., Ivanov P.C., Mark R.G., Mietus J.E., Moody G.B., Peng C.-K., Stanley H.E. PhysioBank, PhysioToolkit, and PhysioNet: Components of a New Research Resource for Complex Physiologic Signals. Circulation. 2000;101:e215&#x2013;e220. doi: 10.1161/01.CIR.101.23.e215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.23.e215</ArticleId><ArticleId IdType="pubmed">10851218</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40428316</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4425</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Genes</Title><ISOAbbreviation>Genes (Basel)</ISOAbbreviation></Journal><ArticleTitle>Unravelling the Genotype of the Apical Variant of Hypertrophic Cardiomyopathy in a Swedish Cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">494</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/genes16050494</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Apical hypertrophic cardiomyopathy (ApHCM) is a distinct variant of hypertrophic cardiomyopathy (HCM). Few studies have focused on the genetic determinants of this subtype. We aimed to investigate the genetic basis of apical hypertrophy in a Swedish cohort.</AbstractText><AbstractText Label="METHODS-RESULTS" NlmCategory="RESULTS">Longitudinal data on 58 unrelated index patients with ApHCM from the Southeast healthcare region in Sweden from 2010 to 2024 were assessed retrospectively. Additionally, the original raw data from genetic testing were re-evaluated using AI-based Emedgene software. Patients were 47 &#xb1; 14 years old, and 60% males. A total of 72.4% had the pure apical type and the remaining had the mixed phenotype, dominant distal. In the cohort, 50/58 (86.2%) underwent genetic testing, of whom 7/50 (14%) were considered genotype positive for a pathogenic/likely pathogenic variant, mainly in MYH7 (43%) and in the non-sarcomeric ALPK3 gene (28.6%). A re-evaluation of the original data from genetic testing identified a previously unreported variant in the skeletal muscle &#x3b1;-actin (ACTA1) gene. Overall, 21 of 58 patients (36.2%) had HCM-related events during their disease course: 10% had a stroke, and 12% had heart failure. Atrial fibrillation was present in 41.4% and non-sustained ventricular tachycardia occurred in 29.3% of the patients. Apical aneurysm was observed in 17.2% of cases. Patients with a positive genotype were more likely to have a positive family history of HCM compared to those with a negative genotype (<i>p</i> = 0.020).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In ApHCM, a positive genotype was found less frequently compared to classic HCM. Only 14% of patients with ApHCM were found to be genotype positive, indicating that apical hypertrophy represents a genetically unique population with low risk of mortality. Nevertheless, patients with ApHCM faced higher rates of atrial fibrillation, ventricular arrhythmias, and apical aneurysms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kissopoulou</LastName><ForeName>Antheia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8988-5591</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, County Council of J&#xf6;nk&#xf6;ping, Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elleg&#xe5;rd</LastName><ForeName>Rada</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2097-6778</Identifier><AffiliationInfo><Affiliation>Department of Clinical Genetics, and Department of Biomedical and Clinical Sciences, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernlund</LastName><ForeName>Eva Ingemarsdotter</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, Division of Pediatrics, Link&#xf6;ping University, Crown Princess Victoria Children's Hospital, Link&#xf6;ping University Hospital, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Lund University, Skane University Hospital, Pediatric Heart Center, 22185 Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsson</LastName><ForeName>Jan-Erik</ForeName><Initials>JE</Initials><Identifier Source="ORCID">0000-0003-2632-4065</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, County Council of J&#xf6;nk&#xf6;ping, Department of Health, Medicine and Caring Sciences, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8015-5728</Identifier><AffiliationInfo><Affiliation>Division of Clinical Chemistry and Pharmacology, Department of Biomedical and Clinical Sciences, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnarsson</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Genetics, and Department of Biomedical and Clinical Sciences, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Rare Diseases in South East Region of Sweden, Link&#xf6;ping University, 58185 Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FUTURUM-1012003</GrantID><Agency>Grants from Region &#xd6;sterg&#xf6;tland (ALF), FORSS (Medical Research Council of Southeast Sweden) and by Futurum (the research council of Region J&#xf6;nk&#xf6;ping).</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Genes (Basel)</MedlineTA><NlmUniqueID>101551097</NlmUniqueID><ISSNLinking>2073-4425</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D024722">Cardiac Myosins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501641">MYH7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.1</RegistryNumber><NameOfSubstance UI="D018995">Myosin Heavy Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000199">Actins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024722" MajorTopicYN="N">Cardiac Myosins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018995" MajorTopicYN="Y">Myosin Heavy Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000199" MajorTopicYN="N">Actins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="N">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apical aneurysm</Keyword><Keyword MajorTopicYN="N">apical hypertrophy</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">genetic variant</Keyword><Keyword MajorTopicYN="N">sarcomere</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40428316</ArticleId><ArticleId IdType="pmc">PMC12111543</ArticleId><ArticleId IdType="doi">10.3390/genes16050494</ArticleId><ArticleId IdType="pii">genes16050494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sakamoto T., Tei C., Murayama M., Ichiyasu H., Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn. Heart J. 1976;17:611&#x2013;629. doi: 10.1536/ihj.17.611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/ihj.17.611</ArticleId><ArticleId IdType="pubmed">136532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi H., Ishimura T., Nishiyama S., Nagasaki F., Nakanishi S., Takatsu F., Nishijo T., Umeda T., Machii K. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): Ventriculographic and echocardiographic features in 30 patients. Am. J. Cardiol. 1979;44:401&#x2013;412. doi: 10.1016/0002-9149(79)90388-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(79)90388-6</ArticleId><ArticleId IdType="pubmed">573056</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Fang J., Liu Y., Wei X. Apical hypertrophic cardiomyopathy: Pathophysiology, diagnosis and management. Clin. Res. Cardiol. Off. J. Ger. Card. Soc. 2024;113:680&#x2013;693. doi: 10.1007/s00392-023-02328-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-023-02328-8</ArticleId><ArticleId IdType="pmc">PMC11026226</ArticleId><ArticleId IdType="pubmed">37982860</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajj-Ali A., Gaballa A., Akintoye E., Jadam S., Ramchand J., Xu B., Ospina S., Thamilarasan M., Smedira N.G., Popovic Z.B., et al. Long-Term Outcomes of Patients With Apical Hypertrophic Cardiomyopathy Utilizing a New Risk Score. JACC Adv. 2024;3:101235. doi: 10.1016/j.jacadv.2024.101235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101235</ArticleId><ArticleId IdType="pmc">PMC11540864</ArticleId><ArticleId IdType="pubmed">39512540</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson M.J., Sonnenberg B., Woo A., Rakowski P., Parker T.G., Wigle E.D., Rakowski H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 2002;39:638&#x2013;645. doi: 10.1016/S0735-1097(01)01778-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(01)01778-8</ArticleId><ArticleId IdType="pubmed">11849863</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R.K., Knott K.D., Malcolmson J., Augusto J.B., Mohiddin S.A., Kellman P., Moon J.C., Captur G. Apical Hypertrophic Cardiomyopathy: The Variant Less Known. J. Am. Heart Assoc. 2020;9:e015294. doi: 10.1161/JAHA.119.015294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.015294</ArticleId><ArticleId IdType="pmc">PMC7335568</ArticleId><ArticleId IdType="pubmed">32106746</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q.F., Zou J., Katsouras C.S., You S., Zhou J., Ge H.B., Liu C., Zhou X., Ni C., Peng Y., et al. Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy. J. Am. Heart Assoc. 2024;13:e036663. doi: 10.1161/JAHA.124.036663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.124.036663</ArticleId><ArticleId IdType="pmc">PMC11681465</ArticleId><ArticleId IdType="pubmed">39291501</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B. Personalizing Apical Hypertrophic Cardiomyopathy Diagnosis: A Major Step Forward, but Challenges Remain. JACC Cardiovasc. Imaging. 2024;17:513&#x2013;515. doi: 10.1016/j.jcmg.2023.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.08.016</ArticleId><ArticleId IdType="pubmed">37855798</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P.M., Anastasakis A., Borger M.A., Borggrefe M., Cecchi F., Charron P., Hagege A.A., Lafont A., Limongelli G., Mahrholdt H., et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) Eur. Heart J. 2014;35:2733&#x2013;2779. doi: 10.1093/eurheartj/ehu284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehu284</ArticleId><ArticleId IdType="pubmed">25173338</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen S.R., Mital S., Burke M.A., Day S.M., Deswal A., Elliott P., Evanovich L.L., Hung J., Joglar J.A., Kantor P., et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2020;76:e159&#x2013;e240. doi: 10.1016/j.jacc.2020.08.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.045</ArticleId><ArticleId IdType="pubmed">33229116</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E., Protonotarios A., Gimeno J.R., Arbustini E., Barriales-Villa R., Basso C., Bezzina C.R., Biagini E., Blom N.A., de Boer R.A., et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur. Heart J. 2023;44:3503&#x2013;3626. doi: 10.1093/eurheartj/ehad194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad194</ArticleId><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R.K., Shiwani H., Rosmini S., Augusto J.B., Burke L., Jiang Y., Pierce I., Joy G., Castelletti S., Orini M., et al. Improved Diagnostic Criteria for Apical Hypertrophic Cardiomyopathy. JACC Cardiovasc. Imaging. 2024;17:501&#x2013;512. doi: 10.1016/j.jcmg.2023.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2023.07.012</ArticleId><ArticleId IdType="pubmed">37831014</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., He J., Xu J., Zhuang B., Wu B., Wei B., Huang J., Yin G., Chen X., Zhu Z., et al. Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: A cardiovascular magnetic resonance mid-term follow-up study. J. Cardiovasc. Magn. Reson. Off. J. Soc. Cardiovasc. Magn. Reson. 2021;23:67. doi: 10.1186/s12968-020-00700-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00700-5</ArticleId><ArticleId IdType="pmc">PMC8173876</ArticleId><ArticleId IdType="pubmed">34078401</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura K., Kubo T., Yamada T., Inoue S., Nomura S., Ochi Y., Baba Y., Hirota T., Morita H., Yamasaki N., et al. Clinical significance and genetic basis of hypertrophic cardiomyopathy with apical phenotype: Comparison of pure-apical form and distal-dominant form. Eur. Heart J. 2023;44((Suppl. S2)):ehad655-1850. doi: 10.1093/eurheartj/ehad655.1850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad655.1850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura K., Kubo T., Inoue S., Nomura S., Yamada T., Tobita T., Kuramoto Y., Miyashita Y., Asano Y., Ochi Y., et al. Unveiling Clinical and Genetic Distinctions in Pure-Apical Versus Distal-Dominant Apical Hypertrophic Cardiomyopathy. J. Am. Heart Assoc. 2025;14:e038208. doi: 10.1161/JAHA.124.038208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.124.038208</ArticleId><ArticleId IdType="pubmed">40055852</ArticleId></ArticleIdList></Reference><Reference><Citation>Arad M., Penas-Lado M., Monserrat L., Maron B.J., Sherrid M., Ho C.Y., Barr S., Karim A., Olson T.M., Kamisago M., et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005;112:2805&#x2013;2811. doi: 10.1161/CIRCULATIONAHA.105.547448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.547448</ArticleId><ArticleId IdType="pubmed">16267253</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruner C., Care M., Siminovitch K., Moravsky G., Wigle E.D., Woo A., Rakowski H. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 2011;4:288&#x2013;295. doi: 10.1161/CIRCGENETICS.110.958835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGENETICS.110.958835</ArticleId><ArticleId IdType="pubmed">21511876</ArticleId></ArticleIdList></Reference><Reference><Citation>Towe E.C., Bos J.M., Ommen S.R., Gersh B.J., Ackerman M.J. Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy. Congenit. Heart Dis. 2015;10:E139&#x2013;E145. doi: 10.1111/chd.12242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/chd.12242</ArticleId><ArticleId IdType="pubmed">25495007</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson T.M., Doan T.P., Kishimoto N.Y., Whitby F.G., Ackerman M.J., Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2000;32:1687&#x2013;1694. doi: 10.1006/jmcc.2000.1204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmcc.2000.1204</ArticleId><ArticleId IdType="pubmed">10966831</ArticleId></ArticleIdList></Reference><Reference><Citation>Monserrat L., Hermida-Prieto M., Fernandez X., Rodr&#xed;guez I., Dumont C., Caz&#xf3;n L., Cuesta M.G., Gonzalez-Juanatey C., Peteiro J., Alvarez N., et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur. Heart J. 2007;28:1953&#x2013;1961. doi: 10.1093/eurheartj/ehm239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehm239</ArticleId><ArticleId IdType="pubmed">17611253</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. Off. J. Am. Coll. Med. Genet. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng L., Attali R., Talmy T., Regev Y., Mizrahi N., Smirin-Yosef P., Vossaert L., Taborda C., Santana M., Machol I., et al. Evaluation of an automated genome interpretation model for rare disease routinely used in a clinical genetic laboratory. Genet. Med. Off. J. Am. Coll. Med. Genet. 2023;25:100830. doi: 10.1016/j.gim.2023.100830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gim.2023.100830</ArticleId><ArticleId IdType="pubmed">36939041</ArticleId></ArticleIdList></Reference><Reference><Citation>Reza N., Garg A., Merrill S.L., Chowns J.L., Rao S., Owens A.T. ACTA1 Novel Likely Pathogenic Variant in a Family With Dilated Cardiomyopathy. Circ. Genom. Precis. Med. 2018;11:e002243. doi: 10.1161/CIRCGEN.118.002243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCGEN.118.002243</ArticleId><ArticleId IdType="pmc">PMC6208136</ArticleId><ArticleId IdType="pubmed">30354303</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az Exp&#xf3;sito A., Robles Mezcua A., P&#xe9;rez Cabeza A.I., Garc&#xed;a Pinilla J.M. A new mutation in the ACTA1 gene possibly associated with dilated cardiomyopathy without concomitant myopathy. Rev. Espa&#xf1;ola Cardiol. 2022;75:850&#x2013;852. doi: 10.1016/j.rec.2022.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2022.03.005</ArticleId><ArticleId IdType="pubmed">35597757</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes L.R., Ho C.Y., Elliott P.M. Genetics of hypertrophic cardiomyopathy: Established and emerging implications for clinical practice. Eur. Heart J. 2024;45:2727&#x2013;2734. doi: 10.1093/eurheartj/ehae421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae421</ArticleId><ArticleId IdType="pmc">PMC11313585</ArticleId><ArticleId IdType="pubmed">38984491</ArticleId></ArticleIdList></Reference><Reference><Citation>Velicki L., Jakovljevic D.G., Preveden A., Golubovic M., Bjelobrk M., Ilic A., Stojsic S., Barlocco F., Tafelmeier M., Okwose N., et al. Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy. BMC Cardiovasc. Disord. 2020;20:516. doi: 10.1186/s12872-020-01807-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-020-01807-4</ArticleId><ArticleId IdType="pmc">PMC7727200</ArticleId><ArticleId IdType="pubmed">33297970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen J., Perrot A., Andersen P.S., Havndrup O., Klausen I.C., Christiansen M., Bross P., Egeblad H., Bundgaard H., Osterziel K.J., et al. Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy. J. Med. Genet. 2004;41:e10. doi: 10.1136/jmg.2003.010447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2003.010447</ArticleId><ArticleId IdType="pmc">PMC1757257</ArticleId><ArticleId IdType="pubmed">14729850</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J.S., Hassanzadeh S., Winitsky S., Lin H., Satorius C., Vemuri R., Aletras A.H., Wen H., Epstein N.D. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 2001;107:631&#x2013;641. doi: 10.1016/S0092-8674(01)00586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00586-4</ArticleId><ArticleId IdType="pubmed">11733062</ArticleId></ArticleIdList></Reference><Reference><Citation>Middelbeek J., Clark K., Venselaar H., Huynen M.A., van Leeuwen F.N. The alpha-kinase family: An exceptional branch on the protein kinase tree. Cell. Mol. Life Sci. 2010;67:875&#x2013;890. doi: 10.1007/s00018-009-0215-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-009-0215-z</ArticleId><ArticleId IdType="pmc">PMC2827801</ArticleId><ArticleId IdType="pubmed">20012461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes L.R., Garcia-Hern&#xe1;ndez S., Lorenzini M., Futema M., Chumakova O., Zateyshchikov D., Isidoro-Garcia M., Villacorta E., Escobar-Lopez L., Garcia-Pavia P., et al. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur. Heart J. 2021;42:3063&#x2013;3073. doi: 10.1093/eurheartj/ehab424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab424</ArticleId><ArticleId IdType="pmc">PMC8380059</ArticleId><ArticleId IdType="pubmed">34263907</ArticleId></ArticleIdList></Reference><Reference><Citation>Ader F., Jedraszak G., Janin A., Billon C., Buisson N.R., Bloch A., Bensalah M., De Sandre-Giovannoli A., Goudal A., Marsili L., et al. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy. Clin. Genet. 2024;105:676&#x2013;682. doi: 10.1111/cge.14505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cge.14505</ArticleId><ArticleId IdType="pubmed">38356193</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse L., Huth E.A., Abraham M.R., Abraham T., Padmanabhan A., Wojciak J., Wright G., Aatre R., Campagna R., Jackson E., et al. ALPK3 heterozygous truncating variants cause late-onset hypertrophic cardiomyopathy with frequent apical involvement and apical aneurysm. medRxiv. 2024 doi: 10.1101/2024.11.14.24317359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2024.11.14.24317359</ArticleId></ArticleIdList></Reference><Reference><Citation>Laing N.G., Dye D.E., Wallgren-Pettersson C., Richard G., Monnier N., Lillis S., Winder T.L., Lochm&#xfc;ller H., Graziano C., Mitrani-Rosenbaum S., et al. Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1) Hum. Mutat. 2009;30:1267&#x2013;1277. doi: 10.1002/humu.21059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21059</ArticleId><ArticleId IdType="pmc">PMC2784950</ArticleId><ArticleId IdType="pubmed">19562689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.Y., Park Y.E., Kim H.S., Lee C.H., Yang D.H., Kim D.S. Nemaline myopathy and non-fatal hypertrophic cardiomyopathy caused by a novel ACTA1 E239K mutation. J. Neurol. Sci. 2011;307:171&#x2013;173. doi: 10.1016/j.jns.2011.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.04.022</ArticleId><ArticleId IdType="pubmed">21570694</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico A., Graziano C., Pacileo G., Petrini S., Nowak K.J., Boldrini R., Jacques A., Feng J.J., Porfirio B., Sewry C.A., et al. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation. Neuromuscul. Disord. 2006;16:548&#x2013;552. doi: 10.1016/j.nmd.2006.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2006.07.005</ArticleId><ArticleId IdType="pubmed">16945537</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfares A.A., Kelly M.A., McDermott G., Funke B.H., Lebo M.S., Baxter S.B., Shen J., McLaughlin H.M., Clark E.H., Babb L.J., et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: Expanded panels offer limited additional sensitivity. Genet. Med. 2015;17:880&#x2013;888. doi: 10.1038/gim.2014.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2014.205</ArticleId><ArticleId IdType="pubmed">25611685</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A., Jansen S., Greenberg L., Zhang R., Lavine K.J., Greenberg M.J. Dilated cardiomyopathy-associated skeletal muscle actin (ACTA1) mutation R256H disrupts actin structure and function and causes cardiomyocyte hypocontractility. Proc. Natl. Acad. Sci. USA. 2024;121:e2405020121. doi: 10.1073/pnas.2405020121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2405020121</ArticleId><ArticleId IdType="pmc">PMC11572969</ArticleId><ArticleId IdType="pubmed">39503885</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan V., Vukadinovic M., Kwan A.C., Rader F., Li D., Ouyang D. Clinical and genetic associations of asymmetric apical and septal left ventricular hypertrophy. Eur. Heart J. Digit. Health. 2024;5:591&#x2013;600. doi: 10.1093/ehjdh/ztae060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztae060</ArticleId><ArticleId IdType="pmc">PMC11417484</ArticleId><ArticleId IdType="pubmed">39318696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y., Hu W., Zhang L., Wu D., Yang C., Ye X. Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy. Int. J. Cardiovasc. Imaging. 2022;38:643&#x2013;651. doi: 10.1007/s10554-021-02430-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-021-02430-w</ArticleId><ArticleId IdType="pubmed">34652588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.E., Park J.K., Uhm J.S., Kim J.Y., Pak H.N., Lee M.H., Joung B. Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy. Heart. 2017;103:1496&#x2013;1501. doi: 10.1136/heartjnl-2016-310720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2016-310720</ArticleId><ArticleId IdType="pubmed">28428444</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivotto I., Cecchi F., Casey S.A., Dolara A., Traverse J.H., Maron B.J. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517&#x2013;2524. doi: 10.1161/hc4601.097997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc4601.097997</ArticleId><ArticleId IdType="pubmed">11714644</ArticleId></ArticleIdList></Reference><Reference><Citation>Debonnaire P., Joyce E., Hiemstra Y., Mertens B.J., Atsma D.E., Schalij M.J., Bax J.J., Delgado V., Marsan N.A. Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation. Circ. Arrhythmia Electrophysiol. 2017;10:e004052. doi: 10.1161/CIRCEP.116.004052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.116.004052</ArticleId><ArticleId IdType="pubmed">28183843</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes L.R., Syrris P., Guttmann O.P., O'Mahony C., Tang H.C., Dalageorgou C., Jenkins S., Hubank M., Monserrat L., McKenna W.J., et al. Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy. Heart. 2015;101:294&#x2013;301. doi: 10.1136/heartjnl-2014-306387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-306387</ArticleId><ArticleId IdType="pmc">PMC4345808</ArticleId><ArticleId IdType="pubmed">25351510</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat-Hamedani F., Kayvanpour E., Tugrul O.F., Lai A., Amr A., Haas J., Proctor T., Ehlermann P., Jensen K., Katus H.A., et al. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: A meta-analysis on 7675 individuals. Clin. Res. Cardiol. Off. J. Ger. Card. Soc. 2018;107:30&#x2013;41. doi: 10.1007/s00392-017-1155-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-017-1155-5</ArticleId><ArticleId IdType="pubmed">28840316</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.C., Lei M.H., Hsu Y.C., Chung S.L., Sung Y.J. Apical hypertrophic cardiomyopathy: Correlations between echocardiographic parameters, angiographic left ventricular morphology, and clinical outcomes. Clin. Cardiol. 2011;34:233&#x2013;238. doi: 10.1002/clc.20874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.20874</ArticleId><ArticleId IdType="pmc">PMC6652360</ArticleId><ArticleId IdType="pubmed">21400548</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40432696</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2398-8835</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Health science reports</Title><ISOAbbreviation>Health Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Adrenal Insufficiency Associated Cardiomyopathy, From Molecule to Clinic: A Comprehensive Review.</ArticleTitle><Pagination><StartPage>e70702</StartPage><MedlinePgn>e70702</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70702</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/hsr2.70702</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM" NlmCategory="UNASSIGNED">Adrenal insufficiency (AI), the lack of glucocorticoids (GCs) production or function with or without a lack of mineralocorticoids (MCs) and adrenal androgens, can result in uncommon but life-threatening complications like shock, circulatory failure, syncope, arrhythmias, dilated cardiomyopathy (DCM), and congestive heart failure (CHF). In this article, we aim to comprehensively review the cardiomyopathy (CMP) secondary to AI.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This review focused on CMP secondary to AI. A systematic search was conducted in Pubmed, GoogleScholar, and Embase. The relevant articles were included in this review.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All three kinds of AI-primary, secondary, and tertiary-have been associated with CMP. AI can cause takotsubo CMP, lethal arrhythmias, and DCM. There have been reports of CMP in all three kinds of AI: primary, secondary, and tertiary. AI can manifest as newly developed systolic HF and contribute to cardiovascular disease. When adrenal replacement therapy is started in patients with adrenal failure, heart function improves quickly. Early detection could stop this phenomenon from happening again.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Herein, we provided an overview of AI-associated CMP regarding underlying causes, pathophysiology, associated symptoms, diagnosis, and treatment of AI-associated CMP. Adrenal replacement therapy can quickly improve heart function. More research is needed to explore the effects of GCs and MCs on the heart and to better understand associated conditions.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Health Science Reports published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bazgir</LastName><ForeName>Narges</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Hearing Disorder Research Center, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soltani</LastName><ForeName>Afsaneh</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network of Interdisciplinarity in Neonates and Infants (NINI) Universal Scientific Education and Research Network (USERN) Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>USERN Office Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohajer</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Network of Interdisciplinarity in Neonates and Infants (NINI) Universal Scientific Education and Research Network (USERN) Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>USERN Office Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabari</LastName><ForeName>Mohammad Amin Khazeei</ForeName><Initials>MAK</Initials><Identifier Source="ORCID">0000-0001-6415-8403</Identifier><AffiliationInfo><Affiliation>Network of Interdisciplinarity in Neonates and Infants (NINI) Universal Scientific Education and Research Network (USERN) Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Student Research Committee Mazandaran University of Medical Sciences Sari Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>USERN Office Mazandaran University of Medical Sciences Sari Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslami</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-4304-3997</Identifier><AffiliationInfo><Affiliation>USERN Office Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interventional Cardiology, Clinical Research Development Center, Shahid Modarres Educational Hospital Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Research Center Shahid Beheshti University of Medical Sciences Tehran Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Health Sci Rep</MedlineTA><NlmUniqueID>101728855</NlmUniqueID><ISSNLinking>2398-8835</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenal insufficiency</Keyword><Keyword MajorTopicYN="N">cardiomyopathies</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">dilated</Keyword><Keyword MajorTopicYN="N">takotsubo cardiomyopathy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40432696</ArticleId><ArticleId IdType="pmc">PMC12107600</ArticleId><ArticleId IdType="doi">10.1002/hsr2.70702</ArticleId><ArticleId IdType="pii">HSR270702</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bornstein S. R., &#x201c;Predisposing Factors for Adrenal Insufficiency,&#x201d; New England Journal of Medicine 360, no. 22 (2009): 2328&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pubmed">19474430</ArticleId></ArticleIdList></Reference><Reference><Citation>Huecker M. R., Bhutta B. S., and Dominique E., &#x201c;Adrenal Insufficiency,&#x201d; in StatPearls (StatPearls Publishing, 2025).</Citation><ArticleIdList><ArticleId IdType="pubmed">28722862</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison T., On the Constitutional and Local Effects of Disease of the Supura&#x2010;Renal Capsules (1855).</Citation></Reference><Reference><Citation>Mitchell A. L. and Pearce S. H. S., &#x201c;Autoimmune Addison Disease: Pathophysiology and Genetic Complexity,&#x201d; Nature Reviews Endocrinology 8, no. 5 (2012): 306&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">22290360</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E. S. and L&#xf8;v&#xe5;s K., &#x201c;Immunology of Addison's Disease and Premature Ovarian Failure,&#x201d; Endocrinology and Metabolism Clinics of North America 38, no. 2 (2009): 389&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">19328418</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E. and L&#xf8;v&#xe5;s K., &#x201c;Pathogenesis of Primary Adrenal Insufficiency,&#x201d; Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism 23, no. 2 (2009): 147&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">19500759</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E. S., Anderson M. S., and K&#xe4;mpe O., &#x201c;Autoimmune Polyendocrine Syndromes,&#x201d; New England Journal of Medicine 378, no. 12 (2018): 1132&#x2013;1141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6007870</ArticleId><ArticleId IdType="pubmed">29562162</ArticleId></ArticleIdList></Reference><Reference><Citation>Nieman L. K. and Chanco Turner M. L., &#x201c;Addison's Disease,&#x201d; Clinics in Dermatology 24, no. 4 (2006): 276&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">16828409</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsote M. and Nistor C., &#x201c;Addison's Disease: Diagnosis and Management Strategies,&#x201d; International Journal of General Medicine 16 (2023): 2187&#x2013;2210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10243343</ArticleId><ArticleId IdType="pubmed">37287503</ArticleId></ArticleIdList></Reference><Reference><Citation>Ten S., New M., and Maclaren N., &#x201c;Clinical Review 130: Addison's Disease 2001,&#x201d; Journal of Clinical Endocrinology and Metabolism 86, no. 7 (2001): 2909&#x2013;2922.</Citation><ArticleIdList><ArticleId IdType="pubmed">11443143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bancos I., Hahner S., Tomlinson J., and Arlt W., &#x201c;Diagnosis and Management of Adrenal Insufficiency,&#x201d; Lancet Diabetes &amp; Endocrinology 3, no. 3 (2015): 216&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">25098712</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensing S., Hulting A.&#x2010;L., Husebye E. S., K&#xe4;mpe O., and L&#xf8;v&#xe5;s K., &#x201c;Management of Endocrine Disease: Epidemiology, Quality of Life and Complications of Primary Adrenal Insufficiency: A Review,&#x201d; European Journal of Endocrinology 175, no. 3 (2016): R107&#x2013;R116.</Citation><ArticleIdList><ArticleId IdType="pubmed">27068688</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolaides N. C., Chrousos G. P., and Charmandari E., &#x201c;Adrenal Insufficiency,&#x201d; Lancet 383, no. 9935 (2014): 2152&#x2013;2167, 10.1016/S0140-6736(13)61684-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61684-0</ArticleId><ArticleId IdType="pubmed">24503135</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumaecker M. M., Larsen T. R., and Sane D. C., &#x201c;Cardiac Manifestations of Adrenal Insufficiency,&#x201d; Reviews in Cardiovascular Medicine 17, no. 3&#x2013;4 (2016): 131&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">28144020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushner G. B., Zahler S. F., and Hills A. G., &#x201c;Untreated Addison's Disease Complicated by Pulmonary Congestion Due to Left Ventricular Failure,&#x201d; Annals of Internal Medicine 58, no. 2 (1963): 341&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">14024378</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff B., Machill K., Schulzki I., Schumacher D., and Werner D., &#x201c;Acute Reversible Cardiomyopathy With Cardiogenic Shock in a Patient With Addisonian Crisis: A Case Report,&#x201d; International Journal of Cardiology 116, no. 2 (2007): e71&#x2013;e73.</Citation><ArticleIdList><ArticleId IdType="pubmed">17079038</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug J. J., &#x201c;Cardiac Arrest Secondary to Addison's Disease,&#x201d; Annals of Emergency Medicine 15, no. 6 (1986): 735&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">3706867</ArticleId></ArticleIdList></Reference><Reference><Citation>Erichsen M. M., L&#xf8;v&#xe5;s K., Fougner K. J., et al., &#x201c;Normal Overall Mortality Rate in Addison's Disease, But Young Patients Are at Risk of Premature Death,&#x201d; European Journal of Endocrinology 160, no. 2 (2009): 233&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">19011006</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G., Neumann K., Badenhoop K., and Linder R., &#x201c;Increasing Prevalence of Addison's Disease in German Females: Health Insurance Data 2008&#x2013;2012,&#x201d; European Journal of Endocrinology 170, no. 3 (2014): 367&#x2013;373.</Citation><ArticleIdList><ArticleId IdType="pubmed">24322183</ArticleId></ArticleIdList></Reference><Reference><Citation>Charmandari E., Nicolaides N. C., and Chrousos G. P., &#x201c;Adrenal Insufficiency,&#x201d; Lancet 383, no. 9935 (2014): 2152&#x2013;2167.</Citation><ArticleIdList><ArticleId IdType="pubmed">24503135</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S. and White P. C., &#x201c;Presentation of Primary Adrenal Insufficiency in Childhood,&#x201d; Journal of Clinical Endocrinology and Metabolism 96, no. 6 (2011): 925&#x2013;928.</Citation><ArticleIdList><ArticleId IdType="pubmed">21470994</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry R., Kecha O., Paquette J., Huot C., Van Vliet G., and Deal C., &#x201c;Primary Adrenal Insufficiency in Children: Twenty Years Experience at the Sainte&#x2010;Justine Hospital, Montreal,&#x201d; Journal of Clinical Endocrinology and Metabolism 90, no. 6 (2005): 3243&#x2013;3250.</Citation><ArticleIdList><ArticleId IdType="pubmed">15811934</ArticleId></ArticleIdList></Reference><Reference><Citation>Capalbo D., Moracas C., Cappa M., et al., &#x201c;Primary Adrenal Insufficiency in Childhood: Data From a Large Nationwide Cohort,&#x201d; Journal of Clinical Endocrinology and Metabolism 106, no. 3 (2021): 762&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pubmed">33247909</ArticleId></ArticleIdList></Reference><Reference><Citation>Therrell B. L. Jr., Berenbaum S. A., Manter&#x2010;Kapanke V., et al., &#x201c;Results of Screening 1.9 Million Texas Newborns for 21&#x2010;Hydroxylase&#x2010;Deficient Congenital Adrenal Hyperplasia,&#x201d; Pediatrics 101, no. 4 Pt 1 (1998): 583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521938</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyal O., Levin Y., Oren A., et al., &#x201c;Adrenal Crises in Children With Adrenal Insufficiency: Epidemiology and Risk Factors,&#x201d; European Journal of Pediatrics 178, no. 5 (2019): 731&#x2013;738.</Citation><ArticleIdList><ArticleId IdType="pubmed">30806790</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonocore F. and Achermann J. C., &#x201c;Primary Adrenal Insufficiency: New Genetic Causes and Their Long&#x2010;Term Consequences,&#x201d; Clinical Endocrinology 92, no. 1 (2020): 11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6916405</ArticleId><ArticleId IdType="pubmed">31610036</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zer Y., Turan H., Da&#x11f;deviren &#xc7;ak&#x131;r A., et al., &#x201c;Left Ventricular Systolic Dysfunction Related to Adrenal Insufficiency in a Case Due to Autoimmune Polyendocrine Syndrome Type 1 With a Novel Variant,&#x201d; Molecular Syndromology 14, no. 1 (2023): 65&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9911995</ArticleId><ArticleId IdType="pubmed">36777707</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer G. and Badenhoop K., &#x201c;Addison&#x2010;Krise&#x2013;Risiko Erkennen Und Rasch Behandeln,&#x201d; DMW&#x2010;Deutsche Medizinische Wochenschrift 143, no. 06 (2018): 392&#x2013;396.</Citation><ArticleIdList><ArticleId IdType="pubmed">29544234</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushworth R. L., Torpy D. J., Stratakis C. A., and Falhammar H., &#x201c;Adrenal Crises in Children: Perspectives and Research Directions,&#x201d; Hormone Research in Paediatrics 89, no. 5 (2018): 341&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">29874655</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary N. and Nieman L., &#x201c;Adrenal Insufficiency&#x2010;Etiology, Diagnosis and Treatment,&#x201d; Current Opinion in Endocrinology, Diabetes &amp; Obesity 17, no. 3 (2010): 217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2928659</ArticleId><ArticleId IdType="pubmed">20375886</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipsson H., Monson J. P., Koltowska&#x2010;H&#xe4;ggstr&#xf6;m M., Mattsson A., and Johannsson G., &#x201c;The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients,&#x201d; Journal of Clinical Endocrinology and Metabolism 91, no. 10 (2006): 3954&#x2013;3961.</Citation><ArticleIdList><ArticleId IdType="pubmed">16895963</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergthorsdottir R., Ragnarsson O., Skrtic S., et al., &#x201c;Visceral Fat and Novel Biomarkers of Cardiovascular Disease in Patients With Addison's Disease: A Case&#x2010;Control Study,&#x201d; Journal of Clinical Endocrinology and Metabolism 102, no. 11 (2017): 4264&#x2013;4272.</Citation><ArticleIdList><ArticleId IdType="pubmed">28945861</ArticleId></ArticleIdList></Reference><Reference><Citation>Pignatti E. and Fl&#xfc;ck C. E., &#x201c;Adrenal Cortex Development and Related Disorders Leading to Adrenal Insufficiency,&#x201d; Molecular and Cellular Endocrinology 527 (2021): 111206.</Citation><ArticleIdList><ArticleId IdType="pubmed">33607267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira S., Carvalho L., Costa M., et al., &#x201c;Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology,&#x201d; Biomedicines 9, no. 4 (2021): 441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8074383</ArticleId><ArticleId IdType="pubmed">33924172</ArticleId></ArticleIdList></Reference><Reference><Citation>Svedmyr N., &#x201c;Action of Corticosteroids on Beta&#x2010;Adrenergic Receptors. Clinical Aspects,&#x201d; American Review of Respiratory Disease 141, no. 2 pt. 2 (1990): 31&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">1968733</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitworth J. A., Mangos G. J., and Kelly J. J., &#x201c;Cushing, Cortisol, and Cardiovascular Disease,&#x201d; Hypertension 36, no. 5 (2000): 912&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pubmed">11082166</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcayre C., &#x201c;Molecular Mechanisms of Myocardial Remodeling. The Role of Aldosterone,&#x201d; Journal of Molecular and Cellular Cardiology 34, no. 12 (2002): 1577&#x2013;1584.</Citation><ArticleIdList><ArticleId IdType="pubmed">12505056</ArticleId></ArticleIdList></Reference><Reference><Citation>Bratland E. and Husebye E. S., &#x201c;Cellular Immunity and Immunopathology in Autoimmune Addison's Disease,&#x201d; Molecular and Cellular Endocrinology 336, no. 1&#x2013;2 (2011): 180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">21167251</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallo F., Betterle C., Budano S., Lupia M., Boscaro M., and Sonino N., &#x201c;Regression of Cardiac Abnormalities After Replacement Therapy in Addison's Disease,&#x201d; European Journal of Endocrinology 140, no. 5 (1999): 425&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">10229908</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.&#x2010;K., Yang Z.&#x2010;G., Li Y., et al., &#x201c;Addison's Disease Due to Adrenal Tuberculosis: Contrast&#x2010;Enhanced CT Features and Clinical Duration Correlation,&#x201d; European Journal of Radiology 62, no. 1 (2007): 126&#x2013;131.</Citation><ArticleIdList><ArticleId IdType="pubmed">17182208</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik P. E., Kiminyo K., and Zaloga G. P., &#x201c;Adrenal Insufficiency in Critically Ill Patients With Human Immunodeficiency Virus,&#x201d; Critical Care Medicine 30, no. 6 (2002): 1267&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pubmed">12072680</ArticleId></ArticleIdList></Reference><Reference><Citation>Alirezaei T., Agha Mohammadi M. K., and Irilouzadian R., &#x201c;Marijuana&#x2010;Induced Myocarditis in a 24&#x2010;Year&#x2010;Old Man,&#x201d; Archive of Clinical Cases 9, no. 2 (2022): 69&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262081</ArticleId><ArticleId IdType="pubmed">35813492</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscatelli F., Strom T. M., Walker A. P., et al., &#x201c;Mutations in the DAX&#x2010;1 Gene Give Rise to Both X&#x2010;Linked Adrenal Hypoplasia Congenita and Hypogonadotropic Hypogonadism,&#x201d; Nature 372, no. 6507 (1994): 672&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">7990958</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanaria E., Muscatelli F., Bardoni B., et al., &#x201c;An Unusual Member of the Nuclear Hormone Receptor Superfamily Responsible for X&#x2010;Linked Adrenal Hypoplasia Congenita,&#x201d; Nature 372, no. 6507 (1994): 635&#x2013;641.</Citation><ArticleIdList><ArticleId IdType="pubmed">7990953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel H., Shemer R., Borochowitz Z. U., et al., &#x201c;SERKAL Syndrome: an Autosomal&#x2010;Recessive Disorder Caused by a Loss&#x2010;of&#x2010;Function Mutation in WNT4,&#x201d; American Journal of Human Genetics 82, no. 1 (2008): 39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2253972</ArticleId><ArticleId IdType="pubmed">18179883</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraz&#x2010;de&#x2010;Souza B., Lin L., and Achermann J. C., &#x201c;Steroidogenic Factor&#x2010;1 (SF&#x2010;1, NR5A1) and Human Disease,&#x201d; Molecular and Cellular Endocrinology 336, no. 1&#x2013;2 (2011): 198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3057017</ArticleId><ArticleId IdType="pubmed">21078366</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilain E., Le Merrer M., Lecointre C., et al., &#x201c;IMAGe, a New Clinical Association of I Ntrauterine Growth Retardation, M Etaphyseal Dysplasia, A Drenal Hypoplasia Congenita, and Ge Nital Anomalies,&#x201d; Journal of Clinical Endocrinology and Metabolism 84, no. 12 (1999): 4335&#x2013;4340.</Citation><ArticleIdList><ArticleId IdType="pubmed">10599684</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan C. V., Murray J. E., Parry D. A., et al., &#x201c;DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome With Variable Immunodeficiency,&#x201d; American Journal of Human Genetics 103, no. 6 (2018): 1038&#x2013;1044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288413</ArticleId><ArticleId IdType="pubmed">30503519</ArticleId></ArticleIdList></Reference><Reference><Citation>Narumi S., Amano N., Ishii T., et al., &#x201c;SAMD9 Mutations Cause a Novel Multisystem Disorder, Mirage Syndrome, and Are Associated With Loss of Chromosome 7,&#x201d; Nature Genetics 48, no. 7 (2016): 792&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">27182967</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A. J., Metherell L. A., Cheetham M. E., and Huebner A., &#x201c;Inherited ACTH Insensitivity Illuminates the Mechanisms of ACTH Action,&#x201d; Trends in Endocrinology and Metabolism: TEM 16, no. 10 (2005): 451&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">16271481</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A. J. L. and Weber A., &#x201c;Adrenocorticotropin Insensitivity Syndromes,&#x201d; Endocrine Reviews 19, no. 6 (1998): 828&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pubmed">9861547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan L. F., Chung T.&#x2010;T., Massoud A. F., Metherell L. A., and Clark A. J. L., &#x201c;Functional Consequence of a Novel Y129C Mutation in a Patient With Two Contradictory Melanocortin&#x2010;2&#x2010;Receptor Mutations,&#x201d; European Journal of Endocrinology 160, no. 4 (2009): 705&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754377</ArticleId><ArticleId IdType="pubmed">19151134</ArticleId></ArticleIdList></Reference><Reference><Citation>White P. C., &#x201c;Aldosterone Synthase Deficiency and Related Disorders,&#x201d; Molecular and Cellular Endocrinology 217, no. 1&#x2013;2 (2004): 81&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">15134805</ArticleId></ArticleIdList></Reference><Reference><Citation>Zennaro M.&#x2010;C. and Lomb&#xe8;s M., &#x201c;Mineralocorticoid Resistance,&#x201d; Trends in Endocrinology and Metabolism: TEM 15, no. 6 (2004): 264&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">15358279</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandison A. T., &#x201c;A Form of Lipoidosis of the Adrenal Cortex in an Infant,&#x201d; Archives of Disease in Childhood 30, no. 154 (1955): 538&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2011836</ArticleId><ArticleId IdType="pubmed">13275986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C. J., &#x201c;Congenital Lipoid Adrenal Hyperplasia,&#x201d; Annals of Pediatric Endocrinology &amp; Metabolism 19, no. 4 (2014): 179&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4316413</ArticleId><ArticleId IdType="pubmed">25654062</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S., &#x201c;The Molecular and Clinical Spectrum of 3Beta&#x2010;Hydroxysteroid Dehydrogenase Deficiency Disorder,&#x201d; Trends in Endocrinology and Metabolism: TEM 9, no. 2 (1998): 82&#x2013;86, 10.1016/s1043-2760(98)00015-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1043-2760(98)00015-0</ArticleId><ArticleId IdType="pubmed">18406247</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahakitrungruang T., Huang N., Tee M. K., et al., &#x201c;Clinical, Genetic, and Enzymatic Characterization of P450 Oxidoreductase Deficiency in Four Patients,&#x201d; Journal of Clinical Endocrinology &amp; Metabolism 94, no. 12 (2009): 4992&#x2013;5000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795645</ArticleId><ArticleId IdType="pubmed">19837910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimkarn S., Gangishetti P. K., Yau M., and M. I. New, &#x201c;21&#x2010;Hydroxylase&#x2010;Deficient Congenital Adrenal Hyperplasia,&#x201d; 2016.</Citation></Reference><Reference><Citation>Nimkarn S. and New M. I., &#x201c;Steroid 11Beta&#x2010;Hydroxylase Deficiency Congenital Adrenal Hyperplasia,&#x201d; Trends in Endocrinology and Metabolism: TEM 19, no. 3 (2008): 96&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">18294861</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Lu L., Wang O., et al., &#x201c;High Incidence of Hypertension&#x2010;Mediated Organ Damage in a Series of Chinese Patients With 17&#x3b1;&#x2010;Hydroxylase Deficiency,&#x201d; Endocrine 76, no. 1 (2022): 151&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">35032013</ArticleId></ArticleIdList></Reference><Reference><Citation>Auchus R. J., &#x201c;Steroid 17&#x2010;Hydroxylase and 17, 20&#x2010;Lyase Deficiencies, Genetic and Pharmacologic,&#x201d; Journal of Steroid Biochemistry and Molecular Biology 165 (2017): 71&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4976049</ArticleId><ArticleId IdType="pubmed">26862015</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller W. L., &#x201c;Mechanisms in Endocrinology: Rare Defects in Adrenal Steroidogenesis,&#x201d; European Journal of Endocrinology 179, no. 3 (2018): R125&#x2013;R141.</Citation><ArticleIdList><ArticleId IdType="pubmed">29880708</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabre O., Goichot B., Zenaty D., and Bertherat J., eds., Group 1. Epidemiology of Primary and Secondary Adrenal Insufficiency: Prevalence and Incidence, Acute Adrenal Insufficiency, Long&#x2010;Term Morbidity and Mortality (Annales d'endocrinologie, Elsevier, 2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29174931</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngaosuwan K., Johnston D. G., Godsland I. F., et al., &#x201c;Increased Mortality Risk in Patients With Primary and Secondary Adrenal Insufficiency,&#x201d; Journal of Clinical Endocrinology and Metabolism 106, no. 7 (2021): 2759.</Citation><ArticleIdList><ArticleId IdType="pubmed">33596308</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu M. V., Poonam P., Ramteke V. V., et al., &#x201c;A Case of Sheehan Syndrome Presenting With Pancytopenia and Dilated Cardiomyopathy: A Rare Combination,&#x201d; Journal of Advanced Research in Medicine (E&#x2010;ISSN: 2349&#x2010;7181 &amp; P&#x2010;ISSN: 2394&#x2010;7047) 9, no. 3 (2022): 18&#x2013;21.</Citation></Reference><Reference><Citation>Varis T., Kivist&#xf6; K. T., Backman J. T., and Neuvonen P. J., &#x201c;The Cytochrome P450 3A4 Inhibitor Itraconazole Markedly Increases the Plasma Concentrations of Dexamethasone and Enhances Its Adrenal&#x2010;Suppressant Effect,&#x201d; Clinical Pharmacology and Therapeutics 68, no. 5 (2000): 487&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">11103751</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;cke H., Berger M., Rehwinkel H., and Asadullah K., &#x201c;Selective Glucocorticoid Receptor Agonists (SEGRAs): Novel Ligands With an Improved Therapeutic Index,&#x201d; Molecular and Cellular Endocrinology 275, no. 1&#x2013;2 (2007): 109&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">17630119</ArticleId></ArticleIdList></Reference><Reference><Citation>Smans L. C. C. J., Van der Valk E. S., Hermus A. R. M. M., and Zelissen P. M. J., &#x201c;Incidence of Adrenal Crisis in Patients With Adrenal Insufficiency,&#x201d; Clinical Endocrinology 84, no. 1 (2016): 17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">26208266</ArticleId></ArticleIdList></Reference><Reference><Citation>Endert E., Ouwehand A., Fliers E., Prummel M. F., and Wiersinga W. M., &#x201c;Establishment of Reference Values for Endocrine Tests. Part IV: Adrenal Insufficiency,&#x201d; Netherlands Journal of Medicine 63, no. 11 (2005): 435&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">16397312</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu B., Strom J., and Chen Q. M., &#x201c;Dexamethasone Induces Transcriptional Activation of Bcl&#x2010;xL Gene and Inhibits Cardiac Injury by Myocardial Ischemia,&#x201d; European Journal of Pharmacology 668, no. 1&#x2013;2 (2011): 194&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4148007</ArticleId><ArticleId IdType="pubmed">21723861</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley R. H. and Cidlowski J. A., &#x201c;Glucocorticoid Signaling in the Heart: A Cardiomyocyte Perspective,&#x201d; Journal of Steroid Biochemistry and Molecular Biology 153 (2015): 27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568128</ArticleId><ArticleId IdType="pubmed">25804222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bal M. P., De Vries W. B., Van Der Leij F. R., et al., &#x201c;Neonatal Glucocorticosteroid Treatment Causes Systolic Dysfunction and Compensatory Dilatation in Early Life: Studies in 4&#x2010;Week&#x2010;Old Prepubertal Rats,&#x201d; Pediatric Research 58, no. 1 (2005): 46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15985685</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R., Oakley R. H., Cruz&#x2010;Topete D., and Cidlowski J. A., &#x201c;Dual Role for Glucocorticoids in Cardiomyocyte Hypertrophy and Apoptosis,&#x201d; Endocrinology 153, no. 11 (2012): 5346&#x2013;5360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3473206</ArticleId><ArticleId IdType="pubmed">22989630</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodof I. I. and Macbryde C. M., &#x201c;Heart Failure in Addison's Disease With Myocardial Changes of Potassium Deficiency,&#x201d; Journal of Clinical Endocrinology &amp; Metabolism 4, no. 1 (1944): 30&#x2013;34.</Citation></Reference><Reference><Citation>Nagura F., Kodera S., Hayakawa N., Kushida S., and Kanda J., &#x201c;A Case of Congestive Heart Failure Caused by Secondary Hypocortisolism,&#x201d; Clinical Case Reports 5, no. 5 (2017): 630&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5412797</ArticleId><ArticleId IdType="pubmed">28469865</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamoorthy A., Mentz R. J., Hyland K. A., et al., &#x201c;A Crisis of the Heart: An Acute Reversible Cardiomyopathy Bridged to Recovery in a Patient With Addison's Disease,&#x201d; ASAIO Journal 59, no. 6 (2013): 668&#x2013;670.</Citation><ArticleIdList><ArticleId IdType="pubmed">24172274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Luo Y., and Feng J., &#x201c;Cardiomyopathy Associated With Tertiary Adrenal Insufficiency Manifesting as Refractory Heart Failure, Shock and Sudden Cardiac Death: A Case Report,&#x201d; Frontiers in Cardiovascular Medicine 8 (2021): 720154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8591098</ArticleId><ArticleId IdType="pubmed">34790704</ArticleId></ArticleIdList></Reference><Reference><Citation>Devareddy A., Sawicki K. T., Choudhury L., and Wilcox J. E., &#x201c;Reversible Biventricular Heart Failure Due to Primary Adrenal Insufficiency,&#x201d; JACC Case Reports 2, no. 3 (2020): 411&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194194</ArticleId><ArticleId IdType="pubmed">32363353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotyo N., Kida M., Horiuchi T., and Hirata Y., &#x201c;Torsade De Pointes Associated With Recurrent Ampulla Cardiomyopathy in a Patient With Idiopathic ACTH Deficiency,&#x201d; Endocrine Journal 56, no. 6 (2009): 807&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">19506326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikegami Y., Fukuda T., Jo R., and Momiyama Y., &#x201c;Reversible Cardiomyopathy Accompanied by Secondary Adrenal Insufficiency,&#x201d; Circulation. Heart Failure 9, no. 3 (2016): e002919.</Citation><ArticleIdList><ArticleId IdType="pubmed">26920218</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami M., Matsushita N., Arai R., et al., &#x201c;Isolated Adrenocorticotropin Deficiency Associated With Delirium and Takotsubo Cardiomyopathy,&#x201d; Case Reports in Endocrinology 2012, no. 1 (2012): 580481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518949</ArticleId><ArticleId IdType="pubmed">23243525</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;dek &#xc7;., Kendirli T., Kocaay P., et al., &#x201c;Acute Reversible Cardiomyopathy and Heart Failure in a Child With Acute Adrenal Crisis,&#x201d; Paediatrics and International Child Health 37, no. 2 (2017): 148&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pubmed">27077627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakihara S., Kageyama K., Nigawara T., Kidani Y., and Suda T., &#x201c;Ampulla (Takotsubo) Cardiomyopathy Caused by Secondary Adrenal Insufficiency in ACTH Isolated Deficiency,&#x201d; Endocrine Journal 54, no. 4 (2007): 631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">17664847</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C. and Butt W., &#x201c;A Case of Cardiovascular Collapse Due to Adrenal Insufficiency,&#x201d; Journal of Paediatrics and Child Health 24, no. 3 (1988): 197&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">3421879</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga T., Sakamoto A., Kawazoe N., Sadoshima S., Onoyama K., and Eto K., &#x201c;Adult Reversible Cardiomyopathy With Pituitary Adrenal Insufficiency Caused by Empty Sella: A Case Report,&#x201d; Angiology 51, no. 4 (2000): 319&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">10779002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukita C., Miyazaki H., Toyoda N., Kosaki A., Nishikawa M., and Iwasaka T., &#x201c;Takotsubo Cardiomyopathy During Acute Adrenal Crisis Due to Isolated Adrenocorticotropin Deficiency,&#x201d; Internal Medicine 48, no. 5 (2009): 347&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">19252360</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozolevska V., Schwartz A., Cheung D., Shaikh B., Bhagirath K. M., and Jassal D. S., &#x201c;Addison's Disease and Dilated Cardiomyopathy: A Case Report and Review of the Literature,&#x201d; Case Reports in Cardiology 2016, no. 1 (2016): 4362514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149592</ArticleId><ArticleId IdType="pubmed">28003914</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao S. S. and Fisher S. J., &#x201c;Repairing a &#x2018;Broken Heart&#x2019; With Hormone Replacement Therapy: Case Report of Cardiogenic Shock Due to Undiagnosed Pituitary Insufficiency,&#x201d; Endocrine Practice 18, no. 2 (2012): e26&#x2013;e31.</Citation><ArticleIdList><ArticleId IdType="pubmed">22138080</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarallah A. S. A., &#x201c;Reversible Cardiomyopathy Caused by an Uncommon Form of Congenital Adrenal Hyperplasia,&#x201d; Pediatric Cardiology 25, no. 6 (2004): 675&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">15136908</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris C. L., Khalid M., Hashmi A., Shani J., and Malik B. A., &#x201c;A Case of Adrenal Crisis&#x2010;Induced Stress Cardiomyopathy,&#x201d; Cureus 13, no. 4 (2021): e14420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117259</ArticleId><ArticleId IdType="pubmed">33996290</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrahy I., Nicholas P., Oladiran O., and Nazir S., &#x201c;Takotsubo Cardiomyopathy Secondary to Adrenal Insufficiency: A Case Report and Literature Review,&#x201d; Case Reports in Cardiology 2020, no. 1 (2020): 6876951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298333</ArticleId><ArticleId IdType="pubmed">32566318</ArticleId></ArticleIdList></Reference><Reference><Citation>Derish M., Eckert K., and Chin C., &#x201c;Reversible Cardiomyopathy in a Child With Addison's Disease,&#x201d; Intensive Care Medicine 22 (1996): 460&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">8796402</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltshire E., Wilson R., and Pringle K., &#x201c;Addison's Disease Presenting With an Acute Abdomen and Complicated by Cardiomyopathy,&#x201d; Journal of Paediatrics and Child Health 40, no. 11 (2004): 644&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">15469537</ArticleId></ArticleIdList></Reference><Reference><Citation>Conwell L. S., Gray L. M., Delbridge R. G., Thomsett M. J., and Batch J. A., &#x201c;Reversible Cardiomyopathy in Paediatric Addison's Disease: A Cautionary Tale,&#x201d; Journal of Pediatric Endocrinology and Metabolism 16, no. 8 (2003): 1191&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">14594181</ArticleId></ArticleIdList></Reference><Reference><Citation>Awadji F. B., Sasmita B. R., Huang B., et al., &#x201c;Takotsubo Cardiomyopathy Induced by Pheochromocytoma: A Case Report,&#x201d; Oxford Medical Case Reports 2023, no. 2 (2023): omad011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9969823</ArticleId><ArticleId IdType="pubmed">36860954</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekontso&#x2010;Dessap A., &#x201c;Images in Cardiology: Acute Adrenal Insufficiency Complicated by Cardiogenic Shock,&#x201d; Heart 91, no. 4 (2005): e31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1768830</ArticleId><ArticleId IdType="pubmed">15772180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefer A., &#x201c;Influence of Corticosteroids on Mechanical Performance of Isolated Rat Papillary Muscles,&#x201d; American Journal of Physiology&#x2010;Legacy Content 214, no. 3 (1968): 518&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">5638983</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleghorn R. A., &#x201c;Cardiovascular Failure in Experimental Adrenal Insufficiency: A Historical Revival,&#x201d; Perspectives in Biology and Medicine 27, no. 1 (1983): 135&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">6359051</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb W. R. and Degerli I. U., &#x201c;Myocardial Metabolism. Effects of Adrenalectomy and Acute Cortisol Replacement,&#x201d; Journal of Surgical Research 8, no. 2 (1968): 73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">5638665</ArticleId></ArticleIdList></Reference><Reference><Citation>Stith R. D., Bhaskar M., Reddy Y. S., Brackett D. J., Lerner M. R., and Wilson M. F., &#x201c;Cardiovascular Changes in Chronically Adrenalectomized Conscious Rats,&#x201d; Circulatory Shock 28, no. 4 (1989): 395&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">2776284</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan N., &#x201c;Effects of Adrenalectomy and in Vivo Administration of Dexamethasone on ATP&#x2010;Dependent Calcium Accumulation by Sarcoplasmic Reticulum From Rat Heart,&#x201d; Journal of Molecular and Cellular Cardiology 15, no. 1 (1983): 7&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">6133005</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley R. H., Ren R., Cruz&#x2010;Topete D., et al., &#x201c;Essential Role of Stress Hormone Signaling in Cardiomyocytes for the Prevention of Heart Disease,&#x201d; Proceedings of the National Academy of Sciences of the United States of America 110, no. 42 (2013): 17035&#x2013;17040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3801058</ArticleId><ArticleId IdType="pubmed">24082121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemba E. A. and John R., &#x201c;Mechanical Circulatory Support for Bridge to Decision: Which Device and When to Decide,&#x201d; Journal of Cardiac Surgery 25, no. 4 (2010): 425&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pubmed">20412350</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito D., Bobbio E., Di Fraia R., et al., &#x201c;Patients With Adrenal Insufficiency Have Cardiovascular Features Associated With Hypovolemia,&#x201d; Endocrine 70, no. 2 (2020): 412&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7581570</ArticleId><ArticleId IdType="pubmed">32813212</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlt W. and Allolio B., &#x201c;Adrenal Insufficiency,&#x201d; Lancet 361, no. 9372 (2003): 1881&#x2013;1893.</Citation><ArticleIdList><ArticleId IdType="pubmed">12788587</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu M., Monguchi T., Takano T., and Miwa Y., &#x201c;Isolated ACTH Deficiency Presenting With Severe Myocardial Dysfunction,&#x201d; Journal of Cardiology Cases 4, no. 1 (2011): e26&#x2013;e30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6265152</ArticleId><ArticleId IdType="pubmed">30546710</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami M., Matsushita N., Arai R., et al., &#x201c;Isolated Adrenocorticotropin Deficiency Associated With Delirium and Takotsubo Cardiomyopathy,&#x201d; Case Reports in Endocrinology 2012 (2012): 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3518949</ArticleId><ArticleId IdType="pubmed">23243525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa S., Nakamura T., Hamaoka T., Matsumuro A., Sawada T., and Matsubara H., &#x201c;Lethal Arrhythmia and Corticosteroid Insufficiency,&#x201d; American Journal of Emergency Medicine 27, no. 9 (2009): 1167.e1&#x2013;1167.e3.</Citation><ArticleIdList><ArticleId IdType="pubmed">19931775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakihara S., Kageyama K., Nigawara T., Kidani Y., and Suda T., &#x201c;Ampulla (Takotsubo) Cardiomyopathy Caused by Secondary Adrenal Insufficiency in ACTH Isolated Deficiency,&#x201d; Endocrine Journal 54 (2007): 631&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">17664847</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozolevska V., Schwartz A., Cheung D., Shaikh B., Bhagirath K. M., and Jassal D. S., &#x201c;Addison's Disease and Dilated Cardiomyopathy: A Case Report and Review of the Literature,&#x201d; Case Reports in Cardiology 2016 (2016): 1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149592</ArticleId><ArticleId IdType="pubmed">28003914</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarallah A. S. A., &#x201c;Reversible Cardiomyopathy Caused by an Uncommon Form of Congenital Adrenal Hyperplasia,&#x201d; Pediatric Cardiology 25, no. 6 (2004): 675&#x2013;676.</Citation><ArticleIdList><ArticleId IdType="pubmed">15136908</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrahy I., Nicholas P., Oladiran O., and Nazir S., &#x201c;Takotsubo Cardiomyopathy Secondary to Adrenal Insufficiency: A Case Report and Literature Review,&#x201d; Case Reports in Cardiology 2020 (2020): 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298333</ArticleId><ArticleId IdType="pubmed">32566318</ArticleId></ArticleIdList></Reference><Reference><Citation>Derish M., Eckert K., and Chin C., &#x201c;Reversible Cardiomyopathy in a Child With Addison's Disease,&#x201d; Intensive Care Medicine 22, no. 5 (1996): 460&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">8796402</ArticleId></ArticleIdList></Reference><Reference><Citation>Somerville W., &#x201c;Effect of Cortisone on the Cardiogram,&#x201d; BMJ 2, no. 4684 (1950): 860&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2038961</ArticleId><ArticleId IdType="pubmed">14772500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorin R. I. and Kearns P. J., &#x201c;High Output Circulatory Failure in Acute Adrenal Insufficiency,&#x201d; Critical Care Medicine 16, no. 3 (1988): 296&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">2830078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaue M. and Hoffman B. B., &#x201c;Glucocorticoids Induce Transcription and Expression of the Alpha 1B Adrenergic Receptor Gene in DTT1 MF&#x2010;2 Smooth Muscle Cells,&#x201d; Journal of Clinical Investigation 88, no. 2 (1991): 385&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC295342</ArticleId><ArticleId IdType="pubmed">1650792</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga T., Sakamoto A., Kawazoe N., Sadoshima S., Onoyama K., and Eto K., &#x201c;Adult Reversible Cardiomyopathy With Pituitary Adrenal Insufficiency Caused by Empty Sella,&#x201d; Angiology 51, no. 4 (2000): 319&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">10779002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachova A., Brunerova L., and Gregor P., &#x201c;Cardiac Symptoms in a Patient With Addison's Disease and Hypothyreosis on the Basis of Autoimmune Polyglandular Syndrome Type II,&#x201d; Vnitrni Lekarstvi 58, no. 6 (2012): 473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">22913240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan F., Ustun I., Berker D., Aydin Y., Delibasi T., and Guler S., &#x201c;Inverted T Waves in Patient With Addisonian Crisis,&#x201d; Journal of the National Medical Association 97, no. 11 (2005): 1539&#x2013;1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2594907</ArticleId><ArticleId IdType="pubmed">16334501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sholter D. E. and Armstrong P. W., &#x201c;Adverse Effects of Corticosteroids on the Cardiovascular System,&#x201d; Canadian Journal of Cardiology 16, no. 4 (2000): 505&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">10787466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A. X. and Burt M. G., &#x201c;Cardio&#x2010;Metabolic Pathophysiology in Mild Glucocorticoid Excess: Potential Implications for Management of Adrenal Incidentaloma,&#x201d; Clinical Endocrinology 98, no. 2 (2023): 153&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">36367077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K., &#x201c;&#x2018;Takotsubo&#x2019; Cardiomyopathy A Syndrome Characterized by Transient Left Ventricular Apical Ballooning That Mimics the Shape of a Bottle Used for Trapping Octopus in Japan,&#x201d; Internal Medicine 43, no. 4 (2004): 275&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">15168766</ArticleId></ArticleIdList></Reference><Reference><Citation>Owa M., Aizawa K., Urasawa N., et al., &#x201c;Emotional Stress&#x2010;Induced &#x2018;Ampulla Cardiomyopathy&#x2019;: Discrepancy Between the Metabolic and Sympathetic Innervation Imaging Performed During the Recovery Course,&#x201d; Japanese Circulation Journal 65, no. 4 (2001): 349&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">11316138</ArticleId></ArticleIdList></Reference><Reference><Citation>Templin C., Ghadri J. R., Diekmann J., et al., &#x201c;Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy,&#x201d; New England Journal of Medicine 373, no. 10 (2015): 929&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pubmed">26332547</ArticleId></ArticleIdList></Reference><Reference><Citation>Takizawa M., Kobayakawa N., Uozumi H., et al., &#x201c;A Case of Transient Left Ventricular Ballooning With Pheochromocytoma, Supporting Pathogenetic Role of Catecholamines in Stress&#x2010;Induced Cardiomyopathy or Takotsubo Cardiomyopathy,&#x201d; International Journal of Cardiology 114, no. 1 (2007): E15&#x2013;E17.</Citation><ArticleIdList><ArticleId IdType="pubmed">17052786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohwada R., Hotta M., Kimura H., et al., &#x201c;Ampulla Cardiomyopathy After Hypoglycemia in Three Young Female Patients With Anorexia Nervosa,&#x201d; Internal Medicine 44, no. 3 (2005): 228&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">15805712</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner L. M., Serraro&#x2010;Brown H., McLaren M., Rachel L., and Mosse C., &#x201c;The Heart of the Matter: Secretory Pheochromocytoma Presenting as Recurrent Biventricular Heart Failure (Takotsubo Cardiomyopathy),&#x201d; Oxford Medical Case Reports 2022, no. 6 (2022): omac066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9235020</ArticleId><ArticleId IdType="pubmed">35769190</ArticleId></ArticleIdList></Reference><Reference><Citation>Boston B. A., DeGroff C., Hanna C. E., and Reller M., &#x201c;Reversible Cardiomyopathy in an Infant With Unrecognized Congenital Adrenal Hyperplasia,&#x201d; Journal of Pediatrics 124, no. 6 (1994): 936&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pubmed">8201481</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanson P., Guignat L., Goichot B., et al., Group 2: Adrenal Insufficiency: Screening Methods and Confirmation of Diagnosis (Annales d'endocrinologie, Elsevier, 2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29174200</ArticleId></ArticleIdList></Reference><Reference><Citation>Husebye E. S., Pearce S. H., Krone N. P., and K&#xe4;mpe O., &#x201c;Adrenal Insufficiency,&#x201d; Lancet 397, no. 10274 (2021): 613&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">33484633</ArticleId></ArticleIdList></Reference><Reference><Citation>Patti G., Guzzeti C., Di Iorgi N., et al., &#x201c;Central Adrenal Insufficiency in Children and Adolescents,&#x201d; Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism 32, no. 4 (2018): 425&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">30086867</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.&#x2010;J., Kim H. Y., Han S. H., Kim H. J., Moon Y. S., and Oh J., &#x201c;Takotsubo Cardiomyopathy Following Cerebral Infarction Involving the Insular Cortex,&#x201d; Journal of Clinical Neurology 6, no. 3 (2010): 152&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2950921</ArticleId><ArticleId IdType="pubmed">20944817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S. R., Allolio B., Arlt W., et al., &#x201c;Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline,&#x201d; Journal of Clinical Endocrinology and Metabolism 101, no. 2 (2016): 364&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880116</ArticleId><ArticleId IdType="pubmed">26760044</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito D., Pasquali D., and Johannsson G., &#x201c;Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy,&#x201d; Journal of Clinical Endocrinology and Metabolism 103, no. 2 (2018): 376&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">29156052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya A. and Tymms D. J., &#x201c;Heart Failure With Fludrocortisone in Addison's Disease,&#x201d; Journal of the Royal Society of Medicine 91, no. 8 (1998): 433&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1296847</ArticleId><ArticleId IdType="pubmed">9816363</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A., Thant A. A., Aslam A., Aung P. P. M., and Azmi S., &#x201c;Diagnosis and Management of Adrenal Insufficiency,&#x201d; Clinical Medicine 23, no. 2 (2023): 115&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11046533</ArticleId><ArticleId IdType="pubmed">36958832</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross I. L., Bergthorsdottir R., Levitt N., et al., &#x201c;Cardiovascular Risk Factors in Patients With Addison's Disease: A Comparative Study of South African and Swedish Patients,&#x201d; PLoS One 9, no. 3 (2014): e90768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3948337</ArticleId><ArticleId IdType="pubmed">24603607</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano R., Marzotti S., Balbo M., et al., &#x201c;Metabolic and Cardiovascular Profile in Patients With Addison's Disease Under Conventional Glucocorticoid Replacement,&#x201d; Journal of Endocrinological Investigation 32, no. 11 (2009): 917&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">19620820</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross I., Bergthorsdottir R., Levitt N., Schatz D., Johannsson G., and Marais A., &#x201c;Increased Cardiovascular Risk in South African Patients With Addison's Disease,&#x201d; Hormone and Metabolic Research 45, no. 12 (2013): 905&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">23918685</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannsson G., Falorni A., Skrtic S., et al., &#x201c;Adrenal Insufficiency: Review of Clinical Outcomes With Current Glucocorticoid Replacement Therapy,&#x201d; Clinical Endocrinology 82, no. 1 (2015): 2&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">25187037</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannsson G., Lennern&#xe4;s H., Marelli C., Rockich K., and Skrtic S., &#x201c;Achieving a Physiological Cortisol Profile With Once&#x2010;Daily Dual&#x2010;Release Hydrocortisone: A Pharmacokinetic Study,&#x201d; European Journal of Endocrinology 175, no. 1 (2016): 85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065076</ArticleId><ArticleId IdType="pubmed">27129362</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson A. G., Marelli C., Fitts D., et al., &#x201c;Prospective Evaluation of Long&#x2010;Term Safety of Dual&#x2010;Release Hydrocortisone Replacement Administered Once Daily in Patients With Adrenal Insufficiency,&#x201d; European Journal of Endocrinology 171, no. 3 (2014): 369&#x2013;377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106399</ArticleId><ArticleId IdType="pubmed">24944332</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlt W., Baldeweg S. E., Pearce S. H. S., and Simpson H. L., &#x201c;Endocrinology in the Time of COVID&#x2010;19: Management of Adrenal Insufficiency,&#x201d; European Journal of Endocrinology 183, no. 1 (2020): G25&#x2013;G32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7938015</ArticleId><ArticleId IdType="pubmed">32379699</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K., &#x201c;Understanding Tertiary Adrenal Insufficiency,&#x201d; Journal of Pediatric Nursing 69 (2023): 121&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">37061253</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40446954</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence-enhanced electrocardiogram diastolic function grade predicts post-septal myectomy mortality in hypertrophic cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(25)00457-X</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2025.05.015</ELocationID><Abstract><AbstractText Label="BACKGROUNDS" NlmCategory="BACKGROUND">Diastolic dysfunction is an important pathophysiologic feature of hypertrophic cardiomyopathy that is often challenging to determine noninvasively. This study investigated whether a novel artificial intelligence-enabled electrocardiography (AI-ECG)-determined diastolic function grade is associated with early postoperative outcomes and long-term mortality in patients with obstructive hypertrophic cardiomyopathy (oHCM) following septal myectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed 1953 patients undergoing transaortic septal myectomy and stratified their outcomes by grade of diastolic function as determined by a validated deep-learning AI algorithm applied on each patient's preoperative 12-lead electrocardiogram. Outcomes of interest included early postoperative morbidity, hospital length of stay, and all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with AI-ECG diastolic function grade 3 had a higher prevalence of comorbidities, including dyslipidemia, hypertension, congestive heart failure, and atrial fibrillation/flutter (AF). AI-ECG diastolic function grade significantly correlated with echocardiographic measures, including septal and posterior wall thickness, left atrial volume index, left ventricular mass index, maximum left ventricular outflow tract gradient, medial E/e', medial e', mitral and tricuspid regurgitation. Patients with AI-ECG diastolic (dys)function grades 2 and 3 had an increased risk of late mortality (hazard ratio [HR], 1.73; 95% confidence interval [CI], 1.05-2.87 and HR, 2.45; 95% CI, 1.29-4.67, respectively). Patients with diastolic function grade 3 were more likely to have postoperative AF (odds ratio, 1.63; 95% CI, 1.04-2.56) and had longer hospital length of stay (+0.87 days; P &lt; .01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Higher AI-ECG diastolic grade is associated with an increased risk of postoperative AF, longer hospital length of stay, and worse long-term survival. AI-ECG diastolic grade may be a useful tool for risk stratification of patients with oHCM undergoing septal myectomy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Debertin</LastName><ForeName>Julia G</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaff</LastName><ForeName>Hartzell V</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn. Electronic address: Schaff@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sawma</LastName><ForeName>Tedy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslahishahri</LastName><ForeName>Masi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dearani</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geske</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ommen</LastName><ForeName>Steve R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attia</LastName><ForeName>Zachi I</ForeName><Initials>ZI</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Eunjung</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Jae K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siontis</LastName><ForeName>Konstantinos C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence-enhanced electrocardiogram</Keyword><Keyword MajorTopicYN="N">diastolic function</Keyword><Keyword MajorTopicYN="N">obstructive hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">septal myectomy</Keyword></KeywordList><CoiStatement>Conflict of Interest Statement P.A.F., Z.I.A., E.L., and J.K.O. created the AI-ECG diastolic function algorithm licensed to Anumana Inc. and may benefit from algorithm commercialization via the Mayo Clinic. P.A.F. and Z.I.A. serve on the scientific advisory board for Anumana. K.C.S. is coinventor of AI-ECG algorithms other than the one described herein. Mayo Clinic has licensed such algorithms to Anumana, with potential for commercialization. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>19</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40446954</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2025.05.015</ArticleId><ArticleId IdType="pii">S0022-5223(25)00457-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40442323</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2398-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>NPJ digital medicine</Title><ISOAbbreviation>NPJ Digit Med</ISOAbbreviation></Journal><ArticleTitle>Determinants of artificial intelligence electrocardiogram-derived age and its association with cardiovascular events and mortality: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>322</StartPage><MedlinePgn>322</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">322</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41746-025-01727-7</ELocationID><Abstract><AbstractText>Artificial intelligence (AI)-ECG-derived age (AI-ECG age) and Heart Delta Age (HDA)-the difference between AI-ECG and chronological age-are emerging tools for assessing cardiovascular health. We systematically searched PubMed, Embase, Web of Science, and Scopus from inception through September 2024. Seventeen original studies utilizing AI algorithms to measure HDA and cardiovascular risk factors, outcomes, or mortality were included. Data were pooled using random- and fixed-effects models for meta-analysis. Hypertension and diabetes mellitus emerged as the most prevalent factors contributing to higher HDA, while cardiac diseases including myocardial infarction and heart failure demonstrated the most significant impact. Pooled analysis revealed a significant association between elevated HDA and increased risks of all-cause mortality (hazard ratio [HR] 1.62, 95% confidence interval [CI] 1.49-1.77) and cardiovascular mortality (HR 2.12, 95% CI 1.71-2.63). HDA could enhance existing risk models and play a critical role in primary healthcare prevention.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mossavarali</LastName><ForeName>Shervin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vaezi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gholami</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Imam Khomeini Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molaei</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yekaninejad</LastName><ForeName>Mir Saeed</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselbergs</LastName><ForeName>Folkert W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafiee</LastName><ForeName>Akbar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran. ashafiee@tums.ac.ir.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>NPJ Digit Med</MedlineTA><NlmUniqueID>101731738</NlmUniqueID><ISSNLinking>2398-6352</ISSNLinking></MedlineJournalInfo><CoiStatement>Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>2</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>2</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>23</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40442323</ArticleId><ArticleId IdType="pmc">PMC12122673</ArticleId><ArticleId IdType="doi">10.1038/s41746-025-01727-7</ArticleId><ArticleId IdType="pii">10.1038/s41746-025-01727-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silva, N. et al. Measuring healthy ageing: current and future tools. Biogerontology10.1007/s10522-023-10041-2 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10615962</ArticleId><ArticleId IdType="pubmed">37439885</ArticleId></ArticleIdList></Reference><Reference><Citation>Raisi-Estabragh, Z. et al. Estimation of biological heart age using cardiovascular magnetic resonance radiomics. Sci. Rep.12, 12805 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9329281</ArticleId><ArticleId IdType="pubmed">35896705</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghu, V. K., Weiss, J., Hoffmann, U., Aerts, H. &amp; Lu, M. T. Deep learning to estimate biological age from chest radiographs. JACC Cardiovasc. Imaging14, 2226&#x2013;2236 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11381093</ArticleId><ArticleId IdType="pubmed">33744131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari, M. Y. et al. Estimating age and gender from electrocardiogram signals: a comprehensive review of the past decade. Artif. Intell. Med.146, 102690 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38042607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu, J. S. et al. Deep learning algorithms for estimation of demographic and anthropometric features from electrocardiograms. J. Clin. Med.12, 10.3390/jcm12082828 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10146401</ArticleId><ArticleId IdType="pubmed">37109165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ball, R. L., Feiveson, A. H., Schlegel, T. T., Starc, V. &amp; Dabney, A. R. Predicting &#x201c;heart age&#x201d; using electrocardiography. J. Pers. Med.4, 65&#x2013;78 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251409</ArticleId><ArticleId IdType="pubmed">25562143</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota, N. et al. Cardiovascular events and artificial intelligence-predicted age using 12-lead electrocardiograms. Int. J. Cardiol. Heart Vasc.44, 101172 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841236</ArticleId><ArticleId IdType="pubmed">36654885</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, C. H., Lin, C. S., Luo, Y. S., Lee, Y. T. &amp; Lin, C. Electrocardiogram-based heart age estimation by a deep learning model provides more information on the incidence of cardiovascular disorders. Front. Cardiovasc. Med.9, 754909 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8860826</ArticleId><ArticleId IdType="pubmed">35211522</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima, E. M. et al. Deep neural network-estimated electrocardiographic age as a mortality predictor. Nat. Commun.12, 5117 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8387361</ArticleId><ArticleId IdType="pubmed">34433816</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladejobi, A. O. et al. The 12-lead electrocardiogram as a biomarker of biological age. Eur. Heart J. Digit Health2, 379&#x2013;389 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9707884</ArticleId><ArticleId IdType="pubmed">36713596</ArticleId></ArticleIdList></Reference><Reference><Citation>Brant, L. C. C. et al. Association between electrocardiographic age and cardiovascular events in community settings: the Framingham Heart Study. Circ. Cardiovasc. Qual. Outcomes16, e009821 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10524985</ArticleId><ArticleId IdType="pubmed">37381910</ArticleId></ArticleIdList></Reference><Reference><Citation>Jylh&#xe4;v&#xe4;, J., Pedersen, N. L. &amp; H&#xe4;gg, S. Biological age predictors. EBioMedicine21, 29&#x2013;36 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5514388</ArticleId><ArticleId IdType="pubmed">28396265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, C. et al. Association of lifestyle with deep learning predicted electrocardiographic age. Front. Cardiovasc. Med.10, 1160091 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10165078</ArticleId><ArticleId IdType="pubmed">37168659</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelly, S. et al. Accelerated aging in LMNA mutations detected by artificial intelligence ECG-derived age. Mayo Clin. Proc.98, 522&#x2013;532 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36775737</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz, E. C. et al. Physiological age by artificial intelligence-enhanced electrocardiograms as a novel risk factor of mortality in kidney transplant candidates. Transplantation107, 1365&#x2013;1372 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10205652</ArticleId><ArticleId IdType="pubmed">36780487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindow, T. et al. Heart age gap estimated by explainable advanced electrocardiography is associated with cardiovascular risk factors and survival. Eur. Heart J. Digit Health4, 384&#x2013;392 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10545529</ArticleId><ArticleId IdType="pubmed">37794867</ArticleId></ArticleIdList></Reference><Reference><Citation>Meenakshi-Siddharthan, D. V. et al. Artificial intelligence-derived electrocardiogram assessment of cardiac age and molecular markers of senescence in heart failure. Mayo Clin. Proc.98, 372&#x2013;385 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36868745</ArticleId></ArticleIdList></Reference><Reference><Citation>Toya, T. et al. Vascular aging detected by peripheral endothelial dysfunction is associated with ECG-derived physiological aging. J. Am. Heart Assoc.10, e018656 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955452</ArticleId><ArticleId IdType="pubmed">33455414</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia, Z. I. et al. Age and sex estimation using artificial intelligence from standard 12-lead ECGs. Circ. Arrhythm. Electrophysiol.12, e007284 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7661045</ArticleId><ArticleId IdType="pubmed">31450977</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung, R. et al. Association between deep neural network-derived electrocardiographic-age and incident stroke. Front. Cardiovasc. Med.11, 10.3389/fcvm.2024.1368094 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11239432</ArticleId><ArticleId IdType="pubmed">39006167</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek, Y. S. et al. Artificial intelligence-estimated biological heart age using a 12-lead electrocardiogram predicts mortality and cardiovascular outcomes. Front. Cardiovasc. Med.10, 1137892 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10133724</ArticleId><ArticleId IdType="pubmed">37123475</ArticleId></ArticleIdList></Reference><Reference><Citation>Iakunchykova, O. et al. Machine-learning-derived heart and brain age are independently associated with cognition. Eur. J. Neurol.30, 2611&#x2013;2619 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37254942</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez Benavente, E. et al. Studying accelerated cardiovascular ageing in Russian adults through a novel deep-learning ECG biomarker [version 1; peer review: 1 approved with reservations]. Wellcome Open Res. 6, 10.12688/wellcomeopenres.16499.1 (2021).</Citation></Reference><Reference><Citation>Libiseller-Egger, J. et al. Deep learning-derived cardiovascular age shares a genetic basis with other cardiac phenotypes. Sci. Rep.12, 22625 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9805465</ArticleId><ArticleId IdType="pubmed">36587059</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Rodero, S. et al. Aging genetics and aging. Aging Dis.2, 186&#x2013;195 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3295054</ArticleId><ArticleId IdType="pubmed">22396873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J., Wang, S. &amp; Liu, B. New insights into the genetics and epigenetics of aging plasticity. Genes14, 1&#x2013;19 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9956228</ArticleId><ArticleId IdType="pubmed">36833255</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodes, R. J. et al. Disease drivers of aging. Ann. N. Y. Acad. Sci.1386, 45&#x2013;68 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373660</ArticleId><ArticleId IdType="pubmed">27943360</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, W. H. Effect of modifiable lifestyle factors on biological aging. JAR Life13, 88&#x2013;92 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11161669</ArticleId><ArticleId IdType="pubmed">38855439</ArticleId></ArticleIdList></Reference><Reference><Citation>Salih, A., Nichols, T., Szabo, L., Petersen, S. E. &amp; Raisi-Estabragh, Z. Conceptual overview of biological age estimation. Aging Dis.14, 583&#x2013;588 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10187689</ArticleId><ArticleId IdType="pubmed">37191413</ArticleId></ArticleIdList></Reference><Reference><Citation>Khane, R. S., Surdi, A. D. &amp; Bhatkar, R. S. Changes in ECG pattern with advancing age. J. Basic Clin. Physiol. Pharm.22, 97&#x2013;101 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22865429</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanveer, M. et al. Deep learning for brain age estimation: a systematic review. Inf. Fusion96, 130&#x2013;143 (2023).</Citation></Reference><Reference><Citation>Cole, J. H. &amp; Franke, K. Predicting age using neuroimaging: innovative brain ageing biomarkers. Trends Neurosci.40, 681&#x2013;690 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29074032</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin, M. G. et al. Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure. Nat. Commun.13, 6914 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9663424</ArticleId><ArticleId IdType="pubmed">36376295</ArticleId></ArticleIdList></Reference><Reference><Citation>Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res.47, D1005&#x2013;d1012 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323933</ArticleId><ArticleId IdType="pubmed">30445434</ArticleId></ArticleIdList></Reference><Reference><Citation>Worman, H. J. &amp; Michaelis, S. Prelamin A and ZMPSTE24 in premature and physiological aging. Nucleus14, 2270345 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10730219</ArticleId><ArticleId IdType="pubmed">37885131</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Distinct roles of telomerase activity in age-related chronic diseases: an update literature review. Biomed. Pharmacother.167, 115553 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37738798</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, J. et al. Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduct. Target Ther.7, 391 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9755275</ArticleId><ArticleId IdType="pubmed">36522308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollila, L. et al. Clinical disease presentation and ECG characteristics of LMNA mutation carriers. Open Heart4, e000474 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5255551</ArticleId><ArticleId IdType="pubmed">28123761</ArticleId></ArticleIdList></Reference><Reference><Citation>Belfiori, M., Lazzari, L., Hezzell, M., Angelini, G. D. &amp; Dong, T. Transcriptomics, proteomics and bioinformatics in atrial fibrillation: a descriptive review. Bioengineering12, 149 (2025).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11851880</ArticleId><ArticleId IdType="pubmed">40001669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicent, L. &amp; Mart&#xed;nez-Sell&#xe9;s, M. Electrocardiogeriatrics: ECG in advanced age. J. Electrocardiol.50, 698&#x2013;700 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28623017</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittayaphong, R. et al. Electrocardiographic predictors of cardiovascular events in patients at high cardiovascular risk: a multicenter study. J. Geriatr. Cardiol.16, 630&#x2013;638 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6748904</ArticleId><ArticleId IdType="pubmed">31555331</ArticleId></ArticleIdList></Reference><Reference><Citation>Starc, V. et al. Can functional cardiac age be predicted from the ECG in a normal healthy population?. In 2012 Computing in Cardiology, 101&#x2013;104. IEEE, 2012.</Citation></Reference><Reference><Citation>Oehler, A., Feldman, T., Henrikson, C. A. &amp; Tereshchenko, L. G. QRS-T angle: a review. Ann. Noninvasive Electrocardiol.19, 534&#x2013;542 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4237708</ArticleId><ArticleId IdType="pubmed">25201032</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury, M. A. et al. The heart of transformation: exploring artificial intelligence in cardiovascular disease. Biomedicines13, 427 (2025).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11852486</ArticleId><ArticleId IdType="pubmed">40002840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong, T. et al. Development and evaluation of a natural language processing system for curating a trans-thoracic echocardiogram (TTE) database. Bioengineering10, 1307 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10669818</ArticleId><ArticleId IdType="pubmed">38002431</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend, N. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J.37, 3232&#x2013;3245 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27523477</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. et al. Modeling biological age using blood biomarkers and physical measurements in Chinese adults. EBioMedicine89, 104458 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9941058</ArticleId><ArticleId IdType="pubmed">36758480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison, G. H. et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol.3, 409&#x2013;416 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5875390</ArticleId><ArticleId IdType="pubmed">29562087</ArticleId></ArticleIdList></Reference><Reference><Citation>Selder, J. L. et al. Accuracy of a standalone atrial fibrillation detection algorithm added to a popular wristband and smartwatch: prospective diagnostic accuracy study. J. Med. Internet Res.25, e44642 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10257103</ArticleId><ArticleId IdType="pubmed">37234033</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonner, C. et al. Interventions using heart age for cardiovascular disease risk communication: systematic review of psychological, behavioral, and clinical effects. JMIR Cardio5, e31056 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8663444</ArticleId><ArticleId IdType="pubmed">34738908</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkes, G., Greenhalgh, T., Griffin, M. &amp; Dent, R. Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial. Bmj336, 598&#x2013;600 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2267989</ArticleId><ArticleId IdType="pubmed">18326503</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh, G. et al. Artificial intelligence electrocardiogram-derived heart age predicts long-term mortality after transcatheter aortic valve replacement. JACC Adv.3, 101171 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11450920</ArticleId><ArticleId IdType="pubmed">39372454</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, H. et al. Artificial intelligence estimated electrocardiographic age as a recurrence predictor after atrial fibrillation catheter ablation. npj Digital Med.7, 234 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11377779</ArticleId><ArticleId IdType="pubmed">39237703</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha, S. et al. Comparison of machine learning techniques in prediction of mortality following cardiac surgery: analysis of over 220 000 patients from a large national database. Eur. J. Cardiothorac. Surg.63, 10.1093/ejcts/ezad183 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10275911</ArticleId><ArticleId IdType="pubmed">37154705</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee, A. &amp; van Bodegom, D. The necessity for research on the elderly in iran. J. Tehran Heart Cent.7, 40 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466880</ArticleId><ArticleId IdType="pubmed">23074635</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M. J. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ372, n71 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenbroucke, J. P. et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology18, 805&#x2013;835 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18049195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40447041</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-4738</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>May</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of cardiology</Title><ISOAbbreviation>J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Performance of convolutional neural network-enhanced electrocardiography in detecting acute coronary syndrome: focusing on subtypes and reduced leads.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0914-5087(25)00137-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jjcc.2025.05.014</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early and accurate diagnosis of acute coronary syndrome (ACS), particularly non-ST-elevation ACS (NSTE-ACS), remains a critical challenge in emergency settings. Despite advancements in diagnostic modalities, conventional electrographic (ECG) interpretation often fails to detect subtle ischemic changes, particularly in NSTE-ACS, highlighting the need for artificial intelligence (AI)-driven approaches.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study retrospectively analyzed data from a single-center cohort (Shinken Database 2010-2022, n&#x202f;=&#x202f;32,167) to develop AI-driven ECG models for ACS detection. A convolutional neural network (CNN) model and an integrated neural network (INN) model, which incorporated diagnostic probabilities for ACS subtypes and target vessels, were evaluated using area under the receiver operating characteristics curve (AUROC), area under the precision-recall curve (AUPRC), sensitivity, and F1 scores for all&#x2011;lead ECG and reduced&#x2011;lead ECG models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The CNN model using all&#x2011;lead ECG achieved an AUROC of 0.877, an AUPRC of 0.391, and an F1 score of 0.184, while the INN model showed similar results (AUROC 0.889, AUPRC 0.356, and F1 score 0.188). For subtypes related to NSTE-ACS, the CNN model using all&#x2011;lead ECG (CNN model using double&#x2011;lead ECG) model achieved an AUROC of 0.785 (0.783), sensitivity of 0.723 (0.672), and specificity of 0.699 (0.768) for unstable angina, and an AUROC of 0.795 (0.786), sensitivity of 0.527 (0.567), and specificity of 0.878 (0.849) for NSTE-myocardial infarction. Among patients with troponin testing (n&#x202f;=&#x202f;4169), the CNN model achieved a sensitivity of 76&#x202f;%, a positive predictive rate (PPR) of 32&#x202f;%, and an F1 score of 0.452, while the INN model achieved 78&#x202f;%, 35&#x202f;%, and 0.483, respectively. The leads I and II model demonstrated the highest AUROC among reduced&#x2011;lead models (0.866), with F1 scores in patients with troponin testing of 0.395 and 0.390 for the CNN and INN models, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both CNN and INN-enhanced ECGs demonstrated good performance in detecting ACS including NSTE-ACS with subtle ischemic ECG changes. However, low PPR limit these models' standalone diagnostic utility. Instead, they hold promise as supportive tools, especially in resource-limited settings where reduced&#x2011;lead ECGs may be beneficial.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hori</LastName><ForeName>Koichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan. Electronic address: moat.lights09@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirota</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motogi</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umemoto</LastName><ForeName>Takuya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakai</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Information System Division, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuzawa</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takayanagi</LastName><ForeName>Tsuneo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyodo</LastName><ForeName>Akira</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satoh</LastName><ForeName>Keiichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Nihon Kohden Corporation, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arita</LastName><ForeName>Takuto</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagi</LastName><ForeName>Naoharu</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kishi</LastName><ForeName>Mikio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kano</LastName><ForeName>Hiroto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuno</LastName><ForeName>Shunsuke</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otsuka</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uejima</LastName><ForeName>Tokuhisa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yajima</LastName><ForeName>Junji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okumura</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikawa</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Cardiol</MedlineTA><NlmUniqueID>8804703</NlmUniqueID><ISSNLinking>0914-5087</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword></KeywordList><CoiStatement>Declaration of competing interest Dr. Suzuki received lecture fees from Bristol-Myers Squibb and Daiichi Sankyo. Dr. Yamashita received research funds and/or lecture fees from Daiichi Sankyo, Bayer Yakuhin, Bristol-Myers Squibb, Pfizer, Nippon Boehringer Ingelheim, Eisai, Mitsubishi Tanabe Pharm, Ono Pharmaceutical, and Toa Eiyo.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>31</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>30</Day><Hour>19</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40447041</ArticleId><ArticleId IdType="doi">10.1016/j.jjcc.2025.05.014</ArticleId><ArticleId IdType="pii">S0914-5087(25)00137-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40457637</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2192-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>21</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Advanced healthcare materials</Title><ISOAbbreviation>Adv Healthc Mater</ISOAbbreviation></Journal><ArticleTitle>Advanced Multipurpose Spectroscopic Nanobio-Device for Concurrent Lab-on-a-Chip Label-Free Separation and Detection of Extracellular Vesicles as Key-Biomarkers for Point-of-Care Cardiovascular Disease Diagnostics.</ArticleTitle><Pagination><StartPage>e2500122</StartPage><MedlinePgn>e2500122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2500122</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/adhm.202500122</ELocationID><Abstract><AbstractText>The global aging population presents a major public health challenge, with cardiovascular diseases (CVDs) remaining the leading cause of death worldwide. Often asymptomatic in early-stages, CVDs are frequently undiagnosed until critical events like myocardial infarction or stroke occur. To address this gap, an advanced integrated multipurpose spectroscopic lab-on-a-chip bionano-device has been developed for early CVD detection through extracellular vesicle (EV). EVs, which reflect the molecular state of their originating cells, are separated and analyzed using the combined Raman spectroscopy's molecular specificity with AI-driven classification from clinical CVD biofluids. AIMSpec-LoC unprecedently achieves rapid, label-free, size-based separation of EV subtypes, including small, mid and large EVs from biofluids, whilst preserving EV integrity and eliminating extensive preprocessing. The device enables real-time, multiplexed molecular profiling of EV cargo, identifying CVD-specific biomarkers with sensitivity and specificity &gt;96% and linking these to CVD progression, achieving &gt;97% accuracy in identifying disease-specific molecular fingerprints. This bionanotechnological device generates quantitative barcodes to support prognostic modeling and therapeutic evaluation, providing clinicians with actionable insights for timely-diagnosis and personalized treatment. AIMSpec-LoC platform offers a transformative solution for point-of-care CVD diagnostics, addressing critical unmet needs in cardiovascular medicine, enhancing clinical decision-making, improving patient health and reducing the global burden of CVDs.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Advanced Healthcare Materials published by Wiley&#x2010;VCH GmbH.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buchan</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>School of Chemical Engineering, College of Engineering and Physical Science, University of Birmingham, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rickard</LastName><ForeName>Jonathan James Stanley</ForeName><Initials>JJS</Initials><AffiliationInfo><Affiliation>Department of Physics, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Mark Robert</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oppenheimer</LastName><ForeName>Pola Goldberg</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-1014-4724</Identifier><AffiliationInfo><Affiliation>School of Chemical Engineering, College of Engineering and Physical Science, University of Birmingham, Birmingham, B15 2TT, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physics, Cavendish Laboratory, University of Cambridge, JJ Thomson Avenue, Cambridge, CB3 0HE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Healthcare Technologies Institute, Institute of Translational Medicine, Mindelsohn Way, Birmingham, B15 2TH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>National Institute for Health Research</Agency><Country/></Grant><Grant><GrantID>EP/Y030206/1</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>EP/V029983/1</GrantID><Agency>Engineering and Physical Sciences Research Council</Agency><Country/></Grant><Grant><GrantID>174ISSFPP</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>EP/L016346/1</GrantID><Agency>Engineering and Physical Sciences Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Adv Healthc Mater</MedlineTA><NlmUniqueID>101581613</NlmUniqueID><ISSNLinking>2192-2640</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056656" MajorTopicYN="Y">Lab-On-A-Chip Devices</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013059" MajorTopicYN="Y">Spectrum Analysis, Raman</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="Y">Point-of-Care Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiovascular diseases</Keyword><Keyword MajorTopicYN="N">extracellular vesicles</Keyword><Keyword MajorTopicYN="N">lab&#x2010;on&#x2010;a&#x2010;chip label&#x2010;free separation and detection</Keyword><Keyword MajorTopicYN="N">point&#x2010;of&#x2010;care diagnostics</Keyword><Keyword MajorTopicYN="N">spectroscopic nanobio&#x2010;device</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>3</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>3</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40457637</ArticleId><ArticleId IdType="pmc">PMC12365627</ArticleId><ArticleId IdType="doi">10.1002/adhm.202500122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
World Heart Federation
. WORLD HEART REPORT 2023 &#x2010; Confronting the World's Number One Killer. 2023; Available from: https://world&#x2010;heart&#x2010;federation.org/wp&#x2010;content/uploads/World&#x2010;Heart&#x2010;Report&#x2010;2023.pdf.</Citation></Reference><Reference><Citation>Dhingra R., Vasan R. S., Trends Cardiovasc. Med. 2017, 27, 123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5253084</ArticleId><ArticleId IdType="pubmed">27576060</ArticleId></ArticleIdList></Reference><Reference><Citation>Balagopal P., (Babu) de Ferranti S. D., Cook S., Daniels S. R., Gidding S. S., Hayman L. L., Circulation 2011, 123, 2749.</Citation><ArticleIdList><ArticleId IdType="pubmed">21555711</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon K., Bonon R., Ivander F., Ale Ebrahim S., Namdar K., Shayegannia M., ACS Appl. Nano Mater. 2023, 6, 15385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10496841</ArticleId><ArticleId IdType="pubmed">37706067</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y., Huang C., Su J., Pan C. W., Ke C., Nutr., Metab. Cardiovasc. Dis. 2021, 31, 382.</Citation><ArticleIdList><ArticleId IdType="pubmed">33495028</ArticleId></ArticleIdList></Reference><Reference><Citation>Laslett L. J., Alagona P., Clark B. A., Drozda J. P., Saldivar F., Wilson S. R., Poe C., Hart M., J. Am. Coll. Cardiol. 2012, 60, S1.</Citation><ArticleIdList><ArticleId IdType="pubmed">23257320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricotta J. J., Pagan J., Xenos M., Alemu Y., Einav S., Bluestein D., Med. Biol. Eng. Comput. 2008, 46, 1059.</Citation><ArticleIdList><ArticleId IdType="pubmed">19002517</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickhout A., Koenen R. R., Front. Cardiovasc. Med. 2018, 5, 113..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113364</ArticleId><ArticleId IdType="pubmed">30186839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawaz M., Camussi G., Valadi H., Nazarenko I., Ekstr&#xf6;m K., Wang X., Principe S., Shah N., Ashraf N. M., Fatima F., Neder L., Kislinger T., Nat. Rev. Urol. 2014, 11, 688.</Citation><ArticleIdList><ArticleId IdType="pubmed">25403245</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., He X., Li Q., Lai H., Zhang H., Hu Z., Li Y., Huang S., Comput. Struct. Biotechnol. J. 2020, 18, 2851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7588739</ArticleId><ArticleId IdType="pubmed">33133426</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano&#x2010;Ramos I., Bancu I., Oliveira&#x2010;Tercero A., Armengol M. P., Menezes&#x2010;Neto A., Portillo H. A. D., Lauzurica&#x2010;Valdemoros R., Borr&#xe0;s F. E., J. Extracell. Vesicles 2015, 4, 27369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4449362</ArticleId><ArticleId IdType="pubmed">26025625</ArticleId></ArticleIdList></Reference><Reference><Citation>Comfort N., Bloomquist T. R., Shephard A. P., Petty C. R., Cunningham A., Hauptman M., Phipatanakul W., Baccarelli A., Extracell. Vesicles Circ. Nucl. Acids 2021, 2, 29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340923</ArticleId><ArticleId IdType="pubmed">34368811</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwai K., Minamisawa T., Suga K., Yajima Y., Shiba K., J. Extracell. Vesicles 2016, 5, 30829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4871899</ArticleId><ArticleId IdType="pubmed">27193612</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickhout A., Koenen R. R., Front. Cardiovasc. Med. 2018, 5, 113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113364</ArticleId><ArticleId IdType="pubmed">30186839</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins P. D., Morelli A. E., Nat. Rev. Immunol. 2014, 14, 195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4350779</ArticleId><ArticleId IdType="pubmed">24566916</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanelli L., Buratta S., Sagini K., Tancini B., Emiliani C., Int. J. Mol. Sci. 2016, 17, 1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5037688</ArticleId><ArticleId IdType="pubmed">27571072</ArticleId></ArticleIdList></Reference><Reference><Citation>Peinado H., Zhang H., Matei I. R., Costa&#x2010;Silva B., Hoshino A., Rodrigues G., Psaila B., Kaplan R. N., Bromberg J. F., Kang Y., Bissell M. J., Cox T. R., Giaccia A. J., Erler J. T., Hiratsuka S., Ghajar C. M., Lyden D., Nat. Rev. Cancer 2017, 17, 302.</Citation><ArticleIdList><ArticleId IdType="pubmed">28303905</ArticleId></ArticleIdList></Reference><Reference><Citation>Akers J. C., Gonda D., Kim R., Carter B. S., Chen C. C., J. Neurooncol. 2013, 113, 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5533094</ArticleId><ArticleId IdType="pubmed">23456661</ArticleId></ArticleIdList></Reference><Reference><Citation>Raposo G., Stoorvogel W., J. Cell Biol. 2013, 200, 373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575529</ArticleId><ArticleId IdType="pubmed">23420871</ArticleId></ArticleIdList></Reference><Reference><Citation>van Niel G., D'Angelo G., Raposo G., Nat. Rev. Mol. Cell Biol. 2018, 19, 213.</Citation><ArticleIdList><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl P. D., Raposo G., Physiology 2019, 34, 169.</Citation><ArticleIdList><ArticleId IdType="pubmed">30968753</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller L., Hong C. S., Stolz D. B., Watkins S. C., Whiteside T. L., J. Immunol. Methods 2014, 411, 55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260336</ArticleId><ArticleId IdType="pubmed">24952243</ArticleId></ArticleIdList></Reference><Reference><Citation>Szatanek R., Baj&#x2010;Krzyworzeka M., Zimoch J., Lekka M., Siedlar M., Baran J., Int. J. Mol. Sci. 2017, 18, 1153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485977</ArticleId><ArticleId IdType="pubmed">28555055</ArticleId></ArticleIdList></Reference><Reference><Citation>Muralidharan&#x2010;Chari V., Clancy J. W., Sedgwick A., D'Souza&#x2010;Schorey C., J. Cell Sci. 2010, 123, 1603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864708</ArticleId><ArticleId IdType="pubmed">20445011</ArticleId></ArticleIdList></Reference><Reference><Citation>Battistelli M., Falcieri E., Biology (Basel) 2020, 9, 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7168913</ArticleId><ArticleId IdType="pubmed">31968627</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips W., Willms E., Hill A. F., Proteomics 2021, 21, 2000118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8365743</ArticleId><ArticleId IdType="pubmed">33857352</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbidge K., Zwikelmaier V., Cook B., Long M. M., Balva B., Lonigro M., Ispas G., Rademacher D. J., Campbell E. M., J. Extracell. Vesicles 2020, 9, 1789326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7480458</ArticleId><ArticleId IdType="pubmed">32944176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellar E. R., Hill C., Melling G. E., Carter D. R. F., Baena&#x2010;Lopez L. A., J. Extracell. Biol. 2022, 1, 40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11080855</ArticleId><ArticleId IdType="pubmed">38939528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir B., Goettsch C., Cells 2020, 9, 1601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7407641</ArticleId><ArticleId IdType="pubmed">32630649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol E. A., Goumans M. J., Doevendans P. A., Sluijter J. P. G., Vader P., Nanomedicine 2017, 13, 2061.</Citation><ArticleIdList><ArticleId IdType="pubmed">28365418</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan K., Martin K., FitzGerald S. P., O'Sullivan J., Wu Y., Blanco A., Richardson C., Mc Gee M. M., Sci. Rep. 2020, 10, 1039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6978318</ArticleId><ArticleId IdType="pubmed">31974468</ArticleId></ArticleIdList></Reference><Reference><Citation>MYu K., Lekchnov E. A., Vlassov A. V., Laktionov P. P., Biomed Res. Int. 2018, 2018, 8545347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831698</ArticleId><ArticleId IdType="pubmed">29662902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongui&#xf3;&#x2010;Tortajada M., G&#xe1;lvez&#x2010;Mont&#xf3;n C., Bayes&#x2010;Genis A., Roura S., Borr&#xe0;s F. E., Cell. Mol. Life Sci. 2019, 76, 2369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11105396</ArticleId><ArticleId IdType="pubmed">30891621</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z., Wijerathne H., Godwin A. K., Soper S. A., Extracell. Vesicles Circ. Nucl. Acids 2021, 2, 80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8372011</ArticleId><ArticleId IdType="pubmed">34414401</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S. C., Tao S. C., Dawn H., J. Extracell. Vesicles 2018, 7, 1508271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6104604</ArticleId><ArticleId IdType="pubmed">30151077</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Deng J., Li J., Tian F., Liu C., Fang L., Sun J., TrAC, Trends Anal. Chem. 2022, 157, 116817.</Citation></Reference><Reference><Citation>Bazaz S. R., Zhand S., Salomon R., Beheshti E. H., Jin D., Warkiani M. E., Appl. Mater. Today 2023, 30, 101730.</Citation></Reference><Reference><Citation>Dong X., Chi J., Zheng L., Ma B., Li Z., Wang S., Zhao C., Liu H., Lab Chip 2019, 19, 2897.</Citation><ArticleIdList><ArticleId IdType="pubmed">31363724</ArticleId></ArticleIdList></Reference><Reference><Citation>Raju D., Bathini S., Badilescu S., Ghosh A., Packirisamy M., Micromachines (Basel) 2022, 13, 730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9147043</ArticleId><ArticleId IdType="pubmed">35630197</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalmers J. M., Edwards H. G. M., Hargreaves M. D., Infrared and Raman Spectroscopy in Forensic Science, 2012, Wiley, Hoboken, New Jersey.</Citation></Reference><Reference><Citation>Das R. S., Agrawal Y. K., Vib. Spectrosc. 2011, 57, 163.</Citation></Reference><Reference><Citation>Gualerzi A., Kooijmans S. A. A., Niada S., Picciolini S., Brini A. T., Camussi G., Bedoni M., J. Extracell. Vesicles 2019, 8, 1568780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6352930</ArticleId><ArticleId IdType="pubmed">30728924</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W., Nanou A., Rikkert L., Coumans F. A. W., Otto C., Terstappen L. W. M. M., Offerhaus H. L., Anal. Chem. 2018, 90, 11290.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170952</ArticleId><ArticleId IdType="pubmed">30157378</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H., Seo D., Choi Y., Molecules 2020, 25, 5209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664897</ArticleId><ArticleId IdType="pubmed">33182340</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualerzi A., Niada S., Giannasi C., Picciolini S., Morasso C., Vanna R., Rossella V., Masserini M., Bedoni M., Ciceri F., Bernardo M. E., Brini A. T., Gramatica F., Sci. Rep. 2017, 7, 9820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575260</ArticleId><ArticleId IdType="pubmed">28852131</ArticleId></ArticleIdList></Reference><Reference><Citation>Samoylenko A., K&#xf6;gler M., Zhyvolozhnyi A., Makieieva O., Bart G., Andoh S. S., Roussey M., Vainio S. J., Hiltunen J., Sci. Rep. 2021, 11, 19594.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486794</ArticleId><ArticleId IdType="pubmed">34599227</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Ren T., Cao K., Xu Z., Biosens. Bioelectron. 2024, 251, 116076.</Citation><ArticleIdList><ArticleId IdType="pubmed">38340580</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuypers S., Smisdom N., Pintelon I., Timmermans J., Ameloot M., Michiels L., Hendrix J., Hosseinkhani B., Small 2021, 17, 202006786.</Citation><ArticleIdList><ArticleId IdType="pubmed">33448084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Chen E. W., Thomas J., Liu Y., Tu H., Boppart S. A., Opt. Lett. 2020, 45, 3613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537796</ArticleId><ArticleId IdType="pubmed">32630912</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H., Jeong H., Park J., Hong S., Choi Y., ACS Sens. 2018, 3, 2637.</Citation><ArticleIdList><ArticleId IdType="pubmed">30381940</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Zhu L., Li K., Ye S., Wang H., Wang Y., Xue J., Wang C., Li S., Liang N., Yang Y., Nanomaterials 2022, 12, 809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8912499</ArticleId><ArticleId IdType="pubmed">35269297</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F., Gui Y., Liu W., Li C., Yang Y., Anal. Chem. 2022, 94, 875.</Citation><ArticleIdList><ArticleId IdType="pubmed">34982534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliam L., Liston M., Sun B., Narvid J., J. Neurovirol. 2020, 26, 880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718328</ArticleId><ArticleId IdType="pubmed">32681213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D., Lee C., Han K., Goo T., Kim B., Han Y., Kwon W., Lee S., Jang J., Park T., Sci. Rep. 2025, 15, 10995.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11958759</ArticleId><ArticleId IdType="pubmed">40164714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen M. N., Guerreiro E. M., Enciso&#x2010;Martinez A., Kruglik S. G., Otto C., Snir O., Ricaud B., Helles&#xf8; O. G., Sci. Rep. 2024, 14, 6791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10957939</ArticleId><ArticleId IdType="pubmed">38514697</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobra G., Bukva M., Szabo Z., Bruszel B., Harmati M., Gyukity&#x2010;Sebestyen E., Jenei A., Szucs M., Horvath P., Biro T., Klekner A., Buzas K., Int. J. Mol. Sci. 2020, 21, 5359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7432723</ArticleId><ArticleId IdType="pubmed">32731530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Lyden D., Nat. Protoc. 2019, 14, 1027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733524</ArticleId><ArticleId IdType="pubmed">30833697</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H., Kim J., Park J., Micro Nano Syst. Lett. 2017, 5, 15.</Citation></Reference><Reference><Citation>Bachurski D., Schuldner M., Nguyen P., Malz A., Reiners K. S., Grenzi P. C., Babatz F., Schauss A. C., Hansen H. P., Hallek M., von Strandmann E. P., J. Extracell. Vesicles 2019, 8, 1596016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450530</ArticleId><ArticleId IdType="pubmed">30988894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwak H., Park S., Kim J., Lee J. D., Kim I., Kim S., Hyun K., Jung H., Biosens. Bioelectron. 2021, 192, 113495.</Citation><ArticleIdList><ArticleId IdType="pubmed">34273737</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies R. T., Kim J., Jang S. C., Choi E. J., Gho Y. S., Park J., Lab Chip 2012, 12, 5202.</Citation><ArticleIdList><ArticleId IdType="pubmed">23111789</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y. Q., Bao Q. Y., Yu S. X., Liu Q., Xie Y., Li X., Liu Y.&#x2010;J., Shen Y.&#x2010;H., Front. Oncol. 2021, 11, 709255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8437394</ArticleId><ArticleId IdType="pubmed">34527582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang Y., Purcell E., Palacios&#x2010;Rolston C., Lo T., Ramnath N., Jolly S., Small 2019, 15, 1903600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6951813</ArticleId><ArticleId IdType="pubmed">31588683</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Gong M., Hu Y., Liu H., Zhang W., Zhang M., Hu X., Aubert D., Zhu S., Wu L., Yan X., J. Extracell. Vesicles 2020, 9, 1697028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6896440</ArticleId><ArticleId IdType="pubmed">31839906</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay H. M., Leong S. Y., Xu X., Kong F., Upadya M., Dalan R., Tay C. Y., Dao M., Suresh S., Hou H. W., Lab Chip 2021, 21, 2511.</Citation><ArticleIdList><ArticleId IdType="pubmed">34042931</ArticleId></ArticleIdList></Reference><Reference><Citation>Liangsupree T., Multia E., Riekkola M. L., J. Chromatogr. A 2021, 1636, 461773.</Citation><ArticleIdList><ArticleId IdType="pubmed">33316564</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimi N., Cvjetkovic A., Jang S. C., Crescitelli R., Hosseinpour Feizi M. A., Nieuwland R., L&#xf6;tvall J., L&#xe4;sser C., Cell. Mol. Life Sci. 2018, 75, 2873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6021463</ArticleId><ArticleId IdType="pubmed">29441425</ArticleId></ArticleIdList></Reference><Reference><Citation>Stranska R., Gysbrechts L., Wouters J., Vermeersch P., Bloch K., Dierickx D., Andrei G., Snoeck R., J. Transl. Med. 2018, 16, 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5761138</ArticleId><ArticleId IdType="pubmed">29316942</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeringer E., Barta T., Li M., Vlassov A. V., Cold Spring Harb. Protoc.&#xa0; 2015, 2015, pdb.top074476.</Citation><ArticleIdList><ArticleId IdType="pubmed">25834266</ArticleId></ArticleIdList></Reference><Reference><Citation>Doyle L., Wang M., Cells 2019, 8, 727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6678302</ArticleId><ArticleId IdType="pubmed">31311206</ArticleId></ArticleIdList></Reference><Reference><Citation>Krafft C., Neudert L., Simat T., Salzer R., Spectrochim. Acta, Part A 2005, 61, 1529.</Citation><ArticleIdList><ArticleId IdType="pubmed">15820887</ArticleId></ArticleIdList></Reference><Reference><Citation>Czamara K., Majzner K., Pacia M. Z., Kochan K., Kaczor A., Baranska M., J. Raman Spectrosc. 2015, 46, 4.</Citation></Reference><Reference><Citation>Movasaghi Z., Rehman S., Rehman I. U., Appl. Spectrosc. Rev. 2007, 42, 493.</Citation></Reference><Reference><Citation>
Cameron J. M., Bruno C., Parachalil D. R., Baker M. J., Bonnier F., Butler H. J., Byrne H. J., V<i>ibrational Spectroscopy in Protein Research</i>
, 2020, Elsevier, Amsterdam.</Citation></Reference><Reference><Citation>Palviainen M., Saraswat M., Varga Z., Kitka D., Neuvonen M., Puhka M., Joenvaara S., Renkonen R., Nieuwland R., Takatalo M., Sijander P. R. M., PLoS One 2020, 15, 0236439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446890</ArticleId><ArticleId IdType="pubmed">32813744</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso S., Poon I. K. H., Front. Immunol. 2018, 9, 01486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6031707</ArticleId><ArticleId IdType="pubmed">30002658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonda D. D., Akers J. C., Kim R., Kalkanis S. N., Hochberg F. H., Chen C. C., Carter B. S., Neurosurgery 2013, 72, 501.</Citation><ArticleIdList><ArticleId IdType="pubmed">23277376</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlassov A. V., Magdaleno S., Setterquist R., Conrad R., Biochim. Biophys. Acta, Gen. Subj. 2012, 1820, 940.</Citation><ArticleIdList><ArticleId IdType="pubmed">22503788</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#xe1;&#xf1;ez&#x2010;M&#xf3; M., Siljander P. R., Andreu Z., Bedina Zavec A., Borr&#xe0;s F. E., Buzas E. I., Buzas K., Casal E., Cappello F., Carvalho J., Col&#xe1;s E., Cordeiro&#x2010;da Silva A., Fais S., Falcon&#x2010;Perez J. M., Ghobrial I. M., Giebel B., Gimona M., Graner M., Gursel I., Gursel M., Heegaard N. H. H., Hendrix A., Kierulf P., Kokubun K., Kosanovic M., Kralj&#x2010;Iglic V., Kr&#xe4;mer&#x2010;Albers E., Laitinen S., L&#xe4;sser C., et&#xa0;al.,J. Extracell. Vesicles 2015, 4, 27066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4433489</ArticleId><ArticleId IdType="pubmed">25979354</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Niel G., D'Angelo G., Raposo G., Nat. Rev. Mol. Cell Biol. 2018, 19, 213.</Citation><ArticleIdList><ArticleId IdType="pubmed">29339798</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu S., Zhang Y., Li Y., Luo L., Zhao Y., Yao Y., Cell Death Discovery 2020, 6, 68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393487</ArticleId><ArticleId IdType="pubmed">32821437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinakaran V., Rathinavel A., Pushpanathan M., Sivakumar R., Gunasekaran P., Rajendhran J., Bereswill S., PLoS One 2014, 9, 105221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4136842</ArticleId><ArticleId IdType="pubmed">25133738</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekholm S., Karppanen H., Eur. J. Pharmacol. 1989, 163, 209.</Citation><ArticleIdList><ArticleId IdType="pubmed">2566501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekholm S., Karppanen H., Eur. J. Pharmacol. 1987, 143, 27.</Citation><ArticleIdList><ArticleId IdType="pubmed">3691650</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Schnedl W. J., Schr&#xf6;cksnadel S., Geisler S., Murr C., Fuchs D., Pteridines 2013, 24, 51.</Citation></Reference><Reference><Citation>Onozato M., Tanaka Y., Arita M., Sakamoto T., Ichiba H., Sadamoto K., Kondo M., Fukushima T., Pract. Lab Med. 2018, 12, 00099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6044227</ArticleId><ArticleId IdType="pubmed">30014016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangge H., Stelzer I., Reininghaus E. Z., Weghuber D., Postolache T. T., Fuchs D., Curr. Med. Chem. 2014, 21, 1931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4922792</ArticleId><ArticleId IdType="pubmed">24606499</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu E., Ruiz&#x2010;Canela M., Guasch&#x2010;Ferr&#xe9; M., Zheng Y., Toledo E., Clish C. B., Salas&#x2010;Salvad&#xf3; J., Liang L., Wang D. D., Corella D., Fit&#xf3; M., G&#xf3;mez&#x2010;Gracia E., Lapetra J., Estruch R., Ros E., Cof&#xe1;n M., Ar&#xf3;s F., Romaguera D., Serra&#x2010;Majem L., Sorl&#xed; J. V., Hu F. B., Martinez&#x2010;Gonzalez M. A., J. Nutr. 2017, 314, jn241711.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320398</ArticleId><ArticleId IdType="pubmed">28179491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro M. D., Fazio S., Circ. Res. 2016, 118, 732.</Citation><ArticleIdList><ArticleId IdType="pubmed">26892970</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes M. V., Asselbergs F. W., Palmer T. M., Drenos F., Lanktree M. B., Nelson C. P., Dale C. E., Padmanabhan S., Finan C., Swerdlow D. I., Tragante V., van Iperen E. P. A., Sivapalaratnam S., Shah S., Elbers C. C., Shah T., Engmann J., Giambartolomei C., White J., Zabaneh D., Sofat R., McLachlan S., Doevendans P. A., Balmforth A. J., Hall A. S., North K. E., Almoguera B., Hoogeveen R. C., Cushman M., Fornage M., et&#xa0;al., Eur. Heart J. 2015, 36, 539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4344957</ArticleId><ArticleId IdType="pubmed">24474739</ArticleId></ArticleIdList></Reference><Reference><Citation>Leander K., M&#xe4;larstig A., van't Hooft F. M., Hyde C., Hell&#xe9;nius M., Troutt J. S., Konrad R. J., &#xd6;hrvik J., Hamsten A., de Faire U., Circulation. 2016, 133, 1230.</Citation><ArticleIdList><ArticleId IdType="pubmed">26896437</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;mez&#x2010;Valero A., Mongui&#xf3;&#x2010;Tortajada M., Carreras&#x2010;Planella L., Franquesa M., Beyer K., Borr&#xe0;s F. E., Sci. Rep. 2016, 6, 33641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027519</ArticleId><ArticleId IdType="pubmed">27640641</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri V., Lucchetti D., Gatto I., Maiorana A., Marcantoni M., Maulucci G., Papi M., Pola R., De Spirito M., Sgambato A., J. Nanopart. Res. 2014, 16, 2583.</Citation></Reference><Reference><Citation>Gholizadeh S., Shehata Draz M., Zarghooni M., Sanati&#x2010;Nezhad A., Ghavami S., Shafiee H., Akbari M., Biosens. Bioelectron. 2017, 91, 588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5323331</ArticleId><ArticleId IdType="pubmed">28088752</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao H., Im H., Castro C. M., Breakefield X., Weissleder R., Lee H., Chem. Rev. 2018, 118, 1917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6029891</ArticleId><ArticleId IdType="pubmed">29384376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach J. Q., Kr&#xfc;ger A., Gallogly S., Hanley S. A., Hogan M. C., Ward C. J., Joshi L., Griffin M. D., PLoS One 2013, 8, 74801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3777961</ArticleId><ArticleId IdType="pubmed">24069349</ArticleId></ArticleIdList></Reference><Reference><Citation>Couch Y., Akbar N., Davis S., Fischer R., Dickens A. M., Neuhaus A. A., Burgess A. I., Rothwell P. M., Buchan A. M., Stroke. 2017, 48, 2292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5531255</ArticleId><ArticleId IdType="pubmed">28536169</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowal J., Arras G., Colombo M., Jouve M., Morath J. P., Primdal&#x2010;Bengtson B., Dingli F., Loew D., Tkach M., Thery C., Cell Biol. 2016, 113, E968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776515</ArticleId><ArticleId IdType="pubmed">26858453</ArticleId></ArticleIdList></Reference><Reference><Citation>Lischnig A., Bergqvist M., Ochiya T., L&#xe4;sser C., Mol. Cell. Proteomics 2022, 21, 100273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9486130</ArticleId><ArticleId IdType="pubmed">35918030</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C., Witwer K. W., Aikawa E., Alcaraz M. J., Anderson J. D., Andriantsitohaina R., Antoniou A., Arab T., Archer F., Atkin&#x2010;Smith G. K., Ayre D. C., Bach J., Bachurski D., Baharvand H., Balaj L., Baldacchino S., Bauer N. N., Baxter A. A., Bebawy M., Beckham C., Bedina Zavec A., Benmoussa A., Berardi A. C., Bergese P., Bielska E., Blenkiron C., Bobis&#x2010;Wozowicz S., Boilard E., Boireau W., Bongiovanni A., et&#xa0;al., J. Extracell. Vesicles 2018, 7, 1535750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Van D. E. R. P. O. L. E., Hoekstra A. G., Sturk A., Otto C., Van L. E. E. U. W. E. N. T. G., Nieuwland R., J. Thromb. Haemostasis 2010, 8, 2596.</Citation><ArticleIdList><ArticleId IdType="pubmed">20880256</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E. J., Schwartz J. B., Mustapic M., Lobach I. V., Daneman R., Abner E. L., Jicha G. A., FASEB J. 2017, 31, 3689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5503715</ArticleId><ArticleId IdType="pubmed">28476896</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman D. W., Noren Hooten N., Eitan E., Green J., Mode N. A., Bodogai M., Zhang Y., Lehrmann E., Zonderman A. B., Biragyn A., Egan J., Becker K. G., Mattson M. P., Ejiogu N., Evans M. K., Diabetes 2018, 67, 2377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6198336</ArticleId><ArticleId IdType="pubmed">29720498</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40502572</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>24</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Evaluating the performance and potential bias of predictive models for detection of transthyretin cardiac amyloidosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.10.09.24315202</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.10.09.24315202</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Delays in the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) contribute to the significant morbidity of the condition, especially in the era of disease-modifying therapies. Screening for ATTR-CM with AI and other algorithms may improve timely diagnosis, but these algorithms have not been directly compared.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The aim of this study was to compare the performance of four algorithms for ATTR-CM detection in a heart failure population and assess the risk for harms due to model bias.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We identified patients in an integrated health system from 2010-2022 with ATTR-CM and age- and sex-matched them to controls with heart failure to target 5% prevalence. We compared the performance of a claims-based random forest model (Huda et al. model), a regression-based score (Mayo ATTR-CM), and two deep learning echo models (EchoNet-LVH and EchoGo <sup>&#xae;</sup> Amyloidosis). We evaluated for bias using standard fairness metrics.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The analytical cohort included 176 confirmed cases of ATTR-CM and 3192 control patients with 79.2% self-identified as White and 9.0% as Black. The Huda et al. model performed poorly (AUC 0.49). Both deep learning echo models had a higher AUC when compared to the Mayo ATTR-CM Score (EchoNet-LVH 0.88; EchoGo Amyloidosis 0.92; Mayo ATTR-CM Score 0.79; DeLong P&lt;0.001 for both). Bias auditing met fairness criteria for <i>equal opportunity</i> among patients who identified as Black.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Deep learning, echo-based models to detect ATTR-CM demonstrated best overall discrimination when compared to two other models in external validation with low risk of harms due to racial bias.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hourmozdi</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Easton</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Benigeri</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>James D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Narang</LastName><ForeName>Akhil</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Duffy</LastName><ForeName>Grant</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Upton</LastName><ForeName>Ross</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Hawkes</LastName><ForeName>Will</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Akerman</LastName><ForeName>Ashley</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Okwuosa</LastName><ForeName>Ike</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Kline</LastName><ForeName>Adrienne</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kho</LastName><ForeName>Abel N</ForeName><Initials>AN</Initials></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sanjiv J</ForeName><Initials>SJ</Initials></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Faraz S</ForeName><Initials>FS</Initials><Identifier Source="ORCID">0000-0002-2613-2541</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateIn"><RefSource>JACC Adv. 2025 Jul 4;4(8):101901. doi: 10.1016/j.jacadv.2025.101901.</RefSource><PMID Version="1">40616933</PMID></CommentsCorrections></CommentsCorrectionsList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40502572</ArticleId><ArticleId IdType="pmc">PMC12155028</ArticleId><ArticleId IdType="doi">10.1101/2024.10.09.24315202</ArticleId><ArticleId IdType="pii">2024.10.09.24315202</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40462782</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Development and Technical Validation of an Integrated Risk Calculator for Acute Coronary Syndrome Using ChatGPT-Assisted Coding.</ArticleTitle><Pagination><StartPage>e83410</StartPage><MedlinePgn>e83410</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e83410</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.83410</ELocationID><Abstract><AbstractText>Introduction Acute coronary syndrome (ACS) remains a major contributor to cardiovascular morbidity and mortality, necessitating efficient and accurate risk-stratification tools. Widely used models such as the Thrombolysis in Myocardial Infarction (TIMI), Global Registry of Acute Coronary Events (GRACE), and Mehran scores require separate manual inputs, leading to workflow inefficiencies and transcription errors. This study introduces an integrated digital tool that consolidates these scoring systems into a single interface and explores the feasibility of AI-assisted development in clinical software design. Objective The objective of this study is to develop and technically validate an integrated ACS risk calculator that streamlines the computation of TIMI, GRACE, and Mehran scores while demonstrating the utility of AI-assisted coding in clinical applications. Methods A web-based calculator was developed using Hypertext Markup Language (HTML)/JavaScript, with AI-assisted code prototyping via ChatGPT (o3-mini-high) (OpenAI, San Francisco, CA). The interface standardizes shared clinical variables for all three risk scores. Validation was conducted using 226 ACS cases from the Sheikh Khalifa Specialty Hospital registry. TIMI and GRACE scores generated by the tool were compared against Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) registry values using Pearson correlation. The Mehran score was internally validated through manual review. Congestive heart failure was inferred using Killip class &gt; I to align inputs across models. Results The tool showed complete agreement with registry-based TIMI and GRACE scores (TIMI: r = 1.000, p &lt; 0.001; GRACE: r = 1.000, p &lt; 0.001). Manually reviewed Mehran scores demonstrated consistent output. The calculator reduced data entry duplication and preserved computational accuracy. Conclusion This study validates an integrated ACS risk calculator that unifies three established models within a single digital tool. It enhances workflow efficiency and demonstrates the practical value of AI-assisted, clinician-led development in cardiovascular decision support. Further clinical and usability validation is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Egaimi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Egaimi</LastName><ForeName>Musab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corvo</LastName><ForeName>Pierfrancesco</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Houri</LastName><ForeName>Hasan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ji Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seo</LastName><ForeName>Heeyoung</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almorraweh</LastName><ForeName>Alghafek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Wonsuk</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Badreldin</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bashir</LastName><ForeName>Sahla</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serour</LastName><ForeName>Mohamed H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merghani</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Natour</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mukhtar</LastName><ForeName>Musab</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clementi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Sheikh Khalifa Specialty Hospital, Ras Al Khaimah, ARE.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">ai-assisted development</Keyword><Keyword MajorTopicYN="N">chatgpt coding</Keyword><Keyword MajorTopicYN="N">clinical decision support</Keyword><Keyword MajorTopicYN="N">grace score</Keyword><Keyword MajorTopicYN="N">integrated risk calculator</Keyword><Keyword MajorTopicYN="N">mehran score</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword><Keyword MajorTopicYN="N">technical validation</Keyword><Keyword MajorTopicYN="N">timi score</Keyword></KeywordList><CoiStatement>Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Sheikh Khalifa Specialty Hospital Institutional Review Board/Independent Ethic Committee issued approval SKSH-IRB-25-002. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40462782</ArticleId><ArticleId IdType="pmc">PMC12131109</ArticleId><ArticleId IdType="doi">10.7759/cureus.83410</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. Antman EM, Cohen M, Bernink PJ, et al. JAMA. 2000;284:835&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pubmed">10938172</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) Fox KA, Dabbous OH, Goldberg RJ, et al. BMJ. 2006;333:1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1661748</ArticleId><ArticleId IdType="pubmed">17032691</ArticleId></ArticleIdList></Reference><Reference><Citation>A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. Mehran R, Aymong ED, Nikolsky E, et al. J Am Coll Cardiol. 2004;44:1393&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pubmed">15464318</ArticleId></ArticleIdList></Reference><Reference><Citation>Synthesizing lessons learned from get with the guidelines: the value of disease-based registries in improving quality and outcomes. Ellrodt AG, Fonarow GC, Schwamm LH, et al. Circulation. 2013;128:2447&#x2013;2460.</Citation><ArticleIdList><ArticleId IdType="pubmed">24166574</ArticleId></ArticleIdList></Reference><Reference><Citation>ChatGPT in action: analyzing its use in software development. Champa AI, Rabbi MF, Nachuma C, Zibran MF. MSR Int Conf Min Softw Repos. 2024;10:1145.</Citation></Reference><Reference><Citation>Purwoko JW, Abdullah T, Wijaya B, Santoso Gunawan AA, Saputra KE. 2023 International Conference on Networking, Electrical Engineering, Computer Science, and Technology (IConNECT) Bandar Lampung, Indonesia: IEEE; Analysis ChatGPT potential: transforming software development with AI chat bots.</Citation></Reference><Reference><Citation>Correlates and prognostic impact of new-onset heart failure after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: insights from the INFUSE-AMI trial. Giustino G, Redfors B, Brener SJ, et al. Eur Heart J Acute Cardiovasc Care. 2018;7:339&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">28828881</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictors of in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction in patients with a high Killip class. Shiraishi J, Kohno Y, Nakamura T, et al. Intern Med. 2014;53:933&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">24785883</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Sgura FA, Bertelli L, Monopoli D, et al. Circ Cardiovasc Interv. 2010;3:491&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">20923986</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence-based tools in software development processes: application of ChatGPT. &#xd6;zpolat Z, Yildirim &#xd6;, Karabatak M. Eur J Tech. 2023;13:229&#x2013;240.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40471041</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2724-5772</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>05</Day></PubDate></JournalIssue><Title>Minerva cardiology and angiology</Title><ISOAbbreviation>Minerva Cardiol Angiol</ISOAbbreviation></Journal><ArticleTitle>Cardiac amyloidosis in severe aortic stenosis patients: an updated review unraveling their complex interplay.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.23736/S2724-5683.25.06736-5</ELocationID><Abstract><AbstractText>Aortic stenosis (AS) and cardiac amyloidosis (CA) often coexist in elderly patients, complicating diagnosis and treatment. AS is characterized by the narrowing of the aortic valve, leading to left ventricular outflow obstruction, primarily due to age-related calcification and congenital defects. CA, the most common cause of restrictive cardiomyopathy, results from amyloid protein deposits in the myocardium, causing diastolic dysfunction. Accurate diagnosis of CA in AS patients is challenging due to overlapping symptoms and the need for advanced imaging and biomarkers. Aortic valve replacement (AVR), through surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR) methods, is the primary treatment for severe AS. However, the presence of CA significantly impacts perioperative risk and long-term outcomes, with increased rates of heart failure, pacemaker placement, and mortality. Despite conflicting study results, CA in AS patients is associated with poorer long-term survival and more complications. Future research should enhance AI-based diagnostics, explore novel biomarkers, and clarify AS-CA interactions. Gene-silencing therapies and optimizing perioperative management and enhancing patient education are also crucial. Addressing these challenges will improve the prognosis and quality of life for patients with concurrent AS and CA, facilitating better clinical management of this complex dual pathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fakhoury</LastName><ForeName>Marc G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chanda</LastName><ForeName>Upamanyu L</ForeName><Initials>UL</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Nottingham, Nottingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reza</LastName><ForeName>Hasim</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Central America Health Sciences University, Belize City, Belize.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tayal</LastName><ForeName>Kanika</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine, Central America Health Sciences University, Belize City, Belize.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rameshbabu</LastName><ForeName>Sushmitha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Madras Medical College, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nisa</LastName><ForeName>Zaib</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, FMH College of Medicine and Dentistry, Lahore, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raheem</LastName><ForeName>Hajera A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Deccan College of Medical Sciences, Hyderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gudapati</LastName><ForeName>Nikitha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Madras Medical College, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ebanks</LastName><ForeName>Phillip D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Department of Medicine, The University of the West Indies, Mona, Jamaica.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motwani</LastName><ForeName>Jatin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan - jatinjagdeshmotwani@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Cardiol Angiol</MedlineTA><NlmUniqueID>101776555</NlmUniqueID><ISSNLinking>2724-5683</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>5</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40471041</ArticleId><ArticleId IdType="doi">10.23736/S2724-5683.25.06736-5</ArticleId><ArticleId IdType="pii">S2724-5683.25.06736-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40480678</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2632-1009</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>06</Day></PubDate></JournalIssue><Title>BMJ health &amp; care informatics</Title><ISOAbbreviation>BMJ Health Care Inform</ISOAbbreviation></Journal><ArticleTitle>Towards prehospital risk stratification using deep learning for ECG interpretation in suspected acute coronary syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e101292</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjhci-2024-101292</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Most patients presenting with chest pain in the emergency medical services (EMS) setting are suspected of non-ST-elevation acute coronary syndrome (NSTE-ACS). Distinguishing true NSTE-ACS from non-cardiac chest pain based solely on the ECG is challenging. The aim of this study is to develop and validate a convolutional neural network (CNN)-based model for risk stratification of suspected NSTE-ACS patients and to compare its performance with currently available prehospital diagnostic tools.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">For this study, an internal training cohort and an external validation cohort were used, both consisting of suspected NSTE-ACS patients. A CNN (ECG interpretation by CNN (ECG-AI)) was trained and validated to detect NSTE-ACS. The diagnostic value of ECG-AI in detecting NSTE-ACS was compared with on-site ECG analyses by an EMS paramedic (ECG-EMS), point-of-care troponin assessment and a validated prehospital clinical risk score (prehospital History, ECG, Age, Risk factors and POC-troponin (preHEART)).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 5645 patients suspected of NSTE-ACS were included. In the external validation cohort (n=754), 27% were diagnosed with NSTE-ACS. ECG-AI had a better diagnostic performance than ECG-EMS (area under the curve (AUROC) 0.70 (0.66 to 0.74) vs AUROC 0.65 (0.61 to 0.70), p=0.045) for diagnosing NSTE-ACS. The overall diagnostic accuracy of preHEART was AUROC 0.78 (0.74 to 0.82) and superior compared with ECG-AI (p=0.001). Incorporating ECG-AI into preHEART led to a significant improvement in diagnostic performance (AUROC 0.83 (0.79 to 0.86), p&lt;0.001).</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Correctly identifying patients who are at low risk for having NSTE-ACS is crucial for optimal triage in the prehospital setting. Recent studies have shown that these low-risk patients could potentially be left at home or transferred to a general practitioner, leading to less emergency department overcrowding and lower healthcare costs. Other studies demonstrated better overall diagnostic performance compared with our artificial intelligence (AI) model. However, these studies were aimed at a study population with a high prevalence of occlusive myocardial infarction, which could explain the differing levels of diagnostic performance.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Integrating AI in prehospital ECG interpretation improves the identification of patients at low risk for having NSTE-ACS. Nonetheless, clinical risk scores currently yield the best diagnostic performance and their accuracy could be further enhanced through AI. Our results pave the way for new studies focused on exploring the role of AI in prehospital risk-stratification efforts.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Demandt</LastName><ForeName>Jesse P A</ForeName><Initials>JPA</Initials><Identifier Source="ORCID">0000-0001-6506-7108</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands jesse.demandt@catharinaziekenhuis.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mast</LastName><ForeName>Thomas P</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Beek</LastName><ForeName>Konrad A J</ForeName><Initials>KAJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koks</LastName><ForeName>Arjan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>GGD Brabant-Zuidoost, Eindhoven, Noord-Brabant, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bastiaansen</LastName><ForeName>Marieke C V</ForeName><Initials>MCV</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tonino</LastName><ForeName>Pim A L</ForeName><Initials>PAL</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van 't Veer</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zimmermann</LastName><ForeName>Frederik M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Sint Antonius, Nieuwegein, Utrecht, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vlaar</LastName><ForeName>Pieter-Jan</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Catharina Hospital, Eindhoven, Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Health Care Inform</MedlineTA><NlmUniqueID>101745500</NlmUniqueID><ISSNLinking>2632-1009</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="Y">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="N">Chest Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Deep Learning</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>7</Day><Hour>16</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>7</Day><Hour>16</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>6</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40480678</ArticleId><ArticleId IdType="pmc">PMC12161418</ArticleId><ArticleId IdType="doi">10.1136/bmjhci-2024-101292</ArticleId><ArticleId IdType="pii">bmjhci-2024-101292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720&#x2013;826. doi: 10.1093/eurheartj/ehad191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee M 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78:e187&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">34756653</ArticleId></ArticleIdList></Reference><Reference><Citation>Stengaard C, S&#xf8;rensen JT, Rasmussen MB, et al. Prehospital diagnosis of patients with acute myocardial infarction. Diagnosis (Berl) 2016;3:155&#x2013;66. doi: 10.1515/dx-2016-0021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2016-0021</ArticleId><ArticleId IdType="pubmed">29536903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson LP, Smith K, Cullen L, et al. Care Models for Acute Chest Pain That Improve Outcomes and Efficiency: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79:2333&#x2013;48. doi: 10.1016/j.jacc.2022.03.380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.380</ArticleId><ArticleId IdType="pubmed">35680185</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagel D, Vlaar PJ, van Roosmalen R, et al. Prehospital risk stratification in patients with chest pain. Emerg Med J. 2021;38:814&#x2013;9. doi: 10.1136/emermed-2020-210212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-210212</ArticleId><ArticleId IdType="pmc">PMC8551969</ArticleId><ArticleId IdType="pubmed">34373266</ArticleId></ArticleIdList></Reference><Reference><Citation>Niven WGP, Wilson D, Goodacre S, et al. Do all HEART Scores beat the same: evaluating the interoperator reliability of the HEART Score. Emerg Med J. 2018;35:732&#x2013;8. doi: 10.1136/emermed-2018-207540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2018-207540</ArticleId><ArticleId IdType="pmc">PMC6287564</ArticleId><ArticleId IdType="pubmed">30217951</ArticleId></ArticleIdList></Reference><Reference><Citation>Snavely AC, Mahler SA, Hendley NW, et al. Prehospital Translation of Chest Pain Tools (RESCUE Study): Completion Rate and Inter-rater Reliability. West J Emerg Med. 2022;23:222&#x2013;8. doi: 10.5811/westjem.2021.9.52325.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/westjem.2021.9.52325</ArticleId><ArticleId IdType="pmc">PMC8967468</ArticleId><ArticleId IdType="pubmed">35302456</ArticleId></ArticleIdList></Reference><Reference><Citation>Demandt JPA, Zelis JM, Koks A, et al. Prehospital risk assessment in patients suspected of non-ST-segment elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ Open. 2022;12:e057305. doi: 10.1136/bmjopen-2021-057305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-057305</ArticleId><ArticleId IdType="pmc">PMC8984055</ArticleId><ArticleId IdType="pubmed">35383078</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopyra JP, Snavely AC, Smith LM, et al. Prehospital use of a modified HEART Pathway and point-of-care troponin to predict cardiovascular events. PLoS ONE. 2020;15:e0239460. doi: 10.1371/journal.pone.0239460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0239460</ArticleId><ArticleId IdType="pmc">PMC7540888</ArticleId><ArticleId IdType="pubmed">33027260</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolsma RT, Fokkert MJ, van Dongen DN, et al. Referral decisions based on a pre-hospital HEART score in suspected non-ST-elevation acute coronary syndrome: final results of the FamouS Triage study. Eur Heart J Acute Cardiovasc Care. 2022;11:160&#x2013;9. doi: 10.1093/ehjacc/zuab109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjacc/zuab109</ArticleId><ArticleId IdType="pmc">PMC8826840</ArticleId><ArticleId IdType="pubmed">34849660</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaro C, Aarts GWA, Adang EMM, et al. Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial. Eur Heart J. 2023;44:1705&#x2013;14. doi: 10.1093/eurheartj/ehad056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad056</ArticleId><ArticleId IdType="pmc">PMC10182886</ArticleId><ArticleId IdType="pubmed">36755110</ArticleId></ArticleIdList></Reference><Reference><Citation>Demandt J, Koks A, Sagel D, et al. Prehospital risk assessment and direct transfer to a percutaneous coronary intervention centre in suspected acute coronary syndrome. Heart. 2024;110:408&#x2013;15. doi: 10.1136/heartjnl-2023-323346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2023-323346</ArticleId><ArticleId IdType="pubmed">38040452</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dongen DN, Tolsma RT, Fokkert MJ, et al. Pre-hospital risk assessment in suspected non-ST-elevation acute coronary syndrome: A prospective observational study. Eur Heart J Acute Cardiovasc Care. 2020;9:5&#x2013;12. doi: 10.1177/2048872618813846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872618813846</ArticleId><ArticleId IdType="pubmed">30468395</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox KAA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) BMJ. 2006;333:1091. doi: 10.1136/bmj.38985.646481.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38985.646481.55</ArticleId><ArticleId IdType="pmc">PMC1661748</ArticleId><ArticleId IdType="pubmed">17032691</ArticleId></ArticleIdList></Reference><Reference><Citation>Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835&#x2013;42. doi: 10.1001/jama.284.7.835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.284.7.835</ArticleId><ArticleId IdType="pubmed">10938172</ArticleId></ArticleIdList></Reference><Reference><Citation>van Steenbergen GJ, Demandt JPA, Schulz DN, et al. Direct admission versus interhospital transfer for revascularisation in non-ST-segment elevation myocardial infarction. Clin Cardiol. 2023;46:997&#x2013;1006. doi: 10.1002/clc.24060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.24060</ArticleId><ArticleId IdType="pmc">PMC10436781</ArticleId><ArticleId IdType="pubmed">37345218</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia ZI, Harmon DM, Behr ER, et al. Application of artificial intelligence to the electrocardiogram. Eur Heart J. 2021;42:4717&#x2013;30. doi: 10.1093/eurheartj/ehab649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab649</ArticleId><ArticleId IdType="pmc">PMC8500024</ArticleId><ArticleId IdType="pubmed">34534279</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis KC, Noseworthy PA, Attia ZI, et al. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol. 2021;18:465&#x2013;78. doi: 10.1038/s41569-020-00503-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00503-2</ArticleId><ArticleId IdType="pmc">PMC7848866</ArticleId><ArticleId IdType="pubmed">33526938</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia ZI, Friedman PA, Noseworthy PA, et al. Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs. Circ Arrhythm Electrophysiol. 2019;12:e007284. doi: 10.1161/CIRCEP.119.007284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.119.007284</ArticleId><ArticleId IdType="pmc">PMC7661045</ArticleId><ArticleId IdType="pubmed">31450977</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Leur RR, van Sleuwen MTGM, Zwetsloot P-PM, et al. Automatic triage of twelve-lead electrocardiograms using deep convolutional neural networks: a first implementation study. Eur Heart J Digit Health. 2024;5:89&#x2013;96. doi: 10.1093/ehjdh/ztad070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztad070</ArticleId><ArticleId IdType="pmc">PMC10802816</ArticleId><ArticleId IdType="pubmed">38264701</ArticleId></ArticleIdList></Reference><Reference><Citation>Noseworthy PA, Attia ZI, Behnken EM, et al. Artificial intelligence-guided screening for atrial fibrillation using electrocardiogram during sinus rhythm: a prospective non-randomised interventional trial. Lancet. 2022;400:1206&#x2013;12. doi: 10.1016/S0140-6736(22)01637-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01637-3</ArticleId><ArticleId IdType="pubmed">36179758</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti SS, Martin-Gill C, Z&#xe8;gre-Hemsey JK, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023;29:1804&#x2013;13. doi: 10.1038/s41591-023-02396-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02396-3</ArticleId><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti S, Besomi L, Bouzid Z, et al. Machine learning-based prediction of acute coronary syndrome using only the pre-hospital 12-lead electrocardiogram. Nat Commun. 2020;11:3966. doi: 10.1038/s41467-020-17804-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17804-2</ArticleId><ArticleId IdType="pmc">PMC7414145</ArticleId><ArticleId IdType="pubmed">32769990</ArticleId></ArticleIdList></Reference><Reference><Citation>Demandt JPA, Koks A, Haest R, et al. Prehospital triage of patients with suspected non-ST-segment elevation acute coronary syndrome: Rationale and design of the TRIAGE-ACS study. Contemp Clin Trials. 2022;119:106854. doi: 10.1016/j.cct.2022.106854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2022.106854</ArticleId><ArticleId IdType="pubmed">35863696</ArticleId></ArticleIdList></Reference><Reference><Citation>Collet J-P, Thiele H. The &#x201c;Ten Commandments&#x201d; for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2020;41:3495&#x2013;7. doi: 10.1093/eurheartj/ehaa624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa624</ArticleId><ArticleId IdType="pubmed">33085966</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018) Eur Heart J. 2019;40:237&#x2013;69. doi: 10.1093/eurheartj/ehy462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy462</ArticleId><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud T, Fattah SA, Saquib M. DeepArrNet: An Efficient Deep CNN Architecture for Automatic Arrhythmia Detection and Classification From Denoised ECG Beats. IEEE Access. 2020;8:104788&#x2013;800. doi: 10.1109/ACCESS.2020.2998788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2020.2998788</ArticleId></ArticleIdList></Reference><Reference><Citation>Apple FS, Murakami MM, Christenson RH, et al. Analytical performance of the i-STAT cardiac troponin I assay. Clin Chim Acta. 2004;345:123&#x2013;7. doi: 10.1016/j.cccn.2004.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cccn.2004.03.010</ArticleId><ArticleId IdType="pubmed">15193986</ArticleId></ArticleIdList></Reference><Reference><Citation>Backus BE, Six AJ, Kelder JC, et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. Crit Pathw Cardiol. 2010;9:164&#x2013;9. doi: 10.1097/HPC.0b013e3181ec36d8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HPC.0b013e3181ec36d8</ArticleId><ArticleId IdType="pubmed">20802272</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu WK, Yiadom MYAB, Collins SP, et al. Documentation of HEART score discordance between emergency physician and cardiologist evaluations of ED patients with chest pain. Am J Emerg Med. 2017;35:132&#x2013;5. doi: 10.1016/j.ajem.2016.09.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2016.09.058</ArticleId><ArticleId IdType="pmc">PMC6805131</ArticleId><ArticleId IdType="pubmed">27745728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huitema AA, Zhu T, Alemayehu M, et al. Diagnostic accuracy of ST-segment elevation myocardial infarction by various healthcare providers. Int J Cardiol. 2014;177:825&#x2013;9. doi: 10.1016/j.ijcard.2014.11.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.11.032</ArticleId><ArticleId IdType="pubmed">25465827</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xe8;gre-Hemsey JK, Patel MD, Fernandez AR, et al. A Statewide Assessment of Prehospital Electrocardiography Approaches of Acquisition and Interpretation for ST-Elevation Myocardial Infarction Based on Emergency Medical Services Characteristics. Prehosp Emerg Care. 2020;24:550&#x2013;6. doi: 10.1080/10903127.2019.1677831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10903127.2019.1677831</ArticleId><ArticleId IdType="pmc">PMC7190419</ArticleId><ArticleId IdType="pubmed">31593496</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanger EK, Y&#x131;ld&#x131;r&#x131;mt&#xfc;rk &#xd6;, &#x15e;im&#x15f;ek B, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study) Int J Cardiol Heart Vasc. 2020;30:100603. doi: 10.1016/j.ijcha.2020.100603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100603</ArticleId><ArticleId IdType="pmc">PMC7399112</ArticleId><ArticleId IdType="pubmed">32775606</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer JE, Bachmann LM, Jaeschke R. A readers&#x2019; guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043&#x2013;51. doi: 10.1007/s00134-003-1761-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1761-8</ArticleId><ArticleId IdType="pubmed">12734652</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40331418</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2035</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular medicine (Hagerstown, Md.)</Title><ISOAbbreviation>J Cardiovasc Med (Hagerstown)</ISOAbbreviation></Journal><ArticleTitle>Expert consensus document on artificial intelligence of the Italian Society of Cardiology.</ArticleTitle><Pagination><StartPage>200</StartPage><EndPage>215</EndPage><MedlinePgn>200-215</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2459/JCM.0000000000001716</ELocationID><Abstract><AbstractText>Artificial intelligence (AI), a branch of computer science focused on developing algorithms that replicate intelligent behaviour, has recently been used in patients management by enhancing diagnostic and prognostic capabilities of various resources such as hospital datasets, electrocardiograms and echocardiographic acquisitions. Machine learning (ML) and deep learning (DL) models, both key subsets of AI, have demonstrated robust applications across several cardiovascular diseases, from the most diffuse like hypertension and ischemic heart disease to the rare infiltrative cardiomyopathies, as well as to estimation of LDL cholesterol which can be achieved with better accuracy through AI. Additional emerging applications are encountered when unsupervised ML methodology shows promising results in identifying distinct clusters or phenotypes of patients with atrial fibrillation that may have different risks of stroke and response to therapy. Interestingly, since ML techniques do not analyse the possibility that a specific pathology can occur but rather the trajectory of each subject and the chain of events that lead to the occurrence of various cardiovascular pathologies, it has been considered that DL, by resembling the complexity of human brain and using artificial neural networks, might support clinical management through the processing of large amounts of complex information; however, external validity of algorithms cannot be taken for granted, while interpretability of the results may be an issue, also known as a "black box" problem. Notwithstanding these considerations, facilities and governments are willing to unlock the potential of AI in order to reach the final step of healthcare advancements while ensuring that patient safety and equity are preserved.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Italian Federation of Cardiology - I.F.C. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Indolfi</LastName><ForeName>Ciro</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agostoni</LastName><ForeName>Piergiuseppe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences and Community Health, Cardiovascular Section, University of Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barill&#xe0;</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, University of Rome 'Tor Vergata'.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barison</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology and Cardiovascular Medicine, Fondazione Toscana Gabriele Monasterio, Pisa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benenati</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Genoa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilo</LastName><ForeName>Grzegorz</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boriani</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Biomedical, Metabolic and Neural Sciences, Modena University Hospital, University of Modena and Modena and Reggio Emilia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Natale Daniele</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Medical and Surgical Sciences, University of Foggia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Translational Medical Sciences, University of Campania 'Luigi Vanvitelli', Caserta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carugo</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardio-Thoracic-Vascular Area, Foundation IRCCS C&#xe0; Granda Ospedale Maggiore Policlinico, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casella</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology and Arrhythmology Clinic, University Hospital 'Azienda Ospedaliero-Universitaria delle Marche', Ancona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccarelli</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry, University of Salerno.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccone</LastName><ForeName>Marco Matteo</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Interdisciplinary Department of Medicine, 'Aldo Moro' University School of Medicine, University Cardiology Unit, Bari.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Gaetano Maria De</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Turin, Turin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greco</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Computer Science, University of Calabria, Rend.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locati</LastName><ForeName>Emanuela T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>Department of Arrhythmology and Electrophysiology, IRCCS Policlinico San Donato, Milan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merlo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Cardiomyopathies, Cardiothoracovascular Dept, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muscoli</LastName><ForeName>Saverio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Tor Vergata, University of Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nodari</LastName><ForeName>Savina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Day Hospital service, University of Brescia, Brescia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivotto</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Division of Cardiology, University of Florence, Florence.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paolillo</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polimeni</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porcari</LastName><ForeName>Aldostefano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Cardiomyopathies, Cardiothoracovascular Dept, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porto</LastName><ForeName>Italo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Department of Cardiothoracic and Vascular Surgery (DICATOV), San Martino Hospital, Genoa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spaccarotella</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vizza</LastName><ForeName>Carmine Dario</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Pulmonary Hypertension Unit, Department of Cardiovascular and Respiratory Disease, La Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Mathematics and Computer Science, University of Calabria, Rend.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinagra</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Cardiomyopathies, Cardiothoracovascular Dept, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filardi</LastName><ForeName>Pasquale Perrone</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, Federico II University, Naples.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curcio</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Annunziata Hospital, Cosenza, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016446">Consensus Development Conference</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Med (Hagerstown)</MedlineTA><NlmUniqueID>101259752</NlmUniqueID><ISSNLinking>1558-2027</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="Y">Cardiology</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiovascular prevention</Keyword><Keyword MajorTopicYN="N">device</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">telemedicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>7</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>7</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40331418</ArticleId><ArticleId IdType="doi">10.2459/JCM.0000000000001716</ArticleId><ArticleId IdType="pii">01244665-202505000-00002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dorado D&#xed;az PI, Sampedro G&#xf3;mez J, Vicente Palacios V, et al. Applications of artificial intelligence in cardiology. the future is already here. Rev Esp Cardiol 2019; 72:1065&#x2013;1075.</Citation></Reference><Reference><Citation>Karatzia L, Aung N, Aksentijevic D. Artificial intelligence in cardiology: hope for the future and power for the present. Front Cardiovasc Med 2022; 9:945726.</Citation></Reference><Reference><Citation>Makimoto H, Kohro T. Adopting artificial intelligence in cardiovascular medicine: a scoping review. Hypertens Res 2023; 47:685&#x2013;699.</Citation></Reference><Reference><Citation>Ciccarelli M, Giallauria F, Carrizzo A, et al. Artificial intelligence in cardiovascular prevention: new ways will open new doors. J Cardiovasc Med 2023; 24:106&#x2013;115.</Citation></Reference><Reference><Citation>Visco V, Ferruzzi GJ, Nicastro F, et al. Artificial intelligence as a business partner in cardiovascular precision medicine: an emerging approach for disease detection and treatment optimization. Curr Med Chem 2021; 28:6569&#x2013;6590.</Citation></Reference><Reference><Citation>Visco V, Izzo C, Mancusi C, et al. Artificial intelligence in hypertension management: an ace up your sleeve. J Cardiovasc Dev Dis 2023; 10:74.</Citation></Reference><Reference><Citation>Ye C, Fu T, Hao S, et al. Prediction of incident hypertension within the next year: prospective study using statewide electronic health records and machine learning. J Med Internet Res 2018; 20:22.</Citation></Reference><Reference><Citation>Kanegae H, Suzuki K, Fukatani K, et al. Highly precise risk prediction model for new-onset hypertension using artificial intelligence techniques. J Clin Hypertens 2020; 22:445&#x2013;450.</Citation></Reference><Reference><Citation>Held E, Cape J, Tintle N. Comparing machine learning and logistic regression methods for predicting hypertension using a combination of gene expression and next-generation sequencing data. BMC Proc 2016; 10:141&#x2013;145.</Citation></Reference><Reference><Citation>Wu J, Qin S, Wang J, et al. Develop and evaluate a new and effective approach for predicting dyslipidemia in steel workers. Front Bioeng Biotechnol 2020; 8:839.</Citation></Reference><Reference><Citation>Correia M, Kagenaar E, van Schalkwijk DB, et al. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia. Sci Rep 2021; 11:3801.</Citation></Reference><Reference><Citation>Huang J, Yeung AM, Armstrong DG, et al. Artificial intelligence for predicting and diagnosing complications of diabetes. J Diabetes Sci Technol 2023; 17:224&#x2013;238.</Citation></Reference><Reference><Citation>Tanabe H, Sato M, Miyake A, et al. Machine learning-based reproducible prediction of type 2 diabetes subtypes. Diabetologia 2024; 67:2446&#x2013;2458.</Citation></Reference><Reference><Citation>Palmer K, Marengoni A, Forjaz MJ, et al. Joint Action on Chronic Diseases and Promoting Healthy Ageing Across the Life Cycle (JA-CHRODIS). Multimorbidity care model: recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Health Policy 2018; 122:4&#x2013;11.</Citation></Reference><Reference><Citation>Paula DP, Camacho M, Barbosa O, et al. Sex and population differences in the cardiometabolic continuum: a machine learning study using the UK Biobank and ELSA-Brasil cohorts. BMC Public Health 2024; 24:2131.</Citation></Reference><Reference><Citation>Goldstein BA, Navar AM, Carter RE. Moving beyond regression techniques in cardiovascular risk prediction: applying machine learning to address analytic challenges. Eur Heart J 2017; 38:1805&#x2013;1814.</Citation></Reference><Reference><Citation>Shameer K, Johnson KW, Glicksberg BS, et al. Machine learning in cardiovascular medicine: are we there yet? Heart 2018; 104:1156&#x2013;1164.</Citation></Reference><Reference><Citation>Lee W, Lee J, Lee H, et al. Prediction of hypertension complications risk using classification techniques. Ind Eng Manag Syst 2014; 13:449&#x2013;453.</Citation></Reference><Reference><Citation>Chang W, Liu Y, Xiao Y, et al. A machine-learning-based prediction method for hypertension outcomes based on medical data. Diagnostics 2019; 9:178.</Citation></Reference><Reference><Citation>Lacson RC, Baker B, Suresh H, et al. Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients. Clin Kidney J 2018; 12:206&#x2013;212.</Citation></Reference><Reference><Citation>Pei Z, Liu J, Liu M, et al. Risk-predicting model for incident of essential hypertension based on environmental and genetic factors with support vector machine. Comput Life Sci 2018; 10:126&#x2013;130.</Citation></Reference><Reference><Citation>Dave T, Athaluri SA, Singh S. ChatGPT in medicine: an overview of its applications, advantages, limitations, future prospects, and ethical considerations. Front Artif Intell 2023; 6:1169595.</Citation></Reference><Reference><Citation>Gala D, Makaryus AN. The utility of language models in cardiology: a narrative review of the benefits and concerns of ChatGPT-4. Int J Environ Res Public Health 2023; 20:6438.</Citation></Reference><Reference><Citation>Layton AT. AI, machine learning, and ChatGPT in hypertension. Hypertension 2024; 81:709&#x2013;716.</Citation></Reference><Reference><Citation>Almagazzachi A, Mustafa A, Eighaei, et al. Generative artificial intelligence in patient education: ChatGPT takes on hypertension questions. Cureus 2024; 16:53441.</Citation></Reference><Reference><Citation>Kusunose K, Kashima S, Sata M. Evaluation of the accuracy of ChatGPT in answering clinical questions on the Japanese Society of Hypertension Guidelines. Circ J 2023; 87:1030&#x2013;1033.</Citation></Reference><Reference><Citation>D&#x2019;Ascenzo F, De Filippo O, Gallone G, et al. learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet 2021; 397:199&#x2013;207.</Citation></Reference><Reference><Citation>Khan MS, Butler J. Artificial intelligence and heart failure: a state-of-the-art review. Eur J Heart Fail 2023; 25:1507&#x2013;1525.</Citation></Reference><Reference><Citation>Masetic Z, Subasi A. Congestive heart failure detection using random forest classifier. Comput Methods Programs Biomed 2016; 130:54&#x2013;64.</Citation></Reference><Reference><Citation>Vaz JM, Balaji S. Convolutional neural networks (CNNs): concepts and applications in pharmacogenomics. Mol Divers 2021; 25:1569&#x2013;1584.</Citation></Reference><Reference><Citation>Yao X, McCoy RG, Friedman PA, et al. ECG AI-guided screening for low ejection fraction (EAGLE): rationale and design of a pragmatic cluster randomized trial. Am Heart J 2020; 219:31&#x2013;36.</Citation></Reference><Reference><Citation>Zhang J, Gajjala S, Agrawal P, et al. Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy. Circulation 2018; 138:1623&#x2013;1635.</Citation></Reference><Reference><Citation>Benjamens S, Dhunnoo P, Mesk&#xf2; B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med 2020; 3:118.</Citation></Reference><Reference><Citation>Segar MW, Patel KV, Ayers C, et al. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis. Eur J Heart Fail 2020; 22:148&#x2013;158.</Citation></Reference><Reference><Citation>Nordestgaard BG, Chapman MJ, Humphries SE, et al. European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2020; 41:4517.</Citation></Reference><Reference><Citation>Tarugi P, Bertolini S, Calandra S, et al. Consensus document on diagnosis and management of familial hypercholesterolemia from the Italian Society for the Study of Atherosclerosis (SISA). Nutr Metab Cardiovasc Dis 2024; 34:1819&#x2013;1836.</Citation></Reference><Reference><Citation>Lan NSR, Bajaj A, Watts GF, et al. Recent advances in the management and implementation of care for familial hypercholesterolaemia. Pharmacol Res 2023; 194:106857.</Citation></Reference><Reference><Citation>Al-Allaf FA, Athar M, Abduljaleel Z, et al. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease. Gene 2015; 565:76&#x2013;84.</Citation></Reference><Reference><Citation>Raal FJ, Hovingh GK, Catapano AL. Familial hypercholesterolemia treatments: guidelines and new therapies. Atherosclerosis 2018; 277:483&#x2013;492.</Citation></Reference><Reference><Citation>Hesse R, Raal FJ, Blom DJ, et al. Familial hypercholesterolemia identification by machine learning using lipid profile data performs as well as clinical diagnostic criteria. Circ Genom Precis Med 2022; 15:003324.</Citation></Reference><Reference><Citation>Pina A, Helgadottir S, Mancina RM, et al. Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning. Eur J Prev Cardiol 2020; 27:1639&#x2013;1646.</Citation></Reference><Reference><Citation>Nolde JM, Pang J, Chan DC, et al. Neural network modelling for predicting gene variants causative of familial hypercholesterolaemia in the clinic. Heart Lung Circ 2023; 32:44&#x2013;45.</Citation></Reference><Reference><Citation>Banda JM, Sarraju A, Abbasi F, et al. Finding missed cases of familial hypercholesterolemia in health systems using machine learning. NPJ Digit Med 2019; 2:23.</Citation></Reference><Reference><Citation>Andrade MM, Neto Gon&#xe7;alves T, Cruz D. Familial hypercholesterolemia diagnostic challenge: is artificial intelligence the key? Atherosclerosis 2024; 391:117435.</Citation></Reference><Reference><Citation>Albuquerque J, Medeiros AM, Alves AC, et al. Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults. Atherosclerosis 2023; 383:117314.</Citation></Reference><Reference><Citation>Athar M. Potentials of artificial intelligence in familial hypercholesterolemia: advances in screening, diagnosis, and risk stratification for early intervention and treatment. Int J Cardiol 2024; 412:132315.</Citation></Reference><Reference><Citation>Gilstrap LG, Dominici F, Wang Y, et al. Epidemiology of cardiac amyloidosis&#x2013;associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States. Circ Hear Fail 2019; 12:005407.</Citation></Reference><Reference><Citation>Wechalekar AD, Fontana M, Quarta C, et al. AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: cardiooncology state-of-the-art review. JACC Cardiooncol 2022; 4:427&#x2013;441.</Citation></Reference><Reference><Citation>Porcari A, Fontana M, Gillmore JD. Transthyretin cardiac amyloidosis. Cardiovasc Res 2023; 118:3517&#x2013;3535.</Citation></Reference><Reference><Citation>Porcari A, Sinagra G, Gillmore JD, et al. Breakthrough advances enhancing care in ATTR amyloid cardiomyopathy. Eur J Intern Med 2024; 123:29&#x2013;36.</Citation></Reference><Reference><Citation>Grogan M, Lopez Jimenez F, Cohen Shelly M, et al. Artificial intelligence-enhanced electrocardiogram for the early detection of cardiac amyloidosis. Mayo Clin Proc 2021; 96:2768&#x2013;2778.</Citation></Reference><Reference><Citation>Harmon DM, Mangold K, Baez Suarez A, et al. Postdevelopment performance and validation of the artificial intelligence-enhanced electrocardiogram for detection of cardiac amyloidosis. JACC Adv 2023; 2:100612.</Citation></Reference><Reference><Citation>Goto S, Mahara K, Beussink Nelson L, et al. Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms. Nat Commun 2021; 12:2726.</Citation></Reference><Reference><Citation>Pagura L, Porcari A, Cameli M, et al. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: a head-to-head comparison from the AC-TIVE study. Eur J Intern Med 2023; 122:68&#x2013;77.</Citation></Reference><Reference><Citation>Minchol&#xe9; A, Rodriguez B. Artificial intelligence for the electrocardiogram. Nat Med 2019; 25:22&#x2013;23.</Citation></Reference><Reference><Citation>Attia ZI, Harmon DM, Behr ER, et al. Application of artificial intelligence to the electrocardiogram. Eur Heart J 2021; 42:4717&#x2013;4730.</Citation></Reference><Reference><Citation>Somani S, Russak AJ, Richter F, et al. Deep learning and the electrocardiogram: review of the current state-of-the-art. Europace 2021; 23:1179&#x2013;1191.</Citation></Reference><Reference><Citation>Attia ZI, Noseworthy PA, Lopez Jimenez F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet 2019; 394:861&#x2013;867.</Citation></Reference><Reference><Citation>Kolk MZH, Deb B, Ruip&#xe9;rez Campillo S, et al. Machine learning of electrophysiological signals for the prediction of ventricular arrhythmias: systematic review and examination of heterogeneity between studies. EBioMedicine 2023; 89:104462.</Citation></Reference><Reference><Citation>Sun X, Teng Y, Mu S, et al. Diagnostic accuracy of different ECG- based algorithms in wide QRS complex tachycardia: a systematic review and meta- analysis. BMJ Open 2023; 13:069273.</Citation></Reference><Reference><Citation>Chan PZ, Ramli MAIB, Chew HSJ. Diagnostic Test Accuracy of artificial intelligence-assisted detection of acute coronary syndrome: a systematic review and meta-analysis. Comput Biol Med 2023; 167:107636.</Citation></Reference><Reference><Citation>Siranart N, Deepan N, Techasatian W, et al. Diagnostic accuracy of artificial intelligence in detecting left ventricular hypertrophy by electrocardiograph: a systematic review and meta-analysis. Sci Rep 2024; 14:15882.</Citation></Reference><Reference><Citation>Singh S, Chaudhary R, Bliden KP, et al. Meta-analysis of the performance of AI-driven ECG interpretation in the diagnosis of valvular heart diseases. Am J Cardiol 2024; 213:126&#x2013;131.</Citation></Reference><Reference><Citation>Rjoob K, Bond R, Finlay D, et al. Machine learning and the electrocardiogram over two decades: time series and meta-analysis of the algorithms, evaluation metrics and applications. Artif Intell Med 2022; 132:102381.</Citation></Reference><Reference><Citation>Al-Zaiti S, Besomi L, Bouzid Z, et al. Machine learning-based prediction of acute coronary syndrome using only the prehospital 12-lead electrocardiogram. Nat Commun 2020; 11:1&#x2013;10.</Citation></Reference><Reference><Citation>Chen KW, Wang YC, Liu MH, et al. Artificial intelligence-assisted remote detection of ST-elevation myocardial infarction using a mini-12-lead electrocardiogram device in prehospital ambulance care. Front Cardiovasc Med 2022; 9:1001982.</Citation></Reference><Reference><Citation>Zhao Y, Xiong J, Hou Y, et al. Early detection of ST-segment elevated myocardial infarction by artificial intelligence with 12-lead electrocardiogram. Int J Cardiol 2020; 317:223&#x2013;230.</Citation></Reference><Reference><Citation>Choi YJ, Park MJ, Ko Y, et al. Artificial intelligence versus physicians on interpretation of printed ECG images: diagnostic performance of ST-elevation myocardial infarction on electrocardiography. Int J Cardiol 2022; 363:6&#x2013;10.</Citation></Reference><Reference><Citation>Herman R, Meyers HP, Smith SW, et al. International evaluation of an artificial intelligence&#x2013;powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. European Heart Journal. Digital Health 2024; 5:123&#x2013;133.</Citation></Reference><Reference><Citation>Liu WC, Lin CS, Tsai CS, et al. A deep learning algorithm for detecting acute myocardial infarction. EuroIntervention 2021; 17:765&#x2013;773.</Citation></Reference><Reference><Citation>Wu CC, Hsu WD, Islam MM, et al. An artificial intelligence approach to early predict non-ST-elevation myocardial infarction patients with chest pain. Comput Methods Programs Biomed 2019; 173:109&#x2013;117.</Citation></Reference><Reference><Citation>Qin L, Qi Q, Aikeliyaer A, et al. Machine learning algorithm can provide assistance for the diagnosis of non-ST-segment elevation myocardial infarction. Postgrad Med J 2023; 99:1171.</Citation></Reference><Reference><Citation>Than MP, Pickering JW, Sandoval Y, et al. Machine learning to predict the likelihood of acute myocardial infarction. Circulation 2019; 140:899&#x2013;909.</Citation></Reference><Reference><Citation>Doudesis D, Lee K, Boeddinghaus J, et al. Nature medicine machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations. Nat Med 2023; 29:1201&#x2013;1210.</Citation></Reference><Reference><Citation>Kayvanpour E, Gi WT, Sedaghat Hamedani F, et al. microRNA neural networks improve diagnosis of acute coronary syndrome (ACS). J Mol Cell Cardiol 2021; 151:155&#x2013;162.</Citation></Reference><Reference><Citation>Yetisen AK, Martinez Hurtado JL, &#xdc;nal B, et al. Wearables in medicine. Adv Mater 2018; 30:1706910.</Citation></Reference><Reference><Citation>Leclercq C, Witt H, Hindricks G, et al. Wearables, telemedicine, and artificial intelligence in arrhythmias and heart failure: Proceedings of the European Society of Cardiology Cardiovascular Round Table. Europace 2022; 24:1372&#x2013;1383.</Citation></Reference><Reference><Citation>Varma N, Marrouche NF, Aguinaga L, et al. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic: developed in partnership with and endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS). Europace 2021; 23:313.</Citation></Reference><Reference><Citation>Nahavandi D, Alizadehsani R, Khosravi A, et al. Application of artificial intelligence in wearable devices: opportunities and challenges. Comput Methods Programs Biomed 2022; 213:106541.</Citation></Reference><Reference><Citation>Marvasti TB, Gao Y, Murray KR, et al. Unlocking tomorrow's healthcare: expanding the clinical scope of wearables by applying artificial intelligence. Can J Cardiol 2024; 40:1934&#x2013;1945.</Citation></Reference><Reference><Citation>Varma N, Han JK, Passman R, et al. Promises and perils of consumer mobile technologies in cardiovascular care: JACC scientific statement. J Am Coll Cardiol 2024; 83:611&#x2013;631.</Citation></Reference><Reference><Citation>Schnabel RB, Marinelli EA, Arbelo E, et al. Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Europace 2023; 25:6&#x2013;27.</Citation></Reference><Reference><Citation>Svennberg E, Caiani EG, Bruining N, et al. The digital journey: 25&#x200a;years of digital development in electrophysiology from an Europace perspective. Europace 2023; 25:176.</Citation></Reference><Reference><Citation>Kim JY, Kim KG, Tae Y, et al. An artificial intelligence algorithm with 24-h holter monitoring for the identification of occult atrial fibrillation during sinus rhythm. Front Cardiovasc Med 2022; 9:906780.</Citation></Reference><Reference><Citation>Taniguchi H, Takata T, Takechi M, et al. Explainable artificial intelligence model for diagnosis of atrial fibrillation using Holter electrocardiogram waveforms. Int Heart J 2021; 62:534&#x2013;539.</Citation></Reference><Reference><Citation>Hygrell T, Viberg F, Dahlberg E, et al. An artificial intelligence-based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening. Europace 2023; 25:1332&#x2013;1338.</Citation></Reference><Reference><Citation>Xie C, Wang Z, Yang C, et al. Machine learning for detecting atrial fibrillation from ecgs: systematic review and meta-analysis. Rev Cardiovasc Med 2024; 25:8.</Citation></Reference><Reference><Citation>Lip GYH, Lane DA, Lenarczyk R, et al. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J 2022; 43:2442&#x2013;2460.</Citation></Reference><Reference><Citation>Sritharan HP, Chia J, Gardiner K, et al. Utility of conversational artificial intelligence with large language models for patient information on cardiac electrophysiology procedures. Heart Rhythm 2024; S1547-5271:03421-0.</Citation></Reference><Reference><Citation>Crespin E, Rosier A, Ibnouhsein I, et al. Improved diagnostic performance of insertable cardiac monitors by an artificial intelligence-based algorithm. Europace 2023; 26:375.</Citation></Reference><Reference><Citation>Au-Yeung WTM, Reinhall PG, Bardy GH, et al. Development and validation of warning system of ventricular tachyarrhythmia in patients with heart failure with heart rate variability data. PLoS One 2018; 13:0207215.</Citation></Reference><Reference><Citation>Ahmad T, Lund LH, Rao P, et al. Machine learning methods improve prognostication, identify clinically distinct phenotypes, and detect heterogeneity in response to therapy in a large cohort of heart failure patients. J Am Heart Assoc 2018; 7:008081.</Citation></Reference><Reference><Citation>Cikes M, Sanchez Martinez S, Claggett B, et al. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Eur J Heart Fail 2019; 21:74&#x2013;85.</Citation></Reference><Reference><Citation>Kwon JM, Kim KH, Jeon KH, et al. Artificial intelligence algorithm for predicting mortality of patients with acute heart failure. PLoS One 2019; 14:0219302.</Citation></Reference><Reference><Citation>Gronda E, Vanoli E, Zorzi A, et al. CardioMEMS, the real progress in heart failure home monitoring. Heart Fail Rev 2020; 25:93&#x2013;98.</Citation></Reference><Reference><Citation>Stehlik J, Schmalfuss C, Bozkurt B, et al. Continuous wearable monitoring analytics predict heart failure hospitalization: the LINKHF multicenter study. Circ Heart Fail 2020; 13:006513.</Citation></Reference><Reference><Citation>Zhang Z, Zhu Y, Liu M, et al. Artificial intelligence-enhanced echocardiography for systolic function assessment. J Clin Med 2022; 11:2893.</Citation></Reference><Reference><Citation>Ouyang D, He B, Ghorbani A, et al. Video-based AI for beat-to-beat assessment of cardiac function. Nature 2020; 580:252&#x2013;256.</Citation></Reference><Reference><Citation>Kwan AC, Chang EW, Jain I, et al. Deep learning-derived myocardial strain. JACC Cardiovasc Imaging 2024; 17:715&#x2013;725.</Citation></Reference><Reference><Citation>Evain E, Sun Y, Faraz K, et al. Motion estimation by deep learning in 2D echocardiography: synthetic dataset and validation. IEEE Trans Med Imaging 2022; 41:1911&#x2013;1924.</Citation></Reference><Reference><Citation>Thomas L, Marwick TH, Popescu BA, et al. Left atrial structure and function, and left ventricular diastolic dysfunction: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73:1961&#x2013;1977.</Citation></Reference><Reference><Citation>Bianco CM, Farjo PD, Ghaffar YA, et al. Myocardial mechanics in patients with normal LVEF and diastolic dysfunction. JACC Cardiovasc Imaging 2020; 13:258&#x2013;271.</Citation></Reference><Reference><Citation>Arnaout R. Can machine learning help simplify the measurement of diastolic function in echocardiography? JACC Cardiovasc Imaging 2021; 14:2105&#x2013;2106.</Citation></Reference><Reference><Citation>Salte IM, &#xd8;stvik A, Smistad E, et al. Artificial intelligence for automatic measurement of left ventricular strain in echocardiography. JACC Cardiovasc Imaging 2021; 14:1918&#x2013;1928.</Citation></Reference><Reference><Citation>Chiou YA, Hung CL, Lin SF. AI-assisted echocardiographic prescreening of heart failure with preserved ejection fraction on the basis of intrabeat dynamics. JACC Cardiovasc Imaging 2021; 14:2091&#x2013;2104.</Citation></Reference><Reference><Citation>Pandey A, Kagiyama N, Yanamala N, et al. Deep-learning models for the echocardiographic assessment of diastolic dysfunction. JACC Cardiovasc Imaging 2021; 14:1887&#x2013;1900.</Citation></Reference><Reference><Citation>Przewlocka Kosmala M, Marwick TH, Dabrowski A, et al. Contribution of cardiovascular reserve to prognostic categories of heart failure with preserved ejection fraction: a classification based on machine learning. J Am Soc Echocardiogr 2019; 32:604&#x2013;615.</Citation></Reference><Reference><Citation>Kameshima H, Uejima T, Fraser AG, et al. A phenotyping of diastolic function by machine learning improves prediction of clinical outcomes in heart failure. Front Cardiovasc Med 2021; 8:755109.</Citation></Reference><Reference><Citation>Siontis KC, Abreau S, Attia ZI, et al. Patient-level artificial intelligence&#x2013;enhanced electrocardiography in hypertrophic cardiomyopathy. JACC Adv 2023; 2:100582.</Citation></Reference><Reference><Citation>Dai H, Hwang HG, Tseng VS. Convolutional neural network based automatic screening tool for cardiovascular diseases using different intervals of ECG signals. Comput Methods Programs Biomed 2021; 203:106035.</Citation></Reference><Reference><Citation>Duffy G, Cheng PP, Yuan N, et al. High-throughput precision phenotyping of left ventricular hypertrophy with cardiovascular deep learning. JAMA Cardiol 2022; 7:386&#x2013;395.</Citation></Reference><Reference><Citation>Yu F, Huang H, Yu Q, et al. Artificial intelligence-based myocardial texture analysis in etiological differentiation of left ventricular hypertrophy. Ann Transl Med 2021; 9:108.</Citation></Reference><Reference><Citation>Wu ZW, Zheng JL, Kuang L, et al. Machine learning algorithms to automate differentiating cardiac amyloidosis from hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2022; 39:339&#x2013;348.</Citation></Reference><Reference><Citation>Izquierdo C, Casas G, Martin Isla C, et al. Radiomics-based classification of left ventricular noncompaction, hypertrophic cardiomyopathy, and dilated cardiomyopathy in cardiovascular magnetic resonance. Front Cardiovasc Med 2021; 8:764312.</Citation></Reference><Reference><Citation>Guo J, Lu H, Chen Y, et al. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence. Br J Radiol 2022; 95:20201060.</Citation></Reference><Reference><Citation>Bae&#xdf;ler B, Mannil M, Maintz D, et al. Texture analysis and machine learning of noncontrast T1-weighted MR images in patients with hypertrophic cardiomyopathy preliminary results. Eur J Radiol 2018; 102:61&#x2013;67.</Citation></Reference><Reference><Citation>Zhang Q, Burrage MK, Lukaschuk E, et al. Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy. Circulation 2021; 144:589&#x2013;599.</Citation></Reference><Reference><Citation>Mancio J, Pashakhanloo F, El Rewaidy H, et al. Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2022; 23:532&#x2013;542.</Citation></Reference><Reference><Citation>Zaman S, Petri C, Vimalesvaran K, et al. Automatic diagnosis labeling of cardiovascular MRI by using semisupervised natural language processing of text reports. Radiol Artif Intell 2022; 4:210085.</Citation></Reference><Reference><Citation>Kochav SM, Raita Y, Fifer MA, et al. Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. Int J Cardiol 2021; 327:117&#x2013;124.</Citation></Reference><Reference><Citation>Pezoulas VC, Grigoriadis GI, Gkois G, et al. A computational pipeline for data augmentation towards the improvement of disease classification and risk stratification models: a case study in two clinical domains. Comput Biol Med 2021; 134:104520.</Citation></Reference><Reference><Citation>Abraham T, Sehnert AJ, Anderson W, et al. Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis. Eur Heart J 2022; 43:544&#x2013;1718.</Citation></Reference><Reference><Citation>Infante T, Francone M, De Rimini ML, et al. Machine learning and network medicine: a novel approach for precision medicine and personalized therapy in cardiomyopathies. J Cardiovasc Med 2021; 22:429&#x2013;440.</Citation></Reference><Reference><Citation>Nedadur R, Wang B, Tsang W. Artificial intelligence for the echocardiographic assessment of valvular heart disease. Heart 2022; 108:1592&#x2013;1599.</Citation></Reference><Reference><Citation>Krishna H, Desai K, Slostad B, et al. Fully automated artificial intelligence assessment of aortic stenosis by echocardiography. J Am Soc Echocardiogr 2023; 36:769&#x2013;777.</Citation></Reference><Reference><Citation>Wojnarski CM, Roselli EE, Idrees JJ, et al. Machine-learning phenotypic classification of bicuspid aortopathy. J Thorac Cardiovasc Surg 2018; 155:461&#x2013;469.</Citation></Reference><Reference><Citation>Astudillo P, Mortier P, Bosmans J, et al. Enabling automated device size selection for transcatheter aortic valve implantation. J Interv Cardiol 2019; 2019:3591314.</Citation></Reference><Reference><Citation>Kwak S, Everett RJ, Treibel TA, et al. Markers of myocardial damage predict mortality in patients with aortic stenosis. J Am Coll Cardiol 2021; 78:545&#x2013;558.</Citation></Reference><Reference><Citation>Pandey A, Adedinsewo D. The future of AI-enhanced ecg interpretation for valvular heart disease screening. J Am Coll Cardiol 2022; 80:627&#x2013;630.</Citation></Reference><Reference><Citation>Howard JP, Cook CM, Van De Hoef TP, et al. Artificial intelligence for aortic pressure waveform analysis during coronary angiography: machine learning for patient safety. J Am Coll Cardiol Intv 2019; 12:2093&#x2013;2101.</Citation></Reference><Reference><Citation>Rostami B, Fetterly K, Attia Z, et al. Deep learning to estimate left ventricular ejection fraction from routine coronary angiographic images. JACC Adv 2023; 2:100632.</Citation></Reference><Reference><Citation>Shah R, Yow E, Jones WS, et al. Comparison of visual assessment of coronary stenosis with independent quantitative coronary angiography: findings from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. Am Heart J 2017; 184:1&#x2013;9.</Citation></Reference><Reference><Citation>Du T, Xie L, Zhang H, et al. Training and validation of a deep learning architecture for the automatic analysis of coronary angiography. EuroIntervention 2021; 17:32&#x2013;40.</Citation></Reference><Reference><Citation>Liu X, Wang X, Chen D, et al. Automatic quantitative coronary analysis based on deep learning. Appl Sci 2023; 13:2975.</Citation></Reference><Reference><Citation>Avram R, Olgin JE, Ahmed Z, et al. CathAI: fully automated coronary angiography interpretation and stenosis estimation. NPJ Digit Med 2023; 6:142.</Citation></Reference><Reference><Citation>Nobre Menezes M, Silva B, Silva JL, et al. Segmentation of X-ray coronary angiography with an artificial intelligence deep learning model: impact in operator visual assessment of coronary stenosis severity. Catheter Cardiovasc Interv 2023; 102:631&#x2013;640.</Citation></Reference><Reference><Citation>Zhang Q, Fotaki A, Ghadimi S, et al. Improving the efficiency and accuracy of CMR with AI &#x2013; review of evidence and proposition of a roadmap to clinical translation. J Cardiovasc Magn Reson 2024; 26:101051.</Citation></Reference><Reference><Citation>Morales MA, Manning WJ, Nezafat R. Present and future innovations in AI and cardiac MRI. Radiology 2024; 310:231269.</Citation></Reference><Reference><Citation>Davies RH, Augusto JB, Bhuva A, et al. Precision measurement of cardiac structure and function in cardiovascular magnetic resonance using machine learning. J Cardiovasc Magn Reson 2022; 24:16.</Citation></Reference><Reference><Citation>Wang YJ, Yang K, Wen Y, et al. Screening and diagnosis of cardiovascular disease using artificial intelligence-enabled cardiac magnetic resonance imaging. Nat Med 2024; 30:1471&#x2013;1480.</Citation></Reference><Reference><Citation>Antonopoulos AS, Boutsikou M, Simantiris S, et al. Machine learning of native T1 mapping radiomics for classification of hypertrophic cardiomyopathy phenotypes. Sci Rep 2021; 11:23596.</Citation></Reference><Reference><Citation>Martini N, Aimo A, Barison A, et al. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2020; 22:84.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40396866</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1678-4170</ISSN><JournalIssue CitedMedium="Internet"><Volume>122</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Arquivos brasileiros de cardiologia</Title><ISOAbbreviation>Arq Bras Cardiol</ISOAbbreviation></Journal><ArticleTitle>Use of Artificial Intelligence Applied to Electrocardiogram for Diagnosis of Left Ventricular Systolic Dysfunction.</ArticleTitle><Pagination><StartPage>e20240740</StartPage><MedlinePgn>e20240740</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20240740</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.36660/abc.20240740</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0066-782X2025000400309</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Heart failure (HF) is a disease associated with an important type of morbidity and mortality. The electrocardiogram (ECG), one of the tests used to evaluate HF, is low-cost and widely available.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the performance of an artificial intelligence (AI) algorithm applied to ECG to detect HF and compare it with the predictive power of major electrocardiographic alterations (MEA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This work is a diagnostic accuracy cross-sectional study. All participants were from the Longitudinal Study of Adult Health (Estudo Longitudinal da Sa&#xfa;de do Adulto - ELSA-Brasil) and presented a valid ECG and echocardiogram (ECHO). The algorithm estimated probability values for left ventricular systolic dysfunction (LVSD). The assessed endpoint was left ventricular ejection fraction (LVEF) &lt;40% in the ECHO. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic odds ratio (DOR) were determined for both the algorithm and the MEA. The area under the ROC curve (AUC-ROC) for the algorithm was calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the analytical sample of 2,567 individuals, the prevalence of LVEF &lt;40% was 1.13% (29 individuals). The values obtained for sensitivity, specificity, PPV, NPV, LR+, LR-, and DOR for the algorithm were 0.690, 0.976, 0.244, 0.996, 27.6, 0.32, and 88.74, respectively. For the MEA, the values were 0.172, 0.837, 0.012, 0.989, 1.09, 0.990, and 1.07, respectively. The AUC-ROC of the algorithm to predict the LVEF &lt;40% was 0.947 (95% CI: 0.913 - 0.981).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The AI algorithm performed well in detecting LVSD and can be used as a screening tool for LVSD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santana J&#xfa;nior</LastName><ForeName>Wilton Batista de</ForeName><Initials>WB</Initials><Identifier Source="ORCID">0009-0007-6669-0058</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto Filho</LastName><ForeName>Marcelo M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-6646-1163</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreto</LastName><ForeName>Sandhi Maria</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foppa</LastName><ForeName>Murilo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2914-4406</Identifier><AffiliationInfo><Affiliation>Hospital de Clinicas de Porto Alegre, Porto Alegre, RS - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giatti</LastName><ForeName>Luana</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5454-2460</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brasil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Yale University, New Haven - EUA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Antonio Luiz Pinho</ForeName><Initials>ALP</Initials><Identifier Source="ORCID">0000-0002-2740-0042</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG - Brasil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>por</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Uso da Intelig&#xea;ncia Artificial Aplicada ao Eletrocardiograma para Diagn&#xf3;stico de Disfun&#xe7;&#xe3;o Sist&#xf3;lica Ventricular Esquerda.</VernacularTitle></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Arq Bras Cardiol</MedlineTA><NlmUniqueID>0421031</NlmUniqueID><ISSNLinking>0066-782X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="FUNDAMENTO" NlmCategory="OBJECTIVE">A insufici&#xea;ncia card&#xed;aca &#xe9; uma doen&#xe7;a associada a importante morbimortalidade. O eletrocardiograma (ECG), um dos exames utilizados na avalia&#xe7;&#xe3;o da IC, &#xe9; de baixo custo e amplamente dispon&#xed;vel.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Avaliar o desempenho de um algoritmo de intelig&#xea;ncia artificial (IA) aplicado ao ECG na detec&#xe7;&#xe3;o de IC e o comparamos ao poder preditivo das altera&#xe7;&#xf5;es eletrocardiogr&#xe1;ficas maiores (AME).</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Estudo transversal de acur&#xe1;cia diagn&#xf3;stica. Todos os participantes s&#xe3;o oriundos do Estudo Longitudinal da Sa&#xfa;de do Adulto (ELSA-Brasil), e possu&#xed;am ECG e ecocardiograma (ECO) v&#xe1;lidos al&#xe9;m de valores de probabilidade para disfun&#xe7;&#xe3;o sist&#xf3;lica do ventr&#xed;culo esquerdo (DSVE) estimados pelo algoritmo. O desfecho avaliado foi fra&#xe7;&#xe3;o de eje&#xe7;&#xe3;o do ventr&#xed;culo esquerdo (FEVE) &lt; 40% ao ECO. Foram calculados sensibilidade, especificidade, valor preditivo positivo (VPP), valor preditivo negativo (VPN), raz&#xe3;o de verossimilhan&#xe7;a positivo (RVP), raz&#xe3;o de verossimilhan&#xe7;a negativa (RVN), diagnostic odds ratio (DOR) para o algoritmo e para as AME e &#xe1;rea sob a curva ROC (ASC-ROC) para o algoritmo.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">Na amostra final de 2567 indiv&#xed;duos, a preval&#xea;ncia de FEVE &lt; 40% foi de 1,13% (29 indiv&#xed;duos). Os valores obtidos de sensibilidade, especificidade, VPP, VPN, RVP, RVN e DOR para o algoritmo foram de 0,690; 0,976; 0,244; 0,996; 27,6; 0,32 e 88,74, respectivamente. Para as AME, 0,172; 0,837; 0,012; 0,989; 1,09; 0,990 e 1,07, respectivamente. A ASC-ROC do algoritmo para predi&#xe7;&#xe3;o de FEVE &lt; 40% foi de 0,947 (IC 95% 0,913 &#x2013; 0,981).</AbstractText><AbstractText Label="CONCLUS&#xc3;O" NlmCategory="UNASSIGNED">A IA apresentou bom desempenho para detec&#xe7;&#xe3;o de DSVE e pode ser usada como ferramenta de triagem de DSVE.</AbstractText></OtherAbstract><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="BACKGROUND">Heart failure (HF) is a disease associated with an important type of morbidity and mortality. The electrocardiogram (ECG), one of the tests used to evaluate HF, is low-cost and widely available.</AbstractText><AbstractText Label="OBJECTIVE">To evaluate the performance of an artificial intelligence (AI) algorithm applied to ECG to detect HF and compare it with the predictive power of major electrocardiographic alterations (MEA).</AbstractText><AbstractText Label="METHODS">This work is a diagnostic accuracy cross-sectional study. All participants were from the Longitudinal Study of Adult Health (Estudo Longitudinal da Sa&#xfa;de do Adulto - ELSA-Brasil) and presented a valid ECG and echocardiogram (ECHO). The algorithm estimated probability values for left ventricular systolic dysfunction (LVSD). The assessed endpoint was left ventricular ejection fraction (LVEF) &lt;40% in the ECHO. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic odds ratio (DOR) were determined for both the algorithm and the MEA. The area under the ROC curve (AUC-ROC) for the algorithm was calculated.</AbstractText><AbstractText Label="RESULTS">In the analytical sample of 2,567 individuals, the prevalence of LVEF &lt;40% was 1.13% (29 individuals). The values obtained for sensitivity, specificity, PPV, NPV, LR+, LR-, and DOR for the algorithm were 0.690, 0.976, 0.244, 0.996, 27.6, 0.32, and 88.74, respectively. For the MEA, the values were 0.172, 0.837, 0.012, 0.989, 1.09, 0.990, and 1.07, respectively. The AUC-ROC of the algorithm to predict the LVEF &lt;40% was 0.947 (95% CI: 0.913 &#x2013; 0.981).</AbstractText><AbstractText Label="CONCLUSION">The AI algorithm performed well in detecting LVSD and can be used as a screening tool for LVSD.</AbstractText></OtherAbstract><CoiStatement><b>Potencial conflito de interesse:</b> N&#xe3;o h&#xe1; conflito com o presente artigo</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>21</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40396866</ArticleId><ArticleId IdType="pmc">PMC12108124</ArticleId><ArticleId IdType="doi">10.36660/abc.20240740</ArticleId><ArticleId IdType="pii">S0066-782X2025000400309</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oliveira GMM, Brant LCC, Polanczyk CA, Malta DC, Biolo A, Nascimento BR, et al. Cardiovascular Statistics - Brazil 2021. Arq Bras Cardiol. 2022;118(1):115&#x2013;373. doi: 10.36660/abc.20211012.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20211012</ArticleId><ArticleId IdType="pmc">PMC8959063</ArticleId><ArticleId IdType="pubmed">35195219</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):895&#x2013;1032. doi: 10.1161/CIR.0000000000001063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001063</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Bonow R, Mann D, Tomaselli G, Bhatt D, Solomon S, editors, editors. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th. Philadelphia: Elsevier; 2021.</Citation></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, et al. 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. Eur Heart J. 2021;42(36):3599&#x2013;3726. doi: 10.1093/eurheartj/ehab368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab368</ArticleId><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestari VRF, Garces TS, Sousa GJB, Maranh&#xe3;o TA, Souza JD, Neto, Pereira MLD, et al. Distribui&#xe7;&#xe3;o Espacial de Mortalidade por Insufici&#xea;ncia Card&#xed;aca no Brasil, 1996-2017. Arq Bras Cardiol. 2022;118(1) doi: 10.36660/abc.20201325.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/abc.20201325</ArticleId><ArticleId IdType="pmc">PMC8959057</ArticleId><ArticleId IdType="pubmed">35195207</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell SM, Fuat A, Summerton N, Lancaster N, Hobbs FR. Diagnostic Triage and the Role of Natriuretic Peptide Testing and Echocardiography for Suspected Heart Failure: An Appropriateness Ratings Evaluation by UK GPs. Br J Gen Pract. 2011;61(588):e427&#x2013;e435. doi: 10.3399/bjgp11X583218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp11X583218</ArticleId><ArticleId IdType="pmc">PMC3123506</ArticleId><ArticleId IdType="pubmed">21722451</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohde LEP, Montera MW, Bocchi EA, Clausell NO, Albuquerque DC, Rassi S, et al. Diretriz Brasileira de Insufici&#xea;ncia Card&#xed;aca Cr&#xf4;nica e Aguda. Arq Bras Cardiol. 2018;111(3):436&#x2013;539. doi: 10.5935/abc.20180190.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/abc.20180190</ArticleId><ArticleId IdType="pubmed">30379264</ArticleId></ArticleIdList></Reference><Reference><Citation>Haug CJ, Drazen JM. Artificial Intelligence and Machine Learning in Clinical Medicine, 2023. N Engl J Med. 2023;388(13):1201&#x2013;1208. doi: 10.1056/NEJMra2302038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2302038</ArticleId><ArticleId IdType="pubmed">36988595</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SJ, Norvig P. Intelig&#xea;ncia Artificial - Uma Abordagem Moderna. 4th. Rio de Janeiro: Grupo Editorial Nacional; 2022.</Citation></Reference><Reference><Citation>Lima I, Pinheiro CAM, Santos FAO. Intelig&#xea;ncia Artificial. Rio de Janeiro: Grupo Editorial Nacional; 2014.</Citation></Reference><Reference><Citation>Friedrich S, Gro&#xdf; S, K&#xf6;nig IR, Engelhardt S, Bahls M, Heinz J, et al. Applications of Artificial Intelligence/Machine Learning Approaches in Cardiovascular Medicine: A Systematic Review with Recommendations. Eur Heart J Digit Health. 2021;2(3):424&#x2013;436. doi: 10.1093/ehjdh/ztab054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztab054</ArticleId><ArticleId IdType="pmc">PMC9707954</ArticleId><ArticleId IdType="pubmed">36713608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima EM, Ribeiro AH, Paix&#xe3;o GMM, Ribeiro MH, Pinto-Filho MM, Gomes PR, et al. Deep Neural Network-Estimated Electrocardiographic Age as a Mortality Predictor. 5117Nat Commun. 2021;12(1) doi: 10.1038/s41467-021-25351-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25351-7</ArticleId><ArticleId IdType="pmc">PMC8387361</ArticleId><ArticleId IdType="pubmed">34433816</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial Intelligence-Enhanced Electrocardiography in Cardiovascular Disease Management. Nat Rev Cardiol. 2021;18(7):465&#x2013;478. doi: 10.1038/s41569-020-00503-2. doi:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00503-2</ArticleId><ArticleId IdType="pmc">PMC7848866</ArticleId><ArticleId IdType="pubmed">33526938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranka S, Reddy M, Noheria A. Artificial Intelligence in Cardiovascular Medicine. Curr Opin Cardiol. 2021;36(1):26&#x2013;35. doi: 10.1097/HCO.0000000000000812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HCO.0000000000000812</ArticleId><ArticleId IdType="pubmed">33060388</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen CR, Mentz RJ, Anstrom KJ, Page D, Patel PA. Clinical Applications of Machine Learning in the Diagnosis, Classification, and Prediction of Heart Failure. Am Heart J. 2020;229:1&#x2013;17. doi: 10.1016/j.ahj.2020.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2020.07.009</ArticleId><ArticleId IdType="pubmed">32905873</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi DJ, Park JJ, Ali T, Lee S. Artificial Intelligence for the Diagnosis of Heart Failure. 54NPJ Digit Med. 2020;3 doi: 10.1038/s41746-020-0261-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-020-0261-3</ArticleId><ArticleId IdType="pmc">PMC7142093</ArticleId><ArticleId IdType="pubmed">32285014</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasmin F, Shah SMI, Naeem A, Shujauddin SM, Jabeen A, Kazmi S, et al. Artificial Intelligence in the Diagnosis and Detection of Heart Failure: The Past, Present, and Future. Rev Cardiovasc Med. 2021;22(4):1095&#x2013;1113. doi: 10.31083/j.rcm2204121.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2204121</ArticleId><ArticleId IdType="pubmed">34957756</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia ZI, Kapa S, Lopez-Jimenez F, McKie PM, Ladewig DJ, Satam G, et al. Screening for Cardiac Contractile Dysfunction Using an Artificial Intelligence-Enabled Electrocardiogram. Nat Med. 2019;25(1):70&#x2013;74. doi: 10.1038/s41591-018-0240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0240-2</ArticleId><ArticleId IdType="pubmed">30617318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J, Lee B, Kwon JM, Lee Y, Park H, Oh BH, et al. Artificial Intelligence Algorithm for Screening Heart Failure with Reduced Ejection Fraction Using Electrocardiography. ASAIO J. 2021;67(3):314&#x2013;321. doi: 10.1097/MAT.0000000000001218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0000000000001218</ArticleId><ArticleId IdType="pubmed">33627606</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbilgic O, Butler L, Karabayir I, Chang PP, Kitzman DW, Alonso A, et al. ECG-AI: Electrocardiographic Artificial Intelligence Model for Prediction of Heart Failure. Eur Heart J Digit Health. 2021;2(4):626&#x2013;634. doi: 10.1093/ehjdh/ztab080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztab080</ArticleId><ArticleId IdType="pmc">PMC8715759</ArticleId><ArticleId IdType="pubmed">34993487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HY, Lin CS, Fang WH, Lou YS, Cheng CC, Lee CC, et al. Artificial Intelligence-Enabled Electrocardiography Predicts Left Ventricular Dysfunction and Future Cardiovascular Outcomes: A Retrospective Analysis. J Pers Med. 2022;12(3):455. doi: 10.3390/jpm12030455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12030455</ArticleId><ArticleId IdType="pmc">PMC8950054</ArticleId><ArticleId IdType="pubmed">35330455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;n D, Rudolph F, Gumpfer N, Hannig J, Elsner LK, von Jeinsen B, et al. Identifying Heart Failure in ECG Data with Artificial Intelligence-A Meta-Analysis. 584555Front Digit Health. 2021;2 doi: 10.3389/fdgth.2020.584555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fdgth.2020.584555</ArticleId><ArticleId IdType="pmc">PMC8521986</ArticleId><ArticleId IdType="pubmed">34713056</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XM, Gao XY, Tse G, Hong SD, Chen KY, Li GP, et al. Electrocardiogram-Based Artificial Intelligence for the Diagnosis of Heart Failure: A Systematic Review and Meta-Analysis. J Geriatr Cardiol. 2022;19(12):970&#x2013;980. doi: 10.11909/j.issn.1671-5411.2022.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2022.12.002</ArticleId><ArticleId IdType="pmc">PMC9807402</ArticleId><ArticleId IdType="pubmed">36632204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha V, Nargesi AA, Dhingra LS, Khunte A, Mortazavi BJ, Ribeiro AH, et al. Detection of Left Ventricular Systolic Dysfunction from Electrocardiographic Images. Circulation. 2023;148(9):765&#x2013;777. doi: 10.1161/CIRCULATIONAHA.122.062646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062646</ArticleId><ArticleId IdType="pmc">PMC10982757</ArticleId><ArticleId IdType="pubmed">37489538</ArticleId></ArticleIdList></Reference><Reference><Citation>Cormen TT. Algoritmos - Teoria e Pr&#xe1;tica. Rio de Janeiro: Grupo Editorial Nacional; 2012.</Citation></Reference><Reference><Citation>Bhargava AY. Entendendo Algoritmos: Um Guia Ilustrado Para Programadores e Outros Curiosos. Rio de Janeiro: Novatec Editora; 2017.</Citation></Reference><Reference><Citation>Mill JG, Pinto K, Griep RH, Goulart A, Foppa M, Lotufo PA, et al. Medical Assessments and Measurements in ELSA-Brasil. Rev Saude Publica. 2013;47(Suppl 2):54&#x2013;62. doi: 10.1590/s0034-8910.2013047003851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0034-8910.2013047003851</ArticleId><ArticleId IdType="pubmed">24346721</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40357357</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1880-4276</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of arrhythmia</Title><ISOAbbreviation>J Arrhythm</ISOAbbreviation></Journal><ArticleTitle>Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages.</ArticleTitle><Pagination><StartPage>e70086</StartPage><MedlinePgn>e70086</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70086</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/joa3.70086</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faheem</LastName><ForeName>Muhammad Shaheer Bin</ForeName><Initials>MSB</Initials><Identifier Source="ORCID">0009-0005-6878-2031</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery Karachi Institute of Medical Sciences, KIMS Karachi Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatri</LastName><ForeName>Nisha</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Liaquat University of Medical and Health Sciences Jamshoro Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheema</LastName><ForeName>Shamikha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>King Edward Medical University Lahore Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zahid</LastName><ForeName>Muhammad Rehan</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Sialkot Medical College Punjab Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadi</LastName><ForeName>Sumaya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Kabul University of Medical Sciences "Abu Ali Ibn Sina" Kabul Afghanistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Arrhythm</MedlineTA><NlmUniqueID>101263026</NlmUniqueID><ISSNLinking>1880-4276</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI&#x2010;enhanced diagnostic models</Keyword><Keyword MajorTopicYN="N">Comorbidities</Keyword><Keyword MajorTopicYN="N">Electrocardiographic parameter</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword></KeywordList><CoiStatement>Authors declare no conflict of interests for this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>4</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40357357</ArticleId><ArticleId IdType="pmc">PMC12067050</ArticleId><ArticleId IdType="doi">10.1002/joa3.70086</ArticleId><ArticleId IdType="pii">JOA370086</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hirota N, Suzuki S, Arita T, Yagi N, Kishi M, Semba H, et&#xa0;al. Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages. J Arrhythm. 2025;41(2):e70031. 10.1002/joa3.70031</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/joa3.70031</ArticleId><ArticleId IdType="pmc">PMC11876995</ArticleId><ArticleId IdType="pubmed">40046262</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Granja PE, Sand&#xed;n&#x2010;Fuentes M, Garc&#xed;a&#x2010;Mor&#xe1;n E, Sevilla T, Rubio J. Worsening conduction delay in hypertrophic cardiomyopathy: what drug is responsible? Circulation. 2017;136(6):599&#x2013;601. 10.1161/CIRCULATIONAHA.117.029572</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.029572</ArticleId><ArticleId IdType="pubmed">28784828</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K, Toda G, Iliev II, Hayano M, Yano K. Clinical analysis of hypertrophic cardiomyopathy which evolved into dilated phase during long&#x2010;term follow&#x2010;up. Jpn Heart J. 1999;40(5):579&#x2013;587. 10.1536/jhj.40.579</Citation><ArticleIdList><ArticleId IdType="doi">10.1536/jhj.40.579</ArticleId><ArticleId IdType="pubmed">10888378</ArticleId></ArticleIdList></Reference><Reference><Citation>Butters A, Semsarian CR, Bagnall RD, Yeates L, Stafford F, Burns C, et&#xa0;al. Clinical profile and health disparities in a multiethnic cohort of patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2021;14(3):e007537. 10.1161/CIRCHEARTFAILURE.120.007537</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.007537</ArticleId><ArticleId IdType="pubmed">33724884</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliner V, Levy I, Tsutsui K, Acha MR, Schliamser J, Schuster A, et&#xa0;al. Clinically meaningful interpretability of an AI model for ECG classification. NPJ Digit Med. 2025;8(1):109. 10.1038/s41746-025-01467-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-025-01467-8</ArticleId><ArticleId IdType="pmc">PMC11833077</ArticleId><ArticleId IdType="pubmed">39962214</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40357662</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>10</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>20</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Understanding Transient Left Ventricular Ejection Fraction Reduction During Atrial Fibrillation With Artificial Intelligence.</ArticleTitle><Pagination><StartPage>e040641</StartPage><MedlinePgn>e040641</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e040641</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.124.040641</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atrial fibrillation (AF) can cause a reduction in left ventricular ejection fraction (LVEF) that resolves rapidly upon restoration of sinus rhythm. We used artificial intelligence to understand (1) how often transient LVEF reduction during AF is from mismeasurement due to AF's beat-to-beat variability and (2) whether true transient AF-LVEF reduction has prognostic significance.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this observational study, we analyzed all patients at a large academic center with a transthoracic echocardiogram in AF and subsequent transthoracic echocardiogram in sinus rhythm within 90&#x2009;days. We classified patients by their clinically reported LVEFs: no AF-LVEF reduction, transient AF-LVEF reduction that recovered after conversion to sinus rhythm, or persistent AF-LVEF reduction that did not recover. We evaluated how automated multicycle AF-LVEF measurement using a validated artificial intelligence algorithm affected AF-LVEF and reclassified patients. We used Fine-Gray hazard modeling to analyze 1-year heart failure hospitalization risk.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In 810 patients (mean age 74.1&#x2009;years, 34.3% female), 459 (56.7%) had no reduced AF-LVEF, 71 (8.8%) had transient AF-LVEF reduction, and 280 (34.6%) had persistent AF-LVEF reduction. In the group with transient AF-LVEF reduction, LVEF increased by 19.5% (95% CI, 12.0%-22.1%) upon conversion to sinus rhythm. AI reassessment increased AF-LVEF by 8.2% (95% CI, 6.0%-10.4%), reclassifying 20 (28.2%) patients as no longer having reduced AF-LVEF. The group with transient AF-LVEF reduction, as determined by AI, had significantly higher 1-year heart failure hospitalization risk (hazard ratio, 2.28 [95% CI, 1.23-4.21], <i>P</i>=0.003).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Artificial intelligence may decrease misdiagnosis of reduced LVEF during AF and more accurately identify true transient AF-LVEF reduction, a potentially high-risk phenotype.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Neal</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5782-7437</Identifier><AffiliationInfo><Affiliation>School of Medicine University of California San Francisco CA USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology San Francisco Veterans Affairs Medical Center San Francisco CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Gloria J</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vrudhula</LastName><ForeName>Amey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwan</LastName><ForeName>Alan C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-4393-1011</Identifier><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duffy</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botting</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0967-5728</Identifier><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhruva</LastName><ForeName>Sanket S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-0674-2032</Identifier><AffiliationInfo><Affiliation>School of Medicine University of California San Francisco CA USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology San Francisco Veterans Affairs Medical Center San Francisco CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegel</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-1552-0928</Identifier><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouyang</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3813-7518</Identifier><AffiliationInfo><Affiliation>Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atrial fibrillation</Keyword><Keyword MajorTopicYN="N">deep learning</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>20</Day><Hour>17</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>13</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40357662</ArticleId><ArticleId IdType="pmc">PMC12184549</ArticleId><ArticleId IdType="doi">10.1161/JAHA.124.040641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lippi G, Sanchis&#x2010;Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217&#x2013;221. doi: 10.1177/1747493019897870</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493019897870</ArticleId><ArticleId IdType="pubmed">31955707</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams BA, Chamberlain AM, Blankenship JC, Hylek EM, Voyce S. Trends in atrial fibrillation incidence rates within an integrated health care delivery system, 2006 to 2018. JAMA Netw Open. 2020;3:e2014874. doi: 10.1001/jamanetworkopen.2020.14874</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.14874</ArticleId><ArticleId IdType="pmc">PMC7455855</ArticleId><ArticleId IdType="pubmed">32857147</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation. 2003;107:2920&#x2013;2925. doi: 10.1161/01.CIR.0000072767.89944.6E</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000072767.89944.6E</ArticleId><ArticleId IdType="pubmed">12771006</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Hart CL, Hole DJ, McMurray JJV. A population&#x2010;based study of the long&#x2010;term risks associated with atrial fibrillation: 20&#x2010;year follow&#x2010;up of the Renfrew/Paisley study. Am J Med. 2002;113:359&#x2013;364. doi: 10.1016/s0002-9343(02)01236-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9343(02)01236-6</ArticleId><ArticleId IdType="pubmed">12401529</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin D, Mansour MC, Ruskin JN, Heist EK. Atrial fibrillation&#x2010;mediated cardiomyopathy. Circ Arrhythm Electrophysiol. 2019;12:e007809. doi: 10.1161/CIRCEP.119.007809</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.119.007809</ArticleId><ArticleId IdType="pubmed">31826649</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhu S, Taylor AJ, Costello BT, Kaye DM, McLellan AJA, Voskoboinik A, Sugumar H, Lockwood SM, Stokes MB, Pathik B, et&#xa0;al. Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA&#x2010;MRI study. J Am Coll Cardiol. 2017;70:1949&#x2013;1961. doi: 10.1016/j.jacc.2017.08.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.08.041</ArticleId><ArticleId IdType="pubmed">28855115</ArticleId></ArticleIdList></Reference><Reference><Citation>Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;69:1570&#x2013;1573. doi: 10.1016/0002-9149(92)90705-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9149(92)90705-4</ArticleId><ArticleId IdType="pubmed">1598871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieny JR, Sacrez A, Facello A, Arbogast R, Bareiss P, Roul G, Demangeat JL, Brunot B, Constantinesco A. Increase in radionuclide left ventricular ejection fraction after cardioversion of chronic atrial fibrillation in idiopathic dilated cardiomyopathy. Eur Heart J. 1992;13:1290&#x2013;1295. doi: 10.1093/oxfordjournals.eurheartj.a060351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.eurheartj.a060351</ArticleId><ArticleId IdType="pubmed">1396842</ArticleId></ArticleIdList></Reference><Reference><Citation>Redfield MM, Kay GN, Jenkins LS, Mianulli M, Jensen DN, Ellenbogen KA. Tachycardia&#x2010;related cardiomyopathy: a common cause of ventricular dysfunction in patients with atrial fibrillation referred for atrioventricular ablation. Mayo Clin Proc. 2000;75:790&#x2013;795. doi: 10.4065/75.8.790</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/75.8.790</ArticleId><ArticleId IdType="pubmed">10943231</ArticleId></ArticleIdList></Reference><Reference><Citation>Stulak JM, Dearani JA, Daly RC, Zehr KJ, Sundt TM, Schaff HV. Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the cox&#x2010;maze procedure significantly improves systolic function and functional status. Ann Thorac Surg. 2006;82:494&#x2013;500. discussion 500&#x2013;501. doi: 10.1016/j.athoracsur.2006.03.075</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2006.03.075</ArticleId><ArticleId IdType="pubmed">16863752</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond RJ, Lee AJ, Messineo FC, Manning WJ, Silverman DI. Cardiac performance early after cardioversion from atrial fibrillation. Am Heart J. 1998;136:435&#x2013;442. doi: 10.1016/S0002-8703(98)70217-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8703(98)70217-0</ArticleId><ArticleId IdType="pubmed">9736134</ArticleId></ArticleIdList></Reference><Reference><Citation>Viswanathan K, Daniak SM, Salomone K, Kiely T, Patel U, Converso K, Manning WJ, Silverman DI. Effect of cardioversion of atrial fibrillation on improvement in left ventricular performance. Am J Cardiol. 2001;88:439&#x2013;441. doi: 10.1016/S0002-9149(01)01699-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(01)01699-X</ArticleId><ArticleId IdType="pubmed">11545774</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosselink AT, Blanksma PK, Crijns HJ, Van Gelder IC, de Kam PJ, Hillege HL, Niemeijer MG, Lie KI, Meijler FL. Left ventricular beat&#x2010;to&#x2010;beat performance in atrial fibrillation: contribution of frank&#x2010;Starling mechanism after short rather than long RR intervals. J Am Coll Cardiol. 1995;26:1516&#x2013;1521. doi: 10.1016/0735-1097(95)00340-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(95)00340-1</ArticleId><ArticleId IdType="pubmed">7594079</ArticleId></ArticleIdList></Reference><Reference><Citation>Brookes CI, White PA, Staples M, Oldershaw PJ, Redington AN, Collins PD, Noble MI. Myocardial contractility is not constant during spontaneous atrial fibrillation in patients. Circulation. 1998;98:1762&#x2013;1768. doi: 10.1161/01.cir.98.17.1762</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.98.17.1762</ArticleId><ArticleId IdType="pubmed">9788831</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider F, Martin DT, Schick EC, Gaasch WH. Interval&#x2010;dependent changes in left ventricular contractile state in lone atrial fibrillation and in atrial fibrillation associated with coronary artery disease. Am J Cardiol. 1997;80:586&#x2013;590. doi: 10.1016/S0002-9149(97)00426-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9149(97)00426-8</ArticleId><ArticleId IdType="pubmed">9294986</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R, Chen LY, Chung MK, Cornwell WK, Furie KL, Lakkireddy DR, Marrouche NF, Natale A, Olshansky B, Joglar JA, et&#xa0;al. Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association. Circ Arrhythm Electrophysiol. 2021;14:HAE0000000000000078.</Citation><ArticleIdList><ArticleId IdType="pubmed">34129347</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, et&#xa0;al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378:417&#x2013;427. doi: 10.1056/NEJMoa1707855</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1707855</ArticleId><ArticleId IdType="pubmed">29385358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda T, Kato T, Usuda K, Kusayama T, Usui S, Sakata K, Hayashi K, Kawashiri M&#x2010;A, Yamagishi M, Takamura M, et&#xa0;al. Effect of catheter ablation for atrial fibrillation in heart failure with mid&#x2010;range or preserved ejection fraction &#x2010; pooled analysis of the AF Frontier Ablation Registry and Hokuriku&#x2010;Plus AF Registry. Circ J. 2023;87:939&#x2013;946. doi: 10.1253/circj.CJ-22-0461</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-22-0461</ArticleId><ArticleId IdType="pubmed">36464278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D&#x2010;Y, Chang T&#x2010;Y, Chang S&#x2010;L, Lin Y&#x2010;J, Lo L&#x2010;W, Hu Y&#x2010;F, Chung F&#x2010;P, Tuan T&#x2010;C, Chao T&#x2010;F, Liao J&#x2010;N, et&#xa0;al. Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid&#x2010;range ejection fraction. ESC Heart Fail. 2023;10:177&#x2013;188. doi: 10.1002/ehf2.14178</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14178</ArticleId><ArticleId IdType="pmc">PMC9871718</ArticleId><ArticleId IdType="pubmed">36178105</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohns C, Fox H, Marrouche NF, Crijns HJGM, Costard&#x2010;Jaeckle A, Bergau L, Hindricks G, Dagres N, Sossalla S, Schramm R, et&#xa0;al. Catheter ablation in end&#x2010;stage heart failure with atrial fibrillation. N Engl J Med. 2023;389:1380&#x2013;1389. doi: 10.1056/NEJMoa2306037</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2306037</ArticleId><ArticleId IdType="pubmed">37634135</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250&#x2013;3257. doi: 10.1093/eurheartj/ehv513</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv513</ArticleId><ArticleId IdType="pmc">PMC4670966</ArticleId><ArticleId IdType="pubmed">26419625</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et&#xa0;al. 2022 AHA/ACC/HFSA guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:1757&#x2013;1780. doi: 10.1016/j.jacc.2021.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.12.011</ArticleId><ArticleId IdType="pubmed">35379504</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizar JF, Ellenbogen KA, Tan AY, Kaszala K. Arrhythmia&#x2010;induced cardiomyopathy: JACC state&#x2010;of&#x2010;the&#x2010;art review. J Am Coll Cardiol. 2019;73:2328&#x2013;2344. doi: 10.1016/j.jacc.2019.02.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.02.045</ArticleId><ArticleId IdType="pmc">PMC6538508</ArticleId><ArticleId IdType="pubmed">31072578</ArticleId></ArticleIdList></Reference><Reference><Citation>Melgaard L, Gorst&#x2010;Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GYH. Assessment of the CHA2DS2&#x2010;VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation. Jama. 2015;314:1030&#x2013;1038. doi: 10.1001/jama.2015.10725</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.10725</ArticleId><ArticleId IdType="pubmed">26318604</ArticleId></ArticleIdList></Reference><Reference><Citation>So L, Evans D, Quan H. ICD&#x2010;10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res. 2006;6:161. doi: 10.1186/1472-6963-6-161</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6963-6-161</ArticleId><ArticleId IdType="pmc">PMC1781440</ArticleId><ArticleId IdType="pubmed">17173686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang D, He B, Ghorbani A, Yuan N, Ebinger J, Langlotz CP, Heidenreich PA, Harrington RA, Liang DH, Ashley EA, et&#xa0;al. Video&#x2010;based AI for beat&#x2010;to&#x2010;beat assessment of cardiac function. Nature. 2020;580:252&#x2013;256. doi: 10.1038/s41586-020-2145-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2145-8</ArticleId><ArticleId IdType="pmc">PMC8979576</ArticleId><ArticleId IdType="pubmed">32269341</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496&#x2013;509. doi: 10.1080/01621459.1999.10474144</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1999.10474144</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor&#x2010;Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et&#xa0;al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, Jackson R, Rahneva T, Wage R, Smith G, et&#xa0;al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED&#x2010;HF): an open&#x2010;label, pilot, randomised trial. Lancet. 2019;393:61&#x2013;73. doi: 10.1016/S0140-6736(18)32484-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)32484-X</ArticleId><ArticleId IdType="pmc">PMC6319251</ArticleId><ArticleId IdType="pubmed">30429050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JGF, Lip GYH, Coats AJS, Andersson B, Kirchhof P, et&#xa0;al. Efficacy of &#x3b2; blockers in patients with heart failure plus atrial fibrillation: an individual&#x2010;patient data meta&#x2010;analysis. Lancet. 2014;384:2235&#x2013;2243. doi: 10.1016/S0140-6736(14)61373-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61373-8</ArticleId><ArticleId IdType="pubmed">25193873</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia&#x2010;induced cardiomyopathies: mechanisms, recognition, and management. J Am Coll Cardiol. 2015;66:1714&#x2013;1728. doi: 10.1016/j.jacc.2015.08.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.08.038</ArticleId><ArticleId IdType="pmc">PMC4733572</ArticleId><ArticleId IdType="pubmed">26449143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dandamudi G, Rampurwala AY, Mahenthiran J, Miller JM, Das MK. Persistent left ventricular dilatation in tachycardia&#x2010;induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction. Heart Rhythm. 2008;5:1111&#x2013;1114. doi: 10.1016/j.hrthm.2008.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2008.04.023</ArticleId><ArticleId IdType="pubmed">18675220</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoureshi P, Tan AY, Koneru J, Ellenbogen KA, Kaszala K, Huizar JF. Arrhythmia&#x2010;induced cardiomyopathy: JACC state&#x2010;of&#x2010;the&#x2010;art review. J Am Coll Cardiol. 2024;83:2214&#x2013;2232. doi: 10.1016/j.jacc.2024.03.416</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2024.03.416</ArticleId><ArticleId IdType="pubmed">38811098</ArticleId></ArticleIdList></Reference><Reference><Citation>He B, Kwan AC, Cho JH, Yuan N, Pollick C, Shiota T, Ebinger J, Bello NA, Wei J, Josan K, et&#xa0;al. Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature. 2023;616:520&#x2013;524. doi: 10.1038/s41586-023-05947-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05947-3</ArticleId><ArticleId IdType="pmc">PMC10115627</ArticleId><ArticleId IdType="pubmed">37020027</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40301202</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1875-8312</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The international journal of cardiovascular imaging</Title><ISOAbbreviation>Int J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence-assisted left ventricular global longitudinal strain assessment in patients with acute myocardial infarction: a RESUS-AMI trial sub-analysis.</ArticleTitle><Pagination><StartPage>1225</StartPage><EndPage>1236</EndPage><MedlinePgn>1225-1236</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10554-025-03409-7</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this sub-analysis of the RESUS-AMI trial was to evaluate the correlation of artificial intelligence (AI)-assisted echocardiographic global longitudinal strain (GLS) assessments with infarct size, left ventricular ejection fraction (LVEF) and volumes from cardiac magnetic resonance (CMR) imaging, in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction. The reproducibility of GLS and other echocardiographic parameters derived with the AI-assisted software were also assessed.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a post-hoc imaging sub-analysis of the RESUS-AMI trial. Echocardiographic LVEF, volumes and GLS were measured with AI-assisted software (CAAS Qardia 2.0) using automated and semi-automated methods. The CMR LVEF, LV dimensions and infarct size were obtained from a CMR core lab with an off-line workstation (CAAS MRV 4.1).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total 169 echocardiograms were analysed and the GLS showed moderate correlation with the CMR infarct size (r&#x2009;=&#x2009;0.58 automated and 0.64 semi-automated, both p&#x2009;&lt;&#x2009;0.001) and LVEF (r=-0.63 automated and -&#x2009;0.65 semi-automated, both p&#x2009;&lt;&#x2009;0.001) from 81 CMR recordings. GLS also showed moderate correlation with the LVEF (r= -0.51 automated and -&#x2009;0.67 semi-automated, both p&#x2009;&lt;&#x2009;0.001) from echocardiography. The inter-observer reproducibility was excellent in GLS from both the automated (intraclass correlation (ICC)&#x2009;=&#x2009;0.94, bias&#x2009;=&#x2009;0.08, limit of agreement (LOA)&#x2009;=&#x2009;1.75) and semi-automated analysis (ICC&#x2009;=&#x2009;0.93, bias=-0.68, LOA&#x2009;=&#x2009;1.44). The intra-observer reproducibility was excellent in all echocardiographic measurements.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">GLS derived from the AI-assisted software (automated or semi-automated) could be used as a marker of LV systolic function as it correlates well the infarct size and LVEF assessed with CMR and LVEF with echocardiography.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mekonnen</LastName><ForeName>Demeke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardialysis, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spitzer</LastName><ForeName>Ernest</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardialysis, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McFadden</LastName><ForeName>Eugene P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Cardiology Department, Cork University Hospital, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caplice</LastName><ForeName>Noel M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Cardiology Department, Cork University Hospital, Cork, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Claire B</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Cardialysis, Rotterdam, The Netherlands. cren@cardialysis.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology Department, Erasmus University Medical Center, Rotterdam, The Netherlands. cren@cardialysis.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>, Westblaak 98, 3012KM, Rotterdam, The Netherlands. cren@cardialysis.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cardiovasc Imaging</MedlineTA><NlmUniqueID>100969716</NlmUniqueID><ISSNLinking>1569-5794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="Y">Ventricular Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="Y">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="N">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015588" MajorTopicYN="N">Observer Variation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009200" MajorTopicYN="Y">Myocardial Contraction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="Y">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="Y">Magnetic Resonance Imaging, Cine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094582" MajorTopicYN="N">Global Longitudinal Strain</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Global longitudinal strain</Keyword><Keyword MajorTopicYN="N">Infarct size</Keyword><Keyword MajorTopicYN="N">Left ventricular function</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword></KeywordList><CoiStatement>Declarations. Ethical approval: This study was performed in line with the principles of the Declaration of Helsinki. The RESUS-AMI trial was approved by the Clinical Research Ethics Committee at Cork University Hospital and the Irish Medicines Board (since renamed the Health Products Regulatory Authority), and written informed consent was obtained from all patients. This trial was registered on clinical trials.gov NCT01438086 and was funded by the Health Research Board of Ireland HRB TRA/2010/20. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>12</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>29</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40301202</ArticleId><ArticleId IdType="doi">10.1007/s10554-025-03409-7</ArticleId><ArticleId IdType="pii">10.1007/s10554-025-03409-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller AL, Dib C, Li L et al (2012) Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use. Circ Cardiovasc Qual Outcomes 5(5):662&#x2013;671. https://doi.org/10.1161/circoutcomes.112.965012 [published Online First: 20120904]</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circoutcomes.112.965012</ArticleId><ArticleId IdType="pubmed">22949495</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ et al (2023) 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J 44(38). https://doi.org/10.1093/eurheartj/ehad191</Citation></Reference><Reference><Citation>Liu Y, Sun Y, Dai W (2024) Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis. Front Pharmacol 15:1366035. https://doi.org/10.3389/fphar.2024.1366035 [published Online First: 20240528]</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2024.1366035</ArticleId><ArticleId IdType="pubmed">38863978</ArticleId><ArticleId IdType="pmc">11165101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S et al (2018) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 39(2):119&#x2013;177. https://doi.org/10.1093/eurheartj/ehx393</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx393</ArticleId><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Zhou Q, Yao X et al (2020) Layer-Specific strain for Long-Term outcome prediction after First-Onset myocardial infarction. Ultrasound Med Biol 46(6). https://doi.org/10.1016/j.ultrasmedbio.2020.02.013</Citation></Reference><Reference><Citation>Wei LAI, Ge H, Pu JUN (2021) Impact of concomitant impairments of the left and right ventricular myocardial strain on the prognoses of patients with ST-elevation myocardial infarction. Eur Heart J - Cardiovasc Imaging 22(Supplement2). https://doi.org/10.1093/ehjci/jeab090.094</Citation></Reference><Reference><Citation>Cimino S, Canali E, Petronilli V et al (2013) Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial Scar in patients with acute ST elevation myocardial infarction and relatively preserved LV function. Eur Heart J Cardiovasc Imaging 14(8):805&#x2013;811. https://doi.org/10.1093/ehjci/jes295 [published Online First: 20121220]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jes295</ArticleId><ArticleId IdType="pubmed">23258316</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhafez MA, Aly KME, Youssef AAA (2024) Effect of residual myocardial ischemia on recovery of left ventricular function after primary percutaneous coronary intervention. BMC Cardiovasc Disord 24(1):164. https://doi.org/10.1186/s12872-024-03777-3 [published Online First: 20240319]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-024-03777-3</ArticleId><ArticleId IdType="pubmed">38504186</ArticleId><ArticleId IdType="pmc">10949644</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsen S, Dahlslett T, Grenne B et al (2019) Global longitudinal strain is a more reproducible measure of left ventricular function than ejection fraction regardless of echocardiographic training. Cardiovasc Ultrasound 17(1). https://doi.org/10.1186/s12947-019-0168-9</Citation></Reference><Reference><Citation>van der Linde D, van Hagen I, Veen K, Zuetenhorst H, van Dalen B (2023) Global longitudinal strain: an early marker for cardiotoxicity in patients treated for breast cancer. Neth Heart J 31(3). https://doi.org/10.1007/s12471-022-01734-3</Citation></Reference><Reference><Citation>Spitzer E, Camacho B, Mrevlje B, Brandendburg HJ, Ren CB (2023) Echocardiography core laboratory validation of a novel Vendor-Independent Web-Based software for the assessment of left ventricular global longitudinal strain. J Cardiovasc Imaging 31(3):135&#x2013;141. https://doi.org/10.4250/jcvi.2022.0130</Citation><ArticleIdList><ArticleId IdType="doi">10.4250/jcvi.2022.0130</ArticleId><ArticleId IdType="pubmed">37488918</ArticleId><ArticleId IdType="pmc">10374390</ArticleId></ArticleIdList></Reference><Reference><Citation>Badano LP, Kolias TJ, Muraru D et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: A consensus document of the EACVI/ASE/Industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19(6). https://doi.org/10.1093/ehjci/jey042</Citation></Reference><Reference><Citation>Hauk L (2015) Management of Non-ST elevation acute coronary syndrome: A guideline from the AHA and ACC. Am Family Phys 92(2)</Citation></Reference><Reference><Citation>Otterstad JE, Norum IB, Ruddox V et al (2021) Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction. Int J Cardiovasc Imaging 37(12):3477&#x2013;3487. https://doi.org/10.1007/s10554-021-02349-2 [published Online First: 20210729]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-021-02349-2</ArticleId><ArticleId IdType="pubmed">34327649</ArticleId><ArticleId IdType="pmc">8604850</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;schel J, Kuhnt J, Viezzer D et al (2024) Comparison of manual and artificial intelligence based quantification of myocardial strain by feature tracking-a cardiovascular MR study in health and disease. Eur Radiol 34(2):1003&#x2013;1015. https://doi.org/10.1007/s00330-023-10127-y [published Online First: 20230818]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-023-10127-y</ArticleId><ArticleId IdType="pubmed">37594523</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhre PL, Hung CL, Frost MJ et al (2024) External validation of a deep learning algorithm for automated echocardiographic strain measurements. Eur Heart J Digit Health 5(1):60&#x2013;68. https://doi.org/10.1093/ehjdh/ztad072 [published Online First: 20231120]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztad072</ArticleId><ArticleId IdType="pubmed">38264705</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogstadkjernet M, Zha SZ, Kl&#xe6;boe LG et al (2024) A deep learning based method for left ventricular strain measurements: repeatability and accuracy compared to experienced echocardiographers. BMC Med Imaging 24(1):305. https://doi.org/10.1186/s12880-024-01470-7 [published Online First: 20241112]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12880-024-01470-7</ArticleId><ArticleId IdType="pubmed">39528980</ArticleId><ArticleId IdType="pmc">11555954</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt Y, Lubrecht JM, Adriaans BP et al (2024) Quantification of left ventricular myocardial strain: comparison between MRI tagging, MRI feature tracking, and ultrasound speckle tracking. NMR Biomed 37(9):e5164. https://doi.org/10.1002/nbm.5164 [published Online First: 20240425]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.5164</ArticleId><ArticleId IdType="pubmed">38664924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara A, Iwasaki Y, Kobayashi M et al (2024) Artificial intelligence-derived left ventricular strain in echocardiography in patients treated with chemotherapy. Int J Cardiovasc Imaging 40(9):1903&#x2013;1910. https://doi.org/10.1007/s10554-024-03178-9 [published Online First: 20240723]</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-024-03178-9</ArticleId><ArticleId IdType="pubmed">39042233</ArticleId><ArticleId IdType="pmc">11473551</ArticleId></ArticleIdList></Reference><Reference><Citation>Caplice NM, DeVoe MC, Choi J et al (2018) Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI). Am Heart J 200. https://doi.org/10.1016/j.ahj.2018.03.018</Citation></Reference><Reference><Citation>Baks T, van Geuns RJ, Biagini E et al (2006) Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 47(1):40&#x2013;44 [published Online First: 20051209]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.09.008</ArticleId><ArticleId IdType="pubmed">16386662</ArticleId></ArticleIdList></Reference><Reference><Citation>Knackstedt C, Bekkers SC, Schummers G et al (2015) Fully automated versus standard tracking of left ventricular ejection fraction and longitudinal strain: the FAST-EFs multicenter study. J Am Coll Cardiol 66(13):1456&#x2013;1466. https://doi.org/10.1016/j.jacc.2015.07.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.07.052</ArticleId><ArticleId IdType="pubmed">26403342</ArticleId></ArticleIdList></Reference><Reference><Citation>Smiseth OA, Rider O, Cvijic M, Valkovi&#x10d; L, Remme EW, Voigt JU (2024) Myocardial strain imaging: theory, current practice, and the future. JACC Cardiovasc Imaging. https://doi.org/10.1016/j.jcmg.2024.07.011 [published Online First: 20240826]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2024.07.011</ArticleId><ArticleId IdType="pubmed">39570213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschbaum SW, Baks T, Gronenschild EH et al (2008) Addition of the long-axis information to short-axis contours reduces interstudy variability of left-ventricular analysis in cardiac magnetic resonance studies. Invest Radiol 43(1):1&#x2013;6. https://doi.org/10.1097/RLI.0b013e318154b1dc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0b013e318154b1dc</ArticleId><ArticleId IdType="pubmed">18097271</ArticleId></ArticleIdList></Reference><Reference><Citation>Larose E, Rod&#xe9;s-Cabau J, Pibarot P et al (2010) Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol 55(22):2459&#x2013;2469. https://doi.org/10.1016/j.jacc.2010.02.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.02.033</ArticleId><ArticleId IdType="pubmed">20510213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1&#x2013;39e14. https://doi.org/10.1016/j.echo.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126(5):1763&#x2013;1768. https://doi.org/10.1213/ANE.0000000000002864</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002864</ArticleId><ArticleId IdType="pubmed">29481436</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15(2):155&#x2013;163. https://doi.org/10.1016/j.jcm.2016.02.012 [published Online First: 20160331]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcm.2016.02.012</ArticleId><ArticleId IdType="pubmed">27330520</ArticleId><ArticleId IdType="pmc">4913118</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga T, Hagiwara N, Ogawa H et al (2009) Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Heart 95(3):216&#x2013;220. https://doi.org/10.1136/hrt.2008.145243 [published Online First: 20080826]</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2008.145243</ArticleId><ArticleId IdType="pubmed">18728065</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon SD, Zelenkofske S, McMurray JJV et al (2005) Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 352(25). https://doi.org/10.1056/nejmoa043938</Citation></Reference><Reference><Citation>Diao KY, Yang ZG, Ma M et al (2017) The diagnostic value of global longitudinal strain (GLS) on myocardial infarction size by echocardiography: A systematic review and Meta-analysis. Sci Rep 7(1):10082. https://doi.org/10.1038/s41598-017-09096-2 [published Online First: 20170830]</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09096-2</ArticleId><ArticleId IdType="pubmed">28855658</ArticleId><ArticleId IdType="pmc">5577208</ArticleId></ArticleIdList></Reference><Reference><Citation>Samir A, Nagy S, Abdelhamid M, Kandil H (2024) Clinical, electrocardiographic, echocardiographic, and angiographic predictors for the final infarct size assessed by cardiac magnetic resonance in acute STEMI patients after primary percutaneous coronary intervention. Egypt Heart J 76(1):111. https://doi.org/10.1186/s43044-024-00526-x [published Online First: 20240824]</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43044-024-00526-x</ArticleId><ArticleId IdType="pubmed">39180635</ArticleId><ArticleId IdType="pmc">11344739</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph G, Zaremba T, Johansen MB et al (2019) Echocardiographic global longitudinal strain is associated with infarct size assessed by cardiac magnetic resonance in acute myocardial infarction. Echo Res Pract 6(4):81&#x2013;89. https://doi.org/10.1530/ERP-19-0026 [published Online First: 20190807]</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/ERP-19-0026</ArticleId><ArticleId IdType="pubmed">31516720</ArticleId><ArticleId IdType="pmc">6733366</ArticleId></ArticleIdList></Reference><Reference><Citation>Polacin M, Karolyi M, Eberhard M et al (2021) Segmental strain analysis for the detection of chronic ischemic scars in non-contrast cardiac MRI cine images. Sci Rep 11(1):12376. https://doi.org/10.1038/s41598-021-90283-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90283-7</ArticleId><ArticleId IdType="pubmed">34117271</ArticleId><ArticleId IdType="pmc">8195981</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan JN, Nazir SA, Singh A et al (2016) Relationship of myocardial strain and markers of myocardial injury to predict segmental recovery after acute ST-Segment&#x2013;Elevation myocardial infarction. Circ Cardiovasc Imaging 9(6):e003457. https://doi.org/10.1161/CIRCIMAGING.115.003457</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.115.003457</ArticleId><ArticleId IdType="pubmed">27283007</ArticleId></ArticleIdList></Reference><Reference><Citation>Salte IM, &#xd8;stvik A, Smistad E et al (2021) Artificial intelligence for automatic measurement of left ventricular strain in echocardiography. JACC: Cardiovasc Imaging 14(10). https://doi.org/10.1016/j.jcmg.2021.04.018</Citation></Reference><Reference><Citation>McAlindon E, Pufulete M, Lawton C, Angelini GD, Bucciarelli-Ducci C (2015) Quantification of infarct size and myocardium at risk: evaluation of different techniques and its implications. Eur Heart J Cardiovasc Imaging 16(7):738&#x2013;746. https://doi.org/10.1093/ehjci/jev001 [published Online First: 20150302]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev001</ArticleId><ArticleId IdType="pubmed">25736308</ArticleId><ArticleId IdType="pmc">4463003</ArticleId></ArticleIdList></Reference><Reference><Citation>van Geuns RJ, Baks T, Gronenschild EH et al (2006) Automatic quantitative left ventricular analysis of cine MR images by using three-dimensional information for contour detection. Radiology 240(1):215&#x2013;221. https://doi.org/10.1148/radiol.2401050471</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2401050471</ArticleId><ArticleId IdType="pubmed">16793980</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40304026</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2383-4625</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2025</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Clinical and experimental emergency medicine</Title><ISOAbbreviation>Clin Exp Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Interethnic Validation of an ECG Image Analysis Software for Detecting Left Ventricular Dysfunction in Emergency Department Population.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.15441/ceem.24.342</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">We previously developed and validated an AI-based ECG analysis tool (ECG Buddy) in a Korean population. This study aims to validate its performance in a U.S. population, specifically assessing its left ventricular (LV) Dysfunction Score and left ventricular ejection fraction (LVEF)-ECG feature for predicting LVEF &lt;40%, using N-Terminal Pro-B-Type Natriuretic Peptide (NT-ProBNP) as a comparator.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We identified emergency department (ED) visits from the MIMIC-IV dataset with information on LVEF &lt;40% or &#x2265;40%, along with matched 12-lead ECG data recorded within 48 hours of the ED visit. The performance of ECG Buddy's LV Dysfunction Score and LVEF-ECG feature was compared with NT-ProBNP using Receiver Operating Characteristic - Area Under the Curve (ROCAUC) analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 22,599 ED visits were analyzed. The LV Dysfunction Score had an AUC of 0.905 (95% CI: 0.899 - 0.910), with a sensitivity of 85.4% and specificity of 80.8%. The LVEF-ECG feature had an AUC of 0.908 (95% CI: 0.902 - 0.913), sensitivity 83.5%, and specificity 83.0%. NT-ProBNP had an AUC of 0.740 (95% CI: 0.727 - 0.752), with a sensitivity of 74.8% and specificity of 62.0%. The ECG-based predictors demonstrated superior diagnostic performance compared to NT-ProBNP (all p&lt;0.001). In the Sinus Rhythm subgroup, the LV Dysfunction Score achieved an AUC of 0.913, and LVEF-ECG had an AUC of 0.917, both outperforming NT-ProBNP (0.748, 95% CI: 0.732 - 0.763, all p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">ECG Buddy demonstrated superior accuracy compared to NT-ProBNP in predicting LV systolic dysfunction, validating its utility in a U.S. ED population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Haemin</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARPI Inc., Room 12 Startup Incubation Center, 172, Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13605, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Woon Yong</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongnogu, Seoul, 03080, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Kyoung Jun</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, SMG-SNU Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul, 07061, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jo</LastName><ForeName>You Hwan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Joonghee</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARPI Inc., Room 12 Startup Incubation Center, 172, Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13605, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Youngjin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Cardiovascular Center, Department of Internal Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARPI Inc., Room 12 Startup Incubation Center, 172, Dolma-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13605, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Ji Eun</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yeongho</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Seoul National University Bundang Hospital, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Clin Exp Emerg Med</MedlineTA><NlmUniqueID>101657493</NlmUniqueID><ISSNLinking>2383-4625</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial Intelligence</Keyword><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Ejection Fraction</Keyword><Keyword MajorTopicYN="N">Emergency Department</Keyword><Keyword MajorTopicYN="N">Heart Failure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>5</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40304026</ArticleId><ArticleId IdType="doi">10.15441/ceem.24.342</ArticleId><ArticleId IdType="pii">ceem.24.342</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40305084</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1438-8871</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><PubDate><Year>2025</Year><Month>Apr</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of medical Internet research</Title><ISOAbbreviation>J Med Internet Res</ISOAbbreviation></Journal><ArticleTitle>Harnessing an Artificial Intelligence-Based Large Language Model With Personal Health Record Capability for Personalized Information Support in Postsurgery Myocardial Infarction: Descriptive Qualitative Study.</ArticleTitle><Pagination><StartPage>e68762</StartPage><MedlinePgn>e68762</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68762</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/68762</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Myocardial infarction (MI) remains a leading cause of morbidity and mortality worldwide. Although postsurgical cardiac interventions have improved survival rates, effective management during recovery remains challenging. Traditional informational support systems often provide generic guidance that does not account for individualized medical histories or psychosocial factors. Recently, artificial intelligence (AI)-based large language models (LLM) tools have emerged as promising interventions to deliver personalized health information to post-MI patients.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aim to explore the user experiences and perceptions of an AI-based LLM tool (iflyhealth) with integrated personal health record functionality in post-MI care, assess how patients and their family members engaged with the tool during recovery, identify the perceived benefits and challenges of using the technology, and to understand the factors promoting or hindering continued use.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A purposive sample of 20 participants (12 users and 8 nonusers) who underwent MI surgery within the previous 6 months was recruited between July and August 2024. Data were collected through semistructured, face-to-face interviews conducted in a private setting, using an interview guide to address participants' first impressions, usage patterns, and reasons for adoption or nonadoption of the iflyhealth app. The interviews were audio-recorded, transcribed verbatim, and analyzed using Colaizzi method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four key themes revealed included: (1) participants' experiences varied based on digital literacy, prior exposure to health technologies, and individual recovery needs; (2) users appreciated the app's enhanced accessibility to professional health information, personalized advice tailored to their clinical conditions, and the tool's responsiveness to health status changes; (3) challenges such as difficulties with digital literacy, usability concerns, and data privacy issues were significant barriers; and (4) nonusers and those who discontinued use primarily cited complexity of the interface and perceived limited relevance of the advice as major deterrents.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">iflyhealth, an LLM AI app with a built-in personal health record functionality, shows significant potential in assisting post-MI patients. The main benefits reported by iflyhealth users include improved access to personalized health information and an enhanced ability to respond to changing health conditions. However, challenges such as digital literacy, usability, and privacy and security concerns persist. Overcoming the barriers may further enhance the use of the iflyhealth app, which can play an important role in patient-centered, personalized post-MI management.</AbstractText><CopyrightInformation>&#xa9;Ting-ting Yang, Hong-xia Zheng, Sha Cao, Mei-ling Jing, Ju Hu, Yan Zuo, Qing-yong Chen, Jian-jun Zhang. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 30.04.2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ting-Ting</ForeName><Initials>TT</Initials><Identifier Source="ORCID">0009-0009-3960-9167</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Hong-Xia</ForeName><Initials>HX</Initials><Identifier Source="ORCID">0009-0001-3032-1097</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Sha</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0002-9392-9013</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jing</LastName><ForeName>Mei-Ling</ForeName><Initials>ML</Initials><Identifier Source="ORCID">0009-0000-8316-8092</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Ju</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0006-1260-9931</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-1397-013X</Identifier><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics Nursing, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>West China School of Nursing, West China School of Nursing, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Qing-Yong</ForeName><Initials>QY</Initials><Identifier Source="ORCID">0000-0003-0774-5139</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jian-Jun</ForeName><Initials>JJ</Initials><Identifier Source="ORCID">0000-0002-2532-4736</Identifier><AffiliationInfo><Affiliation>Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>J Med Internet Res</MedlineTA><NlmUniqueID>100959882</NlmUniqueID><ISSNLinking>1438-8871</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055991" MajorTopicYN="Y">Health Records, Personal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057285" MajorTopicYN="N">Precision Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000098342" MajorTopicYN="N">Large Language Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">digital health tools</Keyword><Keyword MajorTopicYN="N">health information accessibility</Keyword><Keyword MajorTopicYN="N">large language model</Keyword><Keyword MajorTopicYN="N">mobile phone</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">personal health record</Keyword><Keyword MajorTopicYN="N">personalized health support</Keyword><Keyword MajorTopicYN="N">post-surgery recovery</Keyword><Keyword MajorTopicYN="N">qualitative study</Keyword></KeywordList><CoiStatement>Conflicts of Interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40305084</ArticleId><ArticleId IdType="pmc">PMC12079068</ArticleId><ArticleId IdType="doi">10.2196/68762</ArticleId><ArticleId IdType="pii">v27i1e68762</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jayaraj J, Davatyan K, Subramanian S, Priya J. Myocardial Infarction. London, England: Intechopen; 2018. Epidemiology of myocardial infarction.</Citation></Reference><Reference><Citation>Zhang Y, Chong JH, Harky A. Enhanced recovery after cardiac surgery and its impact on outcomes: a systematic review. Perfusion. 2022;37(2):162&#x2013;174. doi: 10.1177/0267659121988957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0267659121988957</ArticleId><ArticleId IdType="pubmed">33468017</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandberg C, Ekstedt M, Flink M. Self-management challenges following hospital discharge for patients with multimorbidity: a longitudinal qualitative study of a motivational interviewing intervention. BMJ Open. 2021;11(7):e046896. doi: 10.1136/bmjopen-2020-046896. 
 
bmjopen-2020-046896</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-046896</ArticleId><ArticleId IdType="pmc">PMC8327841</ArticleId><ArticleId IdType="pubmed">34330857</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca L, Piscione F, Colivicchi F, Lucci D, Mascia F, Marinoni B, Cirillo P, Grosseto D, Mauro C, Calabr&#xf2; P, Nardi F, Rossini R, Geraci G, Gabrielli D, Di Lenarda A, Gulizia MM, EYESHOT Post-MI Investigators Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study. Int J Cardiol. 2018;273:8&#x2013;14. doi: 10.1016/j.ijcard.2018.08.055.S0167-5273(18)33347-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2018.08.055</ArticleId><ArticleId IdType="pubmed">30170918</ArticleId></ArticleIdList></Reference><Reference><Citation>Norlund F, Wallin E, Olsson EMG, Wallert J, Burell G, von Essen L, Held C. Internet-based cognitive behavioral therapy for symptoms of depression and anxiety among patients with a recent mocardial infarction: the U-CARE heart randomized controlled trial. J Med Internet Res. 2018;20(3):e88. doi: 10.2196/jmir.9710. 
 
v20i3e88</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.9710</ArticleId><ArticleId IdType="pmc">PMC5874001</ArticleId><ArticleId IdType="pubmed">29519777</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosson S, Monaco F, Miola A, Cascino G, Stubbs B, Correll CU, Firth J, Ermis C, Perrotti A, Marciello F, Carvalho AF, Brunoni AR, Fusar-Poli P, Fornaro M, Gentile G, Granziol U, Pigato G, Favaro A, Solmi M. Longitudinal course of depressive, anxiety, and posttraumatic stress disorder symptoms after heart surgery: a meta-analysis of 94 studies. Psychosom Med. 2021;83(1):85&#x2013;93. doi: 10.1097/PSY.0000000000000872.00006842-202101000-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000872</ArticleId><ArticleId IdType="pubmed">33021524</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Deng C, Yuan P, Ma J, Yu P, Chen J, Zhao Y, Liu X. Anxiety, depression, and medication adherence in Chinese patients with myocardial infarction in the absence of obstructive coronary artery disease. Clin Cardiol. 2020;43(12):1350&#x2013;1351. doi: 10.1002/clc.23495. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23495</ArticleId><ArticleId IdType="pmc">PMC7724221</ArticleId><ArticleId IdType="pubmed">33103795</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy E, Ashen D, Blumenthal RS, Davis DM, Gulati M, Blaha MJ, Michos ED, Nasir K, Cainzos-Achirica M. Communication approaches to enhance patient motivation and adherence in cardiovascular disease prevention. Clin Cardiol. 2021;44(9):1199&#x2013;1207. doi: 10.1002/clc.23555. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23555</ArticleId><ArticleId IdType="pmc">PMC8427972</ArticleId><ArticleId IdType="pubmed">34414588</ArticleId></ArticleIdList></Reference><Reference><Citation>Su JJ, Yu DSF. Effects of a nurse-led eHealth cardiac rehabilitation programme on health outcomes of patients with coronary heart disease: a randomised controlled trial. Int J Nurs Stud. 2021;122:104040. doi: 10.1016/j.ijnurstu.2021.104040.S0020-7489(21)00187-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2021.104040</ArticleId><ArticleId IdType="pubmed">34333211</ArticleId></ArticleIdList></Reference><Reference><Citation>Broers ER, Widdershoven J, Denollet J, Lodder P, Kop WJ, Wetzels M, Ayoola I, Piera-Jimenez J, Habibovi&#x107; M, CHANGE Consortium Do. Personalized eHealth program for life-style change: results from the "Do Cardiac Health Advanced New Generated Ecosystem (Do CHANGE 2)" randomized controlled trial. Psychosom Med. 2020;82(4):409&#x2013;419. doi: 10.1097/PSY.0000000000000802.00006842-202005000-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000802</ArticleId><ArticleId IdType="pubmed">32176191</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcimart&#xed;n P, Astals-Vizcaino M, Badosa N, Linas A, Ivern C, Duran X, Com&#xed;n-Colet J. The impact of motivational interviewing on self-care and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs. 2022;37(5):456&#x2013;464. doi: 10.1097/JCN.0000000000000841.00005082-900000000-99156</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCN.0000000000000841</ArticleId><ArticleId IdType="pubmed">34495916</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez M, Sj&#xf6;lin I, B&#xe4;ck M, &#xd6;gmundsdottir Michelsen H, Tanha T, Sandberg C, Schiopu A, Leosdottir M. Effect of a lifestyle-focused electronic patient support application for improving risk factor management, self-rated health, and prognosis in post-myocardial infarction patients: study protocol for a multi-center randomized controlled trial. Trials. 2019;20(1):76. doi: 10.1186/s13063-018-3118-1. 
 
10.1186/s13063-018-3118-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-018-3118-1</ArticleId><ArticleId IdType="doi">10.1186/s13063-018-3118-1</ArticleId><ArticleId IdType="pmc">PMC6346565</ArticleId><ArticleId IdType="pubmed">30678709</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Y, Yang Y, Shen J, Luo S. Anxiety and prognosis of patients with myocardial infarction: a meta-analysis. Clin Cardiol. 2021;44(6):761&#x2013;770. doi: 10.1002/clc.23605. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23605</ArticleId><ArticleId IdType="pmc">PMC8207975</ArticleId><ArticleId IdType="pubmed">33960435</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallert J, Gustafson E, Held C, Madison G, Norlund F, von Essen L, Olsson EMG. Predicting adherence to internet-delivered psychotherapy for symptoms of depression and anxiety after myocardial infarction: machine learning insights from the U-CARE heart randomized controlled trial. J Med Internet Res. 2018;20(10):e10754. doi: 10.2196/10754. 
 
v20i10e10754</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/10754</ArticleId><ArticleId IdType="pmc">PMC6234350</ArticleId><ArticleId IdType="pubmed">30305255</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannantuono GM, Bracken-Clarke D, Floudas CS, Roselli M, Gulley JL, Karzai F. Applications of large language models in cancer care: current evidence and future perspectives. Front Oncol. 2023;13:1268915. doi: 10.3389/fonc.2023.1268915. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2023.1268915</ArticleId><ArticleId IdType="pmc">PMC10507617</ArticleId><ArticleId IdType="pubmed">37731643</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton CM. Phenomenology for the holistic nurse researcher: underpinnings of descriptive and interpretive traditions. J Holist Nurs. 2020;38(3):278&#x2013;286. doi: 10.1177/0898010119882155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0898010119882155</ArticleId><ArticleId IdType="pubmed">31650887</ArticleId></ArticleIdList></Reference><Reference><Citation>iFlytek Xiaoyi APP. Xunfei Healthcare.  [2025-04-17].  
 https://www.iflyhealth.com/product/244.html
.</Citation></Reference><Reference><Citation>Kim H, Sefcik JS, Bradway C. Characteristics of qualitative descriptive studies: a systematic review. Res Nurs Health. 2017;40(1):23&#x2013;42. doi: 10.1002/nur.21768. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nur.21768</ArticleId><ArticleId IdType="pmc">PMC5225027</ArticleId><ArticleId IdType="pubmed">27686751</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaheen M, Pradhan S, Ranajee . Advances in Business Information Systems and Analytics. Hershey, PA: IGI Global; 2019. Sampling in qualitative research.</Citation></Reference><Reference><Citation>Horton J, Macve R, Struyven G. Qualitative Research: Experiences in Using Semi-Structured Interviews. Amsterdam, The Netherlands: Elsevier Ltd; 2004. pp. 339&#x2013;357.</Citation></Reference><Reference><Citation>Elhami A, Khoshnevisan B. Conducting an interview in qualitative research: the modus operandi. MJ. 2022;46(1):1&#x2013;7. doi: 10.61871/mj.v46n1-3. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.61871/mj.v46n1-3</ArticleId><ArticleId IdType="doi">10.61871/mj.v46n1-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Praveena KR. Application of Colaizzi&#x2019;s method of data analysis in phenomenological research. MLU. 2021;21(2):914&#x2013;918. doi: 10.37506/MLU.V21I2.2800. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.37506/MLU.V21I2.2800</ArticleId><ArticleId IdType="doi">10.37506/MLU.V21I2.2800</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharts-Hopko NC. Assessing rigor in qualitative research. J Assoc Nurses AIDS Care. 2002;13(4):84&#x2013;86. doi: 10.1016/S1055-3290(06)60374-9.S1055-3290(06)60374-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1055-3290(06)60374-9</ArticleId><ArticleId IdType="pubmed">12149888</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias Valencia MM, Giraldo Mora CV. Scientific rigor in qualitative research. Invest Educ Enferm. 2011;29(3) doi: 10.17533/udea.iee.5248. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.17533/udea.iee.5248</ArticleId><ArticleId IdType="doi">10.17533/udea.iee.5248</ArticleId></ArticleIdList></Reference><Reference><Citation>Poland B. Transcription quality as an aspect of rigor in qualitative research. Qualitative Inquiry. 1995;1(3):290&#x2013;310. doi: 10.1177/107780049500100302. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107780049500100302</ArticleId><ArticleId IdType="doi">10.1177/107780049500100302</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairat S, Coleman C, Newlin T, Rand V, Ottmar P, Bice T, Carson SS. A mixed-methods evaluation framework for electronic health records usability studies. J Biomed Inform. 2019;94:103175. doi: 10.1016/j.jbi.2019.103175. 
 
S1532-0464(19)30093-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103175</ArticleId><ArticleId IdType="pmc">PMC6584062</ArticleId><ArticleId IdType="pubmed">30981897</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqahtani F, Orji R. Insights from user reviews to improve mental health apps. Health Informatics J. 2020;26(3):2042&#x2013;2066. doi: 10.1177/1460458219896492. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1460458219896492?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/1460458219896492</ArticleId><ArticleId IdType="pubmed">31920160</ArticleId></ArticleIdList></Reference><Reference><Citation>Staggers N, Xiao Y, Chapman L. Debunking health IT usability myths. Appl Clin Inform. 2013;4(2):241&#x2013;250. doi: 10.4338/ACI-2013-03-IE-0016. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.4338/ACI-2013-03-IE-0016</ArticleId><ArticleId IdType="pmc">PMC3716421</ArticleId><ArticleId IdType="pubmed">23874361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao C, Chang J, Tang K. Exploring the influential factors in continuance usage of mobile social apps: satisfaction, habit, and customer value perspectives. Telematics Inf. 2016;33(2):342&#x2013;355. doi: 10.1016/j.tele.2015.08.014. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tele.2015.08.014</ArticleId><ArticleId IdType="doi">10.1016/j.tele.2015.08.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung D, Bae I. The effect of the perceived value of delivery app services on satisfaction and continuous use intention: focused on the mediating role of perceived control. Foodserv Manag Soc Korea. 2023;26(6):213&#x2013;238. doi: 10.47584/jfm.2023.26.6.213. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.47584/jfm.2023.26.6.213</ArticleId><ArticleId IdType="doi">10.47584/jfm.2023.26.6.213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H, Chi C, Chiu W. Understanding sustained usage of health and fitness apps: Incorporating the technology acceptance model with the investment model. Technol Soc. 2020;63:101429. doi: 10.1016/j.techsoc.2020.101429. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.techsoc.2020.101429</ArticleId><ArticleId IdType="doi">10.1016/j.techsoc.2020.101429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J. The impact of post-adoption beliefs on the continued use of health apps. Int J Med Inform. 2016;87:75&#x2013;83. doi: 10.1016/j.ijmedinf.2015.12.016.S1386-5056(15)30083-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijmedinf.2015.12.016</ArticleId><ArticleId IdType="pubmed">26806714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan M, Filieri R, Raguseo E, Gorton M. Mobile apps for healthy living: factors influencing continuance intention for health apps. Technol Forecast Soc Change. 2021;166:120644. doi: 10.1016/j.techfore.2021.120644. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TECHFORE.2021.120644</ArticleId><ArticleId IdType="doi">10.1016/j.techfore.2021.120644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J, Heinsch M, Betts D, Booth D, Kay-Lambkin F. Barriers and facilitators to the use of e-health by older adults: a scoping review. BMC Public Health. 2021;21(1):1556. doi: 10.1186/s12889-021-11623-w. 
 
10.1186/s12889-021-11623-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11623-w</ArticleId><ArticleId IdType="doi">10.1186/s12889-021-11623-w</ArticleId><ArticleId IdType="pmc">PMC8369710</ArticleId><ArticleId IdType="pubmed">34399716</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakley-Girvan I, Yunis R, Longmire M, Ouillon JS. What works best to engage participants in mobile app interventions and e-health: a scoping review. Telemed J E Health. 2022;28(6):768&#x2013;780. doi: 10.1089/tmj.2021.0176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2021.0176</ArticleId><ArticleId IdType="pmc">PMC9231655</ArticleId><ArticleId IdType="pubmed">34637651</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem M, K&#xfc;hne L, De Santis KK, Christianson L, Brand T, Busse H. Understanding engagement strategies in digital interventions for mental health promotion: scoping review. JMIR Ment Health. 2021;8(12):e30000. doi: 10.2196/30000. 
 
v8i12e30000</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/30000</ArticleId><ArticleId IdType="pmc">PMC8726056</ArticleId><ArticleId IdType="pubmed">34931995</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietvorst E, Hillegers MH, Legerstee JS, Vries LPDe, Vreeker A, Keijsers L. Real-time personalized feedback in mHealth for adolescents. Digit Health. 2024;10:20552076241247937. doi: 10.1177/20552076241247937. 
 
10.1177_20552076241247937</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20552076241247937?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub0pubmed</ArticleId><ArticleId IdType="doi">10.1177/20552076241247937</ArticleId><ArticleId IdType="pmc">PMC11100393</ArticleId><ArticleId IdType="pubmed">38766361</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin D, Lee S, Hwang Y. How do credibility and utility play in the user experience of health informatics services? Comput Hum Behav. 2017;67:292&#x2013;302. doi: 10.1016/j.chb.2016.11.007. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chb.2016.11.007</ArticleId><ArticleId IdType="doi">10.1016/j.chb.2016.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon N, Crouch E. Digital information technology use and patient preferences for internet-based health education modalities: cross-sectional survey study of middle-aged and older adults with chronic health conditions. JMIR Aging. 2019;2(1):e12243. doi: 10.2196/12243. 
 
v2i1e12243</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/12243</ArticleId><ArticleId IdType="pmc">PMC6716442</ArticleId><ArticleId IdType="pubmed">31518291</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Yamashita T, Burston B, Keene JR. The use of online health-management tools and health care utilization among older Americans. Gerontologist. 2020;60(7):1224&#x2013;1232. doi: 10.1093/geront/gnaa068.5856145</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geront/gnaa068</ArticleId><ArticleId IdType="pubmed">32525983</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Yamashita T, Burston B, Keene J. The disparities in accessing online health information and health care utilization among older Americans. Innovation Aging. 2020;4:316&#x2013;317. doi: 10.1093/geroni/igaa057.1013. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igaa057.1013</ArticleId><ArticleId IdType="doi">10.1093/geroni/igaa057.1013</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, Gearon E, Hawkins M, McPhee C, Hanna L, Batterham R, Osborne RH. Digital health literacy as a predictor of awareness, engagement, and use of a national web-based personal health record: population-based survey study. J Med Internet Res. 2022;24(9):e35772. doi: 10.2196/35772. 
 
v24i9e35772</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/35772</ArticleId><ArticleId IdType="pmc">PMC9526109</ArticleId><ArticleId IdType="pubmed">36112404</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhammad N, Alajlani M, Abd-Alrazaq A, Epiphaniou G, Arvanitis T. Patients' perspectives on the data confidentiality, privacy, and security of mHealth apps: systematic review. J Med Internet Res. 2024;26:e50715. doi: 10.2196/50715.v26i1e50715</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/50715</ArticleId><ArticleId IdType="pmc">PMC11179037</ArticleId><ArticleId IdType="pubmed">38820572</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L, Bao J, Watzlaf V, Parmanto B. Barriers to and facilitators of the use of mobile health apps from a security perspective: mixed-methods study. JMIR mHealth uHealth. 2019;7(4):e11223. doi: 10.2196/11223. 
 
v7i4e11223</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/11223</ArticleId><ArticleId IdType="pmc">PMC6488955</ArticleId><ArticleId IdType="pubmed">30990458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurgalieva L, O'Callaghan D, Doherty G. Security and privacy of mHealth applications: a scoping review. IEEE Access. 2020;8:104247&#x2013;104268. doi: 10.1109/access.2020.2999934. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ACCESS.2020.2999934</ArticleId><ArticleId IdType="doi">10.1109/access.2020.2999934</ArticleId></ArticleIdList></Reference><Reference><Citation>Saka S, Das S. Safeguarding in the internet of things age: a comprehensive review of security and privacy risks for older adults. Innovation Aging. 2023;7(Supplement_1):819&#x2013;819. doi: 10.1093/geroni/igad104.2642. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geroni/igad104.2642</ArticleId><ArticleId IdType="doi">10.1093/geroni/igad104.2642</ArticleId></ArticleIdList></Reference><Reference><Citation>Klaver NS, van de Klundert J, van den Broek RJGM, Askari M. Relationship between perceived risks of using mHealth applications and the intention to use them among older adults in the Netherlands: cross-sectional study. JMIR mHealth uHealth. 2021;9(8):e26845. doi: 10.2196/26845. 
 
v9i8e26845</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/26845</ArticleId><ArticleId IdType="pmc">PMC8438611</ArticleId><ArticleId IdType="pubmed">34459745</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder T, Haug M, Gewald H. Data privacy concerns using mHealth apps and smart speakers: comparative interview study among mature adults. JMIR Form Res. 2022;6(6):e28025. doi: 10.2196/28025. 
 
v6i6e28025</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/28025</ArticleId><ArticleId IdType="pmc">PMC9237761</ArticleId><ArticleId IdType="pubmed">35699993</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Sundar S. Is this AI trained on credible data? The effects of labeling quality and performance bias on user trust. CHI '23: Proceedings of the 2023 CHI Conference on Human Factors in Computing Systems; April 23-28, 2023; Hamburg Germany. ACM; 2023. pp. 1&#x2013;11. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3544548.3580805</ArticleId><ArticleId IdType="doi">10.1145/3544548.3580805</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AW, Mishra A. AI credibility and consumer-AI experiences: a&#xa0;conceptual framework. JSTP. 2023;34(1):66&#x2013;97. doi: 10.1108/jstp-03-2023-0108. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/jstp-03-2023-0108</ArticleId><ArticleId IdType="doi">10.1108/jstp-03-2023-0108</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei W, Liu L. Trustworthy distributed AI systems: robustness, privacy, and governance. ACM Comput. Surv. 2025;57(6):1&#x2013;42. doi: 10.1145/3645102. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3645102</ArticleId><ArticleId IdType="doi">10.1145/3645102</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Gao W, Wang Y, Shan X, Lin Y. Enhancing user experience and trust in advanced LLM-based conversational agents. Comput Artif Intell. 2024;2(2):1467. doi: 10.59400/cai.v2i2.1467. 
 
</Citation><ArticleIdList><ArticleId IdType="doi">10.59400/cai.v2i2.1467</ArticleId><ArticleId IdType="doi">10.59400/cai.v2i2.1467</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatherley JJ. Limits of trust in medical AI. J Med Ethics. 2020;46(7):478&#x2013;481. doi: 10.1136/medethics-2019-105935.medethics-2019-105935</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/medethics-2019-105935</ArticleId><ArticleId IdType="pubmed">32220870</ArticleId></ArticleIdList></Reference><Reference><Citation>Du D, Paluch R, Stevens G, M&#xfc;ller C. Exploring patient trust in clinical advice from AI-driven LLMs like ChatGPT for self-diagnosis. arXiv:2402.07920. 2024 doi: 10.48550/arXiv.2402.07920.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2402.07920</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismatullaev U, Kim SH. Review of the factors affecting acceptance of AI-infused systems. Hum Factors. 2024;66(1):126&#x2013;144. doi: 10.1177/00187208211064707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00187208211064707</ArticleId><ArticleId IdType="pubmed">35344676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">40311469</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0534</ISSN><JournalIssue CitedMedium="Internet"><Volume>192</Volume><Issue>Pt A</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Computers in biology and medicine</Title><ISOAbbreviation>Comput Biol Med</ISOAbbreviation></Journal><ArticleTitle>Enhancing clinical decision support with physiological waveforms - A multimodal benchmark in emergency care.</ArticleTitle><Pagination><StartPage>110196</StartPage><MedlinePgn>110196</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2025.110196</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0010-4825(25)00547-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">AI-driven prediction algorithms have the potential to enhance emergency medicine by enabling rapid and accurate decision-making regarding patient status and potential deterioration. However, the integration of multimodal data, including raw waveform signals, remains underexplored in clinical decision support.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We present a dataset and benchmarking protocol designed to advance multimodal decision support in emergency care. Our models utilize demographics, biometrics, vital signs, laboratory values, and electrocardiogram (ECG) waveforms as inputs to predict both discharge diagnoses and patient deterioration.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The diagnostic model achieves area under the receiver operating curve (AUROC) scores above 0.8 for 609 out of 1,428 conditions, covering both cardiac (e.g., myocardial infarction) and non-cardiac (e.g., renal disease, diabetes) diagnoses. The deterioration model attains AUROC scores above 0.8 for 14 out of 15 targets, accurately predicting critical events such as cardiac arrest, mechanical ventilation, ICU admission, and mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study highlights the positive impact of incorporating raw waveform data into decision support models, improving predictive performance. By introducing a unique, publicly available dataset and baseline models, we provide a foundation for measurable progress in AI-driven decision support for emergency care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alcaraz</LastName><ForeName>Juan Miguel Lopez</ForeName><Initials>JML</Initials><AffiliationInfo><Affiliation>AI4Health Division, Carl von Ossietzky Universit&#xe4;t Oldenburg, Ammerl&#xe4;nder Heerstra&#xdf;e 114-118, Oldenburg, 26129, Lower Saxony, Germany. Electronic address: juan.lopez.alcaraz@uol.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bouma</LastName><ForeName>Hjalmar</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Department of Acute Care, and Department of Clinical Pharmacy &amp; Pharmacology, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713, Groningen, Netherlands. Electronic address: h.r.bouma@umcg.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strodthoff</LastName><ForeName>Nils</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>AI4Health Division, Carl von Ossietzky Universit&#xe4;t Oldenburg, Ammerl&#xe4;nder Heerstra&#xdf;e 114-118, Oldenburg, 26129, Lower Saxony, Germany. Electronic address: nils.strodthoff@uol.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Biol Med</MedlineTA><NlmUniqueID>1250250</NlmUniqueID><ISSNLinking>0010-4825</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066264" MajorTopicYN="N">Datasets as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="N">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019985" MajorTopicYN="Y">Benchmarking</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057188" MajorTopicYN="N">Workflow</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015233" MajorTopicYN="N">Models, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Deep-learning</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Medical decision support</Keyword><Keyword MajorTopicYN="N">Multimodal data</Keyword><Keyword MajorTopicYN="N">Patient deterioration</Keyword><Keyword MajorTopicYN="N">Patient diagnostics</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>24</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>2</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>1</Day><Hour>18</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40311469</ArticleId><ArticleId IdType="doi">10.1016/j.compbiomed.2025.110196</ArticleId><ArticleId IdType="pii">S0010-4825(25)00547-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40278309</PMID><DateRevised><Year>2025</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence Detection of Occlusive Myocardial Infarction from Electrocardiograms Interpreted as "Normal" by Conventional Algorithms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">130</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm15040130</ELocationID><Abstract><AbstractText><b>Background</b>: Some authors advocate that ECGs with conventional computer algorithm (CCA) interpretations of "normal" need not be immediately reviewed. However, such ECGs may actually manifest findings of acute coronary occlusion myocardial infarction (OMI). We sought to determine if such cases can be detected by artificial intelligence (AI). <b>Methods</b>: We studied a retrospective series (2014-2024) of cases with &#x2265;1 pre-angiography ECGs with a proven OMI outcome with a CCA ECG interpretation of "normal". The OMI outcome was defined as (1) the diagnosis of acute type I MI, (2) an angiographic culprit with intervention, and (3) one of the following, (a) TIMI-0-2 flow, or (b) TIMI-3 or unknown flow, with high peak troponin or new wall abnormality. Each ECG as retrospectively interpreted by the PMcardio OMI AI ECG model. The primary analysis was the performance of AI in diagnosing "OMI" among these CCA "normal" ECGs. <b>Results</b>: Forty-two patients with OMI met the inclusion criteria. The first ECG was interpreted as "normal" by the CCA in 88% of cases; AI interpreted 81% as OMI and 86% as abnormal. Of the 78 total ECGs interpreted by the CCA, 73% were diagnosed as "normal". Of this 73%, AI identified 81% as abnormal and 72% as OMI. <b>Conclusion</b>: The Conventional Computer Algorithm may interpret an ECG manifesting OMI as "normal". AI not only recognized these as abnormal, but in 81% of patients, correctly recognized OMI on the first ECG and recognized 72% of all the CCA "normal" ECGs as OMI. It was rare for AI to diagnose a normal ECG for any OMI patient.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karim</LastName><ForeName>Shifa R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Baylor University, Waco, TX 76798, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helseth</LastName><ForeName>Hans C</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0009-0005-3282-9504</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Abbott Northwestern Hospital, Minneapolis, MN 55407, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Peter O</ForeName><Initials>PO</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keller</LastName><ForeName>Gabriel A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Hennepin EMS, Hennepin Healthcare, Minneapolis, MN 55415, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><Identifier Source="ORCID">0000-0001-7484-2022</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC 28203, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-8773-1732</Identifier><AffiliationInfo><Affiliation>Powerful Medical, New York, NY 10011, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, MN 55415, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">EKG</Keyword><Keyword MajorTopicYN="N">acute coronary occlusion</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">occlusion myocardial infarction</Keyword><Keyword MajorTopicYN="N">triage</Keyword></KeywordList><CoiStatement>Stephen Smith is a shareholder in Powerful Medical, has no other position in the company, and his only COI is being a shareholder. Stephen Smith conceived this study, designed this study, and was involved with data collection, data analysis, drafting, and editing this manuscript. Smith takes responsibility for this work as a whole. Pendell Meyers is a shareholder in Powerful Medical and employed by Powerful Medical as an &#x201c;ACS Pathway Lead&#x201d;. Meyers was involved with study design and drafting and editing this manuscript. Robert Herman is a shareholder in Powerful Medical and a Chief Medical Officer. Robert Herman was involved with study design and drafting and editing this manuscript. The company, Powerful Medical, played no role in this manuscript. All other contributing authors report no COIs.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>13</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>13</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>25</Day><Hour>10</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40278309</ArticleId><ArticleId IdType="pmc">PMC12028524</ArticleId><ArticleId IdType="doi">10.3390/jpm15040130</ArticleId><ArticleId IdType="pii">jpm15040130</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Writing Committee. Kontos M.C., de Lemos J.A., Deitelzweig S.B., Diercks D.B., Gore M.O., Hess E.P., McCarthy C.P., McCord J.K., Musey P.I., Jr., et al. 2022 ACC expert consensus decision pathway on the evaluation and disposition of acute chest pain in the emergency department: A report of the American college of cardiology solution set oversight committee. J. Am. Coll. Cardiol. 2022;80:1925&#x2013;1960. doi: 10.1016/j.jacc.2022.08.750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.08.750</ArticleId><ArticleId IdType="pmc">PMC10691881</ArticleId><ArticleId IdType="pubmed">36241466</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren J., de Alencar J.N., Aslanger E.K., Pendell Meyers H., Smith S.W. From ST-Segment Elevation MI to Occlusion MI: The New Paradigm Shift in Acute Myocardial Infarction. JACC Adv. 2024;3:101314. doi: 10.1016/j.jacadv.2024.101314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101314</ArticleId><ArticleId IdType="pmc">PMC11492056</ArticleId><ArticleId IdType="pubmed">39435181</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanger E.K., Meyers P.H., Smith S.W. STEMI: A transitional fossil in MI classification? J. Electrocardiol. 2021;65:163&#x2013;169. doi: 10.1016/j.jelectrocard.2021.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2021.02.001</ArticleId><ArticleId IdType="pubmed">33640636</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci F., Martini C., Scordo D.M., Rossi D., Gallina S., Fedorowski A., Sciarra L., Chahal C.A., Meyers H.P., Herman R. ECG Patterns of Occlusion Myocardial Infarction: A Narrative Review.  [(accessed on 5 January 2025)];2025 85:4:330&#x2013;340. Available online:  https://scholar.google.com/citations?view_op=view_citation&amp;hl=en&amp;citation_for_view=ZBKuiKwAAAAJ:-1WLWRmjvKAC.</Citation><ArticleIdList><ArticleId IdType="pubmed">39818676</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.W., Meyers H.P. ST Elevation is a poor surrogate for acute coronary occlusion. Let&#x2019;s Replace STEMI with Occlusion MI (OMI)!! Int. J. Cardiol. 2024;407:131980. doi: 10.1016/j.ijcard.2024.131980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2024.131980</ArticleId><ArticleId IdType="pubmed">38513733</ArticleId></ArticleIdList></Reference><Reference><Citation>Jollis J.G., Granger C.B., Z&#xe8;gre-Hemsey J.K., Henry T.D., Goyal A., Tamis-Holland J.E., Roettig M.L., Ali M.J., French W.J., Poudel R., et al. Treatment Time and In-Hospital Mortality Among Patients with ST-Segment Elevation Myocardial Infarction, 2018&#x2013;2021. JAMA. 2022;328:2033&#x2013;2040. doi: 10.1001/jama.2022.20149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.20149</ArticleId><ArticleId IdType="pmc">PMC9638953</ArticleId><ArticleId IdType="pubmed">36335474</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabner A., Jones M., Fakis A., Johnson G. Can an ECG performed during emergency department triage and interpreted as normal by computer analysis safely wait for clinician review until the time of patient assessment? A pilot study. J. Electrocardiol. 2021;68:145&#x2013;149. doi: 10.1016/j.jelectrocard.2021.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2021.08.006</ArticleId><ArticleId IdType="pubmed">34450449</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes K.E., Lewis S.M., Katz L., Jones J. Safety of computer interpretation of normal triage electrocardiograms. Acad. Emerg. Med. 2017;24:120&#x2013;124. doi: 10.1111/acem.13067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.13067</ArticleId><ArticleId IdType="pubmed">27519772</ArticleId></ArticleIdList></Reference><Reference><Citation>Deutsch A., Poroksy K., Westafer L., Visintainer P., Mader T. Validity of computer-interpreted &#x201c;normal&#x201d; and &#x201c;otherwise normal&#x201d; ECG in emergency department triage patients. West. J. Emerg. Med. 2024;25:3&#x2013;8. doi: 10.5811/WESTJEM.58464.</Citation><ArticleIdList><ArticleId IdType="doi">10.5811/WESTJEM.58464</ArticleId><ArticleId IdType="pmc">PMC10777178</ArticleId><ArticleId IdType="pubmed">38205978</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlois-Carbonneau V., Dufresne F., Labb&#xe9; &#xc8;., Hamelin K., Berbiche D., Gosselin S. Safety and accuracy of the computer interpretation of normal ECGs at triage. [(accessed on 5 January 2025)];Can. J. Emerg. Med. 2024 26:857&#x2013;864. doi: 10.1007/s43678-024-00790-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43678-024-00790-5</ArticleId><ArticleId IdType="pubmed">39548031</ArticleId></ArticleIdList></Reference><Reference><Citation>Noll S., Alvey H., Jayaprakash N., Paranjpe A., Miller J., Moyer M.L., Nowak R. The utility of the triage electrocardiogram for the detection of ST-segment elevation myocardial infarction. Am. J. Emerg. Med. 2018;36:1771&#x2013;1774. doi: 10.1016/j.ajem.2018.01.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2018.01.083</ArticleId><ArticleId IdType="pubmed">29548521</ArticleId></ArticleIdList></Reference><Reference><Citation>Litell J.M., Meyers H.P., Smith S.W. Emergency physicians should be shown all triage ECGs, even those with a computer interpretation of &#x201c;Normal&#x201d;. J. Electrocardiol. 2019;54:79&#x2013;81. doi: 10.1016/j.jelectrocard.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2019.03.003</ArticleId><ArticleId IdType="pubmed">30928822</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracey A., Meyers H.P., Smith S.W. Emergency physicians should interpret every triage ECG, including those with a computer interpretation of &#x201c;normal&#x201d;. Am. J. Emerg. Med. 2022;55:180&#x2013;182. doi: 10.1016/j.ajem.2022.03.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.03.022</ArticleId><ArticleId IdType="pubmed">35361516</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda D.F., Lobo A.S., Walsh B., Sandoval Y., Smith S.W. New Insights Into the Use of the 12-Lead Electrocardiogram for Diagnosing Acute Myocardial Infarction in the Emergency Department. Can. J. Cardiol. 2018;34:132&#x2013;145. doi: 10.1016/j.cjca.2017.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2017.11.011</ArticleId><ArticleId IdType="pubmed">29407007</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanger E.K., Meyers H.P., Smith S.W. Recognizing electrocardiographically subtle occlusion myocardial infarction and differentiating it from mimics: Ten steps to or away from cath lab. Arch. Turk. Soc. Cardiol. 2021;49:488&#x2013;500. doi: 10.5543/tkda.2021.21026.</Citation><ArticleIdList><ArticleId IdType="doi">10.5543/tkda.2021.21026</ArticleId><ArticleId IdType="pubmed">34523597</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers H.P., Bracey A., Lee D., Lichtenheld A., Li W.J., Singer D.D., Rollins Z., Kane J.A., Dodd K.W., Meyers K.E., et al. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction. Int. J. Cardiol. Heart Vasc. 2021;33:100767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8065286</ArticleId><ArticleId IdType="pubmed">33912650</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaren J.T.T., Meyers H.P., Smith S.W., Chartier L.B. Emergency department Code STEMI patients with initial electrocardiogram labeled &#x201c;normal&#x201d; by computer interpretation: A 7-year retrospective review. Acad. Emerg. Med. 2023;31:296&#x2013;300. doi: 10.1111/acem.14795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acem.14795</ArticleId><ArticleId IdType="pubmed">37620163</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.W. Dr. Smith&#x2019;s ECG Blog. 2008&#x2013;2025.  [(accessed on 31 December 2024)].  Available online:  https://hqmeded-ecg.blogspot.com/</Citation></Reference><Reference><Citation>Al-Zaiti S.S., Martin-Gill C., Z&#xe8;gre-Hemsey J.K., Bouzid Z., Faramand Z., Alrawashdeh M.O., Gregg R.E., Helman S., Riek N.T., Kraevsky-Phillips K., et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat. Med. 2023;29:1804&#x2013;1813. doi: 10.1038/s41591-023-02396-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02396-3</ArticleId><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti S., Macleod R., Van Dam P., Smith S.W., Birnbaum Y. Emerging ECG methods for acute coronary syndrome detection: Recommendations &amp; future opportunities. J. Electrocardiol. 2022;74:65&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11867304</ArticleId><ArticleId IdType="pubmed">36027675</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman R., Meyers H.P., Smith S.W., Bertolone D.T., Leone A., Bermpeis K., Viscusi M.M., Belmonte M., Demolder A., Boza V., et al. International evaluation of an artificial intelligence-powered ecg model detecting acute coronary occlusion myocardial infarction. Eur. Heart J. Digit. Health. 2023;5:123&#x2013;133. doi: 10.1093/ehjdh/ztad074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztad074</ArticleId><ArticleId IdType="pmc">PMC10944682</ArticleId><ArticleId IdType="pubmed">38505483</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Kashou A.H., Herman R., Smith S., May A., Echeverri A.G., Del Sueldo M., Berni A.C., Farina J., Garcia-Zamora S., et al. Computer-Interpreted Electrocardiograms: Impact on Cardiology Practice. Int. J. Cardiovasc. Sci. 2024;37:e20240079. doi: 10.36660/ijcs.20240079.</Citation><ArticleIdList><ArticleId IdType="doi">10.36660/ijcs.20240079</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodd K.W., Zvosec D.L., Hart M.A., Glass I.I.I.G., Bannister L.E., Body R.M., Boggust B.A., Brady W.J., Chang A.M., Cullen L., et al. Electrocardiographic Diagnosis of Acute Coronary Occlusion Myocardial Infarction in Ventricular Paced Rhythm Using the Modified Sgarbossa Criteria. Ann. Emerg. Med. 2021;78:517&#x2013;529. doi: 10.1016/j.annemergmed.2021.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2021.03.036</ArticleId><ArticleId IdType="pubmed">34172301</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers H.P., Limkakeng Jr A.T., Jaffa E.J., Patel A., Theiling B.J., Rezaie S.R., Stewart T., Zhuang C., Pera V.K., Smith S.W. Validation of the modified Sgarbossa criteria for acute coronary occlusion in the setting of left bundle branch block: A retrospective case-control study. Am. Heart J. 2015;170:1255&#x2013;1264. doi: 10.1016/j.ahj.2015.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2015.09.005</ArticleId><ArticleId IdType="pubmed">26678648</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.W., Dodd K.W., Henry T.D., Dvorak D.M., Pearce L.A. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann. Emerg. Med. 2012;60:766&#x2013;776. doi: 10.1016/j.annemergmed.2012.07.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2012.07.119</ArticleId><ArticleId IdType="pubmed">22939607</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslanger E.K., Y&#x131;ld&#x131;r&#x131;mt&#xfc;rk &#xd6;., &#x15e;im&#x15f;ek B., Bozbeyo&#x11f;lu E., &#x15e;im&#x15f;ek M.A., Karabay C.Y., Smith S.W., De&#x11f;ertekin M. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study) Int. J. Cardiol. Heart Vasc. 2020;30:100603. doi: 10.1016/j.ijcha.2020.100603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcha.2020.100603</ArticleId><ArticleId IdType="pmc">PMC7399112</ArticleId><ArticleId IdType="pubmed">32775606</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., Chaitman B.R., Bax J.J., Morrow D.A., White H.D. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018) Rev. Esp. Cardiol. 2019;72:72.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M.D., Wolf S.J., Byyny R., Diercks D.B., Gemme S.R., Gerardo C.J., Godwin S.A., Hahn S.A., Harrison N.E., Hatten B.W., et al. Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department Patients With Suspected Non&#x2013;ST-Elevation Acute Coronary Syndromes. Ann. Emerg. Med. 2018;72:e65&#x2013;e106.</Citation><ArticleIdList><ArticleId IdType="pubmed">30342745</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey J.L., Zegre-Hemsey J., Gregg R.E., Studnek J.R. Electrocardiographic diagnosis of ST segment elevation myocardial infarction: An evaluation of three automated interpretation algorithms. J. Electrocardiol. 2016;49:728&#x2013;732. doi: 10.1016/j.jelectrocard.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2016.04.010</ArticleId><ArticleId IdType="pmc">PMC5613667</ArticleId><ArticleId IdType="pubmed">27181187</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alencar Neto J.N., Scheffer M.K., Correia B.P., Franchini K.G., Felicioni S.P., De Marchi M.F.N. Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion. Int. J. Cardiol. 2024;402:131889. doi: 10.1016/j.ijcard.2024.131889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2024.131889</ArticleId><ArticleId IdType="pubmed">38382857</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S.S., Aday A.W., Almarzooq Z.I., Anderson C.A., Arora P., Avery C.L., Baker-Smith C.M., Barone Gibbs B., Beaton A.Z., Boehme A.K., et al. 2024 Heart Disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation. 2024;149:e347&#x2013;e913.</Citation><ArticleIdList><ArticleId IdType="pubmed">38264914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C.S., Chen Y.H., Huang C.C., Lin M.S., Yeh C.F., Li H.Y., Kao H.L. Prevalence and outcome of patients with non-ST segment elevation myocardial infarction with occluded &#x201c;culprit&#x201d; artery&#x2014;A systemic review and meta-analysis. Crit. Care. 2018;22:34. doi: 10.1186/s13054-018-1944-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-1944-x</ArticleId><ArticleId IdType="pmc">PMC5806289</ArticleId><ArticleId IdType="pubmed">29422071</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch R.D., Zalenski R.J., Frederick P.D., Malmgren J.A., Compton S., Grzybowski M., Thomas S., Kowalenko T., Every N.R., National Registry of Myocardial Infarction 2 Prognostic value of a normal or nonspecific initial electrocardiogram in acute myocardial infarction. JAMA. 2001;286:1977&#x2013;1984.</Citation><ArticleIdList><ArticleId IdType="pubmed">11667934</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker P.O., Karim S.R., Smith S.W., Meyers H.P., Robinson A.E., Ibtida I., Karim R.M., Keller G.A., Royce K.A., Puskarich M.A. Artificial intelligence driven prehospital ECG interpretation for the reduction of false positive emergent cardiac catheterization lab activations: A retrospective cohort study.  [(accessed on 5 January 2025)];Prehosp Emerg. Care. 2024 :1&#x2013;9. Available online:  https://scholar.google.com/citations?view_op=view_citation&amp;hl=en&amp;citation_for_view=ZBKuiKwAAAAJ:pqufTfZDgs0C.</Citation><ArticleIdList><ArticleId IdType="pubmed">39235330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontos M.C., Kurz M.C., Roberts C.S., Joyner S.E., Kreisa L., Ornato J.P., Vetrovec G.W. An Evaluation of the Accuracy of Emergency Physician Activation of the Cardiac Catheterization Laboratory for Patients with Suspected ST-Segment Elevation Myocardial Infarction. Ann. Emerg. Med. 2010;55:423&#x2013;430. doi: 10.1016/j.annemergmed.2009.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2009.08.011</ArticleId><ArticleId IdType="pubmed">19767126</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson D.M., Menssen K.M., Sharkey S.W., Duval S., Schwartz R.S., Harris J., Meland J.T., Unger B.T., Henry T.D. &#x201c;False-Positive&#x201d; Cardiac Catheterization Laboratory Activation Among Patients with Suspected ST-Segment Elevation Myocardial Infarction. JAMA. 2007;298:2754&#x2013;2760.</Citation><ArticleIdList><ArticleId IdType="pubmed">18165668</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe J.M., Armstrong E.J., Kulkarni A., Hoffmayer K.S., Bhave P.D., Garg S., Patel A., MacGregor J.S., Hsue P., Stein J.C., et al. Prevalence and Factors Associated With False-Positive ST-Segment Elevation Myocardial Infarction Diagnoses at Primary Percutaneous Coronary Intervention-Capable Centers: A Report From the Activate-SF Registry. Arch. Intern. Med. 2012;172:864&#x2013;871. doi: 10.1001/archinternmed.2012.945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2012.945</ArticleId><ArticleId IdType="pubmed">22566489</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvey J.L., Monk L., Granger C.B., Studnek J.R., Roettig M.L., Corbett C.C., Jollis J.G. Rates of Cardiac Catheterization Cancelation for ST-Segment Elevation Myocardial Infarction After Activation by Emergency Medical Services or Emergency Physicians. Circulation. 2012;125:308&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">22147904</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey S., Herman R., Larson D., Henry T.D., Aguirre F., Murthy A., Rohm H., Smith S.W., Yildiz M., Belzer W. Performance of Artificial Intelligence Powered ECG Analysis in Suspected ST-Segment Elevation Myocardial Infarction.  [(accessed on 25 December 2024)].  Available online:  https://www.powerfulmedical.com/research/na/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40269099</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>A hybrid segmentation and classification CAD framework for automated myocardial infarction prediction from MRI images.</ArticleTitle><Pagination><StartPage>14196</StartPage><MedlinePgn>14196</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14196</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-98893-1</ELocationID><Abstract><AbstractText>Early diagnosis of myocardial infarction (MI) is critical for preserving cardiac function and improving patient outcomes through timely intervention. This study proposes an annovaitive computer-aided diagnosis (CAD) system for the simultaneous segmentation and classification of MI using MRI images. The system is evaluated under two primary approaches: a serial approach, where segmentation is first applied to extract image patches for subsequent classification, and a parallel approach, where segmentation and classification are performed concurrently using full MRI images. The multi-class segmentation model identifies four key heart regions: left ventricular cavity (LV), normal myocardium (Myo), myocardial infarction (MI), and persistent microvascular obstruction (MVO). The classification stage employs three AI-based strategies: a single deep learning model, feature-based fusion of multiple AI models, and a hybrid ensemble model incorporating the Vision Transformer (ViT). Both segmentation and classification models are trained and validated on the EMIDEC MRI dataset using five-fold cross-validation. The adopted ResU-Net achieves high F1-scores for segmentation: 91.12% (LV), 88.39% (Myo), 80.08% (MI), and 68.01% (MVO). For classification, the hybrid CNN-ViT model in the parallel approach demonstrates superior performance, achieving 98.15% accuracy and a 98.63% F1-score. These findings highlight the potential of the proposed CAD system for real-world clinical applications, offering a robust tool to assist healthcare professionals in accurate MI diagnosis, improved treatment planning, and enhanced patient care.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Al-Antari</LastName><ForeName>Mugahed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence and Data Science, College of AI Convergence, Daeyang AI Center, Sejong University, Seoul, 05006, Korea. en.mualshz@sejong.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Tam</LastName><ForeName>Riyadh M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>School of Computational Sciences, Swami Ramanand Teerth Marathwada University, Nanded, 431606, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Hejri</LastName><ForeName>Aymen M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>School of Computational Sciences, Swami Ramanand Teerth Marathwada University, Nanded, 431606, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Huda</LastName><ForeName>Zaid</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Stirling College, Chengdu University, Chengdu, 610106, P. R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Soojeong</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Engineering, College of AI Convergence, Daeyang AI Center, Sejong University, Seoul, 05006, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;ld&#x131;r&#x131;m</LastName><ForeName>&#xd6;zal</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Software Engineering, Technology Faculty, F&#x131;rat University, Elaz&#x131;&#x11f;, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Gu</LastName><ForeName>Yeong Hyeon</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Artificial Intelligence and Data Science, College of AI Convergence, Daeyang AI Center, Sejong University, Seoul, 05006, Korea. yhgu@sejong.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RS-2022-00166402 and RS-2023-00256517</GrantID><Agency>National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)</Agency><Country/></Grant><Grant><GrantID>1711160571</GrantID><Agency>Information and Communications Technology Planning and Evaluation (IITP) grant funded by the Korean government (MSIT)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="N">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003936" MajorTopicYN="Y">Diagnosis, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="Y">Image Processing, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="Y">Image Interpretation, Computer-Assisted</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Classification</Keyword><Keyword MajorTopicYN="N">Computer-Aided diagnosis</Keyword><Keyword MajorTopicYN="N">Ensemble fusion learning</Keyword><Keyword MajorTopicYN="N">Heart diseases</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Segmentation</Keyword><Keyword MajorTopicYN="N">Visual explainable saliency maps</Keyword></KeywordList><CoiStatement>Declarations. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>24</Day><Hour>0</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40269099</ArticleId><ArticleId IdType="pmc">PMC12019538</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-98893-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-98893-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Attallah, O. &amp; Ragab, D. A. Auto-MyIn: automatic diagnosis of myocardial infarction via multiple GLCMs, CNNs, and SVMs. Biomed. Signal Process. Control. 80, 104273 (2023).</Citation></Reference><Reference><Citation>Lalande, A. et al. Emidec: a database usable for the automatic evaluation of myocardial infarction from delayed-enhancement cardiac MRI. Data. 5, 89 (2020).</Citation></Reference><Reference><Citation>Florian, M. et al. Interplay of obesity, ethanol, and contaminant mixture on clinical profiles of cardiovascular and metabolic diseases: evidence from an animal study. Cardiovasc. Toxicol.22, 558&#x2013;578 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107407</ArticleId><ArticleId IdType="pubmed">35429258</ArticleId></ArticleIdList></Reference><Reference><Citation>Motevalli, M. M., Sohrabi, M. K. &amp; Yaghmaee, F. Aspect-based sentiment analysis: A dual-task learning architecture using imbalanced maximized-area under the curve proximate support vector machine and reinforcement learning. Inf. Sci.689, 121449 (2025).</Citation></Reference><Reference><Citation>Ronneberger, O., Fischer, P. &amp; Brox, T. U-net: Convolutional networks for biomedical image segmentation, in Medical Image Computing and Computer-Assisted Intervention&#x2013;MICCAI 2015: 18th International Conference, Munich, Germany, October 5&#x2013;9, Proceedings, Part III 18, 2015, pp. 234&#x2013;241. (2015).</Citation></Reference><Reference><Citation>Chen, J. et al. Transunet: Transformers make strong encoders for medical image segmentation. arXiv preprint arXiv:2102.04306, (2021).</Citation></Reference><Reference><Citation>Khan, A. et al. A survey of the vision Transformers and their CNN-transformer based variants. Artif. Intell. Rev.56, 2917&#x2013;2970 (2023).</Citation></Reference><Reference><Citation>Takahashi, S. et al. Comparison of vision Transformers and convolutional neural networks in medical image analysis: a systematic review. J. Med. Syst.48, 84 (2024).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11393140</ArticleId><ArticleId IdType="pubmed">39264388</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hejri, A. M. et al. ETECADx: Ensemble Self-Attention Transformer Encoder for Breast Cancer Diagnosis Using Full-Field Digital X-ray Breast Images. Diagnostics. 13, 89 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9818801</ArticleId><ArticleId IdType="pubmed">36611382</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Tam, R. M. et al. A Hybrid Workflow of Residual Convolutional Transformer Encoder for Breast Cancer Classification Using Digital X-ray Mammograms. Biomedicines. 10, 2971 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9687367</ArticleId><ArticleId IdType="pubmed">36428538</ArticleId></ArticleIdList></Reference><Reference><Citation>Addo, D. et al. A hybrid lightweight breast cancer classification framework using the histopathological images. Biocybernetics Biomedical Eng.44, 31&#x2013;54 (2024).</Citation></Reference><Reference><Citation>Kosmala, W., Sanders, P. &amp; Marwick, T. H. Subclinical myocardial impairment in metabolic diseases. JACC: Cardiovasc. Imaging. 10, 692&#x2013;703 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28595844</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, S., Ge, Y., Singh, A., Gr&#xe4;ni, C. &amp; Kwong, R. Y. Multimodality Imaging Assess. Myocard. Fibros. Cardiovasc. Imaging, 14, 2457&#x2013;2469, (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34023250</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, Y. &amp; Jung, C. Automatic cardiac MRI segmentation and permutation-invariant pathology classification using deep neural networks and point clouds, Neurocomputing, vol. 418, pp. 270&#x2013;279, (2020).</Citation></Reference><Reference><Citation>Vesal, S., Maier, A. &amp; Ravikumar, N. Fully automated 3d cardiac mri localisation and segmentation using deep neural networks. J. Imaging. 6, 65 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8321054</ArticleId><ArticleId IdType="pubmed">34460658</ArticleId></ArticleIdList></Reference><Reference><Citation>Girum, K. B. et al. Automatic myocardial infarction evaluation from delayed-enhancement cardiac MRI using deep convolutional networks, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 378&#x2013;384. (2020).</Citation></Reference><Reference><Citation>Bhan, A., Mangipudi, P. &amp; Goyal, A. Deep Learning Approach for Automatic Segmentation and Functional Assessment of LV in Cardiac MRI. Electronics. 11, 3594 (2022).</Citation></Reference><Reference><Citation>Poudel, R. P., Lamata, P. &amp; Montana, G. Recurrent fully convolutional neural networks for multi-slice MRI cardiac segmentation, in Reconstruction, Segmentation, and Analysis of Medical Images: First International Workshops, RAMBO 2016 and HVSMR 2016, Held in Conjunction with MICCAI 2016, Athens, Greece, October 17, Revised Selected Papers 1, 2017, pp. 83&#x2013;94. (2016).</Citation></Reference><Reference><Citation>Saito, K., Zhao, Y. &amp; Zhong, J. Heart diseases image classification based on convolutional neural network, in International Conference on Computational Science and Computational Intelligence (CSCI), 2019, pp. 930&#x2013;935. (2019).</Citation></Reference><Reference><Citation>Zhang, Y. Cascaded convolutional neural network for automatic myocardial infarction segmentation from delayed-enhancement cardiac MRI, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 328&#x2013;333. (2020).</Citation></Reference><Reference><Citation>Shaaf, Z. F., Jamil, M. M. A. &amp; Ambar, R. A convolutional neural network model to segment myocardial infarction from MRI images. Int. J. Online Biomedical Eng.19, (2023).</Citation></Reference><Reference><Citation>Brahim, K. et al. A 3D network based shape prior for automatic myocardial disease segmentation in delayed-enhancement MRI. IRBM. 42, 424&#x2013;434 (2021).</Citation></Reference><Reference><Citation>Li, W., Wang, L., Li, F., Qin, S. &amp; Xiao, B. Myocardial pathology segmentation of multi-modal cardiac MR images with a simple but efficient Siamese U-shaped network. Biomed. Signal Process. Control. 71, 103174 (2022).</Citation></Reference><Reference><Citation>Chen, Z. et al. Automatic deep learning-based myocardial infarction segmentation from delayed enhancement MRI. Comput. Med. Imaging Graph.95, 102014 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34864579</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidenreich, J. F., Gassenmaier, T., Ankenbrand, M. J., Bley, T. A. &amp; Wech, T. Self-configuring nnU-net pipeline enables fully automatic infarct segmentation in late enhancement MRI after myocardial infarction. Eur. J. Radiol.141, 109817 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34144308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Z. et al. Multi-modality pathology segmentation framework: application to cardiac magnetic resonance images, in Myocardial Pathology Segmentation Combining Multi-Sequence Cardiac Magnetic Resonance Images: First Challenge, MyoPS 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, 2020, Proceedings 1, pp. 37&#x2013;48. (2020).</Citation></Reference><Reference><Citation>Yang, S. &amp; Wang, X. A hybrid network for automatic myocardial infarction segmentation in delayed enhancement-mri, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 351&#x2013;358. (2020).</Citation></Reference><Reference><Citation>Zhou, Y., Zhang, K., Luo, X., Wang, S. &amp; Zhuang, X. Anatomy prior based u-net for pathology segmentation with attention, in International Workshop on Statistical Atlases and Computational Models of the Heart, pp. 392&#x2013;399. (2020).</Citation></Reference><Reference><Citation>Huellebrand, M. et al. Comparison of a hybrid mixture model and a cnn for the segmentation of myocardial pathologies in delayed enhancement MRI, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 319&#x2013;327. (2020).</Citation></Reference><Reference><Citation>Huellebrand, M., Ivantsits, M., Tautz, L., Kelle, S. &amp; Hennemuth, A. A collaborative approach for the development and application of machine learning solutions for CMR-based cardiac disease classification. Front. Cardiovasc. Med.9, 829512 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8960112</ArticleId><ArticleId IdType="pubmed">35360025</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi, J., Chen, Z. &amp; Couturier, R. Classification of pathological cases of myocardial infarction using convolutional neural network and random forest, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 406&#x2013;413. (2020).</Citation></Reference><Reference><Citation>Isensee, F. et al. Automatic cardiac disease assessment on cine-MRI via time-series segmentation and domain specific features, in Statistical Atlases and Computational Models of the Heart. ACDC and MMWHS Challenges: 8th International Workshop, STACOM 2017, Held in Conjunction with MICCAI 2017, Quebec City, Canada, September 10&#x2013;14, Revised Selected Papers 8, 2018, pp. 120&#x2013;129. (2017).</Citation></Reference><Reference><Citation>Louren&#xe7;o, A. et al. Automatic myocardial disease prediction from delayed-enhancement cardiac MRI and clinical information, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 334&#x2013;341. (2020).</Citation></Reference><Reference><Citation>Brahim, K. et al. An Improved 3D Deep Learning-Based Segmentation of Left Ventricular Myocardial Diseases from Delayed-Enhancement MRI with Inclusion and Classification Prior Information U-Net (ICPIU-Net), Sensors, vol. 22, p. 2022. (2084).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8954140</ArticleId><ArticleId IdType="pubmed">35336258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukwuoma, C. C. et al. A Hybrid Explainable Ensemble Transformer Encoder for Pneumonia Identification from Chest X-ray Images. J. Adv. Res., (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10248870</ArticleId><ArticleId IdType="pubmed">36084812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukwuoma, C. C. et al. Deep Learning Framework for Rapid and Accurate Respiratory COVID-19 Prediction Using Chest X-ray Images. J. King Saud University-Computer Inform. Sci., 101596 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10211254</ArticleId><ArticleId IdType="pubmed">37275558</ArticleId></ArticleIdList></Reference><Reference><Citation>Elmannai, H. et al. Diagnosis Myocardial Infarction Based on Stacking Ensemble of Convolutional Neural Network. Electronics. 11, 3976 (2022).</Citation></Reference><Reference><Citation>Al-Haidri, W. et al. Deep learning-assisted framework for automation of lumbar vertebral body segmentation, measurement, and deformity detection in MR images. Biomed. Signal Process. Control. 106, 107770 (2025).</Citation></Reference><Reference><Citation>Moravvej, S. V. et al. RLMD-PA: a reinforcement learning&#x2010;based myocarditis diagnosis combined with a population&#x2010;based algorithm for pretraining weights. Contrast Media &amp; Molecular Imaging. vol. p. 8733632, 2022. (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262570</ArticleId><ArticleId IdType="pubmed">35833074</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D. et al. Multi-parametric assessment of cardiac magnetic resonance images to distinguish myocardial infarctions: A tensor-based radiomics feature. J. X-Ray Sci. Technol.32, 735&#x2013;749 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38217635</ArticleId></ArticleIdList></Reference><Reference><Citation>D. W. A. David gunning, DARPA&#x2019;s explainable artificial intelligence program. AI Mag. 40, p. 44, (2019).</Citation></Reference><Reference><Citation>Brunese, L., Mercaldo, F., Reginelli, A. &amp; Santone, A. Explainable deep learning for pulmonary disease and coronavirus COVID-19 detection from X-rays. Comput. Methods Programs Biomed.196, 105608 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831868</ArticleId><ArticleId IdType="pubmed">32599338</ArticleId></ArticleIdList></Reference><Reference><Citation>You, C., Zhou, Y., Zhao, R., Staib, L. &amp; Duncan, J. S. Simcvd: simple contrastive voxel-wise representation distillation for semi-supervised medical image segmentation. IEEE Trans. Med. Imaging, (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10325835</ArticleId><ArticleId IdType="pubmed">35320095</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Antari, M. A., Al-Masni, M. A., Choi, M. T., Han, S. M. &amp; Kim, T. S. A fully integrated computer-aided diagnosis system for digital X-ray mammograms via deep learning detection, segmentation, and classification. Int. J. Med. Informatics. 117, 44&#x2013;54 (Sep 2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30032964</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Masni, M. A. et al. Simultaneous detection and classification of breast masses in digital mammograms via a deep learning YOLO-based CAD system. Comput. Methods Programs Biomed.157, 85&#x2013;94 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29477437</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-antari, P. R. M. A. et al. An Automatic Recognition of Multi-class Skin Lesions Via Deep Learning Convolutional Neural Networks, Presented at the ISIC 2018 (Skin Lesion Analysis Towards Melanoma Detection, 2018).</Citation></Reference><Reference><Citation>Al-Masni, M. A., Al-Antari, M. A., Choi, M. T., Han, S. M. &amp; Kim, T. S. Skin lesion segmentation in dermoscopy images via deep full resolution convolutional networks. Comput. Methods Programs Biomed.162, 221&#x2013;231 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29903489</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, C. &amp; Shi, L. ML&#x2013;ResNet: A novel network to detect and locate myocardial infarction using 12 leads ECG. Computer methods and programs in biomedicine, 185, 105138 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31669959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnam, S. K. R., Sistla, V. &amp; Kolli, V. K. K. Multimodal attention-gated cascaded U-Net model for automatic brain tumor detection and segmentation. Biomed. Signal Process. Control. 78, 103907 (2022).</Citation></Reference><Reference><Citation>Raza, R., Bajwa, U. I., Mehmood, Y., Anwar, M. W. &amp; Jamal, M. H. dResU-Net: 3D deep residual U-Net based brain tumor segmentation from multimodal MRI. Biomed. Signal Process. Control. 79, 103861 (2023).</Citation></Reference><Reference><Citation>Abdelhamed, M. K. &amp; Meriaudeau, F. NesT UNet: pure transformer segmentation network with an application for automatic cardiac myocardial infarction evaluation, in Medical Imaging 2023: Computer-Aided Diagnosis, pp. 608&#x2013;619. (2023).</Citation></Reference><Reference><Citation>Li, L. et al. MyoPS: A benchmark of myocardial pathology segmentation combining three-sequence cardiac magnetic resonance images. Med. Image. Anal.87, 102808 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37087838</ArticleId></ArticleIdList></Reference><Reference><Citation>Shamshad, F. et al. Transformers in Medical Imaging: A Survey. arXiv preprint arXiv:2201.09873, (2022).</Citation></Reference><Reference><Citation>Saied Salem, A. S., Elbadawy, R., Mukhlis, E., B&#xfc;t&#xfc;n &amp; Al-Antari, M. A. Artificial Intelligence Segmentation Framework for Identifying Significant Pathological Areas Causing Lumbar Spinal Stenosis, presented at the International conferences on Engineering and Natural Science, Republic of Korea (Jeju), (2024).</Citation></Reference><Reference><Citation>Salem, S. et al. A Novel AI-based Hybrid Ensemble Segmentation CAD System for Lumber Spine Stenosis pathological Regions Using MRI Axial Images, in 2024 8th International Artificial Intelligence and Data Processing Symposium (IDAP), pp. 1&#x2013;5. (2024).</Citation></Reference><Reference><Citation>Anaam, A., Al-antari, M. A. &amp; Gofuku, A. A deep learning self-attention cross residual network with Info-WGANGP for mitotic cell identification in HEp-2 medical microscopic images. Biomed. Signal Process. Control. 86, 105191 (2023).</Citation></Reference><Reference><Citation>Yang, J. et al. MedMNIST v2-A large-scale lightweight benchmark for 2D and 3D biomedical image classification. Sci. Data. 10, 41 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9852451</ArticleId><ArticleId IdType="pubmed">36658144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukwuoma, C. C. et al. A hybrid explainable ensemble transformer encoder for pneumonia identification from chest X-ray images. Journal of Advanced Research. 48, 191&#x2013;211 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10248870</ArticleId><ArticleId IdType="pubmed">36084812</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, R., Eick, C. F. &amp; Tsekos, N. V. Sm2n2: A stacked architecture for multimodal data and its application to myocardial infarction detection, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 342&#x2013;350. (2020).</Citation></Reference><Reference><Citation>Ivantsits, M. et al. Deep-learning-based myocardial pathology detection, in Statistical Atlases and Computational Models of the Heart. M&amp;Ms and EMIDEC Challenges: 11th International Workshop, STACOM 2020, Held in Conjunction with MICCAI 2020, Lima, Peru, October 4, Revised Selected Papers 11, 2021, pp. 369&#x2013;377. (2020).</Citation></Reference><Reference><Citation>Hadamitzky, M. et al. AI-based myocardial segmentation and cardiac disease classification using multi-sequence cardiac MRI. J. Cardiovasc. Magn. Reson.27, (2025).</Citation></Reference><Reference><Citation>Zhang, K. et al. BiomedGPT: A Unified and Generalist Biomedical Generative Pre-trained Transformer for Vision, Language, and Multimodal Tasks. arXiv preprint arXiv:2305.17100, (2023).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40288083</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels.</ArticleTitle><Pagination><StartPage>101727</StartPage><MedlinePgn>101727</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101727</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.101727</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00144-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The AEGIS-II (ApoA-I Event Reducing in Ischemic Syndromes-II; NCT03473223) trial evaluated CSL112, a human plasma-derived apolipoprotein A-I therapy, for reducing cardiovascular events after acute myocardial infarction (AMI). Given CSL112's potential anti-inflammatory properties, we conducted an exploratory post hoc analysis to determine if its efficacy is influenced by baseline neutrophil-lymphocyte ratio (NLR), a marker of systemic inflammation, and low-density lipoprotein cholesterol (LDL-C).</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to investigate the association of baseline NLR and cardiovascular events and explore whether NLR and LDL-C modify CSL112's efficacy in post-AMI patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 18,219 participants with AMI, multivessel coronary artery disease, and additional cardiovascular risk factors were randomized to 4 weekly infusions of 6 g CSL112 or placebo. The primary endpoint was a composite of cardiovascular death, myocardial infarction, or stroke (major adverse cardiovascular events [MACE]). Cox proportional hazards models evaluated risk by dichotomized baseline NLR (&gt;median vs &#x2264;median). Treatment interactions with NLR and LDL-C (&#x2265;100 vs &lt;100 mg/dL) were assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 15,966 participants, those with baseline NLR &gt;median (&gt;3.3) had a significantly greater risk of MACE at 90 days (HR: 1.40; 95% CI: 1.21-1.63), persisting at 180 and 365 days. CSL112 reduced MACE at 90 days among participants with elevated NLR and LDL-C &#x2265;100 mg/dL (HR: 0.63; 95% CI: 0.42-0.93), with sustained benefits at 180 and 365 days. Significant interactions were observed between treatment and NLR (P<sub>interaction</sub> = 0.010) and among treatment, NLR, and LDL-C at 180 days (P<sub>interaction</sub> = 0.029).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Baseline elevated NLR predicts MACE in post-AMI patients, and CSL112 showed an associated reduction in MACE in patients with elevated NLR and LDL-C &#x2265;100 mg/dL.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rikken</LastName><ForeName>Sem A O F</ForeName><Initials>SAOF</Initials><AffiliationInfo><Affiliation>Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Baim Institute for Clinical Research, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gibson</LastName><ForeName>C Michael</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: charlesmichaelgibson@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahit</LastName><ForeName>M Cecilia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; INECO Neurociencias Rosario, Rosario, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duffy</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>CSL Behring, King of Prussia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chi</LastName><ForeName>Gerald</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korjian</LastName><ForeName>Serge</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadnia</LastName><ForeName>Niekbachsh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>White</LastName><ForeName>Harvey</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Health New Zealand Te Toka Tumai Auckland City Hospital, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anschuetz</LastName><ForeName>Gaya</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CSL Behring, King of Prussia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kingwell</LastName><ForeName>Bronwyn A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>CSL Limited, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ophuis</LastName><ForeName>Ton Oude</ForeName><Initials>TO</Initials><AffiliationInfo><Affiliation>Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicolau</LastName><ForeName>Jose C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Renato D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Duke Clinical Research Institute, Duke Health, Durham, North Carolina, USA; Brazilian Clinical Research Institute, Sao Paulo, SP, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Basil S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Lady Davis Carmel Medical Center, Haifa, Israel; The Technion-Israel Institute of Technology, Haifa, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Messaoudi</LastName><ForeName>Saloua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinereanu</LastName><ForeName>Dragos</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ten Berg</LastName><ForeName>Jurri&#xeb;n M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, St. Antonius Hospital, Nieuwegein, the Netherlands; Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; Department of Cardiology, University Medical Center Maastricht, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Shaun G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada; St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada; Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bode</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Heart Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steg</LastName><ForeName>P Gabriel</ForeName><Initials>PG</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Universit&#xe9; Paris-Cit&#xe9;, INSERM U_1148, FACT and AP-HP, H&#xf4;pital Bichat, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Libby</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bainey</LastName><ForeName>Kevin R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Walter Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van 't Hof</LastName><ForeName>Arnoud W J</ForeName><Initials>AWJ</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands; University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania; Department of Cardiology, Zuyderland Medical Center, Heerlen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridker</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahaffey</LastName><ForeName>Kenneth W</ForeName><Initials>KW</Initials><AffiliationInfo><Affiliation>Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholls</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehran</LastName><ForeName>Roxana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, Zena and Michael A. Wiener Cardiovascular Institute, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrington</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Weill Cornell Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornel</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Baim Institute for Clinical Research, Boston, Massachusetts, USA; Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands; Noordwest Ziekenhuisgroep, Alkmaar, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>AEGIS-II Committees and Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>03</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CSL112</Keyword><Keyword MajorTopicYN="N">MACE</Keyword><Keyword MajorTopicYN="N">apolipoprotein A-I</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">neutrophil-lymphocyte ratio</Keyword></KeywordList><CoiStatement>Funding support and author disclosures This study was funded by CSL Behring. Dr Rikken has received speaking honoraria from Daiichi Sankyo. Dr Gibson has received research funding from CSL Behring, Janssen Pharmaceuticals, Johnson &amp; Johnson Corporation, and SCAD Alliance; has provided consulting services for Angel/Avertix Medical Corporation, AstraZeneca, Bayer Corporation, Beren Therapeutics, Boehringer Ingelheim, Boston Clinical Research Institute, Boston Scientific, Bristol Myers Squibb, Cardiovascular Research Foundation, CeleCor Therapeutics, CSL Behring, DCRI, Esperion, EXCITE International (for which no compensation was received), Fortress Biotech, Gilead Sciences, Janssen Pharmaceuticals, MashUp MD, MD Magazine, Microport, MJHealth, Novartis, Novo Nordisk, Pfizer, PHRI, PLxPharma, SCAI, Solstice Health/New Amsterdam Pharma, Somahlution/Marizyme, Vectura, WebMD, and Women as One; holds equity in nference, Dyad Medical, Absolutys, and Fortress Biotech; and has received royalties as a contributor to UpToDate. Dr Bahit has received modest honorarium from MSD, Pfizer, Bristol Myers Squibb, CSL Behring, Janssen, Boehringer Ingelheim, and Anthos Therapeutics. Dr Duffy is an employee of CSL Behring. Dr Chi has received research grant support paid to the Beth Israel Deaconess Medical Center, Harvard Medical School from Bayer, Janssen Scientific Affairs, and CSL Behring. Dr Korjian has received research grant support paid to the Beth Israel Deaconess Medical Center, Harvard Medical School from CSL Behring. Dr White has received grant support to institution from Sanofi, Regeneron Pharmaceuticals, Eli Lilly, Omthera Pharmaceuticals, American Regent, Eisai Inc, DalCor Pharma UK Inc, CSL Behring, NHI, Sanofi-Aventis Australia Pty Ltd, Esperion Therapeutics Inc, and National Institutes of Health; has received fees for serving on Steering Committees of the ODYSSEY trial from Sanofi and Regeneron Pharmaceuticals, the ISCHEMIA and the MINT studies from the National Institutes of Health, the STRENGTH trial from Omthera Pharmaceuticals, the HEART-FID study from American Regent, the DAL-GENE study from DalCor Pharma UK Inc, the AEGIS-II study from CSL Behring, the SCORED trial and the SOLOIST-WHF trial from Sanofi Australia Pty Ltd, and the CLEAR OUTCOMES study from Esperion Therapeutics. Dr Anschuetz has received a salary as an employee of CSL Behring. Dr Kingwell is an employee and shareholder of CSL Ltd. Dr Nicolau has received a scholarship from the National Council of Scientific and Technological Development (CNPq) #303448/2021-0; has received research grants from Amgen, AstraZeneca, Bayer, CSL Behring, Daiichi Sankyo, Dalcor, Esperion, Ionis, Janssen, Novartis, Novo Nordisk, Sanofi, and Vifor; and has received consulting fees from Libbs. Dr Lopes has received grant support from Amgen, Bristol Myers Squibb, GlaxoSmithKline, Medtronic, Pfizer, and Sanofi; has been a consultant for AstraZeneca, Bayer, Boehringer, Bristol Myers Squibb, and Novo Nordisk; and has participated in educational activities for Daiichi Sankyo, AstraZeneca, Novo Nordisk, and Pfizer. Dr Lewis has received consulting fees from Janssen R&amp;D and Idorsia. Dr Vinereanu has received research grants from CSL Behring, Bayer, Novartis, Amgen, and Boehringer Ingelheim; and has received consultancy fees from Bayer, Novartis, Amgen, and Boehringer Ingelheim. Dr ten Berg has received institutional research grants from AstraZeneca, Daiichi Sankyo, and ZonMw and personal fees from AstraZeneca, Bayer, Boehringer Ingelheim, CeleCor Therapeutics, and Daiichi Sankyo. Dr Goodman has received research grant support (eg, steering committee or data and safety monitoring committee) and/or speaker/consulting honoraria (eg, advisory boards) from Alnylam, Amgen, Anthos Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, CSL Behring, CYTE Ltd, Daiichi Sankyo/American Regent, Eli Lilly, Esperion, Ferring Pharmaceuticals, HLS Therapeutics, Idorsia, JAMP Pharma, Merck, Novartis, Novo Nordisk A/C, Pendopharm/Pharmascience, Pfizer, Regeneron, Roche, Sanofi, Servier, Tolmar Pharmaceuticals, Valeo Pharma; has received salary support/honoraria from the Canadian Heart Failure Society, Canadian Heart Research Centre and MD Primer, Canadian VIGOUR Centre, Cleveland Clinic Coordinating Centre for Clinical Research, Duke Clinical Research Institute, Jewish General Hospital\CIUSSS Centre-Ouest-de-l'Ile-de-Montreal, New York University Clinical Coordinating Centre, PERFUSE Research Institute, Peter Munk Cardiac Centre Clinical Trials and Translation Unit, Ted Rogers Centre for Heart Research, and TIMI Study Group (Brigham Health). Dr Bode has received research support from CSL Behring. Dr Steg has received research grants from Amarin and Sano; has served on clinical trials (steering committee, clinical events committee, data and safety monitoring board [DSMB]) for Amarin, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, CSL Behring, Idorsia, Janssen, Novartis, Novo Nordisk, Pfizer, and Sano; has served as a consultant or speaker for Amarin, Amgen, BMS, and Novo Nordisk; and is Senior Associate Editor at Circulation. Dr Libby has served on a scientific advisory board for Amgen, Kowa Pharmaceuticals, Novo Nordisk, Caristo, CSL Behring, DalCor, Dewpoint, Euclid Bioimaging, Xbiotech, Olatec, Medimmune, PlaqueTec, Polygon Therapeutics, TenSixteen Bio, and Soley Therapeutics; and has been a consultant for Amgen, Baim Institute Beren, Esperion, Genentech, Kancera, Kowa Pharmaceuticals, Novo Nordisk, Novartis, and Sanofi-Regeneron. Dr Bainey has received research support from CSL Behring. Dr van &#x2018;t Hof received a consultancy fee from CeleCor as well as unrestricted grants from Boehringer and Abbott Vascular. Dr Ridker has received institutional research grant support from Kowa, Novartis, Amarin, Pfizer, Esperion, Novo Nordisk, and the NHLBI; has served as a consultant to numerous companies including Novartis, Flame, Agepha, Ardelyx, Arrowhead, AstraZeneca, CSL Behring, Janssen, Civi Biopharm, GlaxoSmithKline, SOCAR, Novo Nordisk, Health Outlook, Montai Health, Eli Lilly, New Amsterdam, Boehringer Ingelheim, RTI, Zomagen, Cytokinetics, Horizon Therapeutics, and Cardio Therapeutics; holds minority shareholder equity positions in Uppton, Bitteroot Bio, and Angiowave; and has received compensation for service on the Peter Munk Advisory Board (University of Toronto), the Leducq Foundation (Paris, FR), and the Baim Institute (Boston, Massachusetts). Dr Mahaffey has received grants from AHA, Apple Inc, Bayer, California Institute for Regenerative Medicine, CSL Behring, Eidos, Ferring, Gilead, Google (Verily), Idorsia, Johnson &amp; Johnson, Luitpold, Novartis, PAC-12, Precordior, Sanifit; has received consulting fees from applied Therapeutics, Bayer, BMS, BridgeBio, CSL Behring, Elsevier, Fosun Pharma, Human, Johnson &amp; Johnson, Moderna, Myokardia, Novartis, Novo Nordisk, Otsuka, Phasebio, Portola, Quidel, and Theravance; has received payment or honoraria from CSL Behring; and has stock or stock options in Human, Medeloop, Precordior, and Regencor. Dr Nicholls has received research support from AstraZeneca, Amgen, Anthera, CSL Behring, Cerenis, Eli Lilly, Esperion, Resverlogix, Novartis, InfraReDx, and Sanofi-Regeneron; and has been a consultant for Amgen, Akcea, AstraZeneca, Boehringer Ingelheim, CSL Behring, Daiichi Sankyo, Eli Lilly, Esperion, Kowa, Merck, Takeda, Pfizer, Sanofi-Regeneron, Novo Nordisk, CSL Sequiris, and Vaxxinity. Dr Mehran has received institutional research payments from Abbott, Affluent Medical, Alleviant Medical, Amgen, AstraZeneca, BAIM, Beth Israel Deaconess Medical Center, Boston Scientific, Bristol Myers Squibb, CardiaWave, CERC, Chiesi, Concept Medical, Daiichi Sankyo, Duke, Faraday, Idorsia, Janssen, MedAlliance, Medscape, Mediasphere, Medtelligence, Medtronic, Novartis, OrbusNeich, Pi-Cardia, Protembis, RM Global Bioaccess Fund Management, and Sanofi; has received personal fees from Affluent Medical, Boehringer Ingelheim, Chiesi USA, Cordis, Daiichi Sankyo, Esperion Science/Innovative Biopharma, Gaffney Events, Educational Trust, Global Clinical Trial Partners, Ltd, IQVIA, Medscape/WebMD Global, Novo Nordisk, PeerView Institute for Medical Education, TERUMO Europe N.V., and Radcliffe; has held equity &lt;1% in Elixir Medical, Stel, ControlRad (spouse); has received an honorarium from AMA; is associate editor of JAMA Cardiology; and is a BOT Member, SC Member CTR Program of ACC. Dr Harrington has research relationships with Baim Institute, CSL, Janssen, NHLBI, PCORI, and DCRI; has consulting relationships with Atropos Health, Bitterroot Bio, BMS, BridgeBio, Element Science, Edwards Lifesciences, Foresite Labs, and Medscape/WebMD; and serves on boards of directors for the American Heart Association, College of the Holy Cross, and Cytokinetics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>28</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>27</Day><Hour>18</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40288083</ArticleId><ArticleId IdType="pmc">PMC12059331</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.101727</ArticleId><ArticleId IdType="pii">S2772-963X(25)00144-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Steen D.L., Khan I., Andrade K., Koumas A., Giugliano R.P. Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239 234 patients during 2005 to 2018 in the United States. J&#xa0;Am Heart Assoc. 2022;11(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9238606</ArticleId><ArticleId IdType="pubmed">35475346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton J.S., Tamis-Holland J.E., Bangalore S., et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J&#xa0;Am Coll Cardiol. 2022;79(2):e21&#x2013;e129.</Citation><ArticleIdList><ArticleId IdType="pubmed">34895950</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R.A., Rossello X., Coughlan J.J., et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720&#x2013;3826.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135&#x2013;1143.</Citation><ArticleIdList><ArticleId IdType="pubmed">11877368</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahit M.C., Gibson C.M. Thrombin as target for prevention of recurrent events after acute coronary syndromes. Thromb Res. 2024;235:116&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">38335566</ArticleId></ArticleIdList></Reference><Reference><Citation>Puhl S.-L., Steffens S. Neutrophils in post-myocardial infarction inflammation: damage vs. Resolution? Front Cardiovasc Med. 2019;6:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6431642</ArticleId><ArticleId IdType="pubmed">30937305</ArticleId></ArticleIdList></Reference><Reference><Citation>Matter M.A., Paneni F., Libby P., et al. Inflammation in acute myocardial infarction: the good, the bad and the ugly. Eur Heart J. 2024;45(2):89&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10771378</ArticleId><ArticleId IdType="pubmed">37587550</ArticleId></ArticleIdList></Reference><Reference><Citation>Weirather J., Hofmann U.D.W., Beyersdorf N., et al. Foxp3&#xa0;+ CD4&#xa0;+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ Res. 2014;115(1):55&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">24786398</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamstein N.H., MacFadyen J.G., Rose L.M., et al. The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. Eur Heart J. 2021;42(9):896&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936519</ArticleId><ArticleId IdType="pubmed">33417682</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvain J., Materne C., Zeitouni M., et al. Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event. Eur J Prev Cardiol. 2024 doi: 10.1093/eurjpc/zwae356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwae356</ArticleId><ArticleId IdType="pubmed">39506545</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares A.A.S., Tavoni T.M., de Faria E.C., Remalay A.T., Maranh&#xe3;o R.C., Sposito A.C. HDL acceptor capacities for cholesterol efflux from macrophages and lipid transfer are both acutely reduced after myocardial infarction. Clin Chim Acta. 2018;478:51&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">29274325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingwell B.A., Duffy D., Clementi R., Velkoska E., Feaster J., Gibson C.M. CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-tolymphocyte ratio induced by acute myocardial infarction. J&#xa0;Am Heart Assoc. 2024;13(9):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179901</ArticleId><ArticleId IdType="pubmed">38700008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gille A., Easton R., D&#x2019;Andrea D., Wright S.D., Shear C.L. CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects. Arterioscler Thromb Vasc Biol. 2014;34(9):2106&#x2013;2114.</Citation><ArticleIdList><ArticleId IdType="pubmed">24969776</ArticleId></ArticleIdList></Reference><Reference><Citation>Michael Gibson C., Korjian S., Tricoci P., et al. Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after&#xa0;acute myocardial infarction. Circulation. 2016;134(24):1918&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5147036</ArticleId><ArticleId IdType="pubmed">27881559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson C.M., Kazmi S.H.A., Korjian S., et al. CSL112 (apolipoprotein A-I [human]) strongly enhances plasma apoa-I and cholesterol efflux capacity in post-acute myocardial infarction patients: a PK/PD Substudy of the AEGIS-I trial. J&#xa0;Cardiovasc Pharmacol Ther. 2022;27</Citation><ArticleIdList><ArticleId IdType="pubmed">36282079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson C.M., Duffy D., Korjian S., et al. Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction. N&#xa0;Engl J Med. 2024;390(17):1560&#x2013;1571.</Citation><ArticleIdList><ArticleId IdType="pubmed">38587254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson C.M., Duffy D., Bahit M.C., et al. Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial. Eur Heart J. 2024;45:5023&#x2013;5038.</Citation><ArticleIdList><ArticleId IdType="pubmed">39221651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson C.M., Kastelein J.J.P., Phillips A.T., et al. Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardi. Am Heart J. 2021;231:121&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">33065120</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Cong B.L., Wang M., et al. Neutrophil to lymphocyte ratio as a predictor of myocardial damage and cardiac dysfunction in acute coronary syndrome patients. Integr Med Res. 2018;7(2):192&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6026362</ArticleId><ArticleId IdType="pubmed">29984180</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong P., Cui Z.-Y., Huang X.-F., Zhang D.-D., Guo R.-J., Han M. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7(1):131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9033871</ArticleId><ArticleId IdType="pubmed">35459215</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerterp M., Gourion-Arsiquaud S., Murphy A.J., et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell. 2012;11(2):195&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413200</ArticleId><ArticleId IdType="pubmed">22862945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker P.M., Danielson E., Fonseca F.A.H., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N&#xa0;Engl J Med. 2008;359(21):2195&#x2013;2207.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker P.M., Everett B.M., Thuren T., et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N&#xa0;Engl J Med. 2017;377(12):1119&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pubmed">28845751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker P.M., Libby P., MacFadyen J.G., et al. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) Eur Heart J. 2018;39(38):3499&#x2013;3507.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker P.M., Bhatt D.L., Pradhan A.D., Glynn R.J., MacFadyen J.G., Nissen S.E. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401(10384):1293&#x2013;1301.</Citation><ArticleIdList><ArticleId IdType="pubmed">36893777</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40300816</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1544-1717</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Annals of family medicine</Title><ISOAbbreviation>Ann Fam Med</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence Tools for Preconception Cardiomyopathy Screening Among Women of Reproductive Age.</ArticleTitle><Pagination><StartPage>246</StartPage><EndPage>254</EndPage><MedlinePgn>246-254</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1370/afm.230627</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Identifying cardiovascular disease before conception and in early pregnancy can better inform obstetric cardiovascular care. Our main objective was to evaluate the diagnostic performance of artificial intelligence (AI)-enabled digital tools for detecting left ventricular systolic dysfunction (LVSD) among women of reproductive age.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a pilot cross-sectional study, we enrolled an initial cohort of 100 consecutive women aged 18-49 years who had a primary care physician and a scheduled echocardiography at Mayo Clinic Florida (Jacksonville) (cohort 1). Twelve-lead electrocardiography (ECG) and digital stethoscope recordings (single-lead ECG + phonocardiography) were performed on the date of echocardiography. We used deep learning to generate prediction probabilities for LVSD (defined as left ventricular ejection fraction &lt;50%) for the 12-lead ECG (AI-ECG) and stethoscope (AI-stethoscope) recordings. In a second cohort of 100 participants, we enrolled consecutive women seen in primary care to estimate the prevalence of positive AI screening results when deployed for routine use (cohort 2).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median age of participants was 38.6 years (quartile 1: 30.3 years, quartile 3: 45.5 years), and 71.9% identified as part of the non-Hispanic White population. Among cohort 1, 5% had LVSD. The AI-ECG had an area under the curve of 0.94, and the AI-stethoscope (maximum prediction across all chest locations) had an area under the curve of 0.98. Among cohort 2, the prevalence of a positive AI screen was 1% and 3.2% for AI-ECG and the AI-stethoscope, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We found these AI tools to be effective for the detection of cardiomyopathy associated with LVSD among women of reproductive age. These tools could potentially be useful for preconception cardiovascular evaluations.</AbstractText><CopyrightInformation>&#xa9; 2025 Annals of Family Medicine, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kinaszczuk</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Mayo Clinic, Jacksonville, Florida (Kinaszczuk, Clapp, Olutola).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morales-Lara</LastName><ForeName>Andrea Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida (Morales-Lara, Garzon-Siatoya, El-Attar, Adedinsewo).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garzon-Siatoya</LastName><ForeName>Wendy Tatiana</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida (Morales-Lara, Garzon-Siatoya, El-Attar, Adedinsewo).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Attar</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida (Morales-Lara, Garzon-Siatoya, El-Attar, Adedinsewo).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clapp</LastName><ForeName>Adrianna D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Mayo Clinic, Jacksonville, Florida (Kinaszczuk, Clapp, Olutola).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olutola</LastName><ForeName>Ifeloluwa A</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Family Medicine, Mayo Clinic, Jacksonville, Florida (Kinaszczuk, Clapp, Olutola).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moerer</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida (Moerer, Johnson, Wieczorek, Carter).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida (Moerer, Johnson, Wieczorek, Carter).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieczorek</LastName><ForeName>Mikolaj A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida (Moerer, Johnson, Wieczorek, Carter).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attia</LastName><ForeName>Zachi I</ForeName><Initials>ZI</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (Attia, Lopez-Jimenez, Friedman, Noseworthy).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Jimenez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (Attia, Lopez-Jimenez, Friedman, Noseworthy).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (Attia, Lopez-Jimenez, Friedman, Noseworthy).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>Rickey E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida (Moerer, Johnson, Wieczorek, Carter).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noseworthy</LastName><ForeName>Peter A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota (Attia, Lopez-Jimenez, Friedman, Noseworthy).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adedinsewo</LastName><ForeName>Demilade</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, Florida (Morales-Lara, Garzon-Siatoya, El-Attar, Adedinsewo) adedinsewo.demilade@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HD065987</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Fam Med</MedlineTA><NlmUniqueID>101167762</NlmUniqueID><ISSNLinking>1544-1709</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016742" MajorTopicYN="Y">Preconception Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">preconception care</Keyword><Keyword MajorTopicYN="N">primary health care</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>28</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>30</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>29</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40300816</ArticleId><ArticleId IdType="pmc">PMC12120147</ArticleId><ArticleId IdType="doi">10.1370/afm.230627</ArticleId><ArticleId IdType="pii">afm.230627</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Petersen EE, Davis NL, Goodman D, et al. . Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 68(18): 423-429. doi: 10.15585/mmwr.mm6818e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6818e1</ArticleId><ArticleId IdType="pmc">PMC6542194</ArticleId><ArticleId IdType="pubmed">31071074</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDorman MF, Thoma M, Declcerq E, Howell EA.. Racial and ethnic disparities in maternal mortality in the United States using enhanced vital records, 2016-2017. Am J Public Health. 2021; 111(9): 1673-1681. doi: 10.2105/AJPH.2021.306375</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2021.306375</ArticleId><ArticleId IdType="pmc">PMC8563010</ArticleId><ArticleId IdType="pubmed">34383557</ArticleId></ArticleIdList></Reference><Reference><Citation>Briller J, Koch AR, Geller SE; Illinois Department of Public Health Maternal Mortality Review Committee Working Group . Maternal cardiovascular mortality in Illinois, 2002-2011. Obstet Gynecol. 2017; 129(5): 819-826. doi: 10.1097/AOG.0000000000001981</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000001981</ArticleId><ArticleId IdType="pubmed">28383382</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen EE, Davis NL, Goodman D, et al. . Racial/ethnic disparities in pregnancy-related deaths - United States, 2007-2016. MMWR Morb Mortal Wkly Rep. 2019; 68(35): 762-765. doi: 10.15585/mmwr.mm6835a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6835a3</ArticleId><ArticleId IdType="pmc">PMC6730892</ArticleId><ArticleId IdType="pubmed">31487273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hameed AB, Lawton ES, McCain CL, et al. . Pregnancy-related cardiovascular deaths in California: beyond peripartum cardiomyopathy. Am J Obstet Gynecol. 2015; 213(3): 379.e1-379.e10. doi: 10.1016/j.ajog.2015.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2015.05.008</ArticleId><ArticleId IdType="pubmed">25979616</ArticleId></ArticleIdList></Reference><Reference><Citation>GBD 2015 Maternal Mortality Collaborators . Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1775-1812. doi: 10.1016/S0140-6736(16)31470-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)31470-2</ArticleId><ArticleId IdType="pmc">PMC5224694</ArticleId><ArticleId IdType="pubmed">27733286</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Obstetricians and Gynecologists&#x2019; Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins&#x2014;Obstetrics . ACOG Practice Bulletin No. 212: Pregnancy and heart disease. Obstet Gynecol. 2019; 133(5): e320-e356. doi: 10.1097/AOG.0000000000003243</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/AOG.0000000000003243</ArticleId><ArticleId IdType="pubmed">31022123</ArticleId></ArticleIdList></Reference><Reference><Citation>US Centers for Disease Control and Prevention . Pregnancy-related deaths: data from maternal mortality review committees in 36 U.S. states, 2017-2019. Updated September
19, 2022. https://www.cdc.gov/maternal-mortality/php/data-research/mmrc-2017-2019.html</Citation></Reference><Reference><Citation>Mehta LS, Warnes CA, Bradley E, et al. ; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and Stroke Council . Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association. Circulation. 2020; 141(23): e884-e903. doi: 10.1161/CIR.0000000000000772</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000772</ArticleId><ArticleId IdType="pubmed">32362133</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MB, Arany Z, McNamara DM, Goland S, Elkayam U.. Peripartum cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 75(2): 207-221. doi: 10.1016/j.jacc.2019.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.11.014</ArticleId><ArticleId IdType="pubmed">31948651</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes SN, Tweet MS, Adlam D, et al. . Spontaneous coronary artery dissection: JACC state-of-the-art review. J Am Coll Cardiol. 2020; 76(8): 961-984. doi: 10.1016/j.jacc.2020.05.084</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.05.084</ArticleId><ArticleId IdType="pubmed">32819471</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis EM, Haythe JH, Walsh MN, Kittleson MM.. Intersection of heart failure and pregnancy: beyond peripartum cardiomyopathy. Circ Heart Fail. 2021; 14(5): e008223. doi: 10.1161/CIRCHEARTFAILURE.120.008223</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.120.008223</ArticleId><ArticleId IdType="pubmed">33980039</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao X, Rushlow DR, Inselman JW, et al. . Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial. Nat Med. 2021; 27(5): 815-819. doi: 10.1038/s41591-021-01335-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01335-4</ArticleId><ArticleId IdType="pubmed">33958795</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossen LM, Hamilton BE, Abma JC, et al. . 
Updated methodology to estimate overall and unintended pregnancy rates in the United States. Vital Health Stat 2. Published Apr, 2023. Accessed Mar 4, 2025. https://stacks.cdc.gov/view/cdc/124395</Citation></Reference><Reference><Citation>Attia ZI, Kapa S, Lopez-Jimenez F, et al. . Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat Med. 2019; 25(1): 70-74. doi: 10.1038/s41591-018-0240-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0240-2</ArticleId><ArticleId IdType="pubmed">30617318</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun JY, Qiu Y, Guo HC, et al. . A method to screen left ventricular dysfunction through ECG based on convolutional neural network. J Cardiovasc Electrophysiol. 2021; 32(4): 1095-1102. doi: 10.1111/jce.14936</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14936</ArticleId><ArticleId IdType="pubmed">33565217</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J, Lee S, Chang M, Lee Y, Oh GC, Lee HY.. Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction. Sci Rep. 2022; 12(1): 14235. doi: 10.1038/s41598-022-18640-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-18640-8</ArticleId><ArticleId IdType="pmc">PMC9392508</ArticleId><ArticleId IdType="pubmed">35987961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon JM, Kim KH, Eisen HJ, et al. . Artificial intelligence assessment for early detection of heart failure with preserved ejection fraction based on electrocardiographic features. Eur Heart J Digit Health. 2020; 2(1): 106-116. doi: 10.1093/ehjdh/ztaa015</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztaa015</ArticleId><ArticleId IdType="pmc">PMC9707919</ArticleId><ArticleId IdType="pubmed">36711179</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo DA, Johnson PW, Douglass EJ, et al. . Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model. Eur Heart J Digit Health. 2021; 2(4): 586-596. doi: 10.1093/ehjdh/ztab078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztab078</ArticleId><ArticleId IdType="pmc">PMC8715757</ArticleId><ArticleId IdType="pubmed">34993486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28(1): 1-39.e14. doi: 10.1016/j.echo.2014.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Coats AJ, Tsutsui H, et al. . Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. J Card Fail. 2021; S1071-9164(21)00050-6. doi: 10.1016/j.cardfail.2021.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2021.01.022</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia ZI, Kapa S, Yao X, et al. . Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2019; 30(5): 668-674. doi: 10.1111/jce.13889</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13889</ArticleId><ArticleId IdType="pubmed">30821035</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo D, Carter RE, Attia Z, et al. . Artificial intelligence-enabled ECG algorithm to identify patients with left ventricular systolic dysfunction presenting to the emergency department with dyspnea. Circ Arrhythm Electrophysiol. 2020; 13(8): e008437. doi: 10.1161/CIRCEP.120.008437</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.120.008437</ArticleId><ArticleId IdType="pubmed">32986471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachtiger P, Petri CF, Scott FE, et al. . Point-of-care screening for heart failure with reduced ejection fraction using artificial intelligence during ECG-enabled stethoscope examination in London, UK: a prospective, observational, multicentre study. Lancet Digit Health. 2022; 4(2): e117-e125. doi: 10.1016/S2589-7500(21)00256-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00256-9</ArticleId><ArticleId IdType="pmc">PMC8789562</ArticleId><ArticleId IdType="pubmed">34998740</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia ZI, Dugan J, Rideout A, et al. . Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled digital stethoscope. Eur Heart J Digit Health. 2022; 3(3): 373-379. doi: 10.1093/ehjdh/ztac030</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztac030</ArticleId><ArticleId IdType="pmc">PMC9708035</ArticleId><ArticleId IdType="pubmed">36712160</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food &amp; Drug Administration . 510(k) Premarket notification. Eko Low Ejection Fraction Tool (ELEFT) - Reduced ejection fraction machine learning-based notification software. Mar
28, 2024. Accessed Apr 3, 2025. https://www.accessdata.fda.gov/cdrh_docs/pdf23/K233409.pdf</Citation></Reference><Reference><Citation>Finer LB, Zolna MR.. Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med. 2016; 374(9): 843-852. doi: 10.1056/NEJMsa1506575</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa1506575</ArticleId><ArticleId IdType="pmc">PMC4861155</ArticleId><ArticleId IdType="pubmed">26962904</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng AS, Thao V, Borah BJ, et al. . Cost effectiveness of an electrocardiographic deep learning algorithm to detect asymptomatic left ventricular dysfunction. Mayo Clin Proc. 2021; 96(7): 1835-1844. doi: 10.1016/j.mayocp.2020.11.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.11.032</ArticleId><ArticleId IdType="pubmed">34116837</ArticleId></ArticleIdList></Reference><Reference><Citation>Thao V, Zhu Y, Tseng AS, et al. . Cost-effectiveness of artificial intelligence-enabled electrocardiograms for early detection of low ejection fraction: a secondary analysis of the Electrocardiogram Artificial Intelligence-Guided Screening for Low Ejection Fraction trial. Mayo Clinic Proceedings: Digital Health. 2024; 2(4): 620-631. doi: 10.1016/j.mcpdig.2024.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcpdig.2024.10.001</ArticleId><ArticleId IdType="pmc">PMC11975989</ArticleId><ArticleId IdType="pubmed">40206537</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilensky S, Proser M.. Community approaches to women&#x2019;s health: delivering preconception care in a Community Health Center model. Womens Health Issues. 2008;18(6 Suppl): S52-S60. doi: 10.1016/j.whi.2008.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.whi.2008.06.007</ArticleId><ArticleId IdType="pubmed">18948019</ArticleId></ArticleIdList></Reference><Reference><Citation>Steel A, Lucke J, Adams J.. The prevalence and nature of the use of preconception services by women with chronic health conditions: an integrative review. BMC Womens Health. 2015; 15: 14. doi: 10.1186/s12905-015-0165-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12905-015-0165-6</ArticleId><ArticleId IdType="pmc">PMC4338627</ArticleId><ArticleId IdType="pubmed">25783639</ArticleId></ArticleIdList></Reference><Reference><Citation>Moos MK. From concept to practice: reflections on the preconception health agenda. J Womens Health (Larchmt). 2010; 19(3): 561-567. doi: 10.1089/jwh.2009.1411</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2009.1411</ArticleId><ArticleId IdType="pubmed">20184531</ArticleId></ArticleIdList></Reference><Reference><Citation>Adedinsewo D, Morales-Lara AC, Hardway H, et al. . Artificial intelligence-based screening for cardiomyopathy in an obstetric population: a pilot study. Cardiovasc Digit Health J. 2024; 5(3): 132-140. doi: 10.1016/j.cvdhj.2024.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2024.03.005</ArticleId><ArticleId IdType="pmc">PMC11232425</ArticleId><ArticleId IdType="pubmed">38989045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40238040</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Apr</Month><Day>16</Day></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>Cardiac Magnetic Resonance Guidance for the Pathogenetic Definition of Cardiomyopathies.</ArticleTitle><Pagination><StartPage>85</StartPage><MedlinePgn>85</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">85</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-025-02233-8</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Pathogenetics is the study of genetics in disease pathogenesis. Many abnormal gene alleles have been identified in cardiomyopathies, but their clinical utility remains limited. This review aims to examine the integration of cardiac MRI (CMR) with genetic data to enhance early detection, prognostication, and treatment strategies for cardiomyopathies.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">CMR is the gold standard imaging modality for cardiomyopathy evaluation, capable of detecting subtle structural and functional changes throughout the disease course. When applied to patients with genetic mutations, with or without phenotypic expression, CMR aids in early diagnosis and risk stratification. Cardiomyopathies can be categorized into at least seven clinical groups based on&#xa0;morphology, function, and genetic associations: (1) Dilated cardiomyopathy (DCM), (2) Hypertrophic cardiomyopathy (HCM), (3) Restrictive cardiomyopathy, including transthyretin amyloidosis (ATTR-CM), iron overload, and Anderson-Fabry disease, (4) Arrhythmogenic cardiomyopathy (ACM), (5)&#xa0;Non-dilated left ventricular cardiomyopathy (NDLVC), (6) Peripartum cardiomyopathy, and (7) Muscular dystrophy-related cardiomyopathy. We have described&#xa0;left ventricular noncompaction (LVNC)&#xa0;as a morphological trait&#xa0;rather than a distinct cardiomyopathy.&#xa0;Emerging CMR and genetic data suggest an inflammatory component in DCM and ACM, with potential therapeutic implications for immunotherapy. Advanced CMR techniques, such as quantitative perfusion, can distinguish cardiomyopathies from ischemic heart disease and detect early microvascular dysfunction, particularly in ATTR-CM and HCM. Late gadolinium enhancement (LGE) and parametric mapping (T1 and extracellular volume [ECV]) further enhance early diagnosis, prognostication and treatment response by assessing fibrosis and myocardial composition. The integration of CMR and genetic insights improves our understanding of cardiomyopathy pathogenesis, aiding in early diagnosis and prognostic assessment. Future research should leverage artificial intelligence (AI) to analyze genetic and radiomic CMR features, including perfusion data, to establish a comprehensive pathogenetic framework. This approach could refine disease classification, identify novel therapeutic targets, and advance precision medicine in cardiomyopathy management.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Paudel</LastName><ForeName>Bishow</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singulane</LastName><ForeName>Cristiane C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philips</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Amit R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiovascular Medicine, University of Virginia, Charlottesville, VA, USA. apatel@virginia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 EB003841</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32EB003841</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019028" MajorTopicYN="Y">Magnetic Resonance Imaging, Cine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="N">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMR-pathogenetic</Keyword><Keyword MajorTopicYN="N">Cardiac Magnetic Resonance (CMR) Features</Keyword><Keyword MajorTopicYN="N">Genes</Keyword><Keyword MajorTopicYN="N">Genetic/Inherited cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword></KeywordList><CoiStatement>Declarations. Conflict of Interest: The authors declare no competing interests. Human and Animal Rights and Informed Consent: This article does not contain any studies with human or animal subjects performed by any of the authors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>14</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>16</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40238040</ArticleId><ArticleId IdType="pmc">PMC12003507</ArticleId><ArticleId IdType="doi">10.1007/s11886-025-02233-8</ArticleId><ArticleId IdType="pii">10.1007/s11886-025-02233-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147(2):218&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">14760316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJS, Cleland JGF, et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance. Are they interchangeable? Eur Heart J. 2000;21(16):1387&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">10952828</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang ML, Bogomolovas J, Chen J. Understanding the molecular basis of cardiomyopathy. Am J Physiol Heart Circ Physiol. 2022;322(2):H181&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759964</ArticleId><ArticleId IdType="pubmed">34797172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa A, Moldovan O, Lebreiro A, Bourbon M, Ant&#xf3;nio N, Rato Q, et al. Recommendations for genetic testing in cardiology: review of major international guidelines. Revista Portuguesa de Cardiol (English Edition). 2020;39(10):597&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">33036867</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilde AAM, Semsarian C, M&#xe1;rquez MF, Shamloo AS, Ackerman MJ, Ashley EA, et al. European heart rhythm association (EHRA)/ heart rhythm society (HRS)/Asia pacific heart rhythm society (APHRS)/Latin American heart rhythm society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. Europace. 2022;24(8):1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9989595</ArticleId><ArticleId IdType="pubmed">36040308</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B, Captur G, Francois CJ, Jerosch-Herold M, et al. Reference ranges (&#x201c;normal values&#x201d;) for cardiovascular magnetic resonance (CMR) in adults and children: 2025 update. J Cardiovasc Magn Reson. 2025;101853. 10.1016/j.jocmr.2025.101853.</Citation><ArticleIdList><ArticleId IdType="pubmed">39914499</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman SV, Markl M, Patel AR, Bryant J, Allen BD, Plein S, et al. 30-minute CMR for common clinical indications: a society for cardiovascular magnetic resonance white paper. J Cardiovasc Magn Reson. 2022;24(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8886348</ArticleId><ArticleId IdType="pubmed">35232470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel MA, Anwar S, Broberg C, Browne L, Chung T, Johnson T, et al. Society for cardiovascular magnetic resonance/european society of cardiovascular imaging/American society of echocardiography/society for pediatric radiology/North American society for cardiovascular imaging guidelines for the use of cardiac magnetic resonance in pediatric congenital and acquired heart disease: endorsed by the American heart association. Circulation: Cardiovasc Imaging. 2022;15(6):e014415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9213089</ArticleId><ArticleId IdType="pubmed">35727874</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson. 2010;12(1):71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3016368</ArticleId><ArticleId IdType="pubmed">21118531</ArticleId></ArticleIdList></Reference><Reference><Citation>Biglands JD, Radjenovic A, Ridgway JP. Cardiovascular magnetic resonance physics for clinicians: part II. J Cardiovasc Magn Reson. 2012;14(1):78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3533879</ArticleId><ArticleId IdType="pubmed">22995744</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;20(1):9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5804075</ArticleId><ArticleId IdType="pubmed">29415744</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday BP, Baksi AJ, Gulati A, Ali A, Newsome S, Izgi C, et al. Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement. JACC: Cardiovasc Imaging. 2019;12(8P2):1645&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6682609</ArticleId><ArticleId IdType="pubmed">30219397</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Franco A, Ruggieri R, Pieroni M, Ciabatti M, Zocchi C, Biagioni G, et al. Atlas of regional left ventricular scar in nonischemic cardiomyopathies: substrates and etiologies. JACC Adv. 2024;3(10):101214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11380395</ArticleId><ArticleId IdType="pubmed">39246577</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Martinez-Naharro A, Boldrini M, Knight D, Hawkins P, Kalra S, et al. Automated pixel-wise quantitative myocardial perfusion mapping by cmr to detect obstructive coronary artery disease and coronary microvascular dysfunction: validation against invasive coronary physiology. JACC: Cardiovasc Imaging. 2019;12(10):1958&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414332</ArticleId><ArticleId IdType="pubmed">30772231</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Kim P, Wang H, Ng MY, Arai AE, Singh A, et al. Myocardial blood flow quantification using stress cardiac magnetic resonance improves detection of coronary artery disease. Cardiovasc Imaging. 2024;17(12):1428&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">39297850</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan E, Peterson L, Ai T, Asatryan B, Bronicki L, Brown E, et al. Evidence-based assessment of genes in dilated cardiomyopathy. Circulation. 2021;144(1):7&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247549</ArticleId><ArticleId IdType="pubmed">33947203</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Arbelo E, Barriales-Villa R, et al. 2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European society of cardiology (ESC). Eur Heart J. 2023;44(37):3503&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Escobar-Lopez L, Ochoa JP, Mirelis JG, Espinosa M&#xc1;, Navarro M, Gallego-Delgado M, et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol. 2021;78(17):1682&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">34674813</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonopoulos AS, Xintarakou A, Protonotarios A, Lazaros G, Miliou A, Tsioufis K, et al. Imagenetics for precision medicine in dilated cardiomyopathy. Circulation: Genom Precision Med. 2024;17(2):e004301.</Citation><ArticleIdList><ArticleId IdType="pubmed">38415367</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn JC, Hong YJ, Lee HJ, Han K, Shim CY, Hong GR, et al. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Eur Radiol. 2017;27:3924&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">28439651</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday BP, Gulati A, Ali A, Guha K, Newsome S, Arzanauskaite M, et al. Association between midwall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction. Circulation. 2017;135(22):2106&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5444425</ArticleId><ArticleId IdType="pubmed">28351901</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D, Anastasakis A, Basso C, Bauce B, Blomstr&#xf6;m-Lundqvist C, Bucciarelli-Ducci C, et al. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report. Int J Cardiol. 2024;15:395.</Citation><ArticleIdList><ArticleId IdType="pubmed">37844667</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng XY, He WF, Zhang TY, Wang LL, Yang F, Feng YL, et al. Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: a meta-analysis. World J Radiol. 2023;15(11):324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10696187</ArticleId><ArticleId IdType="pubmed">38058605</ArticleId></ArticleIdList></Reference><Reference><Citation>Monda E, Bakalakos A, Cannie D, O&#x2019;Mahony C, Syrris P, Kaski JP, et al. Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis: a systematic review and meta-analysis. JACC Heart Fail. 2024;12(6):1101&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">38573261</ArticleId></ArticleIdList></Reference><Reference><Citation>Badorff C, Knowlton KU. Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: From bench to bedside. Med Microbiol Immunol. 2004;193:121&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920582</ArticleId></ArticleIdList></Reference><Reference><Citation>Teekakirikul P, Zhu W, Huang HC, Fung E. Hypertrophic cardiomyopathy: an overview of genetics and management. Biomolecules. 2019;9(12):878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6995589</ArticleId><ArticleId IdType="pubmed">31888115</ArticleId></ArticleIdList></Reference><Reference><Citation>Neubauer S, Kolm P, Ho CY, Kwong RY, Desai MY, Dolman SF, et al. Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. J Am Coll Cardiol. 2019;74(19):2333&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6905038</ArticleId><ArticleId IdType="pubmed">31699273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RK, Knott KD, Malcolmson J, Augusto JB, Mohiddin SA, Kellman P, et al. Apical hypertrophic cardiomyopathy: the variant less known. J Am Heart Assoc. 2020;9(5):e015294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7335568</ArticleId><ArticleId IdType="pubmed">32106746</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Maron MS, Semsarian C. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am College Cardiol. 2012;60(8):705&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">22796258</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy. Circulation. 2020;142:e558&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">33215931</ArticleId></ArticleIdList></Reference><Reference><Citation>van Velzen HG, Schinkel AFL, Baart SJ, Oldenburg RA, Frohn-Mulder IME, van Slegtenhorst MA, et al. Outcomes of contemporary family screening in hypertrophic cardiomyopathy. Circ Genom Precis Med. 2018;11(4):e001896.</Citation><ArticleIdList><ArticleId IdType="pubmed">29661763</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes LR, Garcia-Hern&#xe1;ndez S, Lorenzini M, Futema M, Chumakova O, Zateyshchikov D, et al. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy. Eur Heart J. 2021;42(32):3063&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8380059</ArticleId><ArticleId IdType="pubmed">34263907</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura J, Rowin EJ, Chan RH, Chin MT, Puchnerova V, Polakova E, et al. Relationship between genotype status and clinical outcome in hypertrophic cardiomyopathy. J Am Heart Assoc. 2024;13(10):e033565.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179794</ArticleId><ArticleId IdType="pubmed">38757491</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Burrage MK, Lukaschuk E, Shanmuganathan M, Popescu IA, Nikolaidou C, et al. Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy. Circulation. 2021;144(8):589&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378544</ArticleId><ArticleId IdType="pubmed">34229451</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaioni C, Knott KD, Augusto JB, Seraphim A, Rosmini S, Ricci F, et al. Inline perfusion mapping provides insights into the disease mechanism in hypertrophic cardiomyopathy. Heart. 2020;106(11):824&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7282549</ArticleId><ArticleId IdType="pubmed">31822572</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: proposed modification of the task force criteria. Circulation. 2010;121(13). 10.1161/CIRCULATIONAHA.108.84082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860804</ArticleId><ArticleId IdType="pubmed">20172911</ArticleId></ArticleIdList></Reference><Reference><Citation>Graziano F, Zorzi A, Cipriani A, De Lazzari M, Bauce B, Rigato I, et al. The 2020 &#x201c;Padua Criteria&#x201d; for diagnosis and phenotype characterization of arrhythmogenic cardiomyopathy in clinical practice. J Clin Med. 2022;11(1):279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8746198</ArticleId><ArticleId IdType="pubmed">35012021</ArticleId></ArticleIdList></Reference><Reference><Citation>Basharat SA, Hsiung I, Garg J, Alsaid A. Arrhythmogenic cardiomyopathy: evolving diagnostic criteria and insight from cardiac magnetic resonance imaging. Heart Fail Clinics. 2023;19(4):429&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">37714585</ArticleId></ArticleIdList></Reference><Reference><Citation>Matos J, Helle E, Care M, Moayedi Y, Gollob MH, Thavendiranathan P, et al. Cardiac MRI and clinical outcomes in TMEM43 arrhythmogenic cardiomyopathy. Radiol Cardiothorac Imaging. 2023;5(6):e230155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11163247</ArticleId><ArticleId IdType="pubmed">38166344</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee D, Fatah M, Akdis D, Spears DA, Koopmann TT, Mittal K, et al. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. Eur Heart J. 2018;39(44):3932&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247665</ArticleId><ArticleId IdType="pubmed">30239670</ArticleId></ArticleIdList></Reference><Reference><Citation>Asatryan B, Asimaki A, Landstrom AP, Khanji MY, Odening KE, Cooper LT, et al. Inflammation and immune response in arrhythmogenic cardiomyopathy: state-of-the-art review. Circulation. 2021;144(20):1646&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9034711</ArticleId><ArticleId IdType="pubmed">34780255</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D, Basso C, Thiene G, McKenna WJ, Davies MJ, Fontaliran F, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997;30(6):1512&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">9362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretto G, De Luca G, Villatore A, Di Resta C, Sala S, Palmisano A, et al. Multimodal detection and targeting of biopsy-proven myocardial inflammation in genetic cardiomyopathies: a pilot report. JACC Basic Transl Sci. 2023;8(7):755&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10401291</ArticleId><ArticleId IdType="pubmed">37547072</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the society for cardiovascular magnetic resonance (SCMR) endorsed by the European association for cardiovascular imaging (EACVI). J Cardiovasc Magn Reson. 2016;19(1):75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633041</ArticleId><ArticleId IdType="pubmed">28992817</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol. 2017;70(4):466&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">28728692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2023;81(11):1076&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">36697326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S, Haghbayan H, Chan KKW, Deva DP, Jimenez-Juan L, Connelly KA, et al. Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: a systematic review and meta-analysis. Int J Cardiol. 2024;15:403.</Citation><ArticleIdList><ArticleId IdType="pubmed">38382853</ArticleId></ArticleIdList></Reference><Reference><Citation>Chacko L, Kotecha T, Ioannou A, Patel N, Martinez-Naharro A, Razvi Y, et al. Myocardial perfusion in cardiac amyloidosis. Eur J Heart Fail. 2024;26(3):598&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">38247182</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordan R, Wongjaikam S, Gwathmey JK, Chattipakorn N, Chattipakorn SC, Xie LH. Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update. Heart Fail Rev. 2018;23:801&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6093778</ArticleId><ArticleId IdType="pubmed">29675595</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11913479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremastinos DT, Farmakis D. Iron overload cardiomyopathy in clinical practice. Circulation. 2011;124(20):2253&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">22083147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamsi-Pasha MA, Zhan Y, Debs D, Shah DJ. CMR in the evaluation of diastolic dysfunction and phenotyping of HFpEF: current role and future perspectives. JACC Cardiovasc Imaging. 2020;13(1 Pt 2):283&#x2013;96. 10.1016/j.jcmg.2019.02.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">31202753</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombach SM, Dekker N, Bouwman MG, Linthorst GE, Zwinderman AH, Wijburg FA, et al. Plasma globotriaosylsphingosine: diagnostic value and relation to clinical manifestations of Fabry disease. Biochim Biophys Acta Mol Basis Dis. 2010;1802(9):741&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20471476</ArticleId></ArticleIdList></Reference><Reference><Citation>Deva DP, Hanneman K, Li Q, Ng MY, Wasim S, Morel C, et al. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease. J Cardiovasc Magn Reson. 2016;18(1):14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4818406</ArticleId><ArticleId IdType="pubmed">27036375</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiestand R, Nowak A, Sokolska JM, Chan R, Ruschitzka F, Manka R, et al. Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease. Int J Cardiol. 2023;382:46&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">37044180</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung CL, Wu YW, Lin CC, Lai CH, Juang JJM, Chao TH, et al. 2021 tsoc expert consensus on the clinical features, diagnosis, and clinical management of cardiac manifestations of fabry disease. Acta Cardiol Sin. 2021;37(4):337&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8261701</ArticleId><ArticleId IdType="pubmed">34257484</ArticleId></ArticleIdList></Reference><Reference><Citation>Leo I, Dellegrottaglie S, Scatteia A, Torella D, Abete R, Aquaro GD, et al. CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in non-dilated left ventricular cardiomyopathy: a sub-study from the DERIVATE registry. Eur Heart J Cardiovasc Imaging. 2025;jeaf043. 10.1093/ehjci/jeaf043/7997478.</Citation><ArticleIdList><ArticleId IdType="pubmed">39899463</ArticleId></ArticleIdList></Reference><Reference><Citation>Eda Y, Nabeta T, Iikura S, Takigami Y, Fujita T, Iida Y, et al. Non-dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: clinical background and outcomes. ESC Heart Fail. 2024;11(3):1463&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11098659</ArticleId><ArticleId IdType="pubmed">38320776</ArticleId></ArticleIdList></Reference><Reference><Citation>Filomena D, Vandenberk B, Dresselaers T, Willems R, Masci PG, Robyns T, Bogaert J. Cardiac diagnoses and long-term outcomes in ring-like late gadolinium enhancement evaluated by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2025;jeaf055. 10.1093/ehjci/jeaf055/8020540.</Citation><ArticleIdList><ArticleId IdType="pubmed">39964814</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen SE, Jensen B, Aung N, Friedrich MG, McMahon CJ, Mohiddin SA, et al. Excessive trabeculation of the left ventricle: JACC: cardiovascular imaging expert panel paper. Cardiovasc Imaging. 2023;16(3):408&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9988693</ArticleId><ArticleId IdType="pubmed">36764891</ArticleId></ArticleIdList></Reference><Reference><Citation>Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. The Lancet. 2015;386(9995):813&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Li S, Sirajuddin A, Wu W, Huang J, Sun X, et al. CMR Characteristics, gene variants and long-term outcome in patients with left ventricular non-compaction cardiomyopathy. Insights Imaging. 2021;12:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8665949</ArticleId><ArticleId IdType="pubmed">34894296</ArticleId></ArticleIdList></Reference><Reference><Citation>Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, et al. Genome-wide significance and replication of the chromosome 12p11. 22 locus near the PTHLH gene for peripartum cardiomyopathy. Circ Cardiovasc Genet. 2011;4(4):359&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">21665988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JS, Li J, Mazaika E, Yasso CM, DeSouza T, Cappola TP, et al. Shared genetic predisposition in peripartum and dilated cardiomyopathies. New England J Med. 2016;374(3):233&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797319</ArticleId><ArticleId IdType="pubmed">26735901</ArticleId></ArticleIdList></Reference><Reference><Citation>Goli R, Li J, Brandimarto J, Levine LD, Riis V, McAfee Q, et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021;143(19):1852&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8113098</ArticleId><ArticleId IdType="pubmed">33874732</ArticleId></ArticleIdList></Reference><Reference><Citation>Prameswari HS, Kamarullah W, Pranata R, Putra ICS, Undarsa AC, Iqbal M, et al. Meta-analysis of cardiac magnetic resonance in prognosticating left ventricular function in peripartum cardiomyopathy. ESC Heart Fail. 2025;12(1):304&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11769666</ArticleId><ArticleId IdType="pubmed">39295149</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani L, Di Toro A, Urtis M, Smirnova A, Concardi M, Favalli V, et al. Hereditary muscle diseases and the heart: the cardiologist&#x2019;s perspective. Eur Heart J Suppl. 2020;22(Supplement_E):E13&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270924</ArticleId><ArticleId IdType="pubmed">32523431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez F, Weitz C, Gutierrez JM, Mestroni L, Hanneman K, Vargas D. Cardiac MR imaging of muscular dystrophies. Curr Probl Diagn Radiol. 2022;51(2):225&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">33551194</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40320390</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2055-5822</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>ESC heart failure</Title><ISOAbbreviation>ESC Heart Fail</ISOAbbreviation></Journal><ArticleTitle>Novel three-dimensional ECG algorithm for reliable screening for cardiac amyloidosis.</ArticleTitle><Pagination><StartPage>2993</StartPage><EndPage>3002</EndPage><MedlinePgn>2993-3002</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ehf2.15318</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Currently, there is no established screening tool for cardiac amyloidosis, leading to a delay in diagnosis in the majority of patients. We aimed to develop and validate a non-invasive and easy to use tool that allows for screening of cardiac amyloidosis based on structured evaluation of three-dimensional electrocardiograms (ECGs).</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We included patients with confirmed cardiac AL or ATTR amyloidosis and controls of patients with other cardiovascular diseases but without amyloidosis into two independent cohorts: a derivation and validation cohort. All patients received three-dimensional ECGs and vector loops were categorized based on predefined patterns by two independent cardiologists. Consecutively, an AI algorithm was trained in the derivation cohort (n&#xa0;=&#xa0;66 amyloidosis cases, n&#xa0;=&#xa0;89 controls). This algorithm was then applied to the validation cohort (n&#xa0;=&#xa0;33 amyloidosis cases, n&#xa0;=&#xa0;67 controls). Overall, 99 patients with amyloidosis and 156 controls were included (mean age: 69&#xa0;&#xb1;&#xa0;15&#xa0;years, 79% male). In the derivation cohort, the AI algorithm reached a sensitivity of 85%, a specificity of 89%, a positive predictive value of 91%, and a negative predictive value of 87%. Applying the algorithm on the independent validation cohort, a sensitivity of 79%, specificity of 82%, a positive predictive value of 61%, and a negative predictive value of 92% was reached.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We here describe a novel screening tool, which allows for reliable detection of cardiac amyloidosis.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). ESC Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mahabadi</LastName><ForeName>Amir A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0003-2336-7991</Identifier><AffiliationInfo><Affiliation>West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knobeloch</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>INSOMNIA UG, Weimar, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Backmann</LastName><ForeName>Viktoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michel</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anker</LastName><ForeName>Markus S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Cardiology (CBF), German Heart Center Charit&#xe9;, University Medicine Berlin FU and HU, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wakili</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research DZHK, Partner Site Rhine-Main, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Cardiology, Goethe University, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fach</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kardiologie Schadowstra&#xdf;e, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anker</LastName><ForeName>Stefan D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>BIH Center for Regenerative Therapies (BCRT), Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology (CVK), German Heart Center Charit&#xe9;, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassaf</LastName><ForeName>Tienush</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>West German Heart and Vascular Center, Department of Cardiology and Vascular Medicine, University Hospital Essen, Essen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>ESC Heart Fail</MedlineTA><NlmUniqueID>101669191</NlmUniqueID><ISSNLinking>2055-5822</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="Y">Amyloidosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="Y">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">Digital medicine</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">Screening</Keyword><Keyword MajorTopicYN="N">Vector loop</Keyword></KeywordList><CoiStatement>A.A.M. received honoraria, lecture fees, and/or grant support from Amgen, Daiichi&#x2010;Sankyo, Edwards Lifesciences, and Novartis, Sanofi, all unrelated to this work. T.R. received honoraria, lecture fees, and/or grant support from Edwards Lifesciences, AstraZeneca, Bayer, Novartis, Berlin Chemie, Daiichi&#x2010;Sankyo, Boehringer Ingelheim, Novo Nordisk, Cardiac Dimensions, and Pfizer, all unrelated to this work. R.W. received honoraria, lecture fees, and/or grant support from Boehringer&#x2010;Ingelheim, Bristol&#x2010;Myers&#x2010;Squibb, Daiichi&#x2010;Sankyo, Pfizer, Boston Scientific, Biotronik, Abiomed, Zoll, Novartis, Medtronic, Bayer, ArtiCure, and Abbott. L.M. received honoraria, lecture fees and/or grant support from Alnylam, AstraZeneca, Bayer, Bristol Myers Squibb, and IIFM e.V. S.D.A. received grants and personal fees from Vifor and Abbott Laboratories and personal fees for consultancies, trial committee work and/or lectures from Actimed, AstraZeneca, Bayer, Boehringer Ingelheim, Brahms, Cardiac Dimensions, Cardior, Cordio, CVRx, Cytokinetics, Edwards, Farraday Pharmaceuticals, GSK, Impulse Dynamics, Lilly, Mankind Pharma, Medtronic, Novartis, Novo Nordisk, Occlutech, Pfizer, Regeneron, Relaxera, Repairon, Scirent, Sensible Medical, Vectorious, and V&#x2010;Wave. He was named co&#x2010;inventor of two patent applications regarding MR&#x2010;proANP (DE 102007010834 and DE 102007022367), but he does not benefit personally from the related issued patents. A.A.M., J.K., R.W., C.F., and T.R. are co&#x2010;founders of Mycor GmbH, a company focusing on the development of AI&#x2010;based ECG&#x2010;algorithms.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>4</Day><Hour>23</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40320390</ArticleId><ArticleId IdType="pmc">PMC12287817</ArticleId><ArticleId IdType="doi">10.1002/ehf2.15318</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wechalekar AD, Fontana M, Quarta CC, Liedtke M. AL amyloidosis for cardiologists: awareness, diagnosis, and future prospects: JACC: CardioOncology state&#x2010;of&#x2010;the&#x2010;art review. JACC CardioOncol 2022;4:427&#x2010;441. doi: 10.1016/j.jaccao.2022.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2022.08.009</ArticleId><ArticleId IdType="pmc">PMC9700258</ArticleId><ArticleId IdType="pubmed">36444232</ArticleId></ArticleIdList></Reference><Reference><Citation>
Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington&#x2010;Cruz M, <i>et al</i>. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med
2018;379:1007&#x2010;1016. doi: 10.1056/NEJMoa1805689

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805689</ArticleId><ArticleId IdType="pubmed">30145929</ArticleId></ArticleIdList></Reference><Reference><Citation>
Maurer MS, Kale P, Fontana M, Berk JL, Grogan M, Gustafsson F, <i>et al</i>. Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med
2023;389:1553&#x2010;1565. doi: 10.1056/NEJMoa2300757

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2300757</ArticleId><ArticleId IdType="pmc">PMC10757426</ArticleId><ArticleId IdType="pubmed">37888916</ArticleId></ArticleIdList></Reference><Reference><Citation>
Grogan M, Davis MK, Crespo&#x2010;Leiro MG, Sultan MB, Gundapaneni B, Stedile Angeli F, <i>et al</i>. Effect of long&#x2010;term tafamidis treatment on health&#x2010;related quality of life in patients with transthyretin amyloid cardiomyopathy. Eur J Heart Fail
2024;26:612&#x2010;615. doi: 10.1002/ejhf.3190

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3190</ArticleId><ArticleId IdType="pubmed">38439606</ArticleId></ArticleIdList></Reference><Reference><Citation>
Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, <i>et al</i>. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2&#x2010;evidence base and standardized methods of imaging. Circ Cardiovasc Imaging
2021;14:e000029. doi: 10.1161/HCI.0000000000000029

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HCI.0000000000000029</ArticleId><ArticleId IdType="pubmed">34196223</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gonzalez&#x2010;Lopez E, Gallego&#x2010;Delgado M, Guzzo&#x2010;Merello G, de Haro&#x2010;Del Moral FJ, Cobo&#x2010;Marcos M, Robles C, <i>et al</i>. Wild&#x2010;type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J
2015;36:2585&#x2010;2594. doi: 10.1093/eurheartj/ehv338

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehv338</ArticleId><ArticleId IdType="pubmed">26224076</ArticleId></ArticleIdList></Reference><Reference><Citation>
Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, <i>et al</i>. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. J Am Coll Cardiol
2021;77:128&#x2010;139. doi: 10.1016/j.jacc.2020.11.006

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7805267</ArticleId><ArticleId IdType="pubmed">33181246</ArticleId></ArticleIdList></Reference><Reference><Citation>
Muller SA, Peiro&#x2010;Aventin B, Biagioni G, Tini G, Saturi G, Kronberger C, <i>et al</i>. Evaluation of the 2021 ESC recommendations for family screening in hereditary transthyretin cardiac amyloidosis. Eur J Heart Fail
2024;26:2025&#x2010;2034. doi: 10.1002/ejhf.3339

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3339</ArticleId><ArticleId IdType="pubmed">38887861</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cipriani A, De Michieli L, Porcari A, Licchelli L, Sinigiani G, Tini G, <i>et al</i>. Low QRS voltages in cardiac amyloidosis: clinical correlates and prognostic value. JACC CardioOncol
2022;4:458&#x2010;470. doi: 10.1016/j.jaccao.2022.08.007

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2022.08.007</ArticleId><ArticleId IdType="pmc">PMC9700257</ArticleId><ArticleId IdType="pubmed">36444225</ArticleId></ArticleIdList></Reference><Reference><Citation>
Hnatkova K, Andrsova I, Novotny T, Vanderberk B, Sprenkeler D, Junttila J, <i>et al</i>. QRS complex and T wave planarity for the efficacy prediction of automatic implantable defibrillators. Heart
2024;110:178&#x2010;187. doi: 10.1136/heartjnl-2023-322878

</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2023-322878</ArticleId><ArticleId IdType="pmc">PMC10850677</ArticleId><ArticleId IdType="pubmed">37714697</ArticleId></ArticleIdList></Reference><Reference><Citation>
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, <i>et al</i>. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail
2022;24:4&#x2010;131. doi: 10.1002/ejhf.2333

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2333</ArticleId><ArticleId IdType="pubmed">35083827</ArticleId></ArticleIdList></Reference><Reference><Citation>
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, <i>et al</i>. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J
2022;43:561&#x2010;632. doi: 10.1093/eurheartj/ehab395

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab395</ArticleId><ArticleId IdType="pubmed">34453165</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz E, Sch&#xfc;pbach M. Cardiogoniometry: a non&#x2010;invasive electrocardiographic method to diagnose ischemic heart disease at rest. GMS Med Inform Biom Epidemiol 2009;5:D20.</Citation></Reference><Reference><Citation>
Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, <i>et al</i>. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol
2023;81:1076&#x2010;1126. doi: 10.1016/j.jacc.2022.11.022

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.11.022</ArticleId><ArticleId IdType="pubmed">36697326</ArticleId></ArticleIdList></Reference><Reference><Citation>
Fontana M, Berk JL, Gillmore JD, Witteles RM, Grogan M, Drachman B, <i>et al</i>. Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. N Engl J Med
2024;392:33&#x2010;44. doi: 10.1056/NEJMoa2409134

</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2409134</ArticleId><ArticleId IdType="pubmed">39213194</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuvali O, Fassler M, Goland S, Benaim C, Shimoni S, George J. A functional role for spontaneously occurring natural anti&#x2010;transthyretin antibodies from patients with transthyretin cardiac amyloidosis. Eur J Heart Fail 2024; doi: 10.1002/ejhf.3527</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3527</ArticleId><ArticleId IdType="pubmed">39563100</ArticleId></ArticleIdList></Reference><Reference><Citation>Drachman B, Damy T, Hanna M, Wang R, Angeli FS, Garcia&#x2010;Pavia P. Long&#x2010;term tafamidis efficacy in patients with transthyretin amyloid cardiomyopathy by baseline left ventricular ejection fraction. Eur J Heart Fail 2024;26:2038&#x2010;2046. doi: 10.1002/ejhf.3330</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3330</ArticleId><ArticleId IdType="pubmed">38932583</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott P, Gundapaneni B, Sultan MB, Ines M, Garcia&#x2010;Pavia P. Improved long&#x2010;term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms. Eur J Heart Fail 2023;25:2060&#x2010;2064. doi: 10.1002/ejhf.2974</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2974</ArticleId><ArticleId IdType="pubmed">37434378</ArticleId></ArticleIdList></Reference><Reference><Citation>
Rosenblum HR, Griffin JM, Minamisawa M, Prasad N, Vest J, White MT, <i>et al</i>. Effect of patisiran on stroke volume in hereditary transthyretin&#x2010;mediated amyloidosis: insights from pressure&#x2010;volume analysis of the APOLLO study. Eur J Heart Fail
2023;25:727&#x2010;736. doi: 10.1002/ejhf.2783

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2783</ArticleId><ArticleId IdType="pmc">PMC10277223</ArticleId><ArticleId IdType="pubmed">36693807</ArticleId></ArticleIdList></Reference><Reference><Citation>
Bonfioli GB, Tomasoni D, Vergaro G, Castiglione V, Adamo M, Fabiani I, <i>et al</i>. The Mayo ATTR&#x2010;CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis. Eur J Heart Fail
2024; doi: 10.1002/ejhf.3455
</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3455</ArticleId><ArticleId IdType="pubmed">39252401</ArticleId></ArticleIdList></Reference><Reference><Citation>
Vergaro G, Castiglione V, Aimo A, Prontera C, Masotti S, Musetti V, <i>et al</i>. N&#x2010;terminal pro&#x2010;B&#x2010;type natriuretic peptide and high&#x2010;sensitivity troponin T hold diagnostic value in cardiac amyloidosis. Eur J Heart Fail
2023;25:335&#x2010;346. doi: 10.1002/ejhf.2769

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2769</ArticleId><ArticleId IdType="pubmed">36597836</ArticleId></ArticleIdList></Reference><Reference><Citation>
Pagura L, Porcari A, Cameli M, Biagini E, Canepa M, Crotti L, <i>et al</i>. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: a head&#x2010;to&#x2010;head comparison from the AC&#x2010;TIVE study. Eur J Intern Med
2024;122:68&#x2010;77. doi: 10.1016/j.ejim.2023.09.026

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2023.09.026</ArticleId><ArticleId IdType="pubmed">37858441</ArticleId></ArticleIdList></Reference><Reference><Citation>
Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub&#x2010;Weidinger T, <i>et al</i>. Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross&#x2010;tracer development and validation study. Lancet Digit Health
2024;6:e251&#x2010;e260. doi: 10.1016/S2589-7500(23)00265-0

</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(23)00265-0</ArticleId><ArticleId IdType="pubmed">38519153</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cohen OC, Ismael A, Pawarova B, Manwani R, Ravichandran S, Law S, <i>et al</i>. Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. Eur Heart J
2022;43:333&#x2010;341. doi: 10.1093/eurheartj/ehab507

</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab507</ArticleId><ArticleId IdType="pubmed">34472567</ArticleId></ArticleIdList></Reference><Reference><Citation>
Martini N, Aimo A, Barison A, Della Latta D, Vergaro G, Aquaro GD, <i>et al</i>. Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance. J Cardiovasc Magn Reson
2020;22:84. doi: 10.1186/s12968-020-00690-4

</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-020-00690-4</ArticleId><ArticleId IdType="pmc">PMC7720569</ArticleId><ArticleId IdType="pubmed">33287829</ArticleId></ArticleIdList></Reference><Reference><Citation>
Goto S, Mahara K, Beussink&#x2010;Nelson L, Ikura H, Katsumata Y, Endo J, <i>et al</i>. Artificial intelligence&#x2010;enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms. Nat Commun
2021;12:2726. doi: 10.1038/s41467-021-22877-8

</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22877-8</ArticleId><ArticleId IdType="pmc">PMC8113484</ArticleId><ArticleId IdType="pubmed">33976142</ArticleId></ArticleIdList></Reference><Reference><Citation>
Gilstrap LG, Dominici F, Wang Y, El&#x2010;Sady MS, Singh A, Di Carli MF, <i>et al</i>. Epidemiology of cardiac amyloidosis&#x2010;associated heart failure hospitalizations among fee&#x2010;for&#x2010;service Medicare beneficiaries in the United States. Circ Heart Fail
2019;12:e005407. doi: 10.1161/CIRCHEARTFAILURE.118.005407

</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.118.005407</ArticleId><ArticleId IdType="pmc">PMC6557425</ArticleId><ArticleId IdType="pubmed">31170802</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tubben A, Tingen HSA, Prakken NHJ, van Empel VPM, Gorter TM, Meems LMG, <i>et al</i>. Prevalence of wild&#x2010;type transthyretin amyloidosis in a prospective heart failure cohort with preserved and mildly reduced ejection fraction: results of the Amylo&#x2010;VIP&#x2010;HF study. Eur J Heart Fail
2024;26:695&#x2010;698. doi: 10.1002/ejhf.3186

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.3186</ArticleId><ArticleId IdType="pubmed">38439596</ArticleId></ArticleIdList></Reference><Reference><Citation>
Moura B, Aimo A, Al&#x2010;Mohammad A, Keramida K, Ben Gal T, Dorbala S, <i>et al</i>. Diagnosis and management of patients with left ventricular hypertrophy: role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail
2023;25:1493&#x2010;1506. doi: 10.1002/ejhf.2997

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2997</ArticleId><ArticleId IdType="pubmed">37581253</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller SA, Oerlemans M. Implementing clinical pathways to enable early diagnosis and treatment of wild&#x2010;type transthyretin amyloid cardiomyopathy. Eur J Heart Fail 2023;25:854&#x2010;856. doi: 10.1002/ejhf.2890</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2890</ArticleId><ArticleId IdType="pubmed">37191114</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tini G, Milani P, Zampieri M, Caponetti AG, Fabris F, Foli A, <i>et al</i>. Diagnostic pathways to wild&#x2010;type transthyretin amyloid cardiomyopathy: a multicentre network study. Eur J Heart Fail
2023;25:845&#x2010;853. doi: 10.1002/ejhf.2823

</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2823</ArticleId><ArticleId IdType="pubmed">36907828</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>